https://betafinch.comenInvesting2026 Beta Finchhttps://d3wo5wojvuv7l.cloudfront.net/t_rss_itunes_square_1400/images.spreaker.com/original/f2581a9f39b0a0f218ca815ce1dd08ab.jpghttps://betafinch.comFri, 17 Jul 2026 07:17:37 +0000Beta FinchBeta Finchcontact@betafinch.comTop 100 US-listed companies by market capitalization. AI-powered earnings call analysis for S&P 100 (SP100). Two AI hosts break down quarterly results, key metrics, and market implications in digestible podcast episodes.falsetrueepisodichttps://www.spreaker.com/episode/netflix-q2-2026-earnings-analysis--73022853https://betafinch.com
Groups: FAANG (https://betafinch.com/groups/FAANG)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Netflix's Q2 2026 numbers, and there's a lot to unpack here.

Before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Alright Alex, let's start with the topline. Revenue growth is guided at 12% for Q3, 11% FX-neutral, which is a slight deceleration from Q2's 12%. Some analysts flagged that.

ALEX: Right, but CFO Spencer Neumann pretty much waved that off. His point was they don't manage quarter to quarter — they manage to the full year. And the full year guide is 13-14% top-line growth, roughly $6 billion in incremental revenue.

JORDAN: And the context he gave was pretty staggering. They're calling themselves "still just getting started" — under 45% penetrated into their addressable 800 million households, and only capturing about 7% of a $670 billion addressable revenue market. That's a big runway claim.

ALEX: It is. Let's talk engagement, because this was clearly the hot topic on the call — multiple analysts pushed on viewing hours softening. Co-CEO Greg Peters gave this whole framework: quality, variety, quantity, and made the point that not all hours are created equal.

JORDAN: The live programming example was the standout for me. Live is about 5% of their content budget but only 1% of view hours — yet six of the top ten sign-up days in the last five years came from live events. Compare that to animation and kids' content, same 5% of spend, but 8% of view hours. Totally different jobs for the content to do.

ALEX: And the actual number — view hours grew 2% in the first half of 2026, a slight acceleration from 1.5% last year. So the "engagement is dying" narrative doesn't really hold up in the data they're showing.

JORDAN: Ted Sarandos also pushed back hard on the Season 2 drop-off question — said their second-season fall-off is actually slightly improved year over year, no change in release strategy needed.

ALEX: Let's get into content spend, because that's where the checkbook talk gets interesting. Content expense is up about 10% this year — higher than their five-year average of 8%, but still below the 14% decade average. So spend is accelerating a bit, but they're framing it as disciplined, growing slower than revenue.

JORDAN: And the slate highlights were fun — "I Will Find You" was their biggest original series launch this year, "Swapped" is tracking to be their second-biggest animated film ever behind K-Pop: Demon Hunters. Plus some great international examples — a Zimbabwean novel adapted into a South African hit called "The Polygamist," and "Rosario Tijeras" in Latin America getting a Season 6 greenlight.

ALEX: That global content engine is really Netflix's moat at this point. Now, let's talk monetization — ads and pricing. Greg Peters said they manage the ads business for total revenue growth, and there's still a gap between ad-tier ARM and the standard-without-ads tier ARM. He's framing that gap as "under-realized revenue" — basically future growth already baked into the roadmap as they close it.

JORDAN: On pricing, first-half price increases in the U.S., Mexico, and Spain are going "consistent with expectations" — no surprises there. And Peters made a value argument too — saying Netflix subscribers pay the least per hour of viewing compared to other SVOD services, with the ad tier at $8.99 in the U.S. being what he called an incredible entry point.

ALEX: Let's touch on some of the newer bets — gaming and AI. Cloud gaming had a strong quarter: FIFA and Unhinged were their two most successful cloud game debuts, and monthly active players for cloud games are up 11x since O

This episode includes AI-generated content.]]>SP100-NFLX-Q2-2026-enFri, 17 Jul 2026 07:17:36 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: FAANG (https://betafinch.com/groups/FAANG) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Netflix's Q2 2026 numbers, and there's a lot to...https://betafinch.com
Groups: FAANG (https://betafinch.com/groups/FAANG)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Netflix's Q2 2026 numbers, and there's a lot to unpack here.

Before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Alright Alex, let's start with the topline. Revenue growth is guided at 12% for Q3, 11% FX-neutral, which is a slight deceleration from Q2's 12%. Some analysts flagged that.

ALEX: Right, but CFO Spencer Neumann pretty much waved that off. His point was they don't manage quarter to quarter — they manage to the full year. And the full year guide is 13-14% top-line growth, roughly $6 billion in incremental revenue.

JORDAN: And the context he gave was pretty staggering. They're calling themselves "still just getting started" — under 45% penetrated into their addressable 800 million households, and only capturing about 7% of a $670 billion addressable revenue market. That's a big runway claim.

ALEX: It is. Let's talk engagement, because this was clearly the hot topic on the call — multiple analysts pushed on viewing hours softening. Co-CEO Greg Peters gave this whole framework: quality, variety, quantity, and made the point that not all hours are created equal.

JORDAN: The live programming example was the standout for me. Live is about 5% of their content budget but only 1% of view hours — yet six of the top ten sign-up days in the last five years came from live events. Compare that to animation and kids' content, same 5% of spend, but 8% of view hours. Totally different jobs for the content to do.

ALEX: And the actual number — view hours grew 2% in the first half of 2026, a slight acceleration from 1.5% last year. So the "engagement is dying" narrative doesn't really hold up in the data they're showing.

JORDAN: Ted Sarandos also pushed back hard on the Season 2 drop-off question — said their second-season fall-off is actually slightly improved year over year, no change in release strategy needed.

ALEX: Let's get into content spend, because that's where the checkbook talk gets interesting. Content expense is up about 10% this year — higher than their five-year average of 8%, but still below the 14% decade average. So spend is accelerating a bit, but they're framing it as disciplined, growing slower than revenue.

JORDAN: And the slate highlights were fun — "I Will Find You" was their biggest original series launch this year, "Swapped" is tracking to be their second-biggest animated film ever behind K-Pop: Demon Hunters. Plus some great international examples — a Zimbabwean novel adapted into a South African hit called "The Polygamist," and "Rosario Tijeras" in Latin America getting a Season 6 greenlight.

ALEX: That global content engine is really Netflix's moat at this point. Now, let's talk monetization — ads and pricing. Greg Peters said they manage the ads business for total revenue growth, and there's still a gap between ad-tier ARM and the standard-without-ads tier ARM. He's framing that gap as "under-realized revenue" — basically future growth already baked into the roadmap as they close it.

JORDAN: On pricing, first-half price increases in the U.S., Mexico, and Spain are going "consistent with expectations" — no surprises there. And Peters made a value argument too — saying Netflix subscribers pay the least per hour of viewing compared to other SVOD services, with the ad tier at $8.99 in the U.S. being what he...]]>412falsefullhttps://www.spreaker.com/episode/unitedhealth-q2-2026-earnings-analysis--73018926https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**BETA FINCH — UnitedHealth Group (UNH) Q2 2026 Earnings Breakdown**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into UnitedHealth Group's second quarter 2026 results — a quarter that, honestly, marks a pretty big turnaround story.

JORDAN: Big turnaround is right. But before we get into it — quick reminder for everyone listening.

ALEX: Right, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, now let's get into it.

ALEX: So let's start with the headline numbers, because they're strong. Adjusted EPS came in at $6.38, up from $4.08 a year ago — that's a huge jump. Revenue was about $112 billion, roughly flat year-over-year, but operating earnings grew 55%. And they raised full-year guidance to a range of $19.50 to $20 a share.

JORDAN: What jumps out to me is the medical care ratio — that's basically the percentage of premium revenue that goes out the door in medical claims. It dropped to 86.7% from 89.4% last year. Lower is better for the insurer. Part of that is $860 million in favorable prior-period development, meaning they overestimated costs in prior periods and get to release some of that reserve now. But even stripping that out, the underlying trend is improving.

ALEX: And this is really the story CEO Stephen Hemsley told at the top of the call — this is a company about a year into a restructuring after a rough stretch, and he was pretty clear: "we will remain restless." He's not declaring victory, but the discipline is showing up in the numbers.

JORDAN: Let's talk segments, because the picture is genuinely split. Medicare Advantage was the star of the quarter. Membership retention beat expectations, they now expect MA enrollment to decline by only about 1.1 million instead of more, and Medicare margins are tracking above 3% for the year. Medical trend also came in below their original 10% estimate — helped by benefit redesign, network curation, and honestly, a milder flu season.

ALEX: Meanwhile, commercial is the soft spot. Cost trends are running modestly above 11%, worse than they'd hoped. Management pointed to two specific culprits: the No Surprises Act's arbitration process — which they say is being exploited, with average payouts to out-of-network providers now 11 times what Medicare would pay — and more aggressive provider billing and coding practices.

JORDAN: That arbitration point was one of the more eye-opening moments in the Q&A. Executive Dan Kueter said roughly 60% of all arbitration cases are now brought by just five entities, and 40% of claims entering the process are actually ineligible to begin with. It's clogging the system and driving costs up. The upshot: commercial margin recovery, which they'd hoped to complete by 2027, is now going to take longer. Not derailed, in their words — just delayed.

ALEX: Medicaid, meanwhile, is basically playing out as planned — margins pressured, expected to land between -1% and -1.7% for the year, as state reimbursement rates lag behind medical cost growth. Nothing new there, just a slow grind toward better alignment with states.

JORDAN: Now let's flip to Optum, the services side of the business, because that's where a lot of the AI story lives. Optum Health — their value-based care arm — is showing real improvement: a roughly 10% reduction in hospitalizations in regions where they've rolled out new care transition programs, and patient satisfaction up about 5% year-over-year.

ALEX: Optum Rx, the pharmacy benefit manager, is leaning hard into transparency — they're on track to have more than 95% of clients on 100% rebate pass-through by year-end.

This episode includes AI-generated content.]]>SP100-UNH-Q2-2026-enThu, 16 Jul 2026 21:15:35 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE) ────────── **BETA FINCH — UnitedHealth Group (UNH) Q2 2026 Earnings Breakdown** ALEX: Welcome to Beta Finch, your AI-powered earnings...https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
**BETA FINCH — UnitedHealth Group (UNH) Q2 2026 Earnings Breakdown**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into UnitedHealth Group's second quarter 2026 results — a quarter that, honestly, marks a pretty big turnaround story.

JORDAN: Big turnaround is right. But before we get into it — quick reminder for everyone listening.

ALEX: Right, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, now let's get into it.

ALEX: So let's start with the headline numbers, because they're strong. Adjusted EPS came in at $6.38, up from $4.08 a year ago — that's a huge jump. Revenue was about $112 billion, roughly flat year-over-year, but operating earnings grew 55%. And they raised full-year guidance to a range of $19.50 to $20 a share.

JORDAN: What jumps out to me is the medical care ratio — that's basically the percentage of premium revenue that goes out the door in medical claims. It dropped to 86.7% from 89.4% last year. Lower is better for the insurer. Part of that is $860 million in favorable prior-period development, meaning they overestimated costs in prior periods and get to release some of that reserve now. But even stripping that out, the underlying trend is improving.

ALEX: And this is really the story CEO Stephen Hemsley told at the top of the call — this is a company about a year into a restructuring after a rough stretch, and he was pretty clear: "we will remain restless." He's not declaring victory, but the discipline is showing up in the numbers.

JORDAN: Let's talk segments, because the picture is genuinely split. Medicare Advantage was the star of the quarter. Membership retention beat expectations, they now expect MA enrollment to decline by only about 1.1 million instead of more, and Medicare margins are tracking above 3% for the year. Medical trend also came in below their original 10% estimate — helped by benefit redesign, network curation, and honestly, a milder flu season.

ALEX: Meanwhile, commercial is the soft spot. Cost trends are running modestly above 11%, worse than they'd hoped. Management pointed to two specific culprits: the No Surprises Act's arbitration process — which they say is being exploited, with average payouts to out-of-network providers now 11 times what Medicare would pay — and more aggressive provider billing and coding practices.

JORDAN: That arbitration point was one of the more eye-opening moments in the Q&A. Executive Dan Kueter said roughly 60% of all arbitration cases are now brought by just five entities, and 40% of claims entering the process are actually ineligible to begin with. It's clogging the system and driving costs up. The upshot: commercial margin recovery, which they'd hoped to complete by 2027, is now going to take longer. Not derailed, in their words — just delayed.

ALEX: Medicaid, meanwhile, is basically playing out as planned — margins pressured, expected to land between -1% and -1.7% for the year, as state reimbursement rates lag behind medical cost growth. Nothing new there, just a slow grind toward better alignment with states.

JORDAN: Now let's flip to Optum, the services side of the business, because that's where a lot of the AI story lives. Optum Health — their value-based care arm — is showing real improvement: a roughly 10% reduction in hospitalizations in regions where they've rolled...]]>443falsefullhttps://www.spreaker.com/episode/prologis-q2-2026-earnings-analysis--73018925https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the calls that move markets and make sense of the numbers behind them. I'm Alex.

JORDAN: And I'm Jordan. Today we're digging into Prologis — ticker PLD — the industrial and logistics real estate giant, reporting their second quarter of 2026.

ALEX: Before we jump in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Okay, with that out of the way, Alex, this was a strong quarter for Prologis. Where do we start?

ALEX: Let's start with the headline numbers. Core FFO came in at $1.63 per share including promote income, $1.60 without — both ahead of expectations. And because of that strength, they raised full-year guidance: Core FFO now expected between $6.22 and $6.30 per share, and net earnings guidance up to $4.40 to $4.55 per share.

JORDAN: And it's not just a beat-and-raise on the bottom line — the operational metrics back it up. Occupancy hit 95.5%, up 20 basis points from Q1. Same-store NOI growth was 6.4% net effective and 8.5% on a cash basis. Those are really healthy numbers for a REIT this size.

ALEX: The leasing volume stood out to me the most — 67 million square feet signed in the quarter. CEO Dan Letter called it their fourth record in seven quarters.

JORDAN: Right, and it's paired with 66 million square feet of net absorption in the US, the highest since 2022. Vacancy dropped to 7.2%, market rents ticked up about 70 basis points. Management's whole thesis this call was that the industrial market has moved past its "inflection phase" and into what they're calling the next phase of growth.

ALEX: There's also a really interesting structural story here beyond just warehouses. Prologis has been building out data centers and energy as parallel growth engines using the same land and customer relationships.

JORDAN: Yeah, the numbers there are eye-popping. Their power pipeline is now 5.8 gigawatts — that's more than doubled in two years. Depending on how much of that gets built as basic "powered shell" versus fully finished "turnkey" data centers, that represents somewhere between $17 billion and $87 billion of potential investment.

ALEX: Huge range.

JORDAN: Huge range, and CEO Dan Letter was upfront on the call that it's genuinely hard to predict where in that range they'll land — it depends on customer preference. But they did share they've now started nearly $4 billion of data center development, all build-to-suit for hyperscale customers, and they sold a 100-megawatt power land parcel this quarter at an 82% margin.

ALEX: Which tells you how profitable just the land and power entitlement piece of this business can be, even before construction.

JORDAN: Exactly — and CFO Tim Arndt mentioned they see over 10 gigawatts of opportunity over the next decade. It's basically a second growth business layered on top of the core logistics platform.

ALEX: On the guidance side, they raised development starts to a range of $5.5 to $6.5 billion, and increased acquisitions guidance too — they bought $1.8 billion of real estate this quarter at roughly a 20% discount to replacement cost.

JORDAN: That IRR discipline came up a few times. Management noted underwritten IRRs on acquisitions have beaten IRRs on dispositions by 140 basis points year to date — so they're actively upgrading the portfolio, not just growing for growth's sake.

ALEX: Now, one thing listeners should know — there's a corporate development angle hovering over this whole call that management wouldn't discuss.

JORDAN: Right, Prologis has made a possible offer for Segro, a UK logistics REIT, under UK takeover rules. Because of regulatory restrictions, they explicitly said they couldn't answer any que

This episode includes AI-generated content.]]>SP100-PLD-Q2-2026-enThu, 16 Jul 2026 21:15:25 +0000trueBeta FinchMore earnings analysis: https://betafinch.com ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the calls that move markets and make sense of the numbers behind them. I'm Alex. JORDAN: And I'm Jordan. Today...https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take the calls that move markets and make sense of the numbers behind them. I'm Alex.

JORDAN: And I'm Jordan. Today we're digging into Prologis — ticker PLD — the industrial and logistics real estate giant, reporting their second quarter of 2026.

ALEX: Before we jump in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Okay, with that out of the way, Alex, this was a strong quarter for Prologis. Where do we start?

ALEX: Let's start with the headline numbers. Core FFO came in at $1.63 per share including promote income, $1.60 without — both ahead of expectations. And because of that strength, they raised full-year guidance: Core FFO now expected between $6.22 and $6.30 per share, and net earnings guidance up to $4.40 to $4.55 per share.

JORDAN: And it's not just a beat-and-raise on the bottom line — the operational metrics back it up. Occupancy hit 95.5%, up 20 basis points from Q1. Same-store NOI growth was 6.4% net effective and 8.5% on a cash basis. Those are really healthy numbers for a REIT this size.

ALEX: The leasing volume stood out to me the most — 67 million square feet signed in the quarter. CEO Dan Letter called it their fourth record in seven quarters.

JORDAN: Right, and it's paired with 66 million square feet of net absorption in the US, the highest since 2022. Vacancy dropped to 7.2%, market rents ticked up about 70 basis points. Management's whole thesis this call was that the industrial market has moved past its "inflection phase" and into what they're calling the next phase of growth.

ALEX: There's also a really interesting structural story here beyond just warehouses. Prologis has been building out data centers and energy as parallel growth engines using the same land and customer relationships.

JORDAN: Yeah, the numbers there are eye-popping. Their power pipeline is now 5.8 gigawatts — that's more than doubled in two years. Depending on how much of that gets built as basic "powered shell" versus fully finished "turnkey" data centers, that represents somewhere between $17 billion and $87 billion of potential investment.

ALEX: Huge range.

JORDAN: Huge range, and CEO Dan Letter was upfront on the call that it's genuinely hard to predict where in that range they'll land — it depends on customer preference. But they did share they've now started nearly $4 billion of data center development, all build-to-suit for hyperscale customers, and they sold a 100-megawatt power land parcel this quarter at an 82% margin.

ALEX: Which tells you how profitable just the land and power entitlement piece of this business can be, even before construction.

JORDAN: Exactly — and CFO Tim Arndt mentioned they see over 10 gigawatts of opportunity over the next decade. It's basically a second growth business layered on top of the core logistics platform.

ALEX: On the guidance side, they raised development starts to a range of $5.5 to $6.5 billion, and increased acquisitions guidance too — they bought $1.8 billion of real estate this quarter at roughly a 20% discount to replacement cost.

JORDAN: That IRR discipline came up a few times. Management noted underwritten IRRs on acquisitions have beaten IRRs on dispositions by 140 basis points year to date — so they're actively upgrading the portfolio, not just growing for growth's sake.

ALEX: Now, one thing listeners should know — there's a corporate development angle hovering over this whole call...]]>433falsefullhttps://www.spreaker.com/episode/abbott-laboratories-q2-2026-earnings-analysis--73018923https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE), INCOME (https://betafinch.com/groups/INCOME)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown. Here's the Abbott Labs (ABT) Q2 2026 script.

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Abbott Laboratories' second quarter 2026 results. Before we jump in, quick disclaimer — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks, Alex. And there's a lot to like in this print. Let's start with the headline numbers.

**ALEX:** Right, so Abbott posted sales growth of 4.8% for the quarter — that's an acceleration from the last two quarters — and adjusted EPS of $1.31, which beat both the midpoint of their guidance and consensus estimates.

**JORDAN:** And here's the part investors really zeroed in on — Abbott didn't just reaffirm full-year sales guidance of 6.5% to 7.5%, they actually raised their EPS guidance range to $5.45 to $5.60. CEO Robert Ford was pretty clear that gross margin expansion is doing a lot of the heavy lifting there — margins came in at 58%, up 100 basis points year-over-year.

**ALEX:** Let's talk segments, because there's a real story of divergence here. Medical devices grew 8.5%, led by electrophysiology — that's the heart rhythm and ablation business — which grew in the low teens. EPD, their emerging markets pharma division, grew 9%, powered by India, Latin America, and Southeast Asia.

**JORDAN:** Diagnostics was mixed. Core lab was strong, U.S. up 7.5%. But rapid and molecular diagnostics — that's respiratory testing — declined 8% because it was just a weak flu and respiratory virus season. That's expected and temporary though, not a demand problem.

**ALEX:** And then nutrition — this is the comeback story of the quarter. Sales came in ahead of expectations for the second straight quarter, up sequentially by $125 million. Ensure retail consumption in the U.S. is up double digits.

**JORDAN:** Yeah, that's the price increases from late last year finally working through the system — volumes are responding well now that consumers have adjusted. Management is now framing nutrition as a sustainable 2-4% grower going forward.

**ALEX:** Let's get into the strategic stuff, because there's a lot of pipeline news. Abbott completed enrollment in its coronary IVL trial, filed with the FDA for the Amulet 360 left atrial appendage device, and got a CE mark in Europe for Libre Duo — which is notable, it's the world's first dual glucose-ketone monitoring sensor, designed to help prevent diabetic ketoacidosis.

**JORDAN:** The CGM story is worth sitting with for a second. Diabetes care crossed $2 billion in quarterly sales, growing 9.5%. Now, one analyst on the call kind of poked at that number as "only" 9.5%, and Ford pushed back — reasonably, I'd say. He pointed out there's 75 to 80 million people globally who could realistically use a CGM, and only 15 million currently do. Growth right now is basically waiting on reimbursement expansion, especially the big one: U.S. Type 2 non-insulin Medicare coverage, which could unlock roughly 10 million beneficiaries. Ford said that could happen this fall but wouldn't pin down an exact date.

**ALEX:** They're also planning a fifth manufacturing facility for CGM sensors — a billion-dollar investment — because they expect to hit capacity limits at their current facility within a couple years. That's a pretty strong signal of how bullish they are on long-term demand.

**JORDAN:** One theme that came up repeatedly in the Q&A was this investor worry about decelerating hospital procedure volumes — tied to ACA enrollment changes and Medicaid dynamics.

This episode includes AI-generated content.]]>SP100-ABT-Q2-2026-enThu, 16 Jul 2026 21:15:15 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE), INCOME (https://betafinch.com/groups/INCOME) ────────── Welcome to Beta Finch, your AI-powered earnings breakdown. Here's the Abbott Labs (ABT)...https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE), INCOME (https://betafinch.com/groups/INCOME)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown. Here's the Abbott Labs (ABT) Q2 2026 script.

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, joined as always by Jordan, and today we're digging into Abbott Laboratories' second quarter 2026 results. Before we jump in, quick disclaimer — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks, Alex. And there's a lot to like in this print. Let's start with the headline numbers.

**ALEX:** Right, so Abbott posted sales growth of 4.8% for the quarter — that's an acceleration from the last two quarters — and adjusted EPS of $1.31, which beat both the midpoint of their guidance and consensus estimates.

**JORDAN:** And here's the part investors really zeroed in on — Abbott didn't just reaffirm full-year sales guidance of 6.5% to 7.5%, they actually raised their EPS guidance range to $5.45 to $5.60. CEO Robert Ford was pretty clear that gross margin expansion is doing a lot of the heavy lifting there — margins came in at 58%, up 100 basis points year-over-year.

**ALEX:** Let's talk segments, because there's a real story of divergence here. Medical devices grew 8.5%, led by electrophysiology — that's the heart rhythm and ablation business — which grew in the low teens. EPD, their emerging markets pharma division, grew 9%, powered by India, Latin America, and Southeast Asia.

**JORDAN:** Diagnostics was mixed. Core lab was strong, U.S. up 7.5%. But rapid and molecular diagnostics — that's respiratory testing — declined 8% because it was just a weak flu and respiratory virus season. That's expected and temporary though, not a demand problem.

**ALEX:** And then nutrition — this is the comeback story of the quarter. Sales came in ahead of expectations for the second straight quarter, up sequentially by $125 million. Ensure retail consumption in the U.S. is up double digits.

**JORDAN:** Yeah, that's the price increases from late last year finally working through the system — volumes are responding well now that consumers have adjusted. Management is now framing nutrition as a sustainable 2-4% grower going forward.

**ALEX:** Let's get into the strategic stuff, because there's a lot of pipeline news. Abbott completed enrollment in its coronary IVL trial, filed with the FDA for the Amulet 360 left atrial appendage device, and got a CE mark in Europe for Libre Duo — which is notable, it's the world's first dual glucose-ketone monitoring sensor, designed to help prevent diabetic ketoacidosis.

**JORDAN:** The CGM story is worth sitting with for a second. Diabetes care crossed $2 billion in quarterly sales, growing 9.5%. Now, one analyst on the call kind of poked at that number as "only" 9.5%, and Ford pushed back — reasonably, I'd say. He pointed out there's 75 to 80 million people globally who could realistically use a CGM, and only 15 million currently do. Growth right now is basically waiting on reimbursement expansion, especially the big one: U.S. Type 2 non-insulin Medicare coverage, which could unlock roughly 10 million beneficiaries. Ford said that could happen this fall but wouldn't pin down an exact date.

**ALEX:** They're also planning a fifth manufacturing facility for CGM sensors — a billion-dollar investment — because they expect to...]]>421falsefullhttps://www.spreaker.com/episode/general-electric-q2-2026-earnings-analysis--73015075https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown of the companies moving the market. I'm about to walk through GE Aerospace's Q2 2026 results.

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, here with Jordan, and today we're digging into GE Aerospace's second quarter 2026 numbers. Before we get into it — quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And GE Aerospace gave us a lot to talk about this quarter, Alex. This wasn't just a beat — they raised guidance across the board.

ALEX: Right, let's start with the headline numbers. Orders up 17%, revenue up 24% — that's the fifth straight quarter of at least 20% revenue growth — operating profit up 18%, EPS up 22% to $2.02, and free cash flow jumped 43% to $3 billion.

JORDAN: That free cash flow number really stood out to me. They actually reduced working capital even while earnings grew 24%. CFO Rahul Ghai called that out specifically — better receivables, better inventory management. That's not easy to pull off when you're scaling this fast.

ALEX: And both segments contributed. Commercial Engines and Services, or CES, was up 27% in revenue, and Defense and Propulsion, DPT, grew 16%. CES margins did dip about 130 basis points to 21.7%, but that's from investing in installed engine growth — basically the cost of feeding future services revenue.

JORDAN: Which is the classic GE Aerospace story right now — sell more engines at lower margin today, because those engines come back for decades of high-margin maintenance work. Their backlog is over $210 billion total, with $170 billion of that in commercial services alone.

ALEX: So given all that strength, they raised full-year guidance pretty significantly. Revenue now expected to grow high teens, up from low double digits. EPS guidance moved to $7.65 to $7.85, and free cash flow guidance jumped to $8.9 to $9.2 billion.

JORDAN: What's interesting is CEO Larry Culp explained why they didn't raise guidance last quarter despite a strong Q1 — there was real geopolitical and demand uncertainty back in April. He said flat out, "we would play April all over again in the same way." They wanted to see how customer behavior actually played out before getting ahead of themselves.

ALEX: And it turns out demand held up remarkably well. Culp mentioned parked CFM56 aircraft have actually declined since March, and departures — which were roughly flat in the first half — are expected to gradually pick back up in the second half.

JORDAN: The demand side really isn't the constraint here anymore. Multiple times on the call, both Culp and Ghai said this is now a supply-side story, not a demand-side one. Spare parts delinquencies — meaning shipments delayed due to material availability — were actually up 20% sequentially, even as they're growing spare parts revenue over 25%.

ALEX: That's a good problem to have, but still a real constraint. They talked about using their "Flight Deck" operational system to chip away at it — things like a Kaizen event with supplier GKN that led to a 90% improvement in inspection time, and AI-driven demand signal processing that cut processing time by nearly 90% across 190 parts.

JORDAN: And on the product side, a big milestone — they certified the LEAP-1B durability kit, which should roughly double time on wing. That's huge for airlines worried about engine cost of ownership, which came up multiple times in the Q&A. Analysts pushed hard on whether airlines can keep absorbing these costs.

ALEX: Culp's answer was essentially: we hear you, we're not taking a victory lap, but we're doing everything we can short-term — like getting LEAP

This episode includes AI-generated content.]]>SP100-GE-Q2-2026-enThu, 16 Jul 2026 14:15:06 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS) ────────── Welcome to Beta Finch, your AI-powered earnings breakdown of the companies moving the market. I'm about to walk through GE...https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown of the companies moving the market. I'm about to walk through GE Aerospace's Q2 2026 results.

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, here with Jordan, and today we're digging into GE Aerospace's second quarter 2026 numbers. Before we get into it — quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And GE Aerospace gave us a lot to talk about this quarter, Alex. This wasn't just a beat — they raised guidance across the board.

ALEX: Right, let's start with the headline numbers. Orders up 17%, revenue up 24% — that's the fifth straight quarter of at least 20% revenue growth — operating profit up 18%, EPS up 22% to $2.02, and free cash flow jumped 43% to $3 billion.

JORDAN: That free cash flow number really stood out to me. They actually reduced working capital even while earnings grew 24%. CFO Rahul Ghai called that out specifically — better receivables, better inventory management. That's not easy to pull off when you're scaling this fast.

ALEX: And both segments contributed. Commercial Engines and Services, or CES, was up 27% in revenue, and Defense and Propulsion, DPT, grew 16%. CES margins did dip about 130 basis points to 21.7%, but that's from investing in installed engine growth — basically the cost of feeding future services revenue.

JORDAN: Which is the classic GE Aerospace story right now — sell more engines at lower margin today, because those engines come back for decades of high-margin maintenance work. Their backlog is over $210 billion total, with $170 billion of that in commercial services alone.

ALEX: So given all that strength, they raised full-year guidance pretty significantly. Revenue now expected to grow high teens, up from low double digits. EPS guidance moved to $7.65 to $7.85, and free cash flow guidance jumped to $8.9 to $9.2 billion.

JORDAN: What's interesting is CEO Larry Culp explained why they didn't raise guidance last quarter despite a strong Q1 — there was real geopolitical and demand uncertainty back in April. He said flat out, "we would play April all over again in the same way." They wanted to see how customer behavior actually played out before getting ahead of themselves.

ALEX: And it turns out demand held up remarkably well. Culp mentioned parked CFM56 aircraft have actually declined since March, and departures — which were roughly flat in the first half — are expected to gradually pick back up in the second half.

JORDAN: The demand side really isn't the constraint here anymore. Multiple times on the call, both Culp and Ghai said this is now a supply-side story, not a demand-side one. Spare parts delinquencies — meaning shipments delayed due to material availability — were actually up 20% sequentially, even as they're growing spare parts revenue over 25%.

ALEX: That's a good problem to have, but still a real constraint. They talked about using their "Flight Deck" operational system to chip away at it — things like a Kaizen event with supplier GKN that led to a 90% improvement in inspection time, and AI-driven demand signal processing that cut processing time by nearly 90% across 190 parts.

JORDAN: And on the product side, a big milestone — they certified the LEAP-1B durability kit, which should roughly double time on wing. That's huge for airlines worried about engine cost of ownership,...]]>420falsefullhttps://www.spreaker.com/episode/morgan-stanley-q2-2026-earnings-analysis--73000481https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Morgan Stanley's second quarter 2026 results — and Jordan, this one's got some genuinely eye-popping numbers.

JORDAN: It really does. But before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, let's get into it. Morgan Stanley posted record revenues of $21.3 billion for the quarter, with EPS of $3.46 — both records. First half of the year, they're at $42 billion in revenue and a 27% return on tangible common equity. That's an exceptional run.

JORDAN: And it wasn't just one business carrying the load. Institutional Securities hit a record $11 billion in revenue, driven by an absolutely blowout equities quarter — $6.3 billion, up across every product and region, with Asia standing out. Investment banking revenue jumped 58% year-over-year to $2.4 billion.

ALEX: That IPO market really came alive this quarter too, which fed directly into Wealth Management. They added a record $148 billion in net new assets — and CFO Sharon Yeshaya pointed out that stock plan and IPO flows made up just over half of that. Total client assets across Wealth and Investment Management now sit at $10 trillion, which CEO Ted Pick called out as a milestone the firm's been chasing for a while.

JORDAN: The wealth management pre-tax margin came in at 30.5%, also a record. And there was a nice shareholder-friendly move — a 15% dividend increase to $1.15 per share, plus $1.5 billion in buybacks. Their CET1 capital ratio is at 14.8%, giving them roughly 300 basis points of excess capital cushion.

ALEX: That capital question actually drove one of the more interesting exchanges in the Q&A. An analyst asked Pick point blank — why keep sitting on all this excess capital instead of deploying it more aggressively? His answer was basically: there's real client demand for that capital across every business line, and they'd rather feed the organic growth machine first. He didn't rule out bolt-on acquisitions, but said the bias is clearly toward organic investment right now.

JORDAN: The moment that stood out most to me, though, was when Mike Mayo asked about the AI capital expenditure supercycle. Pick actually put real numbers on it — data center CapEx forecasts for 2026 have jumped from an initial $575 billion estimate to about $850 billion actually coming in. For 2027, projections have gone from $700 billion to $1.3 trillion. And he floated a longer-term thesis, using their research team's framework, that the AI compute buildout could eventually reach something like $10 trillion — but stressed we're only maybe 10 to 15% of the way through that cycle.

ALEX: He was pretty careful to caveat that, though — called it a "known unknown" and said the numbers could shift dramatically based on chip innovation, geopolitics, supply chains. He wasn't trying to make it sound like a sure thing.

JORDAN: Right, and that ties into the second big theme he flagged — the return of geopolitics as a force reshaping supply chains and capital allocation. When Gerard Cassidy asked what could make this AI-driven boom crack, Pick's answer was refreshingly candid — he referenced the dot-com bubble and the SPAC boom, and said the firm's watching closely for froth. Their mantra, as he put it, is "higher highs, but also higher lows" — meaning they want durability, not just a hot quarter.

ALEX: On the wealth management side, there was also a good exchange about competition. Steven Chubak asked about smaller RIAs undercutting on price to win workplace clients. Sharon's response was essentially: scale is the moat. Corporate relationships, the breadth o

This episode includes AI-generated content.]]>SP100-MS-Q2-2026-enWed, 15 Jul 2026 20:59:24 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Morgan Stanley's second quarter 2026 results — and...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Morgan Stanley's second quarter 2026 results — and Jordan, this one's got some genuinely eye-popping numbers.

JORDAN: It really does. But before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, let's get into it. Morgan Stanley posted record revenues of $21.3 billion for the quarter, with EPS of $3.46 — both records. First half of the year, they're at $42 billion in revenue and a 27% return on tangible common equity. That's an exceptional run.

JORDAN: And it wasn't just one business carrying the load. Institutional Securities hit a record $11 billion in revenue, driven by an absolutely blowout equities quarter — $6.3 billion, up across every product and region, with Asia standing out. Investment banking revenue jumped 58% year-over-year to $2.4 billion.

ALEX: That IPO market really came alive this quarter too, which fed directly into Wealth Management. They added a record $148 billion in net new assets — and CFO Sharon Yeshaya pointed out that stock plan and IPO flows made up just over half of that. Total client assets across Wealth and Investment Management now sit at $10 trillion, which CEO Ted Pick called out as a milestone the firm's been chasing for a while.

JORDAN: The wealth management pre-tax margin came in at 30.5%, also a record. And there was a nice shareholder-friendly move — a 15% dividend increase to $1.15 per share, plus $1.5 billion in buybacks. Their CET1 capital ratio is at 14.8%, giving them roughly 300 basis points of excess capital cushion.

ALEX: That capital question actually drove one of the more interesting exchanges in the Q&A. An analyst asked Pick point blank — why keep sitting on all this excess capital instead of deploying it more aggressively? His answer was basically: there's real client demand for that capital across every business line, and they'd rather feed the organic growth machine first. He didn't rule out bolt-on acquisitions, but said the bias is clearly toward organic investment right now.

JORDAN: The moment that stood out most to me, though, was when Mike Mayo asked about the AI capital expenditure supercycle. Pick actually put real numbers on it — data center CapEx forecasts for 2026 have jumped from an initial $575 billion estimate to about $850 billion actually coming in. For 2027, projections have gone from $700 billion to $1.3 trillion. And he floated a longer-term thesis, using their research team's framework, that the AI compute buildout could eventually reach something like $10 trillion — but stressed we're only maybe 10 to 15% of the way through that cycle.

ALEX: He was pretty careful to caveat that, though — called it a "known unknown" and said the numbers could shift dramatically based on chip innovation, geopolitics, supply chains. He wasn't trying to make it sound like a sure thing.

JORDAN: Right, and that ties into the second big theme he flagged — the return of geopolitics as a force reshaping supply chains and capital allocation. When Gerard Cassidy asked what could make this AI-driven boom crack, Pick's answer was refreshingly candid — he referenced the dot-com bubble and the SPAC boom, and said the firm's watching closely for froth. Their mantra, as he put it, is "higher highs, but also higher lows" — meaning they want durability, not just a hot quarter.

ALEX: On the wealth management...]]>367falsefullhttps://www.spreaker.com/episode/johnson-johnson-q2-2026-earnings-analysis--73000479https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA), INCOME (https://betafinch.com/groups/INCOME)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Johnson & Johnson's second quarter 2026 results, and Jordan, there's a lot to unpack here.

JORDAN: There really is. But first, the fine print — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, so let's get into it. J&J posted $25.3 billion in quarterly sales, up 5.6% operationally. That doesn't sound huge until you realize they absorbed a 460 basis point headwind from STELARA losing patent protection to biosimilars.

JORDAN: Yeah, strip out STELARA and the rest of the business grew double digits. That's the real story. Net earnings came in at $5.5 billion, diluted EPS of $2.27, and on an adjusted basis, EPS was $2.90, up nearly 5% year-over-year. And here's the kicker — they raised full-year guidance. Operational sales growth now expected at 6.5% to 7.1%, and adjusted EPS guidance moved up to $11.50-$11.65.

ALEX: They're also closing in on a milestone — more than $100 billion in annual revenue for the first time in the company's 140-year history.

JORDAN: Which is wild to say out loud. This is a company with 28 different products or platforms each doing over a billion dollars a year. That's not a one-hit-wonder portfolio, that's just breadth everywhere.

ALEX: Let's talk oncology, because that's really where J&J flexed this quarter. DARZALEX, their multiple myeloma drug, did over $4 billion, up almost 18%. But the newer combo therapies are what caught my eye — CARVYKTI up 47.7%, TECVAYLI up 56%, TALVEY up 62.6%.

JORDAN: Those growth rates on top of an already-dominant multiple myeloma franchise are pretty remarkable. And they're not resting — new data showed the TALVEY-DARZALEX combo keeping over 80% of patients progression-free at two years, with overall survival up to 89%. That's the kind of data that extends a franchise's life for years.

ALEX: Then there's the newer launches — ICOTYDE in psoriasis, INLEXZO in bladder cancer, RYBREVANT in lung and now head-and-neck cancer. ICOTYDE in particular is getting a lot of attention. Over 11,000 patients started therapy, 6,000 unique prescribers, and more than half of commercial payers already covering it within 90 days.

JORDAN: What's interesting is how they're positioning it alongside TREMFYA, which by the way had a monster quarter — 71% growth, its first $2 billion quarter. Instead of cannibalizing each other, management's framing ICOTYDE as the go-to first systemic treatment and TREMFYA as the first-choice biologic, especially for patients trending toward psoriatic arthritis. It's a two-pronged attack on the same disease area.

ALEX: Now, MedTech was the softer spot this quarter — only 3.6% growth. Cardiovascular was the drag, mainly Abiomed's heart pump business.

JORDAN: Right, and this is worth unpacking because it wasn't a demand problem. A neutral clinical trial out of the U.K. made physicians more cautious about patient selection for Impella devices, so usage slowed. Management was pretty direct about it — they called it a "behavioral" issue, not structural. They're leaning on their own much larger evidence base, over 40,000 patients studied versus the UK trial's 300, while they wait for their own PROTECT IV trial data, which won't read out until 2027.

ALEX: Meanwhile, three of MedTech's four businesses — surgery, vision, and orthopedics — actually accelerated and beat expectations. So it's really one segment, heart recovery, dragging on an otherwise solid MedTech story.

JORDAN: And there's real excitement building around the robotics pipeline — the OTTAVA surgical robot and MONARCH for urology are both awaiti

This episode includes AI-generated content.]]>SP100-JNJ-Q2-2026-enWed, 15 Jul 2026 20:59:17 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: PHARMA (https://betafinch.com/groups/PHARMA), INCOME (https://betafinch.com/groups/INCOME) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into...https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA), INCOME (https://betafinch.com/groups/INCOME)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Johnson & Johnson's second quarter 2026 results, and Jordan, there's a lot to unpack here.

JORDAN: There really is. But first, the fine print — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, so let's get into it. J&J posted $25.3 billion in quarterly sales, up 5.6% operationally. That doesn't sound huge until you realize they absorbed a 460 basis point headwind from STELARA losing patent protection to biosimilars.

JORDAN: Yeah, strip out STELARA and the rest of the business grew double digits. That's the real story. Net earnings came in at $5.5 billion, diluted EPS of $2.27, and on an adjusted basis, EPS was $2.90, up nearly 5% year-over-year. And here's the kicker — they raised full-year guidance. Operational sales growth now expected at 6.5% to 7.1%, and adjusted EPS guidance moved up to $11.50-$11.65.

ALEX: They're also closing in on a milestone — more than $100 billion in annual revenue for the first time in the company's 140-year history.

JORDAN: Which is wild to say out loud. This is a company with 28 different products or platforms each doing over a billion dollars a year. That's not a one-hit-wonder portfolio, that's just breadth everywhere.

ALEX: Let's talk oncology, because that's really where J&J flexed this quarter. DARZALEX, their multiple myeloma drug, did over $4 billion, up almost 18%. But the newer combo therapies are what caught my eye — CARVYKTI up 47.7%, TECVAYLI up 56%, TALVEY up 62.6%.

JORDAN: Those growth rates on top of an already-dominant multiple myeloma franchise are pretty remarkable. And they're not resting — new data showed the TALVEY-DARZALEX combo keeping over 80% of patients progression-free at two years, with overall survival up to 89%. That's the kind of data that extends a franchise's life for years.

ALEX: Then there's the newer launches — ICOTYDE in psoriasis, INLEXZO in bladder cancer, RYBREVANT in lung and now head-and-neck cancer. ICOTYDE in particular is getting a lot of attention. Over 11,000 patients started therapy, 6,000 unique prescribers, and more than half of commercial payers already covering it within 90 days.

JORDAN: What's interesting is how they're positioning it alongside TREMFYA, which by the way had a monster quarter — 71% growth, its first $2 billion quarter. Instead of cannibalizing each other, management's framing ICOTYDE as the go-to first systemic treatment and TREMFYA as the first-choice biologic, especially for patients trending toward psoriatic arthritis. It's a two-pronged attack on the same disease area.

ALEX: Now, MedTech was the softer spot this quarter — only 3.6% growth. Cardiovascular was the drag, mainly Abiomed's heart pump business.

JORDAN: Right, and this is worth unpacking because it wasn't a demand problem. A neutral clinical trial out of the U.K. made physicians more cautious about patient selection for Impella devices, so usage slowed. Management was pretty direct about it — they called it a "behavioral" issue, not structural. They're leaning on their own much larger evidence base, over 40,000 patients studied versus the UK trial's 300, while they wait for their own PROTECT IV trial data, which won't read out until 2027.

ALEX: Meanwhile, three of MedTech's four...]]>421falsefullhttps://www.spreaker.com/episode/blackrock-q2-2026-earnings-analysis--72991699https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into BlackRock's second quarter 2026 numbers — and Jordan, this was a genuinely loud quarter.

JORDAN: Loud is the right word. Record revenue, record operating income, record EPS, all in the same three months.

ALEX: Before we get into it, a quick note. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, let's get into it. Revenue came in at $7.1 billion, up 31% year-over-year. Operating income jumped 39% to $2.9 billion, and EPS hit $13.91.

ALEX: And the margin story is what jumped out to me. 45.9% operating margin, up 260 basis points from a year ago — that's their best level in almost five years.

JORDAN: Right, and CFO Martin Small was pretty clear that 45.9% isn't a ceiling. He pointed out BlackRock ran near 47% margins back in 2021, before they even had the scale in private markets or systematic equities they have now. So there's an argument the runway keeps going.

ALEX: Let's talk flows, because $192 billion of net inflows in a single quarter is enormous. That's 8% organic base fee growth for the quarter, and over the trailing twelve months they've pulled in $868 billion with 10% organic base fee growth.

JORDAN: iShares ETFs led the way — $178 billion of inflows, with core equity ETFs at $85 billion and index bond ETFs setting a new record at $61 billion. Active ETFs added another $20 billion, and Larry Fink noted BlackRock has gone from the seventh-largest active ETF manager to third-largest in just three years.

ALEX: The other big storyline is the HPS and GIP integration — the private markets acquisitions that closed about a year ago. Fink said the combination is already "delivering above our plans."

JORDAN: The numbers back that up. HPS alone contributed about $230 million in base fees and $115 million in performance fees this quarter. And on the insurance side, Fink talked about converting general account assets — they've got roughly $800 billion of insurance assets on the platform — into higher-yielding private markets allocations. Even a 5-10% conversion rate, he said, would be a meaningful lift to average fees.

ALEX: There was also that data center deal — Aligned Data Centers — described as the largest data center infrastructure transaction ever announced, bringing together their AIP, GIP, and MGX platforms.

JORDAN: That ties into a theme across the whole call: hyperscalers needing balance-sheet partners to build out AI infrastructure, and BlackRock positioning itself as one of the few firms that can show up with both equity and debt capital at scale.

ALEX: Let's hit tokenization for a second, because Martin Small got pretty specific here. They've filed two SEC registration statements for tokenized money market funds — one a tokenized share class on Ethereum, the other a more digitally native version with features like daily dividend reinvestment.

JORDAN: And the framing was interesting — he called tokenized assets "the spear tip into an entirely new distribution channel," pointing to the roughly 5 billion digital wallets globally as a pool of potential new iShares investors. They're also already managing $60 billion in stablecoin reserves for Circle, about a quarter of that market.

ALEX: On the capital return side, they bumped up guidance — now planning at least $550 million in quarterly share buybacks, higher than what they guided back in January. Combined with the dividend, they're expecting to return over $5.7 billion to shareholders this year, a 16% increase over 2025.

JORDAN: One thing worth flagging for listeners: EPS growth of 15% was actually a bit lower than the 39% operating income growth

This episode includes AI-generated content.]]>SP100-BLK-Q2-2026-enWed, 15 Jul 2026 14:13:41 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into BlackRock's second quarter 2026 numbers — and Jordan,...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into BlackRock's second quarter 2026 numbers — and Jordan, this was a genuinely loud quarter.

JORDAN: Loud is the right word. Record revenue, record operating income, record EPS, all in the same three months.

ALEX: Before we get into it, a quick note. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, let's get into it. Revenue came in at $7.1 billion, up 31% year-over-year. Operating income jumped 39% to $2.9 billion, and EPS hit $13.91.

ALEX: And the margin story is what jumped out to me. 45.9% operating margin, up 260 basis points from a year ago — that's their best level in almost five years.

JORDAN: Right, and CFO Martin Small was pretty clear that 45.9% isn't a ceiling. He pointed out BlackRock ran near 47% margins back in 2021, before they even had the scale in private markets or systematic equities they have now. So there's an argument the runway keeps going.

ALEX: Let's talk flows, because $192 billion of net inflows in a single quarter is enormous. That's 8% organic base fee growth for the quarter, and over the trailing twelve months they've pulled in $868 billion with 10% organic base fee growth.

JORDAN: iShares ETFs led the way — $178 billion of inflows, with core equity ETFs at $85 billion and index bond ETFs setting a new record at $61 billion. Active ETFs added another $20 billion, and Larry Fink noted BlackRock has gone from the seventh-largest active ETF manager to third-largest in just three years.

ALEX: The other big storyline is the HPS and GIP integration — the private markets acquisitions that closed about a year ago. Fink said the combination is already "delivering above our plans."

JORDAN: The numbers back that up. HPS alone contributed about $230 million in base fees and $115 million in performance fees this quarter. And on the insurance side, Fink talked about converting general account assets — they've got roughly $800 billion of insurance assets on the platform — into higher-yielding private markets allocations. Even a 5-10% conversion rate, he said, would be a meaningful lift to average fees.

ALEX: There was also that data center deal — Aligned Data Centers — described as the largest data center infrastructure transaction ever announced, bringing together their AIP, GIP, and MGX platforms.

JORDAN: That ties into a theme across the whole call: hyperscalers needing balance-sheet partners to build out AI infrastructure, and BlackRock positioning itself as one of the few firms that can show up with both equity and debt capital at scale.

ALEX: Let's hit tokenization for a second, because Martin Small got pretty specific here. They've filed two SEC registration statements for tokenized money market funds — one a tokenized share class on Ethereum, the other a more digitally native version with features like daily dividend reinvestment.

JORDAN: And the framing was interesting — he called tokenized assets "the spear tip into an entirely new distribution channel," pointing to the roughly 5 billion digital wallets globally as a pool of potential new iShares investors. They're also already managing $60 billion in stablecoin reserves for Circle, about a quarter of that market.

ALEX: On the capital return side, they bumped up guidance — now planning at least $550 million in quarterly share buybacks, higher than what they...]]>413falsefullhttps://www.spreaker.com/episode/wells-fargo-q2-2026-earnings-analysis--72977418https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, here with Jordan, and today we're diving into Wells Fargo's second quarter 2026 results. Before we jump in — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And Alex, this was a genuinely strong quarter for Wells Fargo. Diluted EPS hit $2, up 25% year-over-year. Revenue grew 9%. Every single operating segment posted growth in both net interest income and non-interest income.

ALEX: That broad-based part is what jumps out to me. CEO Charlie Scharf made a point of saying it's not just a rising-rate-environment story — it's investments and operating discipline paying off. Headcount has now declined for 24 straight quarters, down to 197,000, while they're actually adding bankers, advisors, and traders in growth areas.

JORDAN: Right, they're funding growth with efficiency savings rather than just cutting costs across the board. And the returns numbers back it up — ROTCE jumped to 17.7% this quarter, up from 15.2% a year ago. CFO Mike Santomassimo did flag that venture capital gains — $847 million in equity gains — juiced that number a bit, but even stripping that out, the underlying trend is improving.

ALEX: Wells Fargo has a medium-term target of 17-18% ROTCE, and Scharf was asked repeatedly about timing on that. His answer, essentially: "we're more confident every quarter, but we're not giving you a hard date because rates and markets are unpredictable."

JORDAN: Classic executive hedge, but a reasonable one. Let's talk net interest income, because that's where most of the analyst questions went. Full-year guidance stayed at $50 billion, give or take, but the composition shifted a little — loan growth is coming in better than expected, while non-interest-bearing deposits aren't growing as much as they'd hoped.

ALEX: And net interest margin actually compressed again — down 4 basis points from Q1. Management's explanation is interesting: it's largely self-inflicted, in a good way. They're growing their markets business balance sheet aggressively, financing clients at lower spreads, which drags down NIM but drives higher trading revenue and deeper relationships.

JORDAN: Scharf was pretty emphatic about that point — he said NIM compression "is not happening to us," it's a deliberate choice they can reverse if the payoff isn't there. Markets revenue grew 24% year-over-year, so early signs suggest it's working. They expect a bit more NIM pressure in Q3, then stabilization in Q4.

ALEX: Loan and deposit growth were both double-digit — average loans up 12%, deposits up 10% — which is a big deal since Wells Fargo only got out from under the Fed's asset cap last year. They're finally playing offense after years of being constrained.

JORDAN: Credit quality remained a bright spot too. Net charge-offs declined 10 basis points year-over-year to 34 basis points. Consumer delinquencies are actually coming in better than their models predict. Commercial credit is clean as well, though Scharf did flag caution around wholesale lending — data center financing, leveraged deals — where non-bank lenders are taking on more risk than Wells is willing to.

ALEX: That data center commentary was one of my favorite exchanges. An analyst asked about second-derivative AI exposure, and Scharf gave a really thoughtful answer about how they underwrite different pieces of the data center supply chain differently — chip makers get paid back fast with huge margins, but other players in the chain carry much longer, riskier payback horizons.

JORDAN: It showed real discipline — they're not just chasing the AI infrastructure boom blindly. On the business-line side, the Cor

This episode includes AI-generated content.]]>SP100-WFC-Q2-2026-enTue, 14 Jul 2026 21:31:18 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, here with Jordan, and today we're diving into Wells Fargo's second...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, here with Jordan, and today we're diving into Wells Fargo's second quarter 2026 results. Before we jump in — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: And Alex, this was a genuinely strong quarter for Wells Fargo. Diluted EPS hit $2, up 25% year-over-year. Revenue grew 9%. Every single operating segment posted growth in both net interest income and non-interest income.

ALEX: That broad-based part is what jumps out to me. CEO Charlie Scharf made a point of saying it's not just a rising-rate-environment story — it's investments and operating discipline paying off. Headcount has now declined for 24 straight quarters, down to 197,000, while they're actually adding bankers, advisors, and traders in growth areas.

JORDAN: Right, they're funding growth with efficiency savings rather than just cutting costs across the board. And the returns numbers back it up — ROTCE jumped to 17.7% this quarter, up from 15.2% a year ago. CFO Mike Santomassimo did flag that venture capital gains — $847 million in equity gains — juiced that number a bit, but even stripping that out, the underlying trend is improving.

ALEX: Wells Fargo has a medium-term target of 17-18% ROTCE, and Scharf was asked repeatedly about timing on that. His answer, essentially: "we're more confident every quarter, but we're not giving you a hard date because rates and markets are unpredictable."

JORDAN: Classic executive hedge, but a reasonable one. Let's talk net interest income, because that's where most of the analyst questions went. Full-year guidance stayed at $50 billion, give or take, but the composition shifted a little — loan growth is coming in better than expected, while non-interest-bearing deposits aren't growing as much as they'd hoped.

ALEX: And net interest margin actually compressed again — down 4 basis points from Q1. Management's explanation is interesting: it's largely self-inflicted, in a good way. They're growing their markets business balance sheet aggressively, financing clients at lower spreads, which drags down NIM but drives higher trading revenue and deeper relationships.

JORDAN: Scharf was pretty emphatic about that point — he said NIM compression "is not happening to us," it's a deliberate choice they can reverse if the payoff isn't there. Markets revenue grew 24% year-over-year, so early signs suggest it's working. They expect a bit more NIM pressure in Q3, then stabilization in Q4.

ALEX: Loan and deposit growth were both double-digit — average loans up 12%, deposits up 10% — which is a big deal since Wells Fargo only got out from under the Fed's asset cap last year. They're finally playing offense after years of being constrained.

JORDAN: Credit quality remained a bright spot too. Net charge-offs declined 10 basis points year-over-year to 34 basis points. Consumer delinquencies are actually coming in better than their models predict. Commercial credit is clean as well, though Scharf did flag caution around wholesale lending — data center financing, leveraged deals — where non-bank lenders are taking on more risk than Wells is willing to.

ALEX: That data center commentary was one of my favorite exchanges. An analyst asked about second-derivative AI exposure, and Scharf gave a really thoughtful answer about how they underwrite different pieces of the data center supply chain differently — chip makers get paid...]]>405falsefullhttps://www.spreaker.com/episode/jpmorgan-chase-q2-2026-earnings-analysis--72977414https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take a dense earnings call transcript and turn it into something you can actually enjoy with your coffee. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into JPMorgan Chase, ticker JPM, Q2 2026 results — and Alex, this one had a little bit of everything: blowout numbers, a leadership shakeup, and Jamie Dimon being Jamie Dimon.

ALEX: Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, glad that's out of the way. So let's start with the headline numbers.

ALEX: JPMorgan posted net income of $16.9 billion, EPS of $6.14, and a return on tangible common equity of 23%. Strip out some one-off items and revenue was actually up 15% year-over-year.

JORDAN: And that growth was really broad-based — markets revenue was the biggest driver, but you also had higher asset management fees, stronger investment banking revenue, and higher deposit and loan balances. The one drag was lower rates, but honestly, that barely made a dent.

ALEX: Expenses climbed too — $27.3 billion, up 15%, mostly tied to volume and revenue-related costs plus front-office hiring. Credit costs came in at $2.5 billion. And here's a nice surprise for investors: the board is bumping the quarterly dividend up to $1.65 a share starting next quarter.

JORDAN: Let's talk about the business lines, because two of them really stood out. The CIB — that's the Corporate and Investment Bank — had a monster quarter. Revenue up 27% year-over-year, investment banking fees up 30%, with double-digit growth across the board.

ALEX: And equities trading? Up 86% year-over-year. Eighty-six percent, Jordan.

JORDAN: That's the kind of number that makes you sit up. CFO Jeremy Barnum was pretty candid on the call though — he said this level of equities strength is "a little bit hard to imagine being repeated." So management itself is tapping the brakes on extrapolating this quarter forward.

ALEX: Right, and same with investment banking — some of that came from large deals getting pulled forward and a couple of high-profile IPOs. But he also said the pipeline remains "quite robust," and there's this interesting dynamic where the buzz around big deals seems to be generating even more activity.

JORDAN: Meanwhile, on the asset and wealth management side, AUM hit $5.1 trillion, up 18%, with $50 billion in long-term net inflows. And in consumer banking, they added over 500,000 net new checking accounts this quarter. That's a franchise that's just quietly compounding.

ALEX: Let's get into the bigger story of the call, though — the leadership news. JPMorgan just elevated Doug and Troy to co-presidents, and long-time consumer banking head Marianne Lake is retiring as a result.

JORDAN: This dominated the Q&A. Analysts kept probing Jamie Dimon about succession, and he was pretty firm that the timetable for his own tenure "hasn't changed" — still talking in terms of a few years, plus or minus, with the board ultimately deciding.

ALEX: One exchange I loved — Mike Mayo basically said, half-joking, "you've now got an FX trader running the consumer bank," referring to Troy. Barnum jumped in to correct him: Troy was actually an options trader, not FX. Small detail, but it got a laugh.

JORDAN: Dimon's broader point was that he wants leaders who've operated across the whole company, not just people who came up through investment banking. He was pretty explicit that leaders who only understand trading or dealmaking can end up neglecting the rest of the franchise.

ALEX: Let's talk guidance, because they raised it meaningfully. Full-year NII outlook ex-Markets moved up

This episode includes AI-generated content.]]>SP100-JPM-Q2-2026-enTue, 14 Jul 2026 21:31:01 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take a dense earnings call transcript and turn it into something you...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, where we take a dense earnings call transcript and turn it into something you can actually enjoy with your coffee. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into JPMorgan Chase, ticker JPM, Q2 2026 results — and Alex, this one had a little bit of everything: blowout numbers, a leadership shakeup, and Jamie Dimon being Jamie Dimon.

ALEX: Before we get into it, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, glad that's out of the way. So let's start with the headline numbers.

ALEX: JPMorgan posted net income of $16.9 billion, EPS of $6.14, and a return on tangible common equity of 23%. Strip out some one-off items and revenue was actually up 15% year-over-year.

JORDAN: And that growth was really broad-based — markets revenue was the biggest driver, but you also had higher asset management fees, stronger investment banking revenue, and higher deposit and loan balances. The one drag was lower rates, but honestly, that barely made a dent.

ALEX: Expenses climbed too — $27.3 billion, up 15%, mostly tied to volume and revenue-related costs plus front-office hiring. Credit costs came in at $2.5 billion. And here's a nice surprise for investors: the board is bumping the quarterly dividend up to $1.65 a share starting next quarter.

JORDAN: Let's talk about the business lines, because two of them really stood out. The CIB — that's the Corporate and Investment Bank — had a monster quarter. Revenue up 27% year-over-year, investment banking fees up 30%, with double-digit growth across the board.

ALEX: And equities trading? Up 86% year-over-year. Eighty-six percent, Jordan.

JORDAN: That's the kind of number that makes you sit up. CFO Jeremy Barnum was pretty candid on the call though — he said this level of equities strength is "a little bit hard to imagine being repeated." So management itself is tapping the brakes on extrapolating this quarter forward.

ALEX: Right, and same with investment banking — some of that came from large deals getting pulled forward and a couple of high-profile IPOs. But he also said the pipeline remains "quite robust," and there's this interesting dynamic where the buzz around big deals seems to be generating even more activity.

JORDAN: Meanwhile, on the asset and wealth management side, AUM hit $5.1 trillion, up 18%, with $50 billion in long-term net inflows. And in consumer banking, they added over 500,000 net new checking accounts this quarter. That's a franchise that's just quietly compounding.

ALEX: Let's get into the bigger story of the call, though — the leadership news. JPMorgan just elevated Doug and Troy to co-presidents, and long-time consumer banking head Marianne Lake is retiring as a result.

JORDAN: This dominated the Q&A. Analysts kept probing Jamie Dimon about succession, and he was pretty firm that the timetable for his own tenure "hasn't changed" — still talking in terms of a few years, plus or minus, with the board ultimately deciding.

ALEX: One exchange I loved — Mike Mayo basically said, half-joking, "you've now got an FX trader running the consumer bank," referring to Troy. Barnum jumped in to correct him: Troy was actually an options trader, not FX. Small detail, but it got a laugh.

JORDAN: Dimon's broader point was that he wants leaders who've operated across the whole company, not...]]>461falsefullhttps://www.spreaker.com/episode/goldman-sachs-q2-2026-earnings-analysis--72977412https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the numbers and the narrative behind them. I'm Alex.

JORDAN: And I'm Jordan. And Alex, we've got Goldman Sachs Q2 2026, and this one's a doozy.

ALEX: It really is — but before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, let's get into it. Record quarter, full stop. $20.3 billion in net revenues, record EPS of $20.98, ROE of 23.5%, ROTE of 25.5%. Those are eye-popping numbers for a bank this size.

ALEX: Every single segment contributed. Global Banking & Markets alone hit a record $15.5 billion. Advisory revenue up 17% year-over-year — and get this, Goldman crossed $1 trillion in announced M&A volume in just six months, first bank ever to do that.

JORDAN: And they're not just winning deals, they're winning them by a mile. $425 billion ahead of the next closest competitor in announced M&A. That's not a lead, that's a lap.

ALEX: Equity underwriting revenue up 130%, debt underwriting up 75% — best quarter on record there. A lot of that tied to marquee names too — they were lead bookrunner on the SpaceX IPO and the Alphabet equity raise.

JORDAN: But honestly, the number that made me do a double-take was equities trading. Record $7.4 billion, with intermediation revenue up 60% and equity financing up 91%. CFO Denis Coleman basically said this is the payoff from a multi-year bet on building out their Asia prime brokerage business.

ALEX: Right, and analysts pushed hard on that in Q&A — is this sustainable, or is it a couple of huge clients driving the number? Coleman pushed back, saying it's broad-based across long-short and quant clients globally, not concentrated in a handful of accounts.

JORDAN: FICC was strong too — $4.6 billion, up 32%, with financing revenue hitting a record. Across FICC and equities combined, financing now makes up 37% of total revenue there. Goldman's essentially been turning its balance sheet into a growth engine.

ALEX: Let's talk Asset & Wealth Management, because that story's just as interesting. Revenue up 20% year-over-year to $4.6 billion, 34th straight quarter of long-term net inflows, total assets under supervision crossed $4 trillion for the first time.

JORDAN: And alternatives fundraising — $59 billion in the quarter, $85 billion year-to-date. They actually raised their full-year fundraising guidance to over $125 billion. $31 billion of that was private credit alone this quarter.

ALEX: They also picked up two massive OCIO mandates — Verizon and Lockheed Martin's retirement plans, $70 billion combined in assets. That's the kind of sticky, fee-generating business that makes this segment more durable over time.

JORDAN: Now, the through-line for this whole call was really the AI infrastructure buildout. CEO David Solomon kept coming back to it — data centers, energy, chips, the whole ecosystem is pulling in capital far beyond traditional tech financing, and Goldman's positioning itself as the plumbing for that capital.

ALEX: He was refreshingly honest about the risk side too. When asked directly about bubble concerns, Solomon said, essentially, "I'm not smart enough to tell you if there's a recalibration coming in six or eighteen months, but over three to five years, we're investing in long-term growth." He didn't dodge the question, but he didn't overpromise either.

JORDAN: That was a theme all call — a lot of "this won't be a straight line, there'll be bumps." Which, from a bank CEO in the middle of a record quarter, is actually a pretty disciplined thing to say out loud.

ALEX: One more Q&A moment worth flagging — Mike Mayo asked about the "multiplier eff

This episode includes AI-generated content.]]>SP100-GS-Q2-2026-enTue, 14 Jul 2026 21:30:52 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the numbers and the narrative behind them. I'm Alex. JORDAN: And...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the numbers and the narrative behind them. I'm Alex.

JORDAN: And I'm Jordan. And Alex, we've got Goldman Sachs Q2 2026, and this one's a doozy.

ALEX: It really is — but before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Good, let's get into it. Record quarter, full stop. $20.3 billion in net revenues, record EPS of $20.98, ROE of 23.5%, ROTE of 25.5%. Those are eye-popping numbers for a bank this size.

ALEX: Every single segment contributed. Global Banking & Markets alone hit a record $15.5 billion. Advisory revenue up 17% year-over-year — and get this, Goldman crossed $1 trillion in announced M&A volume in just six months, first bank ever to do that.

JORDAN: And they're not just winning deals, they're winning them by a mile. $425 billion ahead of the next closest competitor in announced M&A. That's not a lead, that's a lap.

ALEX: Equity underwriting revenue up 130%, debt underwriting up 75% — best quarter on record there. A lot of that tied to marquee names too — they were lead bookrunner on the SpaceX IPO and the Alphabet equity raise.

JORDAN: But honestly, the number that made me do a double-take was equities trading. Record $7.4 billion, with intermediation revenue up 60% and equity financing up 91%. CFO Denis Coleman basically said this is the payoff from a multi-year bet on building out their Asia prime brokerage business.

ALEX: Right, and analysts pushed hard on that in Q&A — is this sustainable, or is it a couple of huge clients driving the number? Coleman pushed back, saying it's broad-based across long-short and quant clients globally, not concentrated in a handful of accounts.

JORDAN: FICC was strong too — $4.6 billion, up 32%, with financing revenue hitting a record. Across FICC and equities combined, financing now makes up 37% of total revenue there. Goldman's essentially been turning its balance sheet into a growth engine.

ALEX: Let's talk Asset & Wealth Management, because that story's just as interesting. Revenue up 20% year-over-year to $4.6 billion, 34th straight quarter of long-term net inflows, total assets under supervision crossed $4 trillion for the first time.

JORDAN: And alternatives fundraising — $59 billion in the quarter, $85 billion year-to-date. They actually raised their full-year fundraising guidance to over $125 billion. $31 billion of that was private credit alone this quarter.

ALEX: They also picked up two massive OCIO mandates — Verizon and Lockheed Martin's retirement plans, $70 billion combined in assets. That's the kind of sticky, fee-generating business that makes this segment more durable over time.

JORDAN: Now, the through-line for this whole call was really the AI infrastructure buildout. CEO David Solomon kept coming back to it — data centers, energy, chips, the whole ecosystem is pulling in capital far beyond traditional tech financing, and Goldman's positioning itself as the plumbing for that capital.

ALEX: He was refreshingly honest about the risk side too. When asked directly about bubble concerns, Solomon said, essentially, "I'm not smart enough to tell you if there's a recalibration coming in six or eighteen months, but over three to five years, we're investing in long-term growth." He didn't dodge the question, but he didn't overpromise either.

JORDAN:...]]>459falsefullhttps://www.spreaker.com/episode/citigroup-q2-2026-earnings-analysis--72977409https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the numbers, the color, and the context you actually need. I'm Alex, joined as always by Jordan. Today: Citigroup's Q2 2026.

JORDAN: Before we get into it, quick note from us — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, let's get into it. Citi just posted its best quarterly revenue in a decade. Net income of $5.8 billion, EPS of $3.15, ROTCE of 13%, on $24.8 billion in revenue, and here's the kicker — over 9% positive operating leverage. That means revenue grew way faster than expenses.

JORDAN: And it wasn't one lucky business carrying the firm — double-digit revenue growth in four of five segments. Services had its best quarter ever, over 30% returns. Markets crossed $7 billion again, up 17%, with equities up a stunning 40-plus percent on prime balances jumping nearly 60%. Banking revenue climbed 34%, investment banking up 44% — they had lead roles on marquee IPOs like SpaceX and Cerebras.

ALEX: Wealth notched its ninth straight quarter of growth, up 13%, returns now over 14%. The one soft spot was U.S. Consumer Cards — heavy investment spend, including that American Airlines-Barclays portfolio acquisition, weighed on operating leverage there, even though ROTCE for cards actually rose to 22%.

JORDAN: So strong quarter across the board, and yet — the stock dropped about 5% on the print. That's the real story here.

ALEX: Exactly, and it all comes down to guidance. CFO Gonzalo Luchetti kept the full-year ROTCE target at 10-11%, even after hitting 13.1% year-to-date. Analysts did the math out loud — Glenn Schorr and Mike Mayo both pressed hard on this. If you're at 13% for the first half, holding 10-11% for the year implies a real step-down in the second half.

JORDAN: And management's answer was essentially: some of that's normal seasonality — markets revenue historically drops about 20% between first and second half — but a lot of it is a deliberate choice. They said if the environment stays strong, they're going to lean in and accelerate investments and severance actions rather than just let the extra profit flow to the bottom line this year.

ALEX: Jane Fraser put it bluntly: "This is 100% offense." They're not defending market share or patching up legacy systems — they're pulling forward spending on things like AI, technology, marketing in cards, and structural efficiency work to lock in higher, more durable returns in 2027 and beyond.

JORDAN: It's a "spend the windfall now" strategy. They already took $800 million in severance in just the first half — matching all of last year — and signaled there could be more in the second half if opportunities arise.

ALEX: On the balance sheet side, capital looks solid. CET1 ratio at 12.8%, well above their regulatory minimum. They announced a 12% dividend increase and are running a $30 billion buyback program, having already repurchased $4 billion this quarter.

JORDAN: Credit quality was also a bright spot — corporate credit stayed clean, and even in cards, delinquencies and losses came in better than expected. Consumer spending looked resilient, up 6-7% even excluding the new airline card portfolio.

ALEX: There were a couple of housekeeping items too — Jenn Landis wrapped up her run as head of Investor Relations to become CFO of the Markets business, handing the reins to Margo Pilic. And Citi continues unwinding its Mexico business, Banamex — they've now sold down over 49% of that stake, with full deconsolidation expected in early 2027.

JORDAN: The other big theme was AI — not as a buzzword, but operationally. Nearly nine in ten Citi employees are using their internal AI tools

This episode includes AI-generated content.]]>SP100-C-Q2-2026-enTue, 14 Jul 2026 21:30:39 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the numbers, the color, and the context you actually need. I'm Alex,...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the numbers, the color, and the context you actually need. I'm Alex, joined as always by Jordan. Today: Citigroup's Q2 2026.

JORDAN: Before we get into it, quick note from us — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Right, let's get into it. Citi just posted its best quarterly revenue in a decade. Net income of $5.8 billion, EPS of $3.15, ROTCE of 13%, on $24.8 billion in revenue, and here's the kicker — over 9% positive operating leverage. That means revenue grew way faster than expenses.

JORDAN: And it wasn't one lucky business carrying the firm — double-digit revenue growth in four of five segments. Services had its best quarter ever, over 30% returns. Markets crossed $7 billion again, up 17%, with equities up a stunning 40-plus percent on prime balances jumping nearly 60%. Banking revenue climbed 34%, investment banking up 44% — they had lead roles on marquee IPOs like SpaceX and Cerebras.

ALEX: Wealth notched its ninth straight quarter of growth, up 13%, returns now over 14%. The one soft spot was U.S. Consumer Cards — heavy investment spend, including that American Airlines-Barclays portfolio acquisition, weighed on operating leverage there, even though ROTCE for cards actually rose to 22%.

JORDAN: So strong quarter across the board, and yet — the stock dropped about 5% on the print. That's the real story here.

ALEX: Exactly, and it all comes down to guidance. CFO Gonzalo Luchetti kept the full-year ROTCE target at 10-11%, even after hitting 13.1% year-to-date. Analysts did the math out loud — Glenn Schorr and Mike Mayo both pressed hard on this. If you're at 13% for the first half, holding 10-11% for the year implies a real step-down in the second half.

JORDAN: And management's answer was essentially: some of that's normal seasonality — markets revenue historically drops about 20% between first and second half — but a lot of it is a deliberate choice. They said if the environment stays strong, they're going to lean in and accelerate investments and severance actions rather than just let the extra profit flow to the bottom line this year.

ALEX: Jane Fraser put it bluntly: "This is 100% offense." They're not defending market share or patching up legacy systems — they're pulling forward spending on things like AI, technology, marketing in cards, and structural efficiency work to lock in higher, more durable returns in 2027 and beyond.

JORDAN: It's a "spend the windfall now" strategy. They already took $800 million in severance in just the first half — matching all of last year — and signaled there could be more in the second half if opportunities arise.

ALEX: On the balance sheet side, capital looks solid. CET1 ratio at 12.8%, well above their regulatory minimum. They announced a 12% dividend increase and are running a $30 billion buyback program, having already repurchased $4 billion this quarter.

JORDAN: Credit quality was also a bright spot — corporate credit stayed clean, and even in cards, delinquencies and losses came in better than expected. Consumer spending looked resilient, up 6-7% even excluding the new airline card portfolio.

ALEX: There were a couple of housekeeping items too — Jenn Landis wrapped up her run as head of Investor Relations to become CFO of the Markets business, handing the reins to Margo Pilic. And Citi continues unwinding its Mexico...]]>346falsefullhttps://www.spreaker.com/episode/bank-of-america-q2-2026-earnings-analysis--72977407https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Bank of America's second quarter 2026 results, and there's a lot to unpack.

Before we get into the numbers — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Alright, let's get into it, because BAC put up some genuinely strong numbers this quarter.

ALEX: Yeah, headline stats first — revenue grew 15% year-over-year to $31.6 billion. Net income came in at $9.1 billion, up 27%. And EPS jumped 34% to $1.21 a share.

JORDAN: What stood out to me is that every single business segment contributed to that growth — revenue up, net income up, operating leverage positive, efficiency ratio improved. That's not one hot business carrying the quarter, that's the whole franchise firing.

ALEX: Right, and CEO Brian Moynihan leaned into that on the call — 6.6% operating leverage for the quarter, efficiency ratio down to 59%, return on tangible common equity at 17%.

JORDAN: Let's talk about net interest income, because that's really the engine here. NII came in around $16.2 billion, up 9% year-over-year. CFO Alastair Borthwick has basically been raising guidance all year — started at 5-7% NII growth for the full year, bumped it to 6-8% in April, and now they're saying they'll land at the top end of that range.

ALEX: And that's even with one rate hike priced into the forward curve for September. The bank is asset-sensitive, so higher rates actually help them here.

JORDAN: The fee businesses were the real fireworks though. Investment banking fees up 50% year-over-year to $2.1 billion. Sales and trading revenue up 33% to $7.2 billion. And within that, equities hit a record $3.6 billion, up 70%, while FICC had its best quarter in over a decade.

ALEX: Seventeen consecutive quarters of year-over-year sales and trading growth. Fourteen consecutive quarters of net income growth in that segment. That's a streak.

JORDAN: On the balance sheet side — deposits grew for a 12th straight quarter, averaging just over $2 trillion. Loans grew for a ninth consecutive quarter, up 8% year-over-year, led by commercial lending. And credit quality stayed stable — charge-offs basically flat versus Q1, consumer card delinquencies actually improving.

ALEX: They also raised their full-year operating leverage guidance pretty dramatically — from an expected 200 basis points at the start of the year to now 300-400 basis points, after putting up 450 in the first half alone.

JORDAN: Management was careful to flag that the second half comps get tougher, since last year's growth was heavily back-half-loaded. So don't expect the same blowout pace, even though the underlying business is healthy.

ALEX: The other big theme was AI. They dedicated a whole new slide to it — over 200,000 employees actively using AI tools, more than 400,000 prompts a day, 300-plus approved AI use cases, 114 of those live.

JORDAN: Moynihan framed it as helping in two ways — one, it's driving revenue indirectly because BAC is financing a lot of the AI infrastructure buildout happening across the economy. And two, internally, it's a productivity lever — helping bankers prep faster, developers code more efficiently, advisors personalize client conversations.

ALEX: One analyst question I found interesting — Erika Najarian from UBS pushed on whether the NII guidance was actually conservative, and whether returns this strong might tempt the bank into chasing lower-return business for growth.

JORDAN: Moynihan's answer was pretty disciplined — he said they still hold every business to that roughly 16% return on tangible common equity standard, and any capital reallocation goes toward higher-return

This episode includes AI-generated content.]]>SP100-BAC-Q2-2026-enTue, 14 Jul 2026 21:30:33 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: BANKS (https://betafinch.com/groups/BANKS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Bank of America's second quarter 2026 results, and...https://betafinch.com
Groups: BANKS (https://betafinch.com/groups/BANKS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Bank of America's second quarter 2026 results, and there's a lot to unpack.

Before we get into the numbers — this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Alright, let's get into it, because BAC put up some genuinely strong numbers this quarter.

ALEX: Yeah, headline stats first — revenue grew 15% year-over-year to $31.6 billion. Net income came in at $9.1 billion, up 27%. And EPS jumped 34% to $1.21 a share.

JORDAN: What stood out to me is that every single business segment contributed to that growth — revenue up, net income up, operating leverage positive, efficiency ratio improved. That's not one hot business carrying the quarter, that's the whole franchise firing.

ALEX: Right, and CEO Brian Moynihan leaned into that on the call — 6.6% operating leverage for the quarter, efficiency ratio down to 59%, return on tangible common equity at 17%.

JORDAN: Let's talk about net interest income, because that's really the engine here. NII came in around $16.2 billion, up 9% year-over-year. CFO Alastair Borthwick has basically been raising guidance all year — started at 5-7% NII growth for the full year, bumped it to 6-8% in April, and now they're saying they'll land at the top end of that range.

ALEX: And that's even with one rate hike priced into the forward curve for September. The bank is asset-sensitive, so higher rates actually help them here.

JORDAN: The fee businesses were the real fireworks though. Investment banking fees up 50% year-over-year to $2.1 billion. Sales and trading revenue up 33% to $7.2 billion. And within that, equities hit a record $3.6 billion, up 70%, while FICC had its best quarter in over a decade.

ALEX: Seventeen consecutive quarters of year-over-year sales and trading growth. Fourteen consecutive quarters of net income growth in that segment. That's a streak.

JORDAN: On the balance sheet side — deposits grew for a 12th straight quarter, averaging just over $2 trillion. Loans grew for a ninth consecutive quarter, up 8% year-over-year, led by commercial lending. And credit quality stayed stable — charge-offs basically flat versus Q1, consumer card delinquencies actually improving.

ALEX: They also raised their full-year operating leverage guidance pretty dramatically — from an expected 200 basis points at the start of the year to now 300-400 basis points, after putting up 450 in the first half alone.

JORDAN: Management was careful to flag that the second half comps get tougher, since last year's growth was heavily back-half-loaded. So don't expect the same blowout pace, even though the underlying business is healthy.

ALEX: The other big theme was AI. They dedicated a whole new slide to it — over 200,000 employees actively using AI tools, more than 400,000 prompts a day, 300-plus approved AI use cases, 114 of those live.

JORDAN: Moynihan framed it as helping in two ways — one, it's driving revenue indirectly because BAC is financing a lot of the AI infrastructure buildout happening across the economy. And two, internally, it's a productivity lever — helping bankers prep faster, developers code more efficiently, advisors personalize client conversations.

ALEX: One analyst question I found interesting — Erika Najarian from UBS pushed on whether the NII guidance was actually conservative, and whether returns...]]>386falsefullhttps://www.spreaker.com/episode/pepsico-q2-2026-earnings-analysis--72889935https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown of the calls that move markets. Today we're digging into PepsiCo's Q2 2026 results.

ALEX: Hey everyone, welcome back to Beta Finch! I'm Alex, here with Jordan, and today we're breaking down PepsiCo's second quarter 2026 earnings call. This one's got a real tale-of-two-businesses vibe — strong international, choppier North America. Before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Right, and there's a lot to unpack here, Alex. This wasn't a blowout quarter, but it also wasn't a disaster — it's more of a "here's exactly where the pressure points are" kind of call.

ALEX: Let's start with the headline numbers. First-half revenue grew almost 7% company-wide, which is solid. Global volumes were up 3% in foods and 2% in beverages — CEO Ramon Laguarta called that the fastest volume growth since 2022.

JORDAN: And on earnings, reported EPS grew 6% in the first half, constant currency EPS up 3%. They reaffirmed full-year guidance, though CFO Steve Schmitt flagged it might land toward the low end of their EPS range.

ALEX: The story underneath those numbers, though, is really about a split business. International is on fire — set to cross $40 billion this year, growing 7% and accelerating. Meanwhile North America, especially the food business, PFNA, came in softer than expected.

JORDAN: Yeah, PFNA volume was flat in the quarter. And that's notable because PepsiCo spent the first half of the year specifically investing in affordability — lowering prices, portion control packs — to get salty snacks volume growing again after a stretch of decline.

ALEX: And it kind of worked, right? Laguarta made the point that the category went from negative volume to positive, and PepsiCo is actually gaining share within that. So directionally the strategy's working, just not as fast as hoped.

JORDAN: Right, and he was pretty candid about why: gas prices. Rising fuel costs hit convenience and gas station channels hard — those impulse-purchase locations where price sensitivity shows up fast. People are pulling into the pump but not converting that traffic into snack and drink purchases the way they used to.

ALEX: That convenience-and-gas weakness actually shows up directly in the numbers too. PBNA — the North America beverage business — saw operating margin down about 90 basis points. Steve Schmitt broke that into three pieces: about half tied to the Alani Nu commercial arrangement, then the soft convenience-and-gas channel, and product mix.

JORDAN: What I found interesting was management resisting the idea of some big "reset" — a phrase one analyst used. Laguarta pushed back pretty firmly, saying they don't need one because of record productivity gains funding the growth investments.

ALEX: There was also a nice tailwind mentioned — tariff refund claims from last year, expected to add about a full point of EPS growth for the full year. That's helping offset rising commodity costs, particularly some inflation expected in Europe and the Middle East in the back half.

JORDAN: On the international side, it's honestly the highlight of the call. Laguarta did a world tour — Vietnam, Thailand, China, the Middle East, all more resilient than expected despite higher gas prices there too. Europe's getting a real boost from World Cup sponsorship activations. Latin America's a bit softer but still trending positive.

ALEX: And Schmitt added that international operating margin actually grew a full point in the quarter — so it's not just top-line growth, it's profitable, efficient growth.

JORDAN: One thing

This episode includes AI-generated content.]]>SP100-PEP-Q2-2026-enThu, 09 Jul 2026 14:16:05 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME) ────────── Welcome to Beta Finch, your AI-powered earnings breakdown of the calls that move markets. Today...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
──────────
Welcome to Beta Finch, your AI-powered earnings breakdown of the calls that move markets. Today we're digging into PepsiCo's Q2 2026 results.

ALEX: Hey everyone, welcome back to Beta Finch! I'm Alex, here with Jordan, and today we're breaking down PepsiCo's second quarter 2026 earnings call. This one's got a real tale-of-two-businesses vibe — strong international, choppier North America. Before we dive in, quick disclaimer: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Right, and there's a lot to unpack here, Alex. This wasn't a blowout quarter, but it also wasn't a disaster — it's more of a "here's exactly where the pressure points are" kind of call.

ALEX: Let's start with the headline numbers. First-half revenue grew almost 7% company-wide, which is solid. Global volumes were up 3% in foods and 2% in beverages — CEO Ramon Laguarta called that the fastest volume growth since 2022.

JORDAN: And on earnings, reported EPS grew 6% in the first half, constant currency EPS up 3%. They reaffirmed full-year guidance, though CFO Steve Schmitt flagged it might land toward the low end of their EPS range.

ALEX: The story underneath those numbers, though, is really about a split business. International is on fire — set to cross $40 billion this year, growing 7% and accelerating. Meanwhile North America, especially the food business, PFNA, came in softer than expected.

JORDAN: Yeah, PFNA volume was flat in the quarter. And that's notable because PepsiCo spent the first half of the year specifically investing in affordability — lowering prices, portion control packs — to get salty snacks volume growing again after a stretch of decline.

ALEX: And it kind of worked, right? Laguarta made the point that the category went from negative volume to positive, and PepsiCo is actually gaining share within that. So directionally the strategy's working, just not as fast as hoped.

JORDAN: Right, and he was pretty candid about why: gas prices. Rising fuel costs hit convenience and gas station channels hard — those impulse-purchase locations where price sensitivity shows up fast. People are pulling into the pump but not converting that traffic into snack and drink purchases the way they used to.

ALEX: That convenience-and-gas weakness actually shows up directly in the numbers too. PBNA — the North America beverage business — saw operating margin down about 90 basis points. Steve Schmitt broke that into three pieces: about half tied to the Alani Nu commercial arrangement, then the soft convenience-and-gas channel, and product mix.

JORDAN: What I found interesting was management resisting the idea of some big "reset" — a phrase one analyst used. Laguarta pushed back pretty firmly, saying they don't need one because of record productivity gains funding the growth investments.

ALEX: There was also a nice tailwind mentioned — tariff refund claims from last year, expected to add about a full point of EPS growth for the full year. That's helping offset rising commodity costs, particularly some inflation expected in Europe and the Middle East in the back half.

JORDAN: On the international side, it's honestly the highlight of the call. Laguarta did a world tour — Vietnam, Thailand, China, the Middle East, all more resilient than expected despite higher gas prices there...]]>401falsefullhttps://www.spreaker.com/episode/oracle-q4-2026-earnings-analysis--72817945https://betafinch.com
Groups: AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
# Beta Finch Podcast Script: Oracle Q4 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we translate corporate speak into plain English. I'm Alex, and I'm here with my co-host Jordan to dive into Oracle's absolutely massive Q4 2026 earnings results.

**JORDAN**: Hey everyone! And Alex, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely crucial reminder, Jordan. Now, let's talk Oracle because - wow - this was a quarter that's going to have people talking. Oracle just reported what they're calling a "record quarter" with revenues hitting $19.2 billion, up 21%. But the real story here isn't just the top line growth.

**JORDAN**: Right, and what's absolutely eye-popping is their remaining performance obligations - their RPO - which hit $638 billion. Alex, that's up 363% year-over-year. To put that in perspective, that's more than half a trillion dollars in contracted future revenue.

**ALEX**: That number is almost incomprehensible. For listeners who aren't familiar, RPO is essentially Oracle's backlog - money customers have already committed to pay them for services they'll deliver over the coming years. It's like having a crystal ball for future revenue growth.

**JORDAN**: And here's the kicker - 12% of that RPO gets recognized in the next 12 months, with another 34% coming in the following two years. New CFO Hilary Maxson said these percentages are expected to accelerate, which suggests Oracle's revenue growth is about to shift into a much higher gear.

**ALEX**: Speaking of growth drivers, let's talk about the elephant in the room - AI infrastructure. Clayton Magouyrk, who runs Oracle Cloud Infrastructure, dropped some serious numbers. They signed $67 billion in AI infrastructure contracts just this quarter. And get this - most of these were either "bring your own hardware" deals or prepaid contracts.

**JORDAN**: That's fascinating because it shows customers are so confident in Oracle's infrastructure capabilities that they're willing to bring their own expensive GPU hardware or pay Oracle upfront. It's like customers saying, "We trust you so much, here's our own equipment - just run it for us."

**ALEX**: Exactly! And Clayton mentioned they delivered over 1.2 gigawatts of capacity to customers in fiscal 2026. Their Q1 delivery is approaching 1 gigawatt alone - nearly matching what they delivered in the previous four quarters combined. The scale here is just staggering.

**JORDAN**: What I found really interesting was their GPU utilization rate - 97.5% globally. When you've got that kind of utilization, it means demand is absolutely crushing supply. And when GPUs came up for renewal in Q4, 49% of customers renewed for 92% of the capacity. The GPUs that weren't renewed? They got sold to other customers in the same quarter.

**ALEX**: That's a great point about the supply-demand imbalance. But let's not forget Oracle isn't just an infrastructure play. Mike Sicilia talked about their applications business, which grew 10% to $4.1 billion in revenue. They're embedding AI agents directly into their software - over 1,000 AI agents across their application suites.

**JORDAN**: And this is where Oracle's full-stack approach really shines. They're not just providing the infrastructure to run AI - they're building AI directly into the business applications that companies use every day. Sicilia mentioned they're introducing new pricing models too, including outcome-based pricing and token bundles for AI capabilities.

**ALEX**: The token bundles are particularly interesting - it's like buying prepaid minutes for AI ser

This episode includes AI-generated content.]]>SP100-ORCL-Q4-2026-enSat, 04 Jul 2026 15:20:15 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: AI_LEADERS (https://betafinch.com/groups/AI_LEADERS) ────────── # Beta Finch Podcast Script: Oracle Q4 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we...https://betafinch.com
Groups: AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
# Beta Finch Podcast Script: Oracle Q4 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we translate corporate speak into plain English. I'm Alex, and I'm here with my co-host Jordan to dive into Oracle's absolutely massive Q4 2026 earnings results.

**JORDAN**: Hey everyone! And Alex, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely crucial reminder, Jordan. Now, let's talk Oracle because - wow - this was a quarter that's going to have people talking. Oracle just reported what they're calling a "record quarter" with revenues hitting $19.2 billion, up 21%. But the real story here isn't just the top line growth.

**JORDAN**: Right, and what's absolutely eye-popping is their remaining performance obligations - their RPO - which hit $638 billion. Alex, that's up 363% year-over-year. To put that in perspective, that's more than half a trillion dollars in contracted future revenue.

**ALEX**: That number is almost incomprehensible. For listeners who aren't familiar, RPO is essentially Oracle's backlog - money customers have already committed to pay them for services they'll deliver over the coming years. It's like having a crystal ball for future revenue growth.

**JORDAN**: And here's the kicker - 12% of that RPO gets recognized in the next 12 months, with another 34% coming in the following two years. New CFO Hilary Maxson said these percentages are expected to accelerate, which suggests Oracle's revenue growth is about to shift into a much higher gear.

**ALEX**: Speaking of growth drivers, let's talk about the elephant in the room - AI infrastructure. Clayton Magouyrk, who runs Oracle Cloud Infrastructure, dropped some serious numbers. They signed $67 billion in AI infrastructure contracts just this quarter. And get this - most of these were either "bring your own hardware" deals or prepaid contracts.

**JORDAN**: That's fascinating because it shows customers are so confident in Oracle's infrastructure capabilities that they're willing to bring their own expensive GPU hardware or pay Oracle upfront. It's like customers saying, "We trust you so much, here's our own equipment - just run it for us."

**ALEX**: Exactly! And Clayton mentioned they delivered over 1.2 gigawatts of capacity to customers in fiscal 2026. Their Q1 delivery is approaching 1 gigawatt alone - nearly matching what they delivered in the previous four quarters combined. The scale here is just staggering.

**JORDAN**: What I found really interesting was their GPU utilization rate - 97.5% globally. When you've got that kind of utilization, it means demand is absolutely crushing supply. And when GPUs came up for renewal in Q4, 49% of customers renewed for 92% of the capacity. The GPUs that weren't renewed? They got sold to other customers in the same quarter.

**ALEX**: That's a great point about the supply-demand imbalance. But let's not forget Oracle isn't just an infrastructure play. Mike Sicilia talked about their applications business, which grew 10% to $4.1 billion in revenue. They're embedding AI agents directly into their software - over 1,000 AI agents across their application suites.

**JORDAN**: And this is where Oracle's full-stack approach really shines. They're not just providing the infrastructure to run AI - they're building AI directly into the business applications that...]]>506falsefullhttps://www.spreaker.com/episode/micron-technology-q3-2026-earnings-analysis--72817943https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Micron Technology's fiscal Q3 2026 results, and folks, this is one of those quarters where the numbers almost don't sound real. Before we get into it, quick reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Yeah, "don't sound real" is right. Let's just start with the top line — $41.5 billion in revenue. That's up 74% sequentially and 346% year-over-year.

ALEX: Year over year! Not sequentially — year over year revenue more than quadrupled. And it's their fifth straight record quarter, with the single largest sequential dollar jump in company history, $17.6 billion.

JORDAN: DRAM did most of the heavy lifting — $31.3 billion, up 67% sequentially, three quarters of total revenue. But NAND actually grew even faster percentage-wise, up 99% sequentially to $9.9 billion. Prices in NAND jumped mid-80s percent.

ALEX: And the profitability is what really jumps out to me. Gross margin hit 84.9%, up 10 points in a single quarter. Operating margin over 81%. EPS came in at $25.11, more than doubling sequentially.

JORDAN: These aren't small beats over guidance either — Sanjay Mehrotra said revenue, gross margin, and EPS all exceeded the high end of guidance. And the data center number is the real story underneath all this — data center revenue exceeded $25 billion in the quarter, annualizing above $100 billion. Data center SSDs alone more than doubled sequentially to over $5 billion.

ALEX: So let's talk about the big strategic news, because this is arguably bigger than the quarterly numbers themselves — these Strategic Customer Agreements, or SCAs. Micron now has 16 of them signed.

JORDAN: This is the part I think investors are going to spend the next few quarters trying to fully digest. These are take-or-pay, multi-year deals — five years for most, three years for automotive — running roughly calendar 2026 through 2030. They cover about 20% of Micron's DRAM volume and a third of NAND volume over that period.

ALEX: And the pricing structure is interesting. The largest agreements have a ceiling tied to current, very elevated prices, and a floor — but Sanjay was emphatic that even at that floor price, gross margins would be "well above" any peak margin Micron has ever hit in a past cycle.

JORDAN: That's the headline for me. Historically Micron's margins have been this brutal boom-bust cycle — peaks in the low 60s percent gross margin, then crashing during downturns. If the floor on these new contracts is above the old ceiling, that's a structurally different business.

ALEX: Fourteen of the sixteen SCAs represent about $100 billion in cumulative minimum revenue over their terms — that's the RPO, remaining performance obligation, a new disclosure they're rolling out this quarter under ASC 606.

JORDAN: And this is where the Q&A got really interesting. Analysts pushed hard on what that $100 billion actually represents. Tim Arcuri from UBS did the math — $100 billion over roughly five years is about $20 billion a year, which is well below Micron's current $40-plus billion quarterly run rate.

ALEX: Right, and Sanjay's response was basically: don't read too much into that number, it's a conservative floor. He said about 20% of DRAM and 30% of NAND volume is covered, translating to roughly 25% of revenue over the agreement term — and actual revenue is expected to run "much higher" than the RPO minimum.

JORDAN: Mark Murphy also fielded some good detective work from Morgan Stanley's Joe Moore on the cash deposits — Micron's getting about $22 billion in deposits and financial commitments tied to these deals, $18 billion of that i

This episode includes AI-generated content.]]>SP100-MU-Q3-2026-enSat, 04 Jul 2026 15:20:09 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: CHIPS (https://betafinch.com/groups/CHIPS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Micron Technology's fiscal Q3 2026 results, and...https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. Today we're digging into Micron Technology's fiscal Q3 2026 results, and folks, this is one of those quarters where the numbers almost don't sound real. Before we get into it, quick reminder: this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Yeah, "don't sound real" is right. Let's just start with the top line — $41.5 billion in revenue. That's up 74% sequentially and 346% year-over-year.

ALEX: Year over year! Not sequentially — year over year revenue more than quadrupled. And it's their fifth straight record quarter, with the single largest sequential dollar jump in company history, $17.6 billion.

JORDAN: DRAM did most of the heavy lifting — $31.3 billion, up 67% sequentially, three quarters of total revenue. But NAND actually grew even faster percentage-wise, up 99% sequentially to $9.9 billion. Prices in NAND jumped mid-80s percent.

ALEX: And the profitability is what really jumps out to me. Gross margin hit 84.9%, up 10 points in a single quarter. Operating margin over 81%. EPS came in at $25.11, more than doubling sequentially.

JORDAN: These aren't small beats over guidance either — Sanjay Mehrotra said revenue, gross margin, and EPS all exceeded the high end of guidance. And the data center number is the real story underneath all this — data center revenue exceeded $25 billion in the quarter, annualizing above $100 billion. Data center SSDs alone more than doubled sequentially to over $5 billion.

ALEX: So let's talk about the big strategic news, because this is arguably bigger than the quarterly numbers themselves — these Strategic Customer Agreements, or SCAs. Micron now has 16 of them signed.

JORDAN: This is the part I think investors are going to spend the next few quarters trying to fully digest. These are take-or-pay, multi-year deals — five years for most, three years for automotive — running roughly calendar 2026 through 2030. They cover about 20% of Micron's DRAM volume and a third of NAND volume over that period.

ALEX: And the pricing structure is interesting. The largest agreements have a ceiling tied to current, very elevated prices, and a floor — but Sanjay was emphatic that even at that floor price, gross margins would be "well above" any peak margin Micron has ever hit in a past cycle.

JORDAN: That's the headline for me. Historically Micron's margins have been this brutal boom-bust cycle — peaks in the low 60s percent gross margin, then crashing during downturns. If the floor on these new contracts is above the old ceiling, that's a structurally different business.

ALEX: Fourteen of the sixteen SCAs represent about $100 billion in cumulative minimum revenue over their terms — that's the RPO, remaining performance obligation, a new disclosure they're rolling out this quarter under ASC 606.

JORDAN: And this is where the Q&A got really interesting. Analysts pushed hard on what that $100 billion actually represents. Tim Arcuri from UBS did the math — $100 billion over roughly five years is about $20 billion a year, which is well below Micron's current $40-plus billion quarterly run rate.

ALEX: Right, and Sanjay's response was basically: don't read too much into that number, it's a conservative floor. He said about 20% of DRAM and 30% of NAND volume is covered, translating to roughly 25% of revenue over the agreement term — and actual revenue is expected to run "much...]]>507falsefullhttps://www.spreaker.com/episode/medtronic-q4-2026-earnings-analysis--72353350https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
# Beta Finch Podcast Script: Medtronic Q4 2026 Earnings

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Medtronic's fourth quarter 2026 results, and folks, this is a company that's clearly hitting its stride.

Before we dive in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and wow - where do we even start with Medtronic? These numbers are impressive. The company just posted $9.8 billion in Q4 revenue, up nearly 10% reported and 6.6% organically. But here's what really caught my attention - this caps off their strongest annual performance in a decade.

**ALEX:** That's right, Jordan. For the full fiscal year, they hit $36.4 billion in revenue with 8.4% reported growth and 5.8% organic growth. CEO Geoff Martha was clearly proud of these results, calling it a reflection of their "commitment to operational rigor" while investing in durable growth. But let's talk about what's really driving this performance.

**JORDAN:** The star of the show has got to be their Cardiac Ablation Solutions business - or CAS. This division delivered 78% worldwide growth and gained 8 points of U.S. market share. Their PFA technology saw 145% global growth, with their Sphere-9 catheter continuing to show "broad versatility," as Martha put it.

**ALEX:** And here's what's really exciting about CAS - they're still in the "early innings," as CFO Thierry Pieton noted. The company increased their installed base by 40% just in the fourth quarter alone. They're now annualizing over $2 billion in revenue and are on track to hit that $2 billion trailing mark in the first quarter of fiscal 2027. That's massive scale in a high-growth market.

**JORDAN:** What I found fascinating was Martha's comment about "completely surrounding the electrophysiology space." They're not just selling one product - they're building an entire ecosystem. They launched Sphere-9 in Japan, got FDA approval for a U.S. VT pivotal trial, and even announced two targeted investments in ICE catheter technology this morning.

**ALEX:** Speaking of investments, let's talk about their capital allocation strategy because this is where you really see the company's long-term vision. In Q4 alone, they closed or announced nearly $2 billion in additional investments through M&A and venture deals. They acquired CathWorks for their AI-powered FFRangio system, announced plans to buy Scientia for neurovascular guidewire tech, and made investments in everything from chronic pain management to pulmonary artery denervation.

**JORDAN:** That's a great point, Alex. And it's not just about buying technology - it's about strategic positioning. Take their Symplicity Spyral system for treating hypertension. This business is now annualizing at $100 million, and they've doubled their weekly procedure volumes since getting the NCD coverage decision. Martha emphasized that 18 million Americans still have uncontrolled hypertension despite multiple medications - that's a massive addressable market.

**ALEX:** Let's shift to the numbers that investors will be watching closely. For fiscal 2027, Medtronic is guiding to organic revenue growth of 6.75% to 7.25%. Now, there's an extra selling week baked into that, which adds about 125 basis points, but even adjusting for that, we're looking at solid mid-single-digit growth acceleration.

**JORDAN:** The guidance is particularly interesting because of how they're handling the MiniMed diabetes business. They completed the IPO in March, but

This episode includes AI-generated content.]]>SP100-MDT-Q4-2026-enThu, 04 Jun 2026 21:26:20 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE) ────────── # Beta Finch Podcast Script: Medtronic Q4 2026 Earnings **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown...https://betafinch.com
Groups: HEALTHCARE (https://betafinch.com/groups/HEALTHCARE)
──────────
# Beta Finch Podcast Script: Medtronic Q4 2026 Earnings

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Medtronic's fourth quarter 2026 results, and folks, this is a company that's clearly hitting its stride.

Before we dive in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and wow - where do we even start with Medtronic? These numbers are impressive. The company just posted $9.8 billion in Q4 revenue, up nearly 10% reported and 6.6% organically. But here's what really caught my attention - this caps off their strongest annual performance in a decade.

**ALEX:** That's right, Jordan. For the full fiscal year, they hit $36.4 billion in revenue with 8.4% reported growth and 5.8% organic growth. CEO Geoff Martha was clearly proud of these results, calling it a reflection of their "commitment to operational rigor" while investing in durable growth. But let's talk about what's really driving this performance.

**JORDAN:** The star of the show has got to be their Cardiac Ablation Solutions business - or CAS. This division delivered 78% worldwide growth and gained 8 points of U.S. market share. Their PFA technology saw 145% global growth, with their Sphere-9 catheter continuing to show "broad versatility," as Martha put it.

**ALEX:** And here's what's really exciting about CAS - they're still in the "early innings," as CFO Thierry Pieton noted. The company increased their installed base by 40% just in the fourth quarter alone. They're now annualizing over $2 billion in revenue and are on track to hit that $2 billion trailing mark in the first quarter of fiscal 2027. That's massive scale in a high-growth market.

**JORDAN:** What I found fascinating was Martha's comment about "completely surrounding the electrophysiology space." They're not just selling one product - they're building an entire ecosystem. They launched Sphere-9 in Japan, got FDA approval for a U.S. VT pivotal trial, and even announced two targeted investments in ICE catheter technology this morning.

**ALEX:** Speaking of investments, let's talk about their capital allocation strategy because this is where you really see the company's long-term vision. In Q4 alone, they closed or announced nearly $2 billion in additional investments through M&A and venture deals. They acquired CathWorks for their AI-powered FFRangio system, announced plans to buy Scientia for neurovascular guidewire tech, and made investments in everything from chronic pain management to pulmonary artery denervation.

**JORDAN:** That's a great point, Alex. And it's not just about buying technology - it's about strategic positioning. Take their Symplicity Spyral system for treating hypertension. This business is now annualizing at $100 million, and they've doubled their weekly procedure volumes since getting the NCD coverage decision. Martha emphasized that 18 million Americans still have uncontrolled hypertension despite multiple medications - that's a massive addressable market.

**ALEX:** Let's shift to the numbers that investors will be watching closely. For fiscal 2027, Medtronic is guiding to organic revenue growth of 6.75% to 7.25%. Now, there's an extra selling week baked into that, which adds about 125 basis points, but...]]>549falsefullhttps://www.spreaker.com/episode/broadcom-q2-2026-earnings-analysis--72340017https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
# Beta Finch Podcast Script: Broadcom Q2 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex, and joining me as always is Jordan. Today we're diving into Broadcom's absolutely explosive Q2 2026 results that had Wall Street buzzing. But before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex, and wow - where do we even begin with these numbers? Broadcom just delivered what might be one of the most impressive quarters we've seen in the semiconductor space. We're talking about $22.2 billion in total revenue, up 48% year-over-year, with AI semiconductor revenue alone hitting $10.8 billion.

**ALEX**: That AI number is just staggering, Jordan. To put it in perspective, their AI semiconductor business grew 143% year-over-year. But what really caught my attention was CEO Hock Tan's guidance - they're expecting AI semiconductor revenue to hit $16 billion in Q3, which would be over 200% growth year-over-year.

**JORDAN**: And let's talk about those margins, because this is where Broadcom really shows its operational excellence. Operating margin hit a record 67% with adjusted EBITDA at 69% of revenue. Even as they're scaling up massively, they're maintaining these incredible margins through operational leverage.

**ALEX**: The bookings number was absolutely wild too - $30 billion in AI semiconductor bookings against $10.8 billion they actually shipped. That's nearly 3x coverage, which tells us demand is just insatiable right now.

**JORDAN**: Speaking of demand, let's break down what's driving this growth. Broadcom has essentially become the go-to partner for the biggest names in AI. They've got long-term agreements with Google for multiple generations of TPUs and AI networking. They're providing Anthropic with access to over 1 gigawatt of compute this year, with plans to scale that to 5 gigawatts starting in 2027.

**ALEX**: And the OpenAI partnership is massive - they're on track for production late this year with a commitment to deploy 1.3 gigawatts in 2027 as part of a larger 10-gigawatt agreement through 2029. Then there's Meta with their MTIA partnership expecting to deploy 3 gigawatts through the end of 2028.

**JORDAN**: What I found fascinating in the Q&A was when Tan talked about their strategic vision. They're not just selling chips anymore - they're creating what they call the "AI XPU platform" with Apollo, Blackstone, and other major investors to deploy over 20 gigawatts of compute capacity. The first tranche alone is valued at $35 billion.

**ALEX**: That's a brilliant move, Jordan. Instead of just hoping their customers can finance these massive deployments, Broadcom is essentially helping create the infrastructure to fund it. It's like they're not just building the highway, they're helping finance the construction too.

**JORDAN**: And let's not forget about networking - this was about 40% of their AI revenue in the quarter. Tan mentioned they have at least one generation of technology leadership in networking, which is crucial because you can't build scalable AI clusters without world-class networking. They're shipping the industry's only 100 terabit Ethernet switch and are already taping out a 200 terabit version.

**ALEX**: The guidance going forward is just jaw-dropping. For fiscal 2026, they're expecting AI semiconductor revenue of $56 billion - that's up approximately 180% from fiscal 2025. And they're reiterating that fiscal 2027 will exceed $100 billion in AI semiconductor revenue.

**JORDAN**: One thing that

This episode includes AI-generated content.]]>SP100-AVGO-Q2-2026-enThu, 04 Jun 2026 09:11:57 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS) ────────── # Beta Finch Podcast Script: Broadcom Q2 2026 Earnings **ALEX**: Welcome to Beta Finch,...https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
# Beta Finch Podcast Script: Broadcom Q2 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex, and joining me as always is Jordan. Today we're diving into Broadcom's absolutely explosive Q2 2026 results that had Wall Street buzzing. But before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex, and wow - where do we even begin with these numbers? Broadcom just delivered what might be one of the most impressive quarters we've seen in the semiconductor space. We're talking about $22.2 billion in total revenue, up 48% year-over-year, with AI semiconductor revenue alone hitting $10.8 billion.

**ALEX**: That AI number is just staggering, Jordan. To put it in perspective, their AI semiconductor business grew 143% year-over-year. But what really caught my attention was CEO Hock Tan's guidance - they're expecting AI semiconductor revenue to hit $16 billion in Q3, which would be over 200% growth year-over-year.

**JORDAN**: And let's talk about those margins, because this is where Broadcom really shows its operational excellence. Operating margin hit a record 67% with adjusted EBITDA at 69% of revenue. Even as they're scaling up massively, they're maintaining these incredible margins through operational leverage.

**ALEX**: The bookings number was absolutely wild too - $30 billion in AI semiconductor bookings against $10.8 billion they actually shipped. That's nearly 3x coverage, which tells us demand is just insatiable right now.

**JORDAN**: Speaking of demand, let's break down what's driving this growth. Broadcom has essentially become the go-to partner for the biggest names in AI. They've got long-term agreements with Google for multiple generations of TPUs and AI networking. They're providing Anthropic with access to over 1 gigawatt of compute this year, with plans to scale that to 5 gigawatts starting in 2027.

**ALEX**: And the OpenAI partnership is massive - they're on track for production late this year with a commitment to deploy 1.3 gigawatts in 2027 as part of a larger 10-gigawatt agreement through 2029. Then there's Meta with their MTIA partnership expecting to deploy 3 gigawatts through the end of 2028.

**JORDAN**: What I found fascinating in the Q&A was when Tan talked about their strategic vision. They're not just selling chips anymore - they're creating what they call the "AI XPU platform" with Apollo, Blackstone, and other major investors to deploy over 20 gigawatts of compute capacity. The first tranche alone is valued at $35 billion.

**ALEX**: That's a brilliant move, Jordan. Instead of just hoping their customers can finance these massive deployments, Broadcom is essentially helping create the infrastructure to fund it. It's like they're not just building the highway, they're helping finance the construction too.

**JORDAN**: And let's not forget about networking - this was about 40% of their AI revenue in the quarter. Tan mentioned they have at least one generation of technology leadership in networking, which is crucial because you can't build scalable AI clusters without world-class networking. They're shipping the industry's only 100 terabit Ethernet switch and are already taping out a 200 terabit version.507falsefullhttps://www.spreaker.com/episode/boeing-q1-2026-earnings-analysis--72307818https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
# Beta Finch Podcast Script: Boeing Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the quarterly results that are moving markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Boeing's first quarter 2026 earnings, and folks, this is a company that's been through quite a journey over the past few years.

Before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Boeing. We're seeing some real signs of stability and momentum building across their business segments. The headline numbers tell a compelling story - revenue jumped 14% to $22.2 billion, which is solid growth across all three of their main divisions.

**ALEX:** That's right, and while they're still posting a core loss of 20 cents per share, that's actually an improvement from last year. What really caught my attention was CEO Kelly Ortberg's tone - he seems genuinely optimistic about where they're headed. He said they're "off to a really good start and headed in the right direction."

**JORDAN:** Absolutely, and let's talk about what's driving that optimism. The production story is fascinating here. They've stabilized 737 production at 42 aircraft per month, and they're planning to ramp up to 47 per month this summer. But here's what's really interesting - they delivered the final 737 MAX from their "shadow factory" inventory in Q1. That's significant because it means they're finally clearing out the backlog of aircraft built during the production halt.

**ALEX:** That's huge, Jordan. And speaking of production, they're bringing online a fourth 737 production line - the "North Line" in Everett. This is part of their plan to eventually reach 52 aircraft per month. What struck me was how methodical they're being about this ramp-up. They're moving experienced workers from their stable Renton facility to train new employees at Everett.

**JORDAN:** Smart approach, especially given their quality focus. They mentioned a 20% reduction in final assembly rework hours compared to last year - that's the kind of operational improvement that builds confidence. But let's address the elephant in the room - the Middle East conflict and its potential impact.

**ALEX:** Right, this came up several times during the Q&A. Ortberg was pretty clear that they haven't seen any delivery deferrals yet, and they actually delivered four aircraft to Middle East customers during the quarter. But he acknowledged they're watching fuel prices closely, since higher jet fuel costs could impact airline operations and aftermarket demand.

**JORDAN:** What's interesting is how Boeing is positioned if defense spending increases due to the conflict. Ortberg highlighted that their defense platforms - the Apache helicopter, Patriot missile systems, F-15EX fighters - are all seeing increased demand. He mentioned seeing potential upside in their five-year defense outlook compared to what they planned last year.

**ALEX:** Let's dig into those segment numbers. Commercial Airplanes had revenue of $9.2 billion, up 13%, though they're still posting negative margins. Defense, Space & Security grew 21% to $7.6 billion with a 3.1% operating margin. And Global Services - their most profitable segment - delivered $5.4 billion in revenue with an impressive 18.1% operating margin.

**JORDAN:** Those Global Services numbers are really solid. They booked $8 billion in new orders with a book-to-bill ratio of 1.6, and their backlog hit a record $33 billion. This is the steady, cash-generating business th

This episode includes AI-generated content.]]>SP100-BA-Q1-2026-enTue, 02 Jun 2026 21:43:40 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS) ────────── # Beta Finch Podcast Script: Boeing Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we...https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
# Beta Finch Podcast Script: Boeing Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the quarterly results that are moving markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Boeing's first quarter 2026 earnings, and folks, this is a company that's been through quite a journey over the past few years.

Before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Boeing. We're seeing some real signs of stability and momentum building across their business segments. The headline numbers tell a compelling story - revenue jumped 14% to $22.2 billion, which is solid growth across all three of their main divisions.

**ALEX:** That's right, and while they're still posting a core loss of 20 cents per share, that's actually an improvement from last year. What really caught my attention was CEO Kelly Ortberg's tone - he seems genuinely optimistic about where they're headed. He said they're "off to a really good start and headed in the right direction."

**JORDAN:** Absolutely, and let's talk about what's driving that optimism. The production story is fascinating here. They've stabilized 737 production at 42 aircraft per month, and they're planning to ramp up to 47 per month this summer. But here's what's really interesting - they delivered the final 737 MAX from their "shadow factory" inventory in Q1. That's significant because it means they're finally clearing out the backlog of aircraft built during the production halt.

**ALEX:** That's huge, Jordan. And speaking of production, they're bringing online a fourth 737 production line - the "North Line" in Everett. This is part of their plan to eventually reach 52 aircraft per month. What struck me was how methodical they're being about this ramp-up. They're moving experienced workers from their stable Renton facility to train new employees at Everett.

**JORDAN:** Smart approach, especially given their quality focus. They mentioned a 20% reduction in final assembly rework hours compared to last year - that's the kind of operational improvement that builds confidence. But let's address the elephant in the room - the Middle East conflict and its potential impact.

**ALEX:** Right, this came up several times during the Q&A. Ortberg was pretty clear that they haven't seen any delivery deferrals yet, and they actually delivered four aircraft to Middle East customers during the quarter. But he acknowledged they're watching fuel prices closely, since higher jet fuel costs could impact airline operations and aftermarket demand.

**JORDAN:** What's interesting is how Boeing is positioned if defense spending increases due to the conflict. Ortberg highlighted that their defense platforms - the Apache helicopter, Patriot missile systems, F-15EX fighters - are all seeing increased demand. He mentioned seeing potential upside in their five-year defense outlook compared to what they planned last year.

**ALEX:** Let's dig into those segment numbers. Commercial Airplanes had revenue of $9.2 billion, up 13%, though they're still posting negative margins. Defense, Space & Security grew 21% to $7.6 billion with a 3.1% operating margin. And Global Services - their most profitable segment - delivered $5.4 billion in revenue with an impressive 18.1%...]]>514falsefullhttps://www.spreaker.com/episode/costco-q3-2026-earnings-analysis--72222171https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script: Costco Q3 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Costco's third quarter 2026 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex! And what a quarter to analyze - Costco just delivered some pretty impressive numbers amid what they're calling "macro uncertainty." The headline numbers are solid: $69.2 billion in net sales, up 11.6% year-over-year, and earnings per share of $4.93, up 15% from last year's $4.28.

**ALEX**: Those are strong top and bottom line results, but Jordan, what really caught my attention was the gas business story. CEO Ron Vachris mentioned they hit successive all-time company volume sales records in all three 4-week periods of the quarter. That's pretty remarkable.

**JORDAN**: Absolutely! And here's what's fascinating about that gas story - it wasn't just about higher prices driving revenue. They actually saw record-breaking volumes because members were flocking to Costco gas stations as Middle East tensions drove up gas prices everywhere else. Vachris mentioned that the high consumer price sensitivity drove many members to use their gas stations for the very first time in Q3.

**ALEX**: That's a great point about customer acquisition through gas. And speaking of members, let's talk about the membership business, which is really Costco's secret sauce. They reported membership fee income of $1.37 billion, up 10.7% year-over-year. Jordan, what stood out to you in the membership metrics?

**JORDAN**: Two things really jumped out. First, they now have 41.2 million paid executive memberships - that's up 9.6% versus last year. Executive members are their higher-spending, more loyal customers. Second, they launched the executive program in China this quarter and saw "strong early adoption" that exceeded expectations. That's a huge market opportunity.

**ALEX**: The renewal rates are holding steady too - 92.2% in the US and Canada, which is incredibly strong. But let's dig into the financial performance a bit. The gross margin story is interesting here. Overall gross margin was down 21 basis points, but excluding gas inflation, it was actually up 1 basis point.

**JORDAN**: Right, and CFO Gary Millerchip was pretty clear that they intentionally invested in lower prices for members on everyday items like eggs and beef during the quarter. This is classic Costco - when they have the capacity to invest in member value, they do it. They're always trying to be "first to lower prices and last to raise them," as Vachris put it.

**ALEX**: That pricing philosophy really showed up in their digital business too. Digitally enabled comparable sales were up 21.5% - that's significantly outpacing their overall comp growth of 9.8%. What's driving that digital momentum?

**JORDAN**: A few key things. Their same-day delivery service is now averaging less than 45 minutes in the US with a 4.8 out of 5 member satisfaction rating. They've expanded same-day delivery to Spain and France. And here's something really forward-looking - they're starting to leverage AI to enhance their product pages online, which is increasing their relevance with large language models.

**ALEX**: That AI piece is fascinating. Millerchip mentioned they saw triple-digit growth in traffic from AI search, even though the volume is still low. But get this - that AI-driven traffic had the highest conversion rate of all traffic coming to their site.

**JORDAN**: That makes total sense when you think about it. Costco's value proposition - qua

This episode includes AI-generated content.]]>SP100-COST-Q3-2026-enFri, 29 May 2026 08:15:43 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL) ────────── # Beta Finch Podcast Script: Costco Q3 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script: Costco Q3 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Costco's third quarter 2026 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex! And what a quarter to analyze - Costco just delivered some pretty impressive numbers amid what they're calling "macro uncertainty." The headline numbers are solid: $69.2 billion in net sales, up 11.6% year-over-year, and earnings per share of $4.93, up 15% from last year's $4.28.

**ALEX**: Those are strong top and bottom line results, but Jordan, what really caught my attention was the gas business story. CEO Ron Vachris mentioned they hit successive all-time company volume sales records in all three 4-week periods of the quarter. That's pretty remarkable.

**JORDAN**: Absolutely! And here's what's fascinating about that gas story - it wasn't just about higher prices driving revenue. They actually saw record-breaking volumes because members were flocking to Costco gas stations as Middle East tensions drove up gas prices everywhere else. Vachris mentioned that the high consumer price sensitivity drove many members to use their gas stations for the very first time in Q3.

**ALEX**: That's a great point about customer acquisition through gas. And speaking of members, let's talk about the membership business, which is really Costco's secret sauce. They reported membership fee income of $1.37 billion, up 10.7% year-over-year. Jordan, what stood out to you in the membership metrics?

**JORDAN**: Two things really jumped out. First, they now have 41.2 million paid executive memberships - that's up 9.6% versus last year. Executive members are their higher-spending, more loyal customers. Second, they launched the executive program in China this quarter and saw "strong early adoption" that exceeded expectations. That's a huge market opportunity.

**ALEX**: The renewal rates are holding steady too - 92.2% in the US and Canada, which is incredibly strong. But let's dig into the financial performance a bit. The gross margin story is interesting here. Overall gross margin was down 21 basis points, but excluding gas inflation, it was actually up 1 basis point.

**JORDAN**: Right, and CFO Gary Millerchip was pretty clear that they intentionally invested in lower prices for members on everyday items like eggs and beef during the quarter. This is classic Costco - when they have the capacity to invest in member value, they do it. They're always trying to be "first to lower prices and last to raise them," as Vachris put it.

**ALEX**: That pricing philosophy really showed up in their digital business too. Digitally enabled comparable sales were up 21.5% - that's significantly outpacing their overall comp growth of 9.8%. What's driving that digital momentum?

**JORDAN**: A few key things. Their same-day delivery service is now averaging less than 45 minutes in the US with a 4.8 out of 5 member satisfaction rating. They've expanded same-day delivery to Spain and France. And here's something really forward-looking - they're starting to leverage AI to enhance their product pages online, which is increasing their relevance with large language models.

**ALEX**: That AI piece is fascinating. Millerchip mentioned they saw triple-digit growth in traffic from AI...]]>492falsefullhttps://www.spreaker.com/episode/salesforce-q1-2027-earnings-analysis--72217912https://betafinch.com
──────────
# Beta Finch Podcast Script - Salesforce Q1 2027 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Salesforce's first quarter fiscal 2027 results - and wow, this was quite the show.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, Salesforce really came out swinging this quarter. They beat expectations across the board and seem to be riding this massive AI wave. What were the headline numbers that caught your attention?

**ALEX:** The numbers were impressive, Jordan. Revenue hit $11.13 billion, up 13% year-over-year, which beat their guidance. But what really stood out was their profitability story - non-GAAP operating margin expanded 250 basis points to 34.8%. That's significant margin expansion for a company of this size.

**JORDAN:** And let's talk about what's driving this growth - their "Agentforce" AI platform. Marc Benioff was really excited about this, claiming they processed 28.6 trillion tokens in the quarter, up 152% quarter-over-quarter. That's an astronomical number.

**ALEX:** It really is. And they're converting those tokens into what they call "Agentic work units" - essentially AI doing actual work for customers. They hit 3.8 billion work units, up 111% quarter-over-quarter. But here's what's fascinating - Agentforce ARR has now surpassed $1 billion, and when you combine it with their data products, they're talking about $3.4 billion in AI and data ARR.

**JORDAN:** The customer testimonials were pretty compelling too. That PenFed Credit Union CEO, James Gank, was essentially giving Salesforce a live endorsement on their earnings call. He talked about deploying 76 AI agents across their operations and saving $1.6 million annually just from their call center AI alone.

**ALEX:** Right, and it wasn't just cost savings. He mentioned they're handling 500 transactions per second with the same headcount because the AI is making their employees more productive - what he called "bionic employees." That's the kind of real-world ROI that investors want to hear about.

**JORDAN:** Now, let's talk about this "Headless 360" strategy they announced. This was new terminology for Salesforce, and it seems to be generating a lot of buzz. What's your take on this?

**ALEX:** This is potentially huge, Jordan. Essentially, they're making all of Salesforce accessible through APIs, command-line interfaces, and what they call MCP - which allows other AI agents and coding tools to interact directly with Salesforce data. They processed 4.5 million MCP calls since launching in April.

**JORDAN:** And Marc Benioff called this "the biggest growth opportunity that any of us will see in our lifetime." That's a pretty bold statement. But I can see the logic - instead of customers having to log into Salesforce applications, they can access that data and functionality from anywhere, including ChatGPT, Claude, or their own custom agents.

**ALEX:** Exactly. And Miguel Milano, their Chief Revenue Officer, gave some great examples. Anthropic, one of the leading AI companies, increased their Salesforce usage fivefold because they can now access it "headlessly" through other tools. It's making Salesforce more valuable, not less.

**JORDAN:** Speaking of growth, let's talk about Slack. This was quietly one of the most impressive parts of the call. Slack drove nearly half of their million-dollar-plus deals this quarter, up 80% year-over-year.

**ALEX:** And the usage metrics are staggering. Slack Agentic Work Units grew 350% quarter-over-quarter. Benioff made a prediction that

This episode includes AI-generated content.]]>SP100-CRM-Q1-2027-enFri, 29 May 2026 02:02:54 +0000trueBeta FinchMore earnings analysis: https://betafinch.com ────────── # Beta Finch Podcast Script - Salesforce Q1 2027 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex. **JORDAN:** And...https://betafinch.com
──────────
# Beta Finch Podcast Script - Salesforce Q1 2027 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Salesforce's first quarter fiscal 2027 results - and wow, this was quite the show.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, Salesforce really came out swinging this quarter. They beat expectations across the board and seem to be riding this massive AI wave. What were the headline numbers that caught your attention?

**ALEX:** The numbers were impressive, Jordan. Revenue hit $11.13 billion, up 13% year-over-year, which beat their guidance. But what really stood out was their profitability story - non-GAAP operating margin expanded 250 basis points to 34.8%. That's significant margin expansion for a company of this size.

**JORDAN:** And let's talk about what's driving this growth - their "Agentforce" AI platform. Marc Benioff was really excited about this, claiming they processed 28.6 trillion tokens in the quarter, up 152% quarter-over-quarter. That's an astronomical number.

**ALEX:** It really is. And they're converting those tokens into what they call "Agentic work units" - essentially AI doing actual work for customers. They hit 3.8 billion work units, up 111% quarter-over-quarter. But here's what's fascinating - Agentforce ARR has now surpassed $1 billion, and when you combine it with their data products, they're talking about $3.4 billion in AI and data ARR.

**JORDAN:** The customer testimonials were pretty compelling too. That PenFed Credit Union CEO, James Gank, was essentially giving Salesforce a live endorsement on their earnings call. He talked about deploying 76 AI agents across their operations and saving $1.6 million annually just from their call center AI alone.

**ALEX:** Right, and it wasn't just cost savings. He mentioned they're handling 500 transactions per second with the same headcount because the AI is making their employees more productive - what he called "bionic employees." That's the kind of real-world ROI that investors want to hear about.

**JORDAN:** Now, let's talk about this "Headless 360" strategy they announced. This was new terminology for Salesforce, and it seems to be generating a lot of buzz. What's your take on this?

**ALEX:** This is potentially huge, Jordan. Essentially, they're making all of Salesforce accessible through APIs, command-line interfaces, and what they call MCP - which allows other AI agents and coding tools to interact directly with Salesforce data. They processed 4.5 million MCP calls since launching in April.

**JORDAN:** And Marc Benioff called this "the biggest growth opportunity that any of us will see in our lifetime." That's a pretty bold statement. But I can see the logic - instead of customers having to log into Salesforce applications, they can access that data and functionality from anywhere, including ChatGPT, Claude, or their own custom agents.

**ALEX:** Exactly. And Miguel Milano, their Chief Revenue Officer, gave some great examples. Anthropic, one of the leading AI companies, increased their Salesforce usage fivefold because they can now access it "headlessly" through other tools. It's making Salesforce more valuable, not less.

**JORDAN:** Speaking of growth, let's talk about Slack. This was quietly one of the most impressive parts of the call. Slack drove nearly half of...]]>521falsefullhttps://www.spreaker.com/episode/walmart-q1-2027-earnings-analysis--72104696https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and with me as always is Jordan. Today we're unpacking Walmart's Q1 2027 earnings - and folks, this retailer continues to surprise on multiple fronts.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Walmart just delivered their ninth consecutive quarter of 20%+ eCommerce growth in the U.S. That's remarkable consistency for a company this size.

**JORDAN**: Absolutely, Alex. And the headline numbers are impressive across the board. Consolidated revenue grew nearly 6% in constant currency - that's 120 basis points above the top end of their guidance range. What really caught my attention though is how they're transforming their profit mix. Alternative revenue streams like advertising and membership now represent about one-third of operating income. That's a completely different Walmart than we saw even five years ago.

**ALEX**: Let's break down some of these key metrics. CEO John Furner mentioned they now have about 7,200 rollbacks in place - that's up 20% from last year. But the real story seems to be their speed game. They can now reach 60% of the U.S. population with delivery in 30 minutes or less. Jordan, what's driving this acceleration?

**JORDAN**: It's their omnichannel infrastructure finally hitting its stride, Alex. They delivered over 3.5 billion units same or next day globally this quarter. More than 36% of U.S. store-fulfilled deliveries arrived in under 3 hours - that's an 800 basis point improvement over just two years. And here's the kicker: their AI shopping agent "Sparky" is seeing weekly active users up over 100% quarter-over-quarter, with customers using Sparky spending 35% more on average.

**ALEX**: Speaking of technology, the automation story is fascinating. CFO John Rainey noted that about half of their eCommerce fulfillment center volume is now automated, and over 60% of stores receive freight from automated distribution centers. But they're dealing with some headwinds too - fuel costs hit them with about $175 million in unexpected expenses this quarter.

**JORDAN**: That fuel impact was significant - about 250 basis points of operating income growth. But here's what impressed me: they absorbed that hit and still reiterated their full-year guidance. Rainey was clear they're viewing this as a temporary cost to maintain their competitive position and drive market share gains. Transaction growth in the U.S. was their strongest in six quarters, so the strategy seems to be working.

**ALEX**: The marketplace business really stood out - 50% net sales growth in the U.S. They're expanding this globally too, launching cross-border marketplace capabilities into Canada and Mexico. How should investors think about this growth engine?

**JORDAN**: This is where the platform strategy gets exciting, Alex. They've built these capabilities once and now they're scaling globally. Marketplace growth of nearly 50% combined with their Walmart Fulfillment Services seeing 150% growth in same-day and next-day units - it's creating a flywheel effect. More sellers attract more selection, which drives more customers, which generates more advertising revenue. Their third-party marketplace advertising revenues alone grew over 50% year-over-year.

**ALEX**: Let's talk about the consumer environment because there were some interesting insights in the Q&A. They're seeing a real bifurcation - higher income customers spending with confidence while lower income consumers are more budget conscious. Rainey

This episode includes AI-generated content.]]>SP100-WMT-Q1-2027-enThu, 21 May 2026 22:20:39 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL) ────────── **BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and with me as always is Jordan. Today we're unpacking Walmart's Q1 2027 earnings - and folks, this retailer continues to surprise on multiple fronts.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Walmart just delivered their ninth consecutive quarter of 20%+ eCommerce growth in the U.S. That's remarkable consistency for a company this size.

**JORDAN**: Absolutely, Alex. And the headline numbers are impressive across the board. Consolidated revenue grew nearly 6% in constant currency - that's 120 basis points above the top end of their guidance range. What really caught my attention though is how they're transforming their profit mix. Alternative revenue streams like advertising and membership now represent about one-third of operating income. That's a completely different Walmart than we saw even five years ago.

**ALEX**: Let's break down some of these key metrics. CEO John Furner mentioned they now have about 7,200 rollbacks in place - that's up 20% from last year. But the real story seems to be their speed game. They can now reach 60% of the U.S. population with delivery in 30 minutes or less. Jordan, what's driving this acceleration?

**JORDAN**: It's their omnichannel infrastructure finally hitting its stride, Alex. They delivered over 3.5 billion units same or next day globally this quarter. More than 36% of U.S. store-fulfilled deliveries arrived in under 3 hours - that's an 800 basis point improvement over just two years. And here's the kicker: their AI shopping agent "Sparky" is seeing weekly active users up over 100% quarter-over-quarter, with customers using Sparky spending 35% more on average.

**ALEX**: Speaking of technology, the automation story is fascinating. CFO John Rainey noted that about half of their eCommerce fulfillment center volume is now automated, and over 60% of stores receive freight from automated distribution centers. But they're dealing with some headwinds too - fuel costs hit them with about $175 million in unexpected expenses this quarter.

**JORDAN**: That fuel impact was significant - about 250 basis points of operating income growth. But here's what impressed me: they absorbed that hit and still reiterated their full-year guidance. Rainey was clear they're viewing this as a temporary cost to maintain their competitive position and drive market share gains. Transaction growth in the U.S. was their strongest in six quarters, so the strategy seems to be working.

**ALEX**: The marketplace business really stood out - 50% net sales growth in the U.S. They're expanding this globally too, launching cross-border marketplace capabilities into Canada and Mexico. How should investors think about this growth engine?

**JORDAN**: This is where the platform strategy gets exciting, Alex. They've built these capabilities once and now they're scaling globally. Marketplace growth of nearly 50% combined with their Walmart Fulfillment Services seeing 150% growth in same-day and next-day units - it's creating a flywheel effect. More sellers attract more selection, which drives more customers, which generates more advertising revenue. Their third-party marketplace advertising revenues alone grew over 50% year-over-year.
510falsefullhttps://www.spreaker.com/episode/deere-company-q2-2026-earnings-analysis--72104695https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Deere & Company's Q2 2026 earnings call. Jordan, before we dig in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter it was for Deere! The agricultural giant posted some really interesting results that tell a tale of resilience despite challenging market conditions. Let me start with the headline numbers - net sales came in at $13.37 billion, up 5% year-over-year, with equipment operations margins hitting 16.9%.

**ALEX**: Those are solid numbers, but there's a big asterisk here, right? The margins got a significant boost from something pretty unusual.

**JORDAN**: Exactly! Deere recorded a massive $272 million recovery from IEEPA tariff refunds - basically getting money back from tariffs they'd previously paid. Without that one-time benefit, the underlying story becomes more nuanced. This refund alone lifted margins by about 2.5 percentage points.

**ALEX**: So let's break down what's happening across their three main business segments, because this is where the story gets really interesting. Jordan, it sounds like we're seeing very different cycles playing out simultaneously.

**JORDAN**: That's the key insight, Alex. Production and Precision Ag - their large agriculture business - saw sales drop 14% to $4.5 billion. This reflects the ongoing challenges in large ag markets with elevated input costs, high interest rates, and cautious farmer sentiment despite recent grain price increases.

**ALEX**: But on the flip side, their smaller segments are firing on all cylinders?

**JORDAN**: Absolutely. Small Ag and Turf was the star performer with sales up 16% to $3.48 billion and operating margins over 20%. Management highlighted strength in turf markets recovering after several down years, plus healthy dairy and livestock sectors. Construction & Forestry also impressed with sales jumping 29% to $3.79 billion, driven by robust infrastructure spending and data center construction.

**ALEX**: I found it fascinating how CEO Brent Norwood described this as having all three segments "operating at different points in the cycle." Can you explain what that means for investors?

**JORDAN**: It's actually a strength, Alex. While large ag is operating "below trough levels," small ag and turf is progressing toward "mid-cycle," and construction is "slightly above mid-cycle." This diversification provides resilience - when one segment struggles, others can compensate. It's like having a balanced portfolio within a single company.

**ALEX**: Now, let's talk about the elephant in the room - tariffs. This has been a major headwind for Deere, but the dynamics are shifting, right?

**JORDAN**: The tariff situation is incredibly complex. While they got that $272 million refund I mentioned, their overall tariff exposure remains about $1.2 billion annually - roughly a 3% margin headwind. What's interesting is management's approach. CFO Josh Beal emphasized they're not passing tariff costs to customers through surcharges, instead focusing on cost mitigation strategies like reshoring and sourcing adjustments.

**ALEX**: That seems like a customer-friendly approach, but how sustainable is it?

**JORDAN**: Management seems confident in their mitigation efforts. About 80% of Deere's U.S. sales are produced domestically with 75% of components sourced from U.S. suppliers. They're doubling down on this with $20 billion committed to U.S. manufacturing investment over the next decade. They just started building excavators in North Carolina following a

This episode includes AI-generated content.]]>SP100-DE-Q2-2026-enThu, 21 May 2026 22:20:34 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS) ────────── **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into...https://betafinch.com
Groups: INDUSTRIALS (https://betafinch.com/groups/INDUSTRIALS)
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Deere & Company's Q2 2026 earnings call. Jordan, before we dig in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter it was for Deere! The agricultural giant posted some really interesting results that tell a tale of resilience despite challenging market conditions. Let me start with the headline numbers - net sales came in at $13.37 billion, up 5% year-over-year, with equipment operations margins hitting 16.9%.

**ALEX**: Those are solid numbers, but there's a big asterisk here, right? The margins got a significant boost from something pretty unusual.

**JORDAN**: Exactly! Deere recorded a massive $272 million recovery from IEEPA tariff refunds - basically getting money back from tariffs they'd previously paid. Without that one-time benefit, the underlying story becomes more nuanced. This refund alone lifted margins by about 2.5 percentage points.

**ALEX**: So let's break down what's happening across their three main business segments, because this is where the story gets really interesting. Jordan, it sounds like we're seeing very different cycles playing out simultaneously.

**JORDAN**: That's the key insight, Alex. Production and Precision Ag - their large agriculture business - saw sales drop 14% to $4.5 billion. This reflects the ongoing challenges in large ag markets with elevated input costs, high interest rates, and cautious farmer sentiment despite recent grain price increases.

**ALEX**: But on the flip side, their smaller segments are firing on all cylinders?

**JORDAN**: Absolutely. Small Ag and Turf was the star performer with sales up 16% to $3.48 billion and operating margins over 20%. Management highlighted strength in turf markets recovering after several down years, plus healthy dairy and livestock sectors. Construction & Forestry also impressed with sales jumping 29% to $3.79 billion, driven by robust infrastructure spending and data center construction.

**ALEX**: I found it fascinating how CEO Brent Norwood described this as having all three segments "operating at different points in the cycle." Can you explain what that means for investors?

**JORDAN**: It's actually a strength, Alex. While large ag is operating "below trough levels," small ag and turf is progressing toward "mid-cycle," and construction is "slightly above mid-cycle." This diversification provides resilience - when one segment struggles, others can compensate. It's like having a balanced portfolio within a single company.

**ALEX**: Now, let's talk about the elephant in the room - tariffs. This has been a major headwind for Deere, but the dynamics are shifting, right?

**JORDAN**: The tariff situation is incredibly complex. While they got that $272 million refund I mentioned, their overall tariff exposure remains about $1.2 billion annually - roughly a 3% margin headwind. What's interesting is management's approach. CFO Josh Beal emphasized they're not passing tariff costs to customers through surcharges, instead focusing on cost mitigation strategies like reshoring and sourcing adjustments.

**ALEX**: That seems like a customer-friendly approach, but how sustainable is it?

**JORDAN**: Management seems confident in their mitigation efforts. About 80% of...]]>534falsefullhttps://www.spreaker.com/episode/nvidia-q1-2027-earnings-analysis--72095860https://betafinch.com
Groups: MAG7 (https://betafinch.com/groups/MAG7), CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
# Beta Finch Podcast Script: Nvidia Q1 2027 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex, and I'm here with my co-host Jordan. Today we're diving into Nvidia's absolutely mind-blowing Q1 2027 results that just dropped. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, where do we even begin with these numbers? Nvidia just reported $82 billion in quarterly revenue - that's up 85% year-over-year and 20% sequentially. To put that in perspective, they added $13.5 billion in revenue in just one quarter, which they're calling a record sequential increase.

**ALEX**: It's absolutely staggering, Jordan. And what really caught my attention is that this marks their third consecutive quarter of year-over-year acceleration. When you're already at this massive scale, continuing to accelerate growth is almost unprecedented. Their data center revenue alone hit $75 billion, up 92% year-over-year.

**JORDAN**: The Blackwell architecture is really the star of the show here. CEO Jensen Huang called it "the fastest product ramp in our company's history." What's interesting is they're seeing demand from everywhere - hyperscalers, AI cloud providers, sovereign customers, even enterprise and industrial applications.

**ALEX**: Speaking of segmentation, Jordan, they made some pretty significant changes to how they report their business. They've broken their data center segment into two main categories: Hyperscale and something they're calling ACIE - which stands for AI clouds, industrial, and enterprise. What's your take on this restructuring?

**JORDAN**: It's actually brilliant strategic positioning, Alex. The Hyperscale segment, which includes the big public cloud providers, generated $38 billion and grew 12% quarter-over-quarter. But here's what's really exciting - that ACIE segment hit $37 billion and grew 31% quarter-over-quarter. This shows Nvidia isn't just dependent on the big tech giants anymore.

**ALEX**: Exactly. And Jensen Huang was pretty eloquent about this during the Q&A. He explained that AI is incredibly diverse - from language models to 3D graphics for manufacturing, to proteins for life sciences. The applications run everywhere from hyperscale clouds to enterprise on-premises to industrial facilities. Nvidia is positioning itself as the only company that can serve all these different use cases with their full-stack solution.

**JORDAN**: What absolutely blew my mind was their announcement about Vera - their new CPU designed specifically for agentic AI. Jensen said this opens up a brand new $200 billion total addressable market that they've never addressed before. And get this - they're projecting nearly $20 billion in CPU revenue visibility just this year.

**ALEX**: That's a massive new growth driver, Jordan. And Jensen was really passionate explaining how agentic AI works differently. He described agents as essentially having "harnesses" around AI models that handle orchestration, memory management, and tool use - and all of that runs on CPUs. With billions of potential agents in the future, each needing their own computational resources, you can see why this CPU opportunity is so massive.

**JORDAN**: The financial metrics are just incredible across the board. They generated a record $49 billion in free cash flow, up from $35 billion in Q4. And speaking of returning value to shareholders - they're increasing their quarterly dividend from one cent to 25 cents per share, plus announcing an $80 billion share repu

This episode includes AI-generated content.]]>SP100-NVDA-Q1-2027-enThu, 21 May 2026 10:29:58 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: MAG7 (https://betafinch.com/groups/MAG7), CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS) ────────── # Beta Finch Podcast Script: Nvidia Q1 2027...https://betafinch.com
Groups: MAG7 (https://betafinch.com/groups/MAG7), CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
# Beta Finch Podcast Script: Nvidia Q1 2027 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex, and I'm here with my co-host Jordan. Today we're diving into Nvidia's absolutely mind-blowing Q1 2027 results that just dropped. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, where do we even begin with these numbers? Nvidia just reported $82 billion in quarterly revenue - that's up 85% year-over-year and 20% sequentially. To put that in perspective, they added $13.5 billion in revenue in just one quarter, which they're calling a record sequential increase.

**ALEX**: It's absolutely staggering, Jordan. And what really caught my attention is that this marks their third consecutive quarter of year-over-year acceleration. When you're already at this massive scale, continuing to accelerate growth is almost unprecedented. Their data center revenue alone hit $75 billion, up 92% year-over-year.

**JORDAN**: The Blackwell architecture is really the star of the show here. CEO Jensen Huang called it "the fastest product ramp in our company's history." What's interesting is they're seeing demand from everywhere - hyperscalers, AI cloud providers, sovereign customers, even enterprise and industrial applications.

**ALEX**: Speaking of segmentation, Jordan, they made some pretty significant changes to how they report their business. They've broken their data center segment into two main categories: Hyperscale and something they're calling ACIE - which stands for AI clouds, industrial, and enterprise. What's your take on this restructuring?

**JORDAN**: It's actually brilliant strategic positioning, Alex. The Hyperscale segment, which includes the big public cloud providers, generated $38 billion and grew 12% quarter-over-quarter. But here's what's really exciting - that ACIE segment hit $37 billion and grew 31% quarter-over-quarter. This shows Nvidia isn't just dependent on the big tech giants anymore.

**ALEX**: Exactly. And Jensen Huang was pretty eloquent about this during the Q&A. He explained that AI is incredibly diverse - from language models to 3D graphics for manufacturing, to proteins for life sciences. The applications run everywhere from hyperscale clouds to enterprise on-premises to industrial facilities. Nvidia is positioning itself as the only company that can serve all these different use cases with their full-stack solution.

**JORDAN**: What absolutely blew my mind was their announcement about Vera - their new CPU designed specifically for agentic AI. Jensen said this opens up a brand new $200 billion total addressable market that they've never addressed before. And get this - they're projecting nearly $20 billion in CPU revenue visibility just this year.

**ALEX**: That's a massive new growth driver, Jordan. And Jensen was really passionate explaining how agentic AI works differently. He described agents as essentially having "harnesses" around AI models that handle orchestration, memory management, and tool use - and all of that runs on CPUs. With billions of potential agents in the future, each needing their own computational resources, you can see why this...]]>484falsefullhttps://www.spreaker.com/episode/tjx-companies-q1-2027-earnings-analysis--72091041https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**Beta Finch Podcast Script: TJX Companies Q1 2027 Earnings**

---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into TJX Companies' first quarter 2027 results - and wow, what a quarter for the off-price retail giant.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, TJX just delivered some seriously impressive numbers. Walk us through the headline figures.

**ALEX:** The numbers are genuinely eye-popping, Jordan. TJX posted earnings per share of $1.19, up 29% year-over-year and well above expectations. But here's what really caught my attention - they achieved a 6% comparable sales increase across the board. That's not just one division carrying the load; every single banner delivered strong comp growth.

**JORDAN:** That consistency is remarkable. And it wasn't just top-line growth, right? Their pretax profit margin hit 12.0%, up 170 basis points. Gross margin expanded 180 basis points to 31.3%. These are the kind of margin expansions that make investors sit up and take notice.

**ALEX:** Exactly. And get this - CEO Ernie Herrman said this performance was so strong that they're raising full-year guidance. They bumped consolidated sales guidance to $63.2 to $63.7 billion, and increased earnings per share guidance to $5.08 to $5.15. When's the last time you saw a company raise full-year guidance in their first quarter?

**JORDAN:** That's confidence right there. Let's break down what's driving this performance. The comp sales growth was split equally between higher average basket and increased customer transactions. So they're getting more people through the doors AND those people are spending more per visit.

**ALEX:** The geographic spread is fascinating too. Marmaxx in the US delivered 6% comp growth, but HomeGoods absolutely crushed it with 9% comp growth. Even their international segments performed well - Canada up 7%, international up 4%.

**JORDAN:** I love what Herrman said about their buying power in this environment. He mentioned they have over 1,400 buyers in the marketplace, and with economic uncertainty, they're often the "first call" for vendors looking to clear inventory. It's like TJX is built for these kinds of challenging retail environments.

**ALEX:** That's a great point. There was an interesting exchange during the Q&A about customer behavior. An analyst asked if customers were trading down or avoiding higher-priced items, but management pushed back, saying they're not seeing any change in purchasing patterns across income demographics.

**JORDAN:** Which suggests their "good, better, best" strategy is really working. They're capturing customers across all income levels. Herrman also mentioned something intriguing about new customer acquisition - they're seeing a "disproportionately younger age group" of new customers, particularly Gen Z and millennials.

**ALEX:** That's huge for long-term growth. Speaking of long-term, they just opened their first store in Spain, and management sounds very bullish about international expansion opportunities. They mentioned potentially revisiting their long-term store count targets.

**JORDAN:** The fuel situation is worth noting too. CFO John Klinger explained that they benefited from fuel hedges in Q1, but they're assuming current diesel prices remain elevated for the rest of the year. If fuel prices drop, that could be upside to profitability.

**ALEX:** There was also a subtle but important comment about inventory levels being up 8%. Normally that might concern investors, but in TJX

This episode includes AI-generated content.]]>SP100-TJX-Q1-2027-enWed, 20 May 2026 22:26:32 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL) ────────── **Beta Finch Podcast Script: TJX Companies Q1 2027 Earnings** --- **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown....https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
**Beta Finch Podcast Script: TJX Companies Q1 2027 Earnings**

---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into TJX Companies' first quarter 2027 results - and wow, what a quarter for the off-price retail giant.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, TJX just delivered some seriously impressive numbers. Walk us through the headline figures.

**ALEX:** The numbers are genuinely eye-popping, Jordan. TJX posted earnings per share of $1.19, up 29% year-over-year and well above expectations. But here's what really caught my attention - they achieved a 6% comparable sales increase across the board. That's not just one division carrying the load; every single banner delivered strong comp growth.

**JORDAN:** That consistency is remarkable. And it wasn't just top-line growth, right? Their pretax profit margin hit 12.0%, up 170 basis points. Gross margin expanded 180 basis points to 31.3%. These are the kind of margin expansions that make investors sit up and take notice.

**ALEX:** Exactly. And get this - CEO Ernie Herrman said this performance was so strong that they're raising full-year guidance. They bumped consolidated sales guidance to $63.2 to $63.7 billion, and increased earnings per share guidance to $5.08 to $5.15. When's the last time you saw a company raise full-year guidance in their first quarter?

**JORDAN:** That's confidence right there. Let's break down what's driving this performance. The comp sales growth was split equally between higher average basket and increased customer transactions. So they're getting more people through the doors AND those people are spending more per visit.

**ALEX:** The geographic spread is fascinating too. Marmaxx in the US delivered 6% comp growth, but HomeGoods absolutely crushed it with 9% comp growth. Even their international segments performed well - Canada up 7%, international up 4%.

**JORDAN:** I love what Herrman said about their buying power in this environment. He mentioned they have over 1,400 buyers in the marketplace, and with economic uncertainty, they're often the "first call" for vendors looking to clear inventory. It's like TJX is built for these kinds of challenging retail environments.

**ALEX:** That's a great point. There was an interesting exchange during the Q&A about customer behavior. An analyst asked if customers were trading down or avoiding higher-priced items, but management pushed back, saying they're not seeing any change in purchasing patterns across income demographics.

**JORDAN:** Which suggests their "good, better, best" strategy is really working. They're capturing customers across all income levels. Herrman also mentioned something intriguing about new customer acquisition - they're seeing a "disproportionately younger age group" of new customers, particularly Gen Z and millennials.

**ALEX:** That's huge for long-term growth. Speaking of long-term, they just opened their first store in Spain, and management sounds very bullish about international expansion opportunities. They mentioned potentially revisiting their long-term store count targets.

**JORDAN:** The fuel situation is worth noting too. CFO John Klinger explained that they benefited from fuel hedges in Q1,...]]>464falsefullhttps://www.spreaker.com/episode/lowe-s-q1-2027-earnings-analysis--72091039https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script - Lowe's Q1 2027 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate earnings calls so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Lowe's first quarter 2027 results, and folks, this one's got some interesting twists.

Before we jump in though, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. So Lowe's just reported their Q1 2027 numbers, and there's actually quite a bit to unpack here. The headline numbers look solid - they hit $23.1 billion in sales, up over 10% year-over-year, with comparable sales growing 0.6%. That might not sound like much, but in this housing environment, any positive comp growth is actually pretty impressive.

**ALEX:** Absolutely. And their adjusted earnings per share came in at $3.03, up nearly 4% from last year. But Jordan, what really caught my attention was how weather played such a big role in shaping their quarter. February storms apparently knocked 30 basis points off their entire quarterly performance just from the first weekend alone!

**JORDAN:** That's wild when you think about it - one weekend of bad weather impacting an entire quarter. But they recovered nicely. March comps were actually up 2.1% as spring weather kicked in. What I found interesting is how CEO Marvin Ellison described this as "the most difficult housing market since the financial crisis," yet they're still managing positive growth.

**ALEX:** Right, and that's where their strategy really shines through. They're not just sitting back waiting for the housing market to recover. Their "Total Home" strategy is firing on multiple cylinders. Let's talk about some of these growth drivers - their online business grew 15.5% in the quarter, which is huge.

**JORDAN:** And here's where it gets really interesting from a tech perspective, Alex. They've got this AI shopping assistant called "Mylow" that's now handling over 1 million customer inquiries per month. But get this - customers who use Mylow have triple the conversion rate of those who don't. That's not just incremental improvement, that's transformational.

**ALEX:** That's a perfect example of AI actually delivering measurable business results rather than just being a buzzword. And they're using AI on the associate side too with something called "Mylow Companion" - their store employees have asked over 5 million questions through this system since launch. Even veteran employees are embracing it because it's making them more effective.

**JORDAN:** Speaking of effectiveness, let's talk about their Pro business, because this is where Lowe's is really differentiating itself. They're seeing continued strength with small to medium professional contractors, and they've launched this "Pro Extended Aisle" concept that lets them offer products without actually stocking them in stores.

**ALEX:** It's like having infinite shelf space, right? And they're backing that up with same-day delivery for loyalty members on orders over $25. But here's something that really stood out to me - they just announced a $250 million investment in skilled trades training through the Lowe's Foundation. That's not just corporate social responsibility, that's strategic.

**JORDAN:** Exactly! They're literally investing in creating their future customers. If there aren't enough skilled tradespeople, that directly impacts demand for their products. It's brilliant long-term thinking. Now, let's talk about the challenges because it wasn't all roses. Gross margins were down 70 basis points, largely due to

This episode includes AI-generated content.]]>SP100-LOW-Q1-2027-enWed, 20 May 2026 22:26:26 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL) ────────── # Beta Finch Podcast Script - Lowe's Q1 2027 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script - Lowe's Q1 2027 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate earnings calls so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Lowe's first quarter 2027 results, and folks, this one's got some interesting twists.

Before we jump in though, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. So Lowe's just reported their Q1 2027 numbers, and there's actually quite a bit to unpack here. The headline numbers look solid - they hit $23.1 billion in sales, up over 10% year-over-year, with comparable sales growing 0.6%. That might not sound like much, but in this housing environment, any positive comp growth is actually pretty impressive.

**ALEX:** Absolutely. And their adjusted earnings per share came in at $3.03, up nearly 4% from last year. But Jordan, what really caught my attention was how weather played such a big role in shaping their quarter. February storms apparently knocked 30 basis points off their entire quarterly performance just from the first weekend alone!

**JORDAN:** That's wild when you think about it - one weekend of bad weather impacting an entire quarter. But they recovered nicely. March comps were actually up 2.1% as spring weather kicked in. What I found interesting is how CEO Marvin Ellison described this as "the most difficult housing market since the financial crisis," yet they're still managing positive growth.

**ALEX:** Right, and that's where their strategy really shines through. They're not just sitting back waiting for the housing market to recover. Their "Total Home" strategy is firing on multiple cylinders. Let's talk about some of these growth drivers - their online business grew 15.5% in the quarter, which is huge.

**JORDAN:** And here's where it gets really interesting from a tech perspective, Alex. They've got this AI shopping assistant called "Mylow" that's now handling over 1 million customer inquiries per month. But get this - customers who use Mylow have triple the conversion rate of those who don't. That's not just incremental improvement, that's transformational.

**ALEX:** That's a perfect example of AI actually delivering measurable business results rather than just being a buzzword. And they're using AI on the associate side too with something called "Mylow Companion" - their store employees have asked over 5 million questions through this system since launch. Even veteran employees are embracing it because it's making them more effective.

**JORDAN:** Speaking of effectiveness, let's talk about their Pro business, because this is where Lowe's is really differentiating itself. They're seeing continued strength with small to medium professional contractors, and they've launched this "Pro Extended Aisle" concept that lets them offer products without actually stocking them in stores.

**ALEX:** It's like having infinite shelf space, right? And they're backing that up with same-day delivery for loyalty members on orders over $25. But here's something that really stood out to me - they just announced a $250 million investment in skilled trades training through the Lowe's Foundation. That's not just corporate social responsibility, that's strategic.

**JORDAN:** Exactly! They're literally investing in creating their future customers. If...]]>510falsefullhttps://www.spreaker.com/episode/analog-devices-q2-2026-earnings-analysis--72086498https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm joined by my co-host Jordan to break down some truly impressive results from Analog Devices.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, ADI just dropped some seriously impressive Q2 2026 numbers. What jumped out at you first?

JORDAN: Alex, these weren't just good results - they were record-breaking across the board. ADI posted $3.62 billion in revenue, which beat the high end of their guidance and represents 15% sequential growth and a massive 37% year-over-year jump. But here's what really caught my attention: their earnings per share hit $3.09, up 67% year-over-year. That's the kind of growth that makes investors sit up and take notice.

ALEX: Those are some serious numbers. And what's fascinating is that this growth isn't coming from just one area - it's broad-based. Can you break down where this strength is coming from?

JORDAN: Absolutely. The industrial segment, which now represents 50% of their revenue, was the real powerhouse - up 20% sequentially and 56% year-over-year. But what's really exciting is their data center business within communications. This segment grew over 90% year-over-year, and CEO Vincent Roche mentioned it's being driven equally by their optical and power portfolios. That's where the AI infrastructure boom is really showing up.

ALEX: Speaking of AI, they made a pretty significant strategic move during the quarter. Tell us about this Empower Semiconductor acquisition.

JORDAN: This is where things get really interesting from a technology standpoint. ADI is acquiring Empower Semiconductor for their integrated voltage regulator technology and silicon capacitors. Roche described this as the "final piece" of their comprehensive grid-to-core power platform. The compelling part? Empower's technology can allegedly reduce data center power consumption by 10-15% while shrinking power footprints by up to 4x. In an AI world where power efficiency is becoming critical, that's huge.

ALEX: And the timing seems perfect given what we're hearing about power constraints in data centers. What did management say about when this technology will start generating meaningful revenue?

JORDAN: Roche was pretty clear - they expect to see significant revenue starting in 2027. Right now, Empower has minimal revenue, but there are design wins already in the pipeline. The combination of Empower's cutting-edge tech with ADI's manufacturing scale and go-to-market capabilities should accelerate deployment significantly.

ALEX: Let's talk about their automotive business, because that's been a mixed bag across the semiconductor industry lately. How did ADI perform there?

JORDAN: This was actually one of the pleasant surprises. Auto revenue was up 8% sequentially and 2% year-over-year, which doesn't sound massive until you consider the broader auto semiconductor headwinds we've been seeing. What's really impressive is that their battery management systems for EVs returned to year-over-year growth for the first time in two years. CFO Richard Puccio mentioned they saw record performance in Europe and Japan, plus a material pickup in China during the back part of the quarter.

ALEX: That China recovery is interesting. Now, let's talk margins because 73% gross margin is pretty extraordinary. Is this sustainable?

JORDAN: That's the key question. The 73% gross margin was driven by favorable mix, higher utilization, and pricing actions. But Puccio was pretty candid that they're running factories near capacity, so there's limited upside from utiliza

This episode includes AI-generated content.]]>SP100-ADI-Q2-2026-enWed, 20 May 2026 17:13:32 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: CHIPS (https://betafinch.com/groups/CHIPS) ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm joined by my...https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm joined by my co-host Jordan to break down some truly impressive results from Analog Devices.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, ADI just dropped some seriously impressive Q2 2026 numbers. What jumped out at you first?

JORDAN: Alex, these weren't just good results - they were record-breaking across the board. ADI posted $3.62 billion in revenue, which beat the high end of their guidance and represents 15% sequential growth and a massive 37% year-over-year jump. But here's what really caught my attention: their earnings per share hit $3.09, up 67% year-over-year. That's the kind of growth that makes investors sit up and take notice.

ALEX: Those are some serious numbers. And what's fascinating is that this growth isn't coming from just one area - it's broad-based. Can you break down where this strength is coming from?

JORDAN: Absolutely. The industrial segment, which now represents 50% of their revenue, was the real powerhouse - up 20% sequentially and 56% year-over-year. But what's really exciting is their data center business within communications. This segment grew over 90% year-over-year, and CEO Vincent Roche mentioned it's being driven equally by their optical and power portfolios. That's where the AI infrastructure boom is really showing up.

ALEX: Speaking of AI, they made a pretty significant strategic move during the quarter. Tell us about this Empower Semiconductor acquisition.

JORDAN: This is where things get really interesting from a technology standpoint. ADI is acquiring Empower Semiconductor for their integrated voltage regulator technology and silicon capacitors. Roche described this as the "final piece" of their comprehensive grid-to-core power platform. The compelling part? Empower's technology can allegedly reduce data center power consumption by 10-15% while shrinking power footprints by up to 4x. In an AI world where power efficiency is becoming critical, that's huge.

ALEX: And the timing seems perfect given what we're hearing about power constraints in data centers. What did management say about when this technology will start generating meaningful revenue?

JORDAN: Roche was pretty clear - they expect to see significant revenue starting in 2027. Right now, Empower has minimal revenue, but there are design wins already in the pipeline. The combination of Empower's cutting-edge tech with ADI's manufacturing scale and go-to-market capabilities should accelerate deployment significantly.

ALEX: Let's talk about their automotive business, because that's been a mixed bag across the semiconductor industry lately. How did ADI perform there?

JORDAN: This was actually one of the pleasant surprises. Auto revenue was up 8% sequentially and 2% year-over-year, which doesn't sound massive until you consider the broader auto semiconductor headwinds we've been seeing. What's really impressive is that their battery management systems for EVs returned to year-over-year growth for the first time in two years. CFO Richard Puccio mentioned they saw record performance in Europe and Japan, plus a material pickup in China during the back part of the quarter.

ALEX: That China recovery is interesting. Now, let's talk margins because 73% gross margin is pretty extraordinary. Is...]]>489falsefullhttps://www.spreaker.com/episode/home-depot-q1-2026-earnings-analysis--72075053https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script - Home Depot Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate speak into plain English. I'm Alex, and I'm here with my co-host Jordan to dive into Home Depot's first quarter 2026 results.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter to unpack from the home improvement giant. Home Depot just reported $41.8 billion in sales - that's up 4.8% year-over-year. But the real story is in the details, isn't it?

**ALEX:** Absolutely. The headline numbers look decent, but when you dig deeper, you can see the challenges they're facing. Comparable store sales were only up 0.6% - barely positive. And here's what's interesting about the monthly breakdown: February was up 0.7%, March jumped to positive 2%, but then April went negative 0.5%.

**JORDAN:** That April drop really tells a story about weather impact and consumer behavior. CEO Ted Decker mentioned that when weather was favorable in the Northern and Western divisions, customers engaged in outdoor projects. But those bigger discretionary projects? Still under pressure. It's like consumers are buying the essentials but holding back on major renovations.

**ALEX:** The earnings picture reflects that cautiousness too. Adjusted diluted earnings per share came in at $3.43, down from $3.56 last year. That's about a 3.7% decline. And gross margins? They dropped 75 basis points to 33%, largely due to the GMS acquisition they completed.

**JORDAN:** Let's talk about that GMS acquisition because it's reshaping their entire strategy. Home Depot is going all-in on the professional contractor market. They just completed the Mingledorff's acquisition too - that's an HVAC distributor with 42 locations across five southeastern states.

**ALEX:** This is fascinating from a strategic standpoint. Ted Decker laid out some impressive numbers - they're targeting a $700 billion professional market opportunity. With all their acquisitions, they now have over 1,300 branches through SRS, plus their 2,360+ stores. That's a delivery fleet of about 16,000 assets and over 5,000 professional sales associates.

**JORDAN:** The HVAC move is particularly smart. HVAC distribution represents about a $100 billion addressable market, which brings their total addressable market to $1.2 trillion. And here's the key - HVAC is more repair and replacement focused rather than new construction, which fits perfectly with the current market environment.

**ALEX:** Speaking of market environment, there was a revealing exchange during the Q&A. When analysts pressed about whether they'd consider lowering guidance given rising interest rates and energy prices, CFO Richard McPhail stood firm. They reaffirmed their comp sales guidance of flat to 2% growth.

**JORDAN:** That confidence is interesting because the housing market backdrop is still challenging. Existing home sales are below $4 million, HELOC activity has plateaued, and mortgage rates remain elevated. But Decker made a compelling point about their core customer - these are homeowners who saw their home values jump 50% over recent years and have healthy equity portfolios.

**ALEX:** The Pro business performance really stands out too. Billy Bastek, their merchandising chief, noted that Pro posted positive comps and outperformed DIY customers. Nine of their 16 merchandising departments had positive comps, including power tools, plumbing, electrical, and paint.

**JORDAN:** And their digital strategy is paying off. Online sales leveraging their digital platforms grew over 10% - that

This episode includes AI-generated content.]]>SP100-HD-Q1-2026-enTue, 19 May 2026 21:51:46 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL) ────────── # Beta Finch Podcast Script - Home Depot Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script - Home Depot Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate speak into plain English. I'm Alex, and I'm here with my co-host Jordan to dive into Home Depot's first quarter 2026 results.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter to unpack from the home improvement giant. Home Depot just reported $41.8 billion in sales - that's up 4.8% year-over-year. But the real story is in the details, isn't it?

**ALEX:** Absolutely. The headline numbers look decent, but when you dig deeper, you can see the challenges they're facing. Comparable store sales were only up 0.6% - barely positive. And here's what's interesting about the monthly breakdown: February was up 0.7%, March jumped to positive 2%, but then April went negative 0.5%.

**JORDAN:** That April drop really tells a story about weather impact and consumer behavior. CEO Ted Decker mentioned that when weather was favorable in the Northern and Western divisions, customers engaged in outdoor projects. But those bigger discretionary projects? Still under pressure. It's like consumers are buying the essentials but holding back on major renovations.

**ALEX:** The earnings picture reflects that cautiousness too. Adjusted diluted earnings per share came in at $3.43, down from $3.56 last year. That's about a 3.7% decline. And gross margins? They dropped 75 basis points to 33%, largely due to the GMS acquisition they completed.

**JORDAN:** Let's talk about that GMS acquisition because it's reshaping their entire strategy. Home Depot is going all-in on the professional contractor market. They just completed the Mingledorff's acquisition too - that's an HVAC distributor with 42 locations across five southeastern states.

**ALEX:** This is fascinating from a strategic standpoint. Ted Decker laid out some impressive numbers - they're targeting a $700 billion professional market opportunity. With all their acquisitions, they now have over 1,300 branches through SRS, plus their 2,360+ stores. That's a delivery fleet of about 16,000 assets and over 5,000 professional sales associates.

**JORDAN:** The HVAC move is particularly smart. HVAC distribution represents about a $100 billion addressable market, which brings their total addressable market to $1.2 trillion. And here's the key - HVAC is more repair and replacement focused rather than new construction, which fits perfectly with the current market environment.

**ALEX:** Speaking of market environment, there was a revealing exchange during the Q&A. When analysts pressed about whether they'd consider lowering guidance given rising interest rates and energy prices, CFO Richard McPhail stood firm. They reaffirmed their comp sales guidance of flat to 2% growth.

**JORDAN:** That confidence is interesting because the housing market backdrop is still challenging. Existing home sales are below $4 million, HELOC activity has plateaued, and mortgage rates remain elevated. But Decker made a compelling point about their core customer - these are homeowners who saw their home values jump 50% over recent years and have healthy equity portfolios.

**ALEX:** The Pro business performance really stands out too. Billy Bastek, their merchandising chief, noted that Pro posted positive comps and outperformed...]]>517falsefullhttps://www.spreaker.com/episode/applied-materials-q2-2026-earnings-analysis--72025630https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
**Beta Finch Podcast Script**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Applied Materials' Q2 2026 earnings - and wow, what a quarter this was.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Applied Materials just posted some truly impressive numbers. We're talking record revenue of $7.91 billion - that's up 13% sequentially and 11% year-over-year.

ALEX: And it gets better. Their non-GAAP earnings per share hit $2.86, up 20% year-over-year. But Jordan, what really caught my attention was their gross margin crossing 50% for the first time in over 25 years.

JORDAN: That's huge! And CEO Gary Dickerson was pretty clear about what's driving this - it's all about AI. He mentioned that global token generation has increased more than threefold in just the past three months. That's an incredible acceleration.

ALEX: Right, and what's interesting is how AI demand is diversifying. Dickerson talked about "agentic AI" - these aren't just chatbots responding to queries, but AI systems that can plan, reason, and execute tasks autonomously. This is creating demand for more CPU-intensive computing, plus additional DRAM and NAND memory.

JORDAN: Which plays perfectly into Applied's sweet spot. CFO Brice Hill said they expect their semiconductor equipment business to grow more than 30% this calendar year. And get this - their customers are now providing 8-quarter rolling forecasts. That's unprecedented visibility for planning.

ALEX: That long-term visibility is fascinating. It tells us customers aren't just thinking quarters ahead - they're planning years out. Hill mentioned they're tracking over 100 factory projects globally and added more than 10 just in the last quarter.

JORDAN: And Applied is positioning itself right at the center of the most critical technologies. Dickerson said leading-edge foundry logic, DRAM, and advanced packaging will account for more than 80% of wafer fab equipment spending growth in 2026, with a similar profile expected in 2027.

ALEX: Let's talk about their new products. They announced two new solutions for gate-all-around transistors - the Trillium ALD system and a precision PECVD system. These are designed specifically for the complex requirements of AI chips.

JORDAN: The technical details are impressive, but what investors should understand is that these products command premium pricing because they solve critical problems that no one else can. That's how Applied's gross margins have expanded 800 basis points since 2013.

ALEX: Speaking of growth drivers, their Applied Global Services segment hit record revenue of $1.67 billion, up 17% year-over-year. Hill raised their long-term AGS growth expectation to mid-teens annually, potentially higher this year.

JORDAN: That's significant because services typically have higher margins and more predictable revenue streams. With over 35,000 chambers now connected to their AIx software platform, they're using AI to optimize customer operations and drive higher service revenues.

ALEX: Now let's talk about the elephant in the room - China. China represented 24% of their semiconductor systems and services revenue. There are ongoing export restrictions, but management seems confident in their guidance despite these headwinds.

JORDAN: The Q&A session revealed some interesting dynamics. When asked about pricing power given the tight equipment market, Dickerson emphasized they typically work on 2-3 year pricing contracts per project, so changes happen gradually. But their portfolio is getting more valuab

This episode includes AI-generated content.]]>SP100-AMAT-Q2-2026-enFri, 15 May 2026 21:30:16 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: CHIPS (https://betafinch.com/groups/CHIPS) ────────── **Beta Finch Podcast Script** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're...https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS)
──────────
**Beta Finch Podcast Script**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Applied Materials' Q2 2026 earnings - and wow, what a quarter this was.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Applied Materials just posted some truly impressive numbers. We're talking record revenue of $7.91 billion - that's up 13% sequentially and 11% year-over-year.

ALEX: And it gets better. Their non-GAAP earnings per share hit $2.86, up 20% year-over-year. But Jordan, what really caught my attention was their gross margin crossing 50% for the first time in over 25 years.

JORDAN: That's huge! And CEO Gary Dickerson was pretty clear about what's driving this - it's all about AI. He mentioned that global token generation has increased more than threefold in just the past three months. That's an incredible acceleration.

ALEX: Right, and what's interesting is how AI demand is diversifying. Dickerson talked about "agentic AI" - these aren't just chatbots responding to queries, but AI systems that can plan, reason, and execute tasks autonomously. This is creating demand for more CPU-intensive computing, plus additional DRAM and NAND memory.

JORDAN: Which plays perfectly into Applied's sweet spot. CFO Brice Hill said they expect their semiconductor equipment business to grow more than 30% this calendar year. And get this - their customers are now providing 8-quarter rolling forecasts. That's unprecedented visibility for planning.

ALEX: That long-term visibility is fascinating. It tells us customers aren't just thinking quarters ahead - they're planning years out. Hill mentioned they're tracking over 100 factory projects globally and added more than 10 just in the last quarter.

JORDAN: And Applied is positioning itself right at the center of the most critical technologies. Dickerson said leading-edge foundry logic, DRAM, and advanced packaging will account for more than 80% of wafer fab equipment spending growth in 2026, with a similar profile expected in 2027.

ALEX: Let's talk about their new products. They announced two new solutions for gate-all-around transistors - the Trillium ALD system and a precision PECVD system. These are designed specifically for the complex requirements of AI chips.

JORDAN: The technical details are impressive, but what investors should understand is that these products command premium pricing because they solve critical problems that no one else can. That's how Applied's gross margins have expanded 800 basis points since 2013.

ALEX: Speaking of growth drivers, their Applied Global Services segment hit record revenue of $1.67 billion, up 17% year-over-year. Hill raised their long-term AGS growth expectation to mid-teens annually, potentially higher this year.

JORDAN: That's significant because services typically have higher margins and more predictable revenue streams. With over 35,000 chambers now connected to their AIx software platform, they're using AI to optimize customer operations and drive higher service revenues.

ALEX: Now let's talk about the elephant in the room - China. China represented 24% of their semiconductor systems and services revenue. There are ongoing export restrictions, but management seems confident in their guidance despite these...]]>517falsefullhttps://www.spreaker.com/episode/cisco-q3-2026-earnings-analysis--72007429https://betafinch.com
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly confessions. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dive in, let me get our disclaimer out of the way - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Today we're breaking down Cisco's Q3 2026 earnings, and wow Jordan, this was a monster quarter. When was the last time we saw Cisco post numbers like this?

**JORDAN:** Alex, I had to double-check these numbers because they're almost too good to believe. Revenue hit a record $15.8 billion - that's up 12% year-over-year. But here's the kicker - product orders were up 35%. That's not a typo, folks. Thirty-five percent.

**ALEX:** And it gets better. EPS grew 10% to $1.06, coming in above the high end of guidance. But Jordan, let's talk about the elephant in the room - or should I say the AI in the room?

**JORDAN:** Absolutely. This is really the story of two different businesses here. You've got the traditional Cisco networking business, which is doing quite well, and then you've got this AI infrastructure juggernaut that's completely reshaping the company. Chuck Robbins said they're now expecting $9 billion in AI infrastructure orders from hyperscalers for fiscal 2026. That's 4.5 times what they did last year.

**ALEX:** That's incredible. And their Acacia optics business - I mean, over $1 billion in orders in Q3 alone, growing over 200% year-over-year. But let's break this down for our listeners. What's actually driving this massive surge?

**JORDAN:** It really comes down to Silicon One, Alex. Cisco's been saying for years that if you don't control your own silicon, you can't compete with the hyperscalers. Well, they're proving it now. They had five new design wins with hyperscalers in Q3, including their first wins for the P200-powered systems. Chuck was pretty clear - roughly half of their AI infrastructure revenue comes from systems powered by their own silicon.

**ALEX:** And there's a supply chain angle here too, right? While competitors are talking about getting tighter supply constraints and possible decommits, Cisco seems pretty confident.

**JORDAN:** Exactly. Mark Patterson, their CFO, was very clear - they haven't seen any decommits. They've secured silicon supply through calendar 2026, they've got over 20 programs to reduce memory utilization, and they've bumped up inventory and purchase commitments by $6.7 billion just in the last 90 days. When you control your own silicon, you control your own destiny.

**ALEX:** Now, it wasn't all perfect. Gross margins were down 260 basis points year-over-year, mainly due to product mix and those memory cost increases everyone's dealing with. How concerned should investors be?

**JORDAN:** I think Patterson handled this well on the call. He said gross margins have stabilized around 66%, and they're focused on driving operating leverage - growing the bottom line faster than the top line. They're making trade-offs. While gross margins declined 2.6%, operating expenses actually declined over 2% as a percentage of revenue. They're maintaining that 34% operating margin target.

**ALEX:** Let's talk guidance because this is where things get really interesting. Q4 revenue guidance of $16.7 to $16.9 billion implies about 14.5% growth. And for the full fiscal year, they're looking at $62.8 to $63 billion in revenue.

**JORDAN:** What caught my attention was Patterson's comment about fiscal 2027. He said it's reasonable to expect at least $6 billion in AI infrastructure revenue next year, while the rest of the portfolio should grow in line with their long-te

This episode includes AI-generated content.]]>SP100-CSCO-Q3-2026-enThu, 14 May 2026 16:00:17 +0000trueBeta FinchMore earnings analysis: https://betafinch.com ────────── **BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's...https://betafinch.com
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly confessions. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dive in, let me get our disclaimer out of the way - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Today we're breaking down Cisco's Q3 2026 earnings, and wow Jordan, this was a monster quarter. When was the last time we saw Cisco post numbers like this?

**JORDAN:** Alex, I had to double-check these numbers because they're almost too good to believe. Revenue hit a record $15.8 billion - that's up 12% year-over-year. But here's the kicker - product orders were up 35%. That's not a typo, folks. Thirty-five percent.

**ALEX:** And it gets better. EPS grew 10% to $1.06, coming in above the high end of guidance. But Jordan, let's talk about the elephant in the room - or should I say the AI in the room?

**JORDAN:** Absolutely. This is really the story of two different businesses here. You've got the traditional Cisco networking business, which is doing quite well, and then you've got this AI infrastructure juggernaut that's completely reshaping the company. Chuck Robbins said they're now expecting $9 billion in AI infrastructure orders from hyperscalers for fiscal 2026. That's 4.5 times what they did last year.

**ALEX:** That's incredible. And their Acacia optics business - I mean, over $1 billion in orders in Q3 alone, growing over 200% year-over-year. But let's break this down for our listeners. What's actually driving this massive surge?

**JORDAN:** It really comes down to Silicon One, Alex. Cisco's been saying for years that if you don't control your own silicon, you can't compete with the hyperscalers. Well, they're proving it now. They had five new design wins with hyperscalers in Q3, including their first wins for the P200-powered systems. Chuck was pretty clear - roughly half of their AI infrastructure revenue comes from systems powered by their own silicon.

**ALEX:** And there's a supply chain angle here too, right? While competitors are talking about getting tighter supply constraints and possible decommits, Cisco seems pretty confident.

**JORDAN:** Exactly. Mark Patterson, their CFO, was very clear - they haven't seen any decommits. They've secured silicon supply through calendar 2026, they've got over 20 programs to reduce memory utilization, and they've bumped up inventory and purchase commitments by $6.7 billion just in the last 90 days. When you control your own silicon, you control your own destiny.

**ALEX:** Now, it wasn't all perfect. Gross margins were down 260 basis points year-over-year, mainly due to product mix and those memory cost increases everyone's dealing with. How concerned should investors be?

**JORDAN:** I think Patterson handled this well on the call. He said gross margins have stabilized around 66%, and they're focused on driving operating leverage - growing the bottom line faster than the top line. They're making trade-offs. While gross margins declined 2.6%, operating expenses actually declined over 2% as a percentage of revenue. They're maintaining that 34% operating margin target.

**ALEX:** Let's talk guidance because this is where things get really interesting. Q4 revenue guidance of $16.7 to $16.9 billion implies about 14.5% growth. And for the full fiscal year, they're looking at $62.8 to $63 billion in revenue.

**JORDAN:** What caught my...]]>484falsefullhttps://www.spreaker.com/episode/lowe-s-q4-2026-earnings-analysis--71996486https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script: Lowe's Q4 2026 Earnings Breakdown

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Lowe's fourth quarter 2026 results, and there's quite a bit to unpack here.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now, let's talk Lowe's. Alex, what were the headline numbers that caught your attention?

**ALEX**: Well, Lowe's delivered $20.6 billion in Q4 sales with comparable sales up 1.3%, which is actually pretty solid given the challenging environment they're operating in. For the full year 2025, they hit $86.3 billion in sales with adjusted earnings per share of $12.28 - that's a 2% increase year-over-year.

**JORDAN**: What I found interesting is how they managed to hold their adjusted operating margins flat despite some serious headwinds. CEO Marvin Ellison was pretty candid about the challenging macro environment - consumers are still hesitant about big-ticket DIY projects, and the housing market remains under pressure from high mortgage rates.

**ALEX**: Speaking of headwinds, they made some tough decisions too. Lowe's announced they're eliminating about 600 corporate and support roles as part of what they call their "perpetual productivity improvement" initiatives. But here's what's notable - they're simultaneously giving out $125 million in discretionary bonuses to frontline workers.

**JORDAN**: That's a fascinating contrast, isn't it? Cut corporate overhead while rewarding the people actually serving customers. It shows they're being very strategic about where they're investing versus where they're cutting costs.

**ALEX**: Exactly. And speaking of investments, let's talk about their growth engines. Three areas really stood out: Pro customers, online sales, and home services. Online grew 10.5% in the quarter, and they set new records on Black Friday and Cyber Monday. Their Lowe's app was actually the number one free shopping app on Apple's App Store on Black Friday.

**JORDAN**: The Pro business momentum is really interesting too. They're expanding their Pro sales force and rolling out this AI-enabled "Pro Companion" tool that helps sales associates prepare for customer conversations. It gives them instant access to relevant information so they can walk into meetings with recommendations already prepared.

**ALEX**: And then there are the big acquisitions - Foundation Building Materials, or FBM, and Artisan Design Group, or ADG. Together, these are expected to contribute about $8 billion in sales for 2026. The strategy here is to create what Ellison calls a "total home" solution for builders - basically everything they need for interior spaces.

**JORDAN**: Though it's worth noting these acquisitions are diluting operating margins by about 30 basis points in 2026, or 50 basis points on an annualized basis. But management says they're earnings accretive overall, which is the key metric.

**ALEX**: Let's talk guidance because this is where things get interesting. For 2026, they're forecasting sales between $92 billion and $94 billion, with comparable sales flat to up 2%. That's a wider range than they usually provide.

**JORDAN**: Right, and when an analyst asked about that wider range, Ellison was pretty transparent. He said there are just too many variables - unpredictable tariffs, high interest rates, and uncertain consumer demand. They're essentially saying "we're confident we'll outperform the market, but the market itself is really hard t

This episode includes AI-generated content.]]>SP100-LOW-Q4-2026-enWed, 13 May 2026 21:55:50 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL) ────────── # Beta Finch Podcast Script: Lowe's Q4 2026 Earnings Breakdown **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL)
──────────
# Beta Finch Podcast Script: Lowe's Q4 2026 Earnings Breakdown

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Lowe's fourth quarter 2026 results, and there's quite a bit to unpack here.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now, let's talk Lowe's. Alex, what were the headline numbers that caught your attention?

**ALEX**: Well, Lowe's delivered $20.6 billion in Q4 sales with comparable sales up 1.3%, which is actually pretty solid given the challenging environment they're operating in. For the full year 2025, they hit $86.3 billion in sales with adjusted earnings per share of $12.28 - that's a 2% increase year-over-year.

**JORDAN**: What I found interesting is how they managed to hold their adjusted operating margins flat despite some serious headwinds. CEO Marvin Ellison was pretty candid about the challenging macro environment - consumers are still hesitant about big-ticket DIY projects, and the housing market remains under pressure from high mortgage rates.

**ALEX**: Speaking of headwinds, they made some tough decisions too. Lowe's announced they're eliminating about 600 corporate and support roles as part of what they call their "perpetual productivity improvement" initiatives. But here's what's notable - they're simultaneously giving out $125 million in discretionary bonuses to frontline workers.

**JORDAN**: That's a fascinating contrast, isn't it? Cut corporate overhead while rewarding the people actually serving customers. It shows they're being very strategic about where they're investing versus where they're cutting costs.

**ALEX**: Exactly. And speaking of investments, let's talk about their growth engines. Three areas really stood out: Pro customers, online sales, and home services. Online grew 10.5% in the quarter, and they set new records on Black Friday and Cyber Monday. Their Lowe's app was actually the number one free shopping app on Apple's App Store on Black Friday.

**JORDAN**: The Pro business momentum is really interesting too. They're expanding their Pro sales force and rolling out this AI-enabled "Pro Companion" tool that helps sales associates prepare for customer conversations. It gives them instant access to relevant information so they can walk into meetings with recommendations already prepared.

**ALEX**: And then there are the big acquisitions - Foundation Building Materials, or FBM, and Artisan Design Group, or ADG. Together, these are expected to contribute about $8 billion in sales for 2026. The strategy here is to create what Ellison calls a "total home" solution for builders - basically everything they need for interior spaces.

**JORDAN**: Though it's worth noting these acquisitions are diluting operating margins by about 30 basis points in 2026, or 50 basis points on an annualized basis. But management says they're earnings accretive overall, which is the key metric.

**ALEX**: Let's talk guidance because this is where things get interesting. For 2026, they're forecasting sales between $92 billion and $94 billion, with comparable sales flat to up 2%. That's a wider range than they usually provide.

**JORDAN**: Right, and when an analyst asked about that...]]>454falsefullhttps://www.spreaker.com/episode/gilead-sciences-q1-2026-earnings-analysis--71925352https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
**Beta Finch Podcast Script - Gilead Q1 2026 Earnings**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Gilead Sciences' first quarter 2026 results - and wow, what a quarter this was for the biotech giant.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Gilead came out swinging with some pretty impressive numbers, didn't they?

**JORDAN:** Absolutely, Alex! Let's start with the headline numbers because they're quite strong. Total product sales hit $6.9 billion, up 5% year-over-year. But here's the kicker - if you exclude their COVID drug Veklury, their base business grew 8% to $6.8 billion. That's solid growth for a company Gilead's size.

**ALEX:** And they're not just talking the talk - they're raising guidance across the board. What stood out to you most about their updated outlook?

**JORDAN:** The HIV business is absolutely on fire. They raised their HIV growth expectations from 6% to 8% for the full year, and get this - their PrEP drug Yes2Go, which prevents HIV, is now expected to hit $1 billion in sales. That would make it a blockbuster drug in just its first full year on the market!

**ALEX:** That's remarkable. Let's break down what's driving this HIV success, because it seems like Gilead is firing on all cylinders here.

**JORDAN:** It really is a multi-pronged success story. Their flagship HIV treatment Biktarvy continues to dominate with over 52% market share in the U.S. - that's a drug pulling in $3.4 billion in the quarter alone. But the real star is Yes2Go, their twice-yearly injectable HIV prevention drug. Sales jumped 72% just from the previous quarter to $166 million.

**ALEX:** And during the Q&A, management seemed pretty confident about Yes2Go's trajectory. What are they seeing that makes them so optimistic?

**JORDAN:** Great question! Johanna Mercier, their commercial chief, mentioned some really encouraging metrics. They now have 95% insurance coverage with 95% of those having zero copay for patients. They're seeing strong uptake from both people switching from other drugs and completely new users. And perhaps most importantly, the "persistency" - meaning people coming back for their second injection - is looking really good.

**ALEX:** Now, Gilead wasn't just focused on HIV this quarter. They made some major acquisition moves. Can you walk us through what they're buying and why?

**JORDAN:** This is where it gets really interesting from a strategic perspective. They closed three major deals: Arcellx for their cancer cell therapy anitocel, they're buying Tubulis for their antibody-drug conjugate technology, and Oral Medicines for autoimmune treatments. The total upfront cost? About $11.5 billion.

**ALEX:** That's a lot of cash! How are investors supposed to think about these deals?

**JORDAN:** Well, it's definitely impacting their near-term earnings - they're actually projecting a loss per share for 2026 because of these upfront costs. But management seemed confident these are strategic investments for the long term. The Arcellx deal brings them anitocel, which they believe could be best-in-class for multiple myeloma. And Tubulis gives them next-generation cancer drug technology that goes beyond their current Trodelvy franchise.

**ALEX:** Speaking of Trodelvy, how's their existing oncology business performing?

**JORDAN:** Trodelvy is growing nicely - up 37% year-over-year to $402 million. They're expecting regulatory decisions this year that could expand its use to first-line breast cancer treatment, which would be a significant ma

This episode includes AI-generated content.]]>SP100-GILD-Q1-2026-enFri, 08 May 2026 15:41:38 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: PHARMA (https://betafinch.com/groups/PHARMA) ────────── **Beta Finch Podcast Script - Gilead Q1 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex,...https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
**Beta Finch Podcast Script - Gilead Q1 2026 Earnings**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Gilead Sciences' first quarter 2026 results - and wow, what a quarter this was for the biotech giant.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Gilead came out swinging with some pretty impressive numbers, didn't they?

**JORDAN:** Absolutely, Alex! Let's start with the headline numbers because they're quite strong. Total product sales hit $6.9 billion, up 5% year-over-year. But here's the kicker - if you exclude their COVID drug Veklury, their base business grew 8% to $6.8 billion. That's solid growth for a company Gilead's size.

**ALEX:** And they're not just talking the talk - they're raising guidance across the board. What stood out to you most about their updated outlook?

**JORDAN:** The HIV business is absolutely on fire. They raised their HIV growth expectations from 6% to 8% for the full year, and get this - their PrEP drug Yes2Go, which prevents HIV, is now expected to hit $1 billion in sales. That would make it a blockbuster drug in just its first full year on the market!

**ALEX:** That's remarkable. Let's break down what's driving this HIV success, because it seems like Gilead is firing on all cylinders here.

**JORDAN:** It really is a multi-pronged success story. Their flagship HIV treatment Biktarvy continues to dominate with over 52% market share in the U.S. - that's a drug pulling in $3.4 billion in the quarter alone. But the real star is Yes2Go, their twice-yearly injectable HIV prevention drug. Sales jumped 72% just from the previous quarter to $166 million.

**ALEX:** And during the Q&A, management seemed pretty confident about Yes2Go's trajectory. What are they seeing that makes them so optimistic?

**JORDAN:** Great question! Johanna Mercier, their commercial chief, mentioned some really encouraging metrics. They now have 95% insurance coverage with 95% of those having zero copay for patients. They're seeing strong uptake from both people switching from other drugs and completely new users. And perhaps most importantly, the "persistency" - meaning people coming back for their second injection - is looking really good.

**ALEX:** Now, Gilead wasn't just focused on HIV this quarter. They made some major acquisition moves. Can you walk us through what they're buying and why?

**JORDAN:** This is where it gets really interesting from a strategic perspective. They closed three major deals: Arcellx for their cancer cell therapy anitocel, they're buying Tubulis for their antibody-drug conjugate technology, and Oral Medicines for autoimmune treatments. The total upfront cost? About $11.5 billion.

**ALEX:** That's a lot of cash! How are investors supposed to think about these deals?

**JORDAN:** Well, it's definitely impacting their near-term earnings - they're actually projecting a loss per share for 2026 because of these upfront costs. But management seemed confident these are strategic investments for the long term. The Arcellx deal brings them anitocel, which they believe could be best-in-class for multiple myeloma. And Tubulis gives them next-generation cancer drug technology that goes beyond their current Trodelvy franchise.

**ALEX:**...]]>521falsefullhttps://www.spreaker.com/episode/zoetis-q1-2026-earnings-analysis--71913445https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
# Beta Finch Podcast Script: Zoetis Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really happening in the market. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dig in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Today we're breaking down Zoetis' Q1 2026 earnings - and wow, this was a quarter that really caught investors off guard. Jordan, what's your first take on these numbers?

**JORDAN:** Alex, this was definitely a reality check for the animal health giant. On the surface, flat organic operational revenue growth doesn't look terrible, but when you peel back the layers, there's a lot more going on here. They had about $100 million in sales that shifted from Q4 2025 into Q1 due to fiscal year alignment changes. Without that boost, they would have seen a 5% organic operational decline.

**ALEX:** That's a significant difference. And CEO Kristin Peck was pretty candid about what went wrong, wasn't she?

**JORDAN:** Absolutely. She laid out four key factors that created what she called "a convergence of interconnected dynamics." First, rising prices at veterinary clinics led to lower clinic traffic - pet owners are feeling the pinch. Second, those same pet owners are showing increased price sensitivity, especially for premium products where Zoetis leads. Third, competition intensified across key categories like dermatology and parasiticides, with competitors using aggressive pricing. And fourth - this is crucial - these competitive launches didn't expand the overall market like they have historically.

**ALEX:** That last point seems really important. Historically, when new competitors entered Zoetis markets, the pie got bigger for everyone. But not this time?

**JORDAN:** Exactly. In the past, competition actually helped grow markets - think about how the parasiticide market expanded when new players came in. But this time, with pet owners being more price-conscious and visiting clinics less frequently, new entrants are just taking share from existing players rather than bringing new customers into the market.

**ALEX:** Let's talk specific numbers. How did their key franchises perform?

**JORDAN:** The companion animal business really struggled, particularly in the U.S. where it declined 11%. Their key dermatology franchise - which includes blockbusters like Apoquel and Cytopoint - fell 11% globally to $347 million. The Simparica parasiticide franchise was down 1% to $385 million globally, but that masks an 8% decline in the U.S. And their OA Pain products, Librela and Solensia, dropped 8% combined to $140 million.

**ALEX:** But it wasn't all bad news, right? I noticed livestock performed well.

**JORDAN:** That's the silver lining here. Livestock delivered 12% organic operational growth to $720 million, with broad-based strength across cattle, poultry, and swine. Favorable producer economics and strong protein demand are driving investment in herd health. It really shows the value of Zoetis' diversified portfolio - when companion animal struggles, livestock can pick up some slack.

**ALEX:** What about guidance? I imagine they had to adjust expectations.

**JORDAN:** They definitely had to recalibrate. Full-year revenue growth guidance came down to 2-5% from what was presumably higher expectations, and adjusted net income growth is now expected at 2-6%. CFO Wetteny Joseph noted that while the fiscal year alignment was supposed to provide a 200-250 basis point tailwind, the challenging operating environment more than offset that benefit.

**ALEX:** During the Q&A, there were some pointe

This episode includes AI-generated content.]]>SP100-ZTS-Q1-2026-enThu, 07 May 2026 22:06:55 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: PHARMA (https://betafinch.com/groups/PHARMA) ────────── # Beta Finch Podcast Script: Zoetis Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep...https://betafinch.com
Groups: PHARMA (https://betafinch.com/groups/PHARMA)
──────────
# Beta Finch Podcast Script: Zoetis Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really happening in the market. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dig in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Today we're breaking down Zoetis' Q1 2026 earnings - and wow, this was a quarter that really caught investors off guard. Jordan, what's your first take on these numbers?

**JORDAN:** Alex, this was definitely a reality check for the animal health giant. On the surface, flat organic operational revenue growth doesn't look terrible, but when you peel back the layers, there's a lot more going on here. They had about $100 million in sales that shifted from Q4 2025 into Q1 due to fiscal year alignment changes. Without that boost, they would have seen a 5% organic operational decline.

**ALEX:** That's a significant difference. And CEO Kristin Peck was pretty candid about what went wrong, wasn't she?

**JORDAN:** Absolutely. She laid out four key factors that created what she called "a convergence of interconnected dynamics." First, rising prices at veterinary clinics led to lower clinic traffic - pet owners are feeling the pinch. Second, those same pet owners are showing increased price sensitivity, especially for premium products where Zoetis leads. Third, competition intensified across key categories like dermatology and parasiticides, with competitors using aggressive pricing. And fourth - this is crucial - these competitive launches didn't expand the overall market like they have historically.

**ALEX:** That last point seems really important. Historically, when new competitors entered Zoetis markets, the pie got bigger for everyone. But not this time?

**JORDAN:** Exactly. In the past, competition actually helped grow markets - think about how the parasiticide market expanded when new players came in. But this time, with pet owners being more price-conscious and visiting clinics less frequently, new entrants are just taking share from existing players rather than bringing new customers into the market.

**ALEX:** Let's talk specific numbers. How did their key franchises perform?

**JORDAN:** The companion animal business really struggled, particularly in the U.S. where it declined 11%. Their key dermatology franchise - which includes blockbusters like Apoquel and Cytopoint - fell 11% globally to $347 million. The Simparica parasiticide franchise was down 1% to $385 million globally, but that masks an 8% decline in the U.S. And their OA Pain products, Librela and Solensia, dropped 8% combined to $140 million.

**ALEX:** But it wasn't all bad news, right? I noticed livestock performed well.

**JORDAN:** That's the silver lining here. Livestock delivered 12% organic operational growth to $720 million, with broad-based strength across cattle, poultry, and swine. Favorable producer economics and strong protein demand are driving investment in herd health. It really shows the value of Zoetis' diversified portfolio - when companion animal struggles, livestock can pick up some slack.

**ALEX:** What about guidance? I imagine they had to adjust expectations.

**JORDAN:** They definitely had to recalibrate. Full-year revenue growth guidance came down to 2-5% from what was presumably higher expectations, and adjusted net...]]>507falsefullhttps://www.spreaker.com/episode/mcdonald-s-q1-2026-earnings-analysis--71913443https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
──────────
# Beta Finch Podcast Script: McDonald's Q1 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and with me as always is Jordan. Today we're diving into McDonald's Q1 2026 results, and wow, there's a lot to unpack here. Jordan, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex, and yeah - McDonald's certainly delivered some interesting headlines this quarter. On the surface, the numbers look pretty solid - global comparable sales up 3.8%, system-wide sales growing 6% in constant currency. But when you dig deeper, there are some real challenges brewing beneath those golden arches.

**ALEX**: Absolutely. Let's start with the good news. The U.S. business showed resilience with 3.9% comparable sales growth, and they're gaining market share in nearly all their top 10 markets globally. That's impressive in this environment. But Jordan, what really caught my attention was CEO Chris Kempczinski's emphasis on their "3 for 3" strategy - value, marketing, and menu innovation.

**JORDAN**: Right, and the value piece is particularly crucial here. They've completely revamped their McValue platform with unanimous franchisee support - that's key. We're talking about items under $3 and a new $4 breakfast meal deal. Kempczinski was pretty emphatic about this, saying "McDonald's is not going to get beat on value and affordability."

**ALEX**: That's a bold statement, but they're backing it up with action. What's interesting is they're applying lessons from international markets back to the U.S. Most of their major international markets already had this dual approach - both everyday affordable items and meal bundles. France was apparently the exception, which might explain some of their struggles there.

**JORDAN**: Speaking of struggles, let's talk about the elephant in the room - those U.S. company-operated store margins. CFO Ian Borden was brutally honest, calling them "not acceptable." That's pretty remarkable transparency from a major corporation.

**ALEX**: It really is. And when you connect the dots, this ties into a bigger strategic question about McDonald's ownership structure. They're essentially saying some of their franchisees are running restaurants better than McDonald's corporate is running their own locations. That's... not ideal.

**JORDAN**: Exactly. And it sounds like they're seriously considering refranchising more company-operated stores. Kempczinski said they're "always looking to put restaurants in the hands of the best operator," which is diplomatic corporate-speak for "we might be selling these to franchisees who can run them better."

**ALEX**: Let's shift to international markets for a moment. The UK really stood out as a success story - they're on their third consecutive quarter of market share gains with mid-to-high single-digit comp growth. Jordan, what's working there?

**JORDAN**: It's that same formula - they introduced something called "Meal Deal Plus" for £5.59, which gives customers more flexibility. Plus they're executing well on marketing campaigns like the "Friends" TV show promotion. Australia's another bright spot using similar tactics. But then you have France struggling, which shows this isn't automatic - you have to execute consistently.

**ALEX**: And speaking of execution, they're rolling out their new beverage platform globally. Yesterday, all U.S. restaurants started offering refreshers and crafted sodas under the McCafe brand, with Red Bull-infused energy drinks coming later this year.

**JORDAN**: That timing on Red Bull is interesti

This episode includes AI-generated content.]]>SP100-MCD-Q1-2026-enThu, 07 May 2026 22:06:50 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME) ────────── # Beta Finch Podcast Script: McDonald's Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your...https://betafinch.com
Groups: RETAIL (https://betafinch.com/groups/RETAIL), INCOME (https://betafinch.com/groups/INCOME)
──────────
# Beta Finch Podcast Script: McDonald's Q1 2026 Earnings

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and with me as always is Jordan. Today we're diving into McDonald's Q1 2026 results, and wow, there's a lot to unpack here. Jordan, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex, and yeah - McDonald's certainly delivered some interesting headlines this quarter. On the surface, the numbers look pretty solid - global comparable sales up 3.8%, system-wide sales growing 6% in constant currency. But when you dig deeper, there are some real challenges brewing beneath those golden arches.

**ALEX**: Absolutely. Let's start with the good news. The U.S. business showed resilience with 3.9% comparable sales growth, and they're gaining market share in nearly all their top 10 markets globally. That's impressive in this environment. But Jordan, what really caught my attention was CEO Chris Kempczinski's emphasis on their "3 for 3" strategy - value, marketing, and menu innovation.

**JORDAN**: Right, and the value piece is particularly crucial here. They've completely revamped their McValue platform with unanimous franchisee support - that's key. We're talking about items under $3 and a new $4 breakfast meal deal. Kempczinski was pretty emphatic about this, saying "McDonald's is not going to get beat on value and affordability."

**ALEX**: That's a bold statement, but they're backing it up with action. What's interesting is they're applying lessons from international markets back to the U.S. Most of their major international markets already had this dual approach - both everyday affordable items and meal bundles. France was apparently the exception, which might explain some of their struggles there.

**JORDAN**: Speaking of struggles, let's talk about the elephant in the room - those U.S. company-operated store margins. CFO Ian Borden was brutally honest, calling them "not acceptable." That's pretty remarkable transparency from a major corporation.

**ALEX**: It really is. And when you connect the dots, this ties into a bigger strategic question about McDonald's ownership structure. They're essentially saying some of their franchisees are running restaurants better than McDonald's corporate is running their own locations. That's... not ideal.

**JORDAN**: Exactly. And it sounds like they're seriously considering refranchising more company-operated stores. Kempczinski said they're "always looking to put restaurants in the hands of the best operator," which is diplomatic corporate-speak for "we might be selling these to franchisees who can run them better."

**ALEX**: Let's shift to international markets for a moment. The UK really stood out as a success story - they're on their third consecutive quarter of market share gains with mid-to-high single-digit comp growth. Jordan, what's working there?

**JORDAN**: It's that same formula - they introduced something called "Meal Deal Plus" for £5.59, which gives customers more flexibility. Plus they're executing well on marketing campaigns like the "Friends" TV show promotion. Australia's another bright spot using similar tactics. But then you have France struggling, which shows this isn't automatic - you have to execute consistently.506falsefullhttps://www.spreaker.com/episode/applovin-q1-2026-earnings-analysis--71913442https://betafinch.com
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into AppLovin's absolutely explosive Q1 2026 earnings call. Jordan, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex, and wow - what a quarter to analyze! AppLovin just delivered numbers that honestly feel almost too good to be true. We're talking about a company that beat guidance across every single metric while posting 59% year-over-year revenue growth. That's not a typo, folks - fifty-nine percent growth on a $1.84 billion revenue base.

**ALEX**: It's absolutely mind-blowing when you think about it. Most companies this size would be thrilled with double-digit growth, and here's AppLovin growing at nearly 60%. But Jordan, what really caught my attention was the margin expansion story. They hit an 85% adjusted EBITDA margin - that's up 400 basis points from last year.

**JORDAN**: The margin story is incredible, Alex. They're generating $1.56 billion in adjusted EBITDA, which represents 86% flow-through from revenue to EBITDA quarter-over-quarter. That kind of operational leverage is just extraordinary. And they're converting that into serious cash - $1.29 billion in free cash flow for the quarter.

**ALEX**: Now let's talk about the elephant in the room - or should I say the rocket ship in the room. CEO Adam Foroughi spent most of his time talking about their upcoming June launch where they're opening their Axon platform to the public for the first time in 14 years. Jordan, help our listeners understand why this is such a big deal.

**JORDAN**: This is potentially transformative, Alex. For over a decade, AppLovin has been a closed platform - meaning only select partners could access their advertising technology. Starting in June, any advertiser globally can sign up and start running campaigns. Foroughi called it "a major milestone" that "changes the trajectory of this company in a very meaningful way."

**ALEX**: And the timing seems perfect because their consumer vertical - that's everything outside of gaming - is absolutely on fire. It grew roughly 25% from January to March alone, and April set a record month that exceeded even their peak Q4 performance. Remember, most advertising businesses see a massive drop from Q4 to Q1, but AppLovin is actually growing through that seasonal headwind.

**JORDAN**: What's fascinating is how early this consumer business still is - Foroughi emphasized it's only 18 months old! Yet it's scaling at a pace that gets the management team "very excited." He shared this incredible example of an Israeli cookware company that went from $4 million in revenue to projecting $80 million, with most of their ad spend on AppLovin's platform.

**ALEX**: That's the kind of success story they want to "replicate thousands of times over," as Foroughi put it. But let's not forget about gaming, which is still the foundation of everything they do. The gaming business continues to grow at these exceptional rates, and there's this interesting shift happening where games that historically only made money from in-app purchases are now testing hybrid models that include advertising.

**JORDAN**: That hybrid monetization trend could be huge, Alex. Foroughi explained that when a puzzle game company realizes a cookware brand isn't their competition, they're suddenly open to showing those ads. He estimates this could unlock 10x the market opportunity for developers because instead of monetizing just the small percentage of users who make purchases, they can now monetize their entire audience through advertising.

**ALEX**: The Q&A session revealed some really interesting

This episode includes AI-generated content.]]>SP100-APP-Q1-2026-enThu, 07 May 2026 22:06:45 +0000trueBeta FinchMore earnings analysis: https://betafinch.com ────────── **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into AppLovin's absolutely explosive Q1 2026 earnings call. Jordan,...https://betafinch.com
──────────
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into AppLovin's absolutely explosive Q1 2026 earnings call. Jordan, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex, and wow - what a quarter to analyze! AppLovin just delivered numbers that honestly feel almost too good to be true. We're talking about a company that beat guidance across every single metric while posting 59% year-over-year revenue growth. That's not a typo, folks - fifty-nine percent growth on a $1.84 billion revenue base.

**ALEX**: It's absolutely mind-blowing when you think about it. Most companies this size would be thrilled with double-digit growth, and here's AppLovin growing at nearly 60%. But Jordan, what really caught my attention was the margin expansion story. They hit an 85% adjusted EBITDA margin - that's up 400 basis points from last year.

**JORDAN**: The margin story is incredible, Alex. They're generating $1.56 billion in adjusted EBITDA, which represents 86% flow-through from revenue to EBITDA quarter-over-quarter. That kind of operational leverage is just extraordinary. And they're converting that into serious cash - $1.29 billion in free cash flow for the quarter.

**ALEX**: Now let's talk about the elephant in the room - or should I say the rocket ship in the room. CEO Adam Foroughi spent most of his time talking about their upcoming June launch where they're opening their Axon platform to the public for the first time in 14 years. Jordan, help our listeners understand why this is such a big deal.

**JORDAN**: This is potentially transformative, Alex. For over a decade, AppLovin has been a closed platform - meaning only select partners could access their advertising technology. Starting in June, any advertiser globally can sign up and start running campaigns. Foroughi called it "a major milestone" that "changes the trajectory of this company in a very meaningful way."

**ALEX**: And the timing seems perfect because their consumer vertical - that's everything outside of gaming - is absolutely on fire. It grew roughly 25% from January to March alone, and April set a record month that exceeded even their peak Q4 performance. Remember, most advertising businesses see a massive drop from Q4 to Q1, but AppLovin is actually growing through that seasonal headwind.

**JORDAN**: What's fascinating is how early this consumer business still is - Foroughi emphasized it's only 18 months old! Yet it's scaling at a pace that gets the management team "very excited." He shared this incredible example of an Israeli cookware company that went from $4 million in revenue to projecting $80 million, with most of their ad spend on AppLovin's platform.

**ALEX**: That's the kind of success story they want to "replicate thousands of times over," as Foroughi put it. But let's not forget about gaming, which is still the foundation of everything they do. The gaming business continues to grow at these exceptional rates, and there's this interesting shift happening where games that historically only made money from in-app purchases are now testing hybrid models that include advertising.

**JORDAN**: That hybrid monetization trend could be huge, Alex. Foroughi explained that when a puzzle game company realizes a cookware brand isn't their competition, they're suddenly open to showing those ads. He estimates this could unlock 10x the market opportunity for developers because instead of monetizing just the small percentage...]]>490falsefullhttps://www.spreaker.com/episode/uber-q1-2026-earnings-analysis--71900943https://betafinch.com
──────────
# Beta Finch Podcast Script - Uber Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're breaking down Uber's Q1 2026 earnings, and wow - this was a quarter that really showed the breadth of what Uber has become.

**ALEX:** Absolutely, Jordan. And before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. Now, let's get into these numbers because they were genuinely impressive. Uber delivered 21% year-over-year growth in gross bookings - that's the total value of all transactions on their platform.

**ALEX:** And what I love about this quarter is how balanced the growth was. Mobility hit 20% growth with record margins, Delivery grew 23% driven by grocery and retail, and here's the kicker - Freight returned to growth for the first time in nearly two years.

**JORDAN:** That Freight turnaround is huge, Alex. That's been a drag on their numbers for a while. But the real standout for me was the profitability story. Non-GAAP earnings per share jumped 44% year-over-year - that's more than twice as fast as their bookings growth.

**ALEX:** Exactly! And they returned a record $3 billion to shareholders through buybacks this quarter. But let's talk about some of the strategic milestones because there were some big ones.

**JORDAN:** Oh absolutely. They crossed 50 million Uber One members - that's their subscription service - and hit 10 million drivers and couriers globally. CEO Dara Khosrowshahi mentioned that Uber One members now account for over 50% of their total bookings and spend three times more than non-members.

**ALEX:** That subscription moat is becoming really powerful. They added 20 million Uber One members in just one year, going from 30 million to 50 million. And speaking of strategic moves, they made some big announcements at their GO-GET event.

**JORDAN:** Right - they're expanding into hotel bookings through a partnership with Expedia, adding 700,000 hotels to the platform. It's a classic Uber move - they're already huge in airport trips, which represent about 15% of their mobility bookings, so hotels are a natural extension.

**ALEX:** And the numbers support this strategy. Khosrowshahi mentioned that 40% of US riders take trips outside their home city, and globally they had over 1.5 billion trips happening outside users' home cities last year. That's a massive travel audience to tap into.

**JORDAN:** But let's talk about what's really driving growth in their core business - insurance cost savings. This is huge for their US operations, Alex.

**ALEX:** Absolutely. CFO Balaji Krishnamurthy said they expect hundreds of millions in insurance savings this year. And here's the key - they're passing those savings back to consumers through lower prices, which is driving trip acceleration, especially in California markets like LA and San Francisco.

**JORDAN:** The elasticity story is working. Lower prices are translating directly to more trips, and LA - which had the biggest insurance headwinds over recent years - is now seeing significantly better growth trends than the rest of California and the country.

**ALEX:** Now, we have to talk about autonomous vehicles because that dominated a lot of the Q&A session. They have over 30 AV partners now and their autonomous mobility trips grew more than 10x year-over-year.

**JORDAN:** And they're on track to be live in up to 15 cities by year-end. But what's interesting is how they're positioning this not as a threat to their driver network, but as expanding the entire market. Khosrowshahi pointed out that in San Francisco and LA, where

This episode includes AI-generated content.]]>SP100-UBER-Q1-2026-enThu, 07 May 2026 02:54:19 +0000trueBeta FinchMore earnings analysis: https://betafinch.com ────────── # Beta Finch Podcast Script - Uber Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex. **JORDAN:**...https://betafinch.com
──────────
# Beta Finch Podcast Script - Uber Q1 2026 Earnings

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're breaking down Uber's Q1 2026 earnings, and wow - this was a quarter that really showed the breadth of what Uber has become.

**ALEX:** Absolutely, Jordan. And before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. Now, let's get into these numbers because they were genuinely impressive. Uber delivered 21% year-over-year growth in gross bookings - that's the total value of all transactions on their platform.

**ALEX:** And what I love about this quarter is how balanced the growth was. Mobility hit 20% growth with record margins, Delivery grew 23% driven by grocery and retail, and here's the kicker - Freight returned to growth for the first time in nearly two years.

**JORDAN:** That Freight turnaround is huge, Alex. That's been a drag on their numbers for a while. But the real standout for me was the profitability story. Non-GAAP earnings per share jumped 44% year-over-year - that's more than twice as fast as their bookings growth.

**ALEX:** Exactly! And they returned a record $3 billion to shareholders through buybacks this quarter. But let's talk about some of the strategic milestones because there were some big ones.

**JORDAN:** Oh absolutely. They crossed 50 million Uber One members - that's their subscription service - and hit 10 million drivers and couriers globally. CEO Dara Khosrowshahi mentioned that Uber One members now account for over 50% of their total bookings and spend three times more than non-members.

**ALEX:** That subscription moat is becoming really powerful. They added 20 million Uber One members in just one year, going from 30 million to 50 million. And speaking of strategic moves, they made some big announcements at their GO-GET event.

**JORDAN:** Right - they're expanding into hotel bookings through a partnership with Expedia, adding 700,000 hotels to the platform. It's a classic Uber move - they're already huge in airport trips, which represent about 15% of their mobility bookings, so hotels are a natural extension.

**ALEX:** And the numbers support this strategy. Khosrowshahi mentioned that 40% of US riders take trips outside their home city, and globally they had over 1.5 billion trips happening outside users' home cities last year. That's a massive travel audience to tap into.

**JORDAN:** But let's talk about what's really driving growth in their core business - insurance cost savings. This is huge for their US operations, Alex.

**ALEX:** Absolutely. CFO Balaji Krishnamurthy said they expect hundreds of millions in insurance savings this year. And here's the key - they're passing those savings back to consumers through lower prices, which is driving trip acceleration, especially in California markets like LA and San Francisco.

**JORDAN:** The elasticity story is working. Lower prices are translating directly to more trips, and LA - which had the biggest insurance headwinds over recent years - is now seeing significantly better growth trends than the rest of California and the country.

**ALEX:** Now, we have to talk about autonomous vehicles because that dominated a lot of the Q&A session. They have over 30 AV partners now and their autonomous mobility trips grew more than 10x year-over-year.

**JORDAN:** And they're on track to be live...]]>477falsefullhttps://www.spreaker.com/episode/eog-resources-q1-2026-earnings-analysis--71900942https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into EOG Resources' first quarter 2026 earnings call. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks, Alex. And wow, what a quarter for EOG! They're definitely benefiting from some major geopolitical tailwinds, but there's a lot more substance here than just riding the oil price wave.

**ALEX:** Absolutely. Let's start with the numbers because they're pretty impressive. EOG generated $1.8 billion in adjusted net income and $1.5 billion in free cash flow for the quarter. They returned nearly $950 million to shareholders through dividends and buybacks. Jordan, what jumped out at you?

**JORDAN:** The cash flow generation is remarkable, especially when you consider they're projecting a record $8.5 billion in free cash flow for the full year 2026. But here's what I found fascinating - they're maintaining their $6.5 billion capital budget while increasing oil production guidance by 2,000 barrels per day and NGL production by 6,000 barrels per day. That's capital discipline in action.

**ALEX:** That's a great point about capital discipline. They're essentially reallocating capital from natural gas assets to oil-weighted assets within the same budget. CEO Ezra Yacob was pretty clear about this being a response to current market dynamics - oil prices surging due to the Iran conflict while natural gas prices remain soft.

**JORDAN:** Right, and let's talk about that geopolitical situation because it's driving a lot of their strategy. The conflict has removed an estimated 900 million barrels from global markets through June 2026, and EOG's management seems to believe this sets up a higher oil price floor going forward, even after the conflict resolves.

**ALEX:** The international expansion story is interesting too. They've got operations starting up in both the UAE and Bahrain. During the Q&A, management mentioned they're seeing strong partnerships with ADNOC and BAPCO, and they expect initial results from these exploration programs in the second half of 2026.

**JORDAN:** And their marketing strategy is really paying dividends - literally. They have 250,000 barrels per day of export capacity out of Corpus Christi, which gives them flexibility to price crude domestically or link to Brent pricing. Plus, their Cheniere LNG contract is expanding to 420,000 BTUs per day, with pricing linked to either JKM or Henry Hub at their election.

**ALEX:** That pricing flexibility is huge in volatile markets. CFO Ann Janssen mentioned they've been able to sell multiple cargoes at attractive pricing thanks to that export capacity. It's like having optionality built into their business model.

**JORDAN:** Speaking of Ann Janssen, let's talk shareholder returns because this is where things get really interesting. They're committed to returning at least 70% of free cash flow this year, which would be a record. And they've been aggressive on buybacks - 3.2 million shares in Q1, plus another 2.3 million shares just in April.

**ALEX:** The buyback strategy seems pretty opportunistic. During the Q&A, there was this great exchange about being tactical versus having a ratable program throughout the year. Management seems confident they're finding value in their own stock, even with oil prices elevated.

**JORDAN:** What I found telling was CEO Yacob's comment about potentially building some cash on the balance sheet during this upcycle to prepare for countercyclical investments when prices eventually pull back. That's exactly what they did with acquisitions like Encino

This episode includes AI-generated content.]]>SP100-EOG-Q1-2026-enThu, 07 May 2026 02:54:13 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: ENERGY (https://betafinch.com/groups/ENERGY) ────────── **BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my...https://betafinch.com
Groups: ENERGY (https://betafinch.com/groups/ENERGY)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into EOG Resources' first quarter 2026 earnings call. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks, Alex. And wow, what a quarter for EOG! They're definitely benefiting from some major geopolitical tailwinds, but there's a lot more substance here than just riding the oil price wave.

**ALEX:** Absolutely. Let's start with the numbers because they're pretty impressive. EOG generated $1.8 billion in adjusted net income and $1.5 billion in free cash flow for the quarter. They returned nearly $950 million to shareholders through dividends and buybacks. Jordan, what jumped out at you?

**JORDAN:** The cash flow generation is remarkable, especially when you consider they're projecting a record $8.5 billion in free cash flow for the full year 2026. But here's what I found fascinating - they're maintaining their $6.5 billion capital budget while increasing oil production guidance by 2,000 barrels per day and NGL production by 6,000 barrels per day. That's capital discipline in action.

**ALEX:** That's a great point about capital discipline. They're essentially reallocating capital from natural gas assets to oil-weighted assets within the same budget. CEO Ezra Yacob was pretty clear about this being a response to current market dynamics - oil prices surging due to the Iran conflict while natural gas prices remain soft.

**JORDAN:** Right, and let's talk about that geopolitical situation because it's driving a lot of their strategy. The conflict has removed an estimated 900 million barrels from global markets through June 2026, and EOG's management seems to believe this sets up a higher oil price floor going forward, even after the conflict resolves.

**ALEX:** The international expansion story is interesting too. They've got operations starting up in both the UAE and Bahrain. During the Q&A, management mentioned they're seeing strong partnerships with ADNOC and BAPCO, and they expect initial results from these exploration programs in the second half of 2026.

**JORDAN:** And their marketing strategy is really paying dividends - literally. They have 250,000 barrels per day of export capacity out of Corpus Christi, which gives them flexibility to price crude domestically or link to Brent pricing. Plus, their Cheniere LNG contract is expanding to 420,000 BTUs per day, with pricing linked to either JKM or Henry Hub at their election.

**ALEX:** That pricing flexibility is huge in volatile markets. CFO Ann Janssen mentioned they've been able to sell multiple cargoes at attractive pricing thanks to that export capacity. It's like having optionality built into their business model.

**JORDAN:** Speaking of Ann Janssen, let's talk shareholder returns because this is where things get really interesting. They're committed to returning at least 70% of free cash flow this year, which would be a record. And they've been aggressive on buybacks - 3.2 million shares in Q1, plus another 2.3 million shares just in April.

**ALEX:** The buyback strategy seems pretty opportunistic. During the Q&A, there was this great exchange about being tactical versus having a ratable program throughout the year. Management seems confident they're finding value in their own stock, even with oil prices elevated.
474falsefullhttps://www.spreaker.com/episode/walt-disney-q2-2026-earnings-analysis--71900940https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what matters most from corporate earnings calls. I'm Alex, and joining me as always is my co-host Jordan.

JORDAN: Hey everyone! Today we're diving into Disney's Q2 2026 earnings call, and wow - this was Josh D'Amaro's first call as CEO, so there was a lot to unpack.

ALEX: Absolutely. And before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Right, so let's get into the numbers first. Disney posted solid results - revenue grew 7%, total segment operating income up 4%. They actually outperformed their own guidance for the quarter, which is always nice to see.

ALEX: Yeah, and what really caught my attention was the streaming business. Disney+ revenue growth actually accelerated from 11% in Q1 to 13% in Q2. That's the opposite of what we're seeing from some other streaming players who are hitting growth walls.

JORDAN: Exactly! And it wasn't just subscriber volume driving that growth - it was both rate increases AND more subscribers. Plus they had double-digit advertising revenue growth. The integrated Disney+ and Hulu experience seems to be helping with retention too.

ALEX: Now, the parks business - Disney Experiences - that was interesting. Revenue up 7%, operating income up 5%, but there were some headwinds. Jordan, can you break down what's happening there?

JORDAN: Sure. So they're dealing with two main challenges: reduced international visitation to US parks, and the impact of Universal's Epic Universe opening, which is pulling some attendance away. Domestic park attendance was actually down 1% in the quarter. But here's the key - Hugh Johnston, the CFO, said they expect these headwinds to ease in the back half of the year as they lap these impacts.

ALEX: And they're still investing heavily in growth. They just opened World of Frozen at Disneyland Paris and launched the Disney Adventure cruise ship in Asia. D'Amaro mentioned they have more projects underway globally than at any time in Disney's history.

JORDAN: That ambitious expansion is really part of D'Amaro's bigger vision. He kept talking about Disney+ becoming the "digital centerpiece" of the company - not just a streaming service, but a hub that connects everything Disney does.

ALEX: Right, and this is where it gets really interesting from a strategic standpoint. D'Amaro is talking about creating a more connected Disney experience across streaming, sports, games, and physical experiences. Think about it - someone watches a Disney movie, then visits a theme park, buys merchandise, plays games - each touchpoint reinforces the others.

JORDAN: It's all about lifetime value. He specifically mentioned that their biggest opportunity might be reducing churn on Disney+. If they can keep subscribers engaged longer, that flows through to everything else.

ALEX: The technology piece was fascinating too. They're going heavy on AI across multiple areas - hyper-personalized recommendations, better ad targeting, even precision labor forecasting at the theme parks to optimize staffing.

JORDAN: And they're experimenting with short-form content and vertical video to meet younger audiences where they are. D'Amaro specifically called out Gen Alpha as important for Disney's future.

ALEX: Now, one thing that came up multiple times in the Q&A was about Disney's portfolio - specifically whether they'd consider selling off some assets. Hugh Johnston was pretty clear that they view their entertainment networks as "brands with studios" rather than just distribution platforms, and separating them would be complex without creating much value.

JORDAN: Yeah, and on ESPN, they're

This episode includes AI-generated content.]]>SP100-DIS-Q2-2026-enThu, 07 May 2026 02:54:08 +0000trueBeta FinchMore earnings analysis: https://betafinch.com ────────── ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what matters most from corporate earnings calls. I'm Alex, and joining me as always is...https://betafinch.com
──────────
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what matters most from corporate earnings calls. I'm Alex, and joining me as always is my co-host Jordan.

JORDAN: Hey everyone! Today we're diving into Disney's Q2 2026 earnings call, and wow - this was Josh D'Amaro's first call as CEO, so there was a lot to unpack.

ALEX: Absolutely. And before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Right, so let's get into the numbers first. Disney posted solid results - revenue grew 7%, total segment operating income up 4%. They actually outperformed their own guidance for the quarter, which is always nice to see.

ALEX: Yeah, and what really caught my attention was the streaming business. Disney+ revenue growth actually accelerated from 11% in Q1 to 13% in Q2. That's the opposite of what we're seeing from some other streaming players who are hitting growth walls.

JORDAN: Exactly! And it wasn't just subscriber volume driving that growth - it was both rate increases AND more subscribers. Plus they had double-digit advertising revenue growth. The integrated Disney+ and Hulu experience seems to be helping with retention too.

ALEX: Now, the parks business - Disney Experiences - that was interesting. Revenue up 7%, operating income up 5%, but there were some headwinds. Jordan, can you break down what's happening there?

JORDAN: Sure. So they're dealing with two main challenges: reduced international visitation to US parks, and the impact of Universal's Epic Universe opening, which is pulling some attendance away. Domestic park attendance was actually down 1% in the quarter. But here's the key - Hugh Johnston, the CFO, said they expect these headwinds to ease in the back half of the year as they lap these impacts.

ALEX: And they're still investing heavily in growth. They just opened World of Frozen at Disneyland Paris and launched the Disney Adventure cruise ship in Asia. D'Amaro mentioned they have more projects underway globally than at any time in Disney's history.

JORDAN: That ambitious expansion is really part of D'Amaro's bigger vision. He kept talking about Disney+ becoming the "digital centerpiece" of the company - not just a streaming service, but a hub that connects everything Disney does.

ALEX: Right, and this is where it gets really interesting from a strategic standpoint. D'Amaro is talking about creating a more connected Disney experience across streaming, sports, games, and physical experiences. Think about it - someone watches a Disney movie, then visits a theme park, buys merchandise, plays games - each touchpoint reinforces the others.

JORDAN: It's all about lifetime value. He specifically mentioned that their biggest opportunity might be reducing churn on Disney+. If they can keep subscribers engaged longer, that flows through to everything else.

ALEX: The technology piece was fascinating too. They're going heavy on AI across multiple areas - hyper-personalized recommendations, better ad targeting, even precision labor forecasting at the theme parks to optimize staffing.

JORDAN: And they're experimenting with short-form content and vertical video to meet younger audiences where they are. D'Amaro specifically called out Gen Alpha as important for Disney's future.

ALEX: Now, one thing that came up multiple times in the Q&A was about Disney's portfolio - specifically whether they'd consider selling off some assets. Hugh Johnston was pretty clear that...]]>446falsefullhttps://www.spreaker.com/episode/advanced-micro-devices-q1-2026-earnings-analysis--71892690https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the quarterly reports so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're diving into AMD's absolutely stellar Q1 2026 results that had Wall Street buzzing.

But before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, AMD just dropped some seriously impressive numbers. Walk us through the headline figures.

**JORDAN:** Alex, these results were nothing short of spectacular. AMD crushed expectations with $10.3 billion in revenue - that's 38% growth year-over-year. But here's the kicker - they're guiding for $11.2 billion in Q2, which would be 46% year-over-year growth. Their data center business is absolutely on fire, hitting a record $5.8 billion, up 57% from last year.

**ALEX:** And the profitability story is even better, right? I saw some incredible cash flow numbers.

**JORDAN:** Exactly! Free cash flow more than tripled to a record $2.6 billion - that's 25% of revenue. Earnings per share jumped 43% to $1.37. Lisa Su called it "a clear inflection in our growth trajectory and a structural shift in our business." Data center is now their primary growth driver, which is a massive change from just a few years ago.

**ALEX:** Now, the really interesting story here seems to be what AMD is calling the "Agentic AI" revolution. Jordan, they literally doubled their server CPU market size projection in just six months. How does that happen?

**JORDAN:** It's pretty remarkable, Alex. Back in November at their analyst day, they projected the server CPU market would grow at about 18% annually to around $60 billion by 2030. Now they're saying it'll grow at over 35% annually, reaching more than $120 billion by 2030.

Lisa Su explained it perfectly - as AI adoption scales and you get more inference workloads and AI agents, you need dramatically more CPU compute for orchestration, data processing, and managing these AI workloads. It's not just about the GPUs anymore.

**ALEX:** And AMD is positioned perfectly for this, aren't they? They're seeing massive growth in both their server CPUs and their AI accelerators.

**JORDAN:** Absolutely. Their EPYC server CPU business grew over 50% year-over-year, and they're guiding for over 70% growth in Q2. They're gaining market share against Intel while also benefiting from this expanding market. Plus, they landed some massive AI partnerships - they announced deals with Meta for up to 6 gigawatts of AMD Instinct GPUs and expanded their OpenAI partnership.

**ALEX:** Six gigawatts? That's... that's a lot of computing power. Put that in perspective for our listeners.

**JORDAN:** To put it simply, that's enough power to run a small city! These are multi-year, multi-billion dollar commitments. AMD is becoming a core infrastructure partner for the world's biggest AI companies. And the exciting part is Lisa Su mentioned they're seeing demand forecasts exceeding their initial plans, with visibility all the way down to which specific data centers these chips are going into.

**ALEX:** Now, it wasn't all perfect news. There were some headwinds mentioned, particularly around memory costs and China. Can you break that down?

**JORDAN:** Right, so memory prices are inflating across the industry, which is impacting both costs and consumer demand. AMD expects this to hurt PC and gaming demand in the second half of the year. They also saw their AI GPU revenue decline slightly in Q1 due to lower China sales, though that's more of a geographic mix shift than a fundamen

This episode includes AI-generated content.]]>SP100-AMD-Q1-2026-enWed, 06 May 2026 16:12:59 +0000trueBeta FinchMore earnings analysis: https://betafinch.com Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS) ────────── **BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered...https://betafinch.com
Groups: CHIPS (https://betafinch.com/groups/CHIPS), AI_LEADERS (https://betafinch.com/groups/AI_LEADERS)
──────────
**BETA FINCH PODCAST SCRIPT**

---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the quarterly reports so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're diving into AMD's absolutely stellar Q1 2026 results that had Wall Street buzzing.

But before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, AMD just dropped some seriously impressive numbers. Walk us through the headline figures.

**JORDAN:** Alex, these results were nothing short of spectacular. AMD crushed expectations with $10.3 billion in revenue - that's 38% growth year-over-year. But here's the kicker - they're guiding for $11.2 billion in Q2, which would be 46% year-over-year growth. Their data center business is absolutely on fire, hitting a record $5.8 billion, up 57% from last year.

**ALEX:** And the profitability story is even better, right? I saw some incredible cash flow numbers.

**JORDAN:** Exactly! Free cash flow more than tripled to a record $2.6 billion - that's 25% of revenue. Earnings per share jumped 43% to $1.37. Lisa Su called it "a clear inflection in our growth trajectory and a structural shift in our business." Data center is now their primary growth driver, which is a massive change from just a few years ago.

**ALEX:** Now, the really interesting story here seems to be what AMD is calling the "Agentic AI" revolution. Jordan, they literally doubled their server CPU market size projection in just six months. How does that happen?

**JORDAN:** It's pretty remarkable, Alex. Back in November at their analyst day, they projected the server CPU market would grow at about 18% annually to around $60 billion by 2030. Now they're saying it'll grow at over 35% annually, reaching more than $120 billion by 2030.

Lisa Su explained it perfectly - as AI adoption scales and you get more inference workloads and AI agents, you need dramatically more CPU compute for orchestration, data processing, and managing these AI workloads. It's not just about the GPUs anymore.

**ALEX:** And AMD is positioned perfectly for this, aren't they? They're seeing massive growth in both their server CPUs and their AI accelerators.

**JORDAN:** Absolutely. Their EPYC server CPU business grew over 50% year-over-year, and they're guiding for over 70% growth in Q2. They're gaining market share against Intel while also benefiting from this expanding market. Plus, they landed some massive AI partnerships - they announced deals with Meta for up to 6 gigawatts of AMD Instinct GPUs and expanded their OpenAI partnership.

**ALEX:** Six gigawatts? That's... that's a lot of computing power. Put that in perspective for our listeners.

**JORDAN:** To put it simply, that's enough power to run a small city! These are multi-year, multi-billion dollar commitments. AMD is becoming a core infrastructure partner for the world's biggest AI companies. And the exciting part is Lisa Su mentioned they're seeing demand forecasts exceeding their initial plans, with visibility all the way down to which specific data centers these chips are going into.

**ALEX:** Now, it wasn't all perfect news. There were some headwinds mentioned, particularly around memory costs and China. Can you break...]]>480falsefullhttps://www.spreaker.com/episode/pfizer-q1-2026-earnings-analysis--71881359
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the latest corporate results. I'm Alex, and joining me as always is Jordan. Today we're unpacking Pfizer's Q1 2026 earnings call, and folks, there's quite a bit to unpack here.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Pfizer! They really came out swinging with some impressive numbers and some game-changing legal developments. Should we start with the headline figures?

**ALEX:** Absolutely. Pfizer reported Q1 revenues of $14.5 billion, which actually exceeded their own expectations. That's a 2% operational increase overall, but here's the kicker - if you strip out their COVID products, the underlying business grew about 7% operationally. That's solid growth in a challenging environment.

**JORDAN:** And the earnings story is even better. They hit $0.75 in adjusted diluted earnings per share, again beating expectations. What really caught my attention though was their launched and acquired products - these grew 22% operationally to $3.1 billion in the quarter. That's the portfolio transformation strategy Albert Bourla has been talking about really starting to pay off.

**ALEX:** Speaking of transformative developments, we need to talk about the elephant in the room - or should I say, the legal victories in the room. Pfizer had two major legal wins that could reshape their entire growth trajectory post-2028.

**JORDAN:** Right, the Vyndamax patent settlement is huge. This drug, which treats a rare heart condition, was facing generic competition, but now Pfizer has extended exclusivity until mid-2031. We're talking about a $6 billion-plus product here, Alex. CEO Albert Bourla said this "has the potential to change the growth profile of the company significantly post-2028."

**ALEX:** And then there's the Belgian court ruling on their Comirnaty contracts with EU countries. CFO Dave Denton called this "a positive for future EPS and cash flow." These aren't just minor legal technicalities - these are major financial game-changers that give Pfizer much clearer visibility into their cash flows.

**JORDAN:** Which brings us to one of the most interesting parts of the call - Pfizer's new confidence about their post-2028 growth trajectory. Bourla said they now expect a "5-year period of high single-digit revenue CAGR" starting in 2029. That's a pretty bold statement, especially when you consider they're still navigating some significant patent cliff challenges.

**ALEX:** Let's break that down for listeners. CAGR stands for Compound Annual Growth Rate. So Pfizer is essentially saying that starting in 2029, they expect to grow revenues at a high single-digit percentage rate - so probably 7-9% annually - for five straight years. That would be impressive for any pharma company, let alone one coming off the COVID revenue peaks.

**JORDAN:** And the foundation for that confidence seems to be their pipeline and their recent acquisitions. They mentioned having about 20 pivotal study starts planned this year, 8 key data readouts, and 4 regulatory decisions. That's a packed R&D calendar. They're particularly excited about their oncology portfolio, especially after the Seagen acquisition.

**ALEX:** The oncology story is fascinating. They reported 20% year-over-year growth in their Seagen products, and they've got some potentially blockbuster readouts coming. There's Padcev for bladder cancer, which affects over 600,000 patients globally, and their multiple myeloma drug Elrexfio just hit positive Phase III results.

**JORDAN:** Don't forget about the obesity play with their Metsera acquisition.

This episode includes AI-generated content.]]>SP100-PFE-Q1-2026-enTue, 05 May 2026 21:54:16 +0000trueBeta Finch# Beta Finch Podcast Script: Pfizer Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the latest corporate results. I'm Alex, and joining me as always is Jordan. Today we're unpacking...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the latest corporate results. I'm Alex, and joining me as always is Jordan. Today we're unpacking Pfizer's Q1 2026 earnings call, and folks, there's quite a bit to unpack here.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Pfizer! They really came out swinging with some impressive numbers and some game-changing legal developments. Should we start with the headline figures?

**ALEX:** Absolutely. Pfizer reported Q1 revenues of $14.5 billion, which actually exceeded their own expectations. That's a 2% operational increase overall, but here's the kicker - if you strip out their COVID products, the underlying business grew about 7% operationally. That's solid growth in a challenging environment.

**JORDAN:** And the earnings story is even better. They hit $0.75 in adjusted diluted earnings per share, again beating expectations. What really caught my attention though was their launched and acquired products - these grew 22% operationally to $3.1 billion in the quarter. That's the portfolio transformation strategy Albert Bourla has been talking about really starting to pay off.

**ALEX:** Speaking of transformative developments, we need to talk about the elephant in the room - or should I say, the legal victories in the room. Pfizer had two major legal wins that could reshape their entire growth trajectory post-2028.

**JORDAN:** Right, the Vyndamax patent settlement is huge. This drug, which treats a rare heart condition, was facing generic competition, but now Pfizer has extended exclusivity until mid-2031. We're talking about a $6 billion-plus product here, Alex. CEO Albert Bourla said this "has the potential to change the growth profile of the company significantly post-2028."

**ALEX:** And then there's the Belgian court ruling on their Comirnaty contracts with EU countries. CFO Dave Denton called this "a positive for future EPS and cash flow." These aren't just minor legal technicalities - these are major financial game-changers that give Pfizer much clearer visibility into their cash flows.

**JORDAN:** Which brings us to one of the most interesting parts of the call - Pfizer's new confidence about their post-2028 growth trajectory. Bourla said they now expect a "5-year period of high single-digit revenue CAGR" starting in 2029. That's a pretty bold statement, especially when you consider they're still navigating some significant patent cliff challenges.

**ALEX:** Let's break that down for listeners. CAGR stands for Compound Annual Growth Rate. So Pfizer is essentially saying that starting in 2029, they expect to grow revenues at a high single-digit percentage rate - so probably 7-9% annually - for five straight years. That would be impressive for any pharma company, let alone one coming off the COVID revenue peaks.

**JORDAN:** And the foundation for that confidence seems to be their pipeline and their recent acquisitions. They mentioned having about 20 pivotal study starts planned this year, 8 key data readouts, and 4 regulatory decisions. That's a packed R&D calendar. They're particularly excited about their oncology portfolio, especially after the Seagen acquisition.

**ALEX:** The oncology story is fascinating. They reported 20% year-over-year growth in their Seagen products, and they've got some potentially blockbuster readouts coming. There's Padcev for bladder cancer, which affects over 600,000 patients globally, and their multiple myeloma drug...]]>552falsefullhttps://www.spreaker.com/episode/duke-energy-q1-2026-earnings-analysis--71881358
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear insights. I'm Alex, and with me as always is Jordan. Today we're diving into Duke Energy's first quarter 2026 results, and folks, this utility giant is making some serious moves in the data center boom.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for Duke Energy! They posted adjusted earnings per share of $1.93, beating last year's $1.76. But honestly, the earnings beat is just the appetizer here - the main course is this massive data center story that's unfolding.

**ALEX:** Absolutely right, Jordan. Duke is sitting at the epicenter of this AI infrastructure buildout. They've now secured 7.6 gigawatts of electric service agreements with data centers - that's adding another 2.7 gigawatts just this quarter alone. To put that in perspective, we're talking about enough power for millions of homes.

**JORDAN:** And what I love about Duke's approach here is how they're protecting existing customers. CEO Harry Sideris really emphasized this - these new data center contracts include minimum demand provisions, credit support, refundable capital advances, and termination charges. Basically, if these big tech companies want Duke's power, they're paying their fair share upfront.

**ALEX:** That's crucial because one of the biggest concerns investors have had about this data center boom is whether utilities will stick existing customers with the bill for all this new infrastructure. Duke seems to have that covered. In fact, they're saying these incremental volumes will actually benefit all customers over time as system costs get spread over a larger base.

**JORDAN:** Speaking of customer benefits, Alex, did you catch those two major announcements that total over $5 billion in customer savings? First, they struck a multi-year deal to monetize up to $3.1 billion in clean energy tax credits through 2028, with proceeds flowing back to customers. And second, they got regulatory approval to combine their two Carolina utilities, which should save customers $2.3 billion through 2040.

**ALEX:** Those are massive numbers, Jordan. And the timing is perfect because Duke has rate cases pending in the Carolinas right now. CFO Brian Savoy mentioned they might use some of these savings as tools to mitigate rate increases. Smart move - it shows regulators they're serious about keeping rates affordable even as they invest heavily in new infrastructure.

**JORDAN:** Let's talk about that infrastructure investment because it's staggering. Duke is executing a $103 billion capital plan - that's with a "B" - and they're funding it through these strategic asset sales. They closed $2.8 billion from selling a minority stake in their Florida utility to Brookfield, plus another $2.5 billion from selling their Tennessee gas business to Spire.

**ALEX:** Over $5 billion in proceeds that strengthen their balance sheet while funding growth. And they're not just building for data centers - they're adding 14 gigawatts of generation over the next five years. A big chunk of that is natural gas plants, including a 1.4 gigawatt facility in South Carolina that just got approved.

**JORDAN:** The nuclear angle is interesting too, Alex. Duke operates the largest regulated nuclear fleet in the nation, and they just got approval to extend the life of their Robinson Nuclear Plant. That's their second plant to reach this milestone, and they plan to seek similar extensions for all their remaining reactors. Nuclear provides about $600 million in annual tax credits to customers, so keeping these plan

This episode includes AI-generated content.]]>SP100-DUK-Q1-2026-enTue, 05 May 2026 21:54:09 +0000trueBeta Finch**Beta Finch Podcast Script: Duke Energy Q1 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear insights. I'm Alex, and with me as always is Jordan. Today we're...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear insights. I'm Alex, and with me as always is Jordan. Today we're diving into Duke Energy's first quarter 2026 results, and folks, this utility giant is making some serious moves in the data center boom.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for Duke Energy! They posted adjusted earnings per share of $1.93, beating last year's $1.76. But honestly, the earnings beat is just the appetizer here - the main course is this massive data center story that's unfolding.

**ALEX:** Absolutely right, Jordan. Duke is sitting at the epicenter of this AI infrastructure buildout. They've now secured 7.6 gigawatts of electric service agreements with data centers - that's adding another 2.7 gigawatts just this quarter alone. To put that in perspective, we're talking about enough power for millions of homes.

**JORDAN:** And what I love about Duke's approach here is how they're protecting existing customers. CEO Harry Sideris really emphasized this - these new data center contracts include minimum demand provisions, credit support, refundable capital advances, and termination charges. Basically, if these big tech companies want Duke's power, they're paying their fair share upfront.

**ALEX:** That's crucial because one of the biggest concerns investors have had about this data center boom is whether utilities will stick existing customers with the bill for all this new infrastructure. Duke seems to have that covered. In fact, they're saying these incremental volumes will actually benefit all customers over time as system costs get spread over a larger base.

**JORDAN:** Speaking of customer benefits, Alex, did you catch those two major announcements that total over $5 billion in customer savings? First, they struck a multi-year deal to monetize up to $3.1 billion in clean energy tax credits through 2028, with proceeds flowing back to customers. And second, they got regulatory approval to combine their two Carolina utilities, which should save customers $2.3 billion through 2040.

**ALEX:** Those are massive numbers, Jordan. And the timing is perfect because Duke has rate cases pending in the Carolinas right now. CFO Brian Savoy mentioned they might use some of these savings as tools to mitigate rate increases. Smart move - it shows regulators they're serious about keeping rates affordable even as they invest heavily in new infrastructure.

**JORDAN:** Let's talk about that infrastructure investment because it's staggering. Duke is executing a $103 billion capital plan - that's with a "B" - and they're funding it through these strategic asset sales. They closed $2.8 billion from selling a minority stake in their Florida utility to Brookfield, plus another $2.5 billion from selling their Tennessee gas business to Spire.

**ALEX:** Over $5 billion in proceeds that strengthen their balance sheet while funding growth. And they're not just building for data centers - they're adding 14 gigawatts of generation over the next five years. A big chunk of that is natural gas plants, including a 1.4 gigawatt facility in South Carolina that just got approved.

**JORDAN:** The nuclear angle is interesting too, Alex. Duke operates the largest regulated nuclear fleet in the nation, and they just got approval to extend the life of their Robinson Nuclear Plant. That's their second plant to reach this milestone, and they plan to seek similar extensions for...]]>579falsefullhttps://www.spreaker.com/episode/vertex-pharmaceuticals-q1-2026-earnings-analysis--71873072
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Vertex Pharmaceuticals' Q1 2026 earnings call - and wow, Jordan, this was packed with updates.

JORDAN: Absolutely, Alex. But before we jump in, let me get our mandatory disclaimer out of the way. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks, Jordan. Now, let's talk Vertex. This biotech giant just delivered some impressive numbers - $2.99 billion in total revenue for Q1, representing 8% growth year-over-year. But what really caught my attention was how they're diversifying beyond their cystic fibrosis cash cow.

JORDAN: Right, and that diversification story is really the headline here. CEO Reshma Kewalramani emphasized that their newer products - KASJEVY and GERNAVICS - drove about 25% of their total revenue growth. That's a company successfully expanding its footprint beyond a single therapeutic area.

ALEX: Let's break down those newer products. KASJEVY, their gene editing therapy, brought in $43 million in Q1 revenue with over 500 patients now having started treatment. Then there's GERNAVICS for pain management at $29 million in revenue. But the real excitement seems to be around their renal pipeline, particularly something called Povitacicept or "Povi."

JORDAN: Oh, the Povi data was genuinely impressive, Alex. They just completed what Kewalramani called their fastest regulatory submission in company history - 27 days from database lock to filing. The Phase III interim results for IgA nephropathy showed a 52% reduction in proteinuria, which is a key marker doctors watch. Kewalramani described the results as "sparkling from top to bottom."

ALEX: And they're not stopping there with renal disease. They're positioning this as potentially their fourth major franchise alongside CF, blood disorders, and pain. The addressable patient population across their renal programs could be in the hundreds of thousands when you add up all the different kidney diseases they're targeting.

JORDAN: What I found interesting in the Q&A was when analyst Jessica Fye asked about renal potentially rivaling their CF business in size. Kewalramani didn't shy away from that comparison. She pointed out that while each kidney disease is rare, they're "common rare diseases" - IgA nephropathy alone affects about 150,000 patients in North America and Europe.

ALEX: The numbers definitely support the growth story. Non-GAAP earnings per share came in at $4.47, up from $4.06 the previous year. They're managing expenses well while investing heavily in these new areas - SG&A expenses were up 30% year-over-year, but that's driven by commercial investments in pain and renal programs.

JORDAN: Speaking of investments, they spent about $344 million buying back shares in Q1, showing they're returning cash to shareholders while still funding growth. They ended the quarter with $13 billion in cash and investments, so they've got plenty of firepower.

ALEX: Now, it wasn't all good news. They had to discontinue their VX-522 program for CF patients who can't benefit from their current modulators. Kewalramani explained they couldn't overcome tolerability issues related to lung inflammation, likely from the delivery mechanism.

JORDAN: That's about 5,000 patients who still can't be helped by Vertex's current CF portfolio. But Kewalramani was adamant they're not giving up on this population. She said their "commitment to CF is absolute and steadfast" and they'll go back to the drawing board on delivery methods.

ALEX: Let's talk guidance. They're sticking with their full-year revenue guidance of $12.95 to $13.10 billion, repre

This episode includes AI-generated content.]]>SP100-VRTX-Q1-2026-enTue, 05 May 2026 09:14:35 +0000trueBeta Finch**Beta Finch Podcast Script** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Vertex...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Vertex Pharmaceuticals' Q1 2026 earnings call - and wow, Jordan, this was packed with updates.

JORDAN: Absolutely, Alex. But before we jump in, let me get our mandatory disclaimer out of the way. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks, Jordan. Now, let's talk Vertex. This biotech giant just delivered some impressive numbers - $2.99 billion in total revenue for Q1, representing 8% growth year-over-year. But what really caught my attention was how they're diversifying beyond their cystic fibrosis cash cow.

JORDAN: Right, and that diversification story is really the headline here. CEO Reshma Kewalramani emphasized that their newer products - KASJEVY and GERNAVICS - drove about 25% of their total revenue growth. That's a company successfully expanding its footprint beyond a single therapeutic area.

ALEX: Let's break down those newer products. KASJEVY, their gene editing therapy, brought in $43 million in Q1 revenue with over 500 patients now having started treatment. Then there's GERNAVICS for pain management at $29 million in revenue. But the real excitement seems to be around their renal pipeline, particularly something called Povitacicept or "Povi."

JORDAN: Oh, the Povi data was genuinely impressive, Alex. They just completed what Kewalramani called their fastest regulatory submission in company history - 27 days from database lock to filing. The Phase III interim results for IgA nephropathy showed a 52% reduction in proteinuria, which is a key marker doctors watch. Kewalramani described the results as "sparkling from top to bottom."

ALEX: And they're not stopping there with renal disease. They're positioning this as potentially their fourth major franchise alongside CF, blood disorders, and pain. The addressable patient population across their renal programs could be in the hundreds of thousands when you add up all the different kidney diseases they're targeting.

JORDAN: What I found interesting in the Q&A was when analyst Jessica Fye asked about renal potentially rivaling their CF business in size. Kewalramani didn't shy away from that comparison. She pointed out that while each kidney disease is rare, they're "common rare diseases" - IgA nephropathy alone affects about 150,000 patients in North America and Europe.

ALEX: The numbers definitely support the growth story. Non-GAAP earnings per share came in at $4.47, up from $4.06 the previous year. They're managing expenses well while investing heavily in these new areas - SG&A expenses were up 30% year-over-year, but that's driven by commercial investments in pain and renal programs.

JORDAN: Speaking of investments, they spent about $344 million buying back shares in Q1, showing they're returning cash to shareholders while still funding growth. They ended the quarter with $13 billion in cash and investments, so they've got plenty of firepower.

ALEX: Now, it wasn't all good news. They had to discontinue their VX-522 program for CF patients who can't benefit from their current modulators. Kewalramani explained they couldn't overcome tolerability issues related to lung inflammation, likely from the delivery mechanism.

JORDAN: That's about 5,000 patients who still can't be helped by Vertex's current CF portfolio. But Kewalramani was adamant they're not giving up on this population. She said their "commitment to CF is absolute and steadfast" and they'll go back to the drawing board on delivery...]]>520falsefullhttps://www.spreaker.com/episode/palantir-q1-2026-earnings-analysis--71873070
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Palantir's absolutely explosive Q1 2026 results - and folks, when I say explosive, I mean it. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Alex, I've been covering earnings for years, and these Palantir numbers are just wild. We're talking about 85% year-over-year revenue growth - their highest as a public company. But what really caught my eye was their U.S. business hitting triple digits for the first time since their direct listing.

**ALEX:** Right, 104% growth in the U.S.! And get this - their U.S. business now represents 79% of total revenue. They pulled in $1.63 billion in revenue for the quarter, up 16% sequentially. But Jordan, what's your take on their "Rule of 40" score hitting 145?

**JORDAN:** For listeners who might not know, the Rule of 40 combines revenue growth rate and profit margins - and anything over 40 is considered excellent. Palantir just scored 145, up from 127 last quarter. That's not just good, that's almost unheard of at this scale.

**ALEX:** And they're not slowing down. They raised their full-year 2026 revenue guidance to $7.656 billion - that's 71% growth year-over-year and a 10% bump from their previous guidance. What's driving all this growth?

**JORDAN:** It's all about their AIP platform - their Artificial Intelligence Platform. CEO Alex Karp was pretty bold on the call, claiming "almost every single highlighted example of AI that actually is producing results in the U.S. is actually Palantir." That's a huge statement, but the numbers seem to back it up.

**ALEX:** Speaking of bold statements, Karp mentioned they're achieving this growth with essentially just seven salespeople who actually sell, compared to what would normally be 7,000 for a company their size. That suggests incredible product-market fit.

**JORDAN:** The enterprise AI story is fascinating here. While everyone's talking about AI "slop" - their term for unreliable AI outputs - Palantir positions their platform as the "no-slop zone." They're saying enterprises need precision and governance when deploying AI, not just flashy demos.

**ALEX:** Let's break down the segments. Their commercial business grew 95% year-over-year to $774 million, with U.S. commercial specifically up 133%. But government wasn't slouch either - up 76% to $858 million.

**JORDAN:** The government wins are particularly interesting. They landed a $300 million USDA contract and their Maven Smart System for defense continues expanding. Ryan Taylor mentioned that Maven usage has doubled in the past four months and is now 4x what it was twelve months ago.

**ALEX:** What struck me was their customer expansion. Net dollar retention hit 150% - that means existing customers are spending 50% more than they were a year ago. And they're now at 1,007 total customers, up 31% year-over-year.

**JORDAN:** The cash generation is incredible too. They generated $899 million in cash from operations and $925 million in adjusted free cash flow. Karp made a great point - their free cash flow this quarter is larger than their total revenue was in the same quarter last year.

**ALEX:** During the Q&A, there were some interesting exchanges about competition from AI labs like OpenAI and Anthropic moving into enterprise. How did management respond to that?

**JORDAN:** Karp was pretty dismissive, honestly. He basically said "go ahead and try the alternatives" - test out what he calls the "slop" and then compare it to what Palantir delivers. He seems confident that enterprises doing real-world testing will come back to Palantir.

**ALEX:** CTO Shyam Sankar made a fascinatin

This episode includes AI-generated content.]]>SP100-PLTR-Q1-2026-enTue, 05 May 2026 09:14:30 +0000trueBeta Finch# Beta Finch Podcast Script: Palantir Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Palantir's absolutely explosive Q1 2026 results - and...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Palantir's absolutely explosive Q1 2026 results - and folks, when I say explosive, I mean it. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Alex, I've been covering earnings for years, and these Palantir numbers are just wild. We're talking about 85% year-over-year revenue growth - their highest as a public company. But what really caught my eye was their U.S. business hitting triple digits for the first time since their direct listing.

**ALEX:** Right, 104% growth in the U.S.! And get this - their U.S. business now represents 79% of total revenue. They pulled in $1.63 billion in revenue for the quarter, up 16% sequentially. But Jordan, what's your take on their "Rule of 40" score hitting 145?

**JORDAN:** For listeners who might not know, the Rule of 40 combines revenue growth rate and profit margins - and anything over 40 is considered excellent. Palantir just scored 145, up from 127 last quarter. That's not just good, that's almost unheard of at this scale.

**ALEX:** And they're not slowing down. They raised their full-year 2026 revenue guidance to $7.656 billion - that's 71% growth year-over-year and a 10% bump from their previous guidance. What's driving all this growth?

**JORDAN:** It's all about their AIP platform - their Artificial Intelligence Platform. CEO Alex Karp was pretty bold on the call, claiming "almost every single highlighted example of AI that actually is producing results in the U.S. is actually Palantir." That's a huge statement, but the numbers seem to back it up.

**ALEX:** Speaking of bold statements, Karp mentioned they're achieving this growth with essentially just seven salespeople who actually sell, compared to what would normally be 7,000 for a company their size. That suggests incredible product-market fit.

**JORDAN:** The enterprise AI story is fascinating here. While everyone's talking about AI "slop" - their term for unreliable AI outputs - Palantir positions their platform as the "no-slop zone." They're saying enterprises need precision and governance when deploying AI, not just flashy demos.

**ALEX:** Let's break down the segments. Their commercial business grew 95% year-over-year to $774 million, with U.S. commercial specifically up 133%. But government wasn't slouch either - up 76% to $858 million.

**JORDAN:** The government wins are particularly interesting. They landed a $300 million USDA contract and their Maven Smart System for defense continues expanding. Ryan Taylor mentioned that Maven usage has doubled in the past four months and is now 4x what it was twelve months ago.

**ALEX:** What struck me was their customer expansion. Net dollar retention hit 150% - that means existing customers are spending 50% more than they were a year ago. And they're now at 1,007 total customers, up 31% year-over-year.

**JORDAN:** The cash generation is incredible too. They generated $899 million in cash from operations and $925 million in adjusted free cash flow. Karp made a great point - their free cash flow this quarter is larger than their total revenue was in the same quarter last year.

**ALEX:** During the Q&A, there were some interesting exchanges about competition from AI labs like OpenAI and Anthropic moving into enterprise. How did management respond to that?

**JORDAN:** Karp was pretty dismissive, honestly. He basically said "go ahead and try the alternatives" - test out what he calls the "slop" and then compare it to what Palantir...]]>475falsefullhttps://www.spreaker.com/episode/exxon-mobil-q1-2026-earnings-analysis--71826663
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Exxon Mobil's Q1 2026 earnings call - and wow, what a quarter to unpack. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And right off the bat, we need to address the elephant in the room - this earnings call was dominated by the ongoing Middle East conflict and its impact on global energy markets. CEO Darren Woods opened with some pretty sobering commentary about the situation.

**ALEX**: Absolutely. Woods was very direct about the human cost first, mentioning their colleagues and partners living under daily threats in the region. But from a business perspective, Jordan, the disruption has actually highlighted Exxon's competitive advantages in a major way.

**JORDAN**: Exactly. What struck me was how Woods framed this as essentially a stress test for all the changes they've made over the past decade. And by most measures, they seem to have passed with flying colors. Despite what he called "unprecedented disruption in the world supply of oil and natural gas," they maintained deliveries globally and even ramped up refining production by 200,000 barrels per day from February to March.

**ALEX**: That's like adding a mid-sized refinery overnight! And the financial results reflect this operational excellence. Even excluding timing effects and identified items, their first-quarter earnings per share were up versus 2025. CFO Kathy Mikells highlighted that their Energy Products segment made $2.8 billion in the quarter - that's up $2 billion from last year.

**JORDAN**: The refining story is particularly compelling. Remember when Exxon announced that Beaumont refinery expansion back in 2023? There were lots of questions about whether refining investments made sense. Well, Woods announced that expansion has already fully recovered its initial investment - ahead of expectations.

**ALEX**: And they're not just benefiting from higher margins - they're creating structural advantages. Their Gulf Coast refineries ran at record utilization rates, and they've got this global supply chain organization that rapidly executed alternate routings from the US Gulf Coast to Asia. It's that scale and integration advantage Woods keeps talking about.

**JORDAN**: Speaking of scale advantages, let's talk about their growth engines. In Guyana, they hit record production levels again and have three new projects under construction. The Oahu project expects first oil late this year. But what I found interesting was their $100 million commitment over ten years for STEM education in Guyana - that's the kind of long-term relationship building that creates sustainable competitive advantages.

**ALEX**: And in the Permian, they're still on track for 1.8 million oil-equivalent barrels this year, with that longer-term target of 2.5 million. What's interesting is Woods' confidence that they're not seeing any plateau in opportunities there, unlike some competitors who've predicted resource constraints.

**JORDAN**: The LNG story is fascinating too. Golden Pass achieved first LNG in March - that's about a 5% increase in US LNG exports. And by the time all three trains are online, they'll increase current US exports by roughly 15%. But here's what's really notable - with the Middle East disruptions, that "long" LNG market everyone was predicting has essentially disappeared overnight.

**ALEX**: Right, and they've got Papua New Guinea and Mozambique LNG projects expecting final investment decisions later this year. Woods was pretty confident about their positioning in what's now a much tighter LNG market.

**JORDAN**: Let's dive into some of the Q&A highlights, because

This episode includes AI-generated content.]]>SP100-XOM-Q1-2026-enSat, 02 May 2026 08:46:45 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Exxon Mobil's Q1 2026 earnings call - and wow, what a quarter to unpack....
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Exxon Mobil's Q1 2026 earnings call - and wow, what a quarter to unpack. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And right off the bat, we need to address the elephant in the room - this earnings call was dominated by the ongoing Middle East conflict and its impact on global energy markets. CEO Darren Woods opened with some pretty sobering commentary about the situation.

**ALEX**: Absolutely. Woods was very direct about the human cost first, mentioning their colleagues and partners living under daily threats in the region. But from a business perspective, Jordan, the disruption has actually highlighted Exxon's competitive advantages in a major way.

**JORDAN**: Exactly. What struck me was how Woods framed this as essentially a stress test for all the changes they've made over the past decade. And by most measures, they seem to have passed with flying colors. Despite what he called "unprecedented disruption in the world supply of oil and natural gas," they maintained deliveries globally and even ramped up refining production by 200,000 barrels per day from February to March.

**ALEX**: That's like adding a mid-sized refinery overnight! And the financial results reflect this operational excellence. Even excluding timing effects and identified items, their first-quarter earnings per share were up versus 2025. CFO Kathy Mikells highlighted that their Energy Products segment made $2.8 billion in the quarter - that's up $2 billion from last year.

**JORDAN**: The refining story is particularly compelling. Remember when Exxon announced that Beaumont refinery expansion back in 2023? There were lots of questions about whether refining investments made sense. Well, Woods announced that expansion has already fully recovered its initial investment - ahead of expectations.

**ALEX**: And they're not just benefiting from higher margins - they're creating structural advantages. Their Gulf Coast refineries ran at record utilization rates, and they've got this global supply chain organization that rapidly executed alternate routings from the US Gulf Coast to Asia. It's that scale and integration advantage Woods keeps talking about.

**JORDAN**: Speaking of scale advantages, let's talk about their growth engines. In Guyana, they hit record production levels again and have three new projects under construction. The Oahu project expects first oil late this year. But what I found interesting was their $100 million commitment over ten years for STEM education in Guyana - that's the kind of long-term relationship building that creates sustainable competitive advantages.

**ALEX**: And in the Permian, they're still on track for 1.8 million oil-equivalent barrels this year, with that longer-term target of 2.5 million. What's interesting is Woods' confidence that they're not seeing any plateau in opportunities there, unlike some competitors who've predicted resource constraints.

**JORDAN**: The LNG story is fascinating too. Golden Pass achieved first LNG in March - that's about a 5% increase in US LNG exports. And by the time all three trains are online, they'll increase current US exports by roughly 15%. But here's what's really notable - with the Middle East disruptions, that "long" LNG market everyone was predicting has essentially disappeared overnight.

**ALEX**: Right, and they've got Papua New Guinea and Mozambique LNG projects expecting final investment decisions later this year. Woods was pretty confident about...]]>456falsefullhttps://www.spreaker.com/episode/linde-q1-2026-earnings-analysis--71826662
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and joining me as always is Jordan. Today we're unpacking Linde's Q1 2026 results - the industrial gas giant that just delivered another solid quarter despite some serious global headwinds.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter to analyze. Linde really showed why they're considered the gold standard in industrial gases. EPS of $4.33 was up 10% year-over-year, with operating margins hitting that impressive 30% mark. When you've got geopolitical chaos, supply chain disruptions, and economic uncertainty swirling around, delivering those kinds of numbers is no small feat.

**ALEX:** Absolutely. And let's talk about that revenue picture - $8.8 billion in sales, up 8% year-over-year. But here's what I found interesting, Jordan: when you strip out the 5% currency tailwind and 1% from acquisitions, underlying sales growth was a more modest 3%. That tells us the real story is about pricing discipline rather than volume explosions.

**JORDAN:** Exactly right, Alex. CEO Matthew White was pretty clear about this during the call - they're seeing 2% higher pricing and just 1% volume growth. And when you dig into the geographic breakdown, it's really a tale of three regions. The Americas are firing on all cylinders with base volume growth, APAC is holding steady thanks to project startups, but EMEA? That's where the weakness is concentrated.

**ALEX:** The EMEA situation is fascinating from a macro perspective. White mentioned they're seeing production shifting away from Continental Europe to more feedstock-advantaged assets in the Americas. He basically said if your feedstock comes on a ship, you're in trouble right now, but if it's pipeline or rail-based, you're in a better position.

**JORDAN:** And that brings us to one of the most interesting parts of this call - helium. I mean, who would have thought helium would be such a hot topic on an earnings call? But with the Middle East conflict disrupting supply chains, Linde is sitting pretty with their diversified sourcing. They're about 85-90% contracted on helium, and White said they're already securing new long-term agreements rather than chasing spot market gains.

**ALEX:** Smart strategy there. But let's talk about the real growth engine everyone's buzzing about - commercial space. This is where it gets exciting, Jordan. Linde mentioned they're investing over $1 billion in ultra-high-purity plants for advanced semiconductor fabs, and the space business is growing so fast they might break it out as a separate segment when it hits 5% of sales.

**JORDAN:** The math on that is pretty striking, Alex. Five percent of sales would be about $1.7 billion annually. White mentioned they previously thought space might hit $1 billion by decade's end, but now they're talking about potentially reaching $1.7 billion. That's not just growth - that's explosive growth in a completely new market.

**ALEX:** And the drivers make sense. It's all about launch frequency, rocket size, and propellant type. Linde supplies oxygen for oxidizer and nitrogen for densification, plus hydrogen for hydrogen-fueled rockets. With companies racing to build satellite constellations and the entire commercial space economy taking off, Linde is positioned right in the sweet spot.

**JORDAN:** Now let's address the elephant in the room - guidance. For Q2, they're guiding $4.40 to $4.50 EPS, which is 8-10% growth. Full year guidance is $17.60 to $17.90, representing 7-9% growth. Here's what I find notable: they raised the bottom of the range by 20 cent

This episode includes AI-generated content.]]>SP100-LIN-Q1-2026-enSat, 02 May 2026 08:46:40 +0000trueBeta Finch# Beta Finch Podcast Script - Linde Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and joining me as always is Jordan. Today we're unpacking Linde's Q1 2026...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and joining me as always is Jordan. Today we're unpacking Linde's Q1 2026 results - the industrial gas giant that just delivered another solid quarter despite some serious global headwinds.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter to analyze. Linde really showed why they're considered the gold standard in industrial gases. EPS of $4.33 was up 10% year-over-year, with operating margins hitting that impressive 30% mark. When you've got geopolitical chaos, supply chain disruptions, and economic uncertainty swirling around, delivering those kinds of numbers is no small feat.

**ALEX:** Absolutely. And let's talk about that revenue picture - $8.8 billion in sales, up 8% year-over-year. But here's what I found interesting, Jordan: when you strip out the 5% currency tailwind and 1% from acquisitions, underlying sales growth was a more modest 3%. That tells us the real story is about pricing discipline rather than volume explosions.

**JORDAN:** Exactly right, Alex. CEO Matthew White was pretty clear about this during the call - they're seeing 2% higher pricing and just 1% volume growth. And when you dig into the geographic breakdown, it's really a tale of three regions. The Americas are firing on all cylinders with base volume growth, APAC is holding steady thanks to project startups, but EMEA? That's where the weakness is concentrated.

**ALEX:** The EMEA situation is fascinating from a macro perspective. White mentioned they're seeing production shifting away from Continental Europe to more feedstock-advantaged assets in the Americas. He basically said if your feedstock comes on a ship, you're in trouble right now, but if it's pipeline or rail-based, you're in a better position.

**JORDAN:** And that brings us to one of the most interesting parts of this call - helium. I mean, who would have thought helium would be such a hot topic on an earnings call? But with the Middle East conflict disrupting supply chains, Linde is sitting pretty with their diversified sourcing. They're about 85-90% contracted on helium, and White said they're already securing new long-term agreements rather than chasing spot market gains.

**ALEX:** Smart strategy there. But let's talk about the real growth engine everyone's buzzing about - commercial space. This is where it gets exciting, Jordan. Linde mentioned they're investing over $1 billion in ultra-high-purity plants for advanced semiconductor fabs, and the space business is growing so fast they might break it out as a separate segment when it hits 5% of sales.

**JORDAN:** The math on that is pretty striking, Alex. Five percent of sales would be about $1.7 billion annually. White mentioned they previously thought space might hit $1 billion by decade's end, but now they're talking about potentially reaching $1.7 billion. That's not just growth - that's explosive growth in a completely new market.

**ALEX:** And the drivers make sense. It's all about launch frequency, rocket size, and propellant type. Linde supplies oxygen for oxidizer and nitrogen for densification, plus hydrogen for hydrogen-fueled rockets. With companies racing to build satellite constellations and the entire commercial space economy taking off, Linde is positioned right in the sweet spot.

**JORDAN:** Now let's address the elephant in the room - guidance. For Q2, they're guiding $4.40 to $4.50 EPS, which is 8-10% growth. Full year guidance is...]]>505falsefullhttps://www.spreaker.com/episode/chevron-q1-2026-earnings-analysis--71826660
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Chevron's Q1 2026 earnings call. Now, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Chevron just reported some really solid numbers despite operating in what can only be described as a pretty chaotic global environment.

**ALEX:** Absolutely. Let's start with the headline numbers. Chevron posted $2.2 billion in earnings, or $1.11 per share. But the adjusted earnings tell a cleaner story - $2.8 billion or $1.41 per share. Jordan, what stood out to you in these results?

**JORDAN:** Well, the big story here is how Chevron's integrated model really shined during market volatility. They had about $3 billion in unfavorable timing effects due to steep commodity price rises in March, but management was clear this was largely paper positions that would unwind. What's impressive is how they navigated supply disruptions.

**ALEX:** Right, and CEO Michael Wirth really emphasized this integration advantage. They're now running over 40% equity crude in their Asian refineries - compared to their historical 15% across the system. That's a massive operational shift.

**JORDAN:** Exactly. In the U.S., they're above 50% equity crude throughput at some refineries. This isn't just about margins - it's about supply security. When global energy markets are tight, having your own crude to feed your own refineries is like having a strategic ace up your sleeve.

**ALEX:** Let's talk about the geopolitical elephant in the room. There's clearly some major conflict affecting Middle Eastern energy supplies, though the transcript doesn't specify exactly what. How is Chevron positioned?

**JORDAN:** Interestingly, Chevron seems relatively insulated. Less than 5% of their portfolio is in the Middle East region. But they're definitely benefiting from the market dynamics. Their Australian LNG facilities are running at full capacity, and they just sold their first U.S. LNG cargo into Europe - talk about good timing.

**ALEX:** And the production numbers are strong across the board. They're reaffirming 7-10% production growth for the year, with U.S. production over 2 million barrels per day. The TCO project in Kazakhstan is back above 1 million barrels per day after some earlier disruptions.

**JORDAN:** What I found fascinating was the Venezuela update. They've expanded their position there through an asset swap with PDVSA, increasing their stake in Petro Independencia to 49%. But Wirth was clear - they're still in "debt recovery mode" and expect Venezuela to represent just 1-2% of cash flow from operations.

**ALEX:** The Q&A session had some really telling moments. When analysts pressed about capital allocation in this higher price environment, CFO Eimear Bonner was adamant about staying disciplined. No changes to their $2.5-3 billion quarterly buyback range.

**JORDAN:** That's smart. She said it's too early - only eight weeks into the conflict - to fundamentally change their outlook. They're not being pro-cyclical on buybacks, which shows real capital discipline.

**ALEX:** One of the more intriguing discussions was about their exclusive negotiations with Microsoft for power projects. Wirth mentioned they're advancing a West Texas project and could reach FID later this year. That's Chevron diversifying into the data center power space.

**JORDAN:** The timing there is interesting too. With AI driving massive power demand and Microsoft being their cloud provider, this feels like a natural partnership. Wirth seemed confident they could align Microsoft's power price expectations with Chevron's

This episode includes AI-generated content.]]>SP100-CVX-Q1-2026-enSat, 02 May 2026 08:46:34 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Chevron's Q1 2026 earnings call. Now, before we get started, I need to mention that...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Chevron's Q1 2026 earnings call. Now, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Chevron just reported some really solid numbers despite operating in what can only be described as a pretty chaotic global environment.

**ALEX:** Absolutely. Let's start with the headline numbers. Chevron posted $2.2 billion in earnings, or $1.11 per share. But the adjusted earnings tell a cleaner story - $2.8 billion or $1.41 per share. Jordan, what stood out to you in these results?

**JORDAN:** Well, the big story here is how Chevron's integrated model really shined during market volatility. They had about $3 billion in unfavorable timing effects due to steep commodity price rises in March, but management was clear this was largely paper positions that would unwind. What's impressive is how they navigated supply disruptions.

**ALEX:** Right, and CEO Michael Wirth really emphasized this integration advantage. They're now running over 40% equity crude in their Asian refineries - compared to their historical 15% across the system. That's a massive operational shift.

**JORDAN:** Exactly. In the U.S., they're above 50% equity crude throughput at some refineries. This isn't just about margins - it's about supply security. When global energy markets are tight, having your own crude to feed your own refineries is like having a strategic ace up your sleeve.

**ALEX:** Let's talk about the geopolitical elephant in the room. There's clearly some major conflict affecting Middle Eastern energy supplies, though the transcript doesn't specify exactly what. How is Chevron positioned?

**JORDAN:** Interestingly, Chevron seems relatively insulated. Less than 5% of their portfolio is in the Middle East region. But they're definitely benefiting from the market dynamics. Their Australian LNG facilities are running at full capacity, and they just sold their first U.S. LNG cargo into Europe - talk about good timing.

**ALEX:** And the production numbers are strong across the board. They're reaffirming 7-10% production growth for the year, with U.S. production over 2 million barrels per day. The TCO project in Kazakhstan is back above 1 million barrels per day after some earlier disruptions.

**JORDAN:** What I found fascinating was the Venezuela update. They've expanded their position there through an asset swap with PDVSA, increasing their stake in Petro Independencia to 49%. But Wirth was clear - they're still in "debt recovery mode" and expect Venezuela to represent just 1-2% of cash flow from operations.

**ALEX:** The Q&A session had some really telling moments. When analysts pressed about capital allocation in this higher price environment, CFO Eimear Bonner was adamant about staying disciplined. No changes to their $2.5-3 billion quarterly buyback range.

**JORDAN:** That's smart. She said it's too early - only eight weeks into the conflict - to fundamentally change their outlook. They're not being pro-cyclical on buybacks, which shows real capital discipline.

**ALEX:** One of the more intriguing discussions was about their exclusive negotiations with Microsoft for power projects. Wirth mentioned they're advancing a West Texas project and could reach FID later this year. That's Chevron diversifying into the data center power space.

**JORDAN:** The timing there is interesting too. With AI driving massive power demand and Microsoft...]]>475falsefullhttps://www.spreaker.com/episode/colgate-palmolive-q1-2026-earnings-analysis--71826658
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest quarterly results and what they mean for investors. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're breaking down Colgate-Palmolive's Q1 2026 earnings call, and there's quite a bit to unpack here.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now, Alex, Colgate had an interesting quarter - some really strong performance in certain areas, but they're also dealing with significant headwinds. Where do you want to start?

**ALEX**: Let's kick off with the headline numbers. Colgate delivered what CEO Noel Wallace called "strong top and bottom line growth" with organic sales growth actually accelerating from Q4. They saw growth in both volume and pricing across all four categories and four of five divisions, which is pretty impressive breadth.

**JORDAN**: That's right, and what really caught my attention was the geographic mix. Emerging markets were the star of the show, particularly Asia Pacific. Wallace mentioned that these are regions where Colgate's global brands have higher market shares and greater scale advantages, so they're doubling down on investments there.

**ALEX**: Speaking of investments, they're maintaining their focus on brand equity and advertising spending, which is notable given the cost pressures they're facing. But Jordan, let's talk about the elephant in the room - that $300 million increase in expected raw material and logistics costs.

**JORDAN**: Yeah, this is where things get interesting from a margins perspective. They had to revise their gross margin outlook downward because of these cost pressures. CFO Stanley Sutula broke it down - about two-thirds of that $300 million hit is from raw materials, one-third from logistics. The big culprits? Oil byproducts like resins and petrochemicals, with spending in those areas expected to be up more than 20% year-over-year.

**ALEX**: And they're assuming crude oil at around $110 for their planning purposes. But here's what I found encouraging - despite these headwinds, they reaffirmed their full-year guidance for both top and bottom line growth. How are they managing to do that?

**JORDAN**: It comes down to what Wallace calls their "flexible P&L model." They're offsetting these cost pressures through several levers: revenue growth management, or RGM, productivity initiatives, and they just announced an acceleration of their Strategic Growth and Productivity Program - or SGPP.

**ALEX**: Let's dig into that SGPP announcement because it's pretty significant. They're now targeting $200 million to $300 million in annualized savings, with most of those savings hitting in 2027 and 2028. Wallace emphasized this isn't an extension of the program - it's still completing by end of 2028 - but they've identified additional opportunities.

**JORDAN**: Right, and Sutula explained that the strong execution from their teams allowed them to reach the high end of their initial targets, plus they found new ways to simplify operations and enhance efficiency. I like that they're being proactive about organizational structure and reducing complexity.

**ALEX**: Now, the regional performance was really telling. Asia Pacific was a standout, with improvements in both China through their Hawley & Hazel business and strong performance in India. Wallace mentioned they're not "completely out of the woods" in China yet, but the interventions they've made - accelerated innovation, better omnichannel execution - are starting to pay off.

**JORDAN**: Latin America also had another strong volume quarter with mid-single-digit growth. Wallace was particularly enthusiast

This episode includes AI-generated content.]]>SP100-CL-Q1-2026-enSat, 02 May 2026 08:46:28 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest quarterly results and what they mean for investors. I'm Alex. **JORDAN**: And I'm Jordan. Today we're breaking down...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest quarterly results and what they mean for investors. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're breaking down Colgate-Palmolive's Q1 2026 earnings call, and there's quite a bit to unpack here.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now, Alex, Colgate had an interesting quarter - some really strong performance in certain areas, but they're also dealing with significant headwinds. Where do you want to start?

**ALEX**: Let's kick off with the headline numbers. Colgate delivered what CEO Noel Wallace called "strong top and bottom line growth" with organic sales growth actually accelerating from Q4. They saw growth in both volume and pricing across all four categories and four of five divisions, which is pretty impressive breadth.

**JORDAN**: That's right, and what really caught my attention was the geographic mix. Emerging markets were the star of the show, particularly Asia Pacific. Wallace mentioned that these are regions where Colgate's global brands have higher market shares and greater scale advantages, so they're doubling down on investments there.

**ALEX**: Speaking of investments, they're maintaining their focus on brand equity and advertising spending, which is notable given the cost pressures they're facing. But Jordan, let's talk about the elephant in the room - that $300 million increase in expected raw material and logistics costs.

**JORDAN**: Yeah, this is where things get interesting from a margins perspective. They had to revise their gross margin outlook downward because of these cost pressures. CFO Stanley Sutula broke it down - about two-thirds of that $300 million hit is from raw materials, one-third from logistics. The big culprits? Oil byproducts like resins and petrochemicals, with spending in those areas expected to be up more than 20% year-over-year.

**ALEX**: And they're assuming crude oil at around $110 for their planning purposes. But here's what I found encouraging - despite these headwinds, they reaffirmed their full-year guidance for both top and bottom line growth. How are they managing to do that?

**JORDAN**: It comes down to what Wallace calls their "flexible P&L model." They're offsetting these cost pressures through several levers: revenue growth management, or RGM, productivity initiatives, and they just announced an acceleration of their Strategic Growth and Productivity Program - or SGPP.

**ALEX**: Let's dig into that SGPP announcement because it's pretty significant. They're now targeting $200 million to $300 million in annualized savings, with most of those savings hitting in 2027 and 2028. Wallace emphasized this isn't an extension of the program - it's still completing by end of 2028 - but they've identified additional opportunities.

**JORDAN**: Right, and Sutula explained that the strong execution from their teams allowed them to reach the high end of their initial targets, plus they found new ways to simplify operations and enhance efficiency. I like that they're being proactive about organizational structure and reducing complexity.

**ALEX**: Now, the regional performance was really telling. Asia Pacific was a standout, with improvements in both China through their Hawley & Hazel business and strong performance in India. Wallace mentioned they're not "completely out of the woods" in China yet, but the interventions they've made - accelerated innovation, better omnichannel execution - are starting to pay...]]>501falsefullhttps://www.spreaker.com/episode/cigna-q1-2026-earnings-analysis--71815229
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Cigna Group's Q1 2026 earnings call - and wow, there's a lot to unpack here, including some major leadership changes and strategic pivots.

But before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Thanks Alex. And speaking of major changes, this earnings call was pretty historic - it was CEO David Cordani's final quarterly call after 17 years leading the company. But the numbers certainly gave him a strong send-off.

ALEX: Absolutely! So let's start with the headline numbers. Cigna reported Q1 revenue of $68.5 billion and adjusted EPS of $7.79. That EPS represents 16% year-over-year growth, which is pretty impressive. And based on this strong performance, they raised their full-year 2026 EPS guidance to at least $30.35.

JORDAN: What's interesting is that both of their main segments - Evernorth and Cigna Healthcare - performed above internal expectations. Evernorth earnings were slightly ahead, while Cigna Healthcare really exceeded expectations with 18% earnings growth year-over-year. The medical care ratio came in at 79.8%, which was better than their guidance of slightly below 81%.

ALEX: Now Jordan, there were some significant strategic announcements that I think investors need to pay attention to. Can you walk us through those?

JORDAN: Sure thing. Cigna made two big portfolio moves. First, they're planning to exit the individual exchange business at the end of 2026. This isn't a huge surprise - it's been a small and shrinking business for them. CEO-elect Brian Evanko said they couldn't see a clear path to scale it meaningfully within Cigna's overall size.

The second move is potentially bigger - they announced a strategic review for eviCore, which handles prior authorization services for multiple health plans. This seems to be driven by the industry's progress on standardizing and automating prior authorization processes.

ALEX: And these moves really fit into their broader strategy of portfolio shaping, right? They're focusing resources on their three core growth platforms.

JORDAN: Exactly. Evanko outlined those three platforms clearly: Specialty and Care Services, which represents about 35% of company income and is growing 8-12% annually; Pharmacy Benefit Services at about 25% of income; and Cigna Healthcare at 40% of income. They're essentially doubling down on what's working and shedding what isn't.

ALEX: Let's talk about that specialty business because it really shone this quarter. Specialty and Care Services earnings grew 20% to $1.1 billion. What's driving that?

JORDAN: Three main factors. First, solid specialty volume growth across the board. Second - and this is interesting - continued adoption of biosimilars and specialty generics. These deliver savings to patients while actually improving margins for Cigna. Third, they're getting contributions from their investment in Shields Health Solutions, which they made late last year.

David Cordani specifically highlighted how they're using AI to improve biosimilar conversions. For drugs like Humira and Stelara, they're offering $0 out-of-pocket costs to patients while using AI to identify personalized conversion strategies. It's a win-win - lower costs, higher patient satisfaction, and better margins.

ALEX: That ties into something Brian Evanko emphasized about the future - this focus on AI and data analytics. He's clearly putting his stamp on the company's direction.

JORDAN: Right. When he takes over as CEO in July, Evanko outlined three areas of intensification: better use of data and AI for personalized care, drivin

This episode includes AI-generated content.]]>SP100-CI-Q1-2026-enFri, 01 May 2026 14:57:15 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Cigna Group's Q1 2026 earnings call - and wow, there's a lot to...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Cigna Group's Q1 2026 earnings call - and wow, there's a lot to unpack here, including some major leadership changes and strategic pivots.

But before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Thanks Alex. And speaking of major changes, this earnings call was pretty historic - it was CEO David Cordani's final quarterly call after 17 years leading the company. But the numbers certainly gave him a strong send-off.

ALEX: Absolutely! So let's start with the headline numbers. Cigna reported Q1 revenue of $68.5 billion and adjusted EPS of $7.79. That EPS represents 16% year-over-year growth, which is pretty impressive. And based on this strong performance, they raised their full-year 2026 EPS guidance to at least $30.35.

JORDAN: What's interesting is that both of their main segments - Evernorth and Cigna Healthcare - performed above internal expectations. Evernorth earnings were slightly ahead, while Cigna Healthcare really exceeded expectations with 18% earnings growth year-over-year. The medical care ratio came in at 79.8%, which was better than their guidance of slightly below 81%.

ALEX: Now Jordan, there were some significant strategic announcements that I think investors need to pay attention to. Can you walk us through those?

JORDAN: Sure thing. Cigna made two big portfolio moves. First, they're planning to exit the individual exchange business at the end of 2026. This isn't a huge surprise - it's been a small and shrinking business for them. CEO-elect Brian Evanko said they couldn't see a clear path to scale it meaningfully within Cigna's overall size.

The second move is potentially bigger - they announced a strategic review for eviCore, which handles prior authorization services for multiple health plans. This seems to be driven by the industry's progress on standardizing and automating prior authorization processes.

ALEX: And these moves really fit into their broader strategy of portfolio shaping, right? They're focusing resources on their three core growth platforms.

JORDAN: Exactly. Evanko outlined those three platforms clearly: Specialty and Care Services, which represents about 35% of company income and is growing 8-12% annually; Pharmacy Benefit Services at about 25% of income; and Cigna Healthcare at 40% of income. They're essentially doubling down on what's working and shedding what isn't.

ALEX: Let's talk about that specialty business because it really shone this quarter. Specialty and Care Services earnings grew 20% to $1.1 billion. What's driving that?

JORDAN: Three main factors. First, solid specialty volume growth across the board. Second - and this is interesting - continued adoption of biosimilars and specialty generics. These deliver savings to patients while actually improving margins for Cigna. Third, they're getting contributions from their investment in Shields Health Solutions, which they made late last year.

David Cordani specifically highlighted how they're using AI to improve biosimilar conversions. For drugs like Humira and Stelara, they're offering $0 out-of-pocket costs to patients while using AI to identify personalized conversion strategies. It's a win-win - lower costs, higher patient satisfaction, and better margins.

ALEX: That ties into something Brian Evanko emphasized about the future - this focus on AI and data analytics. He's clearly putting his stamp on the company's...]]>512falsefullhttps://www.spreaker.com/episode/stryker-q1-2026-earnings-analysis--71809959
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Stryker's Q1 2026 results, and wow, this was definitely not your typical earnings call.

**ALEX:** Before we get into it, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the elephant in the room - Stryker got hit by a cyberattack late in Q1. How bad was the damage?

**ALEX:** It was significant, Jordan. Organic sales growth came in at just 2.4% - way below what you'd normally expect from Stryker. Even more telling, adjusted earnings per share dropped 8.5% to $2.60. CEO Kevin Lobo mentioned they had 40,000 laptops wiped and were essentially shut down for about three weeks.

**JORDAN:** That's brutal. But here's what caught my attention - despite all this chaos, they maintained their full-year guidance. That's either incredibly optimistic or they have serious confidence in their recovery plan.

**ALEX:** I'm leaning toward confidence. CFO Preston Wells was pretty detailed about why they think they'll bounce back. He explained that different business units were affected differently based on their operating models. For example, their orthopedic business has a lot of consigned inventory sitting right at hospitals, so surgeries could continue even when Stryker's systems were down.

**JORDAN:** Right, it was more of a revenue recognition issue there rather than lost procedures. But their capital equipment business - things like hospital beds and defibrillators - that's where they really got hit because those are made-to-order products.

**ALEX:** Exactly. And Wells said most of that lost production will shift to Q3 and Q4 rather than Q2, which makes sense given manufacturing lead times. What I found interesting was how resilient their underlying business seems to be.

**JORDAN:** Talk about that resilience - what are the bright spots?

**ALEX:** Well, they had their best-ever Q1 for Mako robot installations, both in the US and internationally. That's their surgical robotics platform, and utilization rates are climbing. Plus they just got European approval for Pangaea - that's their trauma plating system that's been driving explosive growth in the US.

**JORDAN:** And let's not forget the M&A activity. They announced they're acquiring Amplitude Vascular Systems, which gets them into the intravascular lithotripsy space. That's basically using sound waves to break up calcified plaque in blood vessels.

**ALEX:** Kevin Lobo was really bullish on that deal during the Q&A. He said it fits perfectly with their existing peripheral vascular business through Inari, which they bought last year. Same call points, same physicians.

**JORDAN:** Speaking of the Q&A, there were some great nuggets in there. One analyst asked about competitive dynamics in orthopedics, and Lobo basically said "bring it on." He mentioned they expect to keep outgrowing the orthopedic market by 200 to 300 basis points, just like they have been.

**ALEX:** I loved his comment about their robotics portfolio too. He said the new Mako RPS - that's their handheld robotic system - is getting great feedback, especially in ambulatory surgery centers. It's like a stepping stone for surgeons who find full Mako too intimidating.

**JORDAN:** The international story is pretty compelling too. While the US grew 1.9%, international was up 3.9% despite the cyber issues. Lobo highlighted Japan as their second-largest market outside the US, and it's experiencing "tremendous growth."

**ALEX:** And they're just getting

This episode includes AI-generated content.]]>SP100-SYK-Q1-2026-enFri, 01 May 2026 09:11:41 +0000trueBeta Finch**Beta Finch Podcast Script - Stryker Q1 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex....
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Stryker's Q1 2026 results, and wow, this was definitely not your typical earnings call.

**ALEX:** Before we get into it, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the elephant in the room - Stryker got hit by a cyberattack late in Q1. How bad was the damage?

**ALEX:** It was significant, Jordan. Organic sales growth came in at just 2.4% - way below what you'd normally expect from Stryker. Even more telling, adjusted earnings per share dropped 8.5% to $2.60. CEO Kevin Lobo mentioned they had 40,000 laptops wiped and were essentially shut down for about three weeks.

**JORDAN:** That's brutal. But here's what caught my attention - despite all this chaos, they maintained their full-year guidance. That's either incredibly optimistic or they have serious confidence in their recovery plan.

**ALEX:** I'm leaning toward confidence. CFO Preston Wells was pretty detailed about why they think they'll bounce back. He explained that different business units were affected differently based on their operating models. For example, their orthopedic business has a lot of consigned inventory sitting right at hospitals, so surgeries could continue even when Stryker's systems were down.

**JORDAN:** Right, it was more of a revenue recognition issue there rather than lost procedures. But their capital equipment business - things like hospital beds and defibrillators - that's where they really got hit because those are made-to-order products.

**ALEX:** Exactly. And Wells said most of that lost production will shift to Q3 and Q4 rather than Q2, which makes sense given manufacturing lead times. What I found interesting was how resilient their underlying business seems to be.

**JORDAN:** Talk about that resilience - what are the bright spots?

**ALEX:** Well, they had their best-ever Q1 for Mako robot installations, both in the US and internationally. That's their surgical robotics platform, and utilization rates are climbing. Plus they just got European approval for Pangaea - that's their trauma plating system that's been driving explosive growth in the US.

**JORDAN:** And let's not forget the M&A activity. They announced they're acquiring Amplitude Vascular Systems, which gets them into the intravascular lithotripsy space. That's basically using sound waves to break up calcified plaque in blood vessels.

**ALEX:** Kevin Lobo was really bullish on that deal during the Q&A. He said it fits perfectly with their existing peripheral vascular business through Inari, which they bought last year. Same call points, same physicians.

**JORDAN:** Speaking of the Q&A, there were some great nuggets in there. One analyst asked about competitive dynamics in orthopedics, and Lobo basically said "bring it on." He mentioned they expect to keep outgrowing the orthopedic market by 200 to 300 basis points, just like they have been.

**ALEX:** I loved his comment about their robotics portfolio too. He said the new Mako RPS - that's their handheld robotic system - is getting great feedback, especially in ambulatory surgery centers. It's like a stepping stone for surgeons who find full Mako too intimidating.

**JORDAN:** The international story is pretty compelling too. While the US grew 1.9%, international was up 3.9%...]]>489falsefullhttps://www.spreaker.com/episode/apple-q2-2026-earnings-analysis--71809958
**JORDAN**: Thanks Alex, and wow – where do we even start with this Apple quarter? I mean, we've got blockbuster numbers AND a major leadership transition announcement all in one call.

**ALEX**: Right? Tim Cook announcing he's stepping down as CEO after 15 years to become Executive Chairman, with John Ternus taking over in September. But let's start with the financial fireworks. Apple absolutely crushed it with $111.2 billion in revenue – that's up 17% year-over-year and a March quarter record.

**JORDAN**: And that revenue beat came despite supply constraints, which is remarkable. iPhone was the star of the show at $57 billion, up 22% year-over-year. Alex, when you're supply constrained and still growing at over 20%, that tells you something about the underlying demand strength.

**ALEX**: Absolutely. And it wasn't just iPhone – they had double-digit growth across every geographic segment, including Greater China which grew 28% and hit a quarterly record. The iPhone 17 family seems to be resonating incredibly well with customers.

**JORDAN**: Let's talk about those supply constraints because this is fascinating from an operational perspective. Cook was pretty transparent about this – the main constraint is availability of advanced nodes for their SoCs, not memory as some might have expected. And get this – for Mac specifically, they're seeing higher than expected demand for Mac mini and Mac Studio because customers are recognizing these as powerful AI platforms.

**ALEX**: And don't forget the MacBook Neo! Cook said customer response has been "off the charts" with higher than expected demand. They set a March record for customers new to Mac, partly due to the Neo. It sounds like Apple's strategy of bringing Mac to more people at a breakthrough price is really working.

**JORDAN**: Services hit another all-time record at $31 billion, up 16%. But here's what caught my attention – they announced they're ending their formal net cash neutrality target. CFO Kevan Parekh said they want more flexibility to evaluate cash and debt independently.

**ALEX**: That's a big strategic shift. They authorized another $100 billion in share buybacks and raised the dividend 4% to 27 cents per share. It sounds like they want more financial flexibility as they ramp up AI investments, which brings us to the elephant in the room – their AI strategy.

**JORDAN**: Cook was asked about agentic AI and the future of smartphones, and while he didn't reveal future products, he emphasized how thrilled they are with Apple Intelligence integration. The company is clearly investing heavily – R&D spending is accelerating much higher than overall company growth.

**ALEX**: The memory cost situation is interesting though. Cook was pretty direct about this – they expect "significantly higher memory costs" in the June quarter and said beyond that, memory costs will drive "an increasing impact" on their business. When analysts pushed on margins, he said they'll "look at a range of options."

**JORDAN**: That's code for potential pricing actions, right? With 99% customer satisfaction on the iPhone 17 family in the US, they clearly have pricing power. But Cook was coy about whether they'd focus on market share gains or profitability in this cost environment.

**ALEX**: Let's talk about the guidance. They're expecting total company revenue to grow 14% to 17% year-over-year in June, which assumes co

This episode includes AI-generated content.]]>SP100-AAPL-Q2-2026-enFri, 01 May 2026 09:11:37 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're breaking down Apple's Q2 2026 earnings – and folks, this wasn't just any...
**JORDAN**: Thanks Alex, and wow – where do we even start with this Apple quarter? I mean, we've got blockbuster numbers AND a major leadership transition announcement all in one call.

**ALEX**: Right? Tim Cook announcing he's stepping down as CEO after 15 years to become Executive Chairman, with John Ternus taking over in September. But let's start with the financial fireworks. Apple absolutely crushed it with $111.2 billion in revenue – that's up 17% year-over-year and a March quarter record.

**JORDAN**: And that revenue beat came despite supply constraints, which is remarkable. iPhone was the star of the show at $57 billion, up 22% year-over-year. Alex, when you're supply constrained and still growing at over 20%, that tells you something about the underlying demand strength.

**ALEX**: Absolutely. And it wasn't just iPhone – they had double-digit growth across every geographic segment, including Greater China which grew 28% and hit a quarterly record. The iPhone 17 family seems to be resonating incredibly well with customers.

**JORDAN**: Let's talk about those supply constraints because this is fascinating from an operational perspective. Cook was pretty transparent about this – the main constraint is availability of advanced nodes for their SoCs, not memory as some might have expected. And get this – for Mac specifically, they're seeing higher than expected demand for Mac mini and Mac Studio because customers are recognizing these as powerful AI platforms.

**ALEX**: And don't forget the MacBook Neo! Cook said customer response has been "off the charts" with higher than expected demand. They set a March record for customers new to Mac, partly due to the Neo. It sounds like Apple's strategy of bringing Mac to more people at a breakthrough price is really working.

**JORDAN**: Services hit another all-time record at $31 billion, up 16%. But here's what caught my attention – they announced they're ending their formal net cash neutrality target. CFO Kevan Parekh said they want more flexibility to evaluate cash and debt independently.

**ALEX**: That's a big strategic shift. They authorized another $100 billion in share buybacks and raised the dividend 4% to 27 cents per share. It sounds like they want more financial flexibility as they ramp up AI investments, which brings us to the elephant in the room – their AI strategy.

**JORDAN**: Cook was asked about agentic AI and the future of smartphones, and while he didn't reveal future products, he emphasized how thrilled they are with Apple Intelligence integration. The company is clearly investing heavily – R&D spending is accelerating much higher than overall company growth.

**ALEX**: The memory cost situation is interesting though. Cook was pretty direct about this – they expect "significantly higher memory costs" in the June quarter and said beyond that, memory costs will drive "an increasing impact" on their business. When analysts pushed on margins, he said they'll "look at a range of options."

**JORDAN**: That's code for potential pricing actions, right? With 99% customer satisfaction on the iPhone 17 family in the US, they clearly have pricing power. But Cook was coy about whether they'd focus on market share gains or profitability in this cost environment.

**ALEX**: Let's...]]>424falsefullhttps://www.spreaker.com/episode/southern-company-q1-2026-earnings-analysis--71798715
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Southern Company's Q1 2026 earnings call, and wow - this utility is absolutely crushing it in the data center boom.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. So Alex, let's start with the numbers because they're pretty impressive.

**ALEX**: They really are. Southern posted adjusted earnings per share of $1.32 for Q1, which was 9 cents higher than last year and beat their own estimate by 12 cents. That's solid execution right there.

**JORDAN**: What's driving this outperformance? Because utilities aren't exactly known for big earnings surprises.

**ALEX**: Here's where it gets interesting - it's all about load growth. Their weather-normal retail electricity sales jumped 2.3% year-over-year, which CEO Chris Womack called "the highest total retail sales growth that we have seen in the first quarter in recent history." But the real story is in the commercial segment.

**JORDAN**: Right, commercial sales were up 4.5% when adjusted for weather, and get this - data center usage alone was up 42% year-over-year. That's not a typo, folks. Forty-two percent.

**ALEX**: And they added 46,000 new residential customers to their system. The Southeast continues to be this massive economic magnet. In Q1 alone, they announced over $7 billion in capital investment and nearly 4,000 permanent jobs coming to their region.

**JORDAN**: The scale of what Southern is dealing with on the large load front is just staggering. They now have 11 gigawatts of fully contracted large load agreements - that's enough to power roughly 8 million homes. And in just the last two months, they signed contracts for another 1.9 gigawatts with hyperscalers.

**ALEX**: But here's what I love about their approach - these aren't your typical utility contracts. Every single large load customer has to cover their full share of costs to serve them. There are minimum bills, collateral requirements, cancellation fees. Southern isn't taking any risks here.

**JORDAN**: Smart structure. And the pipeline is enormous - they're talking about over 75 gigawatts in their prospective pipeline, with 12 gigawatts in late-stage discussions through the mid-2030s. Half of that 12 gigawatts is expected to be finalized with executed contracts in the near term.

**ALEX**: To put that in perspective, Jordan, Southern's entire current generating capacity is around 50 gigawatts. We're potentially talking about doubling their system over the next decade.

**JORDAN**: Which brings us to the infrastructure challenge. Georgia Power just launched an RFP - that's request for proposals - for 2 to 6 gigawatts of new dispatchable generation, including thermal, battery storage, and renewables, all coming online in 2032-2033.

**ALEX**: And they're not just planning - they're already building. They've got 10 gigawatts of new generation resources under development right now. Georgia Power just brought two new battery storage systems online, totaling nearly 200 megawatts of capacity.

**JORDAN**: The financial implications are massive too. CFO David Poroch mentioned that if they get selected for company-owned resources in these RFPs, we could be looking at about $2 billion of incremental capital expenditure per gigawatt. That's serious money.

**ALEX**: Speaking of money, they just secured something pretty remarkable - $26.5 billion in loan agreements with the Department of Energy. This is historic low-cost financing that's projected to save customers $7 billion over the 30-year term.

**JORDAN**: That's huge for their capital structure. It reduces their reli

This episode includes AI-generated content.]]>SP100-SO-Q1-2026-enThu, 30 Apr 2026 23:19:09 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving into Southern Company's Q1 2026 earnings call, and wow - this utility is absolutely...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Southern Company's Q1 2026 earnings call, and wow - this utility is absolutely crushing it in the data center boom.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. So Alex, let's start with the numbers because they're pretty impressive.

**ALEX**: They really are. Southern posted adjusted earnings per share of $1.32 for Q1, which was 9 cents higher than last year and beat their own estimate by 12 cents. That's solid execution right there.

**JORDAN**: What's driving this outperformance? Because utilities aren't exactly known for big earnings surprises.

**ALEX**: Here's where it gets interesting - it's all about load growth. Their weather-normal retail electricity sales jumped 2.3% year-over-year, which CEO Chris Womack called "the highest total retail sales growth that we have seen in the first quarter in recent history." But the real story is in the commercial segment.

**JORDAN**: Right, commercial sales were up 4.5% when adjusted for weather, and get this - data center usage alone was up 42% year-over-year. That's not a typo, folks. Forty-two percent.

**ALEX**: And they added 46,000 new residential customers to their system. The Southeast continues to be this massive economic magnet. In Q1 alone, they announced over $7 billion in capital investment and nearly 4,000 permanent jobs coming to their region.

**JORDAN**: The scale of what Southern is dealing with on the large load front is just staggering. They now have 11 gigawatts of fully contracted large load agreements - that's enough to power roughly 8 million homes. And in just the last two months, they signed contracts for another 1.9 gigawatts with hyperscalers.

**ALEX**: But here's what I love about their approach - these aren't your typical utility contracts. Every single large load customer has to cover their full share of costs to serve them. There are minimum bills, collateral requirements, cancellation fees. Southern isn't taking any risks here.

**JORDAN**: Smart structure. And the pipeline is enormous - they're talking about over 75 gigawatts in their prospective pipeline, with 12 gigawatts in late-stage discussions through the mid-2030s. Half of that 12 gigawatts is expected to be finalized with executed contracts in the near term.

**ALEX**: To put that in perspective, Jordan, Southern's entire current generating capacity is around 50 gigawatts. We're potentially talking about doubling their system over the next decade.

**JORDAN**: Which brings us to the infrastructure challenge. Georgia Power just launched an RFP - that's request for proposals - for 2 to 6 gigawatts of new dispatchable generation, including thermal, battery storage, and renewables, all coming online in 2032-2033.

**ALEX**: And they're not just planning - they're already building. They've got 10 gigawatts of new generation resources under development right now. Georgia Power just brought two new battery storage systems online, totaling nearly 200 megawatts of capacity.

**JORDAN**: The financial implications are massive too. CFO David Poroch mentioned that if they get selected for company-owned resources in these RFPs, we could be looking at about $2 billion of incremental capital expenditure per gigawatt. That's serious money.

**ALEX**: Speaking of money, they just secured something pretty remarkable - $26.5 billion in loan agreements with the Department of...]]>518falsefullhttps://www.spreaker.com/episode/merck-q1-2026-earnings-analysis--71798714
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Merck's Q1 2026 results, and wow - there's a lot to unpack here.

**JORDAN:** That's right, Alex. And before we jump in, I need to share our standard disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks, Jordan. Now, let's talk about the headline numbers. Merck reported revenue of $16.3 billion for Q1, which represents 5% growth year-over-year, or 3% excluding foreign exchange impacts. But here's the kicker - they actually posted a loss of $1.28 per share.

**JORDAN:** Right, and that loss is entirely due to a massive one-time charge. Merck took a $9 billion hit related to their acquisition of Cidara Therapeutics. Without that charge, they would have been profitable. In fact, they raised their full-year guidance, which tells you management feels pretty good about the underlying business.

**ALEX:** Exactly. They bumped up their revenue guidance to between $65.8 billion and $67 billion for the full year, and raised their EPS guidance to $5.04 to $5.16. But Jordan, let's talk about what's really driving this growth - because it's not just KEYTRUDA anymore.

**JORDAN:** That's the big story here, Alex. Yes, KEYTRUDA sales were still strong at $8 billion, up 8%, but what caught my attention was how diversified their growth drivers are becoming. WINREVAIR, their pulmonary arterial hypertension drug, hit $525 million in sales. That's a relatively new product showing real traction.

**ALEX:** And then there's WELIREG, their oral HIF-2-alpha inhibitor, which saw 43% growth to $199 million. Management highlighted they have over 20 new products launching with what they called "blockbuster potential." CEO Rob Davis mentioned a potential commercial opportunity of over $70 billion by the mid-2030s from these new growth drivers alone.

**JORDAN:** Those are big numbers, Alex. But let's talk about some challenges too. GARDASIL sales dropped 22% to $1.1 billion, mainly due to lower demand in China and Japan. And their new RSV prevention drug ENFLONSIA had minimal sales in Q1, though that was expected due to seasonality.

**ALEX:** True, but management seemed confident about the RSV product ramping up in the second half of the year. What really stood out to me from the call was their focus on AI and partnerships. They announced a multi-year deal with Google Cloud for AI capabilities, plus expanded collaborations with Tempus AI and the Mayo Clinic.

**JORDAN:** That's a smart move, especially in drug development where AI could potentially accelerate research timelines. Speaking of their pipeline, they had some interesting updates. The FDA approved their HIV drug IDVYNSO, and they're expecting several priority reviews in the coming months for cancer treatments.

**ALEX:** The pipeline discussion was fascinating. Dr. Dean Li, their research chief, mentioned they have 17 Phase III studies ongoing for their antibody-drug conjugate sac-TMT, with 13 of those in "first mover" indications. That could be huge if those trials are successful.

**JORDAN:** And let's not forget the Terns Pharmaceutical acquisition they're working on. They're paying about $5.8 billion for TERN-701, a chronic myeloid leukemia drug candidate. Management thinks it has "multibillion-dollar commercial potential."

**ALEX:** During the Q&A, analysts were clearly focused on the pipeline readouts coming this year. There was a lot of discussion about their ophthalmology programs and cancer combination therapies. One thing that struck me was how confident management sounded about their diversification strategy.

**JORDAN:** Absolutely. CFO Caroline Litchfield mentioned

This episode includes AI-generated content.]]>SP100-MRK-Q1-2026-enThu, 30 Apr 2026 23:19:03 +0000trueBeta Finch# Beta Finch Podcast Script: Merck Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Merck's Q1 2026 results, and wow - there's a lot to unpack...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Merck's Q1 2026 results, and wow - there's a lot to unpack here.

**JORDAN:** That's right, Alex. And before we jump in, I need to share our standard disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks, Jordan. Now, let's talk about the headline numbers. Merck reported revenue of $16.3 billion for Q1, which represents 5% growth year-over-year, or 3% excluding foreign exchange impacts. But here's the kicker - they actually posted a loss of $1.28 per share.

**JORDAN:** Right, and that loss is entirely due to a massive one-time charge. Merck took a $9 billion hit related to their acquisition of Cidara Therapeutics. Without that charge, they would have been profitable. In fact, they raised their full-year guidance, which tells you management feels pretty good about the underlying business.

**ALEX:** Exactly. They bumped up their revenue guidance to between $65.8 billion and $67 billion for the full year, and raised their EPS guidance to $5.04 to $5.16. But Jordan, let's talk about what's really driving this growth - because it's not just KEYTRUDA anymore.

**JORDAN:** That's the big story here, Alex. Yes, KEYTRUDA sales were still strong at $8 billion, up 8%, but what caught my attention was how diversified their growth drivers are becoming. WINREVAIR, their pulmonary arterial hypertension drug, hit $525 million in sales. That's a relatively new product showing real traction.

**ALEX:** And then there's WELIREG, their oral HIF-2-alpha inhibitor, which saw 43% growth to $199 million. Management highlighted they have over 20 new products launching with what they called "blockbuster potential." CEO Rob Davis mentioned a potential commercial opportunity of over $70 billion by the mid-2030s from these new growth drivers alone.

**JORDAN:** Those are big numbers, Alex. But let's talk about some challenges too. GARDASIL sales dropped 22% to $1.1 billion, mainly due to lower demand in China and Japan. And their new RSV prevention drug ENFLONSIA had minimal sales in Q1, though that was expected due to seasonality.

**ALEX:** True, but management seemed confident about the RSV product ramping up in the second half of the year. What really stood out to me from the call was their focus on AI and partnerships. They announced a multi-year deal with Google Cloud for AI capabilities, plus expanded collaborations with Tempus AI and the Mayo Clinic.

**JORDAN:** That's a smart move, especially in drug development where AI could potentially accelerate research timelines. Speaking of their pipeline, they had some interesting updates. The FDA approved their HIV drug IDVYNSO, and they're expecting several priority reviews in the coming months for cancer treatments.

**ALEX:** The pipeline discussion was fascinating. Dr. Dean Li, their research chief, mentioned they have 17 Phase III studies ongoing for their antibody-drug conjugate sac-TMT, with 13 of those in "first mover" indications. That could be huge if those trials are successful.

**JORDAN:** And let's not forget the Terns Pharmaceutical acquisition they're working on. They're paying about $5.8 billion for TERN-701, a chronic myeloid leukemia drug candidate. Management thinks it has "multibillion-dollar commercial potential."

**ALEX:** During the Q&A, analysts were clearly focused on the pipeline readouts coming this year. There was a lot of discussion about their ophthalmology programs and cancer combination therapies. One thing that struck me...]]>482falsefullhttps://www.spreaker.com/episode/altria-q1-2026-earnings-analysis--71798713
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear, actionable insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Altria Group's Q1 2026 earnings call - and wow, there's a lot to unpack here, including a CEO transition and some fascinating market dynamics in both cigarettes and nicotine pouches.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now, let's talk numbers first. Altria delivered a solid start to 2026 with adjusted diluted EPS growing 7.3% in Q1. They're maintaining their full-year guidance of $5.56 to $5.72 per share, which represents 2.5% to 5.5% growth.

**ALEX:** That's a strong performance, but what really caught my attention was the underlying story about consumer behavior. Jordan, can you break down what's happening in the cigarette market?

**JORDAN:** Sure thing. So there are two major trends colliding here. First, we're seeing moderation in the e-vapor category - particularly those illicit flavored disposable products that have been stealing cigarette smokers for years. Federal and state enforcement is finally having an impact, and it looks like the category may have hit a saturation point.

**ALEX:** Which is helping cigarette volumes, right? They declined only 4% when adjusted for trade inventory movements, compared to much steeper declines we've seen in recent years.

**JORDAN:** Exactly. But here's the fascinating part - all of this volume improvement is happening in the discount segment, not premium. Consumers are under serious economic pressure. Gas prices spiked, inflation is still biting, and people are trading down to cheaper brands.

**ALEX:** And Altria is capturing that trade-down with their Basic brand. The numbers here are pretty impressive - Basic grew 2.4 share points year-over-year in the discount segment. Meanwhile, Marlboro actually lost 1.4 share points overall but gained in the premium segment specifically.

**JORDAN:** That's the beauty of their portfolio strategy. They're essentially playing both ends of the market. When premium smokers stay loyal, Marlboro captures them. When economic pressure forces people to trade down, Basic is there waiting.

**ALEX:** Now let's talk about the growth story - oral nicotine pouches. This category is absolutely exploding. Jordan, what's happening with their on! brand?

**JORDAN:** The oral nicotine pouch segment now represents 58% of the total oral tobacco category - that's remarkable growth. Altria's on! portfolio shipped nearly 18% more volume, hitting over 46 million cans in Q1. They launched on! PLUS nationwide in March, and it's already in about 100,000 stores.

**ALEX:** What makes on! PLUS special?

**JORDAN:** Two things: it's the first and only product authorized under the FDA's pilot program for nicotine pouches, which should give them a regulatory advantage. And they're marketing it as "the softest pouch on the planet" using their proprietary NICOSILK technology. They're really trying to differentiate on the user experience.

**ALEX:** Speaking of the FDA, there was interesting commentary about the regulatory environment. CEO William Gifford - and by the way, this was his final earnings call - was pushing hard for the FDA to streamline authorizations for e-vapor products.

**JORDAN:** Right, and his logic makes sense. The e-vapor category is still about 70% illicit products. Gifford argued that faster authorizations combined with sustained enforcement could create a compliant marketplace where authorized manufacturers can serve adult consumers with quality products.

**ALEX:** Let's talk about that CEO transition. Gifford is stepping d

This episode includes AI-generated content.]]>SP100-MO-Q1-2026-enThu, 30 Apr 2026 23:18:58 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear, actionable insights. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Altria...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear, actionable insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Altria Group's Q1 2026 earnings call - and wow, there's a lot to unpack here, including a CEO transition and some fascinating market dynamics in both cigarettes and nicotine pouches.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now, let's talk numbers first. Altria delivered a solid start to 2026 with adjusted diluted EPS growing 7.3% in Q1. They're maintaining their full-year guidance of $5.56 to $5.72 per share, which represents 2.5% to 5.5% growth.

**ALEX:** That's a strong performance, but what really caught my attention was the underlying story about consumer behavior. Jordan, can you break down what's happening in the cigarette market?

**JORDAN:** Sure thing. So there are two major trends colliding here. First, we're seeing moderation in the e-vapor category - particularly those illicit flavored disposable products that have been stealing cigarette smokers for years. Federal and state enforcement is finally having an impact, and it looks like the category may have hit a saturation point.

**ALEX:** Which is helping cigarette volumes, right? They declined only 4% when adjusted for trade inventory movements, compared to much steeper declines we've seen in recent years.

**JORDAN:** Exactly. But here's the fascinating part - all of this volume improvement is happening in the discount segment, not premium. Consumers are under serious economic pressure. Gas prices spiked, inflation is still biting, and people are trading down to cheaper brands.

**ALEX:** And Altria is capturing that trade-down with their Basic brand. The numbers here are pretty impressive - Basic grew 2.4 share points year-over-year in the discount segment. Meanwhile, Marlboro actually lost 1.4 share points overall but gained in the premium segment specifically.

**JORDAN:** That's the beauty of their portfolio strategy. They're essentially playing both ends of the market. When premium smokers stay loyal, Marlboro captures them. When economic pressure forces people to trade down, Basic is there waiting.

**ALEX:** Now let's talk about the growth story - oral nicotine pouches. This category is absolutely exploding. Jordan, what's happening with their on! brand?

**JORDAN:** The oral nicotine pouch segment now represents 58% of the total oral tobacco category - that's remarkable growth. Altria's on! portfolio shipped nearly 18% more volume, hitting over 46 million cans in Q1. They launched on! PLUS nationwide in March, and it's already in about 100,000 stores.

**ALEX:** What makes on! PLUS special?

**JORDAN:** Two things: it's the first and only product authorized under the FDA's pilot program for nicotine pouches, which should give them a regulatory advantage. And they're marketing it as "the softest pouch on the planet" using their proprietary NICOSILK technology. They're really trying to differentiate on the user experience.

**ALEX:** Speaking of the FDA, there was interesting commentary about the regulatory environment. CEO William Gifford - and by the way, this was his final earnings call - was pushing hard for the FDA to streamline authorizations for e-vapor products.

**JORDAN:** Right, and his logic makes sense. The e-vapor category is still about 70% illicit products. Gifford argued that faster authorizations combined with sustained enforcement could create...]]>514falsefullhttps://www.spreaker.com/episode/mastercard-q1-2026-earnings-analysis--71798711
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to bring you what really matters from the latest earnings calls. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Mastercard's Q1 2026 results - and folks, there's a lot to unpack here.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Mastercard! The numbers are pretty impressive - net revenue up 12% and net income jumping 15% year-over-year on a currency-neutral basis. EPS came in at $4.60, which included a nice 10-cent boost from share buybacks.

**ALEX:** That's solid growth, but what caught my attention was how they're navigating some pretty significant headwinds. CEO Michael Miebach was pretty upfront about the geopolitical tensions affecting their cross-border business, particularly related to the Middle East conflict. Jordan, what did you make of their approach to this challenge?

**JORDAN:** It's interesting, Alex. They're seeing pressure on cross-border travel metrics - growth slowed from 8% to just 2% in the first four weeks of April. But here's what I found compelling: Miebach talked about how they immediately pivoted to help customers understand shifting spending patterns. Within 24 hours of the conflict escalating, they had a website up for Middle East customers showing where spending was moving.

**ALEX:** That's the kind of agility you want to see from management. And they're not just sitting back - they're actively helping customers adapt. Speaking of adaptation, let's talk about some of the more futuristic stuff they're working on. This whole AI agent commerce thing sounds pretty wild.

**JORDAN:** Oh, the agentic commerce initiative is fascinating! So basically, they're preparing for a world where AI agents can make purchases on your behalf. They've got something called "Mastercard Agent Pay" and they're working with heavy hitters like OpenAI, Google, and Microsoft. What's really smart is they've developed "verifiable intent" - basically a tamper-proof record of what you actually authorized an AI agent to do.

**ALEX:** That sounds like it could be huge down the road, but where are we in terms of actual volume and adoption?

**JORDAN:** Miebach was honest about this - they're still in early stages for volume. But the infrastructure building is critical. They've enabled nearly all Mastercards globally for Agent Pay, and they're setting the standards for how this whole ecosystem will work. It's classic Mastercard - get in early, help build the rails, then benefit as adoption scales.

**ALEX:** And speaking of getting in early, they're making a big bet on stablecoins with their planned BVNK acquisition. Help our listeners understand what this is all about.

**JORDAN:** Sure. So BVNK is basically a platform that helps with the messy parts of digital assets - sending, receiving, converting, and storing stablecoins. Mastercard sees stablecoins as becoming a meaningful part of money movement, especially for B2B payments, cross-border transactions, and "me-to-me" transfers like funding your own wallet.

The revenue model is basis points on volume, and this opens up addressable markets that Mastercard doesn't participate in today. Plus, BVNK has those hard-to-get licenses and regulatory tools that make this space work.

**ALEX:** It sounds like they're positioning themselves for a multi-rail future - not just cards, but also real-time payments and digital assets. Now, let's talk about their bread and butter value-added services. This segment grew 18% - what's driving that?

**JORDAN:** This is where their data moat reall

This episode includes AI-generated content.]]>SP100-MA-Q1-2026-enThu, 30 Apr 2026 23:18:53 +0000trueBeta Finch# Beta Finch Podcast Script: Mastercard Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to bring you what really matters from the latest earnings calls. I'm Alex, and I'm...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to bring you what really matters from the latest earnings calls. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Mastercard's Q1 2026 results - and folks, there's a lot to unpack here.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Mastercard! The numbers are pretty impressive - net revenue up 12% and net income jumping 15% year-over-year on a currency-neutral basis. EPS came in at $4.60, which included a nice 10-cent boost from share buybacks.

**ALEX:** That's solid growth, but what caught my attention was how they're navigating some pretty significant headwinds. CEO Michael Miebach was pretty upfront about the geopolitical tensions affecting their cross-border business, particularly related to the Middle East conflict. Jordan, what did you make of their approach to this challenge?

**JORDAN:** It's interesting, Alex. They're seeing pressure on cross-border travel metrics - growth slowed from 8% to just 2% in the first four weeks of April. But here's what I found compelling: Miebach talked about how they immediately pivoted to help customers understand shifting spending patterns. Within 24 hours of the conflict escalating, they had a website up for Middle East customers showing where spending was moving.

**ALEX:** That's the kind of agility you want to see from management. And they're not just sitting back - they're actively helping customers adapt. Speaking of adaptation, let's talk about some of the more futuristic stuff they're working on. This whole AI agent commerce thing sounds pretty wild.

**JORDAN:** Oh, the agentic commerce initiative is fascinating! So basically, they're preparing for a world where AI agents can make purchases on your behalf. They've got something called "Mastercard Agent Pay" and they're working with heavy hitters like OpenAI, Google, and Microsoft. What's really smart is they've developed "verifiable intent" - basically a tamper-proof record of what you actually authorized an AI agent to do.

**ALEX:** That sounds like it could be huge down the road, but where are we in terms of actual volume and adoption?

**JORDAN:** Miebach was honest about this - they're still in early stages for volume. But the infrastructure building is critical. They've enabled nearly all Mastercards globally for Agent Pay, and they're setting the standards for how this whole ecosystem will work. It's classic Mastercard - get in early, help build the rails, then benefit as adoption scales.

**ALEX:** And speaking of getting in early, they're making a big bet on stablecoins with their planned BVNK acquisition. Help our listeners understand what this is all about.

**JORDAN:** Sure. So BVNK is basically a platform that helps with the messy parts of digital assets - sending, receiving, converting, and storing stablecoins. Mastercard sees stablecoins as becoming a meaningful part of money movement, especially for B2B payments, cross-border transactions, and "me-to-me" transfers like funding your own wallet.

The revenue model is basis points on volume, and this opens up addressable markets that Mastercard doesn't participate in today. Plus, BVNK has those hard-to-get licenses and regulatory tools that make this space work.

**ALEX:** It sounds like they're positioning themselves for a multi-rail future - not just cards, but also real-time payments and digital assets. Now, let's talk about...]]>477falsefullhttps://www.spreaker.com/episode/eli-lilly-q1-2026-earnings-analysis--71798710
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Eli Lilly's first quarter 2026 results - and wow, what a quarter this was. Jordan, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And you're absolutely right about this being a wow quarter. Lilly just posted some absolutely staggering numbers. We're talking about 56% revenue growth year-over-year, bringing in what appears to be massive incretin revenues. But what really caught my attention was their guidance raise - they bumped up their full-year revenue expectations by $2 billion to between $82 and $85 billion.

**ALEX:** That's incredible. Let me put that in perspective for our listeners - the midpoint of that guidance represents 28% growth for the full year. For a company of Lilly's size, that's just phenomenal. And the driving force here is clearly their GLP-1 portfolio - Mounjaro and Zepbound combined brought in $12.8 billion in global revenue just in Q1, contributing $6.7 billion of growth compared to last year.

**JORDAN:** What's fascinating is how this growth is playing out globally. We saw really strong international momentum for Mounjaro. In markets like Brazil and Korea, they're claiming around 60% market share. And here's something interesting - they mentioned that generic semaglutide entry in some markets like India actually seems to be stimulating overall market growth rather than hurting Lilly's position.

**ALEX:** That's a great point about the generics. CEO Dave Ricks made a really insightful comment during the Q&A about how this obesity market behaves differently from traditional pharma categories. He said that because so much of the business is out-of-pocket - 75% of ex-US Mounjaro business and a meaningful portion in the US - they see "quite expansionary volume" when they reduce prices. It's almost like the demand curve is more elastic than typical prescription drugs.

**JORDAN:** Exactly. And speaking of new developments, let's talk about Koundeo - their newly approved oral GLP-1. This is huge because it's the first new incretin medicine launched with obesity as the primary indication, not diabetes. They mentioned having over 20,000 patients treated already with about 80% being new to the class entirely.

**ALEX:** The Koundeo launch strategy is really interesting. They're taking a measured approach - they started with digital campaigns, moved to in-person physician promotion, and they're planning full-scale direct-to-consumer TV advertising in Q3. What I found telling was that they already have over 8,000 prescribers, with a third of them never having prescribed an oral GLP-1 before.

**JORDAN:** And the access piece is critical. They've secured commercial access at two of the three largest pharmacy benefit managers, effective mid-May. Plus, the Medicare Bridge program extension through 2027 could be a game-changer - we're talking about $50 monthly copays for seniors. When an analyst asked about Medicare activation, management indicated this will be a gradual build through 2026 and into 2027.

**ALEX:** Let's talk about their pipeline because they were incredibly busy on the R&D front. They announced four acquisitions this quarter - Orna Therapeutics for autoimmune CAR-T therapies, Centessa for sleep disorders, Colonia for cancer treatments, and Ajax for blood cancers. Plus they had positive Phase III data for multiple programs.

**JORDAN:** The retatrutide data particularly caught my eye. This is their triple agonist - GIP, GLP-1, and glucagon. In the TRANSCEND T2D1 trial, patients lost an average of 25 to 37 pounds while also

This episode includes AI-generated content.]]>SP100-LLY-Q1-2026-enThu, 30 Apr 2026 23:18:48 +0000trueBeta Finch# Beta Finch Podcast Script - Eli Lilly Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Eli Lilly's first quarter 2026 results -...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Eli Lilly's first quarter 2026 results - and wow, what a quarter this was. Jordan, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And you're absolutely right about this being a wow quarter. Lilly just posted some absolutely staggering numbers. We're talking about 56% revenue growth year-over-year, bringing in what appears to be massive incretin revenues. But what really caught my attention was their guidance raise - they bumped up their full-year revenue expectations by $2 billion to between $82 and $85 billion.

**ALEX:** That's incredible. Let me put that in perspective for our listeners - the midpoint of that guidance represents 28% growth for the full year. For a company of Lilly's size, that's just phenomenal. And the driving force here is clearly their GLP-1 portfolio - Mounjaro and Zepbound combined brought in $12.8 billion in global revenue just in Q1, contributing $6.7 billion of growth compared to last year.

**JORDAN:** What's fascinating is how this growth is playing out globally. We saw really strong international momentum for Mounjaro. In markets like Brazil and Korea, they're claiming around 60% market share. And here's something interesting - they mentioned that generic semaglutide entry in some markets like India actually seems to be stimulating overall market growth rather than hurting Lilly's position.

**ALEX:** That's a great point about the generics. CEO Dave Ricks made a really insightful comment during the Q&A about how this obesity market behaves differently from traditional pharma categories. He said that because so much of the business is out-of-pocket - 75% of ex-US Mounjaro business and a meaningful portion in the US - they see "quite expansionary volume" when they reduce prices. It's almost like the demand curve is more elastic than typical prescription drugs.

**JORDAN:** Exactly. And speaking of new developments, let's talk about Koundeo - their newly approved oral GLP-1. This is huge because it's the first new incretin medicine launched with obesity as the primary indication, not diabetes. They mentioned having over 20,000 patients treated already with about 80% being new to the class entirely.

**ALEX:** The Koundeo launch strategy is really interesting. They're taking a measured approach - they started with digital campaigns, moved to in-person physician promotion, and they're planning full-scale direct-to-consumer TV advertising in Q3. What I found telling was that they already have over 8,000 prescribers, with a third of them never having prescribed an oral GLP-1 before.

**JORDAN:** And the access piece is critical. They've secured commercial access at two of the three largest pharmacy benefit managers, effective mid-May. Plus, the Medicare Bridge program extension through 2027 could be a game-changer - we're talking about $50 monthly copays for seniors. When an analyst asked about Medicare activation, management indicated this will be a gradual build through 2026 and into 2027.

**ALEX:** Let's talk about their pipeline because they were incredibly busy on the R&D front. They announced four acquisitions this quarter - Orna Therapeutics for autoimmune CAR-T therapies, Centessa for sleep disorders, Colonia for cancer treatments, and Ajax for blood cancers. Plus they had positive Phase III data for multiple programs.

**JORDAN:** The retatrutide data particularly caught my eye. This is their triple agonist - GIP,...]]>503falsefullhttps://www.spreaker.com/episode/caterpillar-q1-2026-earnings-analysis--71798708
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex, and joining me as always is Jordan. Today we're diving into Caterpillar's absolutely explosive Q1 2026 earnings call - and folks, this was a doozy.

But before we dig in, I need to share an important note: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and wow - you're right about this being explosive. I've been covering industrial earnings for years and this Caterpillar quarter was genuinely remarkable. Let me just hit you with some numbers right off the bat - revenue jumped 22% to $17.4 billion, adjusted earnings per share shot up 30% to $5.54, and here's the kicker - their backlog grew to a record $63 billion. That's a 79% increase year-over-year.

**ALEX:** Those are staggering numbers, Jordan. But what really caught my attention was the announcement during the call. Caterpillar is essentially doubling down on their data center bet. They're expanding their large reciprocating engine capacity from 2x their 2024 levels to nearly 3x. That's massive.

**JORDAN:** Absolutely massive, Alex. And CEO Joe Creed was pretty candid about what's driving this - it's the AI revolution. He mentioned that since they first announced capacity expansion plans back in January 2024, their large reciprocating engine backlog has grown by more than 3.5x. Customers aren't just ordering for this year - some orders are going well into 2028.

**ALEX:** What I found fascinating was how this isn't just about backup power anymore. Creed mentioned they're seeing increasing demand for prime power applications - basically data centers that want their own dedicated power generation rather than just backup systems. That's a game changer because prime power means much higher service revenue downstream.

**JORDAN:** Exactly, and that service revenue story is crucial. When you sell backup generators, you get the initial sale and some maintenance. But prime power? That's ongoing fuel, parts, service contracts - it's the gift that keeps on giving. Creed even mentioned this was their sixth agreement for at least 1 gigawatt of equipment for prime power applications.

**ALEX:** Let's talk numbers for investors. They raised their full-year guidance to low double-digit growth - that's up from their previous outlook. And they're projecting free cash flow will be higher than last year's $9.5 billion. But there's a cloud here - tariffs.

**JORDAN:** The tariff situation is really interesting, Alex. They absorbed about $600 million in tariff costs in Q1 alone, which was actually better than their $800 million estimate. But for the full year, they're still looking at $2.2 to $2.4 billion in tariff impacts. CFO Andrew Bonfield, who's retiring after this call, was pretty matter-of-fact about it - they're working on mitigation strategies but it's definitely a headwind.

**ALEX:** Speaking of Bonfield, this was his final earnings call after what sounds like an incredible run as CFO. Kyle Epley is taking over, and he seemed well-prepared during his portion of the call. Any concerns about the transition?

**JORDAN:** Not really - Epley has been with the company for over 20 years and worked closely with Bonfield. What I liked was his detailed breakdown of the Q2 outlook. He's expecting continued strong growth across all segments, with Power and Energy leading the charge. He also provided really granular details on tariff impacts by segment, which shows he's got a handle on the complexities.

**ALEX:** The segment performance was pretty interesting too. Construction Industries had a massive 30% sales increase, Resource Industries grew 4%, and Power and Energy was up 22%.

This episode includes AI-generated content.]]>SP100-CAT-Q1-2026-enThu, 30 Apr 2026 23:18:43 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex, and joining me as always is Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex, and joining me as always is Jordan. Today we're diving into Caterpillar's absolutely explosive Q1 2026 earnings call - and folks, this was a doozy.

But before we dig in, I need to share an important note: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and wow - you're right about this being explosive. I've been covering industrial earnings for years and this Caterpillar quarter was genuinely remarkable. Let me just hit you with some numbers right off the bat - revenue jumped 22% to $17.4 billion, adjusted earnings per share shot up 30% to $5.54, and here's the kicker - their backlog grew to a record $63 billion. That's a 79% increase year-over-year.

**ALEX:** Those are staggering numbers, Jordan. But what really caught my attention was the announcement during the call. Caterpillar is essentially doubling down on their data center bet. They're expanding their large reciprocating engine capacity from 2x their 2024 levels to nearly 3x. That's massive.

**JORDAN:** Absolutely massive, Alex. And CEO Joe Creed was pretty candid about what's driving this - it's the AI revolution. He mentioned that since they first announced capacity expansion plans back in January 2024, their large reciprocating engine backlog has grown by more than 3.5x. Customers aren't just ordering for this year - some orders are going well into 2028.

**ALEX:** What I found fascinating was how this isn't just about backup power anymore. Creed mentioned they're seeing increasing demand for prime power applications - basically data centers that want their own dedicated power generation rather than just backup systems. That's a game changer because prime power means much higher service revenue downstream.

**JORDAN:** Exactly, and that service revenue story is crucial. When you sell backup generators, you get the initial sale and some maintenance. But prime power? That's ongoing fuel, parts, service contracts - it's the gift that keeps on giving. Creed even mentioned this was their sixth agreement for at least 1 gigawatt of equipment for prime power applications.

**ALEX:** Let's talk numbers for investors. They raised their full-year guidance to low double-digit growth - that's up from their previous outlook. And they're projecting free cash flow will be higher than last year's $9.5 billion. But there's a cloud here - tariffs.

**JORDAN:** The tariff situation is really interesting, Alex. They absorbed about $600 million in tariff costs in Q1 alone, which was actually better than their $800 million estimate. But for the full year, they're still looking at $2.2 to $2.4 billion in tariff impacts. CFO Andrew Bonfield, who's retiring after this call, was pretty matter-of-fact about it - they're working on mitigation strategies but it's definitely a headwind.

**ALEX:** Speaking of Bonfield, this was his final earnings call after what sounds like an incredible run as CFO. Kyle Epley is taking over, and he seemed well-prepared during his portion of the call. Any concerns about the transition?

**JORDAN:** Not really - Epley has been with the company for over 20 years and worked closely with Bonfield. What I liked was his detailed breakdown of the Q2 outlook. He's expecting continued strong growth across all segments, with Power and Energy leading the charge. He also provided really granular details on tariff impacts by segment, which shows he's got a handle on the complexities.

**ALEX:** The segment performance was pretty...]]>505falsefullhttps://www.spreaker.com/episode/bristol-myers-squibb-q1-2026-earnings-analysis--71798706
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Bristol-Myers Squibb's first quarter 2026 results, and there's quite a lot to unpack here.

**JORDAN**: Absolutely, Alex. But before we get started, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that, Jordan. Now, let's talk Bristol-Myers Squibb - ticker BMY. This pharmaceutical giant just reported Q1 results, and honestly, they seem to be firing on multiple cylinders right now.

**JORDAN**: The numbers tell a solid story, Alex. Total revenue came in at $11.5 billion, up 1% year-over-year. But here's what's really interesting - their growth portfolio, which includes their newer, more innovative drugs, grew 9% to $6.2 billion. That's nearly half their total revenue now coming from these growth assets.

**ALEX**: That's a massive shift for a company that's been dealing with patent cliffs on older drugs. What stood out to you in terms of specific products driving this growth?

**JORDAN**: Several winners here. Reblozyl grew 15%, Breyanzi - their CAR-T cell therapy - jumped 53%, and Camzyos nearly doubled to $314 million. But the elephant in the room is still Eliquis, their blood thinner, which brought in $4.1 billion and grew 13% despite facing generic competition eventually.

**ALEX**: Let's talk about what CEO Chris Boerner emphasized during the call. He really hammered home three strategic priorities: focusing R&D on life-threatening diseases, executing on their growth portfolio, and maintaining disciplined capital allocation. But Jordan, what caught my attention was all the talk about late 2026 being a make-or-break period for several key programs.

**JORDAN**: Yes, this is crucial, Alex. They have what Boerner called an "increasing cadence of pivotal readouts" coming in late 2026. We're talking about Milvexian for atrial fibrillation and stroke prevention, Cobenfy for Alzheimer's psychosis, and some important cancer drug data. These aren't just incremental updates - these could define the company's growth trajectory for years.

**ALEX**: Let's break down a couple of these. Milvexian is their Factor XI inhibitor, essentially trying to create a blood thinner with less bleeding risk than current options. How big could this be?

**JORDAN**: Potentially massive, Alex. They're testing it against Eliquis - their own blockbuster drug - trying to show it's just as effective but causes less bleeding. Think about it: if you can reduce the main side effect that keeps doctors from prescribing blood thinners, you could expand the treatable patient population significantly. Adam Lenkowsky, their Chief Commercialization Officer, called it having "true blockbuster potential."

**ALEX**: And then there's Cobenfy, which they're testing in Alzheimer's psychosis. This seems like a completely different approach to treating psychiatric symptoms in dementia patients.

**JORDAN**: Right, and this addresses a huge unmet need. Current antipsychotics used in elderly dementia patients carry black box warnings and cause serious side effects like movement disorders and cognitive impairment. Cobenfy works on a completely different mechanism - muscarinic receptors instead of dopamine. If it works, it could be the first approved treatment specifically for Alzheimer's psychosis.

**ALEX**: Now, during the Q&A, there were some really interesting exchanges. One analyst asked about their confidence levels in these trials, and Chief Medical Officer Cristian Massacesi gave pretty detailed responses about trial design and patient selection.

**JORDAN**: What struck me was how specific they we

This episode includes AI-generated content.]]>SP100-BMY-Q1-2026-enThu, 30 Apr 2026 23:18:37 +0000trueBeta Finch# Beta Finch Podcast Script: Bristol-Myers Squibb Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Bristol-Myers Squibb's first quarter 2026...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Bristol-Myers Squibb's first quarter 2026 results, and there's quite a lot to unpack here.

**JORDAN**: Absolutely, Alex. But before we get started, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that, Jordan. Now, let's talk Bristol-Myers Squibb - ticker BMY. This pharmaceutical giant just reported Q1 results, and honestly, they seem to be firing on multiple cylinders right now.

**JORDAN**: The numbers tell a solid story, Alex. Total revenue came in at $11.5 billion, up 1% year-over-year. But here's what's really interesting - their growth portfolio, which includes their newer, more innovative drugs, grew 9% to $6.2 billion. That's nearly half their total revenue now coming from these growth assets.

**ALEX**: That's a massive shift for a company that's been dealing with patent cliffs on older drugs. What stood out to you in terms of specific products driving this growth?

**JORDAN**: Several winners here. Reblozyl grew 15%, Breyanzi - their CAR-T cell therapy - jumped 53%, and Camzyos nearly doubled to $314 million. But the elephant in the room is still Eliquis, their blood thinner, which brought in $4.1 billion and grew 13% despite facing generic competition eventually.

**ALEX**: Let's talk about what CEO Chris Boerner emphasized during the call. He really hammered home three strategic priorities: focusing R&D on life-threatening diseases, executing on their growth portfolio, and maintaining disciplined capital allocation. But Jordan, what caught my attention was all the talk about late 2026 being a make-or-break period for several key programs.

**JORDAN**: Yes, this is crucial, Alex. They have what Boerner called an "increasing cadence of pivotal readouts" coming in late 2026. We're talking about Milvexian for atrial fibrillation and stroke prevention, Cobenfy for Alzheimer's psychosis, and some important cancer drug data. These aren't just incremental updates - these could define the company's growth trajectory for years.

**ALEX**: Let's break down a couple of these. Milvexian is their Factor XI inhibitor, essentially trying to create a blood thinner with less bleeding risk than current options. How big could this be?

**JORDAN**: Potentially massive, Alex. They're testing it against Eliquis - their own blockbuster drug - trying to show it's just as effective but causes less bleeding. Think about it: if you can reduce the main side effect that keeps doctors from prescribing blood thinners, you could expand the treatable patient population significantly. Adam Lenkowsky, their Chief Commercialization Officer, called it having "true blockbuster potential."

**ALEX**: And then there's Cobenfy, which they're testing in Alzheimer's psychosis. This seems like a completely different approach to treating psychiatric symptoms in dementia patients.

**JORDAN**: Right, and this addresses a huge unmet need. Current antipsychotics used in elderly dementia patients carry black box warnings and cause serious side effects like movement disorders and cognitive impairment. Cobenfy works on a completely different mechanism - muscarinic receptors instead of dopamine. If it works, it could be the first approved treatment specifically for Alzheimer's psychosis.

**ALEX**: Now, during the Q&A, there were some really interesting exchanges. One analyst asked about their confidence levels in these trials, and Chief Medical Officer Cristian...]]>504falsefullhttps://www.spreaker.com/episode/amphenol-q1-2026-earnings-analysis--71798704
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into some fascinating quarterly results. Today we're unpacking Amphenol's absolutely monster Q1 2026 earnings call - and folks, when I say monster, I mean it. Jordan, before we jump in, I need to share our standard disclaimer with listeners.

This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, let's talk about these numbers because they're pretty incredible.

**JORDAN:** Alex, I've been covering tech earnings for years, and this Amphenol quarter is genuinely jaw-dropping. They just posted record sales of $7.6 billion - that's up 58% year-over-year and 33% organically. But here's the kicker - their IT datacom segment, which is heavily exposed to AI infrastructure, grew 81% organically. Eighty-one percent!

**ALEX:** That's insane growth. And their guidance for Q2 is equally aggressive - they're projecting $8.1 to $8.2 billion in sales, which would be another 43-45% year-over-year growth. What's driving this AI boom for them specifically?

**JORDAN:** So Amphenol makes connectors and interconnect products - basically the plumbing that connects all the components in data centers. CEO Adam Norwitt made a really interesting point on the call. He said that virtually all of their sequential growth in IT datacom came from AI-related products. These aren't just any connectors - they're high-speed, high-power interconnects that AI systems absolutely depend on.

**ALEX:** And they just made a huge acquisition to strengthen this position, right? The CommScope deal?

**JORDAN:** Exactly. They closed the CommScope acquisition in January for what appears to be around $2.1 billion based on the context. This gives them fiber optic capabilities to complement their copper products. Norwitt was really excited about this on the call - he kept emphasizing that they now have "the industry's broadest range of high-speed copper, power, and fiber optic interconnect products."

**ALEX:** That seems strategic because there's this big debate in the AI world about whether future systems will use copper or fiber optic connections, right?

**JORDAN:** Exactly, and that's where Amphenol's positioning gets really smart. There was a great exchange during the Q&A about co-packaged optics and other next-gen technologies. Norwitt basically said they don't care which technology wins because they play in both spaces now. His quote was memorable: "no matter what, there's going to be more interconnect."

**ALEX:** So they're betting on the overall trend rather than a specific technology. That makes sense. What about their margins? Because with this kind of growth, you'd expect some operational challenges.

**JORDAN:** That's the really impressive part. Despite integrating a major acquisition and growing at breakneck speed, they maintained adjusted operating margins of 27.3%. That's actually up 380 basis points year-over-year. CFO Craig Lampo attributed this to "robust operating leverage" - basically, they're scaling efficiently.

**ALEX:** And this isn't just an AI story, is it? Looking at their other segments, they seem pretty diversified.

**JORDAN:** Right, and this is important for investors to understand. While IT datacom is now 41% of their business, they're still seeing solid growth elsewhere. Defense was up 25% organically, industrial up 16% organically, even automotive grew modestly. Their book-to-bill ratio was 1.24 to 1, and every single end market had a positive book-to-bill.

**ALEX:** That book-to-bill number is telling - it means orders are coming in 24% faster than they can ship products. There was an interesting question about capacity constraints and long-term supply agreements. Wh

This episode includes AI-generated content.]]>SP100-APH-Q1-2026-enThu, 30 Apr 2026 23:18:32 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into some fascinating quarterly results. Today we're unpacking Amphenol's absolutely monster...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into some fascinating quarterly results. Today we're unpacking Amphenol's absolutely monster Q1 2026 earnings call - and folks, when I say monster, I mean it. Jordan, before we jump in, I need to share our standard disclaimer with listeners.

This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, let's talk about these numbers because they're pretty incredible.

**JORDAN:** Alex, I've been covering tech earnings for years, and this Amphenol quarter is genuinely jaw-dropping. They just posted record sales of $7.6 billion - that's up 58% year-over-year and 33% organically. But here's the kicker - their IT datacom segment, which is heavily exposed to AI infrastructure, grew 81% organically. Eighty-one percent!

**ALEX:** That's insane growth. And their guidance for Q2 is equally aggressive - they're projecting $8.1 to $8.2 billion in sales, which would be another 43-45% year-over-year growth. What's driving this AI boom for them specifically?

**JORDAN:** So Amphenol makes connectors and interconnect products - basically the plumbing that connects all the components in data centers. CEO Adam Norwitt made a really interesting point on the call. He said that virtually all of their sequential growth in IT datacom came from AI-related products. These aren't just any connectors - they're high-speed, high-power interconnects that AI systems absolutely depend on.

**ALEX:** And they just made a huge acquisition to strengthen this position, right? The CommScope deal?

**JORDAN:** Exactly. They closed the CommScope acquisition in January for what appears to be around $2.1 billion based on the context. This gives them fiber optic capabilities to complement their copper products. Norwitt was really excited about this on the call - he kept emphasizing that they now have "the industry's broadest range of high-speed copper, power, and fiber optic interconnect products."

**ALEX:** That seems strategic because there's this big debate in the AI world about whether future systems will use copper or fiber optic connections, right?

**JORDAN:** Exactly, and that's where Amphenol's positioning gets really smart. There was a great exchange during the Q&A about co-packaged optics and other next-gen technologies. Norwitt basically said they don't care which technology wins because they play in both spaces now. His quote was memorable: "no matter what, there's going to be more interconnect."

**ALEX:** So they're betting on the overall trend rather than a specific technology. That makes sense. What about their margins? Because with this kind of growth, you'd expect some operational challenges.

**JORDAN:** That's the really impressive part. Despite integrating a major acquisition and growing at breakneck speed, they maintained adjusted operating margins of 27.3%. That's actually up 380 basis points year-over-year. CFO Craig Lampo attributed this to "robust operating leverage" - basically, they're scaling efficiently.

**ALEX:** And this isn't just an AI story, is it? Looking at their other segments, they seem pretty diversified.

**JORDAN:** Right, and this is important for investors to understand. While IT datacom is now 41% of their business, they're still seeing solid growth elsewhere. Defense was up 25% organically, industrial up 16% organically, even automotive grew modestly. Their book-to-bill ratio was 1.24 to 1, and every single end market had a positive book-to-bill.

**ALEX:** That book-to-bill number is telling - it...]]>472falsefullhttps://www.spreaker.com/episode/qualcomm-q2-2026-earnings-analysis--71774180
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Qualcomm's second quarter 2026 results, and wow, there's a lot to unpack here.

**JORDAN**: Absolutely, Alex. But before we jump in, let me remind our listeners: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks, Jordan. Now, let's talk numbers. Qualcomm delivered $10.6 billion in revenue with non-GAAP earnings per share of $2.65, hitting the high end of their guidance. But the real story here isn't just the headline numbers—it's this massive pivot toward what CEO Cristiano Amon calls "agentic AI" and their diversification strategy.

**JORDAN**: Right, and let's break down those business segments because they tell an interesting story. QCT, their chip business, brought in $9.1 billion, while licensing pulled in $1.4 billion. But here's what caught my attention—automotive hit another record at $1.3 billion, up 38% year-over-year. They're now at a $5 billion annualized run rate and expect to exit fiscal 2026 above $6 billion.

**ALEX**: That automotive growth is impressive, but I want to talk about this elephant in the room—the China handset situation. They're dealing with what they call "memory industry dynamics" that are causing handset OEMs, particularly in China, to be super cautious with their build plans.

**JORDAN**: Exactly. CFO Akash Palkhiwala was pretty candid about this. He said their China Android shipments are "meaningfully below the scale of end consumer handset demand" because OEMs are drawing down channel inventory due to memory supply issues and price increases. But here's the key—they believe Q3 will be the bottom, with sequential growth expected after that.

**ALEX**: So basically, people are still buying phones, but manufacturers aren't ordering as many chips because they're worried about memory costs. It's like a supply chain traffic jam. But what really fascinated me was Amon's vision for where AI is heading. He's talking about this shift from basic AI inference to what he calls "agentic AI"—AI that can orchestrate multi-step tasks and run continuously in the background.

**JORDAN**: And this is where Qualcomm thinks they have a competitive advantage. Amon argued that agent orchestration is predominantly CPU-bound, and he claims Qualcomm has "the world's best performing CPU across smartphones, PCs, auto, and soon the data center." That's a bold claim, but they're backing it up with some interesting product launches.

**ALEX**: Speaking of bold claims, let's talk about their data center ambitions. This was probably the biggest surprise in the call. They announced they're starting shipments to a "leading hyperscaler" in December for a custom silicon engagement. When pressed for details, Amon was pretty tight-lipped but called it a "multi-generation engagement."

**JORDAN**: The timing on that is interesting because it suggests they've been working on this longer than many people realized. Remember, they acquired AlphaWave earlier, which gives them custom ASIC capabilities. But Amon mentioned they've been talking to data center customers for several quarters even before that acquisition.

**ALEX**: One analyst asked a great question about the competitive landscape, especially with ARM now trying to vertically integrate and NVIDIA focusing on inference. Amon's response was fascinating—he basically laid out how the AI market is evolving from training-focused to inference-focused to now this new phase of "agentic" experiences.

**JORDAN**: Right, and his argument is that as AI becomes more about generating demand for tokens rather than just generating the tokens themselves, you need different types of

This episode includes AI-generated content.]]>SP100-QCOM-Q2-2026-enThu, 30 Apr 2026 10:07:47 +0000trueBeta Finch# Beta Finch Podcast Script: Qualcomm Q2 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Qualcomm's second quarter 2026 results, and wow, there's...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Qualcomm's second quarter 2026 results, and wow, there's a lot to unpack here.

**JORDAN**: Absolutely, Alex. But before we jump in, let me remind our listeners: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks, Jordan. Now, let's talk numbers. Qualcomm delivered $10.6 billion in revenue with non-GAAP earnings per share of $2.65, hitting the high end of their guidance. But the real story here isn't just the headline numbers—it's this massive pivot toward what CEO Cristiano Amon calls "agentic AI" and their diversification strategy.

**JORDAN**: Right, and let's break down those business segments because they tell an interesting story. QCT, their chip business, brought in $9.1 billion, while licensing pulled in $1.4 billion. But here's what caught my attention—automotive hit another record at $1.3 billion, up 38% year-over-year. They're now at a $5 billion annualized run rate and expect to exit fiscal 2026 above $6 billion.

**ALEX**: That automotive growth is impressive, but I want to talk about this elephant in the room—the China handset situation. They're dealing with what they call "memory industry dynamics" that are causing handset OEMs, particularly in China, to be super cautious with their build plans.

**JORDAN**: Exactly. CFO Akash Palkhiwala was pretty candid about this. He said their China Android shipments are "meaningfully below the scale of end consumer handset demand" because OEMs are drawing down channel inventory due to memory supply issues and price increases. But here's the key—they believe Q3 will be the bottom, with sequential growth expected after that.

**ALEX**: So basically, people are still buying phones, but manufacturers aren't ordering as many chips because they're worried about memory costs. It's like a supply chain traffic jam. But what really fascinated me was Amon's vision for where AI is heading. He's talking about this shift from basic AI inference to what he calls "agentic AI"—AI that can orchestrate multi-step tasks and run continuously in the background.

**JORDAN**: And this is where Qualcomm thinks they have a competitive advantage. Amon argued that agent orchestration is predominantly CPU-bound, and he claims Qualcomm has "the world's best performing CPU across smartphones, PCs, auto, and soon the data center." That's a bold claim, but they're backing it up with some interesting product launches.

**ALEX**: Speaking of bold claims, let's talk about their data center ambitions. This was probably the biggest surprise in the call. They announced they're starting shipments to a "leading hyperscaler" in December for a custom silicon engagement. When pressed for details, Amon was pretty tight-lipped but called it a "multi-generation engagement."

**JORDAN**: The timing on that is interesting because it suggests they've been working on this longer than many people realized. Remember, they acquired AlphaWave earlier, which gives them custom ASIC capabilities. But Amon mentioned they've been talking to data center customers for several quarters even before that acquisition.

**ALEX**: One analyst asked a great question about the competitive landscape, especially with ARM now trying to vertically integrate and NVIDIA focusing on inference. Amon's response was fascinating—he basically laid out how the AI market is evolving from training-focused to inference-focused to now this new phase of "agentic" experiences.

**JORDAN**: Right, and his argument is that as AI...]]>493falsefullhttps://www.spreaker.com/episode/microsoft-q3-2026-earnings-analysis--71774171
JORDAN: Thanks Alex, and wow - where do we even begin with these Microsoft numbers? They just reported record results across the board. Revenue hit $82.9 billion, up 18% year-over-year, and earnings per share came in at $4.27. But the real headline here is their AI business - it's now at a $37 billion annual run rate, growing 123% year-over-year!

ALEX: That AI growth rate is just staggering. But let's put this in perspective - Microsoft Cloud overall generated $54 billion in revenue, up 29%. So AI is becoming a massive piece of their puzzle. What really caught my attention was Satya Nadella talking about how we're at the beginning of "one of the most consequential platform shifts" as agents become the dominant workload.

JORDAN: Absolutely, and you can see this playing out in their Copilot numbers. Microsoft 365 Copilot now has over 20 million paid seats - that's 250% growth year-over-year. Even more impressive, they're seeing weekly engagement levels that match Outlook. Think about that - people are using Copilot as much as they use email!

ALEX: That's a great point about user engagement. And they shared some fascinating customer wins - Accenture alone has over 740,000 seats, which is their largest Copilot deal to date. Companies like Bayer, Johnson & Johnson, and Mercedes are all committing to 90,000+ seats. But Jordan, what I found really interesting was this shift in business model that Amy Hood kept emphasizing.

JORDAN: Yes! The transition from traditional per-seat pricing to what they're calling "seats plus consumption." It's happening across their portfolio - from productivity to coding to security. GitHub Copilot actually announced they're moving to usage-based pricing starting June 1st. This is huge because it means as customers use these AI tools more intensively, Microsoft's revenue can scale accordingly.

ALEX: And they're seeing that intensity increase dramatically. Copilot queries per user were up nearly 20% just quarter-over-quarter. Usage of their first-party agents is up 6x year-to-date. Amy Hood mentioned that in customer service, nearly 60% of their customers are already purchasing usage-based credits.

JORDAN: The infrastructure side of this story is equally compelling. They added another gigawatt of capacity this quarter and are on track to double their overall footprint in two years. But here's the kicker - they're still capacity constrained and expect to remain so through at least 2026. That's both a challenge and an opportunity.

ALEX: Speaking of infrastructure, their CapEx guidance is eye-popping. They're expecting over $40 billion in Q4 alone, and for calendar 2026, they're projecting roughly $190 billion in capital expenditures. That includes about $25 billion from higher component pricing. When an analyst asked about investor concerns over CapEx growing faster than revenue, Amy Hood made a compelling case.

JORDAN: Right, she pointed to their $627 billion in remaining performance obligations - that's contracted revenue they still need to deliver. With demand consistently exceeding supply and usage intensity growing, they feel confident about the ROI on these investments. Satya added that they want to be ready when model capabilities hit those exponential moments - like when agent mode in Excel suddenly "started working."

ALEX: Let's talk about the segment performance. Productivity and Business Processes hit $35 billion in revenue, up 17%. Intelligent Cloud was $34.7 bill

This episode includes AI-generated content.]]>SP100-MSFT-Q3-2026-enThu, 30 Apr 2026 10:07:41 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Microsoft's absolutely explosive Q3 2026 earnings report that just dropped. Jordan, before we get started, I need to...
JORDAN: Thanks Alex, and wow - where do we even begin with these Microsoft numbers? They just reported record results across the board. Revenue hit $82.9 billion, up 18% year-over-year, and earnings per share came in at $4.27. But the real headline here is their AI business - it's now at a $37 billion annual run rate, growing 123% year-over-year!

ALEX: That AI growth rate is just staggering. But let's put this in perspective - Microsoft Cloud overall generated $54 billion in revenue, up 29%. So AI is becoming a massive piece of their puzzle. What really caught my attention was Satya Nadella talking about how we're at the beginning of "one of the most consequential platform shifts" as agents become the dominant workload.

JORDAN: Absolutely, and you can see this playing out in their Copilot numbers. Microsoft 365 Copilot now has over 20 million paid seats - that's 250% growth year-over-year. Even more impressive, they're seeing weekly engagement levels that match Outlook. Think about that - people are using Copilot as much as they use email!

ALEX: That's a great point about user engagement. And they shared some fascinating customer wins - Accenture alone has over 740,000 seats, which is their largest Copilot deal to date. Companies like Bayer, Johnson & Johnson, and Mercedes are all committing to 90,000+ seats. But Jordan, what I found really interesting was this shift in business model that Amy Hood kept emphasizing.

JORDAN: Yes! The transition from traditional per-seat pricing to what they're calling "seats plus consumption." It's happening across their portfolio - from productivity to coding to security. GitHub Copilot actually announced they're moving to usage-based pricing starting June 1st. This is huge because it means as customers use these AI tools more intensively, Microsoft's revenue can scale accordingly.

ALEX: And they're seeing that intensity increase dramatically. Copilot queries per user were up nearly 20% just quarter-over-quarter. Usage of their first-party agents is up 6x year-to-date. Amy Hood mentioned that in customer service, nearly 60% of their customers are already purchasing usage-based credits.

JORDAN: The infrastructure side of this story is equally compelling. They added another gigawatt of capacity this quarter and are on track to double their overall footprint in two years. But here's the kicker - they're still capacity constrained and expect to remain so through at least 2026. That's both a challenge and an opportunity.

ALEX: Speaking of infrastructure, their CapEx guidance is eye-popping. They're expecting over $40 billion in Q4 alone, and for calendar 2026, they're projecting roughly $190 billion in capital expenditures. That includes about $25 billion from higher component pricing. When an analyst asked about investor concerns over CapEx growing faster than revenue, Amy Hood made a compelling case.

JORDAN: Right, she pointed to their $627 billion in remaining performance obligations - that's contracted revenue they still need to deliver. With demand consistently exceeding supply and usage intensity growing, they feel confident about the ROI on these investments. Satya added that they want to be ready when model capabilities hit those exponential moments - like when agent mode in Excel suddenly "started working."

ALEX: Let's talk about the segment performance....]]>488falsefullhttps://www.spreaker.com/episode/meta-platforms-q1-2026-earnings-analysis--71774161
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Meta's Q1 2026 earnings call, and wow - there's a lot to unpack here.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Meta just reported some pretty impressive numbers - $56.3 billion in total revenue, up 33% year-over-year. That's a monster quarter!

**JORDAN:** Absolutely, Alex. And that earnings per share of $10.44 really caught my attention, though there's a big asterisk there - they had an $8 billion tax benefit that boosted things significantly. Without that, we're looking at $7.31 per share, which is still solid but gives us a clearer picture of the underlying performance.

**ALEX:** Right, and speaking of underlying performance, the engagement metrics are where things get really interesting. Mark Zuckerberg spent a lot of time talking about their new AI model called "Muse Spark" from their Meta Superintelligence Labs. This seems like their big bet on competing with OpenAI and Google in the AI race.

**JORDAN:** That's the story of this earnings call, Alex. Meta is going all-in on AI, and I mean ALL-IN. They're increasing their capital expenditure guidance to $125-145 billion for 2026 - that's up from their previous range of $120-135 billion. We're talking about massive infrastructure investments here.

**ALEX:** And the results seem to be paying off already. They're seeing double-digit increases in Meta AI sessions per user since launching Muse Spark. But what really stood out to me was how they're using AI to improve their core recommendation systems. On Instagram, they drove a 10% lift in Reels time spent, and on Facebook, total video time increased more than 8% globally - that's the largest quarter-over-quarter gain in four years!

**JORDAN:** Those engagement improvements are crucial because that's what drives ad revenue, which was $55 billion this quarter, up 33%. But here's what's fascinating - they're not just throwing more ads at people. They're using AI to make ads more effective. They mentioned a 6% increase in conversion rates for landing page view ads and over 8 million advertisers now using their AI-powered creative tools.

**ALEX:** The business AI piece is really taking off too. Susan Li mentioned they now have over 10 million weekly conversations between people and business AIs on their messaging platforms - that's up from just 1 million at the start of the year. That's 10x growth in just one quarter!

**JORDAN:** And let's talk about the elephant in the room - that massive increase in contractual commitments. They added $107 billion in contractual commitments this quarter for infrastructure and cloud deals. That's not just spending money; that's locking in capacity for the next several years.

**ALEX:** Which brings us to the cost management side. Meta announced they're planning workforce reductions in May. They're calling it a move toward a "leaner operating model" to help offset these substantial AI investments. It's interesting - they're betting that AI will make their remaining employees more productive.

**JORDAN:** The Ray-Ban smart glasses story continues to be a bright spot too. Daily users tripled year-over-year, and they're expanding beyond just Ray-Ban to other brands. Mark mentioned this is "one of the fastest growing categories of consumer electronics ever." That's a bold claim, but the numbers seem to back it up.

**ALEX:** In the Q&A, there were some really revealing moments. When asked about return on investment for all this AI spending, Zuckerberg essentially said they're following their traditional playbook: build experiences

This episode includes AI-generated content.]]>SP100-META-Q1-2026-enThu, 30 Apr 2026 10:07:36 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT: Meta Q1 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Meta's Q1 2026 earnings call, and wow -...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Meta's Q1 2026 earnings call, and wow - there's a lot to unpack here.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Meta just reported some pretty impressive numbers - $56.3 billion in total revenue, up 33% year-over-year. That's a monster quarter!

**JORDAN:** Absolutely, Alex. And that earnings per share of $10.44 really caught my attention, though there's a big asterisk there - they had an $8 billion tax benefit that boosted things significantly. Without that, we're looking at $7.31 per share, which is still solid but gives us a clearer picture of the underlying performance.

**ALEX:** Right, and speaking of underlying performance, the engagement metrics are where things get really interesting. Mark Zuckerberg spent a lot of time talking about their new AI model called "Muse Spark" from their Meta Superintelligence Labs. This seems like their big bet on competing with OpenAI and Google in the AI race.

**JORDAN:** That's the story of this earnings call, Alex. Meta is going all-in on AI, and I mean ALL-IN. They're increasing their capital expenditure guidance to $125-145 billion for 2026 - that's up from their previous range of $120-135 billion. We're talking about massive infrastructure investments here.

**ALEX:** And the results seem to be paying off already. They're seeing double-digit increases in Meta AI sessions per user since launching Muse Spark. But what really stood out to me was how they're using AI to improve their core recommendation systems. On Instagram, they drove a 10% lift in Reels time spent, and on Facebook, total video time increased more than 8% globally - that's the largest quarter-over-quarter gain in four years!

**JORDAN:** Those engagement improvements are crucial because that's what drives ad revenue, which was $55 billion this quarter, up 33%. But here's what's fascinating - they're not just throwing more ads at people. They're using AI to make ads more effective. They mentioned a 6% increase in conversion rates for landing page view ads and over 8 million advertisers now using their AI-powered creative tools.

**ALEX:** The business AI piece is really taking off too. Susan Li mentioned they now have over 10 million weekly conversations between people and business AIs on their messaging platforms - that's up from just 1 million at the start of the year. That's 10x growth in just one quarter!

**JORDAN:** And let's talk about the elephant in the room - that massive increase in contractual commitments. They added $107 billion in contractual commitments this quarter for infrastructure and cloud deals. That's not just spending money; that's locking in capacity for the next several years.

**ALEX:** Which brings us to the cost management side. Meta announced they're planning workforce reductions in May. They're calling it a move toward a "leaner operating model" to help offset these substantial AI investments. It's interesting - they're betting that AI will make their remaining employees more productive.

**JORDAN:** The Ray-Ban smart glasses story continues to be a bright spot too. Daily users tripled year-over-year, and they're expanding beyond just Ray-Ban to other brands. Mark mentioned this is "one of the fastest growing categories of consumer electronics ever." That's a bold claim, but the numbers seem to back it up.

**ALEX:** In the Q&A, there were some really revealing moments. When asked...]]>473falsefullhttps://www.spreaker.com/episode/kla-q3-2026-earnings-analysis--71774146
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations you'll actually want to hear. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into KLA Corporation's Q3 2026 results - and wow, what a quarter this was.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And speaking of wow - KLA absolutely crushed it this quarter. Revenue hit $3.415 billion, which was not only up 4% sequentially but also 11% year-over-year. That beat their internal forecasts too.

**ALEX:** Right, and the earnings per share story is even better - $9.40 non-GAAP EPS. But Jordan, what really caught my attention was their forward-looking commentary. They're basically saying 2027 is going to be massive for the semiconductor equipment industry.

**JORDAN:** Exactly. CEO Rick Wallace made some pretty bold statements about visibility into 2027. He said there's "unprecedented demand visibility" from customers and that normally they wouldn't comment on 2027 growth rates in April of 2026, but the demand environment is giving them that confidence. They expect 2027 year-over-year growth to be higher than 2026.

**ALEX:** Let's break down what's driving this optimism. KLA is the leader in process control equipment - think of them as the quality control experts for semiconductor manufacturing. Every time chip makers need to inspect their wafers or measure critical dimensions, they're likely using KLA tools.

**JORDAN:** And AI is clearly the rocket fuel here. The company specifically called out AI as "a core driver of KLA's performance." They're seeing increased investment in leading-edge foundry logic and high bandwidth memory - both critical for AI applications. What's fascinating is they raised their advanced packaging revenue outlook from $635 million to approximately $1 billion for 2026.

**ALEX:** That's a 57% increase! Advanced packaging is becoming crucial as chip companies try to pack more performance into smaller spaces. It's like upgrading from a studio apartment to a high-rise - you need much more sophisticated tools to make sure everything fits perfectly.

**JORDAN:** The numbers tell a compelling story about market share too. KLA increased their global share in both overall wafer equipment and process control markets in 2025. In advanced packaging specifically, they gained 14 percentage points of market share and saw 70% year-over-year revenue growth.

**ALEX:** Now let's talk about the elephant in the room - supply chain constraints. During the Q&A, management acknowledged they're dealing with unprecedented demand urgency from customers. CFO Brent Higgins said customers are showing "a higher level of urgency around securing capacity" than he's seen before.

**JORDAN:** This creates an interesting dynamic. On one hand, it's validation of incredibly strong demand. On the other hand, it means KLA has to rapidly scale operations, hire more people, and ensure they can deliver. The good news is they seem confident about supporting the 2027 ramp.

**ALEX:** Speaking of 2027, let's dig into their industry outlook. They're expecting the wafer equipment market to exceed $140 billion in 2026 - that's up from previous estimates of $135-140 billion. But here's the kicker: they think their semiconductor process control systems business will grow over 20% in 2026, significantly outpacing the broader market.

**JORDAN:** The geographic and end-market mix is interesting too. For the June quarter, they're forecasting foundry logic to be about 82% of revenue with memory at 18%. Within memory, DRAM is expected to be 84% and NAND 16%. This heavy foundry weighting reflects t

This episode includes AI-generated content.]]>SP100-KLAC-Q3-2026-enThu, 30 Apr 2026 10:07:30 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations you'll actually want to hear. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations you'll actually want to hear. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into KLA Corporation's Q3 2026 results - and wow, what a quarter this was.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And speaking of wow - KLA absolutely crushed it this quarter. Revenue hit $3.415 billion, which was not only up 4% sequentially but also 11% year-over-year. That beat their internal forecasts too.

**ALEX:** Right, and the earnings per share story is even better - $9.40 non-GAAP EPS. But Jordan, what really caught my attention was their forward-looking commentary. They're basically saying 2027 is going to be massive for the semiconductor equipment industry.

**JORDAN:** Exactly. CEO Rick Wallace made some pretty bold statements about visibility into 2027. He said there's "unprecedented demand visibility" from customers and that normally they wouldn't comment on 2027 growth rates in April of 2026, but the demand environment is giving them that confidence. They expect 2027 year-over-year growth to be higher than 2026.

**ALEX:** Let's break down what's driving this optimism. KLA is the leader in process control equipment - think of them as the quality control experts for semiconductor manufacturing. Every time chip makers need to inspect their wafers or measure critical dimensions, they're likely using KLA tools.

**JORDAN:** And AI is clearly the rocket fuel here. The company specifically called out AI as "a core driver of KLA's performance." They're seeing increased investment in leading-edge foundry logic and high bandwidth memory - both critical for AI applications. What's fascinating is they raised their advanced packaging revenue outlook from $635 million to approximately $1 billion for 2026.

**ALEX:** That's a 57% increase! Advanced packaging is becoming crucial as chip companies try to pack more performance into smaller spaces. It's like upgrading from a studio apartment to a high-rise - you need much more sophisticated tools to make sure everything fits perfectly.

**JORDAN:** The numbers tell a compelling story about market share too. KLA increased their global share in both overall wafer equipment and process control markets in 2025. In advanced packaging specifically, they gained 14 percentage points of market share and saw 70% year-over-year revenue growth.

**ALEX:** Now let's talk about the elephant in the room - supply chain constraints. During the Q&A, management acknowledged they're dealing with unprecedented demand urgency from customers. CFO Brent Higgins said customers are showing "a higher level of urgency around securing capacity" than he's seen before.

**JORDAN:** This creates an interesting dynamic. On one hand, it's validation of incredibly strong demand. On the other hand, it means KLA has to rapidly scale operations, hire more people, and ensure they can deliver. The good news is they seem confident about supporting the 2027 ramp.

**ALEX:** Speaking of 2027, let's dig into their industry outlook. They're expecting the wafer equipment market to exceed $140 billion in 2026 - that's up from previous estimates of $135-140 billion. But here's the kicker: they think their semiconductor process control systems business will grow over 20% in 2026, significantly outpacing the broader market.

**JORDAN:** The geographic and end-market mix is interesting too. For the June quarter, they're forecasting foundry...]]>527falsefullhttps://www.spreaker.com/episode/amazon-q1-2026-earnings-analysis--71774134
**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's latest results. I'm Alex, and joining me as always is Jordan. Today we're diving into Amazon's blockbuster Q1 2026 earnings that just dropped, and folks, this was a quarter that reminded everyone why AMZN remains one of the most closely watched stocks in the market.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Amazon just posted some absolutely staggering numbers. Walk us through the headline figures.

**JORDAN:** Alex, these results were genuinely impressive across the board. Amazon delivered $181.5 billion in revenue, up 17% year-over-year, or 15% excluding foreign exchange impacts. But here's the kicker - operating income hit $23.9 billion with a 13.1% operating margin. Andy Jassy specifically called this their highest operating margin ever.

**ALEX:** That margin number really jumps out. For a company of Amazon's scale to be hitting record profitability while still growing at this pace is remarkable. But the real story here seems to be AWS, right?

**JORDAN:** Absolutely. AWS was the star of the show. Revenue hit $37.6 billion with 28% year-over-year growth - that's the fastest growth rate AWS has seen in 15 quarters. And get this - Jassy said it's very unusual for a business to grow this fast on a $150 billion annualized run rate. The last time they saw growth at this clip, AWS was roughly half the size.

**ALEX:** The AI story is clearly driving a lot of this growth. What stood out to you from their AI commentary?

**JORDAN:** The AI numbers are just mind-blowing when you put them in context. Jassy mentioned that three years after AWS launched, it had a $58 million revenue run rate. But in the first three years of this AI wave, AWS's AI revenue run rate is over $15 billion - that's 260 times larger. He said they've never seen a technology grow as rapidly as AI.

**ALEX:** And they're not just riding the wave - they're building their own chips to compete. Tell us about their custom silicon story.

**JORDAN:** This might be the most underappreciated part of Amazon's business right now. Their chips business saw nearly 40% quarter-over-quarter growth, with an annual revenue run rate now over $20 billion. But here's the fascinating part - Jassy said if their chips business sold chips like other leading chip companies do, their annual revenue run rate would be $50 billion. He believes they're now one of the top three data center chip businesses in the world.

**ALEX:** That's incredible positioning, especially when you consider the supply constraints everyone's dealing with. Speaking of which, how are they handling the memory and component cost inflation that's hitting everyone right now?

**JORDAN:** Jassy was pretty candid about this challenge. He said component costs, particularly memory, have "skyrocketed" due to insufficient capacity for the demand. But interestingly, he sees this as actually helping AWS win more enterprise customers. Since cloud providers are getting priority from suppliers, companies with on-premises infrastructure are being pushed to migrate to the cloud faster because AWS has more supply than they can get on their own.

**ALEX:** That's a fascinating competitive dynamic. Now, outside of AWS, how did the core retail business perform?

**JORDAN:** The retail side showed impressive momentum too. Units grew 15% year-over-year - Jassy said that's the highest they've seen since the tail end of COVID lockdowns. Their grocery business is now generating more than $150 billion in gross sales, making them the second-largest grocer in the U.S.

This episode includes AI-generated content.]]>SP100-AMZN-Q1-2026-enThu, 30 Apr 2026 10:07:23 +0000trueBeta Finch# Beta Finch Podcast Script: Amazon Q1 2026 Earnings **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's latest results. I'm Alex, and...
**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's latest results. I'm Alex, and joining me as always is Jordan. Today we're diving into Amazon's blockbuster Q1 2026 earnings that just dropped, and folks, this was a quarter that reminded everyone why AMZN remains one of the most closely watched stocks in the market.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Amazon just posted some absolutely staggering numbers. Walk us through the headline figures.

**JORDAN:** Alex, these results were genuinely impressive across the board. Amazon delivered $181.5 billion in revenue, up 17% year-over-year, or 15% excluding foreign exchange impacts. But here's the kicker - operating income hit $23.9 billion with a 13.1% operating margin. Andy Jassy specifically called this their highest operating margin ever.

**ALEX:** That margin number really jumps out. For a company of Amazon's scale to be hitting record profitability while still growing at this pace is remarkable. But the real story here seems to be AWS, right?

**JORDAN:** Absolutely. AWS was the star of the show. Revenue hit $37.6 billion with 28% year-over-year growth - that's the fastest growth rate AWS has seen in 15 quarters. And get this - Jassy said it's very unusual for a business to grow this fast on a $150 billion annualized run rate. The last time they saw growth at this clip, AWS was roughly half the size.

**ALEX:** The AI story is clearly driving a lot of this growth. What stood out to you from their AI commentary?

**JORDAN:** The AI numbers are just mind-blowing when you put them in context. Jassy mentioned that three years after AWS launched, it had a $58 million revenue run rate. But in the first three years of this AI wave, AWS's AI revenue run rate is over $15 billion - that's 260 times larger. He said they've never seen a technology grow as rapidly as AI.

**ALEX:** And they're not just riding the wave - they're building their own chips to compete. Tell us about their custom silicon story.

**JORDAN:** This might be the most underappreciated part of Amazon's business right now. Their chips business saw nearly 40% quarter-over-quarter growth, with an annual revenue run rate now over $20 billion. But here's the fascinating part - Jassy said if their chips business sold chips like other leading chip companies do, their annual revenue run rate would be $50 billion. He believes they're now one of the top three data center chip businesses in the world.

**ALEX:** That's incredible positioning, especially when you consider the supply constraints everyone's dealing with. Speaking of which, how are they handling the memory and component cost inflation that's hitting everyone right now?

**JORDAN:** Jassy was pretty candid about this challenge. He said component costs, particularly memory, have "skyrocketed" due to insufficient capacity for the demand. But interestingly, he sees this as actually helping AWS win more enterprise customers. Since cloud providers are getting priority from suppliers, companies with on-premises infrastructure are being pushed to migrate to the cloud faster because AWS has more supply than they can get on their own.

**ALEX:** That's a fascinating competitive dynamic. Now, outside of AWS, how did the core retail business perform?

**JORDAN:** The retail side showed impressive momentum too. Units grew 15% year-over-year - Jassy said that's the highest they've seen since the tail end of...]]>528falsefullhttps://www.spreaker.com/episode/visa-q2-2026-earnings-analysis--71766323
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to break down Visa's absolutely stellar Q2 2026 results. Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and wow - where do we even start with these numbers? Visa just delivered what CEO Ryan McInerney called "the strongest net revenue growth since 2022" - and when you exclude post-pandemic recovery periods, we're talking about the strongest growth since 2013!

**ALEX:** The headline numbers are just incredible. Net revenue jumped 17% year-over-year to $11.2 billion, and earnings per share grew 20%. But Jordan, what really caught my attention was how broad-based this strength was across all their business segments.

**JORDAN:** Absolutely. Let's break this down for our listeners. Payments volume grew 9% to $3.7 trillion - that's trillion with a T - and they processed 66 billion transactions, also up 9%. But here's what's really interesting: their Value-Added Services business, which is becoming a huge growth driver, jumped 27% and now represents 30% of their total revenue.

**ALEX:** That VAS number is crucial because it shows Visa isn't just a traditional payments processor anymore. They're becoming this comprehensive financial technology platform. Ryan McInerney spent a lot of time talking about four key growth drivers, and AI-powered "agentic commerce" was front and center.

**JORDAN:** Right, and I have to admit, some of this agentic commerce stuff sounds pretty futuristic. Essentially, they're betting that AI agents - think ChatGPT but for shopping - will create entirely new categories of transactions. These agents might split purchases across multiple transactions to optimize pricing, or even pay for their own data consumption transaction by transaction.

**ALEX:** It sounds wild, but McInerney made a compelling case. He said agents will prefer to use Visa cards because they offer privacy, broad acceptance, built-in security protections, and rewards. Plus, Visa already has 5 billion credentials across 200 countries - that's a massive head start.

**JORDAN:** The stablecoin strategy was equally fascinating. They're positioning themselves as what McInerney called a "hyperscaling bridge layer" between cryptocurrency infrastructure and real-world applications. They now have over 160 stablecoin card programs globally, and that payment volume grew nearly 200% year-over-year.

**ALEX:** And get this - they're settling $7 billion annually in stablecoins with their financial partners, up more than 50% just since last quarter. They've added five new blockchains for settlement, bringing their total to nine. This isn't some distant future play - it's happening right now.

**JORDAN:** Let's talk about that Wells Fargo announcement because that was a huge validation of their Pismo acquisition. Wells Fargo is migrating to Pismo's core account ledger as part of their banking modernization. When you can land one of the biggest banks in the US, that's a pretty strong signal about your technology.

**ALEX:** CFO Chris Suh was really bullish about their guidance too. They raised their full-year net revenue growth outlook to "low double-digit to low teens" - and they specifically mentioned increased client enthusiasm around the FIFA World Cup driving higher value-added services revenue.

**JORDAN:** The FIFA example he gave was incredible. They partnered with one client in Latin America with nearly 20 million cards for FIFA campaigns. In just over three months, that client saw a 10% lift in active cards, and Visa generated $10 million in VAS revenue. That's th

This episode includes AI-generated content.]]>SP100-V-Q2-2026-enThu, 30 Apr 2026 02:54:26 +0000trueBeta Finch# Beta Finch Podcast Script - Visa Q2 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to break down Visa's absolutely...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to break down Visa's absolutely stellar Q2 2026 results. Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and wow - where do we even start with these numbers? Visa just delivered what CEO Ryan McInerney called "the strongest net revenue growth since 2022" - and when you exclude post-pandemic recovery periods, we're talking about the strongest growth since 2013!

**ALEX:** The headline numbers are just incredible. Net revenue jumped 17% year-over-year to $11.2 billion, and earnings per share grew 20%. But Jordan, what really caught my attention was how broad-based this strength was across all their business segments.

**JORDAN:** Absolutely. Let's break this down for our listeners. Payments volume grew 9% to $3.7 trillion - that's trillion with a T - and they processed 66 billion transactions, also up 9%. But here's what's really interesting: their Value-Added Services business, which is becoming a huge growth driver, jumped 27% and now represents 30% of their total revenue.

**ALEX:** That VAS number is crucial because it shows Visa isn't just a traditional payments processor anymore. They're becoming this comprehensive financial technology platform. Ryan McInerney spent a lot of time talking about four key growth drivers, and AI-powered "agentic commerce" was front and center.

**JORDAN:** Right, and I have to admit, some of this agentic commerce stuff sounds pretty futuristic. Essentially, they're betting that AI agents - think ChatGPT but for shopping - will create entirely new categories of transactions. These agents might split purchases across multiple transactions to optimize pricing, or even pay for their own data consumption transaction by transaction.

**ALEX:** It sounds wild, but McInerney made a compelling case. He said agents will prefer to use Visa cards because they offer privacy, broad acceptance, built-in security protections, and rewards. Plus, Visa already has 5 billion credentials across 200 countries - that's a massive head start.

**JORDAN:** The stablecoin strategy was equally fascinating. They're positioning themselves as what McInerney called a "hyperscaling bridge layer" between cryptocurrency infrastructure and real-world applications. They now have over 160 stablecoin card programs globally, and that payment volume grew nearly 200% year-over-year.

**ALEX:** And get this - they're settling $7 billion annually in stablecoins with their financial partners, up more than 50% just since last quarter. They've added five new blockchains for settlement, bringing their total to nine. This isn't some distant future play - it's happening right now.

**JORDAN:** Let's talk about that Wells Fargo announcement because that was a huge validation of their Pismo acquisition. Wells Fargo is migrating to Pismo's core account ledger as part of their banking modernization. When you can land one of the biggest banks in the US, that's a pretty strong signal about your technology.

**ALEX:** CFO Chris Suh was really bullish about their guidance too. They raised their full-year net revenue growth outlook to "low double-digit to low teens" - and they specifically mentioned increased client enthusiasm around the FIFA World Cup driving higher value-added services revenue.

**JORDAN:** The FIFA example he gave was incredible. They partnered with one client in Latin America with nearly 20 million cards for FIFA campaigns. In...]]>472falsefullhttps://www.spreaker.com/episode/mondelez-q1-2026-earnings-analysis--71766322
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into Mondelez International's Q1 2026 results - and folks, this one's got some interesting twists.

Now, before we get into the snack food giant's performance, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter this was for Mondelez. Right off the bat, we're seeing some really compelling geographic dynamics here. Emerging markets absolutely crushed it with 6.3% growth, while developed markets are showing signs of recovery after some challenging periods.

**ALEX**: That's right. And Jordan, I think what stood out to me most was CEO Dirk Van de Put's commentary about the consumer landscape. It's this tale of two worlds - you've got emerging markets like India showing double-digit growth, but then you have this underlying fragility everywhere due to Middle East tensions affecting energy and commodity costs.

**JORDAN**: Exactly. And let's talk numbers for a second. That emerging markets growth of 6.3% is really broad-based. India was particularly strong with double-digit growth in both chocolate and biscuits. They even launched Biscoff in India and the line is already sold out - that's the kind of execution you want to see.

**ALEX**: Speaking of Biscoff, this partnership keeps coming up as a major growth driver. Van de Put seemed genuinely excited about it, calling it something that will be "really quite big for them and for us in the coming years." They're not just doing biscuits - they're incorporating Biscoff cream and crumbs into their chocolate products too.

**JORDAN**: And that innovation strategy is fascinating. They're making what Van de Put called "bigger and fewer bets." Instead of throwing everything at the wall, they're focusing on four key areas: well-being products with protein and fiber, premium chocolate, the Biscoff partnership, and cakes and pastries through acquisitions and brand extensions.

**ALEX**: Now, here's where it gets interesting from a financial perspective. CFO Luca Zaramella said they're ahead of expectations in Q1, but they're maintaining their EPS guidance for 2026. Why? Because they're facing unexpected headwinds from the Middle East situation - extra costs for alternative supply routes, higher oil prices affecting some regulated markets.

**JORDAN**: Right, and this is where management's capital allocation philosophy really shows. Zaramella was pretty clear - if they do see EPS upside materializing, they're going to invest it back into the business rather than just dropping it to the bottom line. They're playing the long game here, especially with their commitment to "strong 2027 EPS growth."

**ALEX**: Let's talk about Europe for a moment, because this was a real bright spot. They completed most of their retail negotiations ahead of Easter, saw market share gains, and had what Van de Put called a "very robust Easter season." The Biscoff partnership is performing particularly well in Australia and New Zealand too.

**JORDAN**: And the competitive dynamics in Europe around chocolate pricing seem to have stabilized. Remember, there were big concerns about cocoa price volatility and how that might trigger a pricing war. But Van de Put said customer negotiations went well, and they're not seeing any major price movements right now. The industry seems to be waiting to see what the main crop brings.

**ALEX**: The U.S. market is more challenging though. Van de Put was pretty candid about consumer confidence remaining low, with expectations it could deteriorate further. But here's the thing - they're

This episode includes AI-generated content.]]>SP100-MDLZ-Q1-2026-enThu, 30 Apr 2026 02:54:20 +0000trueBeta Finch# Beta Finch Podcast Script: Mondelez Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into Mondelez...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into Mondelez International's Q1 2026 results - and folks, this one's got some interesting twists.

Now, before we get into the snack food giant's performance, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter this was for Mondelez. Right off the bat, we're seeing some really compelling geographic dynamics here. Emerging markets absolutely crushed it with 6.3% growth, while developed markets are showing signs of recovery after some challenging periods.

**ALEX**: That's right. And Jordan, I think what stood out to me most was CEO Dirk Van de Put's commentary about the consumer landscape. It's this tale of two worlds - you've got emerging markets like India showing double-digit growth, but then you have this underlying fragility everywhere due to Middle East tensions affecting energy and commodity costs.

**JORDAN**: Exactly. And let's talk numbers for a second. That emerging markets growth of 6.3% is really broad-based. India was particularly strong with double-digit growth in both chocolate and biscuits. They even launched Biscoff in India and the line is already sold out - that's the kind of execution you want to see.

**ALEX**: Speaking of Biscoff, this partnership keeps coming up as a major growth driver. Van de Put seemed genuinely excited about it, calling it something that will be "really quite big for them and for us in the coming years." They're not just doing biscuits - they're incorporating Biscoff cream and crumbs into their chocolate products too.

**JORDAN**: And that innovation strategy is fascinating. They're making what Van de Put called "bigger and fewer bets." Instead of throwing everything at the wall, they're focusing on four key areas: well-being products with protein and fiber, premium chocolate, the Biscoff partnership, and cakes and pastries through acquisitions and brand extensions.

**ALEX**: Now, here's where it gets interesting from a financial perspective. CFO Luca Zaramella said they're ahead of expectations in Q1, but they're maintaining their EPS guidance for 2026. Why? Because they're facing unexpected headwinds from the Middle East situation - extra costs for alternative supply routes, higher oil prices affecting some regulated markets.

**JORDAN**: Right, and this is where management's capital allocation philosophy really shows. Zaramella was pretty clear - if they do see EPS upside materializing, they're going to invest it back into the business rather than just dropping it to the bottom line. They're playing the long game here, especially with their commitment to "strong 2027 EPS growth."

**ALEX**: Let's talk about Europe for a moment, because this was a real bright spot. They completed most of their retail negotiations ahead of Easter, saw market share gains, and had what Van de Put called a "very robust Easter season." The Biscoff partnership is performing particularly well in Australia and New Zealand too.

**JORDAN**: And the competitive dynamics in Europe around chocolate pricing seem to have stabilized. Remember, there were big concerns about cocoa price volatility and how that might trigger a pricing war. But Van de Put said customer negotiations went well, and they're not seeing any major price movements right now. The industry seems to be waiting to see what the main crop brings.

**ALEX**: The U.S. market is more challenging though. Van de Put was pretty...]]>484falsefullhttps://www.spreaker.com/episode/regeneron-q1-2026-earnings-analysis--71752133
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're breaking down Regeneron's first quarter 2026 results, and folks, this biotech giant is firing on all cylinders.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk numbers because Regeneron just posted some impressive results. Revenue jumped 19% to $3.6 billion, and non-GAAP earnings per share grew 15%. Those are solid double-digit growth numbers across the board.

**ALEX:** What really caught my attention is the DUPIXENT story. This drug is becoming an absolute juggernaut - global net sales hit $4.9 billion in the quarter, up 31% on a constant currency basis. Jordan, we're looking at annualized sales approaching $20 billion for this single drug.

**JORDAN:** It's incredible when you put it in perspective. DUPIXENT is now treating over 1.4 million patients worldwide, and they keep expanding into new indications. This quarter alone, they got approval for allergic fungal rhinosinusitis and chronic spontaneous urticaria in younger patients. It's like they're building a franchise within a franchise.

**ALEX:** Speaking of franchises, let's talk about their eye drug portfolio. EYLEA HD had a strong quarter with U.S. sales of $468 million, up 52% year-over-year. But here's the interesting dynamic - while EYLEA HD is growing rapidly, the original EYLEA is declining as expected, down 36%. It's a classic product transition story.

**JORDAN:** And there's still some uncertainty hanging over that transition. They're waiting on FDA approval for the EYLEA HD prefilled syringe, which missed its April deadline. Management expects a decision this quarter, but it shows how regulatory timing can impact even established companies like Regeneron.

**ALEX:** Now, what really excited me during the call was the pipeline discussion. CEO Leonard Schleifer and Chief Scientific Officer George Yancopoulos laid out some compelling near-term catalysts. They've got this complement inhibitor cemdisiran for myasthenia gravis that showed really impressive Phase 3 results.

**JORDAN:** The data on that was striking. Their drug delivered a 2.3-point improvement compared to placebo, which actually outperformed existing treatments that showed 1.6 to 1.9 points in their trials. Plus, it's dosed quarterly versus every two weeks for competitors. That convenience factor could be huge.

**ALEX:** And then there's their obesity play with olatorepatide. This is where Regeneron is trying to differentiate in the crowded GLP-1 space. Their strategy is fascinating - they want to combine this obesity drug with their cholesterol drug Praluent.

**JORDAN:** George Yancopoulos made a compelling pitch on this during the Q&A. He basically said, imagine you have a GLP-1 that works as well as the best ones out there, but also lowers your bad cholesterol by 50% and reduces cardiovascular risk. Why would anyone choose a different GLP-1? It's an interesting value proposition in a competitive market.

**ALEX:** What struck me about that answer is how confident they sounded. Yancopoulos said it would be a "no-brainer" choice for physicians and patients. That's either brilliant positioning or they're setting themselves up for disappointment. Time will tell.

**JORDAN:** One moment that really stood out was when they announced they're giving away their new gene therapy, Otarmeni, for free in the U.S. This treats genetic hearing loss in children, and they got FDA approval just last week.

**ALEX:** That was such an interesting strategic decision. Schleifer said they'r

This episode includes AI-generated content.]]>SP100-REGN-Q1-2026-enWed, 29 Apr 2026 21:43:51 +0000trueBeta Finch# Beta Finch Podcast Script: Regeneron Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex. **JORDAN:** And I'm Jordan. Today we're breaking down...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're breaking down Regeneron's first quarter 2026 results, and folks, this biotech giant is firing on all cylinders.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk numbers because Regeneron just posted some impressive results. Revenue jumped 19% to $3.6 billion, and non-GAAP earnings per share grew 15%. Those are solid double-digit growth numbers across the board.

**ALEX:** What really caught my attention is the DUPIXENT story. This drug is becoming an absolute juggernaut - global net sales hit $4.9 billion in the quarter, up 31% on a constant currency basis. Jordan, we're looking at annualized sales approaching $20 billion for this single drug.

**JORDAN:** It's incredible when you put it in perspective. DUPIXENT is now treating over 1.4 million patients worldwide, and they keep expanding into new indications. This quarter alone, they got approval for allergic fungal rhinosinusitis and chronic spontaneous urticaria in younger patients. It's like they're building a franchise within a franchise.

**ALEX:** Speaking of franchises, let's talk about their eye drug portfolio. EYLEA HD had a strong quarter with U.S. sales of $468 million, up 52% year-over-year. But here's the interesting dynamic - while EYLEA HD is growing rapidly, the original EYLEA is declining as expected, down 36%. It's a classic product transition story.

**JORDAN:** And there's still some uncertainty hanging over that transition. They're waiting on FDA approval for the EYLEA HD prefilled syringe, which missed its April deadline. Management expects a decision this quarter, but it shows how regulatory timing can impact even established companies like Regeneron.

**ALEX:** Now, what really excited me during the call was the pipeline discussion. CEO Leonard Schleifer and Chief Scientific Officer George Yancopoulos laid out some compelling near-term catalysts. They've got this complement inhibitor cemdisiran for myasthenia gravis that showed really impressive Phase 3 results.

**JORDAN:** The data on that was striking. Their drug delivered a 2.3-point improvement compared to placebo, which actually outperformed existing treatments that showed 1.6 to 1.9 points in their trials. Plus, it's dosed quarterly versus every two weeks for competitors. That convenience factor could be huge.

**ALEX:** And then there's their obesity play with olatorepatide. This is where Regeneron is trying to differentiate in the crowded GLP-1 space. Their strategy is fascinating - they want to combine this obesity drug with their cholesterol drug Praluent.

**JORDAN:** George Yancopoulos made a compelling pitch on this during the Q&A. He basically said, imagine you have a GLP-1 that works as well as the best ones out there, but also lowers your bad cholesterol by 50% and reduces cardiovascular risk. Why would anyone choose a different GLP-1? It's an interesting value proposition in a competitive market.

**ALEX:** What struck me about that answer is how confident they sounded. Yancopoulos said it would be a "no-brainer" choice for physicians and patients. That's either brilliant positioning or they're setting themselves up for disappointment. Time will tell.

**JORDAN:** One moment that really stood out was when they announced they're giving away their new gene therapy, Otarmeni, for free in the U.S. This treats genetic...]]>487falsefullhttps://www.spreaker.com/episode/abbvie-q1-2026-earnings-analysis--71752131
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into AbbVie's first quarter 2026 results.

**JORDAN**: Hey everyone! Before we jump in, we need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely. Now Jordan, AbbVie just delivered what I'd call a knockout quarter. They beat expectations across the board and raised guidance - what stood out to you first?

**JORDAN**: The numbers are impressive, Alex. They hit $2.65 in adjusted earnings per share, which was 7 cents above their guidance midpoint. But what really caught my eye was that revenue growth - 12.4% to $15 billion, beating expectations by $300 million. That's some serious momentum.

**ALEX**: And they're not just celebrating - they're doubling down. They raised their full-year EPS guidance by 12 cents to between $14.08 and $14.28. What's driving this confidence?

**JORDAN**: Two words: Skyrizi and immunology. Skyrizi alone pulled in $4.5 billion in sales, up over 29% operationally. CEO Robert Michael specifically called out the "momentum in immunology and neuroscience" with both segments gaining market share in growing markets. This isn't just about riding a wave - they're creating it.

**ALEX**: The Skyrizi story is fascinating because it shows how a well-positioned drug can dominate even in a competitive landscape. Jeff Stewart, their commercial head, mentioned they have "over 4x basically the in-play share" versus their next competitor. How sustainable is that kind of dominance?

**JORDAN**: That's the million-dollar question, Alex. They're facing new competition, including an oral competitor that launched recently. But Stewart seemed pretty confident during the Q&A, pointing to their head-to-head trials across five different mechanisms in psoriasis, superior durability data, and that convenient quarterly dosing. He even suggested the oral competition might expand the market rather than just steal share.

**ALEX**: Speaking of competition, one analyst specifically asked about competitive pressure, and I found Stewart's response really telling. He basically said their audit data shows NBRx - new prescriptions - hitting all-time highs despite having incredibly high market share already. That suggests real physician preference, not just early adoption.

**JORDAN**: Exactly. And they're not just defending Skyrizi - they're expanding it. The subcutaneous induction data for Crohn's disease looked impressive. Dr. Roopal Thakkar highlighted that in treatment-naive patients, 61% achieved endoscopic response and 73% achieved clinical remission. Those are some serious numbers.

**ALEX**: But here's where it gets really interesting - their combination strategy. Tell our listeners about this Skyrizi plus alpha-4 beta-7 antibody data.

**JORDAN**: This is potentially game-changing, Alex. In their platform study, the combination doubled the endoscopic remission rate compared to either drug alone - about 42% of patients at week 24. And remember, this was in severely refractory patients where 82% had failed advanced treatments. Thakkar called it "potentially transformative efficacy."

**ALEX**: The R&D pipeline seems to be the real story here. They're not just maintaining current success - they're building the next generation. What else caught your attention?

**JORDAN**: Their obesity program is heating up. The early data on ABBV-295, their long-acting amylin analog, showed nearly 10% weight loss in just 12 weeks. In a predominantly male, non-obese population, no less. With a 270-hour half-life, they're talking about potential monthly dosing, which could be huge for patient compliance.

**ALEX**: And let's not forget neu

This episode includes AI-generated content.]]>SP100-ABBV-Q1-2026-enWed, 29 Apr 2026 21:43:45 +0000trueBeta Finch# Beta Finch Podcast Script: AbbVie Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into AbbVie's first quarter 2026 results. **JORDAN**: Hey everyone!...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into AbbVie's first quarter 2026 results.

**JORDAN**: Hey everyone! Before we jump in, we need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely. Now Jordan, AbbVie just delivered what I'd call a knockout quarter. They beat expectations across the board and raised guidance - what stood out to you first?

**JORDAN**: The numbers are impressive, Alex. They hit $2.65 in adjusted earnings per share, which was 7 cents above their guidance midpoint. But what really caught my eye was that revenue growth - 12.4% to $15 billion, beating expectations by $300 million. That's some serious momentum.

**ALEX**: And they're not just celebrating - they're doubling down. They raised their full-year EPS guidance by 12 cents to between $14.08 and $14.28. What's driving this confidence?

**JORDAN**: Two words: Skyrizi and immunology. Skyrizi alone pulled in $4.5 billion in sales, up over 29% operationally. CEO Robert Michael specifically called out the "momentum in immunology and neuroscience" with both segments gaining market share in growing markets. This isn't just about riding a wave - they're creating it.

**ALEX**: The Skyrizi story is fascinating because it shows how a well-positioned drug can dominate even in a competitive landscape. Jeff Stewart, their commercial head, mentioned they have "over 4x basically the in-play share" versus their next competitor. How sustainable is that kind of dominance?

**JORDAN**: That's the million-dollar question, Alex. They're facing new competition, including an oral competitor that launched recently. But Stewart seemed pretty confident during the Q&A, pointing to their head-to-head trials across five different mechanisms in psoriasis, superior durability data, and that convenient quarterly dosing. He even suggested the oral competition might expand the market rather than just steal share.

**ALEX**: Speaking of competition, one analyst specifically asked about competitive pressure, and I found Stewart's response really telling. He basically said their audit data shows NBRx - new prescriptions - hitting all-time highs despite having incredibly high market share already. That suggests real physician preference, not just early adoption.

**JORDAN**: Exactly. And they're not just defending Skyrizi - they're expanding it. The subcutaneous induction data for Crohn's disease looked impressive. Dr. Roopal Thakkar highlighted that in treatment-naive patients, 61% achieved endoscopic response and 73% achieved clinical remission. Those are some serious numbers.

**ALEX**: But here's where it gets really interesting - their combination strategy. Tell our listeners about this Skyrizi plus alpha-4 beta-7 antibody data.

**JORDAN**: This is potentially game-changing, Alex. In their platform study, the combination doubled the endoscopic remission rate compared to either drug alone - about 42% of patients at week 24. And remember, this was in severely refractory patients where 82% had failed advanced treatments. Thakkar called it "potentially transformative efficacy."

**ALEX**: The R&D pipeline seems to be the real story here. They're not just maintaining current success - they're building the next generation. What else caught your attention?

**JORDAN**: Their obesity program is heating up. The early data on ABBV-295, their long-acting amylin analog, showed nearly 10% weight loss in just 12 weeks. In a predominantly male, non-obese population, no less. With a...]]>478falsefullhttps://www.spreaker.com/episode/t-mobile-us-q1-2026-earnings-analysis--71730104
Before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, T-Mobile really came out swinging this quarter. Let's start with the headline numbers because they're pretty impressive. Service revenue grew 11% year-over-year - that's four times faster than their closest competitor. But what really caught my eye was their customer satisfaction score, or NPS, hitting 45 - that's over 20% higher than their nearest rival.

**ALEX**: That NPS number is huge, Jordan. It really speaks to their strategy of providing "best network, best value, and best experience" all in one package. CEO Srinivasan Gopalan kept hammering this point that customers don't need to make trade-offs anymore with T-Mobile. And the numbers back it up - they added 217,000 postpaid net accounts, up 6% year-over-year, while also growing their average revenue per account by 3.9%.

**JORDAN**: Exactly. That's the holy grail - growing both customer volume AND revenue per customer. Speaking of growth, their broadband business continues to be a monster. They added over 500,000 broadband customers this quarter and called themselves "the fastest-growing ISP in America" yet again. They're targeting 15 million broadband customers by 2030, and here's the kicker - that projection assumes they don't buy any more spectrum and doesn't factor in 6G improvements.

**ALEX**: The broadband story is fascinating because they're using what they call "fallow capacity" on their 5G network. Essentially, they've built this massive network infrastructure, and during off-peak times, they can sell that unused capacity as home internet service. It's brilliant from a capital efficiency standpoint.

But Jordan, I think the most intriguing part of this call was their discussion about AI and what they're calling "physical AI." They announced a partnership with Figure AI to connect humanoid robots to their 5G Advanced network.

**JORDAN**: This is where things get really futuristic, Alex. T-Mobile is positioning itself at the intersection of AI and connectivity. They talked about building AI capabilities directly into their network core, and they're already beta-testing something called "Live Translation" that can translate your voice into 80 different languages in real-time. But the physical AI angle is what has me excited - they see a world where their network becomes the backbone for robotics and automation.

**ALEX**: The key insight from network chief John Saw was that T-Mobile built their 5G Advanced network specifically with this future in mind. They have innovations like uplink transmit switching and higher transmit power that give them advantages for these AI applications. It's not just about faster phones - they're thinking about robots, autonomous systems, and edge computing.

**JORDAN**: And that brings us to their guidance updates. CFO Peter Osvaldik raised several key metrics. They're now expecting 950,000 to 1.05 million total postpaid net account additions for the full year, up from previous guidance. Core adjusted EBITDA guidance went up by $100 million at the low end to $37.1-37.5 billion. Free cash flow guidance also increased by $100 million to $18.1-18.7 billion.

**ALEX**: Those guidance raises show real confidence in the business momentum. But what really caught investors' attention was the announcement that they're increasing their shareholder return authorization by $3.6 billion to

This episode includes AI-generated content.]]>SP100-TMUS-Q1-2026-enWed, 29 Apr 2026 10:35:11 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown, bringing you the latest insights from corporate America's quarterly results. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into T-Mobile's Q1 2026 earnings call,...
Before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, T-Mobile really came out swinging this quarter. Let's start with the headline numbers because they're pretty impressive. Service revenue grew 11% year-over-year - that's four times faster than their closest competitor. But what really caught my eye was their customer satisfaction score, or NPS, hitting 45 - that's over 20% higher than their nearest rival.

**ALEX**: That NPS number is huge, Jordan. It really speaks to their strategy of providing "best network, best value, and best experience" all in one package. CEO Srinivasan Gopalan kept hammering this point that customers don't need to make trade-offs anymore with T-Mobile. And the numbers back it up - they added 217,000 postpaid net accounts, up 6% year-over-year, while also growing their average revenue per account by 3.9%.

**JORDAN**: Exactly. That's the holy grail - growing both customer volume AND revenue per customer. Speaking of growth, their broadband business continues to be a monster. They added over 500,000 broadband customers this quarter and called themselves "the fastest-growing ISP in America" yet again. They're targeting 15 million broadband customers by 2030, and here's the kicker - that projection assumes they don't buy any more spectrum and doesn't factor in 6G improvements.

**ALEX**: The broadband story is fascinating because they're using what they call "fallow capacity" on their 5G network. Essentially, they've built this massive network infrastructure, and during off-peak times, they can sell that unused capacity as home internet service. It's brilliant from a capital efficiency standpoint.

But Jordan, I think the most intriguing part of this call was their discussion about AI and what they're calling "physical AI." They announced a partnership with Figure AI to connect humanoid robots to their 5G Advanced network.

**JORDAN**: This is where things get really futuristic, Alex. T-Mobile is positioning itself at the intersection of AI and connectivity. They talked about building AI capabilities directly into their network core, and they're already beta-testing something called "Live Translation" that can translate your voice into 80 different languages in real-time. But the physical AI angle is what has me excited - they see a world where their network becomes the backbone for robotics and automation.

**ALEX**: The key insight from network chief John Saw was that T-Mobile built their 5G Advanced network specifically with this future in mind. They have innovations like uplink transmit switching and higher transmit power that give them advantages for these AI applications. It's not just about faster phones - they're thinking about robots, autonomous systems, and edge computing.

**JORDAN**: And that brings us to their guidance updates. CFO Peter Osvaldik raised several key metrics. They're now expecting 950,000 to 1.05 million total postpaid net account additions for the full year, up from previous guidance. Core adjusted EBITDA guidance went up by $100 million at the low end to $37.1-37.5 billion. Free cash flow guidance also increased by $100 million to $18.1-18.7 billion.

**ALEX**: Those guidance raises show real confidence in the business momentum. But what really caught investors'...]]>511falsefullhttps://www.spreaker.com/episode/starbucks-q2-2026-earnings-analysis--71730103
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Starbucks' second quarter 2026 results, and folks, this is a story about a turnaround that's actually working.

**ALEX:** Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Right, and what a quarter to analyze! Starbucks just delivered something they haven't done in over two years - simultaneous top and bottom line growth.

**ALEX:** The numbers are pretty impressive. Revenue hit $9.5 billion, up 9% year-over-year. But Jordan, what really caught my attention was that earnings per share jump - $0.50, up 22% from last year.

**JORDAN:** Exactly! And CEO Brian Niccol was clearly excited about this milestone. He called it "a turn in our turnaround," which is quite the statement. The global comparable sales growth of 6% was driven by what he described as "terrific performance across the business, especially in the U.S."

**ALEX:** Let's break down those U.S. numbers because they're really telling. U.S. comps accelerated to over 7%, with more than 4 percentage points coming from transaction growth. Niccol mentioned they haven't seen this kind of transaction strength in three years.

**JORDAN:** That transaction growth is huge, Alex. It means people are actually visiting more, not just spending more per visit. And here's what's fascinating - they're seeing broad-based growth across all income levels and age demographics. In this economic environment, that's remarkable.

**ALEX:** Speaking of remarkable, let's talk about their "Back to Starbucks" strategy. Niccol really emphasized their "Green Apron Service" model. Jordan, can you explain what they're tracking here?

**JORDAN:** Sure! They use something called a "Grow scorecard" that tracks customer comments, throughput, staffing, and food safety. They measure stores on a 5-shot system, and since launching this in October, they've seen over a 30 percentage point increase in stores delivering 4 or more shots. But here's the kicker - about 40% of stores still aren't at that 4-shot level, so there's room to grow.

**ALEX:** That's a great operational insight. And internationally, all top 10 markets, including China, posted positive comparable sales for the first time in 9 quarters. Though there's a big strategic shift happening with China, isn't there?

**JORDAN:** Absolutely. They completed their transaction with Boyu Capital, transitioning China to a joint venture model. CFO Catherine Smith mentioned this deal is valued at more than $13 billion, and Starbucks received about $3.1 billion in cash proceeds. Starting in Q3, China will be deconsolidated from their financials.

**ALEX:** Now let's talk guidance, because management got pretty confident here. They raised their global comparable sales growth guidance to "5% or better" and boosted their EPS range to $2.25 to $2.45.

**JORDAN:** Right, and when analysts pressed on why the EPS raise wasn't even higher given the strong performance, Smith was candid about macro headwinds. She mentioned elevated coffee prices - almost a dollar per pound year-over-year - and tariff impacts, though both are expected to moderate in the back half of the year.

**ALEX:** One thing that jumped out in the Q&A was the discussion about their rewards program. They just redesigned it in March, and typically that causes some disruption. But Niccol said membership actually grew, which is unusual for that quarter.

**JORDAN:** That's impressive execution. The new program has three tiers - green, gold, and reserve - and they introduced a popular 60-star redemption option that accounts for about a third of al

This episode includes AI-generated content.]]>SP100-SBUX-Q2-2026-enWed, 29 Apr 2026 10:35:05 +0000trueBeta Finch# Beta Finch Podcast Script: Starbucks Q2 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Starbucks' second quarter 2026 results, and folks, this is a...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Starbucks' second quarter 2026 results, and folks, this is a story about a turnaround that's actually working.

**ALEX:** Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Right, and what a quarter to analyze! Starbucks just delivered something they haven't done in over two years - simultaneous top and bottom line growth.

**ALEX:** The numbers are pretty impressive. Revenue hit $9.5 billion, up 9% year-over-year. But Jordan, what really caught my attention was that earnings per share jump - $0.50, up 22% from last year.

**JORDAN:** Exactly! And CEO Brian Niccol was clearly excited about this milestone. He called it "a turn in our turnaround," which is quite the statement. The global comparable sales growth of 6% was driven by what he described as "terrific performance across the business, especially in the U.S."

**ALEX:** Let's break down those U.S. numbers because they're really telling. U.S. comps accelerated to over 7%, with more than 4 percentage points coming from transaction growth. Niccol mentioned they haven't seen this kind of transaction strength in three years.

**JORDAN:** That transaction growth is huge, Alex. It means people are actually visiting more, not just spending more per visit. And here's what's fascinating - they're seeing broad-based growth across all income levels and age demographics. In this economic environment, that's remarkable.

**ALEX:** Speaking of remarkable, let's talk about their "Back to Starbucks" strategy. Niccol really emphasized their "Green Apron Service" model. Jordan, can you explain what they're tracking here?

**JORDAN:** Sure! They use something called a "Grow scorecard" that tracks customer comments, throughput, staffing, and food safety. They measure stores on a 5-shot system, and since launching this in October, they've seen over a 30 percentage point increase in stores delivering 4 or more shots. But here's the kicker - about 40% of stores still aren't at that 4-shot level, so there's room to grow.

**ALEX:** That's a great operational insight. And internationally, all top 10 markets, including China, posted positive comparable sales for the first time in 9 quarters. Though there's a big strategic shift happening with China, isn't there?

**JORDAN:** Absolutely. They completed their transaction with Boyu Capital, transitioning China to a joint venture model. CFO Catherine Smith mentioned this deal is valued at more than $13 billion, and Starbucks received about $3.1 billion in cash proceeds. Starting in Q3, China will be deconsolidated from their financials.

**ALEX:** Now let's talk guidance, because management got pretty confident here. They raised their global comparable sales growth guidance to "5% or better" and boosted their EPS range to $2.25 to $2.45.

**JORDAN:** Right, and when analysts pressed on why the EPS raise wasn't even higher given the strong performance, Smith was candid about macro headwinds. She mentioned elevated coffee prices - almost a dollar per pound year-over-year - and tariff impacts, though both are expected to moderate in the back half of the year.

**ALEX:** One thing that jumped out in the Q&A was the discussion about their rewards program. They just redesigned it in March, and typically that causes some disruption. But Niccol said membership actually grew, which is unusual for that quarter.

**JORDAN:** That's impressive...]]>460falsefullhttps://www.spreaker.com/episode/booking-holdings-q1-2026-earnings-analysis--71730102
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Booking Holdings' Q1 2026 results - and folks, this one's got some interesting twists.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Booking. On the surface, the numbers look solid - revenue up 16% to $5.5 billion, adjusted EBITDA growing 19% to about $1.3 billion. But dig deeper and there's a significant geopolitical shadow hanging over these results.

**ALEX:** Absolutely. The Middle East conflict that started in late February really threw a wrench into what could have been an even stronger quarter. CEO Glenn Fogel estimated it knocked about 2 percentage points off their room night growth. Without that impact, their 6% room night growth would have been closer to 8%.

**JORDAN:** That's a meaningful difference, Alex. And what struck me was how transparent management was about the impact. CFO Ewout Steenbergen broke it down pretty clearly - the Middle East represents about 4% of their global room nights from bookers in the region, but when you include inbound travel, it's about 7% of their total 2025 room nights. So this isn't a small market for them.

**ALEX:** Right, and the ripple effects went beyond just the Middle East itself. They saw impacts on major transit corridors, particularly between Europe and Asia, since places like Dubai are huge connection hubs. March was especially brutal with room night growth of just 1% - half from reduced bookings, half from increased cancellations.

**JORDAN:** But here's what I found encouraging - despite all this disruption, they still beat the high end of their guidance on adjusted EBITDA. And Glenn Fogel's commentary was pretty reassuring about their long-term view. He pointed out they've navigated crises before - 9/11, the financial crisis, COVID, Russia-Ukraine. The fundamental desire for travel doesn't disappear.

**ALEX:** Speaking of things that don't disappear - their capital allocation strategy. Jordan, they returned a record $3.6 billion in share buybacks this quarter alone. Since 2014, they've reduced their share count by over 40% at an average price of $93 per share. That's some serious confidence in their long-term value.

**JORDAN:** It really is. And you know what caught my attention? The U.S. performance. This was their fourth consecutive quarter of acceleration in the U.S., hitting low teens growth in room nights. That's impressive market share gains in what Glenn called a market where they "have room to grow."

**ALEX:** The U.S. story is fascinating because it shows their strategy working. They've been talking for years about investing in the U.S. market - better products, brand awareness, supply relationships. And now we're seeing it pay off with domestic travel driving that growth and their direct channel seeing double-digit growth.

**JORDAN:** And they're not just winning in accommodations. Their "Connected Trip" vision is gaining real traction. Flights were up 28%, attractions up 25%. Connected transactions - where travelers book multiple verticals with them - grew at a high teens rate, about 3x faster than their total transaction growth.

**ALEX:** Let's talk AI for a moment because that was a major theme. Their Priceline AI assistant Penny is showing some promising early results. In limited testing, they're seeing conversion rate improvements from users who engage with Penny versus those who don't.

**JORDAN:** The AI investments seem comprehensive too. It's not just customer-facing stuff like Pe

This episode includes AI-generated content.]]>SP100-BKNG-Q1-2026-enWed, 29 Apr 2026 10:34:59 +0000trueBeta Finch# Beta Finch Podcast Script: Booking Holdings Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're unpacking Booking Holdings' Q1 2026 results - and folks, this one's got some interesting twists.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Booking. On the surface, the numbers look solid - revenue up 16% to $5.5 billion, adjusted EBITDA growing 19% to about $1.3 billion. But dig deeper and there's a significant geopolitical shadow hanging over these results.

**ALEX:** Absolutely. The Middle East conflict that started in late February really threw a wrench into what could have been an even stronger quarter. CEO Glenn Fogel estimated it knocked about 2 percentage points off their room night growth. Without that impact, their 6% room night growth would have been closer to 8%.

**JORDAN:** That's a meaningful difference, Alex. And what struck me was how transparent management was about the impact. CFO Ewout Steenbergen broke it down pretty clearly - the Middle East represents about 4% of their global room nights from bookers in the region, but when you include inbound travel, it's about 7% of their total 2025 room nights. So this isn't a small market for them.

**ALEX:** Right, and the ripple effects went beyond just the Middle East itself. They saw impacts on major transit corridors, particularly between Europe and Asia, since places like Dubai are huge connection hubs. March was especially brutal with room night growth of just 1% - half from reduced bookings, half from increased cancellations.

**JORDAN:** But here's what I found encouraging - despite all this disruption, they still beat the high end of their guidance on adjusted EBITDA. And Glenn Fogel's commentary was pretty reassuring about their long-term view. He pointed out they've navigated crises before - 9/11, the financial crisis, COVID, Russia-Ukraine. The fundamental desire for travel doesn't disappear.

**ALEX:** Speaking of things that don't disappear - their capital allocation strategy. Jordan, they returned a record $3.6 billion in share buybacks this quarter alone. Since 2014, they've reduced their share count by over 40% at an average price of $93 per share. That's some serious confidence in their long-term value.

**JORDAN:** It really is. And you know what caught my attention? The U.S. performance. This was their fourth consecutive quarter of acceleration in the U.S., hitting low teens growth in room nights. That's impressive market share gains in what Glenn called a market where they "have room to grow."

**ALEX:** The U.S. story is fascinating because it shows their strategy working. They've been talking for years about investing in the U.S. market - better products, brand awareness, supply relationships. And now we're seeing it pay off with domestic travel driving that growth and their direct channel seeing double-digit growth.

**JORDAN:** And they're not just winning in accommodations. Their "Connected Trip" vision is gaining real traction. Flights were up 28%, attractions up 25%. Connected transactions - where travelers book multiple verticals with them - grew at a high teens rate, about 3x faster than their total transaction growth.

**ALEX:** Let's talk AI for a moment because that was a major theme. Their Priceline AI assistant Penny is showing some promising early results. In limited testing, they're seeing conversion rate improvements from users who engage with Penny...]]>494falsefullhttps://www.spreaker.com/episode/united-parcel-service-q1-2026-earnings-analysis--71716971
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate calls into conversations you can actually follow. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into UPS's first quarter 2026 results, and wow - this was one packed earnings call.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Right, thanks Alex. So UPS - the brown trucks we all know - just reported Q1 numbers, and there's a lot to unpack here. They're in the middle of what CEO Carol Tomé calls "the largest driver reduction in company history."

**ALEX:** That's quite a statement. Let's start with the numbers though. Revenue came in at $21.2 billion, operating profit was $1.3 billion, and operating margin hit 6.2%. But Jordan, the real story here isn't just the numbers - it's this massive strategic transformation they're executing.

**JORDAN:** Absolutely. The elephant in the room is Amazon. UPS has been deliberately reducing their Amazon business - they call it the "Amazon glidedown" - and they're almost done. Amazon now represents just 8.8% of total revenue, down from over 13% not too long ago.

**ALEX:** I found it fascinating how Carol Tomé framed this. She said they're "overturning the old industry assumption that scale alone drives profitability." Instead, they're focusing on premium segments like small and medium businesses, B2B customers, and healthcare.

**JORDAN:** And that strategy seems to be working. Their revenue per piece grew 6.5% year-over-year in the US, even as total volume dropped 8%. That's a classic example of making less revenue worth more profit.

**ALEX:** Speaking of healthcare - this was a standout. UPS generated over $3 billion in healthcare revenue for the first time ever in a single quarter. Jordan, why is this so significant?

**JORDAN:** Healthcare logistics is a premium business with higher margins. Think about it - if you're shipping temperature-sensitive medicines or medical devices, you need specialized handling, tracking, and delivery. You pay more for that reliability. Carol mentioned they're seeing opportunities with pharmaceutical companies going direct-to-consumer, especially with those GLP-1 diabetes and weight-loss drugs.

**ALEX:** The international segment was interesting too. Despite all the geopolitical challenges - trade wars, Middle East conflicts affecting airspace - they actually outperformed expectations. Revenue grew 3.8% to $4.5 billion.

**JORDAN:** That's impressive given the headwinds. Their China-to-US trade lane, which is their most profitable international route, was still down 18.3%. But here's the key insight from the call: trade doesn't stop, it just moves. They're seeing volume growth in other parts of the world as supply chains adapt.

**ALEX:** Now let's talk about the controversial part - this "Driver Choice" buyout program. They offered voluntary buyouts to reduce about 7,500 full-time driver positions, and it was apparently oversubscribed.

**JORDAN:** This is where the human element of these corporate transformations really hits home. UPS says they needed to right-size their workforce for the new volume levels after the Amazon reduction. The program was oversubscribed, meaning more drivers wanted to take the buyout than UPS could accept.

**ALEX:** The financial impact is significant. CFO Brian Dykes mentioned about $350 million in transitional costs in Q1, including this driver program, aircraft lease expenses, and weather-related costs. But they expect these costs to largely disappear in Q2.

**JORDAN:** Which brings us to guidance. They're sticking with their full-year targets: $89.7 billion in revenue and a 9.6% operating margin. Bu

This episode includes AI-generated content.]]>SP100-UPS-Q1-2026-enTue, 28 Apr 2026 22:21:50 +0000trueBeta Finch# Beta Finch Podcast Script - UPS Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate calls into conversations you can actually follow. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate calls into conversations you can actually follow. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into UPS's first quarter 2026 results, and wow - this was one packed earnings call.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Right, thanks Alex. So UPS - the brown trucks we all know - just reported Q1 numbers, and there's a lot to unpack here. They're in the middle of what CEO Carol Tomé calls "the largest driver reduction in company history."

**ALEX:** That's quite a statement. Let's start with the numbers though. Revenue came in at $21.2 billion, operating profit was $1.3 billion, and operating margin hit 6.2%. But Jordan, the real story here isn't just the numbers - it's this massive strategic transformation they're executing.

**JORDAN:** Absolutely. The elephant in the room is Amazon. UPS has been deliberately reducing their Amazon business - they call it the "Amazon glidedown" - and they're almost done. Amazon now represents just 8.8% of total revenue, down from over 13% not too long ago.

**ALEX:** I found it fascinating how Carol Tomé framed this. She said they're "overturning the old industry assumption that scale alone drives profitability." Instead, they're focusing on premium segments like small and medium businesses, B2B customers, and healthcare.

**JORDAN:** And that strategy seems to be working. Their revenue per piece grew 6.5% year-over-year in the US, even as total volume dropped 8%. That's a classic example of making less revenue worth more profit.

**ALEX:** Speaking of healthcare - this was a standout. UPS generated over $3 billion in healthcare revenue for the first time ever in a single quarter. Jordan, why is this so significant?

**JORDAN:** Healthcare logistics is a premium business with higher margins. Think about it - if you're shipping temperature-sensitive medicines or medical devices, you need specialized handling, tracking, and delivery. You pay more for that reliability. Carol mentioned they're seeing opportunities with pharmaceutical companies going direct-to-consumer, especially with those GLP-1 diabetes and weight-loss drugs.

**ALEX:** The international segment was interesting too. Despite all the geopolitical challenges - trade wars, Middle East conflicts affecting airspace - they actually outperformed expectations. Revenue grew 3.8% to $4.5 billion.

**JORDAN:** That's impressive given the headwinds. Their China-to-US trade lane, which is their most profitable international route, was still down 18.3%. But here's the key insight from the call: trade doesn't stop, it just moves. They're seeing volume growth in other parts of the world as supply chains adapt.

**ALEX:** Now let's talk about the controversial part - this "Driver Choice" buyout program. They offered voluntary buyouts to reduce about 7,500 full-time driver positions, and it was apparently oversubscribed.

**JORDAN:** This is where the human element of these corporate transformations really hits home. UPS says they needed to right-size their workforce for the new volume levels after the Amazon reduction. The program was oversubscribed, meaning more drivers wanted to take the buyout than UPS could accept.

**ALEX:** The financial impact is significant. CFO Brian Dykes mentioned about $350 million in transitional costs in Q1, including this driver program, aircraft lease expenses, and weather-related costs. But they expect these costs to largely...]]>507falsefullhttps://www.spreaker.com/episode/s-p-global-q1-2026-earnings-analysis--71716966
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into S&P Global's first quarter 2026 results. This one's particularly interesting given the backdrop of geopolitical tensions and the company's aggressive AI push.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, S&P Global just reported some pretty solid numbers despite what CEO Martina Cheung called an "incredibly volatile and dynamic operating environment." Walk us through the headline numbers.

**JORDAN**: Absolutely, Alex. These results really showcase the resilience of S&P Global's business model. They posted 10% revenue growth year-over-year, with 9% organic constant currency growth. What really caught my eye was the 14% jump in adjusted diluted EPS and 140 basis points of margin expansion on a trailing twelve-month basis. That's impressive operating leverage.

**ALEX**: And they returned a billion dollars to shareholders through share repurchases alone, on top of dividends. But let's talk about the elephant in the room - this Iranian conflict that's been disrupting energy markets. How did that impact their different divisions?

**JORDAN**: Great question. The conflict created this interesting tale of two cities within S&P Global. On one hand, their Energy division faced direct headwinds - they actually lowered their full-year guidance for that segment by a full percentage point to 4.5% to 6% organic growth. CEO Cheung mentioned that some Middle Eastern energy customers had facilities directly impacted, and supply chain disruptions are expected to persist through the second quarter.

But here's what's fascinating - this volatility actually benefited other parts of the business. Their Ratings division saw 13% revenue growth, partly driven by what they called "hyperscaler" issuance - basically big tech companies issuing debt for AI infrastructure investments.

**ALEX**: That's a perfect segue into what I think is the real story here - S&P Global's AI transformation. Jordan, they're not just talking about using AI internally; they're fundamentally changing how customers access their data. Can you break down this strategy?

**JORDAN**: This is where it gets really interesting, Alex. S&P Global is essentially becoming an AI-native data company. They're making their data accessible through what they call "model context protocol" - basically allowing customers to use S&P data directly within AI platforms like Claude and ChatGPT.

The numbers they shared are eye-popping. API call volumes were 5x higher in Q1 versus just one quarter earlier, and doubled month-over-month from February to March alone. They now have over 300 customers either contracted or in trial periods for their AI-ready APIs.

**ALEX**: And they're seeing real pricing power from this AI integration, right?

**JORDAN**: Exactly. This is where the monetization story gets compelling. During the quarter, two financial clients opted to pay 35% to 45% premium increases just to get their data in AI-ready formats. CFO Eric Aboaf mentioned that customers using their AI solutions are showing much higher growth rates - 30% higher in Market Intelligence and double the growth rate in Energy compared to non-AI customers.

One example really stood out to me: they had a buy-side client working with their Kensho AI team who liked their AI plugin so much that they canceled their existing provider and switched to S&P Global, even though it was 20% more expensive.

**ALEX**: Let's talk about the guidance. They maintained most of their full-year outlook despite the geopolitical headwinds. What should investors expect for the rest of 2026?

**JORDAN**: S&P Global is sti

This episode includes AI-generated content.]]>SP100-SPGI-Q1-2026-enTue, 28 Apr 2026 22:21:46 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into S&P Global's first quarter 2026 results. This one's particularly interesting given the...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into S&P Global's first quarter 2026 results. This one's particularly interesting given the backdrop of geopolitical tensions and the company's aggressive AI push.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, S&P Global just reported some pretty solid numbers despite what CEO Martina Cheung called an "incredibly volatile and dynamic operating environment." Walk us through the headline numbers.

**JORDAN**: Absolutely, Alex. These results really showcase the resilience of S&P Global's business model. They posted 10% revenue growth year-over-year, with 9% organic constant currency growth. What really caught my eye was the 14% jump in adjusted diluted EPS and 140 basis points of margin expansion on a trailing twelve-month basis. That's impressive operating leverage.

**ALEX**: And they returned a billion dollars to shareholders through share repurchases alone, on top of dividends. But let's talk about the elephant in the room - this Iranian conflict that's been disrupting energy markets. How did that impact their different divisions?

**JORDAN**: Great question. The conflict created this interesting tale of two cities within S&P Global. On one hand, their Energy division faced direct headwinds - they actually lowered their full-year guidance for that segment by a full percentage point to 4.5% to 6% organic growth. CEO Cheung mentioned that some Middle Eastern energy customers had facilities directly impacted, and supply chain disruptions are expected to persist through the second quarter.

But here's what's fascinating - this volatility actually benefited other parts of the business. Their Ratings division saw 13% revenue growth, partly driven by what they called "hyperscaler" issuance - basically big tech companies issuing debt for AI infrastructure investments.

**ALEX**: That's a perfect segue into what I think is the real story here - S&P Global's AI transformation. Jordan, they're not just talking about using AI internally; they're fundamentally changing how customers access their data. Can you break down this strategy?

**JORDAN**: This is where it gets really interesting, Alex. S&P Global is essentially becoming an AI-native data company. They're making their data accessible through what they call "model context protocol" - basically allowing customers to use S&P data directly within AI platforms like Claude and ChatGPT.

The numbers they shared are eye-popping. API call volumes were 5x higher in Q1 versus just one quarter earlier, and doubled month-over-month from February to March alone. They now have over 300 customers either contracted or in trial periods for their AI-ready APIs.

**ALEX**: And they're seeing real pricing power from this AI integration, right?

**JORDAN**: Exactly. This is where the monetization story gets compelling. During the quarter, two financial clients opted to pay 35% to 45% premium increases just to get their data in AI-ready formats. CFO Eric Aboaf mentioned that customers using their AI solutions are showing much higher growth rates - 30% higher in Market Intelligence and double the growth rate in Energy compared to non-AI customers.

One example really stood out to me: they had a buy-side client working with their Kensho AI team who liked their AI plugin so much that they canceled their existing provider and switched to S&P Global, even though it was 20% more expensive.

**ALEX**: Let's talk about the guidance. They...]]>482falsefullhttps://www.spreaker.com/episode/coca-cola-q1-2026-earnings-analysis--71716964
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and joining me as always is my co-host Jordan. Today we're breaking down Coca-Cola's Q1 2026 earnings - and folks, this was a strong start to the year for the beverage giant.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter this was for Coca-Cola! Let me hit you with the headline numbers first. The company delivered 10% organic revenue growth with 3% volume growth across all segments. That's particularly impressive when you consider the challenging macro environment we're seeing globally.

**ALEX**: Absolutely. And Jordan, what really caught my attention was the earnings per share performance - 18% growth to 86 cents per share on a comparable basis. That's solid double-digit growth that beat expectations. CEO Henrique Braun seemed pretty confident about their "balanced growth algorithm" approach.

**JORDAN**: Right, and that's a key theme throughout this call - this idea of balancing volume growth with price/mix improvements. They managed 3% volume growth and 2% price/mix growth in Q1, which Braun described as exactly the kind of balanced approach they're targeting. He mentioned they might see this flip to 2% volume and 3% price/mix in other quarters, but the goal is maintaining that balance.

**ALEX**: Now, there were some interesting regional dynamics here. North America showed solid performance with volume and value share gains, but they had some headwinds from Easter timing and category mix issues, particularly with packaged water and production constraints on Topo Chico and Fairlife.

**JORDAN**: And speaking of Fairlife - which investors have been watching closely - Braun confirmed that the Webster facility capacity is coming online in Q2 as planned, which should help address those production constraints. That's a key capacity expansion for their growing dairy business.

**ALEX**: Let's talk about some of the geographic highlights because this really shows Coke's global reach. In Latin America, they gained value share despite challenges in Mexico from the sugar tax that was implemented at the beginning of the year. But Brazil and Central America more than offset those declines.

**JORDAN**: And in EMEA - that's Europe, Middle East, and Africa - they gained value share and grew volume across all operating units, despite some obvious challenges from the Middle East conflict. Braun noted that while they grew volume for the quarter overall, volumes did decline in March after the onset of that conflict.

**ALEX**: The Asia Pacific region is particularly interesting from a strategic standpoint. They grew volume across all operating units despite cycling a tough comparison from the prior year. But Jordan, the margin story there was concerning - operating margins compressed almost 10 percentage points.

**JORDAN**: That's right Alex, and CFO John Murphy addressed this directly. About two-thirds of that margin compression was due to a one-time inventory issue, particularly phasing of juice inventory costs in China. They also had commodity pressures in tea and coffee businesses. Murphy emphasized this was largely a Q1 anomaly and they expect improvement as the year progresses.

**ALEX**: One thing that really stood out in the Q&A was the discussion around innovation and consumer centricity. Braun talked about their "4 I's" approach - insight, innovation, intimacy, and integrated execution. They highlighted the success of Coca-Cola Zero-Zero in Europe, which targets consumers who want to reduce caffeine intake in the evening.

**JORDAN**: That's

This episode includes AI-generated content.]]>SP100-KO-Q1-2026-enTue, 28 Apr 2026 22:21:41 +0000trueBeta Finch# Beta Finch Podcast Script: Coca-Cola Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and joining me as always is my co-host Jordan. Today we're breaking...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and joining me as always is my co-host Jordan. Today we're breaking down Coca-Cola's Q1 2026 earnings - and folks, this was a strong start to the year for the beverage giant.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter this was for Coca-Cola! Let me hit you with the headline numbers first. The company delivered 10% organic revenue growth with 3% volume growth across all segments. That's particularly impressive when you consider the challenging macro environment we're seeing globally.

**ALEX**: Absolutely. And Jordan, what really caught my attention was the earnings per share performance - 18% growth to 86 cents per share on a comparable basis. That's solid double-digit growth that beat expectations. CEO Henrique Braun seemed pretty confident about their "balanced growth algorithm" approach.

**JORDAN**: Right, and that's a key theme throughout this call - this idea of balancing volume growth with price/mix improvements. They managed 3% volume growth and 2% price/mix growth in Q1, which Braun described as exactly the kind of balanced approach they're targeting. He mentioned they might see this flip to 2% volume and 3% price/mix in other quarters, but the goal is maintaining that balance.

**ALEX**: Now, there were some interesting regional dynamics here. North America showed solid performance with volume and value share gains, but they had some headwinds from Easter timing and category mix issues, particularly with packaged water and production constraints on Topo Chico and Fairlife.

**JORDAN**: And speaking of Fairlife - which investors have been watching closely - Braun confirmed that the Webster facility capacity is coming online in Q2 as planned, which should help address those production constraints. That's a key capacity expansion for their growing dairy business.

**ALEX**: Let's talk about some of the geographic highlights because this really shows Coke's global reach. In Latin America, they gained value share despite challenges in Mexico from the sugar tax that was implemented at the beginning of the year. But Brazil and Central America more than offset those declines.

**JORDAN**: And in EMEA - that's Europe, Middle East, and Africa - they gained value share and grew volume across all operating units, despite some obvious challenges from the Middle East conflict. Braun noted that while they grew volume for the quarter overall, volumes did decline in March after the onset of that conflict.

**ALEX**: The Asia Pacific region is particularly interesting from a strategic standpoint. They grew volume across all operating units despite cycling a tough comparison from the prior year. But Jordan, the margin story there was concerning - operating margins compressed almost 10 percentage points.

**JORDAN**: That's right Alex, and CFO John Murphy addressed this directly. About two-thirds of that margin compression was due to a one-time inventory issue, particularly phasing of juice inventory costs in China. They also had commodity pressures in tea and coffee businesses. Murphy emphasized this was largely a Q1 anomaly and they expect improvement as the year progresses.

**ALEX**: One thing that really stood out in the Q&A was the discussion around innovation and consumer centricity. Braun talked about their "4 I's" approach - insight, innovation, intimacy, and integrated execution. They highlighted the success of...]]>498falsefullhttps://www.spreaker.com/episode/american-tower-q1-2026-earnings-analysis--71716958
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into American Tower's Q1 2026 results - and folks, this one's got some interesting twists.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, American Tower - AMT - is one of the biggest tower companies in the world, and they just reported what I'd call a solid but not spectacular quarter. What caught your attention first?

**ALEX**: Well, they raised guidance across the board, which is always nice to see. But when you dig into the numbers, it's really about foreign exchange tailwinds and some accounting stuff rather than explosive underlying growth. Property revenue guidance went up by about $145 million at the midpoint - sounds great until you realize $110 million of that is just FX helping them out.

**JORDAN**: Right, and there's this whole DISH situation hanging over everything. They've basically written DISH out of their numbers completely because of ongoing litigation. CEO Steven Vondran was pretty clear - they think their contract is enforceable, but they've "completely derisked" their guidance by excluding DISH entirely.

**ALEX**: That's a smart move from a guidance perspective. Any upside from DISH is just gravy at this point. But let's talk about the real growth drivers. What's interesting is their data center business - CoreSite - is absolutely on fire. 17% growth when you strip out the accounting noise.

**JORDAN**: CoreSite is fascinating because it's not just a traditional data center play. Vondran kept emphasizing it's really an "interconnection hub" - people come there to connect to other people, cloud providers, and now AI inference services. They're seeing what they call an "inflection in interconnection activity," which is basically their secret sauce for higher margins.

**ALEX**: And they're doubling down on it. Over $700 million in growth capital planned for CoreSite to build out capacity. They're buying land, securing power, even looking at new markets - though Vondran wouldn't spill details on where.

**JORDAN**: The AI angle is particularly interesting. They're not just riding the AI wave passively - they're positioning CoreSite as the place where AI workloads want to be because of all those interconnections. It's like being the popular kid at school that everyone wants to hang out with.

**ALEX**: Ha! That's actually a pretty good analogy. Now on the traditional tower side, organic growth was around 4% when you adjust for the DISH mess - solid but not spectacular. What stood out to me was their commentary about potentially getting back into new tower construction in the U.S.

**JORDAN**: Yeah, that was intriguing. They've been pretty quiet on U.S. build-to-suit for a while, but Vondran hinted they're having conversations with carriers about it. Meanwhile, they're actively building in Europe - 700 new sites planned there. The economics seem to work better overseas right now.

**ALEX**: Let's talk about the elephant in the room - all the M&A speculation in the tower space. When asked about potential deals, Vondran was diplomatically non-committal but said they look at "everything." No strategic imperative to overpay, though.

**JORDAN**: I loved his response to the question about what it means if competitors go private. Basically said they don't run their business based on what others are doing, but acknowledged the valuation disconnect between public and private markets. Very measured response.

**ALEX**: The satellite question was interesting too. David Barden asked about SpaceX potentially disrupting te

This episode includes AI-generated content.]]>SP100-AMT-Q1-2026-enTue, 28 Apr 2026 22:21:36 +0000trueBeta Finch# Beta Finch Podcast Script: American Tower (AMT) Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving into American Tower's Q1 2026 results - and folks, this...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into American Tower's Q1 2026 results - and folks, this one's got some interesting twists.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, American Tower - AMT - is one of the biggest tower companies in the world, and they just reported what I'd call a solid but not spectacular quarter. What caught your attention first?

**ALEX**: Well, they raised guidance across the board, which is always nice to see. But when you dig into the numbers, it's really about foreign exchange tailwinds and some accounting stuff rather than explosive underlying growth. Property revenue guidance went up by about $145 million at the midpoint - sounds great until you realize $110 million of that is just FX helping them out.

**JORDAN**: Right, and there's this whole DISH situation hanging over everything. They've basically written DISH out of their numbers completely because of ongoing litigation. CEO Steven Vondran was pretty clear - they think their contract is enforceable, but they've "completely derisked" their guidance by excluding DISH entirely.

**ALEX**: That's a smart move from a guidance perspective. Any upside from DISH is just gravy at this point. But let's talk about the real growth drivers. What's interesting is their data center business - CoreSite - is absolutely on fire. 17% growth when you strip out the accounting noise.

**JORDAN**: CoreSite is fascinating because it's not just a traditional data center play. Vondran kept emphasizing it's really an "interconnection hub" - people come there to connect to other people, cloud providers, and now AI inference services. They're seeing what they call an "inflection in interconnection activity," which is basically their secret sauce for higher margins.

**ALEX**: And they're doubling down on it. Over $700 million in growth capital planned for CoreSite to build out capacity. They're buying land, securing power, even looking at new markets - though Vondran wouldn't spill details on where.

**JORDAN**: The AI angle is particularly interesting. They're not just riding the AI wave passively - they're positioning CoreSite as the place where AI workloads want to be because of all those interconnections. It's like being the popular kid at school that everyone wants to hang out with.

**ALEX**: Ha! That's actually a pretty good analogy. Now on the traditional tower side, organic growth was around 4% when you adjust for the DISH mess - solid but not spectacular. What stood out to me was their commentary about potentially getting back into new tower construction in the U.S.

**JORDAN**: Yeah, that was intriguing. They've been pretty quiet on U.S. build-to-suit for a while, but Vondran hinted they're having conversations with carriers about it. Meanwhile, they're actively building in Europe - 700 new sites planned there. The economics seem to work better overseas right now.

**ALEX**: Let's talk about the elephant in the room - all the M&A speculation in the tower space. When asked about potential deals, Vondran was diplomatically non-committal but said they look at "everything." No strategic imperative to overpay, though.

**JORDAN**: I loved his response to the question about what it means if competitors go private. Basically said they don't run their business based on what others are doing, but acknowledged the valuation disconnect between public and private...]]>443falsefullhttps://www.spreaker.com/episode/intel-q1-2026-earnings-analysis--71609197
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're unpacking Intel's first quarter 2026 results, and wow - what a turnaround story this is becoming.

**ALEX:** Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about Intel because this earnings call felt like listening to a completely different company than we were hearing from just a year ago.

**ALEX:** You're not wrong, Jordan. CEO Lip Bu Tan literally said "A year ago, the conversation about Intel Corporation was about whether we could survive. Today, it's about how quickly we can add manufacturing capacity." That's quite the transformation narrative.

**JORDAN:** The numbers certainly back that up. Intel delivered $13.6 billion in revenue for Q1, which was $1.4 billion above the midpoint of their guidance. That's their sixth consecutive quarter of beating expectations. EPS came in at 29 cents versus guidance of breakeven.

**ALEX:** And here's what really caught my attention - they're saying demand is outpacing supply across all their businesses, especially in server CPUs. CFO Dave Zinsner said they're missing out on revenue that "starts with a 'b'" - meaning billions in unmet demand.

**JORDAN:** That supply constraint story is fascinating because it's driven by what they're calling the AI infrastructure buildout. Let's break down their segments. Data Center and AI revenue hit $5.1 billion, up 22% year-over-year, with ASIC revenue doubling. Meanwhile, Client Computing was $7.7 billion.

**ALEX:** The AI story Intel is telling is particularly interesting. They're positioning CPUs as becoming more critical as AI moves from training to inference and into what they call "agentic" applications. Lip Bu mentioned that the ratio of CPUs to GPUs used to be 1-to-8, but it's moving toward 1-to-4 and could reach parity.

**JORDAN:** That's a massive shift if it plays out. And they're backing it up with some big partnerships. They announced a multiyear deal with Google and this intriguing collaboration with Elon Musk's companies - SpaceX, xAI, and Tesla - for something called "TeraFab."

**ALEX:** The Elon partnership is pretty wild. Lip Bu said they both believe global semiconductor supply isn't keeping pace with demand, and they want to "explore innovative ways to refactor silicon process technology." Very typical Elon - thinking outside the box on manufacturing efficiency.

**JORDAN:** Let's talk about their foundry business because that's been the big question mark. Intel Foundry revenue was $5.4 billion, up 20% sequentially, though they're still losing $2.4 billion operationally. But here's the key - their 18A process node is running ahead of internal projections.

**ALEX:** Right, and they're getting more confident about external foundry customers. Dave Zinsner said their advanced packaging backlog is now in the "billions of dollars" range, not the hundreds of millions they initially expected. That's a significant scale-up.

**JORDAN:** The guidance for Q2 is solid too - $13.8 to $14.8 billion revenue, with both client and data center segments expected to grow sequentially. Though they are warning about PC market weakness in the second half and some margin pressure from ramping 18A production.

**ALEX:** Speaking of margins, gross margin came in at 41% for Q1, way ahead of guidance, though they're guiding 39% for Q2. The 18A ramp is creating some near-term headwinds, but the volume growth and yield improvements are helping offset that.

**JORDAN:** There was an interesting exchange in the Q&A about competi

This episode includes AI-generated content.]]>SP100-INTC-Q1-2026-enFri, 24 Apr 2026 08:52:37 +0000trueBeta Finch# Beta Finch Podcast Script - Intel Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex. **JORDAN:** And I'm Jordan. Today we're unpacking Intel's first...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're unpacking Intel's first quarter 2026 results, and wow - what a turnaround story this is becoming.

**ALEX:** Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about Intel because this earnings call felt like listening to a completely different company than we were hearing from just a year ago.

**ALEX:** You're not wrong, Jordan. CEO Lip Bu Tan literally said "A year ago, the conversation about Intel Corporation was about whether we could survive. Today, it's about how quickly we can add manufacturing capacity." That's quite the transformation narrative.

**JORDAN:** The numbers certainly back that up. Intel delivered $13.6 billion in revenue for Q1, which was $1.4 billion above the midpoint of their guidance. That's their sixth consecutive quarter of beating expectations. EPS came in at 29 cents versus guidance of breakeven.

**ALEX:** And here's what really caught my attention - they're saying demand is outpacing supply across all their businesses, especially in server CPUs. CFO Dave Zinsner said they're missing out on revenue that "starts with a 'b'" - meaning billions in unmet demand.

**JORDAN:** That supply constraint story is fascinating because it's driven by what they're calling the AI infrastructure buildout. Let's break down their segments. Data Center and AI revenue hit $5.1 billion, up 22% year-over-year, with ASIC revenue doubling. Meanwhile, Client Computing was $7.7 billion.

**ALEX:** The AI story Intel is telling is particularly interesting. They're positioning CPUs as becoming more critical as AI moves from training to inference and into what they call "agentic" applications. Lip Bu mentioned that the ratio of CPUs to GPUs used to be 1-to-8, but it's moving toward 1-to-4 and could reach parity.

**JORDAN:** That's a massive shift if it plays out. And they're backing it up with some big partnerships. They announced a multiyear deal with Google and this intriguing collaboration with Elon Musk's companies - SpaceX, xAI, and Tesla - for something called "TeraFab."

**ALEX:** The Elon partnership is pretty wild. Lip Bu said they both believe global semiconductor supply isn't keeping pace with demand, and they want to "explore innovative ways to refactor silicon process technology." Very typical Elon - thinking outside the box on manufacturing efficiency.

**JORDAN:** Let's talk about their foundry business because that's been the big question mark. Intel Foundry revenue was $5.4 billion, up 20% sequentially, though they're still losing $2.4 billion operationally. But here's the key - their 18A process node is running ahead of internal projections.

**ALEX:** Right, and they're getting more confident about external foundry customers. Dave Zinsner said their advanced packaging backlog is now in the "billions of dollars" range, not the hundreds of millions they initially expected. That's a significant scale-up.

**JORDAN:** The guidance for Q2 is solid too - $13.8 to $14.8 billion revenue, with both client and data center segments expected to grow sequentially. Though they are warning about PC market weakness in the second half and some margin pressure from ramping 18A production.

**ALEX:** Speaking of margins, gross margin came in at 41% for Q1, way ahead of guidance, though they're guiding 39% for Q2. The 18A ramp is creating some...]]>462falsefullhttps://www.spreaker.com/episode/thermo-fisher-scientific-q1-2026-earnings-analysis--71606389
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Thermo Fisher Scientific's Q1 2026 earnings, and let me tell you, this one's got some interesting moving parts.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, TMO just reported their first quarter results, and on the surface, it looks like a pretty solid performance. What caught your attention first?

ALEX: Well, the headline numbers are decent but not spectacular. Revenue grew 6% to $11.01 billion, and adjusted EPS came in at $5.44, also up 6%. But here's the kicker - they actually beat their own guidance by 14 cents per share on the earnings side.

JORDAN: That's a nice beat. And they're raising full-year guidance too, right? New revenue range of $47.3 to $48.1 billion, up from the previous $46.3 to $47.2 billion range.

ALEX: Exactly. And on earnings, they're now expecting $24.64 to $25.12 per share, up from their original $24.22 to $24.80 guide. That represents 8% to 10% growth for the year. But Jordan, there's a big asterisk here - a lot of this guidance raise comes from their massive Clario acquisition.

JORDAN: Right, the $9 billion elephant in the room. They closed that deal in late March. Clario is a digital endpoint data solutions company that complements their clinical research business. Even though it was only in the results for a few days, it contributed $30 million in revenue and a penny per share to Q1.

ALEX: And CEO Marc Casper was pretty excited about it on the call. He kept talking about how it enhances their "trusted partner status" with pharma and biotech customers. The integration seems to be going smoothly, and customers are apparently enthusiastic about combining Thermo's capabilities with Clario's digital endpoints technology.

JORDAN: Speaking of pharma and biotech, that was actually their strongest end market in the quarter with mid-single digit growth. Casper highlighted strength in bioproduction and clinical research. But let's talk about the headwinds they're facing.

ALEX: Yeah, this is where it gets interesting. They had some real operational challenges. First, they had one less selling day compared to last year, which dinged organic growth by about a percentage point. Then there was revenue phasing in pharma services - another roughly one-point headwind.

JORDAN: So if you normalize for those factors, their 1% organic growth in Q1 would have been closer to 3%. And that's exactly what they're guiding for in Q2. The concern from analysts on the call was about this acceleration they need in the back half of the year to hit their full-year 3-4% organic growth target.

ALEX: Casper seemed pretty confident though. He said the markets are playing out exactly as expected, and the ramp isn't really assuming any change in underlying market conditions. It's more about these timing issues and comparisons normalizing.

JORDAN: Let's break down the segments because there were some real divergences. Life Sciences Solutions was the star with 13% reported growth, though only 1% organic. That was driven by their bioproduction business having "another quarter of excellent organic growth," as CFO Stephen Williamson put it.

ALEX: Meanwhile, Analytical Instruments was flat on revenue with organic declining 2%. This is the ongoing story we've been hearing across the industry - weak academic and government spending, especially in the US and China. Margins in that segment got hit hard, down 250 basis points to 20.7%.

JORDAN: Ouch. And a lot of that margin pressure was from tariffs and foreign exchange headwinds. Williamson quantified the tariff

This episode includes AI-generated content.]]>SP100-TMO-Q1-2026-enFri, 24 Apr 2026 06:05:17 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Thermo Fisher Scientific's Q1 2026 earnings, and let me...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that matter. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Thermo Fisher Scientific's Q1 2026 earnings, and let me tell you, this one's got some interesting moving parts.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, TMO just reported their first quarter results, and on the surface, it looks like a pretty solid performance. What caught your attention first?

ALEX: Well, the headline numbers are decent but not spectacular. Revenue grew 6% to $11.01 billion, and adjusted EPS came in at $5.44, also up 6%. But here's the kicker - they actually beat their own guidance by 14 cents per share on the earnings side.

JORDAN: That's a nice beat. And they're raising full-year guidance too, right? New revenue range of $47.3 to $48.1 billion, up from the previous $46.3 to $47.2 billion range.

ALEX: Exactly. And on earnings, they're now expecting $24.64 to $25.12 per share, up from their original $24.22 to $24.80 guide. That represents 8% to 10% growth for the year. But Jordan, there's a big asterisk here - a lot of this guidance raise comes from their massive Clario acquisition.

JORDAN: Right, the $9 billion elephant in the room. They closed that deal in late March. Clario is a digital endpoint data solutions company that complements their clinical research business. Even though it was only in the results for a few days, it contributed $30 million in revenue and a penny per share to Q1.

ALEX: And CEO Marc Casper was pretty excited about it on the call. He kept talking about how it enhances their "trusted partner status" with pharma and biotech customers. The integration seems to be going smoothly, and customers are apparently enthusiastic about combining Thermo's capabilities with Clario's digital endpoints technology.

JORDAN: Speaking of pharma and biotech, that was actually their strongest end market in the quarter with mid-single digit growth. Casper highlighted strength in bioproduction and clinical research. But let's talk about the headwinds they're facing.

ALEX: Yeah, this is where it gets interesting. They had some real operational challenges. First, they had one less selling day compared to last year, which dinged organic growth by about a percentage point. Then there was revenue phasing in pharma services - another roughly one-point headwind.

JORDAN: So if you normalize for those factors, their 1% organic growth in Q1 would have been closer to 3%. And that's exactly what they're guiding for in Q2. The concern from analysts on the call was about this acceleration they need in the back half of the year to hit their full-year 3-4% organic growth target.

ALEX: Casper seemed pretty confident though. He said the markets are playing out exactly as expected, and the ramp isn't really assuming any change in underlying market conditions. It's more about these timing issues and comparisons normalizing.

JORDAN: Let's break down the segments because there were some real divergences. Life Sciences Solutions was the star with 13% reported growth, though only 1% organic. That was driven by their bioproduction business having "another quarter of excellent organic growth," as CFO Stephen Williamson put it.

ALEX: Meanwhile, Analytical Instruments was flat on revenue with organic declining 2%. This is the ongoing story we've been hearing across the industry - weak academic and government spending, especially in the US and China. Margins in that segment got hit hard, down 250...]]>555falsefullhttps://www.spreaker.com/episode/servicenow-q1-2026-earnings-analysis--71606388
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into ServiceNow's Q1 2026 results, and wow - there's a lot to unpack here.

**JORDAN:** There really is, Alex. And before we jump in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks for that, Jordan. So let's start with the headline numbers because ServiceNow delivered what CEO Bill McDermott called a "beat and raise" quarter.

**JORDAN:** Right, they beat across the board. Subscription revenue hit $3.67 billion, growing 19% year-over-year in constant currency - that's above the high end of their guidance. And their remaining performance obligations, or RPO, grew 23.5% to $27.7 billion. That's a massive backlog of contracted revenue.

**ALEX:** The numbers are solid, but what's really interesting is the AI story here. McDermott dropped a pretty big bombshell on the call - they're now forecasting $1.5 billion in AI-specific commitments for 2026, up from their original $1 billion target. That's a 50% increase!

**JORDAN:** That's huge, Alex. And it's not just talk - they're seeing real traction. Now Assist, their AI product suite, had deals with 3 or more products growing nearly 70% year-over-year. They had 36 deals with 5 or more AI products. Customers are clearly moving beyond just experimenting with AI.

**ALEX:** Let's talk about their M&A strategy because they've been very active. They just closed three major acquisitions - Moveworks, Veza, and Armis. McDermott was particularly excited about the Moveworks integration.

**JORDAN:** Yeah, the Moveworks story is pretty remarkable. They integrated it with their employee experience platform in just three weeks and rebranded it as "Employee Works." In Q1 alone, they closed more deals than Moveworks did in their entire previous year. That's execution at its finest.

**ALEX:** And then there's Armis, which McDermott called their potential "Instagram" - referring to how that acquisition transformed Facebook. Armis brings cybersecurity visibility across IT, operational technology, and IoT devices. Given that cybercrime is now a trillion-dollar economy, the timing seems perfect.

**JORDAN:** What I found fascinating was McDermott's framing of their "AI control tower for business reinvention." They're positioning ServiceNow as the orchestration layer that manages both human workers and AI agents. With 2.2 billion more AI agents expected in the workforce over the next few years, that's a massive opportunity.

**ALEX:** The technical differentiation is interesting too. They're emphasizing their "context engine" - basically, 22 years of enterprise workflow data training their AI. As McDermott put it, "There's a perfect correlation between enterprise AI from any source and ServiceNow's expansion."

**JORDAN:** Speaking of expansion, their hybrid pricing model is gaining traction. Fifty percent of new business now comes from non-seat-based pricing, including usage-based models. That's important because it lets them scale with AI adoption rather than just traditional user growth.

**ALEX:** Now, let's address the elephant in the room - the stock dropped about 12% after hours despite these strong results. One analyst pressed them on this disconnect.

**JORDAN:** Yeah, Keith Weiss from Morgan Stanley asked a great question about when ServiceNow will participate in the AI boom in a way that's more analogous to the big AI labs that are seeing massive revenue spikes. There seems to be some investor anxiety about whether ServiceNow is capturing enough of the AI spending.

**ALEX:** McDermott's response was pretty passionate. He emphasized that t

This episode includes AI-generated content.]]>SP100-NOW-Q1-2026-enFri, 24 Apr 2026 06:05:11 +0000trueBeta Finch# Beta Finch Podcast Script: ServiceNow Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into ServiceNow's Q1 2026 results, and wow - there's a lot...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into ServiceNow's Q1 2026 results, and wow - there's a lot to unpack here.

**JORDAN:** There really is, Alex. And before we jump in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks for that, Jordan. So let's start with the headline numbers because ServiceNow delivered what CEO Bill McDermott called a "beat and raise" quarter.

**JORDAN:** Right, they beat across the board. Subscription revenue hit $3.67 billion, growing 19% year-over-year in constant currency - that's above the high end of their guidance. And their remaining performance obligations, or RPO, grew 23.5% to $27.7 billion. That's a massive backlog of contracted revenue.

**ALEX:** The numbers are solid, but what's really interesting is the AI story here. McDermott dropped a pretty big bombshell on the call - they're now forecasting $1.5 billion in AI-specific commitments for 2026, up from their original $1 billion target. That's a 50% increase!

**JORDAN:** That's huge, Alex. And it's not just talk - they're seeing real traction. Now Assist, their AI product suite, had deals with 3 or more products growing nearly 70% year-over-year. They had 36 deals with 5 or more AI products. Customers are clearly moving beyond just experimenting with AI.

**ALEX:** Let's talk about their M&A strategy because they've been very active. They just closed three major acquisitions - Moveworks, Veza, and Armis. McDermott was particularly excited about the Moveworks integration.

**JORDAN:** Yeah, the Moveworks story is pretty remarkable. They integrated it with their employee experience platform in just three weeks and rebranded it as "Employee Works." In Q1 alone, they closed more deals than Moveworks did in their entire previous year. That's execution at its finest.

**ALEX:** And then there's Armis, which McDermott called their potential "Instagram" - referring to how that acquisition transformed Facebook. Armis brings cybersecurity visibility across IT, operational technology, and IoT devices. Given that cybercrime is now a trillion-dollar economy, the timing seems perfect.

**JORDAN:** What I found fascinating was McDermott's framing of their "AI control tower for business reinvention." They're positioning ServiceNow as the orchestration layer that manages both human workers and AI agents. With 2.2 billion more AI agents expected in the workforce over the next few years, that's a massive opportunity.

**ALEX:** The technical differentiation is interesting too. They're emphasizing their "context engine" - basically, 22 years of enterprise workflow data training their AI. As McDermott put it, "There's a perfect correlation between enterprise AI from any source and ServiceNow's expansion."

**JORDAN:** Speaking of expansion, their hybrid pricing model is gaining traction. Fifty percent of new business now comes from non-seat-based pricing, including usage-based models. That's important because it lets them scale with AI adoption rather than just traditional user growth.

**ALEX:** Now, let's address the elephant in the room - the stock dropped about 12% after hours despite these strong results. One analyst pressed them on this disconnect.

**JORDAN:** Yeah, Keith Weiss from Morgan Stanley asked a great question about when ServiceNow will participate in the AI boom in a way that's more analogous to the big AI labs that are seeing massive revenue spikes. There seems to be some investor...]]>514falsefullhttps://www.spreaker.com/episode/nextera-energy-q1-2026-earnings-analysis--71606385
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode quarterly results so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're diving into NextEra Energy's Q1 2026 earnings - and wow, Jordan, this utility giant is really making some bold moves in the AI and data center space.

**JORDAN**: Absolutely, Alex. Before we jump in though, I want to remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. So let's start with the numbers - NextEra posted adjusted earnings per share growth of 10% year-over-year, which is solid for a utility. But the real story here isn't just the financials, it's this massive pivot toward serving data centers and hyperscalers. Jordan, what caught your attention first?

**JORDAN**: What jumped out at me was the sheer scale of opportunity they're talking about. Alex, they mentioned 21 gigawatts of large-load interest at their Florida Power & Light subsidiary alone - that's enormous. To put that in perspective, they're in advanced discussions on about 12 gigawatts of that, which could start being served as soon as 2028. And here's the kicker - every gigawatt under their approved tariff represents roughly $2 billion in capital expenditures.

**ALEX**: That's massive capital deployment potential. But what really struck me was this U.S.-Japan deal they announced. Can you break that down for listeners?

**JORDAN**: This is fascinating, Alex. The U.S. Department of Commerce selected NextEra to build 9.5 gigawatts of new gas-fired generation - one project in Texas, one in Pennsylvania - connected to Japan's $550 billion investment commitment to the United States. But here's what makes it brilliant: it's essentially a capital-light model for NextEra. The U.S. and Japan would own the projects while NextEra develops, builds, and operates them.

**ALEX**: So they get the fees without the massive capital outlay risk. That's smart positioning. Speaking of positioning, their CEO John Ketchum kept emphasizing this "bring your own generation" or BYOG model. What's that about?

**JORDAN**: This is NextEra's answer to a major political and economic challenge, Alex. Essentially, when hyperscalers like Google or Microsoft want massive amounts of power for their data centers, NextEra builds the infrastructure specifically for them - and they pay for it. Regular consumers don't subsidize these massive power needs through their electric bills. It's politically savvy and economically sound.

**ALEX**: And they're not just talking about traditional power generation. They mentioned this collaboration with NVIDIA that sounds almost futuristic.

**JORDAN**: Right! They're essentially treating data centers like giant batteries. The idea is that during extreme weather - think hot summer days or cold winter snaps when power demand spikes - they could temporarily reduce or shift data center computing activity. That freed-up power could then serve regular customers when electricity is scarce and expensive. It's a really innovative approach to grid management.

**ALEX**: Let's talk about their AI initiative called "Rewire." This seems like a utility company trying to become a tech company.

**JORDAN**: It's ambitious, Alex. They're partnering with Google Cloud to develop AI tools for the entire utility industry. They mentioned products like "Conduit" which uses AI to make their renewables workforce more efficient, and "Grid Composer" which optimizes power generation decisions in real-time. The goal is to drive costs even lower - they're already 30% below the national average in Florida.

**ALEX**: The scale of their renewable energy business is also impressive. They

This episode includes AI-generated content.]]>SP100-NEE-Q1-2026-enFri, 24 Apr 2026 06:05:06 +0000trueBeta Finch# Beta Finch Podcast Script - NextEra Energy (NEE) Q1 2026 Earnings --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode quarterly results so you don't have to. I'm Alex, and joining me as always is Jordan. Today...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode quarterly results so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're diving into NextEra Energy's Q1 2026 earnings - and wow, Jordan, this utility giant is really making some bold moves in the AI and data center space.

**JORDAN**: Absolutely, Alex. Before we jump in though, I want to remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. So let's start with the numbers - NextEra posted adjusted earnings per share growth of 10% year-over-year, which is solid for a utility. But the real story here isn't just the financials, it's this massive pivot toward serving data centers and hyperscalers. Jordan, what caught your attention first?

**JORDAN**: What jumped out at me was the sheer scale of opportunity they're talking about. Alex, they mentioned 21 gigawatts of large-load interest at their Florida Power & Light subsidiary alone - that's enormous. To put that in perspective, they're in advanced discussions on about 12 gigawatts of that, which could start being served as soon as 2028. And here's the kicker - every gigawatt under their approved tariff represents roughly $2 billion in capital expenditures.

**ALEX**: That's massive capital deployment potential. But what really struck me was this U.S.-Japan deal they announced. Can you break that down for listeners?

**JORDAN**: This is fascinating, Alex. The U.S. Department of Commerce selected NextEra to build 9.5 gigawatts of new gas-fired generation - one project in Texas, one in Pennsylvania - connected to Japan's $550 billion investment commitment to the United States. But here's what makes it brilliant: it's essentially a capital-light model for NextEra. The U.S. and Japan would own the projects while NextEra develops, builds, and operates them.

**ALEX**: So they get the fees without the massive capital outlay risk. That's smart positioning. Speaking of positioning, their CEO John Ketchum kept emphasizing this "bring your own generation" or BYOG model. What's that about?

**JORDAN**: This is NextEra's answer to a major political and economic challenge, Alex. Essentially, when hyperscalers like Google or Microsoft want massive amounts of power for their data centers, NextEra builds the infrastructure specifically for them - and they pay for it. Regular consumers don't subsidize these massive power needs through their electric bills. It's politically savvy and economically sound.

**ALEX**: And they're not just talking about traditional power generation. They mentioned this collaboration with NVIDIA that sounds almost futuristic.

**JORDAN**: Right! They're essentially treating data centers like giant batteries. The idea is that during extreme weather - think hot summer days or cold winter snaps when power demand spikes - they could temporarily reduce or shift data center computing activity. That freed-up power could then serve regular customers when electricity is scarce and expensive. It's a really innovative approach to grid management.

**ALEX**: Let's talk about their AI initiative called "Rewire." This seems like a utility company trying to become a tech company.

**JORDAN**: It's ambitious, Alex. They're partnering with Google Cloud to develop AI tools for the entire utility industry. They mentioned products like "Conduit" which uses AI to make their renewables workforce more efficient, and "Grid Composer" which optimizes power generation decisions in real-time. The goal is to drive costs even lower -...]]>534falsefullhttps://www.spreaker.com/episode/lam-research-q3-2026-earnings-analysis--71606383
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Lam Research's Q3 2026 earnings call, and wow, what a quarter this was for the semiconductor equipment giant.

But before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and you're absolutely right about this being a standout quarter. Lam just posted their third consecutive record revenue quarter at $5.84 billion - that's up 9% sequentially and a massive 24% year-over-year. But the real headline here might be their Customer Support Business Group hitting $2 billion in quarterly revenue for the first time ever.

**ALEX:** That's incredible growth, and what's really catching my attention is how CEO Tim Archer talked about this AI-driven semiconductor boom. Jordan, they actually raised their wafer fabrication equipment spending forecast from $135 billion to $140 billion for 2026, and Archer said there's a "bias to the upside." What's driving this optimism?

**JORDAN:** It's all about AI demand creating this perfect storm for Lam. Think about it - AI workloads need more advanced memory, more complex chip architectures, and that means more deposition and etching processes, which is exactly Lam's sweet spot. Archer mentioned their served available market as a percentage of total wafer fab equipment spending is expanding to the "mid-30s percent" and heading toward the "high 30s" in the coming years.

**ALEX:** And speaking of memory, there was some fascinating commentary about NAND flash memory. Apparently, AI is changing the entire storage landscape. Archer said they expect total data center memory bits this year to exceed both PC and mobile segments combined. That's a massive shift.

**JORDAN:** Absolutely, and here's where it gets really interesting for Lam's business. They had previously said that about $40 billion in conversion spending would be needed over several years to upgrade existing NAND capacity to produce devices with more than 200 layers. Now they're saying that conversion is being "pulled forward" with most of the spending happening before the end of 2027. That's a significant acceleration.

**ALEX:** Let's talk profitability because the numbers here are impressive. Gross margins hit 49.9% - at the high end of guidance - and they're guiding for 50.5% next quarter. CFO Doug Bettinger attributed this to improved factory efficiencies and better tool performance. Jordan, what stood out to you about their operational improvements?

**JORDAN:** What I found fascinating was how they're leveraging technology to drive these margins. They talked about their Dextro cobots - these are automated maintenance robots - and their Equipment Intelligence services. Archer mentioned that customers using Dextro in production are seeing higher output and in some cases improved yield from existing capacity. That's the kind of value-add service that commands premium pricing.

**ALEX:** The geographical breakdown was interesting too. China came in at 34% of revenue, but Bettinger expects that to decline in the June quarter. Meanwhile, both Korea and Taiwan hit record revenue levels at 23% each. It seems like the growth is really coming from leading-edge customers outside of China.

**JORDAN:** Right, and that ties into their technology leadership story. During the Q&A, there was this great example where a customer actually switched to Lam's tools in the middle of their production ramp because of "superior defect performance and better yield." That's exactly the kind of competitive positioning you want in a supply-c

This episode includes AI-generated content.]]>SP100-LRCX-Q3-2026-enFri, 24 Apr 2026 06:05:01 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Lam Research's Q3 2026 earnings call, and wow, what a quarter this was for the semiconductor equipment giant.

But before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and you're absolutely right about this being a standout quarter. Lam just posted their third consecutive record revenue quarter at $5.84 billion - that's up 9% sequentially and a massive 24% year-over-year. But the real headline here might be their Customer Support Business Group hitting $2 billion in quarterly revenue for the first time ever.

**ALEX:** That's incredible growth, and what's really catching my attention is how CEO Tim Archer talked about this AI-driven semiconductor boom. Jordan, they actually raised their wafer fabrication equipment spending forecast from $135 billion to $140 billion for 2026, and Archer said there's a "bias to the upside." What's driving this optimism?

**JORDAN:** It's all about AI demand creating this perfect storm for Lam. Think about it - AI workloads need more advanced memory, more complex chip architectures, and that means more deposition and etching processes, which is exactly Lam's sweet spot. Archer mentioned their served available market as a percentage of total wafer fab equipment spending is expanding to the "mid-30s percent" and heading toward the "high 30s" in the coming years.

**ALEX:** And speaking of memory, there was some fascinating commentary about NAND flash memory. Apparently, AI is changing the entire storage landscape. Archer said they expect total data center memory bits this year to exceed both PC and mobile segments combined. That's a massive shift.

**JORDAN:** Absolutely, and here's where it gets really interesting for Lam's business. They had previously said that about $40 billion in conversion spending would be needed over several years to upgrade existing NAND capacity to produce devices with more than 200 layers. Now they're saying that conversion is being "pulled forward" with most of the spending happening before the end of 2027. That's a significant acceleration.

**ALEX:** Let's talk profitability because the numbers here are impressive. Gross margins hit 49.9% - at the high end of guidance - and they're guiding for 50.5% next quarter. CFO Doug Bettinger attributed this to improved factory efficiencies and better tool performance. Jordan, what stood out to you about their operational improvements?

**JORDAN:** What I found fascinating was how they're leveraging technology to drive these margins. They talked about their Dextro cobots - these are automated maintenance robots - and their Equipment Intelligence services. Archer mentioned that customers using Dextro in production are seeing higher output and in some cases improved yield from existing capacity. That's the kind of value-add service that commands premium pricing.

**ALEX:** The geographical breakdown was interesting too. China came in at 34% of revenue, but Bettinger expects that to decline in the June quarter. Meanwhile, both Korea and Taiwan hit record revenue levels at 23% each. It seems like the growth is really coming from leading-edge customers outside of China.

**JORDAN:** Right, and that ties into their technology leadership story. During the Q&A, there was this great example where a customer actually switched to Lam's tools in the middle of their production ramp because...]]>458falsefullhttps://www.spreaker.com/episode/international-business-machines-q1-2026-earnings-analysis--71606382
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into IBM's Q1 2026 earnings - and wow, what a quarter this was for Big Blue.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, IBM just posted some pretty impressive numbers. Walk us through the highlights.

**ALEX:** The numbers really tell a story of transformation, Jordan. Revenue grew 6% to kick off 2026, but here's what caught my eye - free cash flow jumped 13% to $2.2 billion. That's their highest first quarter free cash flow in a decade.

**JORDAN:** And when you dig into the segments, you see why CEO Arvind Krishna was so confident on this call. Software revenue grew 8%, with their data business absolutely crushing it at 16% growth. Infrastructure was up 12%, and get this - their mainframe business grew 48%.

**ALEX:** That mainframe number is wild. And here's something fascinating from Krishna's commentary - he talked about how AI is creating entirely new use cases for mainframes. Instead of sampling just 10% of transactions for fraud detection, banks can now run AI inference on every single transaction directly on the platform.

**JORDAN:** That's a perfect example of how IBM is positioning itself in the AI revolution. They're not trying to build the next ChatGPT - they're building the infrastructure that lets enterprises actually use AI securely with their own data. Krishna made this point beautifully when he said they're helping clients "put AI to work on their terms."

**ALEX:** Speaking of AI positioning, one of the most interesting Q&A moments came when an analyst asked about IBM's software mix between infrastructure and applications. Krishna basically said only about 4% of their portfolio could be called applications - everything else is what he called "enabling software."

**JORDAN:** Which is brilliant positioning for the AI era, right? As agents start replacing some human interactions, the value isn't going to be in that interaction layer - it's going to be in the underlying data and business logic. IBM saw this coming and positioned their portfolio accordingly.

**ALEX:** Exactly. And the Confluent acquisition they closed early is a perfect example. This company streams live, governed data to AI models across hybrid environments. CFO Jim Kavanaugh said it should boost their data revenue by more than 15 percentage points.

**JORDAN:** The guidance update was interesting too. They're now projecting software growth of 10-plus percent for the year, up from their previous 10% target. But they kept their overall revenue guidance at 5-plus percent growth and free cash flow growth of about $1 billion.

**ALEX:** When analysts pressed them on why they didn't raise guidance after such a strong quarter, Kavanaugh had a great response. He said they've never raised guidance in the first quarter in his nine years as CFO, and they want to maintain their "beat mentality."

**JORDAN:** That discipline is probably why the stock has performed so well. But there were some concerns raised. One analyst noted that Red Hat's RHEL business decelerated, which Kavanaugh attributed to federal government budget closures and supply chain disruptions in the hardware market.

**ALEX:** The macro environment discussion was revealing too. Krishna said the Middle East actually had their strongest growth in decades - not years, decades. Europe was also strong. The only potential concern he flagged was if Middle East shipping routes stay disrupted for weeks, it could impact European energy costs.

**JORDAN:** What struck me most was how th

This episode includes AI-generated content.]]>SP100-IBM-Q1-2026-enFri, 24 Apr 2026 06:04:55 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into IBM's Q1 2026 earnings -...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into IBM's Q1 2026 earnings - and wow, what a quarter this was for Big Blue.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, IBM just posted some pretty impressive numbers. Walk us through the highlights.

**ALEX:** The numbers really tell a story of transformation, Jordan. Revenue grew 6% to kick off 2026, but here's what caught my eye - free cash flow jumped 13% to $2.2 billion. That's their highest first quarter free cash flow in a decade.

**JORDAN:** And when you dig into the segments, you see why CEO Arvind Krishna was so confident on this call. Software revenue grew 8%, with their data business absolutely crushing it at 16% growth. Infrastructure was up 12%, and get this - their mainframe business grew 48%.

**ALEX:** That mainframe number is wild. And here's something fascinating from Krishna's commentary - he talked about how AI is creating entirely new use cases for mainframes. Instead of sampling just 10% of transactions for fraud detection, banks can now run AI inference on every single transaction directly on the platform.

**JORDAN:** That's a perfect example of how IBM is positioning itself in the AI revolution. They're not trying to build the next ChatGPT - they're building the infrastructure that lets enterprises actually use AI securely with their own data. Krishna made this point beautifully when he said they're helping clients "put AI to work on their terms."

**ALEX:** Speaking of AI positioning, one of the most interesting Q&A moments came when an analyst asked about IBM's software mix between infrastructure and applications. Krishna basically said only about 4% of their portfolio could be called applications - everything else is what he called "enabling software."

**JORDAN:** Which is brilliant positioning for the AI era, right? As agents start replacing some human interactions, the value isn't going to be in that interaction layer - it's going to be in the underlying data and business logic. IBM saw this coming and positioned their portfolio accordingly.

**ALEX:** Exactly. And the Confluent acquisition they closed early is a perfect example. This company streams live, governed data to AI models across hybrid environments. CFO Jim Kavanaugh said it should boost their data revenue by more than 15 percentage points.

**JORDAN:** The guidance update was interesting too. They're now projecting software growth of 10-plus percent for the year, up from their previous 10% target. But they kept their overall revenue guidance at 5-plus percent growth and free cash flow growth of about $1 billion.

**ALEX:** When analysts pressed them on why they didn't raise guidance after such a strong quarter, Kavanaugh had a great response. He said they've never raised guidance in the first quarter in his nine years as CFO, and they want to maintain their "beat mentality."

**JORDAN:** That discipline is probably why the stock has performed so well. But there were some concerns raised. One analyst noted that Red Hat's RHEL business decelerated, which Kavanaugh attributed to federal government budget closures and supply chain disruptions in the hardware market.

**ALEX:** The macro environment discussion was revealing too. Krishna said the Middle East actually had their strongest growth in decades - not years, decades. Europe was also strong. The only...]]>464falsefullhttps://www.spreaker.com/episode/honeywell-q1-2026-earnings-analysis--71606381
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Honeywell's first quarter 2026 results. Now, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to cover! This might be the last time we see Honeywell as we know it, with that massive aerospace spin-off coming up. But let's start with the numbers - how did they perform?

**ALEX:** The headline numbers were actually pretty solid. Honeywell posted adjusted earnings per share of $2.45, up 11% year-over-year. Revenue grew 2% organically, which might sound modest, but given all the geopolitical chaos they're navigating, it's actually quite impressive. Segment margins expanded a whopping 90 basis points to 23.3%.

**JORDAN:** That margin expansion really caught my eye too. But Alex, we need to talk about the elephant in the room - they're basically splitting into two companies. The aerospace spin-off is happening June 29th. That's like, eight weeks away!

**ALEX:** Exactly! CEO Vimal Kapur called this a "momentous day" - the last quarter of Honeywell as we know it. They've already raised $20 billion in financing for the aerospace spinoff and secured strong investment-grade credit ratings. It's fascinating to watch this massive industrial conglomerate break itself apart.

**JORDAN:** And speaking of breaking apart, they're also selling off two other businesses - Productivity Solutions and Services to Brady Corporation, and their Warehouse and Workflow business to American Industrial Partners. It's like they're Marie Kondo-ing their entire portfolio.

**ALEX:** Ha! "Does this business unit spark joy?" But seriously, the strategic rationale makes sense. After all these moves, the remaining Honeywell will be a pure-play automation company focused on three main areas: building automation, industrial automation, and process automation.

**JORDAN:** Let's dig into the segment performance because there were some real mixed signals here. Building Automation was the star - 8% organic growth, margins expanding. But then you had some challenges elsewhere, right?

**ALEX:** Right. Aerospace had supply chain hiccups that really hurt their first quarter. Sales only grew 3% organically when they were expecting much more. The interesting part was how specific and acute these problems were - CEO Jim Courier said they could identify it down to specific line items in their mechanical products business.

**JORDAN:** That's actually somewhat reassuring, isn't it? If you can pinpoint the exact problem, you can theoretically fix it faster than if it's some broad, systemic issue.

**ALEX:** Exactly. And they did see improvement in March - in fact, March was their highest revenue month of the quarter. They're maintaining their full-year aerospace guidance of high single-digit growth, betting that these supply chain issues were temporary.

**JORDAN:** Now, the other big story here is the Middle East conflict. How much is that impacting their business?

**ALEX:** It's significant, especially for their Process Automation and Technology segment. They're seeing about a 0.5% revenue impact to the overall company in Q1, expected to be about 1% in Q2. Most of that is hitting their higher-margin services and software business because, obviously, you can't exactly send technicians into active conflict zones.

**JORDAN:** But here's what's interesting - management seems almost bullish about the long-term opportunity this creates. They talk about three phases: immediate services to restart plants, then refurbishment of damaged facilities, and finally increased demand driven by higher oil prices and

This episode includes AI-generated content.]]>SP100-HON-Q1-2026-enFri, 24 Apr 2026 06:04:50 +0000trueBeta Finch# Beta Finch Podcast Script: Honeywell Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Honeywell's first quarter 2026 results. Now, before we get...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Honeywell's first quarter 2026 results. Now, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to cover! This might be the last time we see Honeywell as we know it, with that massive aerospace spin-off coming up. But let's start with the numbers - how did they perform?

**ALEX:** The headline numbers were actually pretty solid. Honeywell posted adjusted earnings per share of $2.45, up 11% year-over-year. Revenue grew 2% organically, which might sound modest, but given all the geopolitical chaos they're navigating, it's actually quite impressive. Segment margins expanded a whopping 90 basis points to 23.3%.

**JORDAN:** That margin expansion really caught my eye too. But Alex, we need to talk about the elephant in the room - they're basically splitting into two companies. The aerospace spin-off is happening June 29th. That's like, eight weeks away!

**ALEX:** Exactly! CEO Vimal Kapur called this a "momentous day" - the last quarter of Honeywell as we know it. They've already raised $20 billion in financing for the aerospace spinoff and secured strong investment-grade credit ratings. It's fascinating to watch this massive industrial conglomerate break itself apart.

**JORDAN:** And speaking of breaking apart, they're also selling off two other businesses - Productivity Solutions and Services to Brady Corporation, and their Warehouse and Workflow business to American Industrial Partners. It's like they're Marie Kondo-ing their entire portfolio.

**ALEX:** Ha! "Does this business unit spark joy?" But seriously, the strategic rationale makes sense. After all these moves, the remaining Honeywell will be a pure-play automation company focused on three main areas: building automation, industrial automation, and process automation.

**JORDAN:** Let's dig into the segment performance because there were some real mixed signals here. Building Automation was the star - 8% organic growth, margins expanding. But then you had some challenges elsewhere, right?

**ALEX:** Right. Aerospace had supply chain hiccups that really hurt their first quarter. Sales only grew 3% organically when they were expecting much more. The interesting part was how specific and acute these problems were - CEO Jim Courier said they could identify it down to specific line items in their mechanical products business.

**JORDAN:** That's actually somewhat reassuring, isn't it? If you can pinpoint the exact problem, you can theoretically fix it faster than if it's some broad, systemic issue.

**ALEX:** Exactly. And they did see improvement in March - in fact, March was their highest revenue month of the quarter. They're maintaining their full-year aerospace guidance of high single-digit growth, betting that these supply chain issues were temporary.

**JORDAN:** Now, the other big story here is the Middle East conflict. How much is that impacting their business?

**ALEX:** It's significant, especially for their Process Automation and Technology segment. They're seeing about a 0.5% revenue impact to the overall company in Q1, expected to be about 1% in Q2. Most of that is hitting their higher-margin services and software business because, obviously, you can't exactly send technicians into active conflict zones.

**JORDAN:** But here's what's interesting - management seems almost bullish about the long-term opportunity this creates. They talk about three...]]>512falsefullhttps://www.spreaker.com/episode/ge-vernova-q1-2026-earnings-analysis--71606378
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really driving the markets. I'm Alex, and joining me as always is Jordan.

**JORDAN:** Hey everyone! Today we're breaking down GE Vernova's absolutely explosive Q1 2026 results. And Alex, before we jump in, I know we need to mention—

**ALEX:** Absolutely. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. Now Jordan, let's talk about these numbers because wow—GE Vernova just delivered what might be one of the most impressive quarters we've seen in the industrial space.

**JORDAN:** Alex, where do I even start? Orders up 71% year-over-year to $18.3 billion, with a book-to-bill ratio of 2.0. That means for every dollar of revenue they recognized, they booked two dollars in new orders. Their backlog is now sitting at $163 billion—that's billion with a 'B'—and they're saying they'll hit $200 billion in backlog by 2027, a full year ahead of schedule.

**ALEX:** The cash generation story here is just phenomenal. They generated $4.8 billion in free cash flow in just one quarter—that's more than their entire 2025 full-year free cash flow of $3.7 billion. What's driving this massive cash generation?

**JORDAN:** It's really the working capital dynamics. When you're booking orders this aggressively, especially in long-cycle businesses like power generation, you're getting significant down payments upfront. They had $5.3 billion in working capital benefits, primarily from higher down payments on those Power and Electrification orders. It's like getting paid before you do most of the work—a beautiful business model when demand is this strong.

**ALEX:** Let's break down the segments because each one tells a different story. Starting with Power—their bread and butter—revenue up 10%, but EBITDA margins expanded a massive 500 basis points to 16.3%.

**JORDAN:** The Power segment is firing on all cylinders. They shipped 25 gas turbines in the quarter, up 32% year-over-year, and their pricing is getting significantly better. CEO Scott Strazik said their 2026 orders are priced 10-20% higher than Q4 2025 levels on a dollar-per-kilowatt basis. When you have three-year lead times and customers desperate for power generation capacity, you can command premium pricing.

**ALEX:** And this isn't just traditional utility demand. About 20% of their 100 gigawatts under contract are directly supporting data centers. The AI boom is creating this massive secondary demand for power infrastructure that I don't think many investors fully appreciate yet.

**JORDAN:** Exactly! And speaking of underappreciated, let's talk Electrification—this segment is becoming a monster. Orders up 86% year-over-year, and here's the kicker: their Q1 data center orders alone were $2.4 billion, which is more than their entire full-year 2025 data center business.

**ALEX:** The Prolec acquisition is paying off big time. They bought the remaining 50% stake for $5.3 billion in February, and Prolec's backlog has grown 25% just since they announced the deal at Q3 earnings. That's incredible customer enthusiasm for the combined entity.

**JORDAN:** What I love about the Electrification story is the portfolio breadth. They're not just selling transformers—they've got HVDC systems, substations, grid automation software. CFO Ken Parks mentioned they closed their first Energy Management System order, which combines power conversion, substation equipment, and grid software into an integrated solution for data centers.

**ALEX:** The company is really positioning itself as the one-stop shop for electrification. Strazik gave this great example of a project where they're providing the gas turbine for power generation,

This episode includes AI-generated content.]]>SP100-GEV-Q1-2026-enFri, 24 Apr 2026 06:04:44 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really driving the markets. I'm Alex, and joining me as always is Jordan....
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results to help you understand what's really driving the markets. I'm Alex, and joining me as always is Jordan.

**JORDAN:** Hey everyone! Today we're breaking down GE Vernova's absolutely explosive Q1 2026 results. And Alex, before we jump in, I know we need to mention—

**ALEX:** Absolutely. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions. Now Jordan, let's talk about these numbers because wow—GE Vernova just delivered what might be one of the most impressive quarters we've seen in the industrial space.

**JORDAN:** Alex, where do I even start? Orders up 71% year-over-year to $18.3 billion, with a book-to-bill ratio of 2.0. That means for every dollar of revenue they recognized, they booked two dollars in new orders. Their backlog is now sitting at $163 billion—that's billion with a 'B'—and they're saying they'll hit $200 billion in backlog by 2027, a full year ahead of schedule.

**ALEX:** The cash generation story here is just phenomenal. They generated $4.8 billion in free cash flow in just one quarter—that's more than their entire 2025 full-year free cash flow of $3.7 billion. What's driving this massive cash generation?

**JORDAN:** It's really the working capital dynamics. When you're booking orders this aggressively, especially in long-cycle businesses like power generation, you're getting significant down payments upfront. They had $5.3 billion in working capital benefits, primarily from higher down payments on those Power and Electrification orders. It's like getting paid before you do most of the work—a beautiful business model when demand is this strong.

**ALEX:** Let's break down the segments because each one tells a different story. Starting with Power—their bread and butter—revenue up 10%, but EBITDA margins expanded a massive 500 basis points to 16.3%.

**JORDAN:** The Power segment is firing on all cylinders. They shipped 25 gas turbines in the quarter, up 32% year-over-year, and their pricing is getting significantly better. CEO Scott Strazik said their 2026 orders are priced 10-20% higher than Q4 2025 levels on a dollar-per-kilowatt basis. When you have three-year lead times and customers desperate for power generation capacity, you can command premium pricing.

**ALEX:** And this isn't just traditional utility demand. About 20% of their 100 gigawatts under contract are directly supporting data centers. The AI boom is creating this massive secondary demand for power infrastructure that I don't think many investors fully appreciate yet.

**JORDAN:** Exactly! And speaking of underappreciated, let's talk Electrification—this segment is becoming a monster. Orders up 86% year-over-year, and here's the kicker: their Q1 data center orders alone were $2.4 billion, which is more than their entire full-year 2025 data center business.

**ALEX:** The Prolec acquisition is paying off big time. They bought the remaining 50% stake for $5.3 billion in February, and Prolec's backlog has grown 25% just since they announced the deal at Q3 earnings. That's incredible customer enthusiasm for the combined entity.

**JORDAN:** What I love about the Electrification story is the portfolio breadth. They're not just selling transformers—they've got HVDC systems, substations, grid automation software. CFO Ken Parks mentioned they closed their first Energy Management System order, which combines power conversion, substation equipment, and grid software into an integrated solution for data centers.

**ALEX:** The company is really positioning itself as...]]>583falsefullhttps://www.spreaker.com/episode/cme-group-q1-2026-earnings-analysis--71606376
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest corporate earnings calls. I'm Alex, and I'm here with my co-host Jordan to dive into CME Group's Q4 2024 earnings.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for CME Group! This is a company that just keeps hitting records. We're talking about their fourth consecutive year of record volume with average daily volume up 9% to nearly 27 million contracts. Revenue hit $6.1 billion for the year - that's 10% growth - and they delivered their third straight year of record revenues and earnings.

**ALEX:** It really is impressive. But what caught my attention was CEO Terry Duffy's comment about the blurring lines between retail and institutional trading. He said technology is equalizing access to data and improving information flow, bringing new types of traders into their markets. Jordan, what do you make of this trend?

**JORDAN:** It's fascinating, Alex. They're seeing massive growth in their retail business - Julie Winkler mentioned that two-thirds of the $1 billion in revenue from new clients over the last five years came from retail. And get this - new client acquisition was up 23% year-over-year. They're even rolling out futures to Robinhood's 24 million customers, which could be a game-changer.

**ALEX:** Speaking of game-changers, let's talk about their pricing power. CFO Lynne Fitzpatrick announced some interesting fee adjustments. Can you break that down?

**JORDAN:** Sure thing. They implemented transaction fee adjustments in February that should boost futures and options revenue by 1% to 1.5%. They also raised market data fees by 3.5% and - this is clever - they're adding a 10 basis point surcharge for participants who don't post at least 30% of their margin in cash. In aggregate, these changes could add 2% to 2.5% to pre-tax income.

**ALEX:** That cash requirement is smart risk management, especially given the current market environment. Terry Duffy was pretty candid about the economic headwinds ahead - $36 trillion in U.S. debt, geopolitical tensions, potential tariffs. He sees all of this driving demand for risk management tools.

**JORDAN:** Exactly, and it's showing up in their commodities business, which was their third fastest-growing asset class. Metals volume up 23%, energy up 17%, agriculture up 13%. Derek Sammann pointed out they're seeing significant increases from global multi-strategy hedge funds expanding into commodity-focused strategies. This isn't just cyclical - it looks secular.

**ALEX:** The international growth story is compelling too. Their EMEA commodities volume was up 34% year-over-year. But let's pivot to something that came up in the Q&A that I found intriguing - the regulatory environment under the new administration.

**JORDAN:** Terry Duffy was pretty fired up about this, particularly around Treasury futures clearing. He made a strong case that having U.S. sovereign debt cleared overseas - specifically at LCH in the UK - poses systemic risks because the Bank of England would have resolution authority over a market larger than some countries' entire economies.

**ALEX:** His quote was memorable: "If someone gets sick, we all get cancer" when talking about a $28 trillion market. Pretty stark warning. But shifting gears, what about their capital allocation strategy?

**JORDAN:** They've got a new $3 billion buyback authorization, though Lynne Fitzpatrick described their approach as "opportunistic." They're still prioritizing their dividend - raised it from $1.15 to $1.25 - and they just paid out

This episode includes AI-generated content.]]>SP100-CME-Q1-2026-enFri, 24 Apr 2026 06:04:39 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest corporate earnings calls. I'm Alex, and I'm here with my co-host...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest corporate earnings calls. I'm Alex, and I'm here with my co-host Jordan to dive into CME Group's Q4 2024 earnings.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for CME Group! This is a company that just keeps hitting records. We're talking about their fourth consecutive year of record volume with average daily volume up 9% to nearly 27 million contracts. Revenue hit $6.1 billion for the year - that's 10% growth - and they delivered their third straight year of record revenues and earnings.

**ALEX:** It really is impressive. But what caught my attention was CEO Terry Duffy's comment about the blurring lines between retail and institutional trading. He said technology is equalizing access to data and improving information flow, bringing new types of traders into their markets. Jordan, what do you make of this trend?

**JORDAN:** It's fascinating, Alex. They're seeing massive growth in their retail business - Julie Winkler mentioned that two-thirds of the $1 billion in revenue from new clients over the last five years came from retail. And get this - new client acquisition was up 23% year-over-year. They're even rolling out futures to Robinhood's 24 million customers, which could be a game-changer.

**ALEX:** Speaking of game-changers, let's talk about their pricing power. CFO Lynne Fitzpatrick announced some interesting fee adjustments. Can you break that down?

**JORDAN:** Sure thing. They implemented transaction fee adjustments in February that should boost futures and options revenue by 1% to 1.5%. They also raised market data fees by 3.5% and - this is clever - they're adding a 10 basis point surcharge for participants who don't post at least 30% of their margin in cash. In aggregate, these changes could add 2% to 2.5% to pre-tax income.

**ALEX:** That cash requirement is smart risk management, especially given the current market environment. Terry Duffy was pretty candid about the economic headwinds ahead - $36 trillion in U.S. debt, geopolitical tensions, potential tariffs. He sees all of this driving demand for risk management tools.

**JORDAN:** Exactly, and it's showing up in their commodities business, which was their third fastest-growing asset class. Metals volume up 23%, energy up 17%, agriculture up 13%. Derek Sammann pointed out they're seeing significant increases from global multi-strategy hedge funds expanding into commodity-focused strategies. This isn't just cyclical - it looks secular.

**ALEX:** The international growth story is compelling too. Their EMEA commodities volume was up 34% year-over-year. But let's pivot to something that came up in the Q&A that I found intriguing - the regulatory environment under the new administration.

**JORDAN:** Terry Duffy was pretty fired up about this, particularly around Treasury futures clearing. He made a strong case that having U.S. sovereign debt cleared overseas - specifically at LCH in the UK - poses systemic risks because the Bank of England would have resolution authority over a market larger than some countries' entire economies.

**ALEX:** His quote was memorable: "If someone gets sick, we all get cancer" when talking about a $28 trillion market. Pretty stark warning. But shifting gears, what about their capital allocation strategy?

**JORDAN:** They've got a new $3 billion buyback authorization, though Lynne Fitzpatrick...]]>477falsefullhttps://www.spreaker.com/episode/chubb-q1-2026-earnings-analysis--71606375
**JORDAN:** Thanks Alex. And wow, what a quarter for Chubb! The insurance giant just reported some pretty impressive numbers that really showcase why they're considered one of the industry leaders.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Chubb delivered core operating earnings of $2.7 billion, or $6.82 per share - both up substantially from the prior year's first quarter. But there's an important caveat here, right?

**JORDAN:** Exactly. Last year's Q1 was impacted by those devastating California wildfires. When you adjust for catastrophe losses and compare apples to apples, core operating income was still up a solid 10.7% and earnings per share grew 13.5%. But here's the real kicker - tangible book value per share jumped 21.5%. That's the kind of wealth creation that gets investors excited.

**ALEX:** Those are strong numbers across the board. What about the top line growth?

**JORDAN:** Total company net premiums grew 10.7% to over $14 billion. The breakdown is interesting - P&C premiums grew 7.2% while their Life business absolutely exploded with over 33% growth. Both segments benefited from favorable foreign exchange movements, but even accounting for that, these are solid growth figures.

**ALEX:** Now Jordan, one thing that really caught my attention was CEO Evan Greenberg's commentary about the external environment. He opened the call talking about the war in the Middle East and its potential impacts. This isn't typical earnings call fare.

**JORDAN:** You're right, Alex. Greenberg was quite candid about the macro headwinds - mentioning how the conflict could lead to higher inflation, supply chain disruptions, and slower economic growth. But here's what I found reassuring: he explicitly said he likes Chubb's position during times of stress, citing their balance sheet strength, earning power, and liquidity. It shows management is thinking proactively about risk management.

**ALEX:** Speaking of risk management, there was a lot of discussion about pricing dynamics in the property market. This seemed to be a major theme throughout the call.

**JORDAN:** This was probably the most concerning part of the entire earnings report, Alex. Greenberg didn't mince words - he called the pace of property pricing declines in certain markets "dumb." We're talking about market rates declining 25% in the quarter and heading toward 30%. Meanwhile, loss costs are still running at 4-5%. The math just doesn't work.

**ALEX:** And Chubb's response was pretty decisive, wasn't it?

**JORDAN:** Absolutely. They purposefully shrank their large account property exposure, both in the admitted and excess & surplus markets. Greenberg mentioned they walked away from business where market pricing was down 30-40% from what they were willing to accept. They also bought additional reinsurance to reduce their exposure. It's a classic example of underwriting discipline over premium growth.

**ALEX:** Let's talk about some of the bright spots. Their investment portfolio performance was quite strong.

**JORDAN:** Yes, their invested assets now stand at $170 billion, up from $152 billion a year ago. Their fixed income portfolio yield hit 5.1%, with new money rates averaging 5.5%. Adjusted net investment income of $1.8 billion was up more than 10%. For an insurance company, having that investment income engine firing on all cylinders is crucial.

**ALEX:** There were some fascinating Q&A moments around technology and AI. What stood out to you there?

**JORDAN:** G

This episode includes AI-generated content.]]>SP100-CB-Q1-2026-enFri, 24 Apr 2026 06:04:34 +0000trueBeta Finch**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Chubb's Q1 2026 earnings results. Before we get started, I want to remind our listeners that this podcast is AI-generated...
**JORDAN:** Thanks Alex. And wow, what a quarter for Chubb! The insurance giant just reported some pretty impressive numbers that really showcase why they're considered one of the industry leaders.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Chubb delivered core operating earnings of $2.7 billion, or $6.82 per share - both up substantially from the prior year's first quarter. But there's an important caveat here, right?

**JORDAN:** Exactly. Last year's Q1 was impacted by those devastating California wildfires. When you adjust for catastrophe losses and compare apples to apples, core operating income was still up a solid 10.7% and earnings per share grew 13.5%. But here's the real kicker - tangible book value per share jumped 21.5%. That's the kind of wealth creation that gets investors excited.

**ALEX:** Those are strong numbers across the board. What about the top line growth?

**JORDAN:** Total company net premiums grew 10.7% to over $14 billion. The breakdown is interesting - P&C premiums grew 7.2% while their Life business absolutely exploded with over 33% growth. Both segments benefited from favorable foreign exchange movements, but even accounting for that, these are solid growth figures.

**ALEX:** Now Jordan, one thing that really caught my attention was CEO Evan Greenberg's commentary about the external environment. He opened the call talking about the war in the Middle East and its potential impacts. This isn't typical earnings call fare.

**JORDAN:** You're right, Alex. Greenberg was quite candid about the macro headwinds - mentioning how the conflict could lead to higher inflation, supply chain disruptions, and slower economic growth. But here's what I found reassuring: he explicitly said he likes Chubb's position during times of stress, citing their balance sheet strength, earning power, and liquidity. It shows management is thinking proactively about risk management.

**ALEX:** Speaking of risk management, there was a lot of discussion about pricing dynamics in the property market. This seemed to be a major theme throughout the call.

**JORDAN:** This was probably the most concerning part of the entire earnings report, Alex. Greenberg didn't mince words - he called the pace of property pricing declines in certain markets "dumb." We're talking about market rates declining 25% in the quarter and heading toward 30%. Meanwhile, loss costs are still running at 4-5%. The math just doesn't work.

**ALEX:** And Chubb's response was pretty decisive, wasn't it?

**JORDAN:** Absolutely. They purposefully shrank their large account property exposure, both in the admitted and excess & surplus markets. Greenberg mentioned they walked away from business where market pricing was down 30-40% from what they were willing to accept. They also bought additional reinsurance to reduce their exposure. It's a classic example of underwriting discipline over premium growth.

**ALEX:** Let's talk about some of the bright spots. Their investment portfolio performance was quite strong.

**JORDAN:** Yes, their invested assets now stand at $170 billion, up from $152 billion a year ago. Their fixed income portfolio yield hit 5.1%, with new money rates averaging 5.5%. Adjusted net investment income of $1.8 billion was up more than 10%. For an insurance company, having that investment income engine firing on all...]]>468falsefullhttps://www.spreaker.com/episode/blackstone-group-q1-2026-earnings-analysis--71606373
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the key insights from corporate America's quarterly reports. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Blackstone's first quarter 2026 results, and wow, what a quarter this was.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Blackstone just posted some absolutely massive numbers here - we're talking about $13 billion in GAAP net income for the quarter. That's not a typo, right?

**JORDAN:** No typo, Alex! That's a record-breaking number, and it really shows the power of Blackstone's diversified platform. But let me break this down for our listeners because there's a lot to unpack here. Distributable earnings - which is really the metric investors focus on - came in at $1.8 billion, or $1.36 per share. That's up 25% year-over-year, which is impressive given the volatile market backdrop.

**ALEX:** And speaking of that backdrop, CEO Steve Schwarzman really painted a picture of just how crazy this environment has been. Since 2020, they've navigated five major market-moving events around the same time of year - COVID, Ukraine invasion, regional banking crisis, tariff announcements in 2025, and now this conflict in Iran that triggered the largest quarterly oil price increase in over 35 years.

**JORDAN:** That's a great point, Alex. What struck me was Schwarzman's emphasis on patience being key during these events. He said when the world normalizes, risk appetite returns and investors refocus on fundamentals. But here's what's really interesting - despite all this chaos, Blackstone's flagship strategies reported positive appreciation while major equity and credit indices were declining.

**ALEX:** The AI angle is absolutely fascinating here. Schwarzman mentioned he personally got involved in AI back in 2015, way before it became trendy. Now they're claiming to be the largest investor in AI-related infrastructure globally. Jordan, walk us through their AI positioning because it's massive.

**JORDAN:** It really is staggering, Alex. They have over $150 billion in data centers globally, including facilities under construction, with another $160 billion in prospective pipeline development. Two weeks ago, they even filed to launch a new public company to acquire stabilized data centers. They've also become one of the largest investors in modernizing the U.S. electric grid, and they own the longest cross-country network of natural gas pipelines in the U.S.

**ALEX:** What I found interesting was their investment in the actual AI companies themselves - they mentioned stakes in Anthropic and OpenAI through their wealth platform. So they're basically betting on the entire AI ecosystem from infrastructure to the technology itself.

**JORDAN:** Exactly. And this positioning really paid off in their infrastructure business, which grew 41% year-over-year to $84 billion. Their BIP strategy has generated 19% net returns annually since inception - nearly double their original target of 10-12%. That's the kind of performance that attracts institutional money.

**ALEX:** Now let's talk about the elephant in the room - private credit. There's been a lot of negative press about this sector, and it definitely impacted their wealth channel flows. Jordan, what's the real story here?

**JORDAN:** This was probably the most interesting part of the call, Alex. Schwarzman was pretty fired up about what he called "external assertions" ranging from systemic risk concerns to predictions of significant investor losses. He pushed back hard, noting that their institutional and insurance clients - represent

This episode includes AI-generated content.]]>SP100-BX-Q1-2026-enFri, 24 Apr 2026 06:04:29 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT - BLACKSTONE Q1 2026 EARNINGS** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the key insights from corporate America's quarterly reports. I'm Alex,...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the key insights from corporate America's quarterly reports. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Blackstone's first quarter 2026 results, and wow, what a quarter this was.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Blackstone just posted some absolutely massive numbers here - we're talking about $13 billion in GAAP net income for the quarter. That's not a typo, right?

**JORDAN:** No typo, Alex! That's a record-breaking number, and it really shows the power of Blackstone's diversified platform. But let me break this down for our listeners because there's a lot to unpack here. Distributable earnings - which is really the metric investors focus on - came in at $1.8 billion, or $1.36 per share. That's up 25% year-over-year, which is impressive given the volatile market backdrop.

**ALEX:** And speaking of that backdrop, CEO Steve Schwarzman really painted a picture of just how crazy this environment has been. Since 2020, they've navigated five major market-moving events around the same time of year - COVID, Ukraine invasion, regional banking crisis, tariff announcements in 2025, and now this conflict in Iran that triggered the largest quarterly oil price increase in over 35 years.

**JORDAN:** That's a great point, Alex. What struck me was Schwarzman's emphasis on patience being key during these events. He said when the world normalizes, risk appetite returns and investors refocus on fundamentals. But here's what's really interesting - despite all this chaos, Blackstone's flagship strategies reported positive appreciation while major equity and credit indices were declining.

**ALEX:** The AI angle is absolutely fascinating here. Schwarzman mentioned he personally got involved in AI back in 2015, way before it became trendy. Now they're claiming to be the largest investor in AI-related infrastructure globally. Jordan, walk us through their AI positioning because it's massive.

**JORDAN:** It really is staggering, Alex. They have over $150 billion in data centers globally, including facilities under construction, with another $160 billion in prospective pipeline development. Two weeks ago, they even filed to launch a new public company to acquire stabilized data centers. They've also become one of the largest investors in modernizing the U.S. electric grid, and they own the longest cross-country network of natural gas pipelines in the U.S.

**ALEX:** What I found interesting was their investment in the actual AI companies themselves - they mentioned stakes in Anthropic and OpenAI through their wealth platform. So they're basically betting on the entire AI ecosystem from infrastructure to the technology itself.

**JORDAN:** Exactly. And this positioning really paid off in their infrastructure business, which grew 41% year-over-year to $84 billion. Their BIP strategy has generated 19% net returns annually since inception - nearly double their original target of 10-12%. That's the kind of performance that attracts institutional money.

**ALEX:** Now let's talk about the elephant in the room - private credit. There's been a lot of negative press about this sector, and it definitely impacted their wealth channel flows. Jordan, what's the real story here?

**JORDAN:** This was probably the most interesting part of the call, Alex. Schwarzman was pretty fired up about what he called "external assertions" ranging from systemic risk concerns...]]>564falsefullhttps://www.spreaker.com/episode/american-express-q1-2026-earnings-analysis--71606372
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to break down American Express's first quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex! And wow, what a quarter for Amex. They came out swinging with some impressive numbers that really caught my attention.

**ALEX:** Absolutely, Jordan. Let's start with the headline figures. Revenue jumped 11% year-over-year, or 10% on an FX-adjusted basis. But here's what really stands out - earnings per share of $4.28, up 18% from the prior year. That's some serious momentum.

**JORDAN:** What's particularly striking to me is the spending growth. Card member spending was up 10% - and Alex, this is their highest quarterly growth in three years. That's not just a good number, that's a statement about the strength of their premium customer base.

**ALEX:** Exactly. And speaking of premium customers, the Platinum card refresh is really paying dividends. CEO Stephen Squeri mentioned they're seeing accelerated spend growth from that portfolio while maintaining high retention rates even after fee increases. That's the holy grail in the credit card business - raising prices and keeping customers happy.

**JORDAN:** The international business deserves a callout too. Twenty consecutive quarters of double-digit growth on an FX-adjusted basis. That's consistency you don't see very often. And here's something interesting - over 70% of new accounts globally are fee-paying products. They're not just growing, they're growing profitably.

**ALEX:** Now Jordan, let's talk about some of the strategic moves. The NFL partnership announcement really caught my eye. Starting in 2026, American Express becomes the league's official payments partner. Given the NFL's international expansion plans, this could be huge for Amex's global reach.

**JORDAN:** That's smart positioning, Alex. But what really excites me is their commercial business expansion. They announced a roadmap for eight new or enhanced products for businesses - the biggest commercial product expansion in company history. The new Graphite Business Cash Unlimited card and expense management software could be game-changers in the B2B space.

**ALEX:** And we can't ignore the AI story. The ACE Developer Kit - Amex Agentic Commerce Experiences - is fascinating. They're positioning themselves at the forefront of AI-powered transactions with what they call "Amex Agent Purchase Protection."

**JORDAN:** Right, and Squeri made a compelling case during the Q&A about why their closed-loop network gives them an advantage in this space. He said "data is king" in the agentic world, and Amex has end-to-end transaction visibility that their competitors lack. That could be a significant moat.

**ALEX:** Let's dig into some of the more granular details. Luxury retail spending was up 18% - that's a clear indicator their affluent customer base is still spending freely. Restaurant spending up 20%, lodging on their premium hotel programs up 50%. These aren't just numbers, they're showing real engagement with Amex's value proposition.

**JORDAN:** And the credit quality remains pristine. Both delinquency and write-off rates are still below 2019 levels. CFO Christophe Le Caillec mentioned write-off dollars are only up 4% year-over-year while net interest income is growing at double-digit pace. That's impressive risk management.

**ALEX:** Now, one thing that stood out in the Q&A was the discussion about younger customers. There was a question about whether millennials and Gen Z would be more sensitive to economic volatility. Squeri's response was fa

This episode includes AI-generated content.]]>SP100-AXP-Q1-2026-enFri, 24 Apr 2026 06:04:23 +0000trueBeta Finch# Beta Finch Podcast Script: American Express Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to break down...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to break down American Express's first quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex! And wow, what a quarter for Amex. They came out swinging with some impressive numbers that really caught my attention.

**ALEX:** Absolutely, Jordan. Let's start with the headline figures. Revenue jumped 11% year-over-year, or 10% on an FX-adjusted basis. But here's what really stands out - earnings per share of $4.28, up 18% from the prior year. That's some serious momentum.

**JORDAN:** What's particularly striking to me is the spending growth. Card member spending was up 10% - and Alex, this is their highest quarterly growth in three years. That's not just a good number, that's a statement about the strength of their premium customer base.

**ALEX:** Exactly. And speaking of premium customers, the Platinum card refresh is really paying dividends. CEO Stephen Squeri mentioned they're seeing accelerated spend growth from that portfolio while maintaining high retention rates even after fee increases. That's the holy grail in the credit card business - raising prices and keeping customers happy.

**JORDAN:** The international business deserves a callout too. Twenty consecutive quarters of double-digit growth on an FX-adjusted basis. That's consistency you don't see very often. And here's something interesting - over 70% of new accounts globally are fee-paying products. They're not just growing, they're growing profitably.

**ALEX:** Now Jordan, let's talk about some of the strategic moves. The NFL partnership announcement really caught my eye. Starting in 2026, American Express becomes the league's official payments partner. Given the NFL's international expansion plans, this could be huge for Amex's global reach.

**JORDAN:** That's smart positioning, Alex. But what really excites me is their commercial business expansion. They announced a roadmap for eight new or enhanced products for businesses - the biggest commercial product expansion in company history. The new Graphite Business Cash Unlimited card and expense management software could be game-changers in the B2B space.

**ALEX:** And we can't ignore the AI story. The ACE Developer Kit - Amex Agentic Commerce Experiences - is fascinating. They're positioning themselves at the forefront of AI-powered transactions with what they call "Amex Agent Purchase Protection."

**JORDAN:** Right, and Squeri made a compelling case during the Q&A about why their closed-loop network gives them an advantage in this space. He said "data is king" in the agentic world, and Amex has end-to-end transaction visibility that their competitors lack. That could be a significant moat.

**ALEX:** Let's dig into some of the more granular details. Luxury retail spending was up 18% - that's a clear indicator their affluent customer base is still spending freely. Restaurant spending up 20%, lodging on their premium hotel programs up 50%. These aren't just numbers, they're showing real engagement with Amex's value proposition.

**JORDAN:** And the credit quality remains pristine. Both delinquency and write-off rates are still below 2019 levels. CFO Christophe Le Caillec mentioned write-off dollars are only up 4% year-over-year while net interest income is growing at double-digit pace. That's impressive risk management.

**ALEX:** Now, one thing that stood out in the Q&A was the discussion about younger...]]>452falsefullhttps://www.spreaker.com/episode/raytheon-technologies-q1-2026-earnings-analysis--71534081
**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into RTX's first quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. RTX, the aerospace and defense giant formerly known as Raytheon Technologies, just delivered some impressive Q1 numbers. We're talking about a company that's riding high on both commercial aerospace recovery and defense spending surge. Should be a fascinating discussion.

**ALEX:** Absolutely. Let's start with the headline numbers because they're pretty striking. RTX posted adjusted sales of $22.1 billion - that's up 10% organically year-over-year. Even more impressive, adjusted earnings per share came in at $1.78, up a hefty 21% from last year.

**JORDAN:** And don't forget that record backlog, Alex. We're looking at $271 billion in backlog, up 25% year-over-year. That's a massive number that really speaks to the long-term demand they're seeing across both commercial and defense segments.

**ALEX:** Right, and CEO Christopher Calio was pretty clear about what's driving this growth. They're seeing strength across all three channels - commercial OE up 6%, commercial aftermarket up 14%, and defense up 9%. But Jordan, what really caught my attention was how confident they were about raising guidance.

**JORDAN:** Exactly. They bumped up their full-year adjusted sales outlook by $500 million to a range of $92.5 to $93.5 billion. And they raised EPS guidance by 10 cents on both ends - now expecting $6.70 to $6.90 for the year. That's management basically saying "we see sustained momentum ahead."

**ALEX:** Let's break this down by segment because each business has its own story. Starting with Raytheon - their defense segment - this was really the star of the show, wasn't it?

**JORDAN:** Oh absolutely. Raytheon posted $6.9 billion in sales, up 10%, with operating profit jumping $167 million year-over-year. But here's what's really exciting - they booked $6.6 billion in awards during the quarter. We're talking major contracts like over $600 million to supply the Netherlands with Patriot equipment.

**ALEX:** And those framework agreements Calio mentioned - these are game-changers. Five landmark agreements with the Department of Defense for critical munitions including Tomahawk, AMRAAM, and Standard Missiles. Once finalized, these provide long-term visibility that lets RTX and their suppliers invest in ramping production well above existing rates.

**JORDAN:** The geopolitical backdrop here is crucial, Alex. With ongoing conflicts and tensions globally, there's this urgent need for munitions depth and integrated air defense systems. RTX is perfectly positioned with their battle-tested systems that form the backbone of U.S. and allied defense architectures.

**ALEX:** Now let's talk about their commercial aerospace business, particularly the GTF engine program at Pratt & Whitney. This has been a challenging story, but there are some positive developments.

**JORDAN:** The fleet management plan remains on track, which is reassuring. AOGs - that's aircraft on ground - were down about 15% compared to year-end. The key driver was MRO output on the PW1100, which jumped 23% year-over-year. They're making real progress working through the powder metal issues that have plagued this program.

**ALEX:** And they achieved a significant milestone with aircraft certification of the GTF Advantage. This incorporates a decade of learning and should deliver better performance and time on wing for customers. The "Hot Section Plus" retrofit package should provide 95% of the Advantage's durability benefits.

**JORDAN:** Collins Aerospace also had a solid

This episode includes AI-generated content.]]>SP100-RTX-Q1-2026-enTue, 21 Apr 2026 21:35:25 +0000trueBeta Finch# Beta Finch Podcast Script: RTX Q1 2026 Earnings Breakdown **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into RTX's first quarter 2026 results. This podcast is...
**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into RTX's first quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. RTX, the aerospace and defense giant formerly known as Raytheon Technologies, just delivered some impressive Q1 numbers. We're talking about a company that's riding high on both commercial aerospace recovery and defense spending surge. Should be a fascinating discussion.

**ALEX:** Absolutely. Let's start with the headline numbers because they're pretty striking. RTX posted adjusted sales of $22.1 billion - that's up 10% organically year-over-year. Even more impressive, adjusted earnings per share came in at $1.78, up a hefty 21% from last year.

**JORDAN:** And don't forget that record backlog, Alex. We're looking at $271 billion in backlog, up 25% year-over-year. That's a massive number that really speaks to the long-term demand they're seeing across both commercial and defense segments.

**ALEX:** Right, and CEO Christopher Calio was pretty clear about what's driving this growth. They're seeing strength across all three channels - commercial OE up 6%, commercial aftermarket up 14%, and defense up 9%. But Jordan, what really caught my attention was how confident they were about raising guidance.

**JORDAN:** Exactly. They bumped up their full-year adjusted sales outlook by $500 million to a range of $92.5 to $93.5 billion. And they raised EPS guidance by 10 cents on both ends - now expecting $6.70 to $6.90 for the year. That's management basically saying "we see sustained momentum ahead."

**ALEX:** Let's break this down by segment because each business has its own story. Starting with Raytheon - their defense segment - this was really the star of the show, wasn't it?

**JORDAN:** Oh absolutely. Raytheon posted $6.9 billion in sales, up 10%, with operating profit jumping $167 million year-over-year. But here's what's really exciting - they booked $6.6 billion in awards during the quarter. We're talking major contracts like over $600 million to supply the Netherlands with Patriot equipment.

**ALEX:** And those framework agreements Calio mentioned - these are game-changers. Five landmark agreements with the Department of Defense for critical munitions including Tomahawk, AMRAAM, and Standard Missiles. Once finalized, these provide long-term visibility that lets RTX and their suppliers invest in ramping production well above existing rates.

**JORDAN:** The geopolitical backdrop here is crucial, Alex. With ongoing conflicts and tensions globally, there's this urgent need for munitions depth and integrated air defense systems. RTX is perfectly positioned with their battle-tested systems that form the backbone of U.S. and allied defense architectures.

**ALEX:** Now let's talk about their commercial aerospace business, particularly the GTF engine program at Pratt & Whitney. This has been a challenging story, but there are some positive developments.

**JORDAN:** The fleet management plan remains on track, which is reassuring. AOGs - that's aircraft on ground - were down about 15% compared to year-end. The key driver was MRO output on the PW1100, which jumped 23% year-over-year. They're making real progress working through the powder metal issues that have plagued this program.

**ALEX:** And they achieved a significant milestone with aircraft certification of the GTF Advantage. This incorporates a decade of learning and should deliver better performance and time on wing for customers. The "Hot...]]>521falsefullhttps://www.spreaker.com/episode/jpmorgan-chase-q1-2026-earnings-analysis--71534079
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into JPMorgan Chase's Q1 2026 earnings, and wow, what a quarter this was.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because JPMorgan absolutely crushed it this quarter.

**ALEX**: They really did, Jordan. Net income hit $16.5 billion with earnings per share of $5.94 - that's a return on tangible common equity of 23%. Revenue came in at $50.5 billion, up 10% year-over-year. These are the kind of numbers that make other banks jealous.

**JORDAN**: What's really impressive is how broad-based this strength was. Markets revenue was particularly strong, along with Asset Management and Investment Banking fees. But here's the thing - while revenue grew 10%, expenses jumped 14% to $26.9 billion. That caught my attention.

**ALEX**: Good eye, Jordan. Jeremy Barnum, the CFO, explained that the expense growth was largely driven by higher compensation - including revenue-related comp - and growth in front office employees. Essentially, they're paying more because they're making more. It's what Jamie Dimon calls "good expense growth."

**JORDAN**: Speaking of Jamie Dimon, he made some fascinating comments about the competitive landscape. There was this whole discussion about their new AI cash management tool that's getting a lot of attention. Some analysts are worried it could pressure deposits across the industry.

**ALEX**: Right, but Dimon had a very measured response. He basically said, "Look, competition for deposits has always been intense. This is just us trying to help our customers manage their money better." He quoted Jeff Bezos: "Your margin is my opportunity," suggesting they're comfortable with creating more competition if it serves customers better.

**JORDAN**: Now let's talk about the elephant in the room - regulatory capital requirements. This was a major theme throughout the call, and frankly, JPMorgan is not happy about the proposed Basel III and G-SIB surcharge changes.

**ALEX**: This is huge, Jordan. Barnum laid out some pretty stark numbers. While other large banks might see about a 5% reduction in capital requirements under the new rules, JPMorgan is looking at a 4% INCREASE. That translates to roughly $20 billion in additional G-SIB capital requirements based on their current balance sheet.

**JORDAN**: And Dimon was particularly fired up about this. He said they'll have to find ways to "arbitrage" around these rules to serve clients properly, which he admitted he doesn't like doing. The concern is that these rules could make JPMorgan less competitive both domestically against smaller banks and internationally.

**ALEX**: Let's shift to the business segments. The Corporate and Investment Bank was a real standout - net income of $9 billion on revenue of $23.4 billion, up 19% year-over-year. Investment banking fees were up 28%, driven by strong M&A and equity underwriting activity.

**JORDAN**: The trading business continues to be remarkably consistent. Fixed income was up 21%, equities up 17%. When asked about this sustained strength, Dimon gave a great analogy - he compared it to Home Depot managing inventory. "They don't call it trading, but there's that element of risk management there."

**ALEX**: What I found interesting was their discussion of balance sheet growth. A lot of the growth this quarter came from the Markets business - about $60 billion in risk-weighted assets. But Barnum was quick to point out this was mostly seasonal, low-risk dens

This episode includes AI-generated content.]]>SP100-JPM-Q1-2026-enTue, 21 Apr 2026 21:35:19 +0000trueBeta Finch# Beta Finch Podcast Script: JPMorgan Chase Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex. **JORDAN**: And I'm Jordan. Today we're...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into JPMorgan Chase's Q1 2026 earnings, and wow, what a quarter this was.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because JPMorgan absolutely crushed it this quarter.

**ALEX**: They really did, Jordan. Net income hit $16.5 billion with earnings per share of $5.94 - that's a return on tangible common equity of 23%. Revenue came in at $50.5 billion, up 10% year-over-year. These are the kind of numbers that make other banks jealous.

**JORDAN**: What's really impressive is how broad-based this strength was. Markets revenue was particularly strong, along with Asset Management and Investment Banking fees. But here's the thing - while revenue grew 10%, expenses jumped 14% to $26.9 billion. That caught my attention.

**ALEX**: Good eye, Jordan. Jeremy Barnum, the CFO, explained that the expense growth was largely driven by higher compensation - including revenue-related comp - and growth in front office employees. Essentially, they're paying more because they're making more. It's what Jamie Dimon calls "good expense growth."

**JORDAN**: Speaking of Jamie Dimon, he made some fascinating comments about the competitive landscape. There was this whole discussion about their new AI cash management tool that's getting a lot of attention. Some analysts are worried it could pressure deposits across the industry.

**ALEX**: Right, but Dimon had a very measured response. He basically said, "Look, competition for deposits has always been intense. This is just us trying to help our customers manage their money better." He quoted Jeff Bezos: "Your margin is my opportunity," suggesting they're comfortable with creating more competition if it serves customers better.

**JORDAN**: Now let's talk about the elephant in the room - regulatory capital requirements. This was a major theme throughout the call, and frankly, JPMorgan is not happy about the proposed Basel III and G-SIB surcharge changes.

**ALEX**: This is huge, Jordan. Barnum laid out some pretty stark numbers. While other large banks might see about a 5% reduction in capital requirements under the new rules, JPMorgan is looking at a 4% INCREASE. That translates to roughly $20 billion in additional G-SIB capital requirements based on their current balance sheet.

**JORDAN**: And Dimon was particularly fired up about this. He said they'll have to find ways to "arbitrage" around these rules to serve clients properly, which he admitted he doesn't like doing. The concern is that these rules could make JPMorgan less competitive both domestically against smaller banks and internationally.

**ALEX**: Let's shift to the business segments. The Corporate and Investment Bank was a real standout - net income of $9 billion on revenue of $23.4 billion, up 19% year-over-year. Investment banking fees were up 28%, driven by strong M&A and equity underwriting activity.

**JORDAN**: The trading business continues to be remarkably consistent. Fixed income was up 21%, equities up 17%. When asked about this sustained strength, Dimon gave a great analogy - he compared it to Home Depot managing inventory. "They don't call it trading, but there's that element of risk management there."

**ALEX**: What I found interesting was their discussion of balance sheet growth. A lot of the growth this...]]>530falsefullhttps://www.spreaker.com/episode/unitedhealth-q1-2026-earnings-analysis--71525774
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into United Health Group's Q1 2026 results, and wow - this was a strong quarter across the board.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, UNH just reported adjusted earnings per share of $7.23 for Q1, which was well ahead of expectations. They're now guiding for full-year adjusted EPS above $18.25. That's a pretty confident raise this early in the year.

**ALEX:** It really is. And what I found interesting is that all four of their major business segments exceeded their internal plans. Revenue came in at $111.7 billion, which is 2% growth year-over-year. Now, that might seem modest, but remember - they've been very focused on disciplined pricing over growth this year.

**JORDAN:** Right, and that strategy seems to be paying off. Their medical care ratio improved to 83.9% from 84.8% last year. CEO Andrew Witty was pretty clear that 2026 was about "margin recovery and product stability" rather than chasing membership growth. Sometimes you've got to take a step back to take two steps forward.

**ALEX:** Exactly. And speaking of stepping back, they've made some major strategic moves. They completed their exit from all non-U.S. businesses and refreshed nearly half of their top 100 leadership roles. This is clearly a company that's refocusing on its core strengths.

**JORDAN:** The OptumHealth story is particularly interesting here. They reported $1.3 billion in adjusted earnings, which was significantly higher than expected. CFO Wayne DeVeydt mentioned that all segments exceeded their internal plans, but OptumHealth really stood out.

**ALEX:** What caught my attention was how they're improving their value-based care model. Krista Nelson from OptumHealth gave a great example - in their West Region, they increased clinical reviews by over 50% and saw a 35% reduction in skilled nursing facility admissions compared to last year. That's the kind of operational improvement that directly impacts the bottom line.

**JORDAN:** And it makes sense from a patient care perspective too. They're serving over 20 million people in their OptumHealth care models, with 4 million in fully value-based arrangements. The research they cited showed 24% fewer hospital admissions and 29% fewer ER visits for patients in value-based care versus traditional Medicare.

**ALEX:** Now let's talk about the elephant in the room - medical cost trends. This has been a big concern for the entire managed care industry. Tim Noel, who runs UnitedHealthcare, said trends are "progressing in line with expectations" and they're seeing "modest favorability in government programs."

**JORDAN:** That's key because they've been dealing with elevated medical trends running around 7-8% in Medicare Advantage, and they priced for about 10% increases coming into 2026. If trends are coming in a bit better than expected, that's a real positive for margins going forward.

**ALEX:** Let's pivot to their AI strategy because this is where things get really interesting for the long term. They're investing nearly $1.5 billion in AI-related initiatives in 2026. That's not just throwing money at the latest tech trend - they're being very strategic about it.

**JORDAN:** Sandeep Dadlani broke down how they're spending that $1.5 billion - about a third goes to software products and platforms, accelerating OptumInsight's transition to AI-first services. The other two-thirds is spread across core processes throughout the company.

**ALEX:** They launched "Avery," a generative AI chatbot for member questi

This episode includes AI-generated content.]]>SP100-UNH-Q1-2026-enTue, 21 Apr 2026 16:37:10 +0000trueBeta Finch**Beta Finch Podcast Script: United Health Group Q1 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into United Health Group's Q1 2026 results, and...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into United Health Group's Q1 2026 results, and wow - this was a strong quarter across the board.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, UNH just reported adjusted earnings per share of $7.23 for Q1, which was well ahead of expectations. They're now guiding for full-year adjusted EPS above $18.25. That's a pretty confident raise this early in the year.

**ALEX:** It really is. And what I found interesting is that all four of their major business segments exceeded their internal plans. Revenue came in at $111.7 billion, which is 2% growth year-over-year. Now, that might seem modest, but remember - they've been very focused on disciplined pricing over growth this year.

**JORDAN:** Right, and that strategy seems to be paying off. Their medical care ratio improved to 83.9% from 84.8% last year. CEO Andrew Witty was pretty clear that 2026 was about "margin recovery and product stability" rather than chasing membership growth. Sometimes you've got to take a step back to take two steps forward.

**ALEX:** Exactly. And speaking of stepping back, they've made some major strategic moves. They completed their exit from all non-U.S. businesses and refreshed nearly half of their top 100 leadership roles. This is clearly a company that's refocusing on its core strengths.

**JORDAN:** The OptumHealth story is particularly interesting here. They reported $1.3 billion in adjusted earnings, which was significantly higher than expected. CFO Wayne DeVeydt mentioned that all segments exceeded their internal plans, but OptumHealth really stood out.

**ALEX:** What caught my attention was how they're improving their value-based care model. Krista Nelson from OptumHealth gave a great example - in their West Region, they increased clinical reviews by over 50% and saw a 35% reduction in skilled nursing facility admissions compared to last year. That's the kind of operational improvement that directly impacts the bottom line.

**JORDAN:** And it makes sense from a patient care perspective too. They're serving over 20 million people in their OptumHealth care models, with 4 million in fully value-based arrangements. The research they cited showed 24% fewer hospital admissions and 29% fewer ER visits for patients in value-based care versus traditional Medicare.

**ALEX:** Now let's talk about the elephant in the room - medical cost trends. This has been a big concern for the entire managed care industry. Tim Noel, who runs UnitedHealthcare, said trends are "progressing in line with expectations" and they're seeing "modest favorability in government programs."

**JORDAN:** That's key because they've been dealing with elevated medical trends running around 7-8% in Medicare Advantage, and they priced for about 10% increases coming into 2026. If trends are coming in a bit better than expected, that's a real positive for margins going forward.

**ALEX:** Let's pivot to their AI strategy because this is where things get really interesting for the long term. They're investing nearly $1.5 billion in AI-related initiatives in 2026. That's not just throwing money at the latest tech trend - they're being very strategic about it.

**JORDAN:** Sandeep Dadlani broke down how they're spending that $1.5 billion - about a third goes to software products and platforms, accelerating OptumInsight's transition to AI-first...]]>530falsefullhttps://www.spreaker.com/episode/3m-q1-2026-earnings-analysis--71525772
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into 3M's first quarter 2026 results. Jordan, this was quite an interesting call from the industrial giant.

JORDAN: Absolutely, Alex. And before we jump in, I want to remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk 3M. The headline numbers were pretty solid - earnings per share of $2.14, up mid-teens from last year, and operating margins improved 30 basis points to 23.8%. But the revenue story was a bit more nuanced, wasn't it?

JORDAN: That's right. Organic growth came in at just 1.2% for the quarter, which CEO Bill Brown called a "light start to the year." But here's what caught my attention - orders were up over 10%, and backlog grew double digits both sequentially and year-over-year. That's typically a good leading indicator.

ALEX: And Brown seemed pretty confident about that acceleration, didn't he? He kept emphasizing that they expect growth to pick up in Q2 and the back half of the year. What do you think is driving that optimism?

JORDAN: Well, there are a few factors. First, they're seeing strong momentum in what they call their "commercial excellence" initiatives - basically better sales effectiveness and reduced customer churn. They've already captured $80 million of new business against a three-year target of $100 million. Plus, they're launching new products at an accelerated pace - 84 new products in Q1, up 35% from last year.

ALEX: I was fascinated by their AI initiatives. They mentioned using AI tools to analyze sales data and create customized coaching plans for sales managers. And there's this "Ask 3M Company" AI assistant that helps customers find solutions. It feels like they're really embracing technology to drive growth.

JORDAN: Absolutely. And speaking of technology, one of the most interesting parts of the call was their discussion of the data center business. They highlighted expanded beam optics - or EBO - which is apparently a high-performance optical connector for data centers. With hyperscaler validation and what they called a "billion-dollar-plus addressable market," they're investing to more than double capacity.

ALEX: That ties into the broader AI and data center boom we're seeing across the market. But let's talk about some of the challenges. They mentioned softness in consumer electronics and automotive, which affected about 40% of their portfolio.

JORDAN: Right, and this is where the story gets interesting from a portfolio management perspective. Brown talked about how roughly 60% of their businesses showed strength, while 40% faced macro headwinds. In electronics, they saw strong performance in semiconductors and data centers, but consumer electronics was soft due to what they called "industry-wide memory chip issues."

ALEX: And then there was this interesting discussion about pre-buying. CFO Anurag Maheshwari and Brown acknowledged that some of the strong order growth might have been customers buying ahead of price increases. How significant do you think that was?

JORDAN: It's hard to quantify, but they seemed to suggest it was a factor. They're implementing price increases due to rising oil costs - about $125 million of cost impact that they're offsetting with roughly 50 basis points of additional pricing. Brown mentioned they learned from their experience with tariffs and are moving much faster on pricing this time.

ALEX: Let's talk about their operational transformation. They're really reshaping this company, aren't they? They mentioned reducing their manufacturing footprint to below 100 facilities.

JORDAN: That's a major shift. They closed or announ

This episode includes AI-generated content.]]>SP100-MMM-Q1-2026-enTue, 21 Apr 2026 16:37:05 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into 3M's first quarter 2026 results. Jordan, this was quite an interesting call from the...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into 3M's first quarter 2026 results. Jordan, this was quite an interesting call from the industrial giant.

JORDAN: Absolutely, Alex. And before we jump in, I want to remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk 3M. The headline numbers were pretty solid - earnings per share of $2.14, up mid-teens from last year, and operating margins improved 30 basis points to 23.8%. But the revenue story was a bit more nuanced, wasn't it?

JORDAN: That's right. Organic growth came in at just 1.2% for the quarter, which CEO Bill Brown called a "light start to the year." But here's what caught my attention - orders were up over 10%, and backlog grew double digits both sequentially and year-over-year. That's typically a good leading indicator.

ALEX: And Brown seemed pretty confident about that acceleration, didn't he? He kept emphasizing that they expect growth to pick up in Q2 and the back half of the year. What do you think is driving that optimism?

JORDAN: Well, there are a few factors. First, they're seeing strong momentum in what they call their "commercial excellence" initiatives - basically better sales effectiveness and reduced customer churn. They've already captured $80 million of new business against a three-year target of $100 million. Plus, they're launching new products at an accelerated pace - 84 new products in Q1, up 35% from last year.

ALEX: I was fascinated by their AI initiatives. They mentioned using AI tools to analyze sales data and create customized coaching plans for sales managers. And there's this "Ask 3M Company" AI assistant that helps customers find solutions. It feels like they're really embracing technology to drive growth.

JORDAN: Absolutely. And speaking of technology, one of the most interesting parts of the call was their discussion of the data center business. They highlighted expanded beam optics - or EBO - which is apparently a high-performance optical connector for data centers. With hyperscaler validation and what they called a "billion-dollar-plus addressable market," they're investing to more than double capacity.

ALEX: That ties into the broader AI and data center boom we're seeing across the market. But let's talk about some of the challenges. They mentioned softness in consumer electronics and automotive, which affected about 40% of their portfolio.

JORDAN: Right, and this is where the story gets interesting from a portfolio management perspective. Brown talked about how roughly 60% of their businesses showed strength, while 40% faced macro headwinds. In electronics, they saw strong performance in semiconductors and data centers, but consumer electronics was soft due to what they called "industry-wide memory chip issues."

ALEX: And then there was this interesting discussion about pre-buying. CFO Anurag Maheshwari and Brown acknowledged that some of the strong order growth might have been customers buying ahead of price increases. How significant do you think that was?

JORDAN: It's hard to quantify, but they seemed to suggest it was a factor. They're implementing price increases due to rising oil costs - about $125 million of cost impact that they're offsetting with roughly 50 basis points of additional pricing. Brown mentioned they learned from their experience with tariffs and are moving much faster on pricing this time.

ALEX: Let's talk about their operational transformation. They're really reshaping this company,...]]>541falsefullhttps://www.spreaker.com/episode/general-electric-q1-2026-earnings-analysis--71525769
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to unpack GE Aerospace's first quarter 2026 results.

**JORDAN**: Hey everyone! And before we jump in, Alex, we need to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely, Jordan. Now, let's talk about GE Aerospace - and wow, what a quarter this was! The aerospace giant just delivered some seriously impressive numbers despite operating in what CEO Larry Culp called "a dynamic geopolitical environment."

**JORDAN**: Right off the bat, Alex, these top-line numbers are eye-popping. Orders up 87% - that's not a typo, folks - with their Commercial Engines & Services segment nearly doubling. Revenue jumped 29%, operating profit grew 18%, and earnings per share increased 25% to $1.86.

**ALEX**: And let's not forget free cash flow up 14% to $1.7 billion. But Jordan, what really caught my attention was how they're navigating the Middle East conflict. They're being pretty transparent about the headwinds - reducing their full-year air traffic departures outlook from mid-single-digit growth to flat to low single-digit growth.

**JORDAN**: That's a great point, Alex. It shows mature management recognizing reality while still delivering strong results. What's fascinating is their services backlog - over $170 billion, up nearly $30 billion since 2024. That's incredible visibility for a cyclical business.

**ALEX**: Speaking of services, their spare parts business is absolutely on fire. Demand is so strong that they're actually seeing delinquencies - meaning they can't ship parts fast enough to meet demand. Spare parts orders are up over 30% year-over-year, and they're entering Q2 with more than 95% of spare parts revenue already in backlog.

**JORDAN**: It's almost a good problem to have, right? Though I'm sure their customers don't love waiting for parts. What really stood out to me was their "Flight Deck" initiative - this is their digital transformation program that's apparently changing how they operate. They gave some concrete examples, like helping a supplier increase output by over 40% and reducing LEAP engine repair times by over 50%.

**ALEX**: That's the kind of operational excellence that creates lasting competitive advantages. And speaking of competitive advantages, let's talk about their market position. They've got 80,000 engines in their fleet with more than 2.3 billion flight hours of experience.

**JORDAN**: Plus they're investing heavily in the future - $1 billion in U.S. manufacturing for the second consecutive year, plus $100 million in supplier equipment and tooling. They're not just managing the present; they're building for the next decade.

**ALEX**: Now, let's dig into the segments. Commercial Engines & Services saw orders grow 93%, with services up 49% and equipment more than tripling. Their LEAP engine program continues to be a star performer with deliveries up 63%.

**JORDAN**: And on the defense side - Defense & Propulsion Technologies had orders up 67%, including a massive $1.4 billion contract for T408 engines for the Marine Corps. This is their second consecutive quarter with defense book-to-bill above 2, which means they're winning more new business than they're delivering.

**ALEX**: The Q&A session revealed some interesting insights too. When asked about potential prebuying by customers ahead of disruptions, CEO Culp was pretty clear - they're not seeing that behavior. The strength is genuine demand, not artificial pulling forward of orders.

**JORDAN**: What I found reassuring was their discussion about airline retirements. CFM56 retir

This episode includes AI-generated content.]]>SP100-GE-Q1-2026-enTue, 21 Apr 2026 16:37:00 +0000trueBeta Finch# Beta Finch Podcast Script: GE Aerospace Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to unpack GE Aerospace's first...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to unpack GE Aerospace's first quarter 2026 results.

**JORDAN**: Hey everyone! And before we jump in, Alex, we need to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely, Jordan. Now, let's talk about GE Aerospace - and wow, what a quarter this was! The aerospace giant just delivered some seriously impressive numbers despite operating in what CEO Larry Culp called "a dynamic geopolitical environment."

**JORDAN**: Right off the bat, Alex, these top-line numbers are eye-popping. Orders up 87% - that's not a typo, folks - with their Commercial Engines & Services segment nearly doubling. Revenue jumped 29%, operating profit grew 18%, and earnings per share increased 25% to $1.86.

**ALEX**: And let's not forget free cash flow up 14% to $1.7 billion. But Jordan, what really caught my attention was how they're navigating the Middle East conflict. They're being pretty transparent about the headwinds - reducing their full-year air traffic departures outlook from mid-single-digit growth to flat to low single-digit growth.

**JORDAN**: That's a great point, Alex. It shows mature management recognizing reality while still delivering strong results. What's fascinating is their services backlog - over $170 billion, up nearly $30 billion since 2024. That's incredible visibility for a cyclical business.

**ALEX**: Speaking of services, their spare parts business is absolutely on fire. Demand is so strong that they're actually seeing delinquencies - meaning they can't ship parts fast enough to meet demand. Spare parts orders are up over 30% year-over-year, and they're entering Q2 with more than 95% of spare parts revenue already in backlog.

**JORDAN**: It's almost a good problem to have, right? Though I'm sure their customers don't love waiting for parts. What really stood out to me was their "Flight Deck" initiative - this is their digital transformation program that's apparently changing how they operate. They gave some concrete examples, like helping a supplier increase output by over 40% and reducing LEAP engine repair times by over 50%.

**ALEX**: That's the kind of operational excellence that creates lasting competitive advantages. And speaking of competitive advantages, let's talk about their market position. They've got 80,000 engines in their fleet with more than 2.3 billion flight hours of experience.

**JORDAN**: Plus they're investing heavily in the future - $1 billion in U.S. manufacturing for the second consecutive year, plus $100 million in supplier equipment and tooling. They're not just managing the present; they're building for the next decade.

**ALEX**: Now, let's dig into the segments. Commercial Engines & Services saw orders grow 93%, with services up 49% and equipment more than tripling. Their LEAP engine program continues to be a star performer with deliveries up 63%.

**JORDAN**: And on the defense side - Defense & Propulsion Technologies had orders up 67%, including a massive $1.4 billion contract for T408 engines for the Marine Corps. This is their second consecutive quarter with defense book-to-bill above 2, which means they're winning more new business than they're delivering.

**ALEX**: The Q&A session revealed some interesting insights too. When asked about potential prebuying by customers ahead of disruptions, CEO Culp was pretty clear - they're not seeing that behavior. The strength is genuine demand, not...]]>498falsefullhttps://www.spreaker.com/episode/chubb-q4-2025-earnings-analysis--71525766
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the markets one quarter at a time. I'm Alex, and I'm here with my co-host Jordan. Today we're diving into Chubb's absolutely stellar Q4 2025 results.

But before we get started, I need to share an important note: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Chubb just delivered what CEO Evan Greenberg called "another record year" - and the numbers definitely back that up.

**JORDAN**: Absolutely, Alex. These results are genuinely impressive across the board. Let's start with the headline numbers - Chubb posted core operating income of nearly $3 billion for Q4, or $7.52 per share. That's up 22% and 25% respectively. For the full year, they hit just under $10 billion in operating income, or $24.79 per share.

**ALEX**: That's massive growth. And what caught my eye is how broad-based this performance was. They had record results from all three major income sources - P&C underwriting, investment income, and life insurance.

**JORDAN**: Right, and their P&C combined ratio hit a record low of 81.2% for the quarter and 85.7% for the full year. That's exceptional underwriting performance, especially when you consider they still had $2.9 billion in catastrophe losses for the year - largely from those California wildfires in Q1.

**ALEX**: Let's talk about growth, because the premium numbers tell a really interesting geographic story. Total company premiums grew over 6.5% for the year, but when you dig into the international business, that's where things get exciting.

**JORDAN**: Exactly. Their international P&C business, which they call "overseas general," was up 10.8% in Q4. But here's what's really compelling - their consumer lines in that international segment grew 18.7%. Latin America was particularly strong at 14.7% growth, and Asia grew 13%.

**ALEX**: And Greenberg gave some great color on this during the Q&A. He talked about their partnerships with major banks - Banco de Chile in Chile, Nubank in Brazil for digital distribution, Banco Guayaquil in Ecuador. It sounds like they're building these local distribution networks that are really paying off.

**JORDAN**: What I found interesting is how he characterized these markets. He called them "developing and mature market regions" and emphasized that while there's volatility, the long-term trend line is up, especially for Asia. He also made the point that it's "hard yards" to build these local franchises - you can't just parachute in with a couple of underwriters.

**ALEX**: Speaking of hard work paying off, let's talk about their digital transformation initiative. This was fascinating - they're targeting 150 basis points of combined ratio improvement over the next 3-4 years through digital transformation.

**JORDAN**: And Greenberg was pretty specific about this. He said most of it comes from the expense side - both operating expenses and cost of claims. They're focused on nine to ten discrete transformation projects across North America, UK, Europe, and their larger Asian and Latin American markets. It's covering technology, data, AI, and analytics.

**ALEX**: The other big story here is their investment income. They hit a record $1.8 billion in adjusted net investment income for Q4, up 7.3%. Their fixed income portfolio yield is now 5.1%, and they're getting new money at rates slightly above that.

**JORDAN**: That investment performance is crucial because their invested assets now stand at $169 billion, up from $151 billion a year ago. And they're planning to increase their private investment allocation from 12% to 15% over the medium term, which should help boost returns further.

**ALEX**: Now, let's address the elephant in the room - the co

This episode includes AI-generated content.]]>SP100-CB-Q4-2025-enTue, 21 Apr 2026 16:36:55 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the markets one quarter at a time. I'm Alex, and I'm here with my co-host Jordan. Today we're diving into Chubb's absolutely...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the markets one quarter at a time. I'm Alex, and I'm here with my co-host Jordan. Today we're diving into Chubb's absolutely stellar Q4 2025 results.

But before we get started, I need to share an important note: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Chubb just delivered what CEO Evan Greenberg called "another record year" - and the numbers definitely back that up.

**JORDAN**: Absolutely, Alex. These results are genuinely impressive across the board. Let's start with the headline numbers - Chubb posted core operating income of nearly $3 billion for Q4, or $7.52 per share. That's up 22% and 25% respectively. For the full year, they hit just under $10 billion in operating income, or $24.79 per share.

**ALEX**: That's massive growth. And what caught my eye is how broad-based this performance was. They had record results from all three major income sources - P&C underwriting, investment income, and life insurance.

**JORDAN**: Right, and their P&C combined ratio hit a record low of 81.2% for the quarter and 85.7% for the full year. That's exceptional underwriting performance, especially when you consider they still had $2.9 billion in catastrophe losses for the year - largely from those California wildfires in Q1.

**ALEX**: Let's talk about growth, because the premium numbers tell a really interesting geographic story. Total company premiums grew over 6.5% for the year, but when you dig into the international business, that's where things get exciting.

**JORDAN**: Exactly. Their international P&C business, which they call "overseas general," was up 10.8% in Q4. But here's what's really compelling - their consumer lines in that international segment grew 18.7%. Latin America was particularly strong at 14.7% growth, and Asia grew 13%.

**ALEX**: And Greenberg gave some great color on this during the Q&A. He talked about their partnerships with major banks - Banco de Chile in Chile, Nubank in Brazil for digital distribution, Banco Guayaquil in Ecuador. It sounds like they're building these local distribution networks that are really paying off.

**JORDAN**: What I found interesting is how he characterized these markets. He called them "developing and mature market regions" and emphasized that while there's volatility, the long-term trend line is up, especially for Asia. He also made the point that it's "hard yards" to build these local franchises - you can't just parachute in with a couple of underwriters.

**ALEX**: Speaking of hard work paying off, let's talk about their digital transformation initiative. This was fascinating - they're targeting 150 basis points of combined ratio improvement over the next 3-4 years through digital transformation.

**JORDAN**: And Greenberg was pretty specific about this. He said most of it comes from the expense side - both operating expenses and cost of claims. They're focused on nine to ten discrete transformation projects across North America, UK, Europe, and their larger Asian and Latin American markets. It's covering technology, data, AI, and analytics.

**ALEX**: The other big story here is their investment income. They hit a record $1.8 billion in adjusted net investment income for Q4, up 7.3%. Their fixed income portfolio yield is now 5.1%, and they're getting new money at rates slightly above that.

**JORDAN**: That investment performance is crucial because their invested assets now stand at $169 billion, up from $151 billion a year ago. And they're planning to increase their private investment...]]>528falsefullhttps://www.spreaker.com/episode/netflix-q1-2026-earnings-analysis--71400408
Before we get into the numbers, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Netflix just reported some pretty impressive numbers here. Walk us through the key highlights.

JORDAN: Absolutely, Alex. The headline numbers are strong. Netflix is maintaining their full-year 2026 guidance of 12% to 14% revenue growth with operating margins at 31.5%. They ended 2025 with more than 325 million paid subscribers, and here's the kicker - they're now entertaining nearly a billion people globally. That's incredible scale.

ALEX: A billion people! That really puts their reach into perspective. But what caught my attention was their advertising business. They're projecting to roughly double it to about $3 billion this year. That's significant growth in what's becoming a crucial revenue stream for them.

JORDAN: Exactly. And speaking of growth potential, CEO Gregory Peters shared some fascinating market penetration data. Netflix has captured only about 45% of addressable households with smart TVs and good data - that's out of roughly 800 million households. Even more striking, they estimate they account for just 5% of global TV viewing time. That suggests there's massive room for expansion.

ALEX: Those are some pretty compelling growth runway numbers. But Jordan, I have to ask about the elephant in the room - the Warner Brothers deal that they walked away from. What happened there?

JORDAN: This was one of the more interesting parts of the call, Alex. CEO Ted Sarandos was very candid about it. He emphasized from the start that the Warner Brothers acquisition was a "nice-to-have, not a need-to-have." When the cost grew beyond what they felt was the net value to shareholders, they walked away. Sarandos called it a test of their "investment discipline."

ALEX: I respect that kind of discipline, especially in today's market where we've seen some questionable M&A activity. What did they learn from the experience?

JORDAN: Sarandos said they learned they could execute deals of that size, built their "M&A muscle," and proved they could stay focused on their core business during the process. The key takeaway was that when emotion and ego were on one side and shareholder value was on the other, they chose shareholders. That's the kind of capital allocation discipline investors want to see.

ALEX: Speaking of shareholder value, let's talk about what's driving engagement. They had some incredible success with live sports this quarter.

JORDAN: The World Baseball Classic in Japan was a massive hit - literally the most-watched program Netflix has ever had in Japan, with 31.4 million global viewers. But here's what's really impressive: it drove Netflix's largest single sign-up day ever in Japan, and Japan led their Q1 member growth globally.

ALEX: That's a perfect example of how live content can drive different types of value. It's not just about total viewing hours anymore, is it?

JORDAN: Exactly. Gregory Peters made this point beautifully - they're developing more sophisticated engagement metrics beyond just view hours. They have a "primary quality metric" that hit an all-time high in Q1, and while they won't reveal the formula, they say it's predictive of key business metrics like retention.

ALEX: Smart of them to keep that proprietary. Now, one area that fascinated me was their expansion into new content categories. They're really diversifying beyond traditional TV and movies.

JORDAN: Yes! They're pushing into podcasts, regional live sports, and gaming. On podcasts, they're seeing incre

This episode includes AI-generated content.]]>SP100-NFLX-Q1-2026-enFri, 17 Apr 2026 08:35:43 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Netflix's Q1 2026 earnings call, and wow, what a quarter this was for the streaming giant. Before we get into the...
Before we get into the numbers, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Netflix just reported some pretty impressive numbers here. Walk us through the key highlights.

JORDAN: Absolutely, Alex. The headline numbers are strong. Netflix is maintaining their full-year 2026 guidance of 12% to 14% revenue growth with operating margins at 31.5%. They ended 2025 with more than 325 million paid subscribers, and here's the kicker - they're now entertaining nearly a billion people globally. That's incredible scale.

ALEX: A billion people! That really puts their reach into perspective. But what caught my attention was their advertising business. They're projecting to roughly double it to about $3 billion this year. That's significant growth in what's becoming a crucial revenue stream for them.

JORDAN: Exactly. And speaking of growth potential, CEO Gregory Peters shared some fascinating market penetration data. Netflix has captured only about 45% of addressable households with smart TVs and good data - that's out of roughly 800 million households. Even more striking, they estimate they account for just 5% of global TV viewing time. That suggests there's massive room for expansion.

ALEX: Those are some pretty compelling growth runway numbers. But Jordan, I have to ask about the elephant in the room - the Warner Brothers deal that they walked away from. What happened there?

JORDAN: This was one of the more interesting parts of the call, Alex. CEO Ted Sarandos was very candid about it. He emphasized from the start that the Warner Brothers acquisition was a "nice-to-have, not a need-to-have." When the cost grew beyond what they felt was the net value to shareholders, they walked away. Sarandos called it a test of their "investment discipline."

ALEX: I respect that kind of discipline, especially in today's market where we've seen some questionable M&A activity. What did they learn from the experience?

JORDAN: Sarandos said they learned they could execute deals of that size, built their "M&A muscle," and proved they could stay focused on their core business during the process. The key takeaway was that when emotion and ego were on one side and shareholder value was on the other, they chose shareholders. That's the kind of capital allocation discipline investors want to see.

ALEX: Speaking of shareholder value, let's talk about what's driving engagement. They had some incredible success with live sports this quarter.

JORDAN: The World Baseball Classic in Japan was a massive hit - literally the most-watched program Netflix has ever had in Japan, with 31.4 million global viewers. But here's what's really impressive: it drove Netflix's largest single sign-up day ever in Japan, and Japan led their Q1 member growth globally.

ALEX: That's a perfect example of how live content can drive different types of value. It's not just about total viewing hours anymore, is it?

JORDAN: Exactly. Gregory Peters made this point beautifully - they're developing more sophisticated engagement metrics beyond just view hours. They have a "primary quality metric" that hit an all-time high in Q1, and while they won't reveal the formula, they say it's predictive of key business metrics like retention.

ALEX: Smart of them to keep that proprietary. Now, one area that fascinated me was their expansion into new content categories. They're really diversifying...]]>489falsefullhttps://www.spreaker.com/episode/prologis-q1-2026-earnings-analysis--71381296
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results and what they mean for your portfolio. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're breaking down Prologis' Q1 2026 earnings - and wow, what a quarter for the industrial real estate giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because Prologis just delivered some seriously impressive results.

**ALEX:** They really did, Jordan. Let me start with the headline numbers. Core FFO came in at $1.50 per share including net promote expense, and $1.52 excluding it - both beating expectations. But what really caught my eye was that record leasing number: 64 million square feet of signings in just one quarter.

**JORDAN:** That's massive. And here's what I find fascinating - their leasing pipeline didn't just maintain after this record quarter, it actually reached new highs. That tells me the underlying demand is incredibly robust. Plus, occupancy hit 95.3%, which exceeded their own expectations.

**ALEX:** The retention rate was impressive too - nearly 76%. But Jordan, let's talk about what's really driving this story: their expansion beyond traditional logistics into data centers. They started $2.1 billion of new development this quarter, with $1.3 billion of that going to data center projects.

**JORDAN:** This is where it gets really interesting from an investment perspective. CEO Dan Letter mentioned they have 1.3 gigawatts under letter of intent and all of their power pipeline sites are in active discussions. Tim Arndt, their CFO, said they ended the quarter with 5.6 gigawatts of energy either secured or in advanced stages.

**ALEX:** And here's the kicker - Arndt said that just assuming a basic power shell format at $3 million per megawatt, their current pipeline could provide well over $15 billion of investment opportunity. That's not even counting the turnkey format which would be multiples of that.

**JORDAN:** The data center story is compelling, but let's not forget their bread and butter logistics business is still performing. U.S. logistics markets absorbed 45 million square feet on a seasonally adjusted basis - that was actually ahead of their forecast. And vacancy rates stayed stable at 7.5%.

**ALEX:** What I found encouraging was the rent growth story. Market rents grew 30 basis points globally - and this was the first increase in 2.5 years. That suggests we might be at an inflection point where the supply-demand dynamics are finally shifting in landlords' favor.

**JORDAN:** Exactly. And their lease mark-to-market of 17% on a net effective basis represents about $750 million of embedded NOI at current spot rents. That's a lot of upside still to capture as occupancies improve.

**ALEX:** Now, let's address the elephant in the room - the geopolitical backdrop. Letter specifically mentioned the Middle East conflict and its potential impact on their business. How did management handle this?

**JORDAN:** I thought Letter was refreshingly direct about it. He acknowledged the uncertainty, especially around energy prices and inflation pressures, but he focused on what they're actually seeing in their data. He said seven weeks into the conflict, most customers are telling them their 2026 business plans remain unchanged.

**ALEX:** That's a key point. He contrasted this with April 2025 when tariff-related uncertainty caused an immediate pause in leasing activity. This time, he's not seeing that same pattern - March was actually a very active month for new leasing.

**JORDAN:** Speaking of capital, let's talk about their strategic capital platform exp

This episode includes AI-generated content.]]>SP100-PLD-Q1-2026-enThu, 16 Apr 2026 21:19:12 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results and what they mean for your portfolio. I'm Alex. **JORDAN:** And I'm Jordan. Today we're breaking down...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results and what they mean for your portfolio. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're breaking down Prologis' Q1 2026 earnings - and wow, what a quarter for the industrial real estate giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because Prologis just delivered some seriously impressive results.

**ALEX:** They really did, Jordan. Let me start with the headline numbers. Core FFO came in at $1.50 per share including net promote expense, and $1.52 excluding it - both beating expectations. But what really caught my eye was that record leasing number: 64 million square feet of signings in just one quarter.

**JORDAN:** That's massive. And here's what I find fascinating - their leasing pipeline didn't just maintain after this record quarter, it actually reached new highs. That tells me the underlying demand is incredibly robust. Plus, occupancy hit 95.3%, which exceeded their own expectations.

**ALEX:** The retention rate was impressive too - nearly 76%. But Jordan, let's talk about what's really driving this story: their expansion beyond traditional logistics into data centers. They started $2.1 billion of new development this quarter, with $1.3 billion of that going to data center projects.

**JORDAN:** This is where it gets really interesting from an investment perspective. CEO Dan Letter mentioned they have 1.3 gigawatts under letter of intent and all of their power pipeline sites are in active discussions. Tim Arndt, their CFO, said they ended the quarter with 5.6 gigawatts of energy either secured or in advanced stages.

**ALEX:** And here's the kicker - Arndt said that just assuming a basic power shell format at $3 million per megawatt, their current pipeline could provide well over $15 billion of investment opportunity. That's not even counting the turnkey format which would be multiples of that.

**JORDAN:** The data center story is compelling, but let's not forget their bread and butter logistics business is still performing. U.S. logistics markets absorbed 45 million square feet on a seasonally adjusted basis - that was actually ahead of their forecast. And vacancy rates stayed stable at 7.5%.

**ALEX:** What I found encouraging was the rent growth story. Market rents grew 30 basis points globally - and this was the first increase in 2.5 years. That suggests we might be at an inflection point where the supply-demand dynamics are finally shifting in landlords' favor.

**JORDAN:** Exactly. And their lease mark-to-market of 17% on a net effective basis represents about $750 million of embedded NOI at current spot rents. That's a lot of upside still to capture as occupancies improve.

**ALEX:** Now, let's address the elephant in the room - the geopolitical backdrop. Letter specifically mentioned the Middle East conflict and its potential impact on their business. How did management handle this?

**JORDAN:** I thought Letter was refreshingly direct about it. He acknowledged the uncertainty, especially around energy prices and inflation pressures, but he focused on what they're actually seeing in their data. He said seven weeks into the conflict, most customers are telling them their 2026 business plans remain unchanged.

**ALEX:** That's a key point. He contrasted this with April 2025 when tariff-related uncertainty caused an immediate pause in leasing activity. This time, he's not seeing...]]>499falsefullhttps://www.spreaker.com/episode/charles-schwab-q1-2026-earnings-analysis--71373373
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dig into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Charles Schwab's blockbuster Q1 2026 results, and folks, this was a quarter that had everything - record growth, AI innovation, and some serious market volatility.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's start with the headline numbers because Schwab really delivered this quarter.

**ALEX:** They absolutely crushed it, Jordan. Revenue hit a record $6.5 billion, up 16% year-over-year. But here's the kicker - earnings per share came in at $1.43, which is up almost 40% from last year. That's not just beating expectations, that's demolishing them.

**JORDAN:** And the client growth story is equally impressive. They added 1.3 million new brokerage accounts, pulling in $158 billion in core net new assets. CEO Rick Wurster mentioned that March was their second-highest month for net new assets ever, behind only December 2021. Remember that period?

**ALEX:** Oh yeah, the meme stock frenzy. But this feels different - more sustainable. What really caught my attention was the breadth of engagement. They supported nearly 10 million daily average trades, which is a record. But here's the interesting part - revenue per trade actually went down.

**JORDAN:** That's a fascinating dynamic, and Wurster had a really insightful explanation during the Q&A. He said their traders are feeling more uncertain about geopolitics and the economy, so they're taking smaller positions and holding them for shorter durations. More frequent trading, but smaller dollar amounts per trade.

**ALEX:** It's like the market's anxiety manifesting in real trading behavior. Speaking of innovation, Schwab is making some bold moves. They're launching spot crypto trading - Bitcoin and Ethereum to start - with competitive pricing at 75 basis points per trade.

**JORDAN:** And they're not just jumping on the crypto bandwagon. This is classic Schwab - they're doing it "the Schwab way" with education, research, and risk management built in. Plus, they closed the Forge acquisition, which gives clients access to pre-IPO shares. That's a big deal for expanding their private market offerings.

**ALEX:** But the real story here might be AI. Wurster spent significant time detailing how AI is becoming integral to their strategy. They've equipped all 33,000 employees with AI tools, and they're rolling out customer-facing AI assistants starting this summer.

**JORDAN:** The AI strategy is particularly clever. They're using it both for operational efficiency - like their Knowledge Assistant that helps phone reps answer complex questions instantly - and for client engagement through personalized portfolio insights. This isn't just tech for tech's sake.

**ALEX:** Right, and there's a revenue angle too. They mentioned that over half their clients are willing to pay for AI financial tools. That could open up new fee-based revenue streams beyond their traditional model.

**JORDAN:** Let's talk about the elephant in the room - cash management. There's been industry chatter about JPMorgan rolling out tools to reduce cash sweep friction. How did Schwab address this?

**ALEX:** Wurster was pretty confident in their response. He emphasized that clients have "intentionally allocated" their cash and that Schwab already makes it incredibly easy to optimize cash placement. They're launching their own AI agent capabilities this summer, but he seemed to view this as an opportunity rather than a threat.

**JORDAN:** His point about monetization flexibility was interesting too

This episode includes AI-generated content.]]>SP100-SCHW-Q1-2026-enThu, 16 Apr 2026 16:10:21 +0000trueBeta Finch# Beta Finch Podcast Script: Schwab Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dig into the numbers that matter. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Charles Schwab's...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dig into the numbers that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Charles Schwab's blockbuster Q1 2026 results, and folks, this was a quarter that had everything - record growth, AI innovation, and some serious market volatility.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's start with the headline numbers because Schwab really delivered this quarter.

**ALEX:** They absolutely crushed it, Jordan. Revenue hit a record $6.5 billion, up 16% year-over-year. But here's the kicker - earnings per share came in at $1.43, which is up almost 40% from last year. That's not just beating expectations, that's demolishing them.

**JORDAN:** And the client growth story is equally impressive. They added 1.3 million new brokerage accounts, pulling in $158 billion in core net new assets. CEO Rick Wurster mentioned that March was their second-highest month for net new assets ever, behind only December 2021. Remember that period?

**ALEX:** Oh yeah, the meme stock frenzy. But this feels different - more sustainable. What really caught my attention was the breadth of engagement. They supported nearly 10 million daily average trades, which is a record. But here's the interesting part - revenue per trade actually went down.

**JORDAN:** That's a fascinating dynamic, and Wurster had a really insightful explanation during the Q&A. He said their traders are feeling more uncertain about geopolitics and the economy, so they're taking smaller positions and holding them for shorter durations. More frequent trading, but smaller dollar amounts per trade.

**ALEX:** It's like the market's anxiety manifesting in real trading behavior. Speaking of innovation, Schwab is making some bold moves. They're launching spot crypto trading - Bitcoin and Ethereum to start - with competitive pricing at 75 basis points per trade.

**JORDAN:** And they're not just jumping on the crypto bandwagon. This is classic Schwab - they're doing it "the Schwab way" with education, research, and risk management built in. Plus, they closed the Forge acquisition, which gives clients access to pre-IPO shares. That's a big deal for expanding their private market offerings.

**ALEX:** But the real story here might be AI. Wurster spent significant time detailing how AI is becoming integral to their strategy. They've equipped all 33,000 employees with AI tools, and they're rolling out customer-facing AI assistants starting this summer.

**JORDAN:** The AI strategy is particularly clever. They're using it both for operational efficiency - like their Knowledge Assistant that helps phone reps answer complex questions instantly - and for client engagement through personalized portfolio insights. This isn't just tech for tech's sake.

**ALEX:** Right, and there's a revenue angle too. They mentioned that over half their clients are willing to pay for AI financial tools. That could open up new fee-based revenue streams beyond their traditional model.

**JORDAN:** Let's talk about the elephant in the room - cash management. There's been industry chatter about JPMorgan rolling out tools to reduce cash sweep friction. How did Schwab address this?

**ALEX:** Wurster was pretty confident in their response. He emphasized that clients have "intentionally allocated" their cash and that Schwab already makes it incredibly easy to optimize cash placement. They're launching their own AI agent capabilities...]]>494falsefullhttps://www.spreaker.com/episode/pepsico-q1-2026-earnings-analysis--71373371
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to break down PepsiCo's Q1 2026 earnings call. Jordan, this was quite an interesting quarter with some geopolitical backdrop we don't usually see.

**JORDAN**: Absolutely, Alex. And before we jump into the numbers, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks, Jordan. Now, let's talk PepsiCo. The big headline here is that they're showing sequential improvement across their business units, particularly in North America Foods, which has been a challenge area. They maintained their organic revenue guidance of 2% to 4% for the year, with expectations to hit the higher end in the back half.

**JORDAN**: Right, and what's fascinating is how they're navigating this Iran conflict situation. CFO Steve Schmitt was pretty transparent about it - they have 6 to 12-month hedging programs in place, and surprisingly, they're not seeing major supply chain disruptions. In fact, CEO Ramon Laguarta mentioned they might actually have better supply chain resilience than some competitors, especially in the food business.

**ALEX**: That's a great point about competitive advantage during tough times. Let's break down the segment performance. The North America Foods business, which has been under pressure, showed 2% volume growth in Q1. Jordan, this seems like a real turnaround story.

**JORDAN**: It really is, Alex. What's impressive is the scale of this turnaround - they added 300 million new consumption occasions in Q1 compared to the same period last year. That's massive. Ramon talked about this being a "holistic commercial strategy" involving better value propositions, more shelf space, brand restaging for Lay's and Tostitos, and accelerated innovation in what they call "permissible and functional" products.

**ALEX**: And they're seeing results in market share too, right? They mentioned gaining positive share in both volume and value recently, which had been a key performance indicator they set for themselves.

**JORDAN**: Exactly. The away-from-home business is growing at 3x the company average, and their permissible portfolio brands like SunChips and Smartfood are seeing double-digit growth in some cases. But here's what I found most interesting - their costs for North America Foods actually went *down* in Q1 while they're investing more. That speaks to their productivity initiatives really paying off.

**ALEX**: That productivity story is huge. Let's talk about the beverage side - PBNA grew 9% total, which is pretty impressive.

**JORDAN**: Yeah, but it's a mixed bag when you dig deeper. The headline 9% growth includes about 7 points from new platforms and acquisitions like Poppi and expanded energy drink distribution. The organic growth was around 2%. They're still dealing with a case pack water transition that pressured volumes, but Ramon expects that to turn positive in coming quarters.

**ALEX**: One thing that stood out from the Q&A was the discussion around SNAP benefit restrictions and GLP-1 drugs. These are newer headwinds the industry is watching closely.

**JORDAN**: True, eight states began SNAP restrictions in Q1, mainly affecting beverages and candy. But Steve Schmitt said it's too early to draw conclusions. What's more interesting is how they're positioning for these secular changes - they're doubling down on innovation in functional and permissible products, which could actually benefit from health-conscious trends.

**ALEX**: The international business seems to be firing on all cylinders. Ramon mentioned they haven't seen demand impact from the Iran conflict and are actually accelerating in

This episode includes AI-generated content.]]>SP100-PEP-Q1-2026-enThu, 16 Apr 2026 16:10:16 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to break down PepsiCo's Q1 2026 earnings call. Jordan,...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that matter. I'm Alex, and I'm here with my co-host Jordan to break down PepsiCo's Q1 2026 earnings call. Jordan, this was quite an interesting quarter with some geopolitical backdrop we don't usually see.

**JORDAN**: Absolutely, Alex. And before we jump into the numbers, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks, Jordan. Now, let's talk PepsiCo. The big headline here is that they're showing sequential improvement across their business units, particularly in North America Foods, which has been a challenge area. They maintained their organic revenue guidance of 2% to 4% for the year, with expectations to hit the higher end in the back half.

**JORDAN**: Right, and what's fascinating is how they're navigating this Iran conflict situation. CFO Steve Schmitt was pretty transparent about it - they have 6 to 12-month hedging programs in place, and surprisingly, they're not seeing major supply chain disruptions. In fact, CEO Ramon Laguarta mentioned they might actually have better supply chain resilience than some competitors, especially in the food business.

**ALEX**: That's a great point about competitive advantage during tough times. Let's break down the segment performance. The North America Foods business, which has been under pressure, showed 2% volume growth in Q1. Jordan, this seems like a real turnaround story.

**JORDAN**: It really is, Alex. What's impressive is the scale of this turnaround - they added 300 million new consumption occasions in Q1 compared to the same period last year. That's massive. Ramon talked about this being a "holistic commercial strategy" involving better value propositions, more shelf space, brand restaging for Lay's and Tostitos, and accelerated innovation in what they call "permissible and functional" products.

**ALEX**: And they're seeing results in market share too, right? They mentioned gaining positive share in both volume and value recently, which had been a key performance indicator they set for themselves.

**JORDAN**: Exactly. The away-from-home business is growing at 3x the company average, and their permissible portfolio brands like SunChips and Smartfood are seeing double-digit growth in some cases. But here's what I found most interesting - their costs for North America Foods actually went *down* in Q1 while they're investing more. That speaks to their productivity initiatives really paying off.

**ALEX**: That productivity story is huge. Let's talk about the beverage side - PBNA grew 9% total, which is pretty impressive.

**JORDAN**: Yeah, but it's a mixed bag when you dig deeper. The headline 9% growth includes about 7 points from new platforms and acquisitions like Poppi and expanded energy drink distribution. The organic growth was around 2%. They're still dealing with a case pack water transition that pressured volumes, but Ramon expects that to turn positive in coming quarters.

**ALEX**: One thing that stood out from the Q&A was the discussion around SNAP benefit restrictions and GLP-1 drugs. These are newer headwinds the industry is watching closely.

**JORDAN**: True, eight states began SNAP restrictions in Q1, mainly affecting beverages and candy. But Steve Schmitt said it's too early to draw conclusions. What's more interesting is how they're positioning for these secular changes - they're doubling down on innovation in functional and permissible products, which could actually benefit from health-conscious trends.

**ALEX**: The international...]]>462falsefullhttps://www.spreaker.com/episode/abbott-laboratories-q1-2026-earnings-analysis--71373368
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Abbott Laboratories' Q1 2026 earnings call. Jordan, this was a pretty significant quarter for Abbott - they just closed their acquisition of Exact Sciences back in March.

**JORDAN**: Absolutely, Alex. And before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that reminder. So let's talk numbers first. Abbott reported adjusted earnings per share of $1.15 for Q1, which was right in line with their guidance despite some headwinds. Revenue-wise, they're now reporting what they call "comparable growth" of 3.7%, which includes Exact Sciences in both current and prior year numbers.

**JORDAN**: That comparable growth metric is really interesting, Alex. CEO Robert Ford explained they're doing this to give investors a cleaner apples-to-apples view of the combined business. It's similar to what they did during COVID when they separated out COVID sales, or when they acquired St. Jude. The goal is transparency.

**ALEX**: Right, and looking forward, they've updated their full-year guidance to 6.5% to 7.5% comparable sales growth. But here's what caught my attention - their adjusted EPS guidance midpoint dropped from $5.68 to $5.48. That $0.20 dilution is directly from the Exact Sciences acquisition, which was expected.

**JORDAN**: Let's break down the business segments because there were some really interesting dynamics. Medical Devices was the star performer with 8.5% growth. The Electrophysiology business grew 13%, and get this - they had earlier-than-planned approvals for two new pulsed field ablation catheters.

**ALEX**: Those PFA catheters are a big deal, Jordan. The Volt PFA catheter helped drive 14% growth in the U.S., while the TactiFlex Duo catheter contributed to mid-teens growth in Europe. Ford seemed pretty bullish about acceleration in the EP business as these launches broaden.

**JORDAN**: And speaking of acceleration, the continuous glucose monitoring business had some interesting dynamics. CGM sales were $2 billion but only grew 7.5% due to an international tender delay and some tough comparisons from last year's shelf restocking. But management expects a return to double-digit growth in Q2.

**ALEX**: That's a key point. During the Q&A, Ford was asked about concerns that the CGM market might be saturated. His response was fascinating - he said they estimate 70 to 80 million people globally should be on CGM, but the current market is only 10 to 12 million people. That's massive underpenetration.

**JORDAN**: He also mentioned some upcoming catalysts, including expected CMS coverage for type 2 non-insulin patients, which could add close to 10 million people who currently don't have coverage. Ford was very clear he hadn't baked that into guidance, so it could be upside if it materializes.

**ALEX**: Now let's talk about the Exact Sciences integration. This was really the elephant in the room. Ford named Jake Orville to lead that business, reporting directly to him. The Cologuard business grew 13% on a comparable basis, with mid-teens growth of the core Cologuard product.

**JORDAN**: What struck me was Ford's long-term vision here. He doesn't see this as just a one-product deal, but as a beachhead into the entire cancer diagnostics space - screening, therapy selection, and MRD testing. He pointed out that about 50 million Americans aren't up to date with colorectal cancer screening.

**ALEX**: And internationally, Ford said it's very underpenetrated. Abbott brings established regulatory and distribution relationships that could really accelerate international expansion. He even mentioned traveling to

This episode includes AI-generated content.]]>SP100-ABT-Q1-2026-enThu, 16 Apr 2026 16:10:11 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Abbott Laboratories' Q1 2026 earnings call. Jordan, this was a pretty significant...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Abbott Laboratories' Q1 2026 earnings call. Jordan, this was a pretty significant quarter for Abbott - they just closed their acquisition of Exact Sciences back in March.

**JORDAN**: Absolutely, Alex. And before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that reminder. So let's talk numbers first. Abbott reported adjusted earnings per share of $1.15 for Q1, which was right in line with their guidance despite some headwinds. Revenue-wise, they're now reporting what they call "comparable growth" of 3.7%, which includes Exact Sciences in both current and prior year numbers.

**JORDAN**: That comparable growth metric is really interesting, Alex. CEO Robert Ford explained they're doing this to give investors a cleaner apples-to-apples view of the combined business. It's similar to what they did during COVID when they separated out COVID sales, or when they acquired St. Jude. The goal is transparency.

**ALEX**: Right, and looking forward, they've updated their full-year guidance to 6.5% to 7.5% comparable sales growth. But here's what caught my attention - their adjusted EPS guidance midpoint dropped from $5.68 to $5.48. That $0.20 dilution is directly from the Exact Sciences acquisition, which was expected.

**JORDAN**: Let's break down the business segments because there were some really interesting dynamics. Medical Devices was the star performer with 8.5% growth. The Electrophysiology business grew 13%, and get this - they had earlier-than-planned approvals for two new pulsed field ablation catheters.

**ALEX**: Those PFA catheters are a big deal, Jordan. The Volt PFA catheter helped drive 14% growth in the U.S., while the TactiFlex Duo catheter contributed to mid-teens growth in Europe. Ford seemed pretty bullish about acceleration in the EP business as these launches broaden.

**JORDAN**: And speaking of acceleration, the continuous glucose monitoring business had some interesting dynamics. CGM sales were $2 billion but only grew 7.5% due to an international tender delay and some tough comparisons from last year's shelf restocking. But management expects a return to double-digit growth in Q2.

**ALEX**: That's a key point. During the Q&A, Ford was asked about concerns that the CGM market might be saturated. His response was fascinating - he said they estimate 70 to 80 million people globally should be on CGM, but the current market is only 10 to 12 million people. That's massive underpenetration.

**JORDAN**: He also mentioned some upcoming catalysts, including expected CMS coverage for type 2 non-insulin patients, which could add close to 10 million people who currently don't have coverage. Ford was very clear he hadn't baked that into guidance, so it could be upside if it materializes.

**ALEX**: Now let's talk about the Exact Sciences integration. This was really the elephant in the room. Ford named Jake Orville to lead that business, reporting directly to him. The Cologuard business grew 13% on a comparable basis, with mid-teens growth of the core Cologuard product.

**JORDAN**: What struck me was Ford's long-term vision here. He doesn't see this as just a one-product deal, but as a beachhead into the entire cancer diagnostics space - screening, therapy selection, and MRD testing. He pointed out that about 50 million Americans aren't up to date with colorectal cancer screening.

**ALEX**: And internationally, Ford said it's very underpenetrated. Abbott...]]>536falsefullhttps://www.spreaker.com/episode/morgan-stanley-q1-2026-earnings-analysis--71353011
**JORDAN:** And I'm Jordan. Today we're diving into Morgan Stanley's Q1 2026 earnings call - and wow, what a quarter this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk numbers because Morgan Stanley just delivered some eye-popping results. They hit record revenues of $20.6 billion and earnings per share of $3.43. That's a return on tangible equity of 27%.

**ALEX:** Those are monster numbers, Jordan. And what really caught my attention was how CEO Ted Pick framed this - he called it proof of Morgan Stanley's "integrated firm" model working across different market conditions. They're firing on all cylinders - wealth management, investment banking, and markets.

**JORDAN:** The wealth management business was particularly impressive. They pulled in $118 billion in net new assets and $54 billion in fee-based flows. That's a new record for fee-based flows, excluding acquisitions. Their wealth management margins hit 30.4%.

**ALEX:** And here's what I found fascinating - they're really starting to see their client acquisition funnel pay off. Sharon Yeshaya, their CFO, mentioned that since 2020, they've generated over $400 billion in new adviser-led assets from relationships that started in either their workplace or E-TRADE channels.

**JORDAN:** That's the flywheel effect in action. People start with workplace stock plans or retail trading, then migrate to full advisory relationships. Speaking of strategic moves, they closed their acquisition of Equity Zen during the quarter, which positions them better in the private credit ecosystem.

**ALEX:** Let's talk about that private credit discussion because it was really interesting. There's been all this drama in the private credit space recently, and an analyst asked Ted Pick about it directly. His response was brilliant - he called it an "adolescent moment" for private credit.

**JORDAN:** I loved that framing. He's basically saying private credit is growing up, having some learning experiences, but the fundamentals are still solid. And he pointed out that Morgan Stanley's exposure is pretty limited - private credit is only about 1% of their wealth management assets.

**ALEX:** Right, and he made a key point that often gets lost in the headlines: "This is credit, and credit is going to broadly perform when the economy is performing." It's not magic - it follows normal credit cycles.

**JORDAN:** Now, the investment banking side was also strong. They hit $10.7 billion in quarterly revenues, with advisory revenues up 74% year-over-year. The M&A market seems to be awakening from its slumber.

**ALEX:** And their equities business - wow. They hit $5.1 billion in revenues for the first time ever. Ted Pick mentioned their global expansion is really paying off, especially in Asia where they have that strategic partnership with MUFG.

**JORDAN:** That Asia growth story is compelling. Pick talked about how they're not just riding the wave - they've been building relationships there for decades. The integration with their Japanese partners is giving them unique advantages.

**ALEX:** One thing that came up multiple times was AI, and I thought Pick's perspective was refreshing. While a lot of people are worried about AI disrupting wealth management, he was emphatic: "AI is our friend."

**JORDAN:** He explained they're using something called the Claude Mythos model to enhance productivity and adviser effectiveness. It's not about replacing advisers - it's about making them more effective through what he called "co-piloting."

**ALEX:** Though he also acknowledged the cybersecurity risks that come with advanced

This episode includes AI-generated content.]]>SP100-MS-Q1-2026-enWed, 15 Apr 2026 21:36:06 +0000trueBeta Finch**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Morgan Stanley's Q1 2026 earnings call - and wow, what a quarter this was. **ALEX:** Before we jump in, I need to...
**JORDAN:** And I'm Jordan. Today we're diving into Morgan Stanley's Q1 2026 earnings call - and wow, what a quarter this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk numbers because Morgan Stanley just delivered some eye-popping results. They hit record revenues of $20.6 billion and earnings per share of $3.43. That's a return on tangible equity of 27%.

**ALEX:** Those are monster numbers, Jordan. And what really caught my attention was how CEO Ted Pick framed this - he called it proof of Morgan Stanley's "integrated firm" model working across different market conditions. They're firing on all cylinders - wealth management, investment banking, and markets.

**JORDAN:** The wealth management business was particularly impressive. They pulled in $118 billion in net new assets and $54 billion in fee-based flows. That's a new record for fee-based flows, excluding acquisitions. Their wealth management margins hit 30.4%.

**ALEX:** And here's what I found fascinating - they're really starting to see their client acquisition funnel pay off. Sharon Yeshaya, their CFO, mentioned that since 2020, they've generated over $400 billion in new adviser-led assets from relationships that started in either their workplace or E-TRADE channels.

**JORDAN:** That's the flywheel effect in action. People start with workplace stock plans or retail trading, then migrate to full advisory relationships. Speaking of strategic moves, they closed their acquisition of Equity Zen during the quarter, which positions them better in the private credit ecosystem.

**ALEX:** Let's talk about that private credit discussion because it was really interesting. There's been all this drama in the private credit space recently, and an analyst asked Ted Pick about it directly. His response was brilliant - he called it an "adolescent moment" for private credit.

**JORDAN:** I loved that framing. He's basically saying private credit is growing up, having some learning experiences, but the fundamentals are still solid. And he pointed out that Morgan Stanley's exposure is pretty limited - private credit is only about 1% of their wealth management assets.

**ALEX:** Right, and he made a key point that often gets lost in the headlines: "This is credit, and credit is going to broadly perform when the economy is performing." It's not magic - it follows normal credit cycles.

**JORDAN:** Now, the investment banking side was also strong. They hit $10.7 billion in quarterly revenues, with advisory revenues up 74% year-over-year. The M&A market seems to be awakening from its slumber.

**ALEX:** And their equities business - wow. They hit $5.1 billion in revenues for the first time ever. Ted Pick mentioned their global expansion is really paying off, especially in Asia where they have that strategic partnership with MUFG.

**JORDAN:** That Asia growth story is compelling. Pick talked about how they're not just riding the wave - they've been building relationships there for decades. The integration with their Japanese partners is giving them unique advantages.

**ALEX:** One thing that came up multiple times was AI, and I thought Pick's perspective was refreshing. While a lot of people are worried about AI disrupting wealth management, he was emphatic: "AI is our friend."

**JORDAN:** He explained they're using something called the Claude Mythos model to enhance productivity and adviser effectiveness. It's not about replacing advisers - it's...]]>459falsefullhttps://www.spreaker.com/episode/bank-of-america-q1-2026-earnings-analysis--71353010
JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q1 2026 results, and folks, this was a pretty impressive quarter.

ALEX: Before we jump in, I need to share our mandatory disclaimer - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now, let's talk Bank of America. Alex, the numbers were genuinely strong across the board here.

ALEX: They really were, Jordan. Revenue jumped 7% year-over-year to $30.3 billion, and earnings per share surged 25% to $1.11. But what caught my attention was that every single business segment contributed to growth - revenue, earnings, deposits, loans. That's the kind of diversified performance you love to see from a major bank.

JORDAN: And let's talk about that operating leverage - 290 basis points! For those keeping score at home, that means their revenue is growing much faster than their expenses. Their efficiency ratio improved from 63% to 61%, and they hit a 16% return on tangible common equity.

ALEX: Speaking of efficiency, there was this fascinating discussion about headcount. CEO Brian Moynihan mentioned they're down about 1,070 people from year-end 2025, but here's the kicker - they actually have fewer employees today than they did back in 2007, despite being a much larger company now.

JORDAN: That's the power of technology and AI at work. Moynihan talked about having 90 different AI installations running across the company, with all 200,000 employees having access to AI tools. Their virtual assistant Erica is just the tip of the iceberg.

ALEX: Let's dig into the business lines. Net interest income was a real standout - $15.9 billion on a fully taxable equivalent basis, up 9% year-over-year. And here's the big news: they actually raised their full-year NII guidance to 6% to 8% growth, up from their previous expectations.

JORDAN: That guidance increase is significant, Alex. CFO Alastair Borthwick attributed it to better balance sheet optimization, more favorable rate conditions, and the fact that the market now expects zero Fed rate cuts this year instead of the two cuts previously anticipated.

ALEX: The consumer banking segment was particularly strong - net income up 21% year-over-year to $3.1 billion. They added over 100,000 net new checking accounts and now have a record 38.5 million consumer checking accounts. Plus, 79% of households are digitally active.

JORDAN: And their wealth management business hit a record first quarter revenue of $6.7 billion, with net income up 32% year-over-year. Client balances reached $4.6 trillion. Those are some serious numbers.

ALEX: Now, there was an interesting discussion about credit quality. One analyst asked about their reserving approach, noting that Bank of America tends to have lower reserve ratios than peers. Borthwick pushed back, saying it reflects their higher-quality loan portfolio and more conservative client selection.

JORDAN: Right, and the credit metrics support that view. Net charge-offs, card delinquencies, and nonperforming loans all declined versus Q1 2025. They've been the lowest loss rate in Federal Reserve stress tests for 13 of the last 14 years.

ALEX: There was also discussion about their Global Markets lending business. Some investors have been nervous about exposure to private credit markets, but Borthwick emphasized they haven't experienced material losses and have structural protections in place.

JORDAN: The trading revenues were particularly impressive - up 12% year-over-year to $6.3 billion, with equities having their best quarter ever, up 30%. Investment banking fees grew 21% year-over-year, driven by strength in M&A and equity capital markets.

ALEX: One thing that stood out in the Q&A was the discuss

This episode includes AI-generated content.]]>SP100-BAC-Q1-2026-enWed, 15 Apr 2026 21:36:00 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q1 2026 results, and folks, this was a pretty impressive quarter. ALEX: Before we jump in, I need to share...
JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q1 2026 results, and folks, this was a pretty impressive quarter.

ALEX: Before we jump in, I need to share our mandatory disclaimer - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now, let's talk Bank of America. Alex, the numbers were genuinely strong across the board here.

ALEX: They really were, Jordan. Revenue jumped 7% year-over-year to $30.3 billion, and earnings per share surged 25% to $1.11. But what caught my attention was that every single business segment contributed to growth - revenue, earnings, deposits, loans. That's the kind of diversified performance you love to see from a major bank.

JORDAN: And let's talk about that operating leverage - 290 basis points! For those keeping score at home, that means their revenue is growing much faster than their expenses. Their efficiency ratio improved from 63% to 61%, and they hit a 16% return on tangible common equity.

ALEX: Speaking of efficiency, there was this fascinating discussion about headcount. CEO Brian Moynihan mentioned they're down about 1,070 people from year-end 2025, but here's the kicker - they actually have fewer employees today than they did back in 2007, despite being a much larger company now.

JORDAN: That's the power of technology and AI at work. Moynihan talked about having 90 different AI installations running across the company, with all 200,000 employees having access to AI tools. Their virtual assistant Erica is just the tip of the iceberg.

ALEX: Let's dig into the business lines. Net interest income was a real standout - $15.9 billion on a fully taxable equivalent basis, up 9% year-over-year. And here's the big news: they actually raised their full-year NII guidance to 6% to 8% growth, up from their previous expectations.

JORDAN: That guidance increase is significant, Alex. CFO Alastair Borthwick attributed it to better balance sheet optimization, more favorable rate conditions, and the fact that the market now expects zero Fed rate cuts this year instead of the two cuts previously anticipated.

ALEX: The consumer banking segment was particularly strong - net income up 21% year-over-year to $3.1 billion. They added over 100,000 net new checking accounts and now have a record 38.5 million consumer checking accounts. Plus, 79% of households are digitally active.

JORDAN: And their wealth management business hit a record first quarter revenue of $6.7 billion, with net income up 32% year-over-year. Client balances reached $4.6 trillion. Those are some serious numbers.

ALEX: Now, there was an interesting discussion about credit quality. One analyst asked about their reserving approach, noting that Bank of America tends to have lower reserve ratios than peers. Borthwick pushed back, saying it reflects their higher-quality loan portfolio and more conservative client selection.

JORDAN: Right, and the credit metrics support that view. Net charge-offs, card delinquencies, and nonperforming loans all declined versus Q1 2025. They've been the lowest loss rate in Federal Reserve stress tests for 13 of the last 14 years.

ALEX: There was also discussion about their Global Markets lending business. Some investors have been nervous about exposure to private credit markets, but Borthwick emphasized they haven't experienced material losses and have structural protections in place.

JORDAN: The trading revenues were particularly impressive - up 12% year-over-year to $6.3 billion, with equities having their best quarter ever, up 30%....]]>465falsefullhttps://www.spreaker.com/episode/blackrock-q1-2026-earnings-analysis--71332857
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results so you don't have to. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're breaking down BlackRock's absolutely stellar Q1 2026 results that just dropped this morning.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Now, Alex, when you say "stellar," you're not kidding. BlackRock just delivered what CEO Larry Fink called "one of the strongest starts to a year in BlackRock's history." Let's start with the numbers that really matter.

**ALEX**: The headline numbers are impressive across the board. Revenue hit $6.7 billion, up 27% year-over-year. Operating income jumped 31% to $2.7 billion, and earnings per share came in at $12.53, up 11% from last year. But Jordan, what really caught my eye was that margin expansion.

**JORDAN**: Exactly! They expanded margins by over 130 basis points to 44.5%. And get this - they achieved 8% organic base fee growth in the quarter, which marks their seventh consecutive quarter at or above 5%. That's the kind of consistent execution that separates the leaders from the pack.

**ALEX**: The growth engine here seems to be what they're calling "whole portfolio" solutions. Can you explain what that means?

**JORDAN**: It's fascinating, actually. Essentially, clients are moving away from diversifying across multiple asset managers and instead consolidating with fewer strategic partners - sometimes just one. BlackRock is positioned perfectly for this because they can offer everything: public markets, private markets, and technology all on one integrated platform.

**ALEX**: And the numbers back that up. They saw $130 billion in net inflows during the quarter. That's massive! The ETF business alone brought in a record $132 billion in first-quarter flows, with particularly strong demand for international exposures.

**JORDAN**: The international angle is really interesting. When clients rotated toward international exposures this quarter, BlackRock benefited because iShares basically indexes every slice of global markets - from broad benchmarks to emerging markets to what they call "precision single-country allocations." These premium exposures drove double-digit organic base fee growth for ETFs.

**ALEX**: Let's talk about the elephant in the room - private credit. There's been a lot of noise in the market about stress in this sector. How is BlackRock positioned?

**JORDAN**: Larry Fink was pretty direct about this on the call. He said the headlines don't reflect what they're seeing from clients. While there's been some moderation in wealth vehicles like BDCs, institutional demand is actually accelerating. Here's a key stat: about 85% of their Private Financing Solutions investor base is institutional-focused, which gives them more durable capital across market cycles.

**ALEX**: And they're seeing wider spreads as a result of the market uncertainty, right?

**JORDAN**: Exactly. New direct lending is being quoted 25 to 50 basis points wider than Q4, with some opportunities over 100 basis points wider. As Fink put it, "periods of market dislocation are when private credit investment opportunities are most compelling."

**ALEX**: Now, there was one announcement that really grabbed my attention - the Department of Labor's proposed rule about private assets in 401(k) plans. This could be huge for BlackRock.

**JORDAN**: This is potentially transformative. BlackRock has a $600 billion LifePath target date franchise, and they're perfectly positioned if private assets enter the defined contribution market. Martin Small mentioned they've seen more advancement on private markets in 4

This episode includes AI-generated content.]]>SP100-BLK-Q1-2026-enWed, 15 Apr 2026 02:06:45 +0000trueBeta Finch# Beta Finch Podcast Script: BlackRock Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results so you don't have to. I'm Alex. **JORDAN**: And I'm Jordan. Today we're breaking...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results so you don't have to. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're breaking down BlackRock's absolutely stellar Q1 2026 results that just dropped this morning.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Now, Alex, when you say "stellar," you're not kidding. BlackRock just delivered what CEO Larry Fink called "one of the strongest starts to a year in BlackRock's history." Let's start with the numbers that really matter.

**ALEX**: The headline numbers are impressive across the board. Revenue hit $6.7 billion, up 27% year-over-year. Operating income jumped 31% to $2.7 billion, and earnings per share came in at $12.53, up 11% from last year. But Jordan, what really caught my eye was that margin expansion.

**JORDAN**: Exactly! They expanded margins by over 130 basis points to 44.5%. And get this - they achieved 8% organic base fee growth in the quarter, which marks their seventh consecutive quarter at or above 5%. That's the kind of consistent execution that separates the leaders from the pack.

**ALEX**: The growth engine here seems to be what they're calling "whole portfolio" solutions. Can you explain what that means?

**JORDAN**: It's fascinating, actually. Essentially, clients are moving away from diversifying across multiple asset managers and instead consolidating with fewer strategic partners - sometimes just one. BlackRock is positioned perfectly for this because they can offer everything: public markets, private markets, and technology all on one integrated platform.

**ALEX**: And the numbers back that up. They saw $130 billion in net inflows during the quarter. That's massive! The ETF business alone brought in a record $132 billion in first-quarter flows, with particularly strong demand for international exposures.

**JORDAN**: The international angle is really interesting. When clients rotated toward international exposures this quarter, BlackRock benefited because iShares basically indexes every slice of global markets - from broad benchmarks to emerging markets to what they call "precision single-country allocations." These premium exposures drove double-digit organic base fee growth for ETFs.

**ALEX**: Let's talk about the elephant in the room - private credit. There's been a lot of noise in the market about stress in this sector. How is BlackRock positioned?

**JORDAN**: Larry Fink was pretty direct about this on the call. He said the headlines don't reflect what they're seeing from clients. While there's been some moderation in wealth vehicles like BDCs, institutional demand is actually accelerating. Here's a key stat: about 85% of their Private Financing Solutions investor base is institutional-focused, which gives them more durable capital across market cycles.

**ALEX**: And they're seeing wider spreads as a result of the market uncertainty, right?

**JORDAN**: Exactly. New direct lending is being quoted 25 to 50 basis points wider than Q4, with some opportunities over 100 basis points wider. As Fink put it, "periods of market dislocation are when private credit investment opportunities are most compelling."

**ALEX**: Now, there was one announcement that really grabbed my attention - the Department of Labor's proposed rule about private assets in 401(k) plans. This could be huge for BlackRock.

**JORDAN**: This is potentially transformative. BlackRock has a $600 billion LifePath target date franchise,...]]>537falsefullhttps://www.spreaker.com/episode/wells-fargo-q1-2026-earnings-analysis--71328436
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Wells Fargo's Q1 2026 results that just dropped. Jordan, this looks like a pretty solid quarter for the banking giant.

JORDAN: Absolutely, Alex. Before we dig in though, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that important reminder. Now, let's talk numbers. Wells Fargo delivered some impressive growth across the board - diluted earnings per share up 15%, revenue growing 6%, and get this - loans growing 11% year-over-year. That's some serious momentum.

JORDAN: What really caught my eye was that they hit a major milestone - closing their final outstanding consent order. That's 14 consent orders terminated since 2019. This is huge for Wells Fargo because it means they can finally focus fully on growth rather than regulatory remediation.

ALEX: Right, and CEO Charles Scharf seemed pretty energized about this. He said they're now "focusing more fully on accelerating growth and improving returns." But let's break down the business performance. Each operating segment actually grew revenue year-over-year, which is pretty remarkable.

JORDAN: The diversification really shows. Consumer Banking and Lending up 7%, Commercial Banking up 7%, and their Corporate and Investment Bank saw banking revenue up 11% and markets revenue up 19%. That markets number is particularly strong given the volatile trading environment we've seen.

ALEX: And speaking of consumer banking, their credit card business is on fire - new account growth up nearly 60% year-over-year. They've been completely replatforming their credit card offerings over the past five years, and it's clearly paying off.

JORDAN: What's interesting is how they're balancing growth with credit discipline. Their net charge-off ratio held steady at 45 basis points year-over-year. That's solid performance, especially given they're growing the balance sheet aggressively.

ALEX: Now, there was quite a bit of discussion about their "financials except banks" portfolio - basically their non-bank financial lending. This has been getting a lot of attention lately, and CFO Michael Santomassimo did a deep dive on it.

JORDAN: Right, this portfolio is about $210 billion, or 21% of their total loans. There was one fraud-related loss that raised some eyebrows, but management seemed confident it was isolated. They went through the whole portfolio with a fine-tooth comb after that incident.

ALEX: The analysts were definitely pressing on this. One even compared it to commercial real estate office exposure from a few years ago - not necessarily in terms of risk, but in terms of generating negative attention that could overshadow good business performance.

JORDAN: Scharf pushed back on that comparison pretty firmly. He emphasized that the risk characteristics and structural protections are very different. They have advance rates that provide significant margins of protection, and they feel really good about their client selection and underwriting.

ALEX: Let's talk about the economic outlook because this is where things get interesting. They're seeing higher energy prices impacting consumers - gas now represents 75% of debit and credit card spend versus just 6% and 4% respectively before oil prices rose.

JORDAN: That's a staggering shift. Scharf noted that historically it takes consumers several months to adjust their spending in other categories when energy costs spike. They're expecting to see some economic impact in the second half of the year, but they feel good about their customers' financial health right now.

ALEX: On the regulatory front, there was some big news about th

This episode includes AI-generated content.]]>SP100-WFC-Q1-2026-enTue, 14 Apr 2026 21:35:44 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Wells Fargo's Q1 2026 results that just dropped. Jordan, this looks like a pretty solid quarter...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Wells Fargo's Q1 2026 results that just dropped. Jordan, this looks like a pretty solid quarter for the banking giant.

JORDAN: Absolutely, Alex. Before we dig in though, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that important reminder. Now, let's talk numbers. Wells Fargo delivered some impressive growth across the board - diluted earnings per share up 15%, revenue growing 6%, and get this - loans growing 11% year-over-year. That's some serious momentum.

JORDAN: What really caught my eye was that they hit a major milestone - closing their final outstanding consent order. That's 14 consent orders terminated since 2019. This is huge for Wells Fargo because it means they can finally focus fully on growth rather than regulatory remediation.

ALEX: Right, and CEO Charles Scharf seemed pretty energized about this. He said they're now "focusing more fully on accelerating growth and improving returns." But let's break down the business performance. Each operating segment actually grew revenue year-over-year, which is pretty remarkable.

JORDAN: The diversification really shows. Consumer Banking and Lending up 7%, Commercial Banking up 7%, and their Corporate and Investment Bank saw banking revenue up 11% and markets revenue up 19%. That markets number is particularly strong given the volatile trading environment we've seen.

ALEX: And speaking of consumer banking, their credit card business is on fire - new account growth up nearly 60% year-over-year. They've been completely replatforming their credit card offerings over the past five years, and it's clearly paying off.

JORDAN: What's interesting is how they're balancing growth with credit discipline. Their net charge-off ratio held steady at 45 basis points year-over-year. That's solid performance, especially given they're growing the balance sheet aggressively.

ALEX: Now, there was quite a bit of discussion about their "financials except banks" portfolio - basically their non-bank financial lending. This has been getting a lot of attention lately, and CFO Michael Santomassimo did a deep dive on it.

JORDAN: Right, this portfolio is about $210 billion, or 21% of their total loans. There was one fraud-related loss that raised some eyebrows, but management seemed confident it was isolated. They went through the whole portfolio with a fine-tooth comb after that incident.

ALEX: The analysts were definitely pressing on this. One even compared it to commercial real estate office exposure from a few years ago - not necessarily in terms of risk, but in terms of generating negative attention that could overshadow good business performance.

JORDAN: Scharf pushed back on that comparison pretty firmly. He emphasized that the risk characteristics and structural protections are very different. They have advance rates that provide significant margins of protection, and they feel really good about their client selection and underwriting.

ALEX: Let's talk about the economic outlook because this is where things get interesting. They're seeing higher energy prices impacting consumers - gas now represents 75% of debit and credit card spend versus just 6% and 4% respectively before oil prices rose.

JORDAN: That's a staggering shift. Scharf noted that historically it takes consumers several months to adjust their spending in other categories when energy costs spike. They're expecting to see some economic impact in the second half of...]]>462falsefullhttps://www.spreaker.com/episode/citigroup-q1-2026-earnings-analysis--71328434
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we digest the latest corporate results so you don't have to. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Citigroup's first quarter 2026 results, and wow - what a quarter this was.

**ALEX**: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk about these numbers because Citigroup really came out swinging. Net income of $5.8 billion, earnings per share of $3.06, and a return on tangible common equity of 13.1%. That's significantly above their full-year guidance of 10% to 11%.

**ALEX**: Right, and CEO Jane Fraser was quick to temper expectations there, saying - and I love this quote - "One good first quarter does not a full year make." Very British of her! But seriously, the revenue growth was impressive - up 14% year-over-year to $24.6 billion. What really stood out to you in the segment performance?

**JORDAN**: Services was the crown jewel here - and they literally call it that. Revenues up 17%, which Fraser said was the best first quarter in a decade. New client mandates up 40%, deposits growing 16%, and they're seeing major wins like that BlackRock middle office servicing deal. This business is firing on all cylinders with a 27% return on tangible equity.

**ALEX**: And Markets crossed $7 billion in revenues for the first time in a decade. Equities was particularly strong - up nearly 40% and surpassing $2 billion. It seems like all the pieces are coming together for Citi's institutional businesses.

**JORDAN**: Exactly. Banking also had momentum with M&A fees up 19% - their strongest first quarter in a decade there too. They advised on the three largest deals of the year so far. Even their consumer businesses showed resilience with Cards delivering a 19% return on tangible equity.

**ALEX**: Now, one of the biggest themes from this call was around M&A speculation. There have been rumors about Citi potentially pursuing acquisitions, but Fraser was incredibly direct about this. Want to share what she said?

**JORDAN**: She was crystal clear - and used those exact words multiple times. When analyst Mike Mayo pressed her on whether Citi was pursuing any deals, she said unequivocally: "We are not interested in anything other than organic growth." She really wanted to shut down that speculation completely.

**ALEX**: Which makes sense given where they are in their transformation. Speaking of which, they're now 90% complete with their regulatory transformation programs. New CFO Gonzalo Luchetti mentioned they're starting to see those transformation expenses come down, which should help their efficiency ratio going forward.

**JORDAN**: And they're already seeing that benefit. Their efficiency ratio improved to 58% this quarter, even with nearly $500 million in severance costs as they continue to optimize their workforce. For the full year, they're guiding to around 60%, which would be a solid improvement.

**ALEX**: The capital story is interesting too. They deployed $6.3 billion in share buybacks - their highest ever quarterly amount. They're sitting at a 12.7% CET1 ratio, about 110 basis points above their regulatory requirement. And they got a nice capital boost from completing their Russia exit, which freed up about $4 billion.

**JORDAN**: They're also making progress on other divestitures. They've agreed to sell another 24% stake in Banamex to prominent investors, and they're on track to close the sale of their Polish consumer business this summer. Fraser was clear they want to complete these portfolio simplification efforts rather than pursue new acquisitions.

**ALEX**: One thing that

This episode includes AI-generated content.]]>SP100-C-Q1-2026-enTue, 14 Apr 2026 21:35:38 +0000trueBeta Finch# Beta Finch Episode Script: Citigroup Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we digest the latest corporate results so you don't have to. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we digest the latest corporate results so you don't have to. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Citigroup's first quarter 2026 results, and wow - what a quarter this was.

**ALEX**: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk about these numbers because Citigroup really came out swinging. Net income of $5.8 billion, earnings per share of $3.06, and a return on tangible common equity of 13.1%. That's significantly above their full-year guidance of 10% to 11%.

**ALEX**: Right, and CEO Jane Fraser was quick to temper expectations there, saying - and I love this quote - "One good first quarter does not a full year make." Very British of her! But seriously, the revenue growth was impressive - up 14% year-over-year to $24.6 billion. What really stood out to you in the segment performance?

**JORDAN**: Services was the crown jewel here - and they literally call it that. Revenues up 17%, which Fraser said was the best first quarter in a decade. New client mandates up 40%, deposits growing 16%, and they're seeing major wins like that BlackRock middle office servicing deal. This business is firing on all cylinders with a 27% return on tangible equity.

**ALEX**: And Markets crossed $7 billion in revenues for the first time in a decade. Equities was particularly strong - up nearly 40% and surpassing $2 billion. It seems like all the pieces are coming together for Citi's institutional businesses.

**JORDAN**: Exactly. Banking also had momentum with M&A fees up 19% - their strongest first quarter in a decade there too. They advised on the three largest deals of the year so far. Even their consumer businesses showed resilience with Cards delivering a 19% return on tangible equity.

**ALEX**: Now, one of the biggest themes from this call was around M&A speculation. There have been rumors about Citi potentially pursuing acquisitions, but Fraser was incredibly direct about this. Want to share what she said?

**JORDAN**: She was crystal clear - and used those exact words multiple times. When analyst Mike Mayo pressed her on whether Citi was pursuing any deals, she said unequivocally: "We are not interested in anything other than organic growth." She really wanted to shut down that speculation completely.

**ALEX**: Which makes sense given where they are in their transformation. Speaking of which, they're now 90% complete with their regulatory transformation programs. New CFO Gonzalo Luchetti mentioned they're starting to see those transformation expenses come down, which should help their efficiency ratio going forward.

**JORDAN**: And they're already seeing that benefit. Their efficiency ratio improved to 58% this quarter, even with nearly $500 million in severance costs as they continue to optimize their workforce. For the full year, they're guiding to around 60%, which would be a solid improvement.

**ALEX**: The capital story is interesting too. They deployed $6.3 billion in share buybacks - their highest ever quarterly amount. They're sitting at a 12.7% CET1 ratio, about 110 basis points above their regulatory requirement. And they got a nice capital boost from completing their Russia exit, which freed up about $4 billion.

**JORDAN**: They're also making progress on other divestitures. They've agreed to sell another 24% stake in Banamex to prominent investors, and they're on track to close the sale of their Polish consumer business this...]]>475falsefullhttps://www.spreaker.com/episode/goldman-sachs-q1-2026-earnings-analysis--71298824
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Goldman Sachs' absolutely stellar Q1 2026 results that just dropped.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, these numbers are pretty eye-popping. What jumped out at you first?

**JORDAN:** Alex, Goldman just delivered their second-highest quarterly performance in company history. We're talking $17.2 billion in net revenues, $5.6 billion in net earnings, and earnings per share of $17.55. That drove a return on equity of nearly 20% at 19.8%. These are numbers that would make any CFO jealous.

**ALEX:** That ROE is particularly impressive. And what's driving this performance? It seems like their Global Banking & Markets division is firing on all cylinders.

**JORDAN:** Absolutely. Global Banking & Markets hit record quarterly revenues of $12.7 billion with an ROE over 22%. The standout here is equities, which generated a record $5.3 billion in revenues. Their equities financing business alone brought in $2.6 billion - that's up 59% year-over-year.

**ALEX:** Now, there's an interesting geographic story here too, right? Goldman's been talking about Asia as a growth opportunity.

**JORDAN:** Exactly. CEO David Solomon specifically highlighted their progress in Asia, particularly in prime brokerage. They saw record average prime balances during the quarter, and this Asia expansion is a key part of their strategy to close competitive gaps in certain regions. It's paying off - financing revenues across FICC and equities now comprise nearly 40% of total revenues in those divisions.

**ALEX:** Let's talk about the investment banking side. They maintained their number one position in M&A globally, but there are some interesting crosscurrents in the market.

**JORDAN:** Right. Advisory revenues jumped 89% year-over-year to $1.5 billion on higher completed volumes. They're sitting on some massive deals - like the $43 billion Unilever-McCormick merger and Sysco's $29 billion Jetro acquisition. What's really telling is that even after executing on extraordinary deal flow this quarter, their backlog remained "extraordinarily robust" according to Solomon.

**ALEX:** But not everything was smooth sailing. There was some softness in certain areas, and geopolitical tensions seemed to weigh on markets toward the end of the quarter.

**JORDAN:** That's right. Solomon noted that while Q1 started optimistically with markets hitting record highs, the macro environment began weighing on sentiment as the quarter progressed. Volatility increased meaningfully due to AI-driven disruption concerns, uncertainty in parts of private credit, and the Middle East conflict. This particularly impacted IPO activity in March.

**ALEX:** Speaking of private credit - this has been a hot-button issue in the market lately. How did Goldman address the concerns?

**JORDAN:** Solomon was pretty direct about this. He pointed out that while private credit broadly is about $3.5 trillion, the direct lending space getting all the negative attention is around $1.6-1.7 trillion, with only about 20% or $230 billion in retail NAV. Goldman's platform is over 80% institutional investors with very broad diversification.

Interestingly, he noted that 40% of their Q1 subscriptions in their credit BDC came from institutions, many first-time investors including insurance companies and pension funds.

**ALEX:** What was his take on potential credit cycles and losses?

**JORDAN:** He provided some historical context that I found fascinating. During the global financial crisis - arguably the toughes

This episode includes AI-generated content.]]>SP100-GS-Q1-2026-enMon, 13 Apr 2026 21:23:38 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Goldman Sachs'...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Goldman Sachs' absolutely stellar Q1 2026 results that just dropped.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, these numbers are pretty eye-popping. What jumped out at you first?

**JORDAN:** Alex, Goldman just delivered their second-highest quarterly performance in company history. We're talking $17.2 billion in net revenues, $5.6 billion in net earnings, and earnings per share of $17.55. That drove a return on equity of nearly 20% at 19.8%. These are numbers that would make any CFO jealous.

**ALEX:** That ROE is particularly impressive. And what's driving this performance? It seems like their Global Banking & Markets division is firing on all cylinders.

**JORDAN:** Absolutely. Global Banking & Markets hit record quarterly revenues of $12.7 billion with an ROE over 22%. The standout here is equities, which generated a record $5.3 billion in revenues. Their equities financing business alone brought in $2.6 billion - that's up 59% year-over-year.

**ALEX:** Now, there's an interesting geographic story here too, right? Goldman's been talking about Asia as a growth opportunity.

**JORDAN:** Exactly. CEO David Solomon specifically highlighted their progress in Asia, particularly in prime brokerage. They saw record average prime balances during the quarter, and this Asia expansion is a key part of their strategy to close competitive gaps in certain regions. It's paying off - financing revenues across FICC and equities now comprise nearly 40% of total revenues in those divisions.

**ALEX:** Let's talk about the investment banking side. They maintained their number one position in M&A globally, but there are some interesting crosscurrents in the market.

**JORDAN:** Right. Advisory revenues jumped 89% year-over-year to $1.5 billion on higher completed volumes. They're sitting on some massive deals - like the $43 billion Unilever-McCormick merger and Sysco's $29 billion Jetro acquisition. What's really telling is that even after executing on extraordinary deal flow this quarter, their backlog remained "extraordinarily robust" according to Solomon.

**ALEX:** But not everything was smooth sailing. There was some softness in certain areas, and geopolitical tensions seemed to weigh on markets toward the end of the quarter.

**JORDAN:** That's right. Solomon noted that while Q1 started optimistically with markets hitting record highs, the macro environment began weighing on sentiment as the quarter progressed. Volatility increased meaningfully due to AI-driven disruption concerns, uncertainty in parts of private credit, and the Middle East conflict. This particularly impacted IPO activity in March.

**ALEX:** Speaking of private credit - this has been a hot-button issue in the market lately. How did Goldman address the concerns?

**JORDAN:** Solomon was pretty direct about this. He pointed out that while private credit broadly is about $3.5 trillion, the direct lending space getting all the negative attention is around $1.6-1.7 trillion, with only about 20% or $230 billion in retail NAV. Goldman's platform is over 80% institutional investors with very broad diversification.

Interestingly, he noted that 40% of their Q1 subscriptions in their credit BDC came from institutions, many first-time investors including insurance companies and pension funds.

**ALEX:** What was his...]]>560falsefullhttps://www.spreaker.com/episode/charles-schwab-q4-2025-earnings-analysis--70859655
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the market-moving insights that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Charles Schwab's Q4 2025 earnings call, and wow - this was a record-breaking quarter for the brokerage giant.

**ALEX:** Before we jump in, just a quick note - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk numbers because Schwab really delivered some impressive results here.

**ALEX:** They sure did. Full-year 2025 was nothing short of spectacular. Total net revenues hit a record $23.9 billion - that's up 22% year-over-year. But here's the kicker - adjusted earnings per share jumped 50% to $4.87, which actually exceeded their own guidance range.

**JORDAN:** That earnings growth is remarkable, especially when you consider the challenging environment brokerages have faced. What drove this performance?

**ALEX:** It's really a three-pronged story. First, they attracted $519 billion in core net new assets - a 42% increase over 2024. Second, client engagement was through the roof with 1.9 billion trades executed. And third, their diversification strategy is paying off big time.

**JORDAN:** Let's unpack that diversification piece because I think that's what makes Schwab's story so compelling right now. They're not just a traditional brokerage anymore.

**ALEX:** Exactly. Their managed investing net flows grew 36% year-over-year, hitting nearly $70 billion. Bank lending balances reached an all-time high of $58 billion. They're essentially becoming a one-stop financial shop, and clients are responding. CEO Rick Wurster mentioned that only 5% of retail households currently use their managed investing solutions, but 31% say they're willing to pay for advice.

**JORDAN:** That's a massive opportunity gap. And speaking of opportunities, their lending business caught my attention. Pledged asset line balances nearly doubled since 2023, but penetration rates are still really low - only 9% of ultra-high net worth retail clients have a PAL.

**ALEX:** Right, and that low penetration is actually good news for future growth. CFO Mike Verdeschi highlighted they've streamlined the PAL experience to about a day for most clients, with nearly three-quarters completed in less than 24 hours. With spreads north of 100 basis points, it's a win-win for clients and shareholders.

**JORDAN:** Now let's talk about their 2026 outlook because the guidance was pretty bullish. They're projecting total revenue growth of 9.5% to 10.5%, with adjusted earnings potentially reaching $5.70 to $5.80 per share.

**ALEX:** That would represent upper-teens earnings growth, which is impressive. What I found interesting was their assumption of a slight pullback in trading volumes to 7.4 million daily average trades, down from the record levels they saw in 2025. They're being conservative there, which I appreciate.

**JORDAN:** Speaking of trading, there was a fascinating discussion about prediction markets during the Q&A. Rick Wurster was pretty clear - they're open to financial prediction markets if there's client demand, but they're steering clear of sports betting.

**ALEX:** I thought his comment was telling: "Less than 5% of clients that put money into gambling apps leave with more money than they put in." That's a stark contrast to Schwab clients hitting all-time record wealth levels. It shows they're staying true to their mission of helping clients build long-term wealth.

**JORDAN:** Another strategic move that caught my eye was their acquisition of Forge, which is expected to close soon. This gives them access to private company investing, es

This episode includes AI-generated content.]]>SP100-SCHW-Q4-2025-enTue, 24 Mar 2026 22:01:54 +0000trueBeta Finch**Beta Finch Podcast Script - Schwab Q4 2025 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the market-moving insights that matter. I'm Alex. **JORDAN:** And I'm...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the market-moving insights that matter. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Charles Schwab's Q4 2025 earnings call, and wow - this was a record-breaking quarter for the brokerage giant.

**ALEX:** Before we jump in, just a quick note - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk numbers because Schwab really delivered some impressive results here.

**ALEX:** They sure did. Full-year 2025 was nothing short of spectacular. Total net revenues hit a record $23.9 billion - that's up 22% year-over-year. But here's the kicker - adjusted earnings per share jumped 50% to $4.87, which actually exceeded their own guidance range.

**JORDAN:** That earnings growth is remarkable, especially when you consider the challenging environment brokerages have faced. What drove this performance?

**ALEX:** It's really a three-pronged story. First, they attracted $519 billion in core net new assets - a 42% increase over 2024. Second, client engagement was through the roof with 1.9 billion trades executed. And third, their diversification strategy is paying off big time.

**JORDAN:** Let's unpack that diversification piece because I think that's what makes Schwab's story so compelling right now. They're not just a traditional brokerage anymore.

**ALEX:** Exactly. Their managed investing net flows grew 36% year-over-year, hitting nearly $70 billion. Bank lending balances reached an all-time high of $58 billion. They're essentially becoming a one-stop financial shop, and clients are responding. CEO Rick Wurster mentioned that only 5% of retail households currently use their managed investing solutions, but 31% say they're willing to pay for advice.

**JORDAN:** That's a massive opportunity gap. And speaking of opportunities, their lending business caught my attention. Pledged asset line balances nearly doubled since 2023, but penetration rates are still really low - only 9% of ultra-high net worth retail clients have a PAL.

**ALEX:** Right, and that low penetration is actually good news for future growth. CFO Mike Verdeschi highlighted they've streamlined the PAL experience to about a day for most clients, with nearly three-quarters completed in less than 24 hours. With spreads north of 100 basis points, it's a win-win for clients and shareholders.

**JORDAN:** Now let's talk about their 2026 outlook because the guidance was pretty bullish. They're projecting total revenue growth of 9.5% to 10.5%, with adjusted earnings potentially reaching $5.70 to $5.80 per share.

**ALEX:** That would represent upper-teens earnings growth, which is impressive. What I found interesting was their assumption of a slight pullback in trading volumes to 7.4 million daily average trades, down from the record levels they saw in 2025. They're being conservative there, which I appreciate.

**JORDAN:** Speaking of trading, there was a fascinating discussion about prediction markets during the Q&A. Rick Wurster was pretty clear - they're open to financial prediction markets if there's client demand, but they're steering clear of sports betting.

**ALEX:** I thought his comment was telling: "Less than 5% of clients that put money into gambling apps leave with more money than they put in." That's a stark contrast to Schwab clients hitting all-time record wealth levels. It shows they're staying true to their mission of helping clients build long-term wealth.
498falsefullhttps://www.spreaker.com/episode/american-tower-q4-2025-earnings-analysis--70801953
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into American Tower's Q4 2025 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. American Tower just wrapped up what they're calling "a great year and excellent fourth quarter," but there's definitely some complexity beneath the surface. The big headline number looks solid - they delivered 8% growth in attributable AFFO per share for the full year, with an impressive 13% growth in Q4 alone.

**ALEX:** Right, and that 8% growth sits right in their long-term target range of mid-to-high single digits. But Jordan, there's an elephant in the room here that's affecting their 2026 outlook - can you walk us through the DISH situation?

**JORDAN:** Absolutely. So DISH has defaulted on their payment obligations to American Tower, and management has completely removed DISH from their 2026 guidance. To put this in perspective, DISH represented about 2% of consolidated property revenue and 4% of U.S. and Canada property revenue in 2025. We're talking roughly $200 million annually through 2035-2036.

**ALEX:** That's a significant hit. How is this affecting their 2026 outlook?

**JORDAN:** Well, it's pretty dramatic. Their consolidated organic tenant billings growth is expected to be only about 1% in 2026. But here's the key - if you exclude the DISH churn, that number jumps to 4%. So the underlying business is still performing well, but this one-time event is masking that growth.

**ALEX:** I noticed they're being pretty aggressive about pursuing legal action against DISH. What's the company saying about potential recovery?

**JORDAN:** CEO Steven Vondran was clear that they plan to "fight in the litigation" and think their contract is enforceable. But they're not counting on any recovery in their guidance - anything they collect would be upside. Smart approach from a conservative forecasting standpoint.

**ALEX:** Let's talk about the regional performance because there's quite a bit of variation. What stood out to you?

**JORDAN:** The regional story is really interesting. In Africa and Asia-Pacific, they're expecting 8.5% organic tenant billings growth - that's actually accelerating from 2025 levels. Europe is steady at 4%. But Latin America is the real challenge, with organic tenant billings expected to decline 3% due to elevated churn in Brazil from carrier consolidation.

**ALEX:** That Latin America situation sounds concerning. How is management framing that?

**JORDAN:** Actually, they're surprisingly optimistic. They're saying the churn is happening faster than expected, which means the market repair in Brazil should happen sooner - they now expect growth to accelerate in 2027 instead of 2028. It's one of those "short-term pain, long-term gain" situations.

**ALEX:** Now, one area that's been a real bright spot is their data center business through CoreSite. What are the numbers there?

**JORDAN:** CoreSite is absolutely crushing it. They're expecting 13% growth in their U.S. data center business in 2026, and this is their fourth consecutive year of record sales growth. What's really exciting is the AI component - demand for AI-related use cases like inferencing and machine learning is becoming their fastest-growing segment.

**ALEX:** I caught in the Q&A that they actually have more demand for inferencing than they can currently meet. That seems like a good problem to have.

**JORDAN:** Exactly! Vondran mentioned they're being selective about their customer mix, only choosing "the best names in the space." They're investing over $700 million in their data center portfolio in 2026, primarily to replenish capa

This episode includes AI-generated content.]]>SP100-AMT-Q4-2025-enSat, 21 Mar 2026 20:31:43 +0000trueBeta Finch**Beta Finch Podcast Script: American Tower Q4 2025 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into American Tower's Q4 2025 results. This podcast is...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into American Tower's Q4 2025 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. American Tower just wrapped up what they're calling "a great year and excellent fourth quarter," but there's definitely some complexity beneath the surface. The big headline number looks solid - they delivered 8% growth in attributable AFFO per share for the full year, with an impressive 13% growth in Q4 alone.

**ALEX:** Right, and that 8% growth sits right in their long-term target range of mid-to-high single digits. But Jordan, there's an elephant in the room here that's affecting their 2026 outlook - can you walk us through the DISH situation?

**JORDAN:** Absolutely. So DISH has defaulted on their payment obligations to American Tower, and management has completely removed DISH from their 2026 guidance. To put this in perspective, DISH represented about 2% of consolidated property revenue and 4% of U.S. and Canada property revenue in 2025. We're talking roughly $200 million annually through 2035-2036.

**ALEX:** That's a significant hit. How is this affecting their 2026 outlook?

**JORDAN:** Well, it's pretty dramatic. Their consolidated organic tenant billings growth is expected to be only about 1% in 2026. But here's the key - if you exclude the DISH churn, that number jumps to 4%. So the underlying business is still performing well, but this one-time event is masking that growth.

**ALEX:** I noticed they're being pretty aggressive about pursuing legal action against DISH. What's the company saying about potential recovery?

**JORDAN:** CEO Steven Vondran was clear that they plan to "fight in the litigation" and think their contract is enforceable. But they're not counting on any recovery in their guidance - anything they collect would be upside. Smart approach from a conservative forecasting standpoint.

**ALEX:** Let's talk about the regional performance because there's quite a bit of variation. What stood out to you?

**JORDAN:** The regional story is really interesting. In Africa and Asia-Pacific, they're expecting 8.5% organic tenant billings growth - that's actually accelerating from 2025 levels. Europe is steady at 4%. But Latin America is the real challenge, with organic tenant billings expected to decline 3% due to elevated churn in Brazil from carrier consolidation.

**ALEX:** That Latin America situation sounds concerning. How is management framing that?

**JORDAN:** Actually, they're surprisingly optimistic. They're saying the churn is happening faster than expected, which means the market repair in Brazil should happen sooner - they now expect growth to accelerate in 2027 instead of 2028. It's one of those "short-term pain, long-term gain" situations.

**ALEX:** Now, one area that's been a real bright spot is their data center business through CoreSite. What are the numbers there?

**JORDAN:** CoreSite is absolutely crushing it. They're expecting 13% growth in their U.S. data center business in 2026, and this is their fourth consecutive year of record sales growth. What's really exciting is the AI component - demand for AI-related use cases like inferencing and machine learning is becoming their fastest-growing segment.

**ALEX:** I caught in the Q&A that they actually have more demand for inferencing than they can currently meet. That seems like a good problem to have.

**JORDAN:** Exactly! Vondran mentioned they're being selective...]]>522falsefullhttps://www.spreaker.com/episode/illinois-tool-works-q4-2025-earnings-analysis--70801931
---

**ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Illinois Tool Works' latest earnings call. Jordan, ITW just delivered what looks like a solid finish to 2025 and some pretty optimistic guidance for 2026.

**JORDAN**: Absolutely, Alex. But before we get into the numbers, let me remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that important reminder. Now, let's talk ITW. The industrial conglomerate posted some impressive results - Q4 revenue growth of over 4%, with organic growth of 1.3%, and a 7% increase in GAAP EPS to $2.72. But what really caught my eye was their operating margin hitting record levels at 26.5%.

**JORDAN**: Those margins are eye-popping, Alex. What's driving that performance is their "enterprise initiatives" - basically their continuous improvement programs - which contributed 140 basis points to margins in Q4 alone. And here's the kicker: they're projecting another 100 basis points of margin improvement in 2026 from these same initiatives.

**ALEX**: That's massive. Let's talk about their guidance for 2026. They're projecting organic growth of 1% to 3%, total revenue growth of 2% to 4%, and EPS growth of 7% at the midpoint of $11.20. Jordan, what's your take on these numbers?

**JORDAN**: What strikes me is the quality of this guidance, Alex. CEO Chris O'Herlihy emphasized that their incremental margins are running in the "mid to high forties" - that's well above their historical 35-40% range. CFO Michael Larsen explained this isn't just about getting lucky with market conditions. They've fundamentally improved their portfolio quality through years of what they call "PLS" - product line simplification - essentially pruning weaker products and focusing on their best performers.

**ALEX**: Speaking of focus, let's dive into their Customer-Backed Innovation, or CBI initiative. This seems to be a real growth driver for them.

**JORDAN**: CBI is fascinating, Alex. They achieved 2.4% revenue growth from customer-backed innovation in 2025 - that's a 40 basis point improvement year-over-year. But here's what's really interesting: their patent filings increased 18% in 2024 and another 9% in 2025. O'Herlihy called this a "leading indicator" because their patents typically protect customer solutions, suggesting future revenue growth is in the pipeline.

**ALEX**: And they're targeting 3% plus CBI contribution by 2030. That's become so important to their strategy that they've actually added it to their executive compensation plans. Now, during the Q&A, there were some interesting questions about specific segments. What stood out to you?

**JORDAN**: The semiconductor discussion was compelling. Their test and measurement segment saw semis up mid-single digits in Q4 after what had been a challenging year. Andy Kaplowitz from Citi asked about whether this was sustainable, given they'd seen "head fakes" before. O'Herlihy was cautiously optimistic - semis represent about 15% of their test and measurement business, or roughly 3% of total ITW. He emphasized they're well-positioned to take market share as that sector recovers.

**ALEX**: The China story is also worth highlighting. They grew 9% there for the full year, with automotive OEM up 12%. That's largely driven by their success in the EV market, where they've made significant investments over recent years.

**JORDAN**: Exactly. China represents about 65% of worldwide EV builds, and ITW has positioned themselves well with Chinese OEMs, who now represent 70% of that market. They're expecting mid to high single-digit growth in China for 2026, which shows how their strategic investments are paying off.

**ALEX**: One

This episode includes AI-generated content.]]>SP100-ITW-Q4-2025-enSat, 21 Mar 2026 20:29:39 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Illinois Tool Works' latest earnings call. Jordan, ITW just delivered what looks like a solid...
---

**ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Illinois Tool Works' latest earnings call. Jordan, ITW just delivered what looks like a solid finish to 2025 and some pretty optimistic guidance for 2026.

**JORDAN**: Absolutely, Alex. But before we get into the numbers, let me remind our listeners that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks for that important reminder. Now, let's talk ITW. The industrial conglomerate posted some impressive results - Q4 revenue growth of over 4%, with organic growth of 1.3%, and a 7% increase in GAAP EPS to $2.72. But what really caught my eye was their operating margin hitting record levels at 26.5%.

**JORDAN**: Those margins are eye-popping, Alex. What's driving that performance is their "enterprise initiatives" - basically their continuous improvement programs - which contributed 140 basis points to margins in Q4 alone. And here's the kicker: they're projecting another 100 basis points of margin improvement in 2026 from these same initiatives.

**ALEX**: That's massive. Let's talk about their guidance for 2026. They're projecting organic growth of 1% to 3%, total revenue growth of 2% to 4%, and EPS growth of 7% at the midpoint of $11.20. Jordan, what's your take on these numbers?

**JORDAN**: What strikes me is the quality of this guidance, Alex. CEO Chris O'Herlihy emphasized that their incremental margins are running in the "mid to high forties" - that's well above their historical 35-40% range. CFO Michael Larsen explained this isn't just about getting lucky with market conditions. They've fundamentally improved their portfolio quality through years of what they call "PLS" - product line simplification - essentially pruning weaker products and focusing on their best performers.

**ALEX**: Speaking of focus, let's dive into their Customer-Backed Innovation, or CBI initiative. This seems to be a real growth driver for them.

**JORDAN**: CBI is fascinating, Alex. They achieved 2.4% revenue growth from customer-backed innovation in 2025 - that's a 40 basis point improvement year-over-year. But here's what's really interesting: their patent filings increased 18% in 2024 and another 9% in 2025. O'Herlihy called this a "leading indicator" because their patents typically protect customer solutions, suggesting future revenue growth is in the pipeline.

**ALEX**: And they're targeting 3% plus CBI contribution by 2030. That's become so important to their strategy that they've actually added it to their executive compensation plans. Now, during the Q&A, there were some interesting questions about specific segments. What stood out to you?

**JORDAN**: The semiconductor discussion was compelling. Their test and measurement segment saw semis up mid-single digits in Q4 after what had been a challenging year. Andy Kaplowitz from Citi asked about whether this was sustainable, given they'd seen "head fakes" before. O'Herlihy was cautiously optimistic - semis represent about 15% of their test and measurement business, or roughly 3% of total ITW. He emphasized they're well-positioned to take market share as that sector recovers.

**ALEX**: The China story is also worth highlighting. They grew 9% there for the full year, with automotive OEM up 12%. That's largely driven by their success in the EV market, where they've made significant investments over recent years.

**JORDAN**: Exactly. China represents about 65% of worldwide EV builds, and ITW has positioned themselves well with Chinese OEMs, who now represent 70% of that market. They're...]]>494falsefullhttps://www.spreaker.com/episode/zoetis-q4-2025-earnings-analysis--70801914
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to dive into Zoetis' Q4 2025 earnings call. Jordan, this was quite the earnings report from the animal health giant.

JORDAN: Absolutely, Alex. But before we jump into the numbers, I need to share an important disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk Zoetis. The company reported some solid numbers for 2025 - $9.5 billion in revenue with 6% organic operational growth, and adjusted net income growing 7% organically. They hit the high end of their November guidance range.

JORDAN: That's right, and what I found particularly interesting is how their international markets really carried the load here. International delivered 8% organic operational revenue growth while the U.S. was at 4%. It really shows the value of having that global diversification, especially when you're dealing with some headwinds in your home market.

ALEX: Speaking of headwinds, CEO Kristin Peck was pretty candid about what they're seeing in the U.S. veterinary market. She mentioned economic pressure on Gen Z and millennial pet owners, which has led to declining therapeutic visits. But here's the fascinating part - emergency and urgent care are still showing strength.

JORDAN: That's such an important distinction, Alex. It's not that pet owners love their animals any less or that underlying demand for care is declining. It's more about price sensitivity and tighter household budgets when it comes to routine care. Pet owners are still bringing their dogs in when they're sick, but they're being more selective about wellness visits.

ALEX: Exactly. And Peck mentioned that clinics are starting to react by taking a more measured approach to the overall cost of care. The company is responding with targeted actions - optimizing their channel mix, increasing outreach to veterinarians, and reinforcing their scientific leadership through expanded medical education.

JORDAN: Let's talk about their star performer - the Simparica franchise. This is really impressive stuff. The franchise grew 12% operationally for the year, with Simparica Trio hitting over $1 billion in U.S. sales alone. That makes it their first brand to cross that billion-dollar threshold in the U.S.

ALEX: And globally, Trio maintained its position as the number one selling canine brand. What I found interesting is their omnichannel strategy - they're seeing double-digit contributions from retail and home delivery channels, which is helping them navigate those headwinds in traditional veterinary clinics.

JORDAN: That's smart positioning. They're essentially meeting customers where they want to shop, whether that's at the vet, at retail, or having products delivered to their home. It's all about convenience and compliance for pet owners.

ALEX: Now, let's address the elephant in the room - their OA pain franchise. This declined 3% operationally, with Librela specifically down 6%. This has been a challenge for Zoetis, and there have been some safety concerns raised about these monoclonal antibody treatments.

JORDAN: Right, but Peck seemed confident about their multipronged strategy to turn this around. She mentioned they're seeing stabilizing monthly sales trends and that veterinarian and pet owner satisfaction remains high. Plus, they're introducing new products like Lanivia and Portela to expand their OA pain portfolio.

ALEX: The guidance for 2026 is what really caught my attention, Jordan. They're projecting 3% to 5% organic operational revenue growth and 3% to 6% adjusted net income growth. That's a bit more conservative than what we've see

This episode includes AI-generated content.]]>SP100-ZTS-Q4-2025-enSat, 21 Mar 2026 20:28:32 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to dive into Zoetis' Q4 2025 earnings call. Jordan, this...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan to dive into Zoetis' Q4 2025 earnings call. Jordan, this was quite the earnings report from the animal health giant.

JORDAN: Absolutely, Alex. But before we jump into the numbers, I need to share an important disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk Zoetis. The company reported some solid numbers for 2025 - $9.5 billion in revenue with 6% organic operational growth, and adjusted net income growing 7% organically. They hit the high end of their November guidance range.

JORDAN: That's right, and what I found particularly interesting is how their international markets really carried the load here. International delivered 8% organic operational revenue growth while the U.S. was at 4%. It really shows the value of having that global diversification, especially when you're dealing with some headwinds in your home market.

ALEX: Speaking of headwinds, CEO Kristin Peck was pretty candid about what they're seeing in the U.S. veterinary market. She mentioned economic pressure on Gen Z and millennial pet owners, which has led to declining therapeutic visits. But here's the fascinating part - emergency and urgent care are still showing strength.

JORDAN: That's such an important distinction, Alex. It's not that pet owners love their animals any less or that underlying demand for care is declining. It's more about price sensitivity and tighter household budgets when it comes to routine care. Pet owners are still bringing their dogs in when they're sick, but they're being more selective about wellness visits.

ALEX: Exactly. And Peck mentioned that clinics are starting to react by taking a more measured approach to the overall cost of care. The company is responding with targeted actions - optimizing their channel mix, increasing outreach to veterinarians, and reinforcing their scientific leadership through expanded medical education.

JORDAN: Let's talk about their star performer - the Simparica franchise. This is really impressive stuff. The franchise grew 12% operationally for the year, with Simparica Trio hitting over $1 billion in U.S. sales alone. That makes it their first brand to cross that billion-dollar threshold in the U.S.

ALEX: And globally, Trio maintained its position as the number one selling canine brand. What I found interesting is their omnichannel strategy - they're seeing double-digit contributions from retail and home delivery channels, which is helping them navigate those headwinds in traditional veterinary clinics.

JORDAN: That's smart positioning. They're essentially meeting customers where they want to shop, whether that's at the vet, at retail, or having products delivered to their home. It's all about convenience and compliance for pet owners.

ALEX: Now, let's address the elephant in the room - their OA pain franchise. This declined 3% operationally, with Librela specifically down 6%. This has been a challenge for Zoetis, and there have been some safety concerns raised about these monoclonal antibody treatments.

JORDAN: Right, but Peck seemed confident about their multipronged strategy to turn this around. She mentioned they're seeing stabilizing monthly sales trends and that veterinarian and pet owner satisfaction remains high. Plus, they're introducing new products like Lanivia and Portela to expand their OA pain portfolio.

ALEX: The guidance for 2026 is what really caught my attention, Jordan. They're...]]>524falsefullhttps://www.spreaker.com/episode/micron-technology-q2-2026-earnings-analysis--70801731
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the market's biggest stories. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Micron Technology's absolutely explosive Q2 2026 earnings that dropped yesterday. And folks, when I say explosive, I mean it – we're talking about numbers that are rewriting the record books.

**ALEX:** Before we jump in, a quick reminder that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Now let's talk about these mind-blowing numbers. Alex, where do we even start?

**ALEX:** I mean, Jordan, I've covered a lot of earnings calls, but this one... Micron just posted quarterly revenue of $23.9 billion – that's up 196% year-over-year and 75% sequentially. To put that in perspective, their Q3 guidance alone exceeds the full-year revenue of every year in the company's history through 2024.

**JORDAN:** That's insane! And the margins are what really caught my eye. They're guiding for 81% gross margin in Q3. Eighty-one percent! I had to double-check that number. For context, in previous memory cycles, Micron's peak margins were in the low 60s. We're in completely uncharted territory here.

**ALEX:** Absolutely. And CEO Sanjay Mehrotra was pretty clear about what's driving this – it's all about AI. He said something that really stuck with me: "Memory makes AI smarter and more capable, enabling longer context windows, deeper reasoning chains, and multi-agent orchestration." Essentially, as AI gets more sophisticated, it becomes more memory-hungry.

**JORDAN:** Right, and what's fascinating is the supply constraint story. They're only able to fulfill 50% to two-thirds of their key customers' demand. Think about that – in a world where everyone is scrambling for AI chips, the memory bottleneck is so severe that even their biggest customers can't get what they need.

**ALEX:** Speaking of customers, let's talk about the elephant in the room – their new Strategic Customer Agreements or SCAs. They just signed their first five-year SCA, which is a big departure from their traditional one-year agreements.

**JORDAN:** Yeah, this is huge strategically. During the Q&A, analysts kept pushing for details, but Mehrotra was pretty tight-lipped about specifics due to confidentiality. What we do know is these are multi-year agreements with "specific commitments" from both sides, designed to give Micron better visibility and customers more supply assurance.

**ALEX:** And it makes sense why customers would want this. If you're NVIDIA or Microsoft planning your AI infrastructure years out, the last thing you want is to be constrained by memory availability. These SCAs essentially lock in supply, even if it means paying premium prices.

**JORDAN:** Let's talk about the HBM story because this is where things get really interesting. They're now shipping HBM4 36GB modules and have already sampled their HBM4 16-Hi product with 48GB capacity – that's a 33% increase per module. And get this – they're already working on HBM4E for 2027.

**ALEX:** The HBM ramp is incredible. Remember, high-bandwidth memory is the specialized, expensive memory that goes directly on AI accelerators. It's like the premium gasoline of the memory world, and demand is through the roof. They mentioned that AI server demand alone is driving DRAM and NAND data center bits to exceed 50% of industry TAM for the first time.

**JORDAN:** But here's what I found most interesting from the call – they're not just betting on data center AI. Mehrotra talked about on-device AI driving memory content growth everywhere. PCs with agentic AI need at least 32GB of memory, double the current average. And smartphon

This episode includes AI-generated content.]]>SP100-MU-Q2-2026-enSat, 21 Mar 2026 20:17:08 +0000trueBeta Finch**Beta Finch Podcast Script: Micron Technology Q2 2026 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the market's biggest stories. I'm Alex. **JORDAN:** And I'm...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the market's biggest stories. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Micron Technology's absolutely explosive Q2 2026 earnings that dropped yesterday. And folks, when I say explosive, I mean it – we're talking about numbers that are rewriting the record books.

**ALEX:** Before we jump in, a quick reminder that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Now let's talk about these mind-blowing numbers. Alex, where do we even start?

**ALEX:** I mean, Jordan, I've covered a lot of earnings calls, but this one... Micron just posted quarterly revenue of $23.9 billion – that's up 196% year-over-year and 75% sequentially. To put that in perspective, their Q3 guidance alone exceeds the full-year revenue of every year in the company's history through 2024.

**JORDAN:** That's insane! And the margins are what really caught my eye. They're guiding for 81% gross margin in Q3. Eighty-one percent! I had to double-check that number. For context, in previous memory cycles, Micron's peak margins were in the low 60s. We're in completely uncharted territory here.

**ALEX:** Absolutely. And CEO Sanjay Mehrotra was pretty clear about what's driving this – it's all about AI. He said something that really stuck with me: "Memory makes AI smarter and more capable, enabling longer context windows, deeper reasoning chains, and multi-agent orchestration." Essentially, as AI gets more sophisticated, it becomes more memory-hungry.

**JORDAN:** Right, and what's fascinating is the supply constraint story. They're only able to fulfill 50% to two-thirds of their key customers' demand. Think about that – in a world where everyone is scrambling for AI chips, the memory bottleneck is so severe that even their biggest customers can't get what they need.

**ALEX:** Speaking of customers, let's talk about the elephant in the room – their new Strategic Customer Agreements or SCAs. They just signed their first five-year SCA, which is a big departure from their traditional one-year agreements.

**JORDAN:** Yeah, this is huge strategically. During the Q&A, analysts kept pushing for details, but Mehrotra was pretty tight-lipped about specifics due to confidentiality. What we do know is these are multi-year agreements with "specific commitments" from both sides, designed to give Micron better visibility and customers more supply assurance.

**ALEX:** And it makes sense why customers would want this. If you're NVIDIA or Microsoft planning your AI infrastructure years out, the last thing you want is to be constrained by memory availability. These SCAs essentially lock in supply, even if it means paying premium prices.

**JORDAN:** Let's talk about the HBM story because this is where things get really interesting. They're now shipping HBM4 36GB modules and have already sampled their HBM4 16-Hi product with 48GB capacity – that's a 33% increase per module. And get this – they're already working on HBM4E for 2027.

**ALEX:** The HBM ramp is incredible. Remember, high-bandwidth memory is the specialized, expensive memory that goes directly on AI accelerators. It's like the premium gasoline of the memory world, and demand is through the roof. They mentioned that AI server demand alone is driving DRAM and NAND data center bits to exceed 50% of industry TAM for the first time.

**JORDAN:** But here's what I found most interesting from the call – they're not just betting on data center AI. Mehrotra...]]>495falsefullhttps://www.spreaker.com/episode/oracle-q3-2026-earnings-analysis--70587877
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Oracle's Q3 2026 earnings call, and wow, what a quarter this was for the database giant.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and you're absolutely right - this was quite the quarter for Oracle. Let me start with the headline numbers because they're pretty impressive. For the first time in over 15 years, Oracle hit a major milestone with both organic total revenue and non-GAAP earnings per share growing at 20% or better in USD. That's a significant acceleration.

**ALEX:** That's huge, Jordan. And what's driving this growth? It seems like Oracle is really firing on all cylinders here.

**JORDAN:** Exactly. There are two standout segments that are just exploding. Their multicloud database revenue grew 531% year-over-year - that's not a typo, five-hundred-thirty-one percent. And their AI infrastructure revenue grew 243% year-over-year. These aren't just growth numbers, these are transformation numbers.

**ALEX:** Those are mind-blowing growth rates. But let's talk about what's actually happening operationally. It sounds like Oracle has been busy expanding their reach beyond just their own cloud.

**JORDAN:** That's the key insight here, Alex. Oracle has been strategic about bringing their database services to other clouds - Microsoft Azure, Google Cloud, and now Amazon AWS. Clay McGork, one of their CEOs, mentioned they now have global region coverage across all partner clouds. They went from 2 AWS regions at the start of Q3 to 8 by the end, and they're projecting 22 AWS regions by Q4.

**ALEX:** And this multicloud strategy seems to be unlocking pent-up demand. What did they say about their pipeline?

**JORDAN:** Here's where it gets really interesting - Oracle reported a remaining performance obligation, or RPO, of $553 billion. That's essentially contracted future revenue. The demand for AI infrastructure is so strong that they literally have more demand than they can supply right now.

**ALEX:** Speaking of AI infrastructure, I noticed Oracle made some interesting strategic moves this quarter. Can you walk us through the TikTok situation?

**JORDAN:** Absolutely. Oracle secured a 15% stake in the newly independent TikTok US entity, which separated from ByteDance in January. This gives Oracle not just continued revenue from providing TikTok's technology services, but also equity upside from their board seat and ownership stake. It's a clever way to diversify their revenue streams.

**ALEX:** And they've been busy on the financing front too, right?

**JORDAN:** Huge developments there. Oracle announced a $50 billion financing initiative and has already secured $30 billion through bonds and convertible preferred stock. But here's the really smart part - CFO Doug Caring explained that over 90% of their data center capacity investments are being funded by partners. So Oracle is scaling their AI infrastructure without taking on the full capital burden themselves.

**ALEX:** That's brilliant financial engineering. Now, there was some interesting discussion about AI potentially disrupting the SaaS industry. What was Oracle's take on this?

**JORDAN:** This was one of my favorite parts of the call. CEO Mike Cecilia directly addressed what he called the "reported SaaS apocalypse" - this theory that AI coding tools will kill traditional software companies. His response was basically, "bring it on, we're already there."

**ALEX:** How so?

**JORDAN:** Oracle has embedded over 1,000 AI agents direct

This episode includes AI-generated content.]]>SP100-ORCL-Q3-2026-enWed, 11 Mar 2026 08:30:24 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Oracle's Q3 2026 earnings call, and wow, what a quarter this was for the database giant.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and you're absolutely right - this was quite the quarter for Oracle. Let me start with the headline numbers because they're pretty impressive. For the first time in over 15 years, Oracle hit a major milestone with both organic total revenue and non-GAAP earnings per share growing at 20% or better in USD. That's a significant acceleration.

**ALEX:** That's huge, Jordan. And what's driving this growth? It seems like Oracle is really firing on all cylinders here.

**JORDAN:** Exactly. There are two standout segments that are just exploding. Their multicloud database revenue grew 531% year-over-year - that's not a typo, five-hundred-thirty-one percent. And their AI infrastructure revenue grew 243% year-over-year. These aren't just growth numbers, these are transformation numbers.

**ALEX:** Those are mind-blowing growth rates. But let's talk about what's actually happening operationally. It sounds like Oracle has been busy expanding their reach beyond just their own cloud.

**JORDAN:** That's the key insight here, Alex. Oracle has been strategic about bringing their database services to other clouds - Microsoft Azure, Google Cloud, and now Amazon AWS. Clay McGork, one of their CEOs, mentioned they now have global region coverage across all partner clouds. They went from 2 AWS regions at the start of Q3 to 8 by the end, and they're projecting 22 AWS regions by Q4.

**ALEX:** And this multicloud strategy seems to be unlocking pent-up demand. What did they say about their pipeline?

**JORDAN:** Here's where it gets really interesting - Oracle reported a remaining performance obligation, or RPO, of $553 billion. That's essentially contracted future revenue. The demand for AI infrastructure is so strong that they literally have more demand than they can supply right now.

**ALEX:** Speaking of AI infrastructure, I noticed Oracle made some interesting strategic moves this quarter. Can you walk us through the TikTok situation?

**JORDAN:** Absolutely. Oracle secured a 15% stake in the newly independent TikTok US entity, which separated from ByteDance in January. This gives Oracle not just continued revenue from providing TikTok's technology services, but also equity upside from their board seat and ownership stake. It's a clever way to diversify their revenue streams.

**ALEX:** And they've been busy on the financing front too, right?

**JORDAN:** Huge developments there. Oracle announced a $50 billion financing initiative and has already secured $30 billion through bonds and convertible preferred stock. But here's the really smart part - CFO Doug Caring explained that over 90% of their data center capacity investments are being funded by partners. So Oracle is scaling their AI infrastructure without taking on the full capital burden themselves.

**ALEX:** That's brilliant financial engineering. Now, there was some interesting discussion about AI potentially disrupting the SaaS industry. What was Oracle's take on this?

**JORDAN:** This was one of my favorite parts of the call. CEO Mike Cecilia directly addressed what he called the "reported SaaS apocalypse" - this theory that AI coding tools will kill traditional...]]>544falsefullhttps://www.spreaker.com/episode/costco-q2-2026-earnings-analysis--70520997
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're diving into Costco's second quarter 2026 results, and wow - there's a lot to unpack here.

But first, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Costco just delivered some pretty impressive numbers. What jumped out at you first?

**JORDAN**: Alex, these results really showcase why Costco remains such a powerhouse. Net income hit $2.04 billion, up 14% year-over-year, with earnings per share at $4.58 versus $4.02 last year. But what's even more impressive is the revenue growth - $68.2 billion in net sales, up 9.1% from the prior year.

**ALEX**: And let's talk about those comparable sales numbers because they tell a great story about member engagement.

**JORDAN**: Absolutely. Comp sales were up 7.4%, or 6.7% when you adjust for gas deflation and foreign exchange impacts. But here's what really caught my attention - digitally enabled comp sales surged 22.6%. That's a clear sign that Costco's digital transformation is gaining serious traction.

**ALEX**: Speaking of members, the membership side of the business continues to be that reliable cash cow, right?

**JORDAN**: It really is. Membership fee income grew 13.6% to $1.36 billion. Now, about a third of that growth came from the September 2024 membership fee increase in the US and Canada. But even excluding that increase and foreign exchange impacts, membership income still grew 7.5% - that's solid organic growth driven by new members and executive membership upgrades.

**ALEX**: The membership numbers are fascinating too. They now have over 40 million paid memberships, up 9.5% year-over-year. Though I noticed renewal rates dipped slightly in the US and Canada to 92.1%. What's behind that?

**JORDAN**: That's actually an interesting strategic challenge they're navigating. The slight decline is primarily because online member sign-ups are growing as a percentage of their total base, and these digital members historically renew at slightly lower rates than those who sign up in-warehouse. But management is actively addressing this with targeted digital retention strategies, which are showing some positive impact.

**ALEX**: Now, let's talk about the elephant in the room - tariffs. CEO Ron Vachris spent considerable time addressing this during the call.

**JORDAN**: Yes, and this is where Costco's operational expertise really shines. Vachris explained that they're dealing with a complex, fluid tariff environment where the old AIPA tariffs were eliminated but replaced with new global tariffs. Costco's response has been multi-pronged: shifting production countries when it makes sense, consolidating global buying efforts, leaning heavily into their Kirkland Signature private label where they control the supply chain, and sourcing more domestically.

**ALEX**: What I found reassuring was their pricing philosophy. Even with tariff pressures, they maintained their commitment to being "the first to lower prices and the last to raise them."

**JORDAN**: Exactly. They actually lowered prices on key items like eggs, cheese, coffee, and paper products as commodity inflation cooled. And they're already reducing prices on items where tariffs have been eliminated - textiles, bedding, cookware. It's that member-first mentality that keeps customers loyal even in challenging times.

**ALEX**: The expansion story is pretty compelling too. They're targeting 30-plus new warehouse openings per year going forward.

**JORDAN**: That's a significant acceleration from historical norms. What's particularly interesting is how they're getting creative with real estate. They men

This episode includes AI-generated content.]]>SP100-COST-Q2-2026-enSat, 07 Mar 2026 05:03:13 +0000trueBeta Finch# Beta Finch Podcast Script: Costco Q2 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're diving into Costco's second quarter 2026 results, and wow...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're diving into Costco's second quarter 2026 results, and wow - there's a lot to unpack here.

But first, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Costco just delivered some pretty impressive numbers. What jumped out at you first?

**JORDAN**: Alex, these results really showcase why Costco remains such a powerhouse. Net income hit $2.04 billion, up 14% year-over-year, with earnings per share at $4.58 versus $4.02 last year. But what's even more impressive is the revenue growth - $68.2 billion in net sales, up 9.1% from the prior year.

**ALEX**: And let's talk about those comparable sales numbers because they tell a great story about member engagement.

**JORDAN**: Absolutely. Comp sales were up 7.4%, or 6.7% when you adjust for gas deflation and foreign exchange impacts. But here's what really caught my attention - digitally enabled comp sales surged 22.6%. That's a clear sign that Costco's digital transformation is gaining serious traction.

**ALEX**: Speaking of members, the membership side of the business continues to be that reliable cash cow, right?

**JORDAN**: It really is. Membership fee income grew 13.6% to $1.36 billion. Now, about a third of that growth came from the September 2024 membership fee increase in the US and Canada. But even excluding that increase and foreign exchange impacts, membership income still grew 7.5% - that's solid organic growth driven by new members and executive membership upgrades.

**ALEX**: The membership numbers are fascinating too. They now have over 40 million paid memberships, up 9.5% year-over-year. Though I noticed renewal rates dipped slightly in the US and Canada to 92.1%. What's behind that?

**JORDAN**: That's actually an interesting strategic challenge they're navigating. The slight decline is primarily because online member sign-ups are growing as a percentage of their total base, and these digital members historically renew at slightly lower rates than those who sign up in-warehouse. But management is actively addressing this with targeted digital retention strategies, which are showing some positive impact.

**ALEX**: Now, let's talk about the elephant in the room - tariffs. CEO Ron Vachris spent considerable time addressing this during the call.

**JORDAN**: Yes, and this is where Costco's operational expertise really shines. Vachris explained that they're dealing with a complex, fluid tariff environment where the old AIPA tariffs were eliminated but replaced with new global tariffs. Costco's response has been multi-pronged: shifting production countries when it makes sense, consolidating global buying efforts, leaning heavily into their Kirkland Signature private label where they control the supply chain, and sourcing more domestically.

**ALEX**: What I found reassuring was their pricing philosophy. Even with tariff pressures, they maintained their commitment to being "the first to lower prices and the last to raise them."

**JORDAN**: Exactly. They actually lowered prices on key items like eggs, cheese, coffee, and paper products as commodity inflation cooled. And they're already reducing prices on items where tariffs have been eliminated - textiles, bedding, cookware. It's that member-first mentality that keeps customers loyal even in challenging times.

**ALEX**: The expansion story is pretty compelling too. They're targeting 30-plus new warehouse openings per year going forward.496falsefullhttps://www.spreaker.com/episode/broadcom-q1-2026-earnings-analysis--70474118
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Broadcom's absolutely explosive Q1 2026 results. Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, where do we even start with these numbers? Broadcom just delivered what might be the most jaw-dropping AI revenue guidance we've seen yet. We're talking about a company projecting over $100 billion in AI chip revenue by 2027.

**ALEX**: That's right, Jordan. Let's break down the headline numbers first. Q1 revenue hit $19.3 billion, up 29% year-over-year, crushing their guidance. But here's the kicker - they're guiding for Q2 revenue of $22 billion, which represents 47% year-over-year growth. Their AI semiconductor business alone grew 106% year-over-year to $8.4 billion in Q1.

**JORDAN**: And that acceleration is only speeding up. They're projecting AI revenue to grow 140% year-over-year in Q2 to $10.7 billion. But Alex, what really caught my attention was CEO Hock Tan's confidence about 2027. He said they have "line of sight" to achieve AI revenue from chips - just chips - in excess of $100 billion in 2027.

**ALEX**: That's an incredible statement, Jordan. And he backed it up with some pretty specific customer details. They now have six major customers for their custom AI accelerators, including a new addition - OpenAI. Let's talk about what he revealed about each customer.

**JORDAN**: Absolutely. For Google, they're continuing strong demand for seventh-generation TPUs with even stronger demand expected in 2027. Anthropic is scaling from 1 gigawatt of TPU compute in 2026 to over 3 gigawatts in 2027. And here's something interesting - Tan pushed back hard against reports that Meta's MTIA custom accelerator program was dead.

**ALEX**: Right, he was pretty emphatic about that. He said Meta's roadmap is "alive and well" and they're already shipping, with plans to scale to multiple gigawatts in 2027. Then there's the new customer, OpenAI, which is expected to deploy over 1 gigawatt of compute capacity in 2027.

**JORDAN**: What struck me most was Tan's explanation of why these partnerships are so strategic. He emphasized that for these customers, custom AI accelerators aren't optional - they're strategic necessities. These companies are competing against each other and against NVIDIA, so they need the absolute best chips, not just "good enough" ones.

**ALEX**: And that competitive advantage seems to extend beyond just the chips themselves. Broadcom is also crushing it in AI networking. In Q1, AI networking revenue grew 60% year-over-year and represented one-third of total AI revenue. In Q2, they expect that to jump to 40% of total AI revenue.

**JORDAN**: Their networking success is fascinating, Alex. They're the only company with a 100-terabit-per-second switch - the Tomahawk 6 - and they're planning to launch Tomahawk 7 in 2027 with double the performance. Tan made a great point about how they're helping customers stay on direct-attached copper instead of moving to more expensive optical solutions.

**ALEX**: Now, Jordan, I have to ask about the elephant in the room. With AI revenue growing this explosively, what about their other businesses? Their infrastructure software segment, which includes VMware, seems to be holding up well.

**JORDAN**: That's a great point. VMware revenue grew 13% year-over-year with strong bookings exceeding $9.2 billion. Tan was very clear that their infrastructure software "is not disrupted by AI." In fact, he argued that VMware Cloud Foundation is essential for enterprises running generative AI workloads.

**ALEX**: Let's talk margins

This episode includes AI-generated content.]]>SP100-AVGO-Q1-2026-enThu, 05 Mar 2026 09:17:30 +0000trueBeta Finch# Beta Finch Podcast Script: Broadcom Q1 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Broadcom's absolutely explosive Q1 2026 results. Before we jump in...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Broadcom's absolutely explosive Q1 2026 results. Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, where do we even start with these numbers? Broadcom just delivered what might be the most jaw-dropping AI revenue guidance we've seen yet. We're talking about a company projecting over $100 billion in AI chip revenue by 2027.

**ALEX**: That's right, Jordan. Let's break down the headline numbers first. Q1 revenue hit $19.3 billion, up 29% year-over-year, crushing their guidance. But here's the kicker - they're guiding for Q2 revenue of $22 billion, which represents 47% year-over-year growth. Their AI semiconductor business alone grew 106% year-over-year to $8.4 billion in Q1.

**JORDAN**: And that acceleration is only speeding up. They're projecting AI revenue to grow 140% year-over-year in Q2 to $10.7 billion. But Alex, what really caught my attention was CEO Hock Tan's confidence about 2027. He said they have "line of sight" to achieve AI revenue from chips - just chips - in excess of $100 billion in 2027.

**ALEX**: That's an incredible statement, Jordan. And he backed it up with some pretty specific customer details. They now have six major customers for their custom AI accelerators, including a new addition - OpenAI. Let's talk about what he revealed about each customer.

**JORDAN**: Absolutely. For Google, they're continuing strong demand for seventh-generation TPUs with even stronger demand expected in 2027. Anthropic is scaling from 1 gigawatt of TPU compute in 2026 to over 3 gigawatts in 2027. And here's something interesting - Tan pushed back hard against reports that Meta's MTIA custom accelerator program was dead.

**ALEX**: Right, he was pretty emphatic about that. He said Meta's roadmap is "alive and well" and they're already shipping, with plans to scale to multiple gigawatts in 2027. Then there's the new customer, OpenAI, which is expected to deploy over 1 gigawatt of compute capacity in 2027.

**JORDAN**: What struck me most was Tan's explanation of why these partnerships are so strategic. He emphasized that for these customers, custom AI accelerators aren't optional - they're strategic necessities. These companies are competing against each other and against NVIDIA, so they need the absolute best chips, not just "good enough" ones.

**ALEX**: And that competitive advantage seems to extend beyond just the chips themselves. Broadcom is also crushing it in AI networking. In Q1, AI networking revenue grew 60% year-over-year and represented one-third of total AI revenue. In Q2, they expect that to jump to 40% of total AI revenue.

**JORDAN**: Their networking success is fascinating, Alex. They're the only company with a 100-terabit-per-second switch - the Tomahawk 6 - and they're planning to launch Tomahawk 7 in 2027 with double the performance. Tan made a great point about how they're helping customers stay on direct-attached copper instead of moving to more expensive optical solutions.

**ALEX**: Now, Jordan, I have to ask about the elephant in the room. With AI revenue growing this explosively, what about their other businesses? Their infrastructure software segment, which includes VMware, seems to be holding up well.

**JORDAN**: That's a great point. VMware revenue grew 13% year-over-year with strong bookings exceeding $9.2 billion. Tan was very clear that their infrastructure software "is not disrupted by AI." In fact, he...]]>511falsefullhttps://www.spreaker.com/episode/walmart-q4-2026-earnings-analysis--70404605
JORDAN: Absolutely, Alex. Before we jump in though, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks Jordan. Now, let's talk numbers because Walmart absolutely crushed it. Revenue up 4.9% in constant currency, but here's the kicker - adjusted operating income grew 10.5%. That's more than double the sales growth rate.

JORDAN: That margin expansion is impressive, Alex. And it wasn't just one segment carrying the load. All three business segments - Walmart US, Sam's Club, and International - grew profits faster than sales. That's the kind of operational leverage investors love to see.

ALEX: The e-commerce story is particularly compelling here. Global e-commerce growth of 24%, with Walmart US hitting 27%. But Jordan, what really caught my attention was CEO John Furner talking about their AI shopping assistant "Sparky."

JORDAN: Oh, this is fascinating stuff. Customers who use Sparky have an average order value that's 35% higher than non-Sparky customers. And get this - roughly half of their app users have already tried Sparky. We're talking about AI-driven commerce moving from concept to reality at scale.

ALEX: It's like having a personal shopping assistant that understands your intent better than traditional search. Furner mentioned customers using fast delivery - that's under three hours - grew more than 60% for the year. They're not just selling stuff anymore; they're creating an ecosystem.

JORDAN: Exactly. And speaking of ecosystems, let's talk about their alternative profit streams. Advertising revenue hit $6.4 billion globally, up 37%. Walmart Connect in the US accelerated to 41% growth. Membership fees exceeded $4.3 billion. Alex, here's a stat that floored me - advertising income and membership fees combined represented nearly one-third of their operating income this quarter.

ALEX: That's a fundamental business model shift, Jordan. They're becoming less dependent on traditional retail margins and more like a platform company. CFO John David Rainey mentioned they've reached a point where they don't even talk about e-commerce profitability internally anymore - they're well past breakeven and seeing double-digit incremental margins.

JORDAN: The automation story is equally impressive. About 60% of US stores are receiving freight from automated distribution centers, and 50% of e-commerce fulfillment is automated. This isn't just about efficiency - it's about having real-time visibility into inventory and being able to promise customers exactly what they want, when they want it.

ALEX: Let's talk guidance because this is where Walmart shows confidence. They're projecting constant currency sales growth of 3.5% to 4.5% for fiscal 2027, but operating income growth of 6% to 8%. That's the margin expansion story continuing.

JORDAN: And they're putting their money where their mouth is with a $30 billion share repurchase program - their largest ever. With $42 billion in operating cash flow and 18% growth in free cash flow, they've got the financial firepower to invest while returning capital to shareholders.

ALEX: During the Q&A, there were some really telling moments. When asked about consumer health, Furner noted they're still seeing the majority of share gains from households making over $100,000, but even lower-income households are emphasizing convenience nearly as much as price. That's a huge shift.

JORDAN: The global expansion of their platforms is intriguing too. They mentioned their "build once, scale globally" approach. Sparky starts in the US, but the

This episode includes AI-generated content.]]>SP100-WMT-Q4-2026-enTue, 03 Mar 2026 08:53:24 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Walmart's Q4 2026 earnings, and wow - what a quarter this was. JORDAN: Absolutely, Alex. Before we jump...
JORDAN: Absolutely, Alex. Before we jump in though, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks Jordan. Now, let's talk numbers because Walmart absolutely crushed it. Revenue up 4.9% in constant currency, but here's the kicker - adjusted operating income grew 10.5%. That's more than double the sales growth rate.

JORDAN: That margin expansion is impressive, Alex. And it wasn't just one segment carrying the load. All three business segments - Walmart US, Sam's Club, and International - grew profits faster than sales. That's the kind of operational leverage investors love to see.

ALEX: The e-commerce story is particularly compelling here. Global e-commerce growth of 24%, with Walmart US hitting 27%. But Jordan, what really caught my attention was CEO John Furner talking about their AI shopping assistant "Sparky."

JORDAN: Oh, this is fascinating stuff. Customers who use Sparky have an average order value that's 35% higher than non-Sparky customers. And get this - roughly half of their app users have already tried Sparky. We're talking about AI-driven commerce moving from concept to reality at scale.

ALEX: It's like having a personal shopping assistant that understands your intent better than traditional search. Furner mentioned customers using fast delivery - that's under three hours - grew more than 60% for the year. They're not just selling stuff anymore; they're creating an ecosystem.

JORDAN: Exactly. And speaking of ecosystems, let's talk about their alternative profit streams. Advertising revenue hit $6.4 billion globally, up 37%. Walmart Connect in the US accelerated to 41% growth. Membership fees exceeded $4.3 billion. Alex, here's a stat that floored me - advertising income and membership fees combined represented nearly one-third of their operating income this quarter.

ALEX: That's a fundamental business model shift, Jordan. They're becoming less dependent on traditional retail margins and more like a platform company. CFO John David Rainey mentioned they've reached a point where they don't even talk about e-commerce profitability internally anymore - they're well past breakeven and seeing double-digit incremental margins.

JORDAN: The automation story is equally impressive. About 60% of US stores are receiving freight from automated distribution centers, and 50% of e-commerce fulfillment is automated. This isn't just about efficiency - it's about having real-time visibility into inventory and being able to promise customers exactly what they want, when they want it.

ALEX: Let's talk guidance because this is where Walmart shows confidence. They're projecting constant currency sales growth of 3.5% to 4.5% for fiscal 2027, but operating income growth of 6% to 8%. That's the margin expansion story continuing.

JORDAN: And they're putting their money where their mouth is with a $30 billion share repurchase program - their largest ever. With $42 billion in operating cash flow and 18% growth in free cash flow, they've got the financial firepower to invest while returning capital to shareholders.

ALEX: During the Q&A, there were some really telling moments. When asked about consumer health, Furner noted they're still seeing the majority of share gains from households making over $100,000, but even lower-income households are emphasizing convenience nearly as much as price. That's a huge shift.

JORDAN: The global...]]>512falsefullhttps://www.spreaker.com/episode/vertex-pharmaceuticals-q4-2025-earnings-analysis--70404604
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest quarterly results to help you understand what really matters in the markets. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Vertex Pharmaceuticals' Q4 2025 earnings call - and wow, what a story this company is telling about transformation and growth.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Vertex has been known primarily as the cystic fibrosis company for years, but this earnings call really highlighted how they're becoming something much bigger.

ALEX: That's exactly right, Jordan. Let's start with the headline numbers because they're pretty solid. Q4 revenue hit $3.2 billion, up 10% year-over-year, and full-year 2025 revenue reached $12 billion - that's 9% growth. But here's what caught my attention - CEO Reshma Kewalramani kept emphasizing this word "diversification."

JORDAN: Yes! And you can see it in the numbers. While their cystic fibrosis franchise - which includes drugs like TRIKAFTA - still drives the bulk of revenue with 7% growth globally, they're now generating meaningful revenue from completely different disease areas. KASJEVY, their gene therapy for blood disorders, brought in $116 million for the full year. And Gernavix, their non-opioid pain medication, generated $60 million in just eight months since launch.

ALEX: Let's talk about that diversification strategy because it's really the core story here. Duncan McKechnie, their commercial head, painted a picture of a company that's essentially building three new franchises alongside their CF business - in blood disorders, pain management, and now kidney disease.

JORDAN: The kidney disease piece is fascinating, Alex. They have this drug called Povatacept - or "Povi" as they call it - that's being developed for multiple kidney conditions. What's interesting is how confident management sounded about this becoming their "fourth vertical" as they put it. Kewalramani was practically glowing when discussing the clinical data.

ALEX: Right, and there's a reason for that enthusiasm. In their Phase 2 trial for IgA nephropathy - that's a progressive kidney disease - Povatacept showed a 56% reduction in protein in the urine, which is a key measure of kidney function. They've already submitted for FDA approval and expect to complete that submission in the first half of 2026.

JORDAN: But here's what I found most compelling from an investor perspective - the market opportunity. Management estimates that IgA nephropathy affects 330,000 people in the US and Europe alone. And they're not stopping there - they're studying the same drug for other kidney diseases and even expanding into neurological conditions like myasthenia gravis.

ALEX: The "pipeline-in-a-product" concept, as they called it. One drug, multiple indications, multiple revenue streams. It's a smart strategy, especially given how expensive drug development is these days.

JORDAN: Absolutely. Now let's talk about their guidance for 2026 because it tells us a lot about management's confidence level. They're projecting total revenue between $12.95 billion and $13.1 billion - that's 8-9% growth. But here's the kicker: they expect at least $500 million to come from non-CF products. That's basically triple what they generated from those products in 2025.

ALEX: That's aggressive guidance, Jordan. What gives them confidence they can hit those numbers?

JORDAN: Well, for KASJEVY - their gene therapy - they have great visibility because of how the treatment works. Patients go through a months-long process of cell collection and modification before getting infused

This episode includes AI-generated content.]]>SP100-VRTX-Q4-2025-enTue, 03 Mar 2026 08:53:18 +0000trueBeta Finch**Beta Finch Podcast Script: Vertex Pharmaceuticals Q4 2025 Earnings** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest quarterly results to help you understand what really matters in the markets. I'm Alex....
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest quarterly results to help you understand what really matters in the markets. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Vertex Pharmaceuticals' Q4 2025 earnings call - and wow, what a story this company is telling about transformation and growth.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Vertex has been known primarily as the cystic fibrosis company for years, but this earnings call really highlighted how they're becoming something much bigger.

ALEX: That's exactly right, Jordan. Let's start with the headline numbers because they're pretty solid. Q4 revenue hit $3.2 billion, up 10% year-over-year, and full-year 2025 revenue reached $12 billion - that's 9% growth. But here's what caught my attention - CEO Reshma Kewalramani kept emphasizing this word "diversification."

JORDAN: Yes! And you can see it in the numbers. While their cystic fibrosis franchise - which includes drugs like TRIKAFTA - still drives the bulk of revenue with 7% growth globally, they're now generating meaningful revenue from completely different disease areas. KASJEVY, their gene therapy for blood disorders, brought in $116 million for the full year. And Gernavix, their non-opioid pain medication, generated $60 million in just eight months since launch.

ALEX: Let's talk about that diversification strategy because it's really the core story here. Duncan McKechnie, their commercial head, painted a picture of a company that's essentially building three new franchises alongside their CF business - in blood disorders, pain management, and now kidney disease.

JORDAN: The kidney disease piece is fascinating, Alex. They have this drug called Povatacept - or "Povi" as they call it - that's being developed for multiple kidney conditions. What's interesting is how confident management sounded about this becoming their "fourth vertical" as they put it. Kewalramani was practically glowing when discussing the clinical data.

ALEX: Right, and there's a reason for that enthusiasm. In their Phase 2 trial for IgA nephropathy - that's a progressive kidney disease - Povatacept showed a 56% reduction in protein in the urine, which is a key measure of kidney function. They've already submitted for FDA approval and expect to complete that submission in the first half of 2026.

JORDAN: But here's what I found most compelling from an investor perspective - the market opportunity. Management estimates that IgA nephropathy affects 330,000 people in the US and Europe alone. And they're not stopping there - they're studying the same drug for other kidney diseases and even expanding into neurological conditions like myasthenia gravis.

ALEX: The "pipeline-in-a-product" concept, as they called it. One drug, multiple indications, multiple revenue streams. It's a smart strategy, especially given how expensive drug development is these days.

JORDAN: Absolutely. Now let's talk about their guidance for 2026 because it tells us a lot about management's confidence level. They're projecting total revenue between $12.95 billion and $13.1 billion - that's 8-9% growth. But here's the kicker: they expect at least $500 million to come from non-CF products. That's basically triple what they generated from those products in 2025.

ALEX: That's aggressive guidance, Jordan. What gives them confidence they can hit those numbers?

JORDAN: Well, for KASJEVY - their gene therapy - they have great...]]>535falsefullhttps://www.spreaker.com/episode/procter-gamble-q2-2026-earnings-analysis--70404603
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Procter & Gamble's Q2 2026 earnings call. Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter to unpack! P&G just reported what management called their "softest quarter of the fiscal year," but there's actually a lot more optimism here than that headline might suggest.

**ALEX**: Absolutely. Let's start with the numbers, Jordan. Organic sales were flat year-over-year, which sounds underwhelming until you understand the context. They had some major base period disruptions - remember those port strikes and hurricanes last October that caused all that inventory loading?

**JORDAN**: Right, and CFO Andre Schulten was very clear about this. The biggest impacts hit baby care, feminine care, and family care - all concentrated in the U.S. market. But here's the interesting part: the rest of P&G's business outside the U.S. actually grew nearly 3%. That's a pretty solid foundation.

**ALEX**: That's a great point. When you look at the regional breakdown, you see some real bright spots. Latin America grew 8%, Greater China was up 3% - which is impressive given the challenging consumer environment there. Europe's enterprise markets grew 6%. It really was a U.S.-centric slowdown.

**JORDAN**: And speaking of China, I loved CEO Shailesh Jejurikar's example about their Pampers Prestige innovation. They tapped into this deep cultural insight about Chinese parents wanting the best for their babies, and literally incorporated silk - this symbol of luxury for over 2,000 years - into their diapers. It's driving double-digit growth and they've gained nearly three points of market share.

**ALEX**: That's exactly the kind of consumer-centric innovation P&G is doubling down on. Jejurikar talked extensively about what he called "the next important phase of constructive disruption." They're not just tweaking around the edges - they're fundamentally reimagining how a CPG company operates in today's fragmented media landscape.

**JORDAN**: The technology transformation really stood out to me. They've built this massive data lake with petabytes of consumer information, AI-powered tools for product development, and supply chain systems that can react autonomously to demand signals. But Jejurikar was realistic about the timeline - he said it'll take 12 to 18 months to get this "future evenly distributed" across the company.

**ALEX**: Let's talk margins for a second. Core EPS came in at $1.88, flat with last year. But they delivered 270 basis points of productivity improvements, which they reinvested back into innovation and marketing. That's classic P&G - they're not letting a tough quarter derail their long-term investment strategy.

**JORDAN**: And they're maintaining all their full-year guidance, which shows real confidence. Organic sales growth of flat to plus 4%, core EPS growth of flat to plus 4%. They're basically saying "trust us, the back half is going to be much stronger."

**ALEX**: The Q&A session revealed some interesting dynamics too. When analysts pressed about U.S. market share losses, Schulten was pretty direct - they have work to do to recover share, but they're already seeing progress in categories like family care and laundry where they've made those innovation interventions.

**JORDAN**: I thought the discussion about e-commerce was fascinating. One analyst pointed out that Amazon is driving 60-80% of growth in P&G's categories. Jejurikar's response was telling - they're being very deliberate about winning in fast-growing channels, and in some markets like India, their e-commerce share

This episode includes AI-generated content.]]>SP100-PG-Q2-2026-enTue, 03 Mar 2026 08:53:13 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Procter & Gamble's Q2 2026 earnings call. Before we get started, I need to mention that...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Procter & Gamble's Q2 2026 earnings call. Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter to unpack! P&G just reported what management called their "softest quarter of the fiscal year," but there's actually a lot more optimism here than that headline might suggest.

**ALEX**: Absolutely. Let's start with the numbers, Jordan. Organic sales were flat year-over-year, which sounds underwhelming until you understand the context. They had some major base period disruptions - remember those port strikes and hurricanes last October that caused all that inventory loading?

**JORDAN**: Right, and CFO Andre Schulten was very clear about this. The biggest impacts hit baby care, feminine care, and family care - all concentrated in the U.S. market. But here's the interesting part: the rest of P&G's business outside the U.S. actually grew nearly 3%. That's a pretty solid foundation.

**ALEX**: That's a great point. When you look at the regional breakdown, you see some real bright spots. Latin America grew 8%, Greater China was up 3% - which is impressive given the challenging consumer environment there. Europe's enterprise markets grew 6%. It really was a U.S.-centric slowdown.

**JORDAN**: And speaking of China, I loved CEO Shailesh Jejurikar's example about their Pampers Prestige innovation. They tapped into this deep cultural insight about Chinese parents wanting the best for their babies, and literally incorporated silk - this symbol of luxury for over 2,000 years - into their diapers. It's driving double-digit growth and they've gained nearly three points of market share.

**ALEX**: That's exactly the kind of consumer-centric innovation P&G is doubling down on. Jejurikar talked extensively about what he called "the next important phase of constructive disruption." They're not just tweaking around the edges - they're fundamentally reimagining how a CPG company operates in today's fragmented media landscape.

**JORDAN**: The technology transformation really stood out to me. They've built this massive data lake with petabytes of consumer information, AI-powered tools for product development, and supply chain systems that can react autonomously to demand signals. But Jejurikar was realistic about the timeline - he said it'll take 12 to 18 months to get this "future evenly distributed" across the company.

**ALEX**: Let's talk margins for a second. Core EPS came in at $1.88, flat with last year. But they delivered 270 basis points of productivity improvements, which they reinvested back into innovation and marketing. That's classic P&G - they're not letting a tough quarter derail their long-term investment strategy.

**JORDAN**: And they're maintaining all their full-year guidance, which shows real confidence. Organic sales growth of flat to plus 4%, core EPS growth of flat to plus 4%. They're basically saying "trust us, the back half is going to be much stronger."

**ALEX**: The Q&A session revealed some interesting dynamics too. When analysts pressed about U.S. market share losses, Schulten was pretty direct - they have work to do to recover share, but they're already seeing progress in categories like family care and laundry where they've made those innovation interventions.

**JORDAN**: I thought the discussion about e-commerce was fascinating. One analyst pointed out that Amazon is driving 60-80% of growth in P&G's categories. Jejurikar's response was...]]>489falsefullhttps://www.spreaker.com/episode/morgan-stanley-q4-2025-earnings-analysis--70404601
**JORDAN**: And I'm Jordan. Before we dive into today's episode, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. Today we're breaking down Morgan Stanley's Q4 2025 results, and wow - these numbers are pretty impressive across the board. Jordan, what jumped out at you first from these results?

**JORDAN**: Alex, this was really a record-breaking quarter and year for Morgan Stanley. We're talking about $70.6 billion in full-year revenue - that's a record. EPS hit $10.21 for the year, and their return on tangible common equity came in at 21.6%. But what really caught my attention was their total client assets reaching $9.3 trillion. That's just a massive number.

**ALEX**: That's huge. And when you break it down by business segments, it seems like they had strength pretty much everywhere. Their institutional securities business - that's their investment banking and trading operations - hit record full-year revenues of $33.1 billion. Their wealth management business, which has really been their crown jewel, delivered record revenues of $31.8 billion with margins of 29%.

**JORDAN**: Right, and that wealth management story is particularly compelling. They had net new assets of $356 billion for the year - that's like adding a mid-sized asset manager every single year. What I found interesting was CEO Ted Pick's commentary about their "funnel" working. They're seeing about $100 billion migrating from their workplace and E*TRADE channels to their financial advisors, which is higher-margin business.

**ALEX**: That's a great point about the funnel. It sounds like their strategy of having multiple entry points - whether someone starts with E*TRADE for self-directed trading, gets stock options through their workplace program, or comes directly to a financial advisor - is really paying off. Now Jordan, one thing that surprised me was their decision NOT to raise their financial targets, despite clearly exceeding many of them. What's your read on that?

**JORDAN**: This was fascinating, Alex. Multiple analysts pressed them on this during the Q&A. Ted Pick was pretty candid - he basically said they don't want to "chase the dragon" by constantly raising targets just because they hit them. His philosophy seems to be about proving they can compound earnings consistently through different market cycles, not just when everything's going well.

**ALEX**: That's actually pretty refreshing in a world where companies often feel pressure to constantly raise guidance. Pick mentioned wanting to achieve "higher lows" during tougher periods rather than just reaching for higher peaks when times are good.

**JORDAN**: Exactly. And they're sitting on a lot of excess capital - over 300 basis points above their required levels. Pick was asked about potential M&A or returning more capital to shareholders, but he emphasized they want to keep the bar high for acquisitions. They've done four major deals in recent years and know how much work integration takes.

**ALEX**: Speaking of capital allocation, they did return $4.6 billion to shareholders through buybacks in 2025 and raised their dividend by 7.5 cents to $1 per share. But it sounds like they're being pretty disciplined about not getting too aggressive.

**JORDAN**: Right. And looking forward, there are some interesting growth drivers. Pick talked about being in the "third inning" of a capital markets recovery, driven by what he calls the "equitization of global markets" - basically more companies and assets going public and trading. They're also investing he

This episode includes AI-generated content.]]>SP100-MS-Q4-2025-enTue, 03 Mar 2026 08:53:07 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest quarterly results and turn corporate speak into conversations you can actually follow. I'm Alex. **JORDAN**: And I'm Jordan. Before we dive into today's...
**JORDAN**: And I'm Jordan. Before we dive into today's episode, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. Today we're breaking down Morgan Stanley's Q4 2025 results, and wow - these numbers are pretty impressive across the board. Jordan, what jumped out at you first from these results?

**JORDAN**: Alex, this was really a record-breaking quarter and year for Morgan Stanley. We're talking about $70.6 billion in full-year revenue - that's a record. EPS hit $10.21 for the year, and their return on tangible common equity came in at 21.6%. But what really caught my attention was their total client assets reaching $9.3 trillion. That's just a massive number.

**ALEX**: That's huge. And when you break it down by business segments, it seems like they had strength pretty much everywhere. Their institutional securities business - that's their investment banking and trading operations - hit record full-year revenues of $33.1 billion. Their wealth management business, which has really been their crown jewel, delivered record revenues of $31.8 billion with margins of 29%.

**JORDAN**: Right, and that wealth management story is particularly compelling. They had net new assets of $356 billion for the year - that's like adding a mid-sized asset manager every single year. What I found interesting was CEO Ted Pick's commentary about their "funnel" working. They're seeing about $100 billion migrating from their workplace and E*TRADE channels to their financial advisors, which is higher-margin business.

**ALEX**: That's a great point about the funnel. It sounds like their strategy of having multiple entry points - whether someone starts with E*TRADE for self-directed trading, gets stock options through their workplace program, or comes directly to a financial advisor - is really paying off. Now Jordan, one thing that surprised me was their decision NOT to raise their financial targets, despite clearly exceeding many of them. What's your read on that?

**JORDAN**: This was fascinating, Alex. Multiple analysts pressed them on this during the Q&A. Ted Pick was pretty candid - he basically said they don't want to "chase the dragon" by constantly raising targets just because they hit them. His philosophy seems to be about proving they can compound earnings consistently through different market cycles, not just when everything's going well.

**ALEX**: That's actually pretty refreshing in a world where companies often feel pressure to constantly raise guidance. Pick mentioned wanting to achieve "higher lows" during tougher periods rather than just reaching for higher peaks when times are good.

**JORDAN**: Exactly. And they're sitting on a lot of excess capital - over 300 basis points above their required levels. Pick was asked about potential M&A or returning more capital to shareholders, but he emphasized they want to keep the bar high for acquisitions. They've done four major deals in recent years and know how much work integration takes.

**ALEX**: Speaking of capital allocation, they did return $4.6 billion to shareholders through buybacks in 2025 and raised their dividend by 7.5 cents to $1 per share. But it sounds like they're being pretty disciplined about not getting too aggressive.

**JORDAN**: Right. And looking forward, there are some interesting growth drivers. Pick talked about being in the "third inning" of a capital markets recovery, driven by what he calls the...]]>439falsefullhttps://www.spreaker.com/episode/3m-q4-2025-earnings-analysis--70401594
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly calls into coffee-shop conversations. I'm Alex, and I'm here with my co-host Jordan to break down 3M's Q4 2025 earnings call that just wrapped up. Jordan, this was one of those calls where the CEO really wanted to drive home that the turnaround is working.

**JORDAN:** Absolutely, Alex. And before we dive in, let me quickly mention - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks for that reminder. Now, let's get into the numbers because 3M delivered some solid results here. Organic growth of 2.2% in Q4, operating margin of 21.1%, and earnings per share came in at $1.83. But the real story is the full-year performance - they grew organic sales 2.1% for the year, which is a nice acceleration from that 1.2% they posted in 2024.

**JORDAN:** What really caught my attention was the margin expansion story. They delivered 23.4% adjusted operating margin for the full year - that's up 200 basis points year-over-year and at the high end of their guidance. CEO Bill Brown has been hammering this "commercial excellence" message for the past 21 months, and it seems like it's actually working.

**ALEX:** Yeah, and let's talk about innovation because this is where things get interesting. They launched 284 new products in 2025 - that's up 68% from the prior year. Brown was pretty excited about this, saying sales from products launched in the last five years were up 23% for the full year.

**JORDAN:** That's a key metric to watch, Alex. They call it their "new product vitality index" or NPVI, and it hit 13% - about two points above where they started the year. But here's what I found fascinating - Brown said about 80% of their R&D spending is now focused on what they call "priority verticals" - the higher-growth, higher-margin areas.

**ALEX:** Right, and speaking of those priority verticals, they represent about 60% of the business now. Brown hinted that there's going to be some portfolio reshuffling ahead. He mentioned about 10% of their business is in more commodity-like areas that they're probably going to think about exiting over time.

**JORDAN:** The operational metrics were impressive too. Their OTIF - that's on-time, in-full delivery - hit 90%, up 300 basis points from the prior year. Brown called it "the best we've achieved in decades" and they sustained that rate for seven months straight. That's the kind of operational excellence that actually moves the needle with customers.

**ALEX:** Now let's talk guidance because this is where it gets really interesting for investors. For 2026, they're calling for organic sales growth of approximately 3% - so accelerating from that 2.1% they just posted. They expect adjusted operating margin expansion of 70 to 80 basis points, and EPS of $8.50 to $8.70.

**JORDAN:** What I like about this guidance is the confidence in their "outgrowth" strategy. Brown said they expect the macro environment to be around 1.7% growth, but they're guiding to 3% organic growth. That delta - over $300 million - is what he calls outperforming the macro, and about half of that is coming from new product introductions.

**ALEX:** The Q&A had some interesting moments too. There were several questions about tariffs, which makes sense given the current political environment. Brown said they're already dealing with about $140 million in gross tariff impact, and there could be additional headwinds if new Europe tariffs get implemented.

**JORDAN:** Yeah, Brown was pretty measured on that topic. He said if the proposed Europe tariffs play out as discussed - 10% initially, then up to 25% - it could be a $30 to $40 million impact in 2026. But he emphasized that's not in their gui

This episode includes AI-generated content.]]>SP100-MMM-Q4-2025-enTue, 03 Mar 2026 03:10:50 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly calls into coffee-shop conversations. I'm Alex, and I'm here with my co-host Jordan to break down 3M's Q4 2025 earnings...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly calls into coffee-shop conversations. I'm Alex, and I'm here with my co-host Jordan to break down 3M's Q4 2025 earnings call that just wrapped up. Jordan, this was one of those calls where the CEO really wanted to drive home that the turnaround is working.

**JORDAN:** Absolutely, Alex. And before we dive in, let me quickly mention - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks for that reminder. Now, let's get into the numbers because 3M delivered some solid results here. Organic growth of 2.2% in Q4, operating margin of 21.1%, and earnings per share came in at $1.83. But the real story is the full-year performance - they grew organic sales 2.1% for the year, which is a nice acceleration from that 1.2% they posted in 2024.

**JORDAN:** What really caught my attention was the margin expansion story. They delivered 23.4% adjusted operating margin for the full year - that's up 200 basis points year-over-year and at the high end of their guidance. CEO Bill Brown has been hammering this "commercial excellence" message for the past 21 months, and it seems like it's actually working.

**ALEX:** Yeah, and let's talk about innovation because this is where things get interesting. They launched 284 new products in 2025 - that's up 68% from the prior year. Brown was pretty excited about this, saying sales from products launched in the last five years were up 23% for the full year.

**JORDAN:** That's a key metric to watch, Alex. They call it their "new product vitality index" or NPVI, and it hit 13% - about two points above where they started the year. But here's what I found fascinating - Brown said about 80% of their R&D spending is now focused on what they call "priority verticals" - the higher-growth, higher-margin areas.

**ALEX:** Right, and speaking of those priority verticals, they represent about 60% of the business now. Brown hinted that there's going to be some portfolio reshuffling ahead. He mentioned about 10% of their business is in more commodity-like areas that they're probably going to think about exiting over time.

**JORDAN:** The operational metrics were impressive too. Their OTIF - that's on-time, in-full delivery - hit 90%, up 300 basis points from the prior year. Brown called it "the best we've achieved in decades" and they sustained that rate for seven months straight. That's the kind of operational excellence that actually moves the needle with customers.

**ALEX:** Now let's talk guidance because this is where it gets really interesting for investors. For 2026, they're calling for organic sales growth of approximately 3% - so accelerating from that 2.1% they just posted. They expect adjusted operating margin expansion of 70 to 80 basis points, and EPS of $8.50 to $8.70.

**JORDAN:** What I like about this guidance is the confidence in their "outgrowth" strategy. Brown said they expect the macro environment to be around 1.7% growth, but they're guiding to 3% organic growth. That delta - over $300 million - is what he calls outperforming the macro, and about half of that is coming from new product introductions.

**ALEX:** The Q&A had some interesting moments too. There were several questions about tariffs, which makes sense given the current political environment. Brown said they're already dealing with about $140 million in gross tariff impact, and there could be additional headwinds if new Europe tariffs get implemented.

**JORDAN:** Yeah, Brown was pretty measured on that topic. He said if the proposed Europe tariffs play out as...]]>509falsefullhttps://www.spreaker.com/episode/exxon-mobil-q4-2025-earnings-analysis--70320275
JORDAN: And I'm Jordan. Today we're diving into Exxon Mobil's Q4 2025 earnings call - and wow, there's a lot to unpack here.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Exxon's CEO Darren Woods came out swinging in this call, talking about transformation and competitive advantages. What caught your attention first?

ALEX: The numbers are pretty impressive, Jordan. They hit 4.7 million oil equivalent barrels per day in upstream production - that's their highest annual company production in over 40 years. But what really stands out is Woods saying their unit earnings are more than double what they were in 2019 on a constant price basis.

JORDAN: That's a massive improvement. And they're not just talking about past performance - they've got some bold targets for 2030. Tell me about this "advantaged assets" strategy.

ALEX: So they're targeting 65% of production to come from what they call "advantaged assets" by 2030. These are primarily their Permian Basin operations, Guyana offshore fields, and LNG projects. Woods emphasized these have "lower cost of supply, lower emissions intensity, and higher returns."

JORDAN: The Permian numbers are particularly striking. They hit 1.8 million barrels per day in Q4 - a new record. But here's what's interesting: they're deploying this "lightweight proppant" technology in about 25% of wells now, expecting to reach 50% by end of 2026. Woods said there's "no near-term peak Permian" for them and they expect to exceed 2.5 million barrels per day beyond 2030.

ALEX: That's the technology angle that keeps coming up. They've got over 40 what they call "stackable technologies" in various stages of testing. It's not just about drilling more holes - it's about getting more oil out of each hole more efficiently.

JORDAN: And Guyana continues to be their crown jewel. Their Yellowtail project came online ahead of schedule, pushing gross production to about 875,000 barrels per day in Q4. Woods mentioned their first four floating production units are producing 100,000 barrels per day above the investment basis.

ALEX: There was an interesting exchange about Guyana's future too. An analyst asked about the license expiring in 2027 and the disputed waters with Venezuela. Woods seemed optimistic about resolving the border dispute through the International Court of Justice, and hinted that recent developments in Venezuela might make the naval environment "more friendly."

JORDAN: Speaking of Venezuela, that was probably the most intriguing part of the Q&A. Woods acknowledged he told the White House that Venezuela was currently "uninvestable" but said the Trump administration is committed to addressing that. He even offered to send a technical team to assess opportunities there.

ALEX: The geopolitical opportunities don't stop there. Woods mentioned they're looking at Libya, Iraq, and other markets where improved fiscal terms and legal frameworks could unlock significant resources. He emphasized that Exxon's technological advantages and project execution capabilities make them attractive partners for these resource-rich countries.

JORDAN: Let's talk about their broader transformation strategy. This isn't just about oil and gas anymore. They're moving into carbon capture and storage in a big way, with about 9 million tons per year of CO2 sequestration capacity across various projects.

ALEX: And here's something that caught my ear - they're in "very serious substantive conversations" with hyperscale data center companies about carbon capture solutions. Woods expects a project announce

This episode includes AI-generated content.]]>SP100-XOM-Q4-2025-enFri, 27 Feb 2026 06:23:31 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate quarterly results for everyday investors. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Exxon Mobil's Q4 2025 earnings call - and wow, there's a lot...
JORDAN: And I'm Jordan. Today we're diving into Exxon Mobil's Q4 2025 earnings call - and wow, there's a lot to unpack here.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, Exxon's CEO Darren Woods came out swinging in this call, talking about transformation and competitive advantages. What caught your attention first?

ALEX: The numbers are pretty impressive, Jordan. They hit 4.7 million oil equivalent barrels per day in upstream production - that's their highest annual company production in over 40 years. But what really stands out is Woods saying their unit earnings are more than double what they were in 2019 on a constant price basis.

JORDAN: That's a massive improvement. And they're not just talking about past performance - they've got some bold targets for 2030. Tell me about this "advantaged assets" strategy.

ALEX: So they're targeting 65% of production to come from what they call "advantaged assets" by 2030. These are primarily their Permian Basin operations, Guyana offshore fields, and LNG projects. Woods emphasized these have "lower cost of supply, lower emissions intensity, and higher returns."

JORDAN: The Permian numbers are particularly striking. They hit 1.8 million barrels per day in Q4 - a new record. But here's what's interesting: they're deploying this "lightweight proppant" technology in about 25% of wells now, expecting to reach 50% by end of 2026. Woods said there's "no near-term peak Permian" for them and they expect to exceed 2.5 million barrels per day beyond 2030.

ALEX: That's the technology angle that keeps coming up. They've got over 40 what they call "stackable technologies" in various stages of testing. It's not just about drilling more holes - it's about getting more oil out of each hole more efficiently.

JORDAN: And Guyana continues to be their crown jewel. Their Yellowtail project came online ahead of schedule, pushing gross production to about 875,000 barrels per day in Q4. Woods mentioned their first four floating production units are producing 100,000 barrels per day above the investment basis.

ALEX: There was an interesting exchange about Guyana's future too. An analyst asked about the license expiring in 2027 and the disputed waters with Venezuela. Woods seemed optimistic about resolving the border dispute through the International Court of Justice, and hinted that recent developments in Venezuela might make the naval environment "more friendly."

JORDAN: Speaking of Venezuela, that was probably the most intriguing part of the Q&A. Woods acknowledged he told the White House that Venezuela was currently "uninvestable" but said the Trump administration is committed to addressing that. He even offered to send a technical team to assess opportunities there.

ALEX: The geopolitical opportunities don't stop there. Woods mentioned they're looking at Libya, Iraq, and other markets where improved fiscal terms and legal frameworks could unlock significant resources. He emphasized that Exxon's technological advantages and project execution capabilities make them attractive partners for these resource-rich countries.

JORDAN: Let's talk about their broader transformation strategy. This isn't just about oil and gas anymore. They're moving into carbon capture and storage in a big way, with about 9 million tons per year of CO2 sequestration capacity across various projects.

ALEX: And here's something that caught my ear - they're in...]]>481falsefullhttps://www.spreaker.com/episode/wells-fargo-q4-2025-earnings-analysis--70320269
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Wells Fargo's fourth quarter 2025 results, and folks, this is a big one. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: That's right, Alex. And what a transformation story this is becoming. Wells Fargo just reported some pretty impressive numbers - net income hit $5.4 billion for the quarter, up 6% year-over-year, with diluted earnings per share at $1.62, up 13%. But the real story here is what's happening behind these numbers.

**ALEX**: Absolutely. Let's start with the elephant in the room that's actually turned into a huge positive - the removal of that Federal Reserve asset cap. Jordan, this has completely unleashed Wells Fargo's ability to grow their balance sheet again.

**JORDAN**: It's like taking the parking brake off a race car, Alex. CEO Charlie Scharf said their assets grew 11% year-over-year, with broad-based loan growth and higher trading assets. They're finally able to use their balance sheet to support customers properly again. And get this - they've had 22 consecutive quarters of headcount reductions, cutting over 25% since Q2 2020, while simultaneously growing the business.

**ALEX**: That's remarkable efficiency. Now, let's talk about their ambitious targets. They're now shooting for a 17-18% return on tangible common equity in the medium term. That's up from their current 15%. But when analysts pressed Scharf for a timeline, he basically said "look, we don't control interest rates or the economy."

**JORDAN**: Yeah, that was one of the more interesting Q&A moments. Steven Chubak from Wolfe Research pushed back, saying other banks do provide timelines. But Scharf held firm - he's clearly learned from overpromising in the past. His approach is essentially "judge us by our results, not our promises."

**ALEX**: Smart approach given their history. Now let's dive into the business segments. Their consumer business is really starting to show momentum. Credit card accounts opened nearly 3 million new accounts in 2025, up 21% year-over-year. Auto business returned to growth with 19% balance growth. Jordan, what stood out to you here?

**JORDAN**: What I found fascinating is how methodical they're being about this growth. Scharf specifically mentioned they're not just chasing growth for growth's sake - they want profitable growth. In auto, they became the preferred financing provider for Volkswagen and Audi. But he emphasized they're focused on "making sure we have the right level of profitability, not just growth."

**ALEX**: That's a mature approach. On the commercial side, they hired 185 coverage bankers over the last two years, with over 60% hired in 2025. They're seeing early success with higher client acquisition and loan growth. But here's where it gets interesting - they're really pushing into investment banking.

**JORDAN**: Right, they've set a goal to be a top 5 U.S. investment bank. They moved up to 8th in M&A rankings in 2025 from 12th in 2024. And Scharf mentioned they're entering 2026 with their deal pipeline "meaningfully greater than it has been at any point in the last 5 years." That's a bold statement.

**ALEX**: Now, let's talk numbers for 2026. They're guiding for net interest income of around $50 billion, up from $47.5 billion in 2025. But here's where it gets complex - they're breaking out their markets business separately now.

**JORDAN**: This is actually really important for investors to understand. They expect markets net interest income to grow to about $2 billion in 2026, but this growth will be partially offset by lower noninterest income. It's essentially a shift in how reve

This episode includes AI-generated content.]]>SP100-WFC-Q4-2025-enFri, 27 Feb 2026 06:23:27 +0000trueBeta Finch# Beta Finch Podcast Script: Wells Fargo Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Wells Fargo's fourth quarter 2025 results, and folks,...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Wells Fargo's fourth quarter 2025 results, and folks, this is a big one. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: That's right, Alex. And what a transformation story this is becoming. Wells Fargo just reported some pretty impressive numbers - net income hit $5.4 billion for the quarter, up 6% year-over-year, with diluted earnings per share at $1.62, up 13%. But the real story here is what's happening behind these numbers.

**ALEX**: Absolutely. Let's start with the elephant in the room that's actually turned into a huge positive - the removal of that Federal Reserve asset cap. Jordan, this has completely unleashed Wells Fargo's ability to grow their balance sheet again.

**JORDAN**: It's like taking the parking brake off a race car, Alex. CEO Charlie Scharf said their assets grew 11% year-over-year, with broad-based loan growth and higher trading assets. They're finally able to use their balance sheet to support customers properly again. And get this - they've had 22 consecutive quarters of headcount reductions, cutting over 25% since Q2 2020, while simultaneously growing the business.

**ALEX**: That's remarkable efficiency. Now, let's talk about their ambitious targets. They're now shooting for a 17-18% return on tangible common equity in the medium term. That's up from their current 15%. But when analysts pressed Scharf for a timeline, he basically said "look, we don't control interest rates or the economy."

**JORDAN**: Yeah, that was one of the more interesting Q&A moments. Steven Chubak from Wolfe Research pushed back, saying other banks do provide timelines. But Scharf held firm - he's clearly learned from overpromising in the past. His approach is essentially "judge us by our results, not our promises."

**ALEX**: Smart approach given their history. Now let's dive into the business segments. Their consumer business is really starting to show momentum. Credit card accounts opened nearly 3 million new accounts in 2025, up 21% year-over-year. Auto business returned to growth with 19% balance growth. Jordan, what stood out to you here?

**JORDAN**: What I found fascinating is how methodical they're being about this growth. Scharf specifically mentioned they're not just chasing growth for growth's sake - they want profitable growth. In auto, they became the preferred financing provider for Volkswagen and Audi. But he emphasized they're focused on "making sure we have the right level of profitability, not just growth."

**ALEX**: That's a mature approach. On the commercial side, they hired 185 coverage bankers over the last two years, with over 60% hired in 2025. They're seeing early success with higher client acquisition and loan growth. But here's where it gets interesting - they're really pushing into investment banking.

**JORDAN**: Right, they've set a goal to be a top 5 U.S. investment bank. They moved up to 8th in M&A rankings in 2025 from 12th in 2024. And Scharf mentioned they're entering 2026 with their deal pipeline "meaningfully greater than it has been at any point in the last 5 years." That's a bold statement.

**ALEX**: Now, let's talk numbers for 2026. They're guiding for net interest income of around $50 billion, up from $47.5 billion in 2025. But here's where it gets complex - they're breaking out their markets business separately now.

**JORDAN**: This is actually really important for investors to understand. They expect markets net interest income to grow to about $2...]]>472falsefullhttps://www.spreaker.com/episode/tjx-companies-q4-2026-earnings-analysis--70320265
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into TJX Companies' fourth quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, TJX just delivered what CEO Ernie Herrman called an "excellent" quarter with some pretty impressive numbers.

JORDAN: Absolutely, Alex. The off-price retail giant crushed expectations across the board. Fourth quarter sales hit $17.7 billion, up 9% year-over-year, while comparable store sales grew a very strong 5%. That's on top of a 5% comp increase last year, so we're talking about solid momentum here.

ALEX: And the bottom line looked even better. Adjusted earnings per share came in at $1.43, up 16% from $1.23 last year and well above their plan. For the full year, they crossed a major milestone - net sales surpassed $60 billion for the first time, reaching $60.4 billion.

JORDAN: What I found particularly impressive was the breadth of their success. Every single division delivered comp sales growth of 4% or better. Marmaxx, their largest division, grew 4% to $36.6 billion in annual sales. HomeGoods hit its own milestone, surpassing $10 billion in annual sales with a strong 5% comp increase. And their international operations showed real strength - TJX Canada posted an outstanding 7% comp growth.

ALEX: Speaking of profitability, their adjusted gross margin expanded 60 basis points to 31.1% in Q4, driven primarily by higher merchandise margins. CFO John Klinger highlighted that shrink is now essentially back to pre-COVID levels after two consecutive years of 20 basis point improvements.

JORDAN: That shrink improvement is huge, Alex. It shows their operational excellence and suggests they've successfully navigated the inventory challenges that plagued many retailers. What's also interesting is their inventory strategy - balance sheet inventory was up 14%, but they frame this as a positive, with outstanding merchandise availability giving them tremendous buying flexibility.

ALEX: Let's talk about their growth strategy because Herrman was quite bullish about playing offense. He outlined several key initiatives - more aggressive marketing campaigns, including new campaigns for HomeGoods and TJ Maxx, deeper vendor relationships, and continued store remodels and new prototypes to enhance the shopping experience.

JORDAN: The vendor relationship piece is fascinating. They now work with approximately 21,000 vendors through their team of over 1,400 buyers. Herrman mentioned they're being more aggressive than ever in going after brands, particularly as some competitors face closures or disruptions. He said vendors are essentially giving them first call on excess inventory because of their reputation for being straightforward and paying on time.

ALEX: And the expansion story continues. They're planning to add 146 net new stores in fiscal 2027, including their first five stores in Spain. Long-term, they see potential for 7,000 stores globally with existing banners in current countries plus Spain - that's about 1,700 more stores than they have today.

JORDAN: But let's talk about the guidance, which was a bit more conservative. For fiscal 2027, they're projecting comp sales growth of 2% to 3%, total sales of $62.7 to $63.3 billion, and earnings per share of $4.93 to $5.20. That EPS range represents 4% to 6% growth, which is solid but notably more modest than recent performance.

ALEX: During the Q&A, there were some interesting insights. When asked about pricing actions, Herrman explained their flexible approach - they don't dictate retail prices but rather maintain appropriate value gaps versus competitors. He noted their value perception has actually improved over the last six m

This episode includes AI-generated content.]]>SP100-TJX-Q4-2026-enFri, 27 Feb 2026 06:23:22 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into TJX Companies' fourth quarter 2026 results. This podcast is AI-generated content for educational...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into TJX Companies' fourth quarter 2026 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, TJX just delivered what CEO Ernie Herrman called an "excellent" quarter with some pretty impressive numbers.

JORDAN: Absolutely, Alex. The off-price retail giant crushed expectations across the board. Fourth quarter sales hit $17.7 billion, up 9% year-over-year, while comparable store sales grew a very strong 5%. That's on top of a 5% comp increase last year, so we're talking about solid momentum here.

ALEX: And the bottom line looked even better. Adjusted earnings per share came in at $1.43, up 16% from $1.23 last year and well above their plan. For the full year, they crossed a major milestone - net sales surpassed $60 billion for the first time, reaching $60.4 billion.

JORDAN: What I found particularly impressive was the breadth of their success. Every single division delivered comp sales growth of 4% or better. Marmaxx, their largest division, grew 4% to $36.6 billion in annual sales. HomeGoods hit its own milestone, surpassing $10 billion in annual sales with a strong 5% comp increase. And their international operations showed real strength - TJX Canada posted an outstanding 7% comp growth.

ALEX: Speaking of profitability, their adjusted gross margin expanded 60 basis points to 31.1% in Q4, driven primarily by higher merchandise margins. CFO John Klinger highlighted that shrink is now essentially back to pre-COVID levels after two consecutive years of 20 basis point improvements.

JORDAN: That shrink improvement is huge, Alex. It shows their operational excellence and suggests they've successfully navigated the inventory challenges that plagued many retailers. What's also interesting is their inventory strategy - balance sheet inventory was up 14%, but they frame this as a positive, with outstanding merchandise availability giving them tremendous buying flexibility.

ALEX: Let's talk about their growth strategy because Herrman was quite bullish about playing offense. He outlined several key initiatives - more aggressive marketing campaigns, including new campaigns for HomeGoods and TJ Maxx, deeper vendor relationships, and continued store remodels and new prototypes to enhance the shopping experience.

JORDAN: The vendor relationship piece is fascinating. They now work with approximately 21,000 vendors through their team of over 1,400 buyers. Herrman mentioned they're being more aggressive than ever in going after brands, particularly as some competitors face closures or disruptions. He said vendors are essentially giving them first call on excess inventory because of their reputation for being straightforward and paying on time.

ALEX: And the expansion story continues. They're planning to add 146 net new stores in fiscal 2027, including their first five stores in Spain. Long-term, they see potential for 7,000 stores globally with existing banners in current countries plus Spain - that's about 1,700 more stores than they have today.

JORDAN: But let's talk about the guidance, which was a bit more conservative. For fiscal 2027, they're projecting comp sales growth of 2% to 3%, total sales of $62.7 to $63.3 billion, and earnings per share of $4.93 to $5.20. That EPS range represents 4% to 6% growth, which is solid but notably more modest than recent performance.

ALEX: During the Q&A, there were some interesting insights. When asked about pricing actions, Herrman explained their flexible approach - they don't dictate retail prices but rather...]]>481falsefullhttps://www.spreaker.com/episode/stryker-q4-2025-earnings-analysis--70320261
**JORDAN**: And I'm Jordan. Today we're diving into Stryker's Q4 2025 earnings - and folks, this medical device giant just delivered what CEO Kevin Lobo called "outstanding results" across all key metrics.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Stryker really brought the heat this quarter.

**ALEX**: They sure did, Jordan. Stryker crushed it with 11% organic sales growth in Q4, hitting over $25 billion in sales for the full year. That's their fourth consecutive year of double-digit organic growth. And here's what I love - they managed 10.3% growth for the full year against a tough 10.2% comparable from 2024.

**JORDAN**: The consistency is remarkable. And it wasn't just the top line - adjusted earnings per share jumped 11.5% to $4.47 in the quarter, with full-year EPS up 11.8% to $13.63. What really stands out to me is they achieved this while managing $400 million in tariff headwinds, including an incremental $200 million hit they're expecting in 2026.

**ALEX**: That tariff management is impressive. Preston Wells, their CFO, mentioned they're absorbing these costs while still driving meaningful operating margin expansion. Speaking of which, they delivered their second consecutive year of at least 100 basis points of margin expansion. That shows real operational muscle.

**JORDAN**: Let's break down the business segments because there were some real standouts. MedSurg and Neurotechnology posted 12.6% organic growth, with U.S. growth hitting 13%. The instruments business was particularly hot with 19.1% U.S. growth driven by strong capital demand.

**ALEX**: And then there's the Mako story - which honestly feels like the star of this whole show. Jordan, they had another record quarter for Mako installations, both in the U.S. and worldwide. Their installed base now includes over 3,000 Mako systems globally.

**JORDAN**: The Mako 4 transition has been what Lobo called "an absolute home run." Here's a stat that blew me away - over two-thirds of their knee procedures and over one-third of hip procedures in the U.S. are now performed on Mako. One surgeon even told Lobo that the new revision hip application was like a "cheat code" for difficult procedures.

**ALEX**: That's incredible feedback. And they're not stopping there - they're expanding Mako into shoulder applications mid-year, plus they just started cases on their handheld robot called Mako RPS. This is designed for surgeons who want robotic assistance but aren't ready for the full Mako system complexity.

**JORDAN**: The RPS launch is smart positioning. It sits between their manual instruments and full Mako systems, potentially opening up new customer segments, especially in ambulatory surgery centers. Speaking of ASCs, they mentioned hips and knees are now in the high teens percentage flowing through that channel.

**ALEX**: Let's talk guidance because this is where Stryker shows confidence in their momentum. For 2026, they're guiding 8% to 9.5% organic sales growth and adjusted EPS of $14.90 to $15.10. That top end of the range is slightly higher than where they started 2025, which Lobo says reflects their elevated capital backlog and strong procedural outlook.

**JORDAN**: And here's something interesting from the Q&A - when asked if 10% growth was still possible, Lobo said "certainly possible" for their fifth consecutive year of double-digit growth. The confidence seems genuine, backed by that strong order book and Mako momentum.

**ALEX**: There were some organizational changes wo

This episode includes AI-generated content.]]>SP100-SYK-Q4-2025-enFri, 27 Feb 2026 06:23:17 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the insights that matter. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving into Stryker's Q4 2025 earnings - and folks, this...
**JORDAN**: And I'm Jordan. Today we're diving into Stryker's Q4 2025 earnings - and folks, this medical device giant just delivered what CEO Kevin Lobo called "outstanding results" across all key metrics.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Stryker really brought the heat this quarter.

**ALEX**: They sure did, Jordan. Stryker crushed it with 11% organic sales growth in Q4, hitting over $25 billion in sales for the full year. That's their fourth consecutive year of double-digit organic growth. And here's what I love - they managed 10.3% growth for the full year against a tough 10.2% comparable from 2024.

**JORDAN**: The consistency is remarkable. And it wasn't just the top line - adjusted earnings per share jumped 11.5% to $4.47 in the quarter, with full-year EPS up 11.8% to $13.63. What really stands out to me is they achieved this while managing $400 million in tariff headwinds, including an incremental $200 million hit they're expecting in 2026.

**ALEX**: That tariff management is impressive. Preston Wells, their CFO, mentioned they're absorbing these costs while still driving meaningful operating margin expansion. Speaking of which, they delivered their second consecutive year of at least 100 basis points of margin expansion. That shows real operational muscle.

**JORDAN**: Let's break down the business segments because there were some real standouts. MedSurg and Neurotechnology posted 12.6% organic growth, with U.S. growth hitting 13%. The instruments business was particularly hot with 19.1% U.S. growth driven by strong capital demand.

**ALEX**: And then there's the Mako story - which honestly feels like the star of this whole show. Jordan, they had another record quarter for Mako installations, both in the U.S. and worldwide. Their installed base now includes over 3,000 Mako systems globally.

**JORDAN**: The Mako 4 transition has been what Lobo called "an absolute home run." Here's a stat that blew me away - over two-thirds of their knee procedures and over one-third of hip procedures in the U.S. are now performed on Mako. One surgeon even told Lobo that the new revision hip application was like a "cheat code" for difficult procedures.

**ALEX**: That's incredible feedback. And they're not stopping there - they're expanding Mako into shoulder applications mid-year, plus they just started cases on their handheld robot called Mako RPS. This is designed for surgeons who want robotic assistance but aren't ready for the full Mako system complexity.

**JORDAN**: The RPS launch is smart positioning. It sits between their manual instruments and full Mako systems, potentially opening up new customer segments, especially in ambulatory surgery centers. Speaking of ASCs, they mentioned hips and knees are now in the high teens percentage flowing through that channel.

**ALEX**: Let's talk guidance because this is where Stryker shows confidence in their momentum. For 2026, they're guiding 8% to 9.5% organic sales growth and adjusted EPS of $14.90 to $15.10. That top end of the range is slightly higher than where they started 2025, which Lobo says reflects their elevated capital backlog and strong procedural outlook.

**JORDAN**: And here's something interesting from the Q&A - when asked if 10% growth was still possible, Lobo said "certainly possible" for their fifth consecutive year of double-digit growth....]]>514falsefullhttps://www.spreaker.com/episode/philip-morris-international-q4-2025-earnings-analysis--70320257
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Philip Morris International's Q4 2025 earnings call. Now before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex! And what a call this was from Philip Morris. They absolutely crushed it in 2025, delivering what CEO Jacek Olczak called "another outstanding year." We're talking about their fifth consecutive year of positive volumes, driven primarily by their smoke-free products business.

**ALEX**: Right, and the numbers really tell the story here. Philip Morris hit over $40 billion in total net revenues for 2025, with smoke-free products now representing 41.5% of that - nearly $17 billion! That's a massive shift from where they were just a few years ago.

**JORDAN**: The growth trajectory is impressive. Smoke-free product volumes grew 12.8%, with IQOS leading the charge at 11% growth. But here's what caught my attention - their ZYN nicotine pouches in the US grew shipments by 37%, despite supply constraints. That's reaching 11.9 billion pouches, making up about 7% of their total smoke-free volume.

**ALEX**: And let's talk profitability because that's where this story gets really interesting. Their smoke-free gross margin hit 69.5%, which is now four percentage points higher than their combustible business. CFO Emmanuel Babeau made it clear that this improving profitability mix is a key driver of their overall margin expansion.

**JORDAN**: Speaking of margins, they delivered 140 basis points of organic margin expansion to reach 40.4% adjusted operating margin. That's while they're still investing heavily in marketing and brand building for their smoke-free portfolio. It shows real operating leverage in the business model.

**ALEX**: Now, the guidance for 2026 is where things get particularly interesting. They're forecasting organic net revenue growth of 5-7%, which might seem modest compared to recent years, but there are some specific headwinds they're navigating.

**JORDAN**: Exactly. The big story is Japan, where they're facing significant excise tax increases on heated tobacco products - we're talking 50-100 yen per pack, which could be 10-20% of current retail prices. This creates an asymmetry where heated tobacco gets hit first, before cigarettes face similar increases in 2027.

**ALEX**: And in the US, there's the ZYN inventory normalization. They estimate there are about 25 million cans of surplus inventory in the downstream supply chain that needs to work through, likely in Q1. But the underlying demand story remains strong - ZYN maintained about 61.5% volume share in the US nicotine pouch category.

**JORDAN**: What I found fascinating in the Q&A was the discussion around ZYN Ultra, their higher-strength nicotine pouch that's pending FDA approval. Olczak was pretty direct - they have readiness to launch "essentially as we speak," and they're expecting some movement this summer, though he admitted he doesn't have a great track record forecasting the FDA!

**ALEX**: [Laughs] At least he's honest about that! But you can tell they're frustrated with the regulatory environment. When asked about New York's proposed excise tax on nicotine pouches, Olczak called it "counterproductive to the health benefits" and "the wrong idea."

**JORDAN**: The international expansion story is really compelling too. They're now in 106 markets with smoke-free products, and some of these new launches are showing impressive traction. Taiwan caught my eye - they hit 4% market share in just a few weeks after launch. That's remarkable penetration for a new market entry.

**ALEX**: And they're not just focused on IQOS any

This episode includes AI-generated content.]]>SP100-PM-Q4-2025-enFri, 27 Feb 2026 06:23:12 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Philip Morris International's Q4 2025 earnings call. Now before we get started, I need...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Philip Morris International's Q4 2025 earnings call. Now before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex! And what a call this was from Philip Morris. They absolutely crushed it in 2025, delivering what CEO Jacek Olczak called "another outstanding year." We're talking about their fifth consecutive year of positive volumes, driven primarily by their smoke-free products business.

**ALEX**: Right, and the numbers really tell the story here. Philip Morris hit over $40 billion in total net revenues for 2025, with smoke-free products now representing 41.5% of that - nearly $17 billion! That's a massive shift from where they were just a few years ago.

**JORDAN**: The growth trajectory is impressive. Smoke-free product volumes grew 12.8%, with IQOS leading the charge at 11% growth. But here's what caught my attention - their ZYN nicotine pouches in the US grew shipments by 37%, despite supply constraints. That's reaching 11.9 billion pouches, making up about 7% of their total smoke-free volume.

**ALEX**: And let's talk profitability because that's where this story gets really interesting. Their smoke-free gross margin hit 69.5%, which is now four percentage points higher than their combustible business. CFO Emmanuel Babeau made it clear that this improving profitability mix is a key driver of their overall margin expansion.

**JORDAN**: Speaking of margins, they delivered 140 basis points of organic margin expansion to reach 40.4% adjusted operating margin. That's while they're still investing heavily in marketing and brand building for their smoke-free portfolio. It shows real operating leverage in the business model.

**ALEX**: Now, the guidance for 2026 is where things get particularly interesting. They're forecasting organic net revenue growth of 5-7%, which might seem modest compared to recent years, but there are some specific headwinds they're navigating.

**JORDAN**: Exactly. The big story is Japan, where they're facing significant excise tax increases on heated tobacco products - we're talking 50-100 yen per pack, which could be 10-20% of current retail prices. This creates an asymmetry where heated tobacco gets hit first, before cigarettes face similar increases in 2027.

**ALEX**: And in the US, there's the ZYN inventory normalization. They estimate there are about 25 million cans of surplus inventory in the downstream supply chain that needs to work through, likely in Q1. But the underlying demand story remains strong - ZYN maintained about 61.5% volume share in the US nicotine pouch category.

**JORDAN**: What I found fascinating in the Q&A was the discussion around ZYN Ultra, their higher-strength nicotine pouch that's pending FDA approval. Olczak was pretty direct - they have readiness to launch "essentially as we speak," and they're expecting some movement this summer, though he admitted he doesn't have a great track record forecasting the FDA!

**ALEX**: [Laughs] At least he's honest about that! But you can tell they're frustrated with the regulatory environment. When asked about New York's proposed excise tax on nicotine pouches, Olczak called it "counterproductive to the health benefits" and "the wrong idea."

**JORDAN**: The international expansion story is really compelling too. They're now in 106 markets with smoke-free products, and some of these new launches are showing impressive traction. Taiwan caught my eye - they hit 4% market share in...]]>506falsefullhttps://www.spreaker.com/episode/nvidia-q4-2026-earnings-analysis--70320254
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into NVIDIA's absolutely massive Q4 2026 results that just dropped. Jordan, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with these numbers? NVIDIA just reported Q4 revenue of $68 billion - that's up 73% year-over-year and they added $11 billion in sequential growth. This is a company that's now doing nearly $200 billion in annual data center revenue alone.

**ALEX:** Right, and what's really striking is the acceleration. They went from strong growth in Q3 to even stronger growth in Q4. The data center business hit $62 billion for the quarter, up 75% year-over-year. But Jordan, what caught my attention was their guidance for Q1 - they're calling for $78 billion in revenue, which would be another massive jump.

**JORDAN:** Exactly, and that guidance assumes zero revenue from China, which is important context given the ongoing trade restrictions. But let's talk about what's driving this growth - it's really the Blackwell architecture that's just taken off. Jensen mentioned they have 9 gigawatts of Blackwell infrastructure already deployed, and here's the kicker - even their six-year-old Ampere chips are sold out in the cloud.

**ALEX:** That supply constraint theme runs throughout this call. Colette Kress mentioned they've strategically secured inventory and purchase commitments extending into calendar 2027 - that's much further out than usual and reflects the unprecedented demand visibility they're seeing. Speaking of segments, their networking business was a real standout, hitting $11 billion in revenue, up more than 3.5x year-over-year.

**JORDAN:** And that networking growth ties directly into their "AI factory" strategy. Jensen kept emphasizing this concept that in the new world of AI, compute literally equals revenue. When companies can generate tokens faster and more efficiently, that directly translates to higher revenues. It's why their customers are so willing to spend massive amounts on infrastructure.

**ALEX:** Speaking of spending, the numbers Jensen threw out about cloud provider CapEx were staggering. He said analyst expectations for 2026 CapEx across the top five cloud providers are approaching $700 billion - that's up $120 billion just since the start of the year. But there's something bigger happening here with what they're calling "agentic AI."

**JORDAN:** Right, this was probably the most important strategic theme of the call. Jensen talked about how we've hit an inflection point with AI agents - systems like Claude Code and OpenAI Codex that can actually take on complex, long-running tasks. He mentioned these agents are being used extensively by NVIDIA's own engineers, and the demand for the compute power to run them is going exponential.

**ALEX:** And they're betting big on this trend. NVIDIA announced a $10 billion investment in Anthropic this quarter, deepening their partnerships with all the major AI players. They're also working closely with OpenAI, Meta's expanding their deployment to millions of GPUs, and they even acquired talent from Groq to enhance their inference capabilities.

**JORDAN:** Let's talk about their next-generation platform - Rubin. They unveiled this at CES with six new chips, and Jensen claims it will train models with one-fourth the number of GPUs compared to Blackwell and reduce inference costs by up to 10x. They've already started shipping samples and expect production in the second half of the year.

**ALEX:** The margins story is fascinating too. They maintained gross margins around

This episode includes AI-generated content.]]>SP100-NVDA-Q4-2026-enFri, 27 Feb 2026 06:23:07 +0000trueBeta Finch# Beta Finch Podcast Script: NVIDIA Q4 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into NVIDIA's absolutely massive Q4 2026 results that just...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into NVIDIA's absolutely massive Q4 2026 results that just dropped. Jordan, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with these numbers? NVIDIA just reported Q4 revenue of $68 billion - that's up 73% year-over-year and they added $11 billion in sequential growth. This is a company that's now doing nearly $200 billion in annual data center revenue alone.

**ALEX:** Right, and what's really striking is the acceleration. They went from strong growth in Q3 to even stronger growth in Q4. The data center business hit $62 billion for the quarter, up 75% year-over-year. But Jordan, what caught my attention was their guidance for Q1 - they're calling for $78 billion in revenue, which would be another massive jump.

**JORDAN:** Exactly, and that guidance assumes zero revenue from China, which is important context given the ongoing trade restrictions. But let's talk about what's driving this growth - it's really the Blackwell architecture that's just taken off. Jensen mentioned they have 9 gigawatts of Blackwell infrastructure already deployed, and here's the kicker - even their six-year-old Ampere chips are sold out in the cloud.

**ALEX:** That supply constraint theme runs throughout this call. Colette Kress mentioned they've strategically secured inventory and purchase commitments extending into calendar 2027 - that's much further out than usual and reflects the unprecedented demand visibility they're seeing. Speaking of segments, their networking business was a real standout, hitting $11 billion in revenue, up more than 3.5x year-over-year.

**JORDAN:** And that networking growth ties directly into their "AI factory" strategy. Jensen kept emphasizing this concept that in the new world of AI, compute literally equals revenue. When companies can generate tokens faster and more efficiently, that directly translates to higher revenues. It's why their customers are so willing to spend massive amounts on infrastructure.

**ALEX:** Speaking of spending, the numbers Jensen threw out about cloud provider CapEx were staggering. He said analyst expectations for 2026 CapEx across the top five cloud providers are approaching $700 billion - that's up $120 billion just since the start of the year. But there's something bigger happening here with what they're calling "agentic AI."

**JORDAN:** Right, this was probably the most important strategic theme of the call. Jensen talked about how we've hit an inflection point with AI agents - systems like Claude Code and OpenAI Codex that can actually take on complex, long-running tasks. He mentioned these agents are being used extensively by NVIDIA's own engineers, and the demand for the compute power to run them is going exponential.

**ALEX:** And they're betting big on this trend. NVIDIA announced a $10 billion investment in Anthropic this quarter, deepening their partnerships with all the major AI players. They're also working closely with OpenAI, Meta's expanding their deployment to millions of GPUs, and they even acquired talent from Groq to enhance their inference capabilities.

**JORDAN:** Let's talk about their next-generation platform - Rubin. They unveiled this at CES with six new chips, and Jensen claims it will train models with one-fourth the number of GPUs compared to Blackwell and reduce inference costs by up to 10x. They've already started shipping samples and expect production in the second...]]>536falsefullhttps://www.spreaker.com/episode/nextera-energy-q4-2025-earnings-analysis--70320252
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking NextEra Energy's Q4 2025 earnings call - and folks, this one was packed with ambitious growth targets and some pretty bold strategic moves.

But before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. So NextEra delivered adjusted earnings per share of $3.71 for the full year - that's over 8% growth from 2024 and actually came in at the top end of their guidance range. But the real story here isn't just the solid quarter, it's the massive growth ambitions they laid out.

**ALEX:** Absolutely. CEO John Ketchum essentially said "America needs more electrons on the grid, and we're the ones to build them." They're targeting 8% plus compound annual growth in adjusted EPS through 2032, and then maintaining that same pace from 2032 to 2035. That's a decade-plus of aggressive growth targets.

**JORDAN:** And they've got the infrastructure spending to back it up. Florida Power & Light alone is planning $90 to $100 billion in capital investments through 2032. That's not a typo - we're talking about massive utility buildout. But what really caught my attention was their "15 by 35" data center strategy.

**ALEX:** Yeah, break that down for our listeners Jordan, because this is where NextEra is really positioning itself for the AI and data center boom.

**JORDAN:** So they want to place 15 gigawatts of new generation into service specifically for data center hubs by 2035. But here's the kicker - Ketchum said he'd be "disappointed" if they don't actually hit 30 gigawatts instead. They currently have 20 potential data center hubs in discussions and want to double that to 40 by year-end.

**ALEX:** The timing couldn't be better. In Florida alone, they've got over 20 gigawatts of large load interest, with advanced discussions on about 9 gigawatts. And get this - they could start serving some of these data centers as soon as 2028. Every gigawatt represents roughly $2 billion in capital expenditure.

**JORDAN:** What I find fascinating is their "bring your own generation" or BYOG strategy. Essentially, they're positioning themselves to build dedicated power infrastructure for hyperscalers like Google, Amazon, and Microsoft. This addresses the big concern about data centers driving up electricity costs for regular consumers.

**ALEX:** Speaking of Google, there was an interesting question about Google's acquisition of Intersect Power, a renewable developer. Some analysts were worried this could hurt NextEra's partnership with Google.

**JORDAN:** But Ketchum wasn't concerned at all. He made a compelling case that NextEra's advantages are hard to replicate - they've got solar panels secured through 2029, battery storage supply locked up, permits across multiple states, and experience building everything from wind and solar to nuclear and gas plants. A smaller developer like Intersect just can't match that scale.

**ALEX:** The nuclear story is particularly intriguing. They're moving ahead with recommissioning the Duane Arnold plant in Iowa thanks to that 25-year Google power purchase agreement. But they're also evaluating small modular reactors, or SMRs, with 6 gigawatts of potential co-location opportunities at existing nuclear sites.

**JORDAN:** Though they're being smart about nuclear - any new build would need "appropriate risk-sharing mechanisms" to limit their exposure. They've narrowed down from 96 potential SMR partners to about 12 they're doing deep dives on. But importantly, SMRs aren't baked into their base growth projections - that

This episode includes AI-generated content.]]>SP100-NEE-Q4-2025-enFri, 27 Feb 2026 06:23:02 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking NextEra Energy's Q4 2025...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking NextEra Energy's Q4 2025 earnings call - and folks, this one was packed with ambitious growth targets and some pretty bold strategic moves.

But before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. So NextEra delivered adjusted earnings per share of $3.71 for the full year - that's over 8% growth from 2024 and actually came in at the top end of their guidance range. But the real story here isn't just the solid quarter, it's the massive growth ambitions they laid out.

**ALEX:** Absolutely. CEO John Ketchum essentially said "America needs more electrons on the grid, and we're the ones to build them." They're targeting 8% plus compound annual growth in adjusted EPS through 2032, and then maintaining that same pace from 2032 to 2035. That's a decade-plus of aggressive growth targets.

**JORDAN:** And they've got the infrastructure spending to back it up. Florida Power & Light alone is planning $90 to $100 billion in capital investments through 2032. That's not a typo - we're talking about massive utility buildout. But what really caught my attention was their "15 by 35" data center strategy.

**ALEX:** Yeah, break that down for our listeners Jordan, because this is where NextEra is really positioning itself for the AI and data center boom.

**JORDAN:** So they want to place 15 gigawatts of new generation into service specifically for data center hubs by 2035. But here's the kicker - Ketchum said he'd be "disappointed" if they don't actually hit 30 gigawatts instead. They currently have 20 potential data center hubs in discussions and want to double that to 40 by year-end.

**ALEX:** The timing couldn't be better. In Florida alone, they've got over 20 gigawatts of large load interest, with advanced discussions on about 9 gigawatts. And get this - they could start serving some of these data centers as soon as 2028. Every gigawatt represents roughly $2 billion in capital expenditure.

**JORDAN:** What I find fascinating is their "bring your own generation" or BYOG strategy. Essentially, they're positioning themselves to build dedicated power infrastructure for hyperscalers like Google, Amazon, and Microsoft. This addresses the big concern about data centers driving up electricity costs for regular consumers.

**ALEX:** Speaking of Google, there was an interesting question about Google's acquisition of Intersect Power, a renewable developer. Some analysts were worried this could hurt NextEra's partnership with Google.

**JORDAN:** But Ketchum wasn't concerned at all. He made a compelling case that NextEra's advantages are hard to replicate - they've got solar panels secured through 2029, battery storage supply locked up, permits across multiple states, and experience building everything from wind and solar to nuclear and gas plants. A smaller developer like Intersect just can't match that scale.

**ALEX:** The nuclear story is particularly intriguing. They're moving ahead with recommissioning the Duane Arnold plant in Iowa thanks to that 25-year Google power purchase agreement. But they're also evaluating small modular reactors, or SMRs, with 6 gigawatts of potential co-location opportunities at existing nuclear sites.

**JORDAN:** Though they're being smart about nuclear - any new build would need "appropriate risk-sharing mechanisms" to limit their exposure. They've narrowed down from...]]>534falsefullhttps://www.spreaker.com/episode/general-electric-q4-2025-earnings-analysis--70320249
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate earnings calls into conversations that actually make sense. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into GE Aerospace's Q4 2025 earnings call, and wow - this was one impressive quarter to close out the year.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because GE Aerospace just delivered what CEO Larry Culp called "an outstanding year." We're looking at some seriously impressive double-digit growth across the board.

**ALEX:** The headline numbers are pretty striking, Jordan. For Q4, orders were up 74% - that's massive. Revenue increased 20%, earnings per share jumped 19% to $1.57, and free cash flow grew 15%. But the full-year picture is even more compelling.

**JORDAN:** Right, and that's where it gets really interesting. Full-year orders up 32%, revenue up 21%, and here's the kicker - operating profit grew by $1.8 billion dollars. That's not a percentage, that's $1.8 billion in absolute dollars. Free cash flow was up $1.5 billion to $7.7 billion total.

**ALEX:** What I found fascinating was how CEO Larry Culp framed this. He kept coming back to their purpose statement: "We invent the future of flight, lift people up, and bring them home safely." But then he backed that up with some hard data - nearly one million people are in flight right now with GE technology under wing.

**JORDAN:** And let's talk about that backlog, Alex. They're sitting on roughly $190 billion in backlog, up nearly $20 billion over the last year. That's not just a number - that's visibility into future revenue streams. When you have that kind of contracted future business, it gives you incredible confidence in your guidance.

**ALEX:** Speaking of guidance, let's break down what they're expecting for 2026. They're forecasting low double-digit revenue growth, with commercial services up mid-teens. Operating profit is expected to hit $9.85 to $10.25 billion - that's up a billion dollars at the midpoint.

**JORDAN:** And here's what caught my attention - CFO Rahul Ghai said they expect to hit that $10 billion operating profit milestone in 2026, which is two years earlier than their original outlook. That's not just meeting expectations, that's accelerating past them.

**ALEX:** The EPS guidance of $7.10 to $7.40 represents nearly 15% growth at the midpoint. And free cash flow? They're projecting $8 to $8.4 billion. Jordan, when you look at these numbers, what's really driving this performance?

**JORDAN:** It's really a tale of two segments, Alex. Their Commercial Engines & Services segment is absolutely on fire. CES orders were up 35% for the year, revenue grew 24%, and here's the key - services orders up 27% and revenue up 26%. That's the high-margin aftermarket business that keeps printing money for decades after an engine is sold.

**ALEX:** Right, and their Defense, Power & Technology segment, while smaller, also showed solid growth with orders up 19% and revenue up 11%. But let's dig into what's happening operationally because there were some really interesting strategic moves announced.

**JORDAN:** Absolutely. They're doing a major organizational restructuring. They're expanding their CES division to include their Technology & Operations team, now led by Muhammad Ali. The goal is better end-to-end engine lifecycle management. And they're elevating their customer-facing teams to report directly to the CEO.

**ALEX:** That organizational change seems designed to address what Culp acknowledged multiple times - their customers need more from them, faster. They talked extensively a

This episode includes AI-generated content.]]>SP100-GE-Q4-2025-enFri, 27 Feb 2026 06:22:56 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate earnings calls into conversations that actually make sense. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate earnings calls into conversations that actually make sense. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into GE Aerospace's Q4 2025 earnings call, and wow - this was one impressive quarter to close out the year.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because GE Aerospace just delivered what CEO Larry Culp called "an outstanding year." We're looking at some seriously impressive double-digit growth across the board.

**ALEX:** The headline numbers are pretty striking, Jordan. For Q4, orders were up 74% - that's massive. Revenue increased 20%, earnings per share jumped 19% to $1.57, and free cash flow grew 15%. But the full-year picture is even more compelling.

**JORDAN:** Right, and that's where it gets really interesting. Full-year orders up 32%, revenue up 21%, and here's the kicker - operating profit grew by $1.8 billion dollars. That's not a percentage, that's $1.8 billion in absolute dollars. Free cash flow was up $1.5 billion to $7.7 billion total.

**ALEX:** What I found fascinating was how CEO Larry Culp framed this. He kept coming back to their purpose statement: "We invent the future of flight, lift people up, and bring them home safely." But then he backed that up with some hard data - nearly one million people are in flight right now with GE technology under wing.

**JORDAN:** And let's talk about that backlog, Alex. They're sitting on roughly $190 billion in backlog, up nearly $20 billion over the last year. That's not just a number - that's visibility into future revenue streams. When you have that kind of contracted future business, it gives you incredible confidence in your guidance.

**ALEX:** Speaking of guidance, let's break down what they're expecting for 2026. They're forecasting low double-digit revenue growth, with commercial services up mid-teens. Operating profit is expected to hit $9.85 to $10.25 billion - that's up a billion dollars at the midpoint.

**JORDAN:** And here's what caught my attention - CFO Rahul Ghai said they expect to hit that $10 billion operating profit milestone in 2026, which is two years earlier than their original outlook. That's not just meeting expectations, that's accelerating past them.

**ALEX:** The EPS guidance of $7.10 to $7.40 represents nearly 15% growth at the midpoint. And free cash flow? They're projecting $8 to $8.4 billion. Jordan, when you look at these numbers, what's really driving this performance?

**JORDAN:** It's really a tale of two segments, Alex. Their Commercial Engines & Services segment is absolutely on fire. CES orders were up 35% for the year, revenue grew 24%, and here's the key - services orders up 27% and revenue up 26%. That's the high-margin aftermarket business that keeps printing money for decades after an engine is sold.

**ALEX:** Right, and their Defense, Power & Technology segment, while smaller, also showed solid growth with orders up 19% and revenue up 11%. But let's dig into what's happening operationally because there were some really interesting strategic moves announced.

**JORDAN:** Absolutely. They're doing a major organizational restructuring. They're expanding their CES division to include their Technology & Operations team, now led by Muhammad Ali. The goal is better end-to-end engine lifecycle management. And they're elevating their customer-facing teams to report directly to the CEO.

**ALEX:**...]]>530falsefullhttps://www.spreaker.com/episode/eog-resources-q4-2025-earnings-analysis--70320247
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking EOG Resources' fourth quarter 2025 results - and folks, this was a masterclass in disciplined capital allocation and cash generation.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. EOG really delivered what their shareholders have come to expect - consistent execution and massive cash returns. They generated $4.7 billion in free cash flow for 2025 and returned 100% of it to shareholders through dividends and buybacks. That's $2.2 billion in regular dividends plus $2.5 billion in share repurchases.

**ALEX:** Those are impressive numbers. And what caught my eye is they've now generated annual free cash flow every single year since 2016 and haven't cut their dividend in 28 years. Talk about reliability in a volatile sector. What were the key operational drivers behind these results?

**JORDAN:** The story really centers around their multi-basin approach paying off. They exceeded their original oil and total volume targets while keeping capital expenditures in line. But the real magic happened in cost reduction - they drove well costs down 7% in 2025 through what they call "sustainable efficiency gains." That's huge because these savings compound over time as they develop each asset.

**ALEX:** Let's talk about that Encino acquisition they completed. This was a big strategic move for them in the Utica shale.

**JORDAN:** Absolutely transformational, Alex. They hit their $150 million synergy target ahead of their original one-year timeline, and they're not done yet. The numbers Jeff Leitzell shared were pretty remarkable - they increased drilling speed by over 35%, reduced casing costs by 30%, and brought well costs down below $600 per foot. They're even planning to have in-basin sand sourcing in Ohio by year-end, which should drive costs even lower.

**ALEX:** That integration ahead of schedule really shows their operational expertise. Now, one area that seemed to generate some investor questions was their Delaware Basin strategy. Can you break down what's happening there?

**JORDAN:** This is interesting and I think it highlights EOG's technical sophistication. They've actually unlocked nine additional landing zones in the Delaware Basin due to their dramatic cost reductions over the past few years. So while some individual wells might show lower productivity per foot, the economics are still hitting their return hurdles because the wells cost so much less to drill.

**ALEX:** So it's not about well degradation - it's about accessing previously uneconomic zones?

**JORDAN:** Exactly. CEO Ezra Yacob was pretty clear about this - they're co-developing multiple targets now that previously didn't meet their stringent return requirements. Some have lower productivity, some have different gas-oil ratios, but each delivers the high returns shareholders expect. They're optimizing recovery per acre and maximizing NPV, not just chasing the highest initial production rates.

**ALEX:** That makes sense from a capital allocation standpoint. Speaking of their portfolio, they're also elevating Dorado to what they call a "foundational asset" alongside the Delaware Basin, Utica, and Eagle Ford. What's the story there?

**JORDAN:** Dorado is their South Texas gas play, and the progress has been remarkable. They've driven well costs down to $750 per foot with a breakeven of just $1.40 per thousand cubic feet. They exited 2025 at 750 million cubic feet per day and are targeting 1 billion cubic feet per day by the end of 2026.

This episode includes AI-generated content.]]>SP100-EOG-Q4-2025-enFri, 27 Feb 2026 06:22:51 +0000trueBeta Finch**Beta Finch Podcast Script: EOG Resources Q4 2025 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking EOG Resources' fourth quarter 2025 results - and folks, this was a masterclass in disciplined capital allocation and cash generation.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. EOG really delivered what their shareholders have come to expect - consistent execution and massive cash returns. They generated $4.7 billion in free cash flow for 2025 and returned 100% of it to shareholders through dividends and buybacks. That's $2.2 billion in regular dividends plus $2.5 billion in share repurchases.

**ALEX:** Those are impressive numbers. And what caught my eye is they've now generated annual free cash flow every single year since 2016 and haven't cut their dividend in 28 years. Talk about reliability in a volatile sector. What were the key operational drivers behind these results?

**JORDAN:** The story really centers around their multi-basin approach paying off. They exceeded their original oil and total volume targets while keeping capital expenditures in line. But the real magic happened in cost reduction - they drove well costs down 7% in 2025 through what they call "sustainable efficiency gains." That's huge because these savings compound over time as they develop each asset.

**ALEX:** Let's talk about that Encino acquisition they completed. This was a big strategic move for them in the Utica shale.

**JORDAN:** Absolutely transformational, Alex. They hit their $150 million synergy target ahead of their original one-year timeline, and they're not done yet. The numbers Jeff Leitzell shared were pretty remarkable - they increased drilling speed by over 35%, reduced casing costs by 30%, and brought well costs down below $600 per foot. They're even planning to have in-basin sand sourcing in Ohio by year-end, which should drive costs even lower.

**ALEX:** That integration ahead of schedule really shows their operational expertise. Now, one area that seemed to generate some investor questions was their Delaware Basin strategy. Can you break down what's happening there?

**JORDAN:** This is interesting and I think it highlights EOG's technical sophistication. They've actually unlocked nine additional landing zones in the Delaware Basin due to their dramatic cost reductions over the past few years. So while some individual wells might show lower productivity per foot, the economics are still hitting their return hurdles because the wells cost so much less to drill.

**ALEX:** So it's not about well degradation - it's about accessing previously uneconomic zones?

**JORDAN:** Exactly. CEO Ezra Yacob was pretty clear about this - they're co-developing multiple targets now that previously didn't meet their stringent return requirements. Some have lower productivity, some have different gas-oil ratios, but each delivers the high returns shareholders expect. They're optimizing recovery per acre and maximizing NPV, not just chasing the highest initial production rates.

**ALEX:** That makes sense from a capital allocation standpoint. Speaking of their portfolio, they're also elevating Dorado to what they call a "foundational asset" alongside the Delaware Basin, Utica, and Eagle Ford. What's the story there?

**JORDAN:** Dorado is their South Texas gas play, and the progress has been remarkable. They've driven well costs down to $750 per foot with a breakeven of just $1.40...]]>570falsefullhttps://www.spreaker.com/episode/broadcom-q3-2024-earnings-analysis--70320243
Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

So Jordan, let's start with the headline numbers - what jumped out at you?

JORDAN: Alex, these numbers are pretty remarkable. Broadcom posted $13.1 billion in revenue, up 47% year-over-year. Operating profit was up 44%. But here's the thing - when you strip out VMware, which they acquired last year, the underlying semiconductor business only grew 4% year-over-year. So this is really a story of two businesses firing on different cylinders.

ALEX: Right, and speaking of VMware, that integration seems to be going better than expected. Can you break down what's happening there?

JORDAN: Absolutely. VMware contributed $3.8 billion in revenue this quarter, and Hock Tan was pretty excited about their transformation strategy. They're aggressively moving customers from perpetual licenses to subscription models, specifically pushing something called VMware Cloud Foundation - that's their full virtualization stack.

What's impressive is they booked over 15 million CPU cores of this product, representing 80% of total VMware bookings. That translated to $2.5 billion in annualized booking value, up 32% from the prior quarter.

ALEX: And they're cutting costs at the same time, right?

JORDAN: Exactly - classic Broadcom playbook. They brought VMware's operating expenses down to $1.3 billion from $1.6 billion in Q2. Tan said they're on track to hit their target of $8.5 billion in adjusted EBITDA within three years, and maybe even exceed it by fiscal 2025.

ALEX: Now let's talk about the elephant in the room - AI. Everyone wants to know how Broadcom is riding this wave.

JORDAN: AI is absolutely driving their semiconductor business. Tan said AI revenue will hit $3.5 billion in Q4, bringing the full year to $12 billion - up from their previous guidance of $11 billion. That's huge growth.

The interesting part is the mix - about two-thirds is custom AI accelerators and one-third is AI networking. These are the chips that power AI data centers for the big hyperscalers like Google, Amazon, Microsoft.

ALEX: There was some interesting commentary about custom chips versus off-the-shelf GPUs. What's Tan's view on where this market is headed?

JORDAN: This was fascinating, Alex. Tan actually said he's changed his mind on this. He used to think general-purpose merchant chips would win - that's typically how the semiconductor industry works. But now he believes the big cloud companies have the scale and financial resources to justify building their own custom AI accelerators.

His logic is compelling: if GPUs are more important than engineers to these companies right now - and he literally said that - then controlling your own silicon destiny makes sense. He sees this trend accelerating, though it'll take time.

ALEX: What about the non-AI semiconductor business? That's been struggling, right?

JORDAN: Yeah, but here's the key - Tan believes they've hit bottom. Non-AI bookings were up 20% year-over-year in Q3, which is a strong leading indicator. Networking revenue outside of AI was up 17% sequentially, even though it was still down 41% year-over-year.

The company sees different recovery timelines by segment - server and storage are showing early signs of improvement, wireless should get a boost from new device launches, but broadband remains weak due to telecom spending cuts.

ALEX: There were some good questions from analysts during the Q&A. Anything particularly noteworthy?

JORDAN: One analyst asked about th

This episode includes AI-generated content.]]>SP100-AVGO-Q3-2024-enFri, 27 Feb 2026 06:22:46 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Broadcom's Q3 2024 earnings, and wow - this was quite the quarter for CEO Hock Tan and his team. Before we jump in,...
Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

So Jordan, let's start with the headline numbers - what jumped out at you?

JORDAN: Alex, these numbers are pretty remarkable. Broadcom posted $13.1 billion in revenue, up 47% year-over-year. Operating profit was up 44%. But here's the thing - when you strip out VMware, which they acquired last year, the underlying semiconductor business only grew 4% year-over-year. So this is really a story of two businesses firing on different cylinders.

ALEX: Right, and speaking of VMware, that integration seems to be going better than expected. Can you break down what's happening there?

JORDAN: Absolutely. VMware contributed $3.8 billion in revenue this quarter, and Hock Tan was pretty excited about their transformation strategy. They're aggressively moving customers from perpetual licenses to subscription models, specifically pushing something called VMware Cloud Foundation - that's their full virtualization stack.

What's impressive is they booked over 15 million CPU cores of this product, representing 80% of total VMware bookings. That translated to $2.5 billion in annualized booking value, up 32% from the prior quarter.

ALEX: And they're cutting costs at the same time, right?

JORDAN: Exactly - classic Broadcom playbook. They brought VMware's operating expenses down to $1.3 billion from $1.6 billion in Q2. Tan said they're on track to hit their target of $8.5 billion in adjusted EBITDA within three years, and maybe even exceed it by fiscal 2025.

ALEX: Now let's talk about the elephant in the room - AI. Everyone wants to know how Broadcom is riding this wave.

JORDAN: AI is absolutely driving their semiconductor business. Tan said AI revenue will hit $3.5 billion in Q4, bringing the full year to $12 billion - up from their previous guidance of $11 billion. That's huge growth.

The interesting part is the mix - about two-thirds is custom AI accelerators and one-third is AI networking. These are the chips that power AI data centers for the big hyperscalers like Google, Amazon, Microsoft.

ALEX: There was some interesting commentary about custom chips versus off-the-shelf GPUs. What's Tan's view on where this market is headed?

JORDAN: This was fascinating, Alex. Tan actually said he's changed his mind on this. He used to think general-purpose merchant chips would win - that's typically how the semiconductor industry works. But now he believes the big cloud companies have the scale and financial resources to justify building their own custom AI accelerators.

His logic is compelling: if GPUs are more important than engineers to these companies right now - and he literally said that - then controlling your own silicon destiny makes sense. He sees this trend accelerating, though it'll take time.

ALEX: What about the non-AI semiconductor business? That's been struggling, right?

JORDAN: Yeah, but here's the key - Tan believes they've hit bottom. Non-AI bookings were up 20% year-over-year in Q3, which is a strong leading indicator. Networking revenue outside of AI was up 17% sequentially, even though it was still down 41% year-over-year.

The company sees different recovery timelines by segment - server and storage are showing early signs of improvement, wireless should get a boost from new device launches, but broadband...]]>507falsefullhttps://www.spreaker.com/episode/unitedhealth-q4-2025-earnings-analysis--70268529
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate speak into plain talk. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into UnitedHealth's Q4 2025 results, and wow - there's a lot to unpack here.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Right, and speaking of unpacking - UnitedHealth just delivered what I'd call a "everything but the kitchen sink" quarter. They beat expectations slightly with adjusted EPS of $16.35, but there's this massive $1.6 billion charge lurking underneath.

**ALEX:** Yeah, that charge is wild. It's like getting three different bills at once - $800 million related to that cyberattack cleanup, a $440 million gain from selling off assets, and then a whopping $2.5 billion restructuring charge. It's clear they're doing some serious spring cleaning.

**JORDAN:** What caught my attention is how transparent CEO Stephen Hemsley was about this being a "new age" for the company. They're essentially admitting they need to get back to basics while investing heavily in AI - we're talking $1.5 billion in 2026 alone.

**ALEX:** Let's talk numbers first. Revenue hit nearly $448 billion, up 12% year-over-year, which is solid. But the real story is in the 2026 guidance - they're projecting adjusted EPS of greater than $17.75, which represents at least 8.6% growth.

**JORDAN:** That guidance is interesting because it's what I'd call "cautiously optimistic." They're expecting double-digit improvements at UnitedHealthcare but only low-to-high single-digit growth across the Optum segments. It tells me they're being realistic about their turnaround timeline.

**ALEX:** The Medicare Advantage story is probably the biggest concern for investors. Tim Noel basically said they're planning to lose 1.3 to 1.4 million Medicare Advantage members in 2026. That's not a typo - they're intentionally shrinking to focus on profitability over growth.

**JORDAN:** And then yesterday's rate notice for 2027 was apparently even worse than expected. Noel called it "disappointing" and warned of "meaningful benefit reductions" for seniors. When a healthcare executive is that blunt about government rates, you know it's bad.

**ALEX:** What's their strategy to deal with this? It sounds like they're doubling down on margin recovery. They expect Medicare margins to improve by about 50 basis points in 2026, but they're essentially trading membership for profitability.

**JORDAN:** The Optum turnaround is where things get really interesting. Patrick Conway, the new Optum CEO, outlined some pretty dramatic changes. They've narrowed their provider network by 20%, streamlined risk membership by 15%, and consolidated down from 18 different electronic medical record systems to just three.

**ALEX:** That EMR consolidation alone shows you how scattered they were. Imagine trying to implement AI tools across 18 different systems - it's like trying to conduct an orchestra where every musician is reading different sheet music.

**JORDAN:** Speaking of AI, they claim 80% of member calls now use AI tools, and they're expecting nearly $1 billion in AI-enabled cost reductions in 2026. That's not just efficiency gains - that's transformational if they can pull it off.

**ALEX:** Now let's talk about what came up in the Q&A, because that's where executives sometimes reveal what they're really thinking. One analyst asked about the bottom of the Medicare Advantage cycle, and you could sense the frustration in management's response.

**JORDAN:** Right, they're clearly not happy with the regulatory environment. Hemsley mentioned $130 billion in funding reductions over the past three y

This episode includes AI-generated content.]]>SP100-UNH-Q4-2025-enWed, 25 Feb 2026 14:09:07 +0000trueBeta Finch# Beta Finch Podcast Script: UnitedHealth Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate speak into plain talk. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn corporate speak into plain talk. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into UnitedHealth's Q4 2025 results, and wow - there's a lot to unpack here.

**ALEX:** Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Right, and speaking of unpacking - UnitedHealth just delivered what I'd call a "everything but the kitchen sink" quarter. They beat expectations slightly with adjusted EPS of $16.35, but there's this massive $1.6 billion charge lurking underneath.

**ALEX:** Yeah, that charge is wild. It's like getting three different bills at once - $800 million related to that cyberattack cleanup, a $440 million gain from selling off assets, and then a whopping $2.5 billion restructuring charge. It's clear they're doing some serious spring cleaning.

**JORDAN:** What caught my attention is how transparent CEO Stephen Hemsley was about this being a "new age" for the company. They're essentially admitting they need to get back to basics while investing heavily in AI - we're talking $1.5 billion in 2026 alone.

**ALEX:** Let's talk numbers first. Revenue hit nearly $448 billion, up 12% year-over-year, which is solid. But the real story is in the 2026 guidance - they're projecting adjusted EPS of greater than $17.75, which represents at least 8.6% growth.

**JORDAN:** That guidance is interesting because it's what I'd call "cautiously optimistic." They're expecting double-digit improvements at UnitedHealthcare but only low-to-high single-digit growth across the Optum segments. It tells me they're being realistic about their turnaround timeline.

**ALEX:** The Medicare Advantage story is probably the biggest concern for investors. Tim Noel basically said they're planning to lose 1.3 to 1.4 million Medicare Advantage members in 2026. That's not a typo - they're intentionally shrinking to focus on profitability over growth.

**JORDAN:** And then yesterday's rate notice for 2027 was apparently even worse than expected. Noel called it "disappointing" and warned of "meaningful benefit reductions" for seniors. When a healthcare executive is that blunt about government rates, you know it's bad.

**ALEX:** What's their strategy to deal with this? It sounds like they're doubling down on margin recovery. They expect Medicare margins to improve by about 50 basis points in 2026, but they're essentially trading membership for profitability.

**JORDAN:** The Optum turnaround is where things get really interesting. Patrick Conway, the new Optum CEO, outlined some pretty dramatic changes. They've narrowed their provider network by 20%, streamlined risk membership by 15%, and consolidated down from 18 different electronic medical record systems to just three.

**ALEX:** That EMR consolidation alone shows you how scattered they were. Imagine trying to implement AI tools across 18 different systems - it's like trying to conduct an orchestra where every musician is reading different sheet music.

**JORDAN:** Speaking of AI, they claim 80% of member calls now use AI tools, and they're expecting nearly $1 billion in AI-enabled cost reductions in 2026. That's not just efficiency gains - that's transformational if they can pull it off.

**ALEX:** Now let's talk about what came up in the Q&A, because that's where executives sometimes reveal what they're really thinking. One analyst asked about the bottom of the Medicare Advantage cycle, and you could sense the frustration in management's...]]>494falsefullhttps://www.spreaker.com/episode/uber-q4-2025-earnings-analysis--70268526
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Uber's Q4 2025 earnings call. Jordan, this was quite the packed call - we had leadership changes, major autonomous vehicle updates, and some pretty impressive numbers.

**JORDAN**: Absolutely, Alex. But before we dig into all that excitement, I need to mention our standard disclaimer.

**ALEX**: Right - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks, Alex. Now, let's talk about those numbers because Uber really delivered. They hit a $15 billion annual run rate for their platform, grew monthly active users to over 200 million, and saw gross bookings jump 22% year-over-year. But what really caught my eye was that free cash flow number - $9.8 billion, up 42%.

**ALEX**: That's massive, Jordan. And it sounds like this was their fifth consecutive year of over 20% gross bookings growth. But the big story here isn't just the financials - it's the leadership transition and their autonomous vehicle strategy. Prashanth Mahendra-Rajah is stepping down as CFO, and Balaji Krishnamurthy is stepping up. What's your read on that?

**JORDAN**: It seems like a smooth transition, honestly. Prashanth mentioned he's moving on to serve America in some capacity - probably a government role. And Balaji isn't new to the company; he's been working closely with CEO Dara Khosrowshahi for years. The timing makes sense too, with Uber in such a strong cash position to make strategic investments.

**ALEX**: Speaking of strategic investments, let's talk about the elephant in the room - autonomous vehicles. Dara was pretty bullish about AVs, saying they expect to be in 15 cities by the end of 2026. But there's been this ongoing debate about whether AVs will hurt or help Uber's business model.

**JORDAN**: This is fascinating, Alex. Dara made some compelling points. He said that in markets where AVs have been deployed - like San Francisco, Austin, and Atlanta - Uber's overall bookings have actually accelerated. The key insight is that AVs aren't replacing traditional rideshare; they're expanding the total market. Plus, vehicles on Uber's platform are seeing 30% higher utilization than standalone AV services.

**ALEX**: That utilization stat is crucial. It suggests Uber's marketplace advantage - their ability to match supply and demand efficiently - extends to autonomous vehicles too. But what about the competitive threat? What happens when Tesla or Waymo ramp up their own AV services in major cities?

**JORDAN**: Dara addressed this head-on. He pointed out that only 30% of Uber's bookings come from major cities, and 75% of their US profits actually come from outside the top 20 markets. These smaller, less dense markets are unlikely to see AV competition anytime soon. Plus, 60% of their mobility business is international, which gives them even more insulation.

**ALEX**: That's a great point about geographic diversification. And they're not just sitting back waiting for AVs to arrive - they're actively investing. They mentioned partnerships with Waymo, NVIDIA, and newer players like Wabi and Avride. What's their capital strategy here?

**JORDAN**: This is where it gets really interesting. They're taking an asset-light approach, similar to how Marriott doesn't own all its hotels. Uber is making strategic investments in AV companies - like guaranteeing the first 25,000 vehicles from Wabi will be exclusive to their platform - but they're also working with financial institutions to create a financing ecosystem. Think private equity, banks, fleet partners. They want to avoid being overly capital-intensive.

**ALEX**: Smart approach. Now, beyond AVs, what else drove their strong performance? I notic

This episode includes AI-generated content.]]>SP100-UBER-Q4-2025-enWed, 25 Feb 2026 14:08:57 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Uber's Q4 2025 earnings call. Jordan, this was quite the packed call - we had leadership changes, major...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Uber's Q4 2025 earnings call. Jordan, this was quite the packed call - we had leadership changes, major autonomous vehicle updates, and some pretty impressive numbers.

**JORDAN**: Absolutely, Alex. But before we dig into all that excitement, I need to mention our standard disclaimer.

**ALEX**: Right - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks, Alex. Now, let's talk about those numbers because Uber really delivered. They hit a $15 billion annual run rate for their platform, grew monthly active users to over 200 million, and saw gross bookings jump 22% year-over-year. But what really caught my eye was that free cash flow number - $9.8 billion, up 42%.

**ALEX**: That's massive, Jordan. And it sounds like this was their fifth consecutive year of over 20% gross bookings growth. But the big story here isn't just the financials - it's the leadership transition and their autonomous vehicle strategy. Prashanth Mahendra-Rajah is stepping down as CFO, and Balaji Krishnamurthy is stepping up. What's your read on that?

**JORDAN**: It seems like a smooth transition, honestly. Prashanth mentioned he's moving on to serve America in some capacity - probably a government role. And Balaji isn't new to the company; he's been working closely with CEO Dara Khosrowshahi for years. The timing makes sense too, with Uber in such a strong cash position to make strategic investments.

**ALEX**: Speaking of strategic investments, let's talk about the elephant in the room - autonomous vehicles. Dara was pretty bullish about AVs, saying they expect to be in 15 cities by the end of 2026. But there's been this ongoing debate about whether AVs will hurt or help Uber's business model.

**JORDAN**: This is fascinating, Alex. Dara made some compelling points. He said that in markets where AVs have been deployed - like San Francisco, Austin, and Atlanta - Uber's overall bookings have actually accelerated. The key insight is that AVs aren't replacing traditional rideshare; they're expanding the total market. Plus, vehicles on Uber's platform are seeing 30% higher utilization than standalone AV services.

**ALEX**: That utilization stat is crucial. It suggests Uber's marketplace advantage - their ability to match supply and demand efficiently - extends to autonomous vehicles too. But what about the competitive threat? What happens when Tesla or Waymo ramp up their own AV services in major cities?

**JORDAN**: Dara addressed this head-on. He pointed out that only 30% of Uber's bookings come from major cities, and 75% of their US profits actually come from outside the top 20 markets. These smaller, less dense markets are unlikely to see AV competition anytime soon. Plus, 60% of their mobility business is international, which gives them even more insulation.

**ALEX**: That's a great point about geographic diversification. And they're not just sitting back waiting for AVs to arrive - they're actively investing. They mentioned partnerships with Waymo, NVIDIA, and newer players like Wabi and Avride. What's their capital strategy here?

**JORDAN**: This is where it gets really interesting. They're taking an asset-light approach, similar to how Marriott doesn't own all its hotels. Uber is making strategic investments in AV companies - like guaranteeing the first 25,000 vehicles from Wabi will be exclusive to their platform - but they're also working with financial institutions to create a financing ecosystem. Think private equity, banks, fleet partners. They want to avoid...]]>521falsefullhttps://www.spreaker.com/episode/texas-instruments-q4-2025-earnings-analysis--70268525
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations you can actually follow. I'm Alex, and I'm here with Jordan to dive into Texas Instruments' fourth quarter results that just dropped. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, what a quarter to unpack from TXN. They just reported some pretty impressive numbers that have me raising my eyebrows - in a good way.

**ALEX**: Right? Let's start with the headline numbers. Revenue came in at $4.4 billion for Q4, which was actually right in line with expectations. But here's what's interesting - that's a 10% jump year-over-year, even though it was down 7% sequentially, which is pretty normal for a fourth quarter.

**JORDAN**: What really caught my attention was the segment performance. Analog revenue grew 14% year-over-year, embedded processing was up 8%. But Alex, I think the real story here is what's happening with their end markets. They've actually reorganized how they report these, and there's a new player in town.

**ALEX**: You're talking about data center, right? They carved out this new category that includes data center compute, networking, and power management. And Jordan, the numbers here are eye-popping - data center revenue grew around 70% year-over-year.

**JORDAN**: Exactly! And it's not just a flash in the pan. Management said this has been growing for seven consecutive quarters now. They're ending 2025 with about $450 million quarterly run rate in data center, which is becoming a material part of their business.

**ALEX**: Let's zoom out to the full year picture because it really shows TI's strategic positioning. Industrial was their biggest segment at $5.8 billion, up 12% year-over-year. Automotive matched that at $5.8 billion, up 6%. Together with data center, these three segments made up 75% of their revenue.

**JORDAN**: That's a massive shift from where they were in 2013 when these segments were only 43% of revenue. It shows they've really focused their portfolio on higher-growth, more resilient markets. But Alex, what really impressed me was the cash flow story.

**ALEX**: Oh absolutely. Free cash flow nearly doubled to $2.9 billion, or 17% of revenue. That's a 96% increase from 2024. And they returned a whopping $6.5 billion to shareholders over the past twelve months through dividends and buybacks.

**JORDAN**: Speaking of dividends, they raised it 4% to $1.42 per share - that's their 22nd consecutive year of increases. But here's what I found fascinating in the Q&A section: they're guiding Q1 revenue between $4.32 billion and $4.68 billion, which is significantly above normal seasonality.

**ALEX**: Yeah, that really stood out to me too. One analyst pointed out this might be the first time they've guided sequential growth in Q1 since right after the financial crisis, about fifteen years ago. When pressed about what's driving this, management was pretty clear it's not pricing-related.

**JORDAN**: Right, CEO Haviv Ilan was emphatic that pricing isn't the driver here. He actually expects company-wide pricing to be down low single digits in 2026, similar to 2025. Instead, he pointed to stronger bookings, particularly in industrial and data center markets.

**ALEX**: The industrial recovery story is interesting because they're still about 25% below their 2022 peak levels, so there's room to run. But what I found most intriguing was their inventory strategy. They've built up $4.8 billion in inventory - 222 days worth - and management seems really proud of this position.

**JORDAN**: And for good reason, Alex. In today's environment where customers are placing more last-minute orders - what

This episode includes AI-generated content.]]>SP100-TXN-Q4-2025-enWed, 25 Feb 2026 14:08:52 +0000trueBeta Finch# Beta Finch Podcast Script: Texas Instruments Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations you can actually follow. I'm Alex, and I'm here with Jordan to dive...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations you can actually follow. I'm Alex, and I'm here with Jordan to dive into Texas Instruments' fourth quarter results that just dropped. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, what a quarter to unpack from TXN. They just reported some pretty impressive numbers that have me raising my eyebrows - in a good way.

**ALEX**: Right? Let's start with the headline numbers. Revenue came in at $4.4 billion for Q4, which was actually right in line with expectations. But here's what's interesting - that's a 10% jump year-over-year, even though it was down 7% sequentially, which is pretty normal for a fourth quarter.

**JORDAN**: What really caught my attention was the segment performance. Analog revenue grew 14% year-over-year, embedded processing was up 8%. But Alex, I think the real story here is what's happening with their end markets. They've actually reorganized how they report these, and there's a new player in town.

**ALEX**: You're talking about data center, right? They carved out this new category that includes data center compute, networking, and power management. And Jordan, the numbers here are eye-popping - data center revenue grew around 70% year-over-year.

**JORDAN**: Exactly! And it's not just a flash in the pan. Management said this has been growing for seven consecutive quarters now. They're ending 2025 with about $450 million quarterly run rate in data center, which is becoming a material part of their business.

**ALEX**: Let's zoom out to the full year picture because it really shows TI's strategic positioning. Industrial was their biggest segment at $5.8 billion, up 12% year-over-year. Automotive matched that at $5.8 billion, up 6%. Together with data center, these three segments made up 75% of their revenue.

**JORDAN**: That's a massive shift from where they were in 2013 when these segments were only 43% of revenue. It shows they've really focused their portfolio on higher-growth, more resilient markets. But Alex, what really impressed me was the cash flow story.

**ALEX**: Oh absolutely. Free cash flow nearly doubled to $2.9 billion, or 17% of revenue. That's a 96% increase from 2024. And they returned a whopping $6.5 billion to shareholders over the past twelve months through dividends and buybacks.

**JORDAN**: Speaking of dividends, they raised it 4% to $1.42 per share - that's their 22nd consecutive year of increases. But here's what I found fascinating in the Q&A section: they're guiding Q1 revenue between $4.32 billion and $4.68 billion, which is significantly above normal seasonality.

**ALEX**: Yeah, that really stood out to me too. One analyst pointed out this might be the first time they've guided sequential growth in Q1 since right after the financial crisis, about fifteen years ago. When pressed about what's driving this, management was pretty clear it's not pricing-related.

**JORDAN**: Right, CEO Haviv Ilan was emphatic that pricing isn't the driver here. He actually expects company-wide pricing to be down low single digits in 2026, similar to 2025. Instead, he pointed to stronger bookings, particularly in industrial and data center markets.

**ALEX**: The industrial recovery story is interesting because they're still about 25% below their 2022 peak levels, so there's room to run. But what I found most intriguing was their inventory strategy. They've built up $4.8 billion in inventory - 222 days worth - and management seems really proud of...]]>538falsefullhttps://www.spreaker.com/episode/t-mobile-us-q4-2025-earnings-analysis--70268521
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into T-Mobile's Q4 2025 earnings call, which was quite the spectacle - they held it as a special event halfway through their capital markets day cycle.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a call this was! New CEO Srini Gopalan really came out swinging, didn't he? Let's start with the headline numbers because they were impressive across the board.

**ALEX:** Absolutely. T-Mobile delivered 261,000 postpaid net account additions in Q4 - and here's the kicker, Jordan - that's 10 times what their nearest competitor who reports this metric delivered. They're not just winning, they're dominating.

**JORDAN:** That account growth is driving real value creation too. They posted 2.7% year-over-year growth in postpaid ARPA - that's Average Revenue Per Account, which is becoming their key metric going forward. More on that shift in a moment. But this translated to service revenue up 10% year-over-year on a reported basis, 5% organically.

**ALEX:** And here's what I love - they converted 25% of that service revenue into free cash flow for the full year. That's an industry-leading conversion rate that really shows the structural advantages of their business model.

**JORDAN:** Now, one of the biggest announcements was their guidance raise. They're now expecting about $77 billion in service revenue for 2026 - that's 8% growth including M&A, or 6% organic growth, which is actually an acceleration from 2025. For 2027, they're guiding to $80.5-81.5 billion, representing 5% growth with about 5% organic.

**ALEX:** What's driving this confidence? Well, Gopalan spent a lot of time talking about T-Mobile's "widening differentiation" - they claim to offer the best network, best value, and best experience with no trade-offs. And the proof is in their Net Promoter Score, which has really opened up a gap versus competitors over the last three years.

**JORDAN:** That NPS story is compelling, Alex. They showed this chart where back in 2023, they were basically neck-and-neck with competitors, but now they've clearly broken away from the pack. And network perception is shifting too - 26% of network switchers now see T-Mobile as having the best network, up from just 12.5% in 2020.

**ALEX:** Speaking of networks, they made some bold claims about being the undisputed 5G leader and even introduced live translation built directly into their network core using AI. Pretty cool stuff, though we should note they love to talk about being first to market with various technologies.

**JORDAN:** The broadband story is getting more interesting too. They raised their target to 15 million FWA customers by 2030, up from 12 million previously, plus they expect 3-4 million fiber customers. That would give them 18-19 million total broadband customers by 2030 - essentially building a massive business from scratch in just seven years.

**ALEX:** Now here's a significant change that caught my attention - they're dropping subscriber-level reporting and focusing exclusively on postpaid accounts and ARPA going forward. CFO Peter Osvaldik said this better aligns with how customers actually buy - as families and businesses, not individual lines.

**JORDAN:** That's a strategic shift that makes sense when you think about it. Over 90% of their postpaid lines are on multi-line accounts anyway. But it also means we'll have less granular data to work with as analysts and investors.

**ALEX:** Let's talk about capital allocation because this was a big theme. They announced they're doubling their Q1 share buyba

This episode includes AI-generated content.]]>SP100-TMUS-Q4-2025-enWed, 25 Feb 2026 14:08:47 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into T-Mobile's Q4 2025 earnings call, which was quite the spectacle - they held...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into T-Mobile's Q4 2025 earnings call, which was quite the spectacle - they held it as a special event halfway through their capital markets day cycle.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a call this was! New CEO Srini Gopalan really came out swinging, didn't he? Let's start with the headline numbers because they were impressive across the board.

**ALEX:** Absolutely. T-Mobile delivered 261,000 postpaid net account additions in Q4 - and here's the kicker, Jordan - that's 10 times what their nearest competitor who reports this metric delivered. They're not just winning, they're dominating.

**JORDAN:** That account growth is driving real value creation too. They posted 2.7% year-over-year growth in postpaid ARPA - that's Average Revenue Per Account, which is becoming their key metric going forward. More on that shift in a moment. But this translated to service revenue up 10% year-over-year on a reported basis, 5% organically.

**ALEX:** And here's what I love - they converted 25% of that service revenue into free cash flow for the full year. That's an industry-leading conversion rate that really shows the structural advantages of their business model.

**JORDAN:** Now, one of the biggest announcements was their guidance raise. They're now expecting about $77 billion in service revenue for 2026 - that's 8% growth including M&A, or 6% organic growth, which is actually an acceleration from 2025. For 2027, they're guiding to $80.5-81.5 billion, representing 5% growth with about 5% organic.

**ALEX:** What's driving this confidence? Well, Gopalan spent a lot of time talking about T-Mobile's "widening differentiation" - they claim to offer the best network, best value, and best experience with no trade-offs. And the proof is in their Net Promoter Score, which has really opened up a gap versus competitors over the last three years.

**JORDAN:** That NPS story is compelling, Alex. They showed this chart where back in 2023, they were basically neck-and-neck with competitors, but now they've clearly broken away from the pack. And network perception is shifting too - 26% of network switchers now see T-Mobile as having the best network, up from just 12.5% in 2020.

**ALEX:** Speaking of networks, they made some bold claims about being the undisputed 5G leader and even introduced live translation built directly into their network core using AI. Pretty cool stuff, though we should note they love to talk about being first to market with various technologies.

**JORDAN:** The broadband story is getting more interesting too. They raised their target to 15 million FWA customers by 2030, up from 12 million previously, plus they expect 3-4 million fiber customers. That would give them 18-19 million total broadband customers by 2030 - essentially building a massive business from scratch in just seven years.

**ALEX:** Now here's a significant change that caught my attention - they're dropping subscriber-level reporting and focusing exclusively on postpaid accounts and ARPA going forward. CFO Peter Osvaldik said this better aligns with how customers actually buy - as families and businesses, not individual lines.

**JORDAN:** That's a strategic shift that makes sense when you think about it. Over 90% of their postpaid lines are on multi-line accounts anyway. But it also means we'll have less granular data to work with as analysts...]]>483falsefullhttps://www.spreaker.com/episode/raytheon-technologies-q4-2025-earnings-analysis--70268519
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate calls so you don't have to. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into RTX's fourth quarter 2025 results - and wow, what a call this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, RTX just delivered some seriously impressive numbers. Walk us through the highlights.

**ALEX:** The numbers are pretty staggering, Jordan. Full year adjusted sales hit $88.6 billion - that's up $9 billion year-over-year, or 11% organic growth. But here's what really caught my eye: their backlog reached a record $268 billion. That's up 23% from last year.

**JORDAN:** A quarter of a trillion dollars in backlog - that's just mind-boggling. And their free cash flow performance was equally impressive, right?

**ALEX:** Exactly. Free cash flow came in at $7.9 billion for the year, up $3.4 billion from 2024. CEO Chris Calio seemed pretty confident about their momentum, pointing to what he called "durable demand" across both commercial and defense segments.

**JORDAN:** Speaking of segments, let's break down where this growth is coming from. Commercial OE was up 10%, commercial aftermarket up 18%, and defense up 8%. But I think the real story here is what's happening with their defense business, especially given the current geopolitical environment.

**ALEX:** That's a great point. Raytheon, their defense segment, had some massive contract wins. They booked $1.2 billion to supply Spain with Patriot air defense systems, another $1.2 billion for Tamir missile production, and get this - their international backlog mix is now 47%, up from 44% last year.

**JORDAN:** And the timing couldn't be better. Calio mentioned that NATO allies are committed to increasing defense spending from 2% of GDP to 3.5% by 2035. That's a huge tailwind for companies like RTX.

**ALEX:** But let's not forget about the elephant in the room - the GTF engine issues that have been plaguing Pratt & Whitney. How are they handling that?

**JORDAN:** Actually, this was one of the more encouraging parts of the call. They reported that aircraft on ground - that's AOGs - declined in Q4 and are down over 20% from 2025 highs. Their maintenance and repair output was up 39% in the fourth quarter alone.

**ALEX:** That's a significant improvement. And they're expecting similar MRO growth rates in 2026. Plus, they got EU certification for their GTF Advantage engine and expect aircraft certification soon.

**JORDAN:** Now let's talk guidance, because this is where things get really interesting for 2026. They're projecting sales between $92-93 billion, which represents 5-6% organic growth.

**ALEX:** And EPS guidance of $6.60 to $6.80 - that's solid growth on top of their $6.29 in 2025. But what really stood out to me was their free cash flow guidance of $8.25 to $8.75 billion. They're basically saying they can maintain this cash generation machine while investing heavily in capacity.

**JORDAN:** Speaking of investments, they're planning to spend $10.5 billion in CapEx and R&D in 2026, including $3.1 billion in CapEx alone. That's a $500 million increase from last year. They're really betting big on future demand.

**ALEX:** And then we got to the Q&A section, which was fascinating. There were some pointed questions about the new administration's defense policies and expectations for contractors.

**JORDAN:** Right, CEO Calio was pretty diplomatic but direct. He acknowledged the "frustration" from the Department of Defense about production rates and said RTX is "fully aligned" with ramping production faster. But he also defended their d

This episode includes AI-generated content.]]>SP100-RTX-Q4-2025-enWed, 25 Feb 2026 14:08:42 +0000trueBeta Finch**Beta Finch Podcast Script: RTX Q4 2025 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate calls so you don't have to. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into RTX's...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode corporate calls so you don't have to. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into RTX's fourth quarter 2025 results - and wow, what a call this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, RTX just delivered some seriously impressive numbers. Walk us through the highlights.

**ALEX:** The numbers are pretty staggering, Jordan. Full year adjusted sales hit $88.6 billion - that's up $9 billion year-over-year, or 11% organic growth. But here's what really caught my eye: their backlog reached a record $268 billion. That's up 23% from last year.

**JORDAN:** A quarter of a trillion dollars in backlog - that's just mind-boggling. And their free cash flow performance was equally impressive, right?

**ALEX:** Exactly. Free cash flow came in at $7.9 billion for the year, up $3.4 billion from 2024. CEO Chris Calio seemed pretty confident about their momentum, pointing to what he called "durable demand" across both commercial and defense segments.

**JORDAN:** Speaking of segments, let's break down where this growth is coming from. Commercial OE was up 10%, commercial aftermarket up 18%, and defense up 8%. But I think the real story here is what's happening with their defense business, especially given the current geopolitical environment.

**ALEX:** That's a great point. Raytheon, their defense segment, had some massive contract wins. They booked $1.2 billion to supply Spain with Patriot air defense systems, another $1.2 billion for Tamir missile production, and get this - their international backlog mix is now 47%, up from 44% last year.

**JORDAN:** And the timing couldn't be better. Calio mentioned that NATO allies are committed to increasing defense spending from 2% of GDP to 3.5% by 2035. That's a huge tailwind for companies like RTX.

**ALEX:** But let's not forget about the elephant in the room - the GTF engine issues that have been plaguing Pratt & Whitney. How are they handling that?

**JORDAN:** Actually, this was one of the more encouraging parts of the call. They reported that aircraft on ground - that's AOGs - declined in Q4 and are down over 20% from 2025 highs. Their maintenance and repair output was up 39% in the fourth quarter alone.

**ALEX:** That's a significant improvement. And they're expecting similar MRO growth rates in 2026. Plus, they got EU certification for their GTF Advantage engine and expect aircraft certification soon.

**JORDAN:** Now let's talk guidance, because this is where things get really interesting for 2026. They're projecting sales between $92-93 billion, which represents 5-6% organic growth.

**ALEX:** And EPS guidance of $6.60 to $6.80 - that's solid growth on top of their $6.29 in 2025. But what really stood out to me was their free cash flow guidance of $8.25 to $8.75 billion. They're basically saying they can maintain this cash generation machine while investing heavily in capacity.

**JORDAN:** Speaking of investments, they're planning to spend $10.5 billion in CapEx and R&D in 2026, including $3.1 billion in CapEx alone. That's a $500 million increase from last year. They're really betting big on future demand.

**ALEX:** And then we got to the Q&A section, which was fascinating. There were some pointed questions about the new administration's defense policies and expectations for contractors.

**JORDAN:** Right, CEO Calio was pretty...]]>516falsefullhttps://www.spreaker.com/episode/servicenow-q4-2025-earnings-analysis--70268515
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into ServiceNow's Q4 2025 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex! And wow, what a quarter ServiceNow just delivered. CEO Bill McDermott came out swinging right from the opening remarks, essentially saying "Here are the facts" to counter what he called "speculation everywhere." This feels like a company that's tired of being misunderstood by the market.

**ALEX**: Absolutely! Let's start with the numbers because they're pretty impressive. Q4 subscription revenue hit $3.47 billion, growing 19.5% year-over-year in constant currency - that's 150 basis points above the high end of their guidance. And their remaining performance obligations, or RPO, grew 21% to over $28 billion. Jordan, what stood out to you?

**JORDAN**: The acceleration story is huge here. Net new Annual Contract Value growth actually accelerated both quarter-over-quarter and year-over-year. That's not something you see often in mature software companies. And get this - they had 244 deals greater than $1 million in net new ACV, including seven deals over $10 million. That suggests enterprises are making serious platform bets on ServiceNow.

**ALEX**: Right, and let's talk about their AI momentum. Now Assist, their AI product suite, surpassed $600 million in ACV and is tracking toward their $1 billion target for 2026. McDermott mentioned they had 35 deals over $1 million for Now Assist in Q4 alone, with some customers expanding their AI usage by 13 times upon renewal.

**JORDAN**: That renewal expansion story is fascinating. CFO Gina Mastantuono mentioned that customer service Now Assist deals saw over 70% upsell expansion at renewal in Q4. This suggests customers aren't just trying AI - they're getting real value and wanting more. It's moving from proof-of-concept to production scale.

**ALEX**: Now, let's address the elephant in the room - the recent acquisitions. ServiceNow has been busy, acquiring Moveworks, and announcing plans to acquire VESA and ARMS. McDermott was pretty defensive about this, pushing back against speculation that M&A was driven by necessity.

**JORDAN**: He was very clear about their strategy here. McDermott emphasized they've never acquired for revenue alone, and these acquisitions are about expanding their Total Addressable Market to over $600 billion. The story he's telling is about creating an "AI control tower" for enterprises - combining visibility from ARMS, identity governance from VESA, and orchestration from ServiceNow's platform.

**ALEX**: The security angle is interesting. Their security and risk business already generates over $1 billion in ACV and grew nearly 40% year-over-year. With these acquisitions, they're essentially saying they want to be the comprehensive security platform for what they call the "agentic AI world" - where AI agents are running business processes autonomously.

**JORDAN**: Speaking of autonomous AI, I loved McDermott's explanation of why AI needs workflow orchestration. He said AI is "probabilistic" - meaning uncertain outcomes - while workflow orchestration is "deterministic" - predictable and governed. That's actually a compelling argument for why AI doesn't replace platforms like ServiceNow, but rather depends on them.

**ALEX**: The customer examples were pretty compelling too. One stood out where a consumer services company achieved 400% ROI and needed eight times more AI assists after a year. They're flipping from 80% human-led support to 80% automated. That's the kind of business transformation that creates sticky, expanding relationships.

**JORDAN**: And let's talk margi

This episode includes AI-generated content.]]>SP100-NOW-Q4-2025-enWed, 25 Feb 2026 14:08:37 +0000trueBeta Finch# Beta Finch Podcast Script: ServiceNow Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into ServiceNow's Q4 2025 results. This podcast is AI-generated...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into ServiceNow's Q4 2025 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex! And wow, what a quarter ServiceNow just delivered. CEO Bill McDermott came out swinging right from the opening remarks, essentially saying "Here are the facts" to counter what he called "speculation everywhere." This feels like a company that's tired of being misunderstood by the market.

**ALEX**: Absolutely! Let's start with the numbers because they're pretty impressive. Q4 subscription revenue hit $3.47 billion, growing 19.5% year-over-year in constant currency - that's 150 basis points above the high end of their guidance. And their remaining performance obligations, or RPO, grew 21% to over $28 billion. Jordan, what stood out to you?

**JORDAN**: The acceleration story is huge here. Net new Annual Contract Value growth actually accelerated both quarter-over-quarter and year-over-year. That's not something you see often in mature software companies. And get this - they had 244 deals greater than $1 million in net new ACV, including seven deals over $10 million. That suggests enterprises are making serious platform bets on ServiceNow.

**ALEX**: Right, and let's talk about their AI momentum. Now Assist, their AI product suite, surpassed $600 million in ACV and is tracking toward their $1 billion target for 2026. McDermott mentioned they had 35 deals over $1 million for Now Assist in Q4 alone, with some customers expanding their AI usage by 13 times upon renewal.

**JORDAN**: That renewal expansion story is fascinating. CFO Gina Mastantuono mentioned that customer service Now Assist deals saw over 70% upsell expansion at renewal in Q4. This suggests customers aren't just trying AI - they're getting real value and wanting more. It's moving from proof-of-concept to production scale.

**ALEX**: Now, let's address the elephant in the room - the recent acquisitions. ServiceNow has been busy, acquiring Moveworks, and announcing plans to acquire VESA and ARMS. McDermott was pretty defensive about this, pushing back against speculation that M&A was driven by necessity.

**JORDAN**: He was very clear about their strategy here. McDermott emphasized they've never acquired for revenue alone, and these acquisitions are about expanding their Total Addressable Market to over $600 billion. The story he's telling is about creating an "AI control tower" for enterprises - combining visibility from ARMS, identity governance from VESA, and orchestration from ServiceNow's platform.

**ALEX**: The security angle is interesting. Their security and risk business already generates over $1 billion in ACV and grew nearly 40% year-over-year. With these acquisitions, they're essentially saying they want to be the comprehensive security platform for what they call the "agentic AI world" - where AI agents are running business processes autonomously.

**JORDAN**: Speaking of autonomous AI, I loved McDermott's explanation of why AI needs workflow orchestration. He said AI is "probabilistic" - meaning uncertain outcomes - while workflow orchestration is "deterministic" - predictable and governed. That's actually a compelling argument for why AI doesn't replace platforms like ServiceNow, but rather depends on them.

**ALEX**: The customer examples were pretty compelling too. One stood out where a consumer services company achieved 400% ROI and needed eight times more AI assists after a year. They're flipping from 80% human-led support to 80% automated. That's...]]>517falsefullhttps://www.spreaker.com/episode/united-parcel-service-q4-2025-earnings-analysis--70248896
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into UPS's Q4 2025 earnings call - and wow, there's a lot to unpack here.

But before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, this was quite the call. UPS is in the middle of what they're calling their "Amazon accelerated glide down" - essentially deliberately shrinking their network while trying to improve profitability. How'd they do in Q4?

JORDAN: Alex, the headline numbers actually look pretty solid considering they're in the middle of this massive transformation. Q4 revenue came in at $24.5 billion with operating profit of $2.9 billion - that's an 11.8% operating margin. For the full year 2025, they hit $88.7 billion in revenue with $8.7 billion in operating profit.

But here's what's really interesting - they exceeded their own internal expectations despite deliberately reducing Amazon volume by about 1 million pieces per day. That tells you something about the quality improvements they're seeing.

ALEX: Right, and that's the key theme here - this isn't just about getting smaller, it's about getting more profitable per package. What stood out to you in terms of revenue quality improvements?

JORDAN: The numbers are actually quite impressive. U.S. revenue per piece grew 7.1% year-over-year, and in Q4 specifically it jumped 8.3% - that's their strongest fourth quarter revenue per piece growth in four years. They're also seeing their customer mix improve dramatically. Small and medium business penetration hit 31.8% of total volume, and B2B grew to 42.3% - both record highs.

CEO Carol Tomé made a point of saying this isn't a "shrink-the-company strategy" but rather growing in the best parts of the market. They're essentially trading low-margin Amazon volume for higher-margin enterprise and SMB business.

ALEX: Let's talk about the costs though, because this transformation isn't free. They took some pretty significant charges this quarter, right?

JORDAN: Absolutely. They took a $137 million after-tax write-off for their MD-11 aircraft fleet - they're accelerating the retirement of these older, less efficient planes and replacing them with newer Boeing 767s. CFO Brian Dykes mentioned they had about $50 million in incremental lease costs in Q4 just to replace that capacity, and that'll roughly double in 2026.

They also delivered $3.5 billion in savings from network reconfiguration - they closed 93 buildings in the U.S., removed 26.9 million labor hours, and cut 48,000 positions. It's a massive operational overhaul.

ALEX: Now, one of the most interesting developments was around their economy product called "Groundsaver." They're basically handing some of that delivery back to the U.S. Postal Service. What's the story there?

JORDAN: This is actually a reversal of something they did previously. UPS had been doing more of this economy delivery in-house, which was costing them big - we're talking about $400-500 million in headwinds in 2025. Now they're going back to having USPS handle the final mile for some of these packages, which should improve their economics significantly.

Brian Dykes said they expect to see benefits start materializing in the second half of 2026, though the full benefit might not come until 2027. They're using what they call "density matching technology" to decide which packages UPS delivers versus which ones go to USPS.

ALEX: Let's talk guidance because 2026 sounds like it's going to be a tale of two halves. What are they expecting?

JORDAN: Exactly right, Alex. For full year 2026, they're guiding to about $89.7 billi

This episode includes AI-generated content.]]>SP100-UPS-Q4-2025-enTue, 24 Feb 2026 13:15:00 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into UPS's Q4 2025 earnings call - and...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into UPS's Q4 2025 earnings call - and wow, there's a lot to unpack here.

But before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, this was quite the call. UPS is in the middle of what they're calling their "Amazon accelerated glide down" - essentially deliberately shrinking their network while trying to improve profitability. How'd they do in Q4?

JORDAN: Alex, the headline numbers actually look pretty solid considering they're in the middle of this massive transformation. Q4 revenue came in at $24.5 billion with operating profit of $2.9 billion - that's an 11.8% operating margin. For the full year 2025, they hit $88.7 billion in revenue with $8.7 billion in operating profit.

But here's what's really interesting - they exceeded their own internal expectations despite deliberately reducing Amazon volume by about 1 million pieces per day. That tells you something about the quality improvements they're seeing.

ALEX: Right, and that's the key theme here - this isn't just about getting smaller, it's about getting more profitable per package. What stood out to you in terms of revenue quality improvements?

JORDAN: The numbers are actually quite impressive. U.S. revenue per piece grew 7.1% year-over-year, and in Q4 specifically it jumped 8.3% - that's their strongest fourth quarter revenue per piece growth in four years. They're also seeing their customer mix improve dramatically. Small and medium business penetration hit 31.8% of total volume, and B2B grew to 42.3% - both record highs.

CEO Carol Tomé made a point of saying this isn't a "shrink-the-company strategy" but rather growing in the best parts of the market. They're essentially trading low-margin Amazon volume for higher-margin enterprise and SMB business.

ALEX: Let's talk about the costs though, because this transformation isn't free. They took some pretty significant charges this quarter, right?

JORDAN: Absolutely. They took a $137 million after-tax write-off for their MD-11 aircraft fleet - they're accelerating the retirement of these older, less efficient planes and replacing them with newer Boeing 767s. CFO Brian Dykes mentioned they had about $50 million in incremental lease costs in Q4 just to replace that capacity, and that'll roughly double in 2026.

They also delivered $3.5 billion in savings from network reconfiguration - they closed 93 buildings in the U.S., removed 26.9 million labor hours, and cut 48,000 positions. It's a massive operational overhaul.

ALEX: Now, one of the most interesting developments was around their economy product called "Groundsaver." They're basically handing some of that delivery back to the U.S. Postal Service. What's the story there?

JORDAN: This is actually a reversal of something they did previously. UPS had been doing more of this economy delivery in-house, which was costing them big - we're talking about $400-500 million in headwinds in 2025. Now they're going back to having USPS handle the final mile for some of these packages, which should improve their economics significantly.

Brian Dykes said they expect to see benefits start materializing in the second half of 2026, though the full benefit might not come until 2027. They're using what they call "density matching technology" to decide which packages UPS delivers versus which ones go to USPS.

ALEX: Let's talk guidance because...]]>526falsefullhttps://www.spreaker.com/episode/thermo-fisher-scientific-q4-2025-earnings-analysis--70248895
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Thermo Fisher just delivered some really solid numbers to cap off 2025, plus they dropped a massive $9 billion acquisition announcement. There's a lot to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Q4 revenue came in at $12.21 billion, up 7% year-over-year. For the full year, they hit $44.56 billion in revenue, growing 4%. But here's what I found interesting - their adjusted EPS grew 8% in the quarter to $6.57, and 5% for the full year to $22.87.

**JORDAN:** That EPS growth is noteworthy because it shows they're managing their operations really well despite some headwinds. CEO Marc Casper mentioned they faced over 100 basis points of margin pressure from tariffs and foreign exchange impacts. Yet they still delivered solid earnings growth - that's the power of their PPI business system at work.

**ALEX:** Speaking of headwinds, let's talk about how different end markets performed. Pharma and biotech was the standout - high single-digit growth in Q4 and mid-single digits for the full year. That's their core market, so seeing strength there is crucial.

**JORDAN:** Right, and Casper gave some really interesting color on customer sentiment in pharma during the Q&A. He talked about meeting with pharma CEOs who were much more optimistic, saying the tone in January customer meetings was "quite positive." He even shared this great anecdote about a pharma CEO who was so engaged in their discussion that he literally went and found his head of development mid-conversation to dive deeper into specifics.

**ALEX:** That's the kind of customer relationship that's hard to quantify but incredibly valuable. It speaks to their "trusted partner" positioning. But not all end markets were as rosy - academic and government declined low single digits both for the quarter and full year, largely due to macro conditions in the US and China.

**JORDAN:** Yeah, and that's reflected in their 2026 guidance assumptions. They're basically planning for similar market conditions to 2025, which seems prudent. They're guiding for 3-4% organic growth and 4-6% reported revenue growth, targeting $46.3 to $47.2 billion in revenue.

**ALEX:** The earnings guidance is where things get interesting though. They're projecting 6-8% adjusted EPS growth, hitting $24.22 to $24.80 per share. That's pretty strong earnings leverage even with modest revenue growth.

**JORDAN:** Exactly, and that doesn't even include the potential impact from their big acquisition announcement - Clario. This is a $9 billion deal for a digital endpoint data provider that generated about $1.5 billion in 2025 revenue. If it closes by year-end as expected, it could add another $0.45 in adjusted EPS.

**ALEX:** Let's dig into that Clario deal because it's fascinating strategically. They're essentially buying capabilities in one of the fastest-growing areas of clinical research - digital endpoints for clinical trials. This fits perfectly with their "Accelerated Drug Development" solution that combines their pharma services and clinical research businesses.

**JORDAN:** And Casper was really enthusiastic about this during the call. He talked about how it will enable "even deeper clinical insights" and "further accelerate the digital transformation of clinical research." Plus, they mentioned it has an attractive double-digit return profile and will be accretive to both organic growth and margins.

**AL

This episode includes AI-generated content.]]>SP100-TMO-Q4-2025-enTue, 24 Feb 2026 13:14:54 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Thermo Fisher just delivered some really solid numbers to cap off 2025, plus they dropped a massive $9 billion acquisition announcement. There's a lot to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Q4 revenue came in at $12.21 billion, up 7% year-over-year. For the full year, they hit $44.56 billion in revenue, growing 4%. But here's what I found interesting - their adjusted EPS grew 8% in the quarter to $6.57, and 5% for the full year to $22.87.

**JORDAN:** That EPS growth is noteworthy because it shows they're managing their operations really well despite some headwinds. CEO Marc Casper mentioned they faced over 100 basis points of margin pressure from tariffs and foreign exchange impacts. Yet they still delivered solid earnings growth - that's the power of their PPI business system at work.

**ALEX:** Speaking of headwinds, let's talk about how different end markets performed. Pharma and biotech was the standout - high single-digit growth in Q4 and mid-single digits for the full year. That's their core market, so seeing strength there is crucial.

**JORDAN:** Right, and Casper gave some really interesting color on customer sentiment in pharma during the Q&A. He talked about meeting with pharma CEOs who were much more optimistic, saying the tone in January customer meetings was "quite positive." He even shared this great anecdote about a pharma CEO who was so engaged in their discussion that he literally went and found his head of development mid-conversation to dive deeper into specifics.

**ALEX:** That's the kind of customer relationship that's hard to quantify but incredibly valuable. It speaks to their "trusted partner" positioning. But not all end markets were as rosy - academic and government declined low single digits both for the quarter and full year, largely due to macro conditions in the US and China.

**JORDAN:** Yeah, and that's reflected in their 2026 guidance assumptions. They're basically planning for similar market conditions to 2025, which seems prudent. They're guiding for 3-4% organic growth and 4-6% reported revenue growth, targeting $46.3 to $47.2 billion in revenue.

**ALEX:** The earnings guidance is where things get interesting though. They're projecting 6-8% adjusted EPS growth, hitting $24.22 to $24.80 per share. That's pretty strong earnings leverage even with modest revenue growth.

**JORDAN:** Exactly, and that doesn't even include the potential impact from their big acquisition announcement - Clario. This is a $9 billion deal for a digital endpoint data provider that generated about $1.5 billion in 2025 revenue. If it closes by year-end as expected, it could add another $0.45 in adjusted EPS.

**ALEX:** Let's dig into that Clario deal because it's fascinating strategically. They're essentially buying capabilities in one of the fastest-growing areas of clinical research - digital endpoints for clinical trials. This fits perfectly with their "Accelerated Drug Development" solution that combines their pharma services and clinical research businesses.

**JORDAN:** And Casper was really enthusiastic about this during the call. He talked about how it will enable "even deeper clinical insights" and "further accelerate the digital transformation of clinical research."...]]>536falsefullhttps://www.spreaker.com/episode/regeneron-q4-2025-earnings-analysis--70248894
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Regeneron's Q4 2025 earnings - and folks, this biotech giant just delivered some fascinating insights into their pipeline and future strategy.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Regeneron reported total revenue of $3.9 billion, up 3% year-over-year, with some really interesting dynamics happening across their portfolio. The headline number might seem modest, but when you dig into the details, there's a lot more going on here.

**ALEX:** Absolutely. Let's start with the standout performer - Dupixent. Jordan, this drug continues to be an absolute monster for Regeneron and their partner Sanofi.

**JORDAN:** It really is remarkable, Alex. Global Dupixent sales hit $4.9 billion in Q4 alone - that's 32% growth year-over-year. And get this - for the full year 2025, Dupixent brought in $17.8 billion globally. CEO Leonard Schleifer mentioned they now have 1.4 million patients on therapy worldwide across 8 approved indications.

**ALEX:** That's incredible scale. And what I found interesting was how Schleifer emphasized that most of those indications are still "significantly underpenetrated" - suggesting there's still room to grow this massive franchise.

**JORDAN:** Exactly. And speaking of growth, let's talk about their eye care franchise. EYLEA HD had a solid quarter with $506 million in U.S. sales, up 66% year-over-year. But the legacy EYLEA product is facing headwinds - it was down 15% sequentially as biosimilar competition looms.

**ALEX:** Right, and management was very transparent about the challenges ahead. They're expecting multiple biosimilar EYLEA products to launch in 2026, which will intensify competitive pressure. But they seem confident that EYLEA HD can hold its own with its differentiated profile.

**JORDAN:** The FDA just approved EYLEA HD for monthly dosing and a new indication, which should help. And they're waiting on approval for a prefilled syringe version that could make it more convenient for doctors to use. Marion McCourt, their commercial head, seemed optimistic about these enhancements.

**ALEX:** Now Jordan, what really caught my attention was the pipeline discussion. CSO George Yancopoulos laid out an incredibly ambitious clinical development plan.

**JORDAN:** Oh absolutely, Alex. They're planning to initiate 18 new Phase III studies targeting enrollment of 35,000 patients. That's a massive investment in late-stage development across multiple therapeutic areas - oncology, complement diseases, anticoagulation, and more.

**ALEX:** And the financial commitment is significant. CFO Christopher Fenimore guided R&D spending to $5.9-6.1 billion in 2026, up substantially from 2025. That's nearly $6 billion just on research and development!

**JORDAN:** Which brings us to one of the most intriguing parts of the call - their obesity strategy. Instead of just trying to compete head-to-head with existing GLP-1 drugs like Ozempic and Mounjaro, they're taking a differentiated approach.

**ALEX:** This was fascinating. Yancopoulos described their plan to combine a GLP-1/GIP drug with their PCSK9 inhibitor Praluent in a single injection. His quote was memorable - he said imagine if someone invented a new GLP-1 that not only delivers weight loss but also lowers bad cholesterol by 50-60%.

**JORDAN:** That's a clever strategy, Alex. Rather than fighting for an extra 1-2% in weight loss like everyone else, they're adding a completely different benefit. Many obese patients also

This episode includes AI-generated content.]]>SP100-REGN-Q4-2025-enTue, 24 Feb 2026 13:14:49 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Regeneron's Q4...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're breaking down Regeneron's Q4 2025 earnings - and folks, this biotech giant just delivered some fascinating insights into their pipeline and future strategy.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Regeneron reported total revenue of $3.9 billion, up 3% year-over-year, with some really interesting dynamics happening across their portfolio. The headline number might seem modest, but when you dig into the details, there's a lot more going on here.

**ALEX:** Absolutely. Let's start with the standout performer - Dupixent. Jordan, this drug continues to be an absolute monster for Regeneron and their partner Sanofi.

**JORDAN:** It really is remarkable, Alex. Global Dupixent sales hit $4.9 billion in Q4 alone - that's 32% growth year-over-year. And get this - for the full year 2025, Dupixent brought in $17.8 billion globally. CEO Leonard Schleifer mentioned they now have 1.4 million patients on therapy worldwide across 8 approved indications.

**ALEX:** That's incredible scale. And what I found interesting was how Schleifer emphasized that most of those indications are still "significantly underpenetrated" - suggesting there's still room to grow this massive franchise.

**JORDAN:** Exactly. And speaking of growth, let's talk about their eye care franchise. EYLEA HD had a solid quarter with $506 million in U.S. sales, up 66% year-over-year. But the legacy EYLEA product is facing headwinds - it was down 15% sequentially as biosimilar competition looms.

**ALEX:** Right, and management was very transparent about the challenges ahead. They're expecting multiple biosimilar EYLEA products to launch in 2026, which will intensify competitive pressure. But they seem confident that EYLEA HD can hold its own with its differentiated profile.

**JORDAN:** The FDA just approved EYLEA HD for monthly dosing and a new indication, which should help. And they're waiting on approval for a prefilled syringe version that could make it more convenient for doctors to use. Marion McCourt, their commercial head, seemed optimistic about these enhancements.

**ALEX:** Now Jordan, what really caught my attention was the pipeline discussion. CSO George Yancopoulos laid out an incredibly ambitious clinical development plan.

**JORDAN:** Oh absolutely, Alex. They're planning to initiate 18 new Phase III studies targeting enrollment of 35,000 patients. That's a massive investment in late-stage development across multiple therapeutic areas - oncology, complement diseases, anticoagulation, and more.

**ALEX:** And the financial commitment is significant. CFO Christopher Fenimore guided R&D spending to $5.9-6.1 billion in 2026, up substantially from 2025. That's nearly $6 billion just on research and development!

**JORDAN:** Which brings us to one of the most intriguing parts of the call - their obesity strategy. Instead of just trying to compete head-to-head with existing GLP-1 drugs like Ozempic and Mounjaro, they're taking a differentiated approach.

**ALEX:** This was fascinating. Yancopoulos described their plan to combine a GLP-1/GIP drug with their PCSK9 inhibitor Praluent in a single injection. His quote was memorable - he said imagine if someone invented a new GLP-1 that not only delivers weight loss but also lowers bad cholesterol by 50-60%.

**JORDAN:** That's a...]]>557falsefullhttps://www.spreaker.com/episode/prologis-q4-2025-earnings-analysis--70248893
JORDAN: Thanks Alex. And wow, what a quarter for Prologis! They really delivered some impressive numbers. Let's start with the headline metrics - they hit core FFO of $1.44 per share, landing at the top end of their guidance range. But what really caught my eye was their occupancy performance.

ALEX: Absolutely! They finished the year with 95.8% occupancy, which is remarkable when you consider the broader industrial real estate market has been struggling. Tim Arndt mentioned they're outperforming the broader U.S. market by 300 basis points. That's a massive gap that really shows the quality of their portfolio.

JORDAN: And let's talk about that leasing momentum - 57 million square feet of leases signed in just the fourth quarter alone. But here's what's really interesting: they're seeing net effective rent changes of 44% for the quarter, contributing about $60 million in annualized NOI. Even more exciting, they still have an 18% lease mark-to-market representing nearly $800 million of embedded NOI growth.

ALEX: That embedded growth is huge for investors to understand. It means Prologis can grow NOI without market rents even improving further. Speaking of market conditions, I found Chris Caton's commentary particularly insightful. He mentioned they're seeing three stages of market inflection - evidence of enduring demand, building occupancy, and then rent inflection. They're now seeing all three at various stages across their markets.

JORDAN: Right, and the demand drivers are really compelling. E-commerce represented about 20% of their new leasing activity over the past year, making 2025 the best year for e-commerce leasing since 2021. That threefold space multiplier for e-commerce versus traditional retail continues to be a powerful tailwind.

ALEX: Now let's shift to what might be the most exciting part of this story - their data center expansion. Tim mentioned they've expanded their power access to 5.7 gigawatts, and here's the kicker: they have 1.2 gigawatts currently in LOI or pending lease execution. That's massive scale.

JORDAN: The numbers are staggering when you think about it. Just a year ago, they talked about potentially reaching 10 gigawatts of power over ten years. Now they're already at nearly 6 gigawatts after just one year. Dan Letter was careful to clarify that the 10 gigawatt figure represents the total opportunity universe, but the pace of progress is clearly accelerating.

ALEX: And what's smart about their approach is the discipline. Tim explained they're thinking about roughly 60-70% of projects being "powered shell" format versus full turnkey. The powered shell approach is less capital intensive but still captures significant value. In their 2026 guidance, they expect data centers to represent about 40% of their $4-5 billion development start forecast.

JORDAN: Let's talk about that guidance because it's quite robust. They're forecasting development starts between $4-5 billion on an owned and managed basis. Same-store NOI growth is expected to be 4.25% to 5.25% on a net effective basis. And core FFO is guided to $6.00-$6.20 per share including promote expenses.

ALEX: One thing that stood out from the Q&A was the international strength. Japan delivered occupancy above 97% with nearly 600 basis points of outperformance versus their local market. Europe posted its first quarter of positive rental growth in two years. This global diversification is really paying dividends.

JORDAN: And we can't forget about their capital raising success. The IPO of their Ch

This episode includes AI-generated content.]]>SP100-PLD-Q4-2025-enTue, 24 Feb 2026 13:14:43 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with Jordan to dive into Prologis' Q4 2025 earnings call. Before we get started, I want to remind everyone that this podcast is AI-generated content for...
JORDAN: Thanks Alex. And wow, what a quarter for Prologis! They really delivered some impressive numbers. Let's start with the headline metrics - they hit core FFO of $1.44 per share, landing at the top end of their guidance range. But what really caught my eye was their occupancy performance.

ALEX: Absolutely! They finished the year with 95.8% occupancy, which is remarkable when you consider the broader industrial real estate market has been struggling. Tim Arndt mentioned they're outperforming the broader U.S. market by 300 basis points. That's a massive gap that really shows the quality of their portfolio.

JORDAN: And let's talk about that leasing momentum - 57 million square feet of leases signed in just the fourth quarter alone. But here's what's really interesting: they're seeing net effective rent changes of 44% for the quarter, contributing about $60 million in annualized NOI. Even more exciting, they still have an 18% lease mark-to-market representing nearly $800 million of embedded NOI growth.

ALEX: That embedded growth is huge for investors to understand. It means Prologis can grow NOI without market rents even improving further. Speaking of market conditions, I found Chris Caton's commentary particularly insightful. He mentioned they're seeing three stages of market inflection - evidence of enduring demand, building occupancy, and then rent inflection. They're now seeing all three at various stages across their markets.

JORDAN: Right, and the demand drivers are really compelling. E-commerce represented about 20% of their new leasing activity over the past year, making 2025 the best year for e-commerce leasing since 2021. That threefold space multiplier for e-commerce versus traditional retail continues to be a powerful tailwind.

ALEX: Now let's shift to what might be the most exciting part of this story - their data center expansion. Tim mentioned they've expanded their power access to 5.7 gigawatts, and here's the kicker: they have 1.2 gigawatts currently in LOI or pending lease execution. That's massive scale.

JORDAN: The numbers are staggering when you think about it. Just a year ago, they talked about potentially reaching 10 gigawatts of power over ten years. Now they're already at nearly 6 gigawatts after just one year. Dan Letter was careful to clarify that the 10 gigawatt figure represents the total opportunity universe, but the pace of progress is clearly accelerating.

ALEX: And what's smart about their approach is the discipline. Tim explained they're thinking about roughly 60-70% of projects being "powered shell" format versus full turnkey. The powered shell approach is less capital intensive but still captures significant value. In their 2026 guidance, they expect data centers to represent about 40% of their $4-5 billion development start forecast.

JORDAN: Let's talk about that guidance because it's quite robust. They're forecasting development starts between $4-5 billion on an owned and managed basis. Same-store NOI growth is expected to be 4.25% to 5.25% on a net effective basis. And core FFO is guided to $6.00-$6.20 per share including promote expenses.

ALEX: One thing that stood out from the Q&A was the international strength. Japan delivered occupancy above 97% with nearly 600 basis points of outperformance versus their local market. Europe posted its first quarter of positive rental growth in two years. This global diversification is really...]]>459falsefullhttps://www.spreaker.com/episode/meta-platforms-q4-2025-earnings-analysis--70248891
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Meta's Q4 2025 earnings, and folks, this one's a doozy.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with Meta? These numbers are absolutely crushing it. We're talking about $58.9 billion in Q4 revenue - that's up 25% year-over-year. The advertising business alone hit $58.1 billion, up 24%. These are some of the strongest growth numbers we've seen from Meta in years.

**ALEX:** Right, and what's really striking is the guidance for Q1 2026. They're projecting $53.5 to $56.5 billion in revenue - that would be the fastest growth rate in almost five years. Jordan, what's driving this acceleration?

**JORDAN:** It's really a perfect storm of improvements, Alex. Susan Li, their CFO, highlighted three main drivers. First, they're seeing massive gains from their AI-powered recommendation systems. On Facebook alone, they drove a 7% lift in views of organic feed and video posts in Q4 - and get this - that was the largest quarterly revenue impact from Facebook product launches in the past two years.

**ALEX:** That's incredible. And they're not stopping there, right?

**JORDAN:** Not at all. They're completely rebuilding their AI infrastructure. Mark Zuckerberg announced they're investing between $115 to $135 billion in capital expenditures for 2026. That's a massive step-up, primarily for their new Meta Superintelligence Labs. Zuckerberg said they're six months into rebuilding their AI efforts and he's "very pleased with the quality of the team."

**ALEX:** Speaking of Zuckerberg, his vision for 2026 was pretty ambitious. He's talking about "personal superintelligence" and AI agents that really understand users' personal context. What does that actually mean for the business?

**JORDAN:** It's fascinating, Alex. He outlined three key areas. First, they're merging large language models with their existing recommendation systems. So instead of just showing you content based on past behavior, the AI will understand your personal goals and tailor feeds to help you improve your life in specific ways.

Second, they're revolutionizing commerce. Their ads help businesses find the right customers, but soon they want AI shopping tools that help users find exactly the right products from their business catalog.

**ALEX:** And the third area?

**JORDAN:** New content formats. Zuckerberg believes we're moving beyond video to more immersive, interactive experiences. He mentioned their AI glasses sales more than tripled last year, and he compared this moment to when flip phones became smartphones - inevitable transformation.

**ALEX:** Let's talk about the financials though. With all this massive investment, are they still profitable?

**JORDAN:** Here's what's interesting - despite spending up to $169 billion in total expenses for 2026, Susan Li said they expect operating income to be above 2025 levels in absolute dollars. Not growth rate, mind you, but actual dollar amounts. That's pretty impressive given the scale of investment.

**ALEX:** What about their other businesses? Reality Labs has been a drag on profitability for years.

**JORDAN:** Good news there. Zuckerberg said Reality Labs losses will be similar to 2025 levels, and this will "likely be the peak" as they start to gradually reduce losses going forward. They're shifting focus mainly to glasses and wearables rather than VR headsets.

**ALEX:** Now, during the Q&A, there were some interesting questions about their AI strategy. One analyst asked

This episode includes AI-generated content.]]>SP100-META-Q4-2025-enTue, 24 Feb 2026 13:14:38 +0000trueBeta Finch# Beta Finch Podcast Script: Meta Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Meta's...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Meta's Q4 2025 earnings, and folks, this one's a doozy.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with Meta? These numbers are absolutely crushing it. We're talking about $58.9 billion in Q4 revenue - that's up 25% year-over-year. The advertising business alone hit $58.1 billion, up 24%. These are some of the strongest growth numbers we've seen from Meta in years.

**ALEX:** Right, and what's really striking is the guidance for Q1 2026. They're projecting $53.5 to $56.5 billion in revenue - that would be the fastest growth rate in almost five years. Jordan, what's driving this acceleration?

**JORDAN:** It's really a perfect storm of improvements, Alex. Susan Li, their CFO, highlighted three main drivers. First, they're seeing massive gains from their AI-powered recommendation systems. On Facebook alone, they drove a 7% lift in views of organic feed and video posts in Q4 - and get this - that was the largest quarterly revenue impact from Facebook product launches in the past two years.

**ALEX:** That's incredible. And they're not stopping there, right?

**JORDAN:** Not at all. They're completely rebuilding their AI infrastructure. Mark Zuckerberg announced they're investing between $115 to $135 billion in capital expenditures for 2026. That's a massive step-up, primarily for their new Meta Superintelligence Labs. Zuckerberg said they're six months into rebuilding their AI efforts and he's "very pleased with the quality of the team."

**ALEX:** Speaking of Zuckerberg, his vision for 2026 was pretty ambitious. He's talking about "personal superintelligence" and AI agents that really understand users' personal context. What does that actually mean for the business?

**JORDAN:** It's fascinating, Alex. He outlined three key areas. First, they're merging large language models with their existing recommendation systems. So instead of just showing you content based on past behavior, the AI will understand your personal goals and tailor feeds to help you improve your life in specific ways.

Second, they're revolutionizing commerce. Their ads help businesses find the right customers, but soon they want AI shopping tools that help users find exactly the right products from their business catalog.

**ALEX:** And the third area?

**JORDAN:** New content formats. Zuckerberg believes we're moving beyond video to more immersive, interactive experiences. He mentioned their AI glasses sales more than tripled last year, and he compared this moment to when flip phones became smartphones - inevitable transformation.

**ALEX:** Let's talk about the financials though. With all this massive investment, are they still profitable?

**JORDAN:** Here's what's interesting - despite spending up to $169 billion in total expenses for 2026, Susan Li said they expect operating income to be above 2025 levels in absolute dollars. Not growth rate, mind you, but actual dollar amounts. That's pretty impressive given the scale of investment.

**ALEX:** What about their other businesses? Reality Labs has been a drag on profitability for years.

**JORDAN:** Good news there. Zuckerberg said Reality Labs losses will be similar to 2025 levels, and this will "likely be the peak" as they start to gradually reduce losses going forward. They're shifting focus mainly...]]>487falsefullhttps://www.spreaker.com/episode/jpmorgan-chase-q4-2025-earnings-analysis--70248890
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into JPMorgan Chase's Q4 2025 earnings call. Jordan, this was quite the eventful call - Jamie Dimon and Jeremy Barnum had a lot to unpack.

**JORDAN**: They sure did, Alex. But before we dive in, I need to mention something important. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely crucial reminder, Jordan. Now, let's talk numbers. JPMorgan reported some solid Q4 results - net income of $13 billion, EPS of $4.63, and an 18% return on tangible common equity. Revenue came in at $46.8 billion, up 7% year-over-year. What caught your eye first?

**JORDAN**: What jumped out immediately was that $2.2 billion reserve build related to the Apple Card acquisition. That's a massive number that shows JPMorgan is serious about this partnership. Strip that out, and the underlying business performance looks even stronger. The Consumer and Community Banking division would have shown $5.3 billion in net income without that reserve hit.

**ALEX**: The Apple Card deal is fascinating. Jeremy Barnum called it a "win-win-win" for all three parties - JPMorgan, Apple, and Goldman Sachs, who's exiting the business. But Jordan, what really struck me was the timeline - they're saying it'll take two full years to integrate this portfolio. Why so long?

**JORDAN**: That's the really interesting technical aspect here. Jamie Dimon explained that Apple built a completely different tech stack integrated into iOS - it's not just a traditional credit card they can quickly fold into their existing systems. They literally have to rebuild Apple's technology architecture within JPMorgan's infrastructure. It's going to cost significant money, but Dimon seemed genuinely excited about what they'll learn from Apple's customer service standards and user experience approach.

**ALEX**: Speaking of big numbers, let's talk about that $9 billion expense increase guidance for 2026. Total adjusted expenses are expected to hit $105 billion. Mike Mayo from Wells Fargo really pressed them on this during the Q&A, and Jamie Dimon's response was pretty telling.

**JORDAN**: Dimon was almost defiant about it, in a good way. He essentially said "we see huge opportunities, and we're not going to try to meet some expense target and then ten years from now have you asking us how JPMorgan got left behind." They're investing in rural branches, international expansion, better payment systems, AI across the company, and what Dimon called their "SRI initiative" which could be far bigger than expected.

**ALEX**: The guidance for 2026 shows they're expecting net interest income excluding markets of around $95 billion, with total NII at $103 billion. They're also projecting a card net charge-off rate of approximately 3.4%. But Jordan, there was this elephant in the room that dominated much of the Q&A...

**JORDAN**: You're talking about the credit card interest rate cap proposal. This came up right after President Trump's social media post about potentially capping credit card APRs. The timing was incredible - literally happening as earnings calls were taking place across the banking sector.

**ALEX**: Jeremy Barnum and Jamie Dimon were pretty direct about this. Barnum said if price controls are imposed, "people will lose access to credit on a very, very extensive and broad basis, especially the people who need it the most." Dimon added that it would be "very dramatic" and force them to adjust their entire business model.

**JORDAN**: What's important for listeners to understand is that the credit card business is already extremely competitive. When you impose price controls on a competitive market, companies don'

This episode includes AI-generated content.]]>SP100-JPM-Q4-2025-enTue, 24 Feb 2026 13:14:32 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into JPMorgan Chase's Q4 2025 earnings call. Jordan, this was quite the eventful call -...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into JPMorgan Chase's Q4 2025 earnings call. Jordan, this was quite the eventful call - Jamie Dimon and Jeremy Barnum had a lot to unpack.

**JORDAN**: They sure did, Alex. But before we dive in, I need to mention something important. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Absolutely crucial reminder, Jordan. Now, let's talk numbers. JPMorgan reported some solid Q4 results - net income of $13 billion, EPS of $4.63, and an 18% return on tangible common equity. Revenue came in at $46.8 billion, up 7% year-over-year. What caught your eye first?

**JORDAN**: What jumped out immediately was that $2.2 billion reserve build related to the Apple Card acquisition. That's a massive number that shows JPMorgan is serious about this partnership. Strip that out, and the underlying business performance looks even stronger. The Consumer and Community Banking division would have shown $5.3 billion in net income without that reserve hit.

**ALEX**: The Apple Card deal is fascinating. Jeremy Barnum called it a "win-win-win" for all three parties - JPMorgan, Apple, and Goldman Sachs, who's exiting the business. But Jordan, what really struck me was the timeline - they're saying it'll take two full years to integrate this portfolio. Why so long?

**JORDAN**: That's the really interesting technical aspect here. Jamie Dimon explained that Apple built a completely different tech stack integrated into iOS - it's not just a traditional credit card they can quickly fold into their existing systems. They literally have to rebuild Apple's technology architecture within JPMorgan's infrastructure. It's going to cost significant money, but Dimon seemed genuinely excited about what they'll learn from Apple's customer service standards and user experience approach.

**ALEX**: Speaking of big numbers, let's talk about that $9 billion expense increase guidance for 2026. Total adjusted expenses are expected to hit $105 billion. Mike Mayo from Wells Fargo really pressed them on this during the Q&A, and Jamie Dimon's response was pretty telling.

**JORDAN**: Dimon was almost defiant about it, in a good way. He essentially said "we see huge opportunities, and we're not going to try to meet some expense target and then ten years from now have you asking us how JPMorgan got left behind." They're investing in rural branches, international expansion, better payment systems, AI across the company, and what Dimon called their "SRI initiative" which could be far bigger than expected.

**ALEX**: The guidance for 2026 shows they're expecting net interest income excluding markets of around $95 billion, with total NII at $103 billion. They're also projecting a card net charge-off rate of approximately 3.4%. But Jordan, there was this elephant in the room that dominated much of the Q&A...

**JORDAN**: You're talking about the credit card interest rate cap proposal. This came up right after President Trump's social media post about potentially capping credit card APRs. The timing was incredible - literally happening as earnings calls were taking place across the banking sector.

**ALEX**: Jeremy Barnum and Jamie Dimon were pretty direct about this. Barnum said if price controls are imposed, "people will lose access to credit on a very, very extensive and broad basis, especially the people who need it the most." Dimon added that it would be "very dramatic" and force them to adjust their entire business model.

**JORDAN**: What's important for listeners to understand is...]]>476falsefullhttps://www.spreaker.com/episode/international-business-machines-q4-2025-earnings-analysis--70248889
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into IBM's Q4 2025 earnings, and wow - this might be the strongest quarter we've seen from Big Blue in over a decade.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, let's talk numbers because IBM just delivered some pretty impressive results. What caught your eye first?

ALEX: The headline number is huge - 9% revenue growth in Q4, which is their highest in over three years. But what's really striking is the full-year performance. They hit 6% revenue growth for 2025, which might not sound earth-shattering, but for IBM, this represents their best year in ages.

JORDAN: And the cash generation story is even better. They generated $14.7 billion in free cash flow - that's their highest level in over a decade and represents their best free cash flow margin in their 114-year history. That's not a typo, folks - 114 years.

ALEX: Let's break down what's driving this transformation. CEO Arvind Krishna has been repositioning IBM as a software-led company, and it's really paying off. Software now represents 45% of their business, up from just 25% back in 2018.

JORDAN: The software segment is where the magic is happening. It grew 11% in Q4 and 9% for the full year - which Krishna called their highest annual software growth rate in history. Three of their four software sub-segments hit double-digit growth.

ALEX: What's particularly interesting is their AI strategy. Their cumulative Gen AI book of business now stands at over $12.5 billion. That's split between more than $2 billion in software and over $10.5 billion in consulting.

JORDAN: But here's the kicker - this is the last quarter they're going to report that Gen AI metric separately. CFO Jim Kavanaugh said AI is now so embedded across their entire business that a standalone metric doesn't capture the full value anymore.

ALEX: That's actually a smart move. It shows they're not treating AI as a separate product line but as a foundational technology that enhances everything they do. Speaking of which, their mainframe business had an absolute monster year.

JORDAN: The Z17 mainframe launch has been phenomenal. Infrastructure revenue grew 17% in Q4, with IBM Z up 61% year-over-year. Krishna mentioned this represents the highest annual revenue for their mainframe business in about twenty years.

ALEX: What's fascinating about the mainframe story is how they're positioning it for the AI era. The Z17 can process 50% more AI inferencing operations per day than the previous generation, and it brings real-time AI capabilities directly into the mainframe environment.

JORDAN: That's a key differentiator. Instead of having to send data off-platform for AI processing - which takes seconds - they can do it inline in milliseconds. For financial institutions and other mission-critical applications, that speed difference is game-changing.

ALEX: Let's talk acquisitions because that's been a big part of their strategy. They're in the process of acquiring Confluent, which should close by mid-2026. Kavanaugh expects about $600 million in dilution from that deal initially.

JORDAN: But they're confident it'll be accretive to adjusted EBITDA within the first full year. This follows their successful HashiCorp acquisition, which delivered record bookings and is already ahead of accretion expectations.

ALEX: The productivity story is remarkable too. They originally set a goal to achieve $2 billion in productivity savings by the end of 2024. They're now at $4.5 billion in annual run-rate savings and expect to hit $5.5 billion by the end of 2026.

JORDAN: That productiv

This episode includes AI-generated content.]]>SP100-IBM-Q4-2025-enTue, 24 Feb 2026 13:14:27 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into IBM's Q4 2025 earnings, and wow - this might be the strongest quarter we've seen from Big...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into IBM's Q4 2025 earnings, and wow - this might be the strongest quarter we've seen from Big Blue in over a decade.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, let's talk numbers because IBM just delivered some pretty impressive results. What caught your eye first?

ALEX: The headline number is huge - 9% revenue growth in Q4, which is their highest in over three years. But what's really striking is the full-year performance. They hit 6% revenue growth for 2025, which might not sound earth-shattering, but for IBM, this represents their best year in ages.

JORDAN: And the cash generation story is even better. They generated $14.7 billion in free cash flow - that's their highest level in over a decade and represents their best free cash flow margin in their 114-year history. That's not a typo, folks - 114 years.

ALEX: Let's break down what's driving this transformation. CEO Arvind Krishna has been repositioning IBM as a software-led company, and it's really paying off. Software now represents 45% of their business, up from just 25% back in 2018.

JORDAN: The software segment is where the magic is happening. It grew 11% in Q4 and 9% for the full year - which Krishna called their highest annual software growth rate in history. Three of their four software sub-segments hit double-digit growth.

ALEX: What's particularly interesting is their AI strategy. Their cumulative Gen AI book of business now stands at over $12.5 billion. That's split between more than $2 billion in software and over $10.5 billion in consulting.

JORDAN: But here's the kicker - this is the last quarter they're going to report that Gen AI metric separately. CFO Jim Kavanaugh said AI is now so embedded across their entire business that a standalone metric doesn't capture the full value anymore.

ALEX: That's actually a smart move. It shows they're not treating AI as a separate product line but as a foundational technology that enhances everything they do. Speaking of which, their mainframe business had an absolute monster year.

JORDAN: The Z17 mainframe launch has been phenomenal. Infrastructure revenue grew 17% in Q4, with IBM Z up 61% year-over-year. Krishna mentioned this represents the highest annual revenue for their mainframe business in about twenty years.

ALEX: What's fascinating about the mainframe story is how they're positioning it for the AI era. The Z17 can process 50% more AI inferencing operations per day than the previous generation, and it brings real-time AI capabilities directly into the mainframe environment.

JORDAN: That's a key differentiator. Instead of having to send data off-platform for AI processing - which takes seconds - they can do it inline in milliseconds. For financial institutions and other mission-critical applications, that speed difference is game-changing.

ALEX: Let's talk acquisitions because that's been a big part of their strategy. They're in the process of acquiring Confluent, which should close by mid-2026. Kavanaugh expects about $600 million in dilution from that deal initially.

JORDAN: But they're confident it'll be accretive to adjusted EBITDA within the first full year. This follows their successful HashiCorp acquisition, which delivered record bookings and is already ahead of accretion expectations.

ALEX: The productivity story is remarkable too. They originally set a goal to achieve...]]>520falsefullhttps://www.spreaker.com/episode/gilead-sciences-q4-2025-earnings-analysis--70248887
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Gilead Sciences' Q4 2025 results - and folks, there's a lot to dig into here.

Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Gilead! The biotech giant just wrapped up what CEO Dan O'Day called "a remarkable year" - and the numbers certainly back that up. They hit $28.9 billion in total product sales for 2025, beating their guidance range and showing some serious momentum heading into 2026.

**ALEX:** Absolutely, Jordan. Let's break down those headline numbers first. Total product sales came in at $7.9 billion for Q4, up 5% year-over-year. But here's what caught my attention - when you strip out their COVID drug Veclury, which has been declining as expected, their base business actually grew 7% in the quarter and 4% for the full year.

**JORDAN:** That's a key distinction, Alex. And speaking of key numbers, their HIV business - which is still their cash cow - delivered $20.8 billion in sales for the year, up 6%. But here's where it gets interesting: they faced an estimated $900 million headwind from Medicare Part D redesign changes. Without that policy impact, their HIV business would have grown 10%.

**ALEX:** That Medicare Part D impact is huge context, Jordan. For listeners who might not be familiar, this was a policy change that affected how drug pricing works for seniors on Medicare. So when Gilead says their underlying HIV business grew 10%, that's actually pretty impressive growth for what's considered a mature market.

**JORDAN:** Exactly. And let's talk about the star of the show - YES2GO. This is their twice-yearly injectable HIV prevention drug that launched in 2025, and it's already showing blockbuster potential. They did $150 million in sales for the year, and here's the kicker - they're guiding for $800 million in 2026.

**ALEX:** That's more than a 5x increase, Jordan. During the Q&A, analysts were really pressing on how realistic that number is. Management seems confident though, citing 90% payer coverage already - including all major insurers - with about 90% of covered patients getting it with zero co-pay.

**JORDAN:** The coverage piece is critical, Alex. Commercial launch is one thing, but getting insurance companies to pay for a premium-priced injectable is another. The fact that they hit their 90% coverage target well ahead of their one-year timeline suggests the value proposition is resonating with payers.

**ALEX:** Let's shift to their pipeline, because this is where things get really interesting for long-term investors. They have four potential product launches coming in 2026, plus five Phase III data readouts across HIV, cancer, and liver disease.

**JORDAN:** Right, and this diversification strategy is really starting to pay off. Their cancer drug Trodelvy grew 6% to $1.4 billion, and they just got positive Phase III data that could expand it from second-line to first-line treatment in triple-negative breast cancer. That's potentially doubling the addressable market.

**ALEX:** And Trodelvy isn't their only oncology play. They're preparing to launch something called Anidocel - a CAR-T therapy for multiple myeloma. The clinical data looks strong with a 96% overall response rate and what they're calling a "best-in-disease" safety profile.

**JORDAN:** The safety piece is huge in CAR-T, Alex. These are powerful but potentially toxic treatments. If they can deliver the efficacy without the severe side effects, that's a real competitive advant

This episode includes AI-generated content.]]>SP100-GILD-Q4-2025-enTue, 24 Feb 2026 13:14:21 +0000trueBeta Finch# Beta Finch Podcast Script: Gilead Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Gilead Sciences' Q4 2025 results - and folks, there's a lot to dig into here.

Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Gilead! The biotech giant just wrapped up what CEO Dan O'Day called "a remarkable year" - and the numbers certainly back that up. They hit $28.9 billion in total product sales for 2025, beating their guidance range and showing some serious momentum heading into 2026.

**ALEX:** Absolutely, Jordan. Let's break down those headline numbers first. Total product sales came in at $7.9 billion for Q4, up 5% year-over-year. But here's what caught my attention - when you strip out their COVID drug Veclury, which has been declining as expected, their base business actually grew 7% in the quarter and 4% for the full year.

**JORDAN:** That's a key distinction, Alex. And speaking of key numbers, their HIV business - which is still their cash cow - delivered $20.8 billion in sales for the year, up 6%. But here's where it gets interesting: they faced an estimated $900 million headwind from Medicare Part D redesign changes. Without that policy impact, their HIV business would have grown 10%.

**ALEX:** That Medicare Part D impact is huge context, Jordan. For listeners who might not be familiar, this was a policy change that affected how drug pricing works for seniors on Medicare. So when Gilead says their underlying HIV business grew 10%, that's actually pretty impressive growth for what's considered a mature market.

**JORDAN:** Exactly. And let's talk about the star of the show - YES2GO. This is their twice-yearly injectable HIV prevention drug that launched in 2025, and it's already showing blockbuster potential. They did $150 million in sales for the year, and here's the kicker - they're guiding for $800 million in 2026.

**ALEX:** That's more than a 5x increase, Jordan. During the Q&A, analysts were really pressing on how realistic that number is. Management seems confident though, citing 90% payer coverage already - including all major insurers - with about 90% of covered patients getting it with zero co-pay.

**JORDAN:** The coverage piece is critical, Alex. Commercial launch is one thing, but getting insurance companies to pay for a premium-priced injectable is another. The fact that they hit their 90% coverage target well ahead of their one-year timeline suggests the value proposition is resonating with payers.

**ALEX:** Let's shift to their pipeline, because this is where things get really interesting for long-term investors. They have four potential product launches coming in 2026, plus five Phase III data readouts across HIV, cancer, and liver disease.

**JORDAN:** Right, and this diversification strategy is really starting to pay off. Their cancer drug Trodelvy grew 6% to $1.4 billion, and they just got positive Phase III data that could expand it from second-line to first-line treatment in triple-negative breast cancer. That's potentially doubling the addressable market.

**ALEX:** And Trodelvy isn't their only oncology play. They're preparing to launch something called Anidocel - a CAR-T therapy for multiple myeloma. The clinical data looks strong with a 96% overall response rate and what they're calling a "best-in-disease" safety profile.

**JORDAN:** The safety piece is huge in CAR-T, Alex. These are...]]>522falsefullhttps://www.spreaker.com/episode/walt-disney-q1-2026-earnings-analysis--70248885
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Disney's Q1 2026 earnings - and wow, what a quarter this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now, Alex, Disney just reported some pretty impressive numbers. The experiences segment hit over $10 billion in quarterly revenue for the first time ever. That's massive.

**ALEX:** It really is, Jordan. But let's start with the big picture here. Disney seems to be firing on all cylinders - their film studio generated over $6.5 billion in global box office revenue in calendar 2025, making it their third biggest year ever. We're talking about three billion-dollar movies: Avatar: Fire and Ash, Zootopia 2, and Lilo and Stitch.

**JORDAN:** And Zootopia 2 became Hollywood's highest-grossing animated film of all time at $1.7 billion. But here's what I find fascinating - CEO Bob Iger specifically mentioned how these theatrical successes are creating this flywheel effect. When Zootopia 2 and Avatar hit Disney Plus, they're seeing millions of first streams and hundreds of millions of new viewing hours.

**ALEX:** That interconnected strategy is really paying off. Speaking of streaming, they saw a 13% increase in subscription revenue, and the segment is now profitable with margins hitting around that 10% target they set.

**JORDAN:** Right, and CFO Hugh Johnston mentioned they're actually exceeding that target - they hit 12% revenue growth with about 50% earnings growth in streaming. That's serious operating leverage. But what caught my attention was this OpenAI partnership with Sora.

**ALEX:** Oh, the AI content play. So Disney struck a three-year licensing deal where users can prompt Sora to create 30-second videos featuring about 250 Disney characters. Iger was careful to note these don't include human voices or faces - probably for obvious legal and creative reasons.

**JORDAN:** And they're planning to curate this Sora-generated content on Disney Plus as a way to add short-form video features. Iger mentioned they've noticed the huge growth in short-form content on platforms like YouTube, so this is their way of jumping into that space while maintaining that Disney brand control.

**ALEX:** What I found interesting was when an analyst asked about the impact on traditional programming needs, and Iger basically said this won't cannibalize anything. He sees AI as serving three purposes: enhancing creativity, improving productivity, and creating better connectivity with consumers.

**JORDAN:** Smart positioning. Now, let's talk ESPN because that NFL Network acquisition they just closed is a big deal. ESPN delivered its second-highest Monday Night Football viewership in twenty years, and they're gearing up for their first Super Bowl broadcast.

**ALEX:** And Jordan, the timing couldn't be better with ESPN launching their direct-to-consumer streaming service. The subscriber decline in traditional ESPN slowed to just 4% - a major improvement from the 7-8% drops they were seeing before.

**JORDAN:** The bundling strategy is clearly working. Subscribers who get the Disney Plus, Hulu, and ESPN bundle are churning less, which is huge for lifetime value. Iger mentioned they're working toward a fully integrated app experience by the end of the calendar year.

**ALEX:** Let's shift to experiences because $10 billion in quarterly revenue is just staggering. They've got expansion projects at every single theme park, the new Frozen land opening at Disneyland Paris next month, and they just launched the Disney Destiny cru

This episode includes AI-generated content.]]>SP100-DIS-Q1-2026-enTue, 24 Feb 2026 13:14:16 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Disney's Q1 2026 earnings - and wow, what a quarter this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now, Alex, Disney just reported some pretty impressive numbers. The experiences segment hit over $10 billion in quarterly revenue for the first time ever. That's massive.

**ALEX:** It really is, Jordan. But let's start with the big picture here. Disney seems to be firing on all cylinders - their film studio generated over $6.5 billion in global box office revenue in calendar 2025, making it their third biggest year ever. We're talking about three billion-dollar movies: Avatar: Fire and Ash, Zootopia 2, and Lilo and Stitch.

**JORDAN:** And Zootopia 2 became Hollywood's highest-grossing animated film of all time at $1.7 billion. But here's what I find fascinating - CEO Bob Iger specifically mentioned how these theatrical successes are creating this flywheel effect. When Zootopia 2 and Avatar hit Disney Plus, they're seeing millions of first streams and hundreds of millions of new viewing hours.

**ALEX:** That interconnected strategy is really paying off. Speaking of streaming, they saw a 13% increase in subscription revenue, and the segment is now profitable with margins hitting around that 10% target they set.

**JORDAN:** Right, and CFO Hugh Johnston mentioned they're actually exceeding that target - they hit 12% revenue growth with about 50% earnings growth in streaming. That's serious operating leverage. But what caught my attention was this OpenAI partnership with Sora.

**ALEX:** Oh, the AI content play. So Disney struck a three-year licensing deal where users can prompt Sora to create 30-second videos featuring about 250 Disney characters. Iger was careful to note these don't include human voices or faces - probably for obvious legal and creative reasons.

**JORDAN:** And they're planning to curate this Sora-generated content on Disney Plus as a way to add short-form video features. Iger mentioned they've noticed the huge growth in short-form content on platforms like YouTube, so this is their way of jumping into that space while maintaining that Disney brand control.

**ALEX:** What I found interesting was when an analyst asked about the impact on traditional programming needs, and Iger basically said this won't cannibalize anything. He sees AI as serving three purposes: enhancing creativity, improving productivity, and creating better connectivity with consumers.

**JORDAN:** Smart positioning. Now, let's talk ESPN because that NFL Network acquisition they just closed is a big deal. ESPN delivered its second-highest Monday Night Football viewership in twenty years, and they're gearing up for their first Super Bowl broadcast.

**ALEX:** And Jordan, the timing couldn't be better with ESPN launching their direct-to-consumer streaming service. The subscriber decline in traditional ESPN slowed to just 4% - a major improvement from the 7-8% drops they were seeing before.

**JORDAN:** The bundling strategy is clearly working. Subscribers who get the Disney Plus, Hulu, and ESPN bundle are churning less, which is huge for lifetime value. Iger mentioned they're working toward a fully integrated app experience by the end of the calendar year.

**ALEX:** Let's shift to experiences because $10 billion in quarterly revenue is just staggering....]]>531falsefullhttps://www.spreaker.com/episode/deere-company-q1-2026-earnings-analysis--70248884
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by Jordan. Today we're digging into Deere & Company's first quarter 2026 results - and folks, this is a company that's showing some real signs of life after what's been a pretty challenging agricultural cycle.

JORDAN: That's right, Alex. And before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks, Jordan. Now, let's talk numbers because Deere really impressed here. They posted $9.6 billion in net sales and revenues, up 13% year-over-year, with equipment operations specifically growing 18% to $8 billion. Net income came in at $656 million, or $2.42 per share.

JORDAN: What I found particularly encouraging is that they beat their own expectations across the board. Management said all business segments performed ahead of plan, driven primarily by better-than-expected shipment volumes. And here's the kicker - they're calling 2026 the bottom of the current agricultural cycle.

ALEX: That's huge, Jordan. Let's break down the segments because there are some really interesting dynamics here. Small Ag & Turf was the star performer with 24% growth to $2.2 billion in sales and a 9% operating margin. Meanwhile, Construction & Forestry jumped 34% to $2.7 billion.

JORDAN: The Construction & Forestry story is particularly compelling. Their order bank has risen by over 50% in just the past quarter - that's the highest level since May 2024. Management is seeing strength across infrastructure projects, data center construction, and rental re-fleeting. It's giving them clear visibility into the second half of the fiscal year.

ALEX: And that's translating into some serious guidance raises. They bumped their Construction & Forestry net sales forecast to up around 15% for the full year, with operating margins now expected between 9-11%. But what really caught my attention was the Large Ag discussion.

JORDAN: Right, so Large Ag has been the problem child for Deere, but there are green shoots emerging. While the North American Large Ag industry is still expected to decline 15-20% this year, management noted that large tractor order velocity has picked up, and their rolling order books now provide visibility into the fourth quarter.

ALEX: The used inventory story is fascinating too. They've made significant progress reducing used equipment inventory - model year 2022 and 2023 8R tractors are down over 40% from their peak, and just in this quarter alone, they dropped 20% sequentially. That's clearing the trade ladder and enabling more replacement demand.

JORDAN: Let's talk about some of the strategic moves they're making. The big announcement is their new Deere-designed 20-ton class excavators launching at CONEXPO. This is their first fully Deere-designed and North Carolina-built excavator line, targeting about 40% of the North American construction equipment market.

ALEX: And they completed the acquisition of Tenna, which is all about digitizing construction workflows and fleet management. This fits into their three-layer strategy: machines, tasks, and job sites. They want to help contractors optimize not just individual machines, but entire operations.

JORDAN: The technology adoption numbers are impressive too. They now have over 500 million engaged acres - that's up 10% from a year ago, with nearly a third being "highly engaged." On the combine side, 99% of combines ordered through their early order program had some level of harvest automation, with nearly 80% taking the ultimate package.

ALEX: Now, it wasn't all sunshine and rainbows. They're dealing with $1.2 billion in tariff costs this year, and there are some reg

This episode includes AI-generated content.]]>SP100-DE-Q1-2026-enTue, 24 Feb 2026 13:14:10 +0000trueBeta Finch**Beta Finch Podcast Script: Deere Q1 2026 Earnings** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by Jordan. Today we're digging into Deere & Company's first quarter 2026 results - and folks,...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by Jordan. Today we're digging into Deere & Company's first quarter 2026 results - and folks, this is a company that's showing some real signs of life after what's been a pretty challenging agricultural cycle.

JORDAN: That's right, Alex. And before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks, Jordan. Now, let's talk numbers because Deere really impressed here. They posted $9.6 billion in net sales and revenues, up 13% year-over-year, with equipment operations specifically growing 18% to $8 billion. Net income came in at $656 million, or $2.42 per share.

JORDAN: What I found particularly encouraging is that they beat their own expectations across the board. Management said all business segments performed ahead of plan, driven primarily by better-than-expected shipment volumes. And here's the kicker - they're calling 2026 the bottom of the current agricultural cycle.

ALEX: That's huge, Jordan. Let's break down the segments because there are some really interesting dynamics here. Small Ag & Turf was the star performer with 24% growth to $2.2 billion in sales and a 9% operating margin. Meanwhile, Construction & Forestry jumped 34% to $2.7 billion.

JORDAN: The Construction & Forestry story is particularly compelling. Their order bank has risen by over 50% in just the past quarter - that's the highest level since May 2024. Management is seeing strength across infrastructure projects, data center construction, and rental re-fleeting. It's giving them clear visibility into the second half of the fiscal year.

ALEX: And that's translating into some serious guidance raises. They bumped their Construction & Forestry net sales forecast to up around 15% for the full year, with operating margins now expected between 9-11%. But what really caught my attention was the Large Ag discussion.

JORDAN: Right, so Large Ag has been the problem child for Deere, but there are green shoots emerging. While the North American Large Ag industry is still expected to decline 15-20% this year, management noted that large tractor order velocity has picked up, and their rolling order books now provide visibility into the fourth quarter.

ALEX: The used inventory story is fascinating too. They've made significant progress reducing used equipment inventory - model year 2022 and 2023 8R tractors are down over 40% from their peak, and just in this quarter alone, they dropped 20% sequentially. That's clearing the trade ladder and enabling more replacement demand.

JORDAN: Let's talk about some of the strategic moves they're making. The big announcement is their new Deere-designed 20-ton class excavators launching at CONEXPO. This is their first fully Deere-designed and North Carolina-built excavator line, targeting about 40% of the North American construction equipment market.

ALEX: And they completed the acquisition of Tenna, which is all about digitizing construction workflows and fleet management. This fits into their three-layer strategy: machines, tasks, and job sites. They want to help contractors optimize not just individual machines, but entire operations.

JORDAN: The technology adoption numbers are impressive too. They now have over 500 million engaged acres - that's up 10% from a year ago, with nearly a third being "highly engaged." On the combine side, 99% of combines ordered through their early order program had some level of harvest automation, with nearly 80% taking the ultimate package.
459falsefullhttps://www.spreaker.com/episode/blackstone-group-q4-2025-earnings-analysis--70248882
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear conversations. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Blackstone's Q4 2025 earnings – and wow, what a quarter this was for the private equity giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because Blackstone just delivered what they're calling their best results in their 40-year history.

**ALEX:** The headline number that caught my eye – distributable earnings of $1.75 per share for the quarter, capping off a record year where DE increased 20% to $5.57 per share. That's $7.1 billion in distributable earnings for the full year. But Jordan, what really stood out to you?

**JORDAN:** The sheer scale of capital flows. They pulled in $71 billion in inflows just in Q4 – that's the highest level in three and a half years. For the full year, we're talking about $240 billion in fundraising. To put that in perspective, their assets under management hit nearly $1.3 trillion, up 13% year over year.

**ALEX:** That's an almost incomprehensible amount of money. And CEO Jonathan Gray made an interesting point about their market position – according to analyst research, Blackstone has an estimated 50% share of all private wealth revenue across major alternative firms.

**JORDAN:** Which brings us to one of their biggest success stories – the private wealth channel. Their fundraising there jumped 53% year over year to $43 billion. But what's driving this?

**ALEX:** Performance, performance, performance. Their BCRED product – that's their private credit offering for individual investors – delivered 10% net returns annually since inception five years ago. Their private equity flagship BXP has generated 17% annualized returns since launching just two years ago.

**JORDAN:** Let's talk about the elephant in the room though – real estate. This has been a challenging sector, but there are some interesting developments. While real estate values only appreciated about 1.5% for the full year, they're seeing positive signs.

**ALEX:** Right, construction starts have fallen to their lowest level in over 12 years in both logistics and multifamily – their two largest real estate sectors. Less supply typically means better pricing power down the road.

**JORDAN:** And they're not just sitting on the sidelines. They've deployed over $50 billion in real estate since what they call the "cycle trough" two years ago, including a Q4 commitment to privatize Alexander and Baldwin.

**ALEX:** Now let's talk about what might be the most exciting part of this call – the deal environment is finally opening up. Jonathan Gray compared it to 2013-2014, saying it feels like markets are coming out of hibernation.

**JORDAN:** The Medline IPO was a perfect example. This was a $7.2 billion IPO – the largest since 2021 and the largest sponsor-backed IPO in history. Shares popped over 40% on the first day. Gray mentioned they have "one of the largest IPO pipelines in our history."

**ALEX:** What did you make of their commentary on artificial intelligence? They seem to be positioning this as a generational investment opportunity.

**JORDAN:** It's fascinating how they're approaching it on multiple levels. They're investing in the infrastructure – data centers, power generation, the electric grid. But they're also implementing AI across their 270+ portfolio companies. CFO Michael Chae mentioned seeing real productivity gains in software engineering and cyber monitoring already.

**ALEX:** Speaking of their portfolio, the performance numbers across segments were pretty impre

This episode includes AI-generated content.]]>SP100-BX-Q4-2025-enTue, 24 Feb 2026 13:14:04 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear conversations. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Blackstone's Q4...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear conversations. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Blackstone's Q4 2025 earnings – and wow, what a quarter this was for the private equity giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because Blackstone just delivered what they're calling their best results in their 40-year history.

**ALEX:** The headline number that caught my eye – distributable earnings of $1.75 per share for the quarter, capping off a record year where DE increased 20% to $5.57 per share. That's $7.1 billion in distributable earnings for the full year. But Jordan, what really stood out to you?

**JORDAN:** The sheer scale of capital flows. They pulled in $71 billion in inflows just in Q4 – that's the highest level in three and a half years. For the full year, we're talking about $240 billion in fundraising. To put that in perspective, their assets under management hit nearly $1.3 trillion, up 13% year over year.

**ALEX:** That's an almost incomprehensible amount of money. And CEO Jonathan Gray made an interesting point about their market position – according to analyst research, Blackstone has an estimated 50% share of all private wealth revenue across major alternative firms.

**JORDAN:** Which brings us to one of their biggest success stories – the private wealth channel. Their fundraising there jumped 53% year over year to $43 billion. But what's driving this?

**ALEX:** Performance, performance, performance. Their BCRED product – that's their private credit offering for individual investors – delivered 10% net returns annually since inception five years ago. Their private equity flagship BXP has generated 17% annualized returns since launching just two years ago.

**JORDAN:** Let's talk about the elephant in the room though – real estate. This has been a challenging sector, but there are some interesting developments. While real estate values only appreciated about 1.5% for the full year, they're seeing positive signs.

**ALEX:** Right, construction starts have fallen to their lowest level in over 12 years in both logistics and multifamily – their two largest real estate sectors. Less supply typically means better pricing power down the road.

**JORDAN:** And they're not just sitting on the sidelines. They've deployed over $50 billion in real estate since what they call the "cycle trough" two years ago, including a Q4 commitment to privatize Alexander and Baldwin.

**ALEX:** Now let's talk about what might be the most exciting part of this call – the deal environment is finally opening up. Jonathan Gray compared it to 2013-2014, saying it feels like markets are coming out of hibernation.

**JORDAN:** The Medline IPO was a perfect example. This was a $7.2 billion IPO – the largest since 2021 and the largest sponsor-backed IPO in history. Shares popped over 40% on the first day. Gray mentioned they have "one of the largest IPO pipelines in our history."

**ALEX:** What did you make of their commentary on artificial intelligence? They seem to be positioning this as a generational investment opportunity.

**JORDAN:** It's fascinating how they're approaching it on multiple levels. They're investing in the infrastructure – data centers, power generation, the electric grid. But they're also implementing AI across their 270+ portfolio companies. CFO Michael Chae mentioned seeing...]]>487falsefullhttps://www.spreaker.com/episode/bristol-myers-squibb-q4-2025-earnings-analysis--70248879
But first, Jordan, I need to get our mandatory disclaimer out of the way. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of packed earnings calls, Bristol Myers definitely delivered on that front. Let's start with the headline numbers because they tell quite a story about this company's transformation.

**ALEX**: Absolutely. So Q4 revenue came in flat year-over-year at about $12.5 billion, but here's the key detail that investors need to understand - their growth portfolio, which includes all their newer drugs, grew 15% in the quarter and represented nearly 60% of total revenue. That's a massive shift from where this company was just a few years ago.

**JORDAN**: Right, and for the full year, that growth portfolio grew 17%. What's really impressive is that despite losing roughly $4 billion in revenue from legacy products - we're talking about patent cliffs and generic competition - the growth portfolio almost completely offset those declines. That's the kind of pipeline execution that pharma investors dream about.

**ALEX**: Let's talk about some of those growth drivers. Reblozyl, their blood disorder treatment, crossed $2 billion in annual sales. Breyanzi, their CAR-T cell therapy, grew 47% in Q4. And then you have Camzyos for heart disease growing 57%. These aren't just incremental gains - these are blockbuster-level products hitting their stride.

**JORDAN**: And here's what caught my attention from CEO Christopher Boerner's comments - he emphasized they're entering 2026 with "good momentum." But the real story is what's coming in the pipeline. They're expecting six registrational data readouts in the second half of 2026. That's potentially six new revenue streams or major label expansions.

**ALEX**: Jordan, let's break down that pipeline because it spans multiple therapeutic areas. You've got Milvexian for atrial fibrillation and stroke prevention - that's a massive market where they're trying to compete with their own Eliquis. Then there's admilparent for lung fibrosis, and several multiple myeloma treatments. This isn't just one bet - it's a diversified portfolio of shots on goal.

**JORDAN**: Speaking of Eliquis, that was probably the most complex part of the call. The drug is actually expected to grow 10-15% in 2026, which surprised me given it's facing patent cliffs. But management explained they took a strategic pricing reduction that eliminates certain penalty rebates while expanding patient access.

**ALEX**: That's a fascinating strategy. CFO David Elkins explained that the roughly 40% price reduction actually helps them competitively because it removes inflationary penalties that had been building up over years. It's counterintuitive - lower prices leading to higher growth - but it makes sense when you understand the complex rebate structures in pharma.

**JORDAN**: However, they're also guiding for a $1.5 to $2 billion step-down in Eliquis revenue from 2026 to 2027, primarily due to European patent expiries. So investors are looking at one good year before facing those headwinds.

**ALEX**: Let's talk about their cost management because this is where Bristol Myers is really showing discipline. They delivered $1 billion in cost savings in 2025 and expect another billion over 2026-2027. But here's the smart part - they're reinvesting some of those savings into growth initiatives like their partnership with BioNTech on pemiglatinib.

**JORDAN**: That partnership caught

This episode includes AI-generated content.]]>SP100-BMY-Q4-2025-enTue, 24 Feb 2026 13:13:59 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode quarterly reports so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Bristol Myers Squibb's Q4 2025 earnings call -...
But first, Jordan, I need to get our mandatory disclaimer out of the way. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of packed earnings calls, Bristol Myers definitely delivered on that front. Let's start with the headline numbers because they tell quite a story about this company's transformation.

**ALEX**: Absolutely. So Q4 revenue came in flat year-over-year at about $12.5 billion, but here's the key detail that investors need to understand - their growth portfolio, which includes all their newer drugs, grew 15% in the quarter and represented nearly 60% of total revenue. That's a massive shift from where this company was just a few years ago.

**JORDAN**: Right, and for the full year, that growth portfolio grew 17%. What's really impressive is that despite losing roughly $4 billion in revenue from legacy products - we're talking about patent cliffs and generic competition - the growth portfolio almost completely offset those declines. That's the kind of pipeline execution that pharma investors dream about.

**ALEX**: Let's talk about some of those growth drivers. Reblozyl, their blood disorder treatment, crossed $2 billion in annual sales. Breyanzi, their CAR-T cell therapy, grew 47% in Q4. And then you have Camzyos for heart disease growing 57%. These aren't just incremental gains - these are blockbuster-level products hitting their stride.

**JORDAN**: And here's what caught my attention from CEO Christopher Boerner's comments - he emphasized they're entering 2026 with "good momentum." But the real story is what's coming in the pipeline. They're expecting six registrational data readouts in the second half of 2026. That's potentially six new revenue streams or major label expansions.

**ALEX**: Jordan, let's break down that pipeline because it spans multiple therapeutic areas. You've got Milvexian for atrial fibrillation and stroke prevention - that's a massive market where they're trying to compete with their own Eliquis. Then there's admilparent for lung fibrosis, and several multiple myeloma treatments. This isn't just one bet - it's a diversified portfolio of shots on goal.

**JORDAN**: Speaking of Eliquis, that was probably the most complex part of the call. The drug is actually expected to grow 10-15% in 2026, which surprised me given it's facing patent cliffs. But management explained they took a strategic pricing reduction that eliminates certain penalty rebates while expanding patient access.

**ALEX**: That's a fascinating strategy. CFO David Elkins explained that the roughly 40% price reduction actually helps them competitively because it removes inflationary penalties that had been building up over years. It's counterintuitive - lower prices leading to higher growth - but it makes sense when you understand the complex rebate structures in pharma.

**JORDAN**: However, they're also guiding for a $1.5 to $2 billion step-down in Eliquis revenue from 2026 to 2027, primarily due to European patent expiries. So investors are looking at one good year before facing those headwinds.

**ALEX**: Let's talk about their cost management because this is where Bristol Myers is really showing discipline. They delivered $1 billion in cost savings in 2025 and expect another billion over 2026-2027. But here's the smart part - they're reinvesting some of those savings...]]>508falsefullhttps://www.spreaker.com/episode/bank-of-america-q4-2025-earnings-analysis--70248877
JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q4 2025 results, which came out this morning with some pretty solid numbers.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now, let's talk about these results. Bank of America delivered $7.6 billion in net income for Q4, which is up 12% year-over-year. Earnings per share came in at 98 cents, up a whopping 18% from last year.

ALEX: That's a strong finish to 2025. What really caught my attention was the revenue growth - 7% year-over-year, led by net interest income jumping 10% to $15.9 billion. And get this - they delivered 330 basis points of operating leverage in the quarter.

JORDAN: Operating leverage is really the name of the game for banks right now, and Bank of America seems to be executing well on that front. CEO Brian Moynihan highlighted that they kept headcount flat across the entire year despite growing client activity and volumes. That's impressive discipline.

ALEX: Let's break down some of the key drivers. Loan growth was robust at 8% year-over-year, and deposits grew 3%. Both of those outpaced industry averages. What's interesting is they're seeing growth across all their business segments.

JORDAN: Right, and looking at the deposit story - this has been a challenge across the industry post-pandemic. But Bank of America actually added 680,000 new consumer checking accounts during the year while maintaining an average balance of over $9,000. That's 28 consecutive quarters of net growth, or seven straight years.

ALEX: That's remarkable consistency. Now, let's talk about their outlook because this is where it gets really interesting. CFO Alastair Borthwick reiterated their guidance for 5% to 7% net interest income growth in 2026.

JORDAN: And here's why that's significant - they have about $12 to $15 billion in mortgage-backed securities and mortgage loans rolling off each quarter in 2026. These will be replaced with new assets yielding 150 to 200 basis points higher. That's essentially free money dropping to the bottom line.

ALEX: The asset repricing story is huge for Bank of America. They've been positioned for rising rates, but even in a declining rate environment, they're benefiting from this roll-off dynamic. Speaking of rates, how are they thinking about sensitivity?

JORDAN: Good question. They said that if rates dropped another 100 basis points instantly, NII would decline by about $2 billion over 12 months. But if rates went up 100 basis points, they'd benefit by around $700 million. So they're still somewhat asset-sensitive, but much less than before.

ALEX: Let's talk about their business segments. Consumer Banking continues to be a profit machine with a 28% return on allocated capital and what looks like around a 50% profit margin.

JORDAN: And Wealth Management is really hitting its stride. Net income grew from $1 billion in Q2 to $1.4 billion in Q4, with the return on allocated capital jumping from 20% to 28%. They added $500 billion in client balances across the year to reach $4.8 trillion total.

ALEX: Global Markets had another strong quarter too - their 15th consecutive quarter of improvement in sales and trading, generating nearly $21 billion in revenue for the full year. That's a record.

JORDAN: What I found fascinating in the Q&A was the discussion around technology and AI investments. Moynihan mentioned they have 18,000 people coding at the company, and AI has already taken 30% out of the coding process, saving them about 2,000 people equivalent in productivity.

ALEX: That's the kind of operational efficiency that drives long-term competitive advantages. They're spending s

This episode includes AI-generated content.]]>SP100-BAC-Q4-2025-enTue, 24 Feb 2026 13:13:54 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q4 2025 results, which came out this morning with some pretty solid numbers. ALEX: Before we get started, I...
JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q4 2025 results, which came out this morning with some pretty solid numbers.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now, let's talk about these results. Bank of America delivered $7.6 billion in net income for Q4, which is up 12% year-over-year. Earnings per share came in at 98 cents, up a whopping 18% from last year.

ALEX: That's a strong finish to 2025. What really caught my attention was the revenue growth - 7% year-over-year, led by net interest income jumping 10% to $15.9 billion. And get this - they delivered 330 basis points of operating leverage in the quarter.

JORDAN: Operating leverage is really the name of the game for banks right now, and Bank of America seems to be executing well on that front. CEO Brian Moynihan highlighted that they kept headcount flat across the entire year despite growing client activity and volumes. That's impressive discipline.

ALEX: Let's break down some of the key drivers. Loan growth was robust at 8% year-over-year, and deposits grew 3%. Both of those outpaced industry averages. What's interesting is they're seeing growth across all their business segments.

JORDAN: Right, and looking at the deposit story - this has been a challenge across the industry post-pandemic. But Bank of America actually added 680,000 new consumer checking accounts during the year while maintaining an average balance of over $9,000. That's 28 consecutive quarters of net growth, or seven straight years.

ALEX: That's remarkable consistency. Now, let's talk about their outlook because this is where it gets really interesting. CFO Alastair Borthwick reiterated their guidance for 5% to 7% net interest income growth in 2026.

JORDAN: And here's why that's significant - they have about $12 to $15 billion in mortgage-backed securities and mortgage loans rolling off each quarter in 2026. These will be replaced with new assets yielding 150 to 200 basis points higher. That's essentially free money dropping to the bottom line.

ALEX: The asset repricing story is huge for Bank of America. They've been positioned for rising rates, but even in a declining rate environment, they're benefiting from this roll-off dynamic. Speaking of rates, how are they thinking about sensitivity?

JORDAN: Good question. They said that if rates dropped another 100 basis points instantly, NII would decline by about $2 billion over 12 months. But if rates went up 100 basis points, they'd benefit by around $700 million. So they're still somewhat asset-sensitive, but much less than before.

ALEX: Let's talk about their business segments. Consumer Banking continues to be a profit machine with a 28% return on allocated capital and what looks like around a 50% profit margin.

JORDAN: And Wealth Management is really hitting its stride. Net income grew from $1 billion in Q2 to $1.4 billion in Q4, with the return on allocated capital jumping from 20% to 28%. They added $500 billion in client balances across the year to reach $4.8 trillion total.

ALEX: Global Markets had another strong quarter too - their 15th consecutive quarter of improvement in sales and trading, generating nearly $21 billion in revenue for the full year. That's a record.

JORDAN: What I found fascinating in the Q&A was the discussion around technology and AI investments. Moynihan mentioned they have 18,000 people coding at the company, and AI has already taken 30% out of the coding process, saving them about...]]>474falsefullhttps://www.spreaker.com/episode/advanced-micro-devices-q4-2025-earnings-analysis--70248874
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's blockbuster Q4 2025 earnings call. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for AMD! Let me start with the headline numbers because they're pretty impressive. Q4 revenue hit $10.3 billion, up 34% year-over-year, and for the full year they reached a record $34.6 billion in revenue. Net income jumped 42% to $2.5 billion in the quarter.

**ALEX:** Those are strong numbers across the board. But what really caught my attention was their data center segment performance. Jordan, can you break down what's happening there?

**JORDAN:** Absolutely. The data center segment was the star of the show with $5.4 billion in revenue, up 39% year-over-year. What's fascinating is they're seeing growth on two fronts - their traditional EPYC server CPUs are crushing it, and their AI GPU business with the Instinct chips is really starting to ramp up.

**ALEX:** And Lisa Su, AMD's CEO, seemed particularly bullish about their AI prospects. She mentioned they're targeting tens of billions in AI revenue by 2027. That's a pretty bold claim.

**JORDAN:** It is bold, but they've got some big partnerships backing it up. The most notable is their multi-generation deal with OpenAI to deploy six gigawatts of Instinct GPUs. That's massive scale we're talking about. And they're expecting their next-gen MI450 chips and Helios platform to start shipping in the second half of 2026.

**ALEX:** Let's talk about that China situation though, because that added some complexity to the numbers. They had $390 million in revenue from MI308 sales to China in Q4, which wasn't in their original guidance.

**JORDAN:** Right, and that's important context. Those were from licenses approved earlier in 2025, and they're only forecasting another $100 million from China in Q1. Beyond that, they're not providing any guidance on China revenue because of the regulatory uncertainty. So investors should view those China numbers as essentially one-time benefits rather than recurring revenue.

**ALEX:** The other segment that really impressed me was their client and gaming business. $3.9 billion in revenue, up 37% year-over-year. Their Ryzen processors seem to be gaining serious market share.

**JORDAN:** That's a great point, Alex. What I found interesting is they're not just competing on the consumer side - they're making real inroads in commercial PCs. Their Ryzen CPU sell-through for commercial notebooks and desktops grew over 40% year-over-year. That's typically a stickier, higher-margin market.

**ALEX:** Speaking of margins, let's talk about profitability. Their gross margin hit 57% in Q4, though that included a one-time inventory reserve release. Even adjusting for that, they were at about 55%, which is still solid.

**JORDAN:** And Jean Hu, their CFO, seemed confident about margin progression going forward. She mentioned they're benefiting from favorable product mix across all their businesses - newer generation products in data center, moving up-market in client, and recovery in their embedded business.

**ALEX:** The Q&A session had some interesting moments too. One analyst asked about supply constraints for their server CPUs, and Lisa Su acknowledged they've been increasing supply capacity because demand has been so strong.

**JORDAN:** That's a good problem to have, but it does raise questions about whether they can meet all the demand they're seeing. Su mentioned they're working with supply chain partners on multi-year agreements, which suggests they're taking this seriously.

**ALEX:** There was a

This episode includes AI-generated content.]]>SP100-AMD-Q4-2025-enTue, 24 Feb 2026 13:13:48 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's blockbuster Q4 2025 earnings call. Before we get started, I want to remind...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's blockbuster Q4 2025 earnings call. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for AMD! Let me start with the headline numbers because they're pretty impressive. Q4 revenue hit $10.3 billion, up 34% year-over-year, and for the full year they reached a record $34.6 billion in revenue. Net income jumped 42% to $2.5 billion in the quarter.

**ALEX:** Those are strong numbers across the board. But what really caught my attention was their data center segment performance. Jordan, can you break down what's happening there?

**JORDAN:** Absolutely. The data center segment was the star of the show with $5.4 billion in revenue, up 39% year-over-year. What's fascinating is they're seeing growth on two fronts - their traditional EPYC server CPUs are crushing it, and their AI GPU business with the Instinct chips is really starting to ramp up.

**ALEX:** And Lisa Su, AMD's CEO, seemed particularly bullish about their AI prospects. She mentioned they're targeting tens of billions in AI revenue by 2027. That's a pretty bold claim.

**JORDAN:** It is bold, but they've got some big partnerships backing it up. The most notable is their multi-generation deal with OpenAI to deploy six gigawatts of Instinct GPUs. That's massive scale we're talking about. And they're expecting their next-gen MI450 chips and Helios platform to start shipping in the second half of 2026.

**ALEX:** Let's talk about that China situation though, because that added some complexity to the numbers. They had $390 million in revenue from MI308 sales to China in Q4, which wasn't in their original guidance.

**JORDAN:** Right, and that's important context. Those were from licenses approved earlier in 2025, and they're only forecasting another $100 million from China in Q1. Beyond that, they're not providing any guidance on China revenue because of the regulatory uncertainty. So investors should view those China numbers as essentially one-time benefits rather than recurring revenue.

**ALEX:** The other segment that really impressed me was their client and gaming business. $3.9 billion in revenue, up 37% year-over-year. Their Ryzen processors seem to be gaining serious market share.

**JORDAN:** That's a great point, Alex. What I found interesting is they're not just competing on the consumer side - they're making real inroads in commercial PCs. Their Ryzen CPU sell-through for commercial notebooks and desktops grew over 40% year-over-year. That's typically a stickier, higher-margin market.

**ALEX:** Speaking of margins, let's talk about profitability. Their gross margin hit 57% in Q4, though that included a one-time inventory reserve release. Even adjusting for that, they were at about 55%, which is still solid.

**JORDAN:** And Jean Hu, their CFO, seemed confident about margin progression going forward. She mentioned they're benefiting from favorable product mix across all their businesses - newer generation products in data center, moving up-market in client, and recovery in their embedded business.

**ALEX:** The Q&A session had some interesting moments too. One analyst asked about supply constraints for their server CPUs, and Lisa Su acknowledged they've been increasing supply capacity because demand has been so strong.

**JORDAN:** That's a good problem to have, but it does raise questions about whether they can meet all the demand they're...]]>524falsefullhttps://www.spreaker.com/episode/abbott-laboratories-q4-2025-earnings-analysis--70248872
---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Abbott's fourth quarter 2025 results, and folks, there's quite a story here.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Abbott just reported their Q4 numbers, and CEO Robert Ford had some interesting things to say about the year ahead. What caught your attention first?

**JORDAN:** Alex, the headline numbers tell a tale of two companies, honestly. On one hand, you've got Abbott delivering on their original double-digit EPS growth target with adjusted earnings per share hitting $1.50 – that's 12% growth year-over-year. But then there's this nutrition business headwind that's creating some near-term challenges.

**ALEX:** Right, and let's talk about that guidance because it's pretty telling. For 2026, Abbott is projecting organic sales growth of 6.5% to 7.5% – so 7% at the midpoint – and they're calling for 10% growth in adjusted EPS. That EPS growth is solid, but that revenue guidance seems a bit more cautious than what some were expecting.

**JORDAN:** Exactly, and Ford was pretty transparent about why. The nutrition business is essentially going through what he called a "transition back to a more sustainable volume-driven business." Here's what's fascinating – Abbott has been raising prices to offset post-pandemic commodity cost increases, but now those higher prices are actually suppressing demand as consumers become more price-sensitive.

**ALEX:** It's like a classic consumer goods dilemma, right? You raise prices to maintain margins, but eventually you price yourself out of volume growth. Ford mentioned they started implementing "price and promotion initiatives" in Q4 to try to reignite volume growth. How big of an impact is this having on the overall company?

**JORDAN:** Well, nutrition is a meaningful piece of Abbott's portfolio, but what I found encouraging is how Ford framed the rest of the business. He said a "significant majority of the company" is either maintaining high single-digit growth or actually accelerating. The medical devices segment, for example, grew 10.5% in the quarter.

**ALEX:** And that medical devices growth is really impressive when you dig into the details. Continuous glucose monitors grew 17% for the full year, exceeding $7.5 billion in sales. That's the third consecutive year their CGM business has grown by more than a billion dollars. Jordan, when an analyst asked about CGM growth expectations, Ford had a pretty confident response.

**JORDAN:** He did! Ford pushed back on the narrative that the CGM market is slowing down, saying "I don't consider growing a billion dollars every single year and doing it four years in a row to be slowing down." He sees continued penetration opportunities across all patient groups – intensive insulin users, basal insulin users, and non-insulin users. Plus, there's potential for expanded reimbursement coverage for non-insulin Type 2 diabetes patients.

**ALEX:** Speaking of new products, Abbott got FDA approval for their BOLT PFA catheter in December and CE Mark approval for their Tactiflex Duo ablation catheter. Ford seemed pretty excited about their electrophysiology portfolio positioning.

**JORDAN:** Absolutely. He made this great point about how three years ago, there were concerns that Abbott's EP franchise would struggle without PFA technology, but they've maintained double-digit growth even without those products. Now with Volt launching in the US and Tactiflex Duo internationally, Ford said "I do

This episode includes AI-generated content.]]>SP100-ABT-Q4-2025-enTue, 24 Feb 2026 13:13:42 +0000trueBeta Finch**Beta Finch Podcast Script: Abbott Laboratories Q4 2025 Earnings** --- **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host...
---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Abbott's fourth quarter 2025 results, and folks, there's quite a story here.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Abbott just reported their Q4 numbers, and CEO Robert Ford had some interesting things to say about the year ahead. What caught your attention first?

**JORDAN:** Alex, the headline numbers tell a tale of two companies, honestly. On one hand, you've got Abbott delivering on their original double-digit EPS growth target with adjusted earnings per share hitting $1.50 – that's 12% growth year-over-year. But then there's this nutrition business headwind that's creating some near-term challenges.

**ALEX:** Right, and let's talk about that guidance because it's pretty telling. For 2026, Abbott is projecting organic sales growth of 6.5% to 7.5% – so 7% at the midpoint – and they're calling for 10% growth in adjusted EPS. That EPS growth is solid, but that revenue guidance seems a bit more cautious than what some were expecting.

**JORDAN:** Exactly, and Ford was pretty transparent about why. The nutrition business is essentially going through what he called a "transition back to a more sustainable volume-driven business." Here's what's fascinating – Abbott has been raising prices to offset post-pandemic commodity cost increases, but now those higher prices are actually suppressing demand as consumers become more price-sensitive.

**ALEX:** It's like a classic consumer goods dilemma, right? You raise prices to maintain margins, but eventually you price yourself out of volume growth. Ford mentioned they started implementing "price and promotion initiatives" in Q4 to try to reignite volume growth. How big of an impact is this having on the overall company?

**JORDAN:** Well, nutrition is a meaningful piece of Abbott's portfolio, but what I found encouraging is how Ford framed the rest of the business. He said a "significant majority of the company" is either maintaining high single-digit growth or actually accelerating. The medical devices segment, for example, grew 10.5% in the quarter.

**ALEX:** And that medical devices growth is really impressive when you dig into the details. Continuous glucose monitors grew 17% for the full year, exceeding $7.5 billion in sales. That's the third consecutive year their CGM business has grown by more than a billion dollars. Jordan, when an analyst asked about CGM growth expectations, Ford had a pretty confident response.

**JORDAN:** He did! Ford pushed back on the narrative that the CGM market is slowing down, saying "I don't consider growing a billion dollars every single year and doing it four years in a row to be slowing down." He sees continued penetration opportunities across all patient groups – intensive insulin users, basal insulin users, and non-insulin users. Plus, there's potential for expanded reimbursement coverage for non-insulin Type 2 diabetes patients.

**ALEX:** Speaking of new products, Abbott got FDA approval for their BOLT PFA catheter in December and CE Mark approval for their Tactiflex Duo ablation catheter. Ford seemed pretty excited about their electrophysiology portfolio positioning.

**JORDAN:** Absolutely. He made this great point about how three years ago, there were concerns that Abbott's EP franchise would struggle without PFA technology, but they've maintained...]]>506falsefullhttps://www.spreaker.com/episode/johnson-johnson-q4-2025-earnings-analysis--70233696
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and joining me as always is my co-host Jordan. Today we're dissecting Johnson & Johnson's Q4 2025 earnings call, and wow - what a way to cap off the year.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Thanks Alex, and yeah, JNJ really delivered here. They're calling 2025 a "catapult year" - and the numbers back that up. Let's start with the headline figures because they're impressive across the board.

ALEX: Absolutely. Fourth quarter operational sales growth came in at 7.1%, which is solid, but the full-year picture is even better. They hit $94.2 billion in total revenue for 2025 with 5.3% operational growth. But here's the kicker, Jordan - they're guiding for $100 billion at the midpoint for 2026. That's a massive psychological milestone for any healthcare company.

JORDAN: Right, and what's fascinating is how they're positioning this growth. CEO Joaquin Duato kept emphasizing their "28 billion-dollar products" - that's an incredible diversification of revenue streams. No other healthcare company has that kind of breadth. They're not relying on one or two blockbusters like some of their competitors.

ALEX: Let's break down the two main segments. On the Innovative Medicine side, they posted 5.3% operational growth for the year, crossing $60 billion in pharma sales for the first time. The star performer here continues to be DARZALEX in multiple myeloma - $14 billion in annual sales with 22% growth. That's just staggering for a drug of that size.

JORDAN: And they're not stopping there. The multiple myeloma franchise is becoming a juggernaut. They mentioned being the number one company in that space, with 80% of patients treated with at least one of their four medicines. Plus, CARVICTI, their CAR-T therapy, is showing strong momentum with over 10,000 patients treated across 14 markets.

ALEX: The immunology story is equally compelling. Tremfya hit $5 billion in sales and grew 65% in Q4 - that's not a typo, sixty-five percent! They're confident it'll exceed $10 billion in peak sales, especially as it continues taking share in inflammatory bowel disease where STELARA used to dominate.

JORDAN: Speaking of STELARA, that's the elephant in the room that's actually becoming less relevant. STELARA declined 48.6% due to biosimilar competition, but here's what's remarkable - JNJ grew double digits for the full year excluding STELARA. They've successfully navigated that cliff, which was a major investor concern.

ALEX: Now let's talk MedTech. 5.4% operational growth for the year with some really strong pockets. Cardiovascular was the standout with 15% operational growth, reaching $9 billion. The Abiomed and Shockwave acquisitions are clearly paying dividends here.

JORDAN: What caught my attention was their robotics ambition. They just submitted their Ottava robotic surgery system for FDA approval via a de novo pathway - meaning there's no predicate device to compare it against. That suggests they truly believe they have something differentiated in a space dominated by Intuitive Surgical.

ALEX: The guidance for 2026 is aggressive but achievable based on their pipeline momentum. 5.7% to 6.7% operational sales growth, with that $100 billion midpoint I mentioned. Adjusted EPS growth of 5.5% at the midpoint, which factors in about $500 million in medtech tariffs - significantly higher than 2025.

JORDAN: I want to highlight something CFO Joe Wolk said about margins. They're expecting at least 50 basis points of adjusted operating margin improvement despite those tariff headwinds and increased investment in

This episode includes AI-generated content.]]>SP100-JNJ-Q4-2025-enMon, 23 Feb 2026 18:33:47 +0000trueBeta Finch**Beta Finch Podcast Script: Johnson & Johnson Q4 2025** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and joining me as always is my co-host Jordan. Today we're dissecting...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex, and joining me as always is my co-host Jordan. Today we're dissecting Johnson & Johnson's Q4 2025 earnings call, and wow - what a way to cap off the year.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Thanks Alex, and yeah, JNJ really delivered here. They're calling 2025 a "catapult year" - and the numbers back that up. Let's start with the headline figures because they're impressive across the board.

ALEX: Absolutely. Fourth quarter operational sales growth came in at 7.1%, which is solid, but the full-year picture is even better. They hit $94.2 billion in total revenue for 2025 with 5.3% operational growth. But here's the kicker, Jordan - they're guiding for $100 billion at the midpoint for 2026. That's a massive psychological milestone for any healthcare company.

JORDAN: Right, and what's fascinating is how they're positioning this growth. CEO Joaquin Duato kept emphasizing their "28 billion-dollar products" - that's an incredible diversification of revenue streams. No other healthcare company has that kind of breadth. They're not relying on one or two blockbusters like some of their competitors.

ALEX: Let's break down the two main segments. On the Innovative Medicine side, they posted 5.3% operational growth for the year, crossing $60 billion in pharma sales for the first time. The star performer here continues to be DARZALEX in multiple myeloma - $14 billion in annual sales with 22% growth. That's just staggering for a drug of that size.

JORDAN: And they're not stopping there. The multiple myeloma franchise is becoming a juggernaut. They mentioned being the number one company in that space, with 80% of patients treated with at least one of their four medicines. Plus, CARVICTI, their CAR-T therapy, is showing strong momentum with over 10,000 patients treated across 14 markets.

ALEX: The immunology story is equally compelling. Tremfya hit $5 billion in sales and grew 65% in Q4 - that's not a typo, sixty-five percent! They're confident it'll exceed $10 billion in peak sales, especially as it continues taking share in inflammatory bowel disease where STELARA used to dominate.

JORDAN: Speaking of STELARA, that's the elephant in the room that's actually becoming less relevant. STELARA declined 48.6% due to biosimilar competition, but here's what's remarkable - JNJ grew double digits for the full year excluding STELARA. They've successfully navigated that cliff, which was a major investor concern.

ALEX: Now let's talk MedTech. 5.4% operational growth for the year with some really strong pockets. Cardiovascular was the standout with 15% operational growth, reaching $9 billion. The Abiomed and Shockwave acquisitions are clearly paying dividends here.

JORDAN: What caught my attention was their robotics ambition. They just submitted their Ottava robotic surgery system for FDA approval via a de novo pathway - meaning there's no predicate device to compare it against. That suggests they truly believe they have something differentiated in a space dominated by Intuitive Surgical.

ALEX: The guidance for 2026 is aggressive but achievable based on their pipeline momentum. 5.7% to 6.7% operational sales growth, with that $100 billion midpoint I mentioned. Adjusted EPS growth of 5.5% at the midpoint, which factors in about $500 million in medtech tariffs - significantly higher than 2025.

JORDAN: I want to highlight something CFO Joe Wolk said about margins. They're...]]>533falsefullhttps://www.spreaker.com/episode/intuitive-surgical-q4-2025-earnings-analysis--70233690
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking Intuitive Surgical's Q4 2025 results - and folks, this robotics giant just delivered some seriously impressive numbers.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with these results? Intuitive absolutely crushed it this quarter. We're talking about a company that just crossed the 20 million patient milestone since 1997 and shows no signs of slowing down.

**ALEX:** Let's hit the headline numbers first. Revenue grew 21% to hit $10.1 billion for the full year - that's massive growth for a company this size. And quarterly revenue was up 19% to $2.87 billion. But Jordan, what really caught my eye was the procedure growth.

**JORDAN:** Absolutely. Total procedures grew 19% for the year to over 3.1 million. That's not just impressive - it's accelerating adoption of robotic surgery worldwide. Da Vinci procedures specifically were up 18%, with their single-port procedures exploding 87% year-over-year. That tells me surgeons are really embracing these newer technologies.

**ALEX:** And geographically, the story gets even better. US procedures grew 15%, but international was the real star - up 23% with particularly strong performance in Europe at 21%, Asia at 24%, and rest of world markets at 27%. It's becoming a truly global story.

**JORDAN:** What I found fascinating was the capital equipment side. They placed 1,721 da Vinci systems in 2025, including 870 of their newest da Vinci 5 systems. The demand for upgrades is clearly there, especially with the dual console systems for training and mentoring. That speaks to hospitals really investing in their robotic surgery capabilities long-term.

**ALEX:** Let's talk margins for a second. Operating margins came in at 37%, which is solid, though they're dealing with some headwinds. CEO David Rosa mentioned tariffs are hitting them for about 95 basis points, plus they're investing heavily in R&D and scaling manufacturing. But they're managing it well with cost efficiency initiatives.

**JORDAN:** The tariff impact is significant - they're forecasting 120 basis points of impact in 2026, up from about 65 basis points in 2025. That's a real cost pressure they're navigating. But here's what's interesting - they're still guiding for gross margins of 67-68% in 2026, essentially flat despite these headwinds.

**ALEX:** Now, one of the most exciting developments from this call was the FDA clearance for cardiac procedures on the da Vinci 5. Jordan, this could be huge, right?

**JORDAN:** Potentially massive, Alex. They performed about 17,000 cardiac procedures globally in 2025, which sounds small, but Rosa mentioned the addressable market for da Vinci 5 in just the US and Korea is around 160,000 procedures annually. Cardiac surgery is complex, high-value work, so even modest penetration could move the needle significantly.

**ALEX:** The Q&A session revealed some really interesting strategic directions. They're making a big push into ambulatory surgery centers - ASCs. Rosa explained they're targeting higher-volume ASCs, particularly those affiliated with existing hospital customers where surgeons are already da Vinci trained.

**JORDAN:** That ASC strategy is smart. About 70% of the ASC opportunity is with their existing IDN customers, so they have built-in relationships and trained surgeons. They're using their refurbished XI systems - the "XIR" - as the entry point, which gives them a lower-cost option for price-sensitive ASC market.

**ALE

This episode includes AI-generated content.]]>SP100-ISRG-Q4-2025-enMon, 23 Feb 2026 18:33:41 +0000trueBeta Finch# Beta Finch Podcast Script: Intuitive Surgical Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're unpacking Intuitive Surgical's Q4 2025 results - and folks, this robotics giant just delivered some seriously impressive numbers.

Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with these results? Intuitive absolutely crushed it this quarter. We're talking about a company that just crossed the 20 million patient milestone since 1997 and shows no signs of slowing down.

**ALEX:** Let's hit the headline numbers first. Revenue grew 21% to hit $10.1 billion for the full year - that's massive growth for a company this size. And quarterly revenue was up 19% to $2.87 billion. But Jordan, what really caught my eye was the procedure growth.

**JORDAN:** Absolutely. Total procedures grew 19% for the year to over 3.1 million. That's not just impressive - it's accelerating adoption of robotic surgery worldwide. Da Vinci procedures specifically were up 18%, with their single-port procedures exploding 87% year-over-year. That tells me surgeons are really embracing these newer technologies.

**ALEX:** And geographically, the story gets even better. US procedures grew 15%, but international was the real star - up 23% with particularly strong performance in Europe at 21%, Asia at 24%, and rest of world markets at 27%. It's becoming a truly global story.

**JORDAN:** What I found fascinating was the capital equipment side. They placed 1,721 da Vinci systems in 2025, including 870 of their newest da Vinci 5 systems. The demand for upgrades is clearly there, especially with the dual console systems for training and mentoring. That speaks to hospitals really investing in their robotic surgery capabilities long-term.

**ALEX:** Let's talk margins for a second. Operating margins came in at 37%, which is solid, though they're dealing with some headwinds. CEO David Rosa mentioned tariffs are hitting them for about 95 basis points, plus they're investing heavily in R&D and scaling manufacturing. But they're managing it well with cost efficiency initiatives.

**JORDAN:** The tariff impact is significant - they're forecasting 120 basis points of impact in 2026, up from about 65 basis points in 2025. That's a real cost pressure they're navigating. But here's what's interesting - they're still guiding for gross margins of 67-68% in 2026, essentially flat despite these headwinds.

**ALEX:** Now, one of the most exciting developments from this call was the FDA clearance for cardiac procedures on the da Vinci 5. Jordan, this could be huge, right?

**JORDAN:** Potentially massive, Alex. They performed about 17,000 cardiac procedures globally in 2025, which sounds small, but Rosa mentioned the addressable market for da Vinci 5 in just the US and Korea is around 160,000 procedures annually. Cardiac surgery is complex, high-value work, so even modest penetration could move the needle significantly.

**ALEX:** The Q&A session revealed some really interesting strategic directions. They're making a big push into ambulatory surgery centers - ASCs. Rosa explained they're targeting higher-volume ASCs, particularly those affiliated with existing hospital customers where surgeons are already da Vinci trained.

**JORDAN:** That ASC strategy is smart. About 70% of the ASC opportunity is with their existing IDN customers, so they have built-in relationships and trained surgeons. They're using...]]>572falsefullhttps://www.spreaker.com/episode/intel-q4-2025-earnings-analysis--70233686
**JORDAN**: And I'm Jordan. Today we're unpacking Intel's Q4 2025 earnings call, and wow - there's a lot to discuss here.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, Intel's been on quite a journey lately, especially with new CEO Lip-Bu Tan at the helm. What were the headline numbers?

**ALEX**: The numbers actually look pretty solid on the surface. Q4 revenue came in at $13.7 billion - that's at the high end of their guidance range. They delivered non-GAAP earnings per share of 15 cents versus guidance of just 8 cents. And here's something interesting - this marks their fifth consecutive quarter of beating guidance.

**JORDAN**: That's a nice streak, but I'm sensing there's a "but" coming here, right?

**ALEX**: You know me too well, Jordan. The big story here isn't what they delivered - it's what they couldn't deliver due to supply constraints. CEO Lip-Bu Tan was pretty candid about this. He said they're "disappointed that we are not able to fully meet the demand in our markets."

**JORDAN**: Supply constraints in a chip shortage - where have we heard that before? But what's driving the demand they can't meet?

**ALEX**: It's all about AI infrastructure build-out. Their traditional server business saw 15% sequential growth - the fastest this decade, according to CFO Dave Zinsner. AI PCs were up 16% in units. But here's the kicker - Zinsner said revenue "would have been meaningfully higher if we had more supply."

**JORDAN**: So they're essentially leaving money on the table. What about their guidance for Q1 2026?

**ALEX**: This is where it gets interesting. They're guiding to $11.7 to $12.7 billion for Q1, with a midpoint of $12.2 billion. That's actually below typical seasonality. Zinsner said they'd be "well above seasonal if we had all the supply."

**JORDAN**: That's a pretty significant admission. But I noticed something in the transcript - they're prioritizing server shipments over client. Can you explain that strategy?

**ALEX**: Exactly right. They're deliberately shifting their constrained wafer supply toward higher-margin data center customers and away from PC clients. It's a smart move financially, but it shows just how tight their supply situation really is. They've basically depleted their inventory buffers and are operating hand-to-mouth.

**JORDAN**: Let's talk about their foundry ambitions. Lip-Bu has been making a lot of noise about building a world-class foundry business. What's the latest there?

**ALEX**: This is probably the most forward-looking part of the call. They're shipping products on Intel 18A - which they claim is the most advanced process manufactured on U.S. soil. But the real excitement is around Intel 14A. They expect customers to start making firm supplier decisions in the second half of 2026, with volume production targeted for 2028.

**JORDAN**: That timeline puts them roughly in line with TSMC's advanced nodes. But there was some interesting commentary about advanced packaging too, wasn't there?

**ALEX**: Yes! Zinsner said their advanced packaging opportunities - particularly something called EMIB-T - could be "well north of $1 billion" per customer engagement. He initially thought these would be "hundreds of millions" but customer interest is way stronger than expected. Some customers are even making prepayments to secure capacity.

**JORDAN**: That's a strong vote of confidence. Now, one thing that caught my attention was their ASIC business hitting a $1 billion run rate. That seems to be flying under the radar.

**ALEX**: Great point. Their custom ASIC business g

This episode includes AI-generated content.]]>SP100-INTC-Q4-2025-enMon, 23 Feb 2026 18:33:35 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that matter. I'm Alex. **JORDAN**: And I'm Jordan. Today we're unpacking Intel's Q4 2025 earnings call, and wow - there's a lot to discuss here....
**JORDAN**: And I'm Jordan. Today we're unpacking Intel's Q4 2025 earnings call, and wow - there's a lot to discuss here.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, Intel's been on quite a journey lately, especially with new CEO Lip-Bu Tan at the helm. What were the headline numbers?

**ALEX**: The numbers actually look pretty solid on the surface. Q4 revenue came in at $13.7 billion - that's at the high end of their guidance range. They delivered non-GAAP earnings per share of 15 cents versus guidance of just 8 cents. And here's something interesting - this marks their fifth consecutive quarter of beating guidance.

**JORDAN**: That's a nice streak, but I'm sensing there's a "but" coming here, right?

**ALEX**: You know me too well, Jordan. The big story here isn't what they delivered - it's what they couldn't deliver due to supply constraints. CEO Lip-Bu Tan was pretty candid about this. He said they're "disappointed that we are not able to fully meet the demand in our markets."

**JORDAN**: Supply constraints in a chip shortage - where have we heard that before? But what's driving the demand they can't meet?

**ALEX**: It's all about AI infrastructure build-out. Their traditional server business saw 15% sequential growth - the fastest this decade, according to CFO Dave Zinsner. AI PCs were up 16% in units. But here's the kicker - Zinsner said revenue "would have been meaningfully higher if we had more supply."

**JORDAN**: So they're essentially leaving money on the table. What about their guidance for Q1 2026?

**ALEX**: This is where it gets interesting. They're guiding to $11.7 to $12.7 billion for Q1, with a midpoint of $12.2 billion. That's actually below typical seasonality. Zinsner said they'd be "well above seasonal if we had all the supply."

**JORDAN**: That's a pretty significant admission. But I noticed something in the transcript - they're prioritizing server shipments over client. Can you explain that strategy?

**ALEX**: Exactly right. They're deliberately shifting their constrained wafer supply toward higher-margin data center customers and away from PC clients. It's a smart move financially, but it shows just how tight their supply situation really is. They've basically depleted their inventory buffers and are operating hand-to-mouth.

**JORDAN**: Let's talk about their foundry ambitions. Lip-Bu has been making a lot of noise about building a world-class foundry business. What's the latest there?

**ALEX**: This is probably the most forward-looking part of the call. They're shipping products on Intel 18A - which they claim is the most advanced process manufactured on U.S. soil. But the real excitement is around Intel 14A. They expect customers to start making firm supplier decisions in the second half of 2026, with volume production targeted for 2028.

**JORDAN**: That timeline puts them roughly in line with TSMC's advanced nodes. But there was some interesting commentary about advanced packaging too, wasn't there?

**ALEX**: Yes! Zinsner said their advanced packaging opportunities - particularly something called EMIB-T - could be "well north of $1 billion" per customer engagement. He initially thought these would be "hundreds of millions" but customer interest is way stronger than expected. Some customers are even making prepayments to secure capacity.

**JORDAN**: That's a strong vote of confidence. Now, one thing...]]>530falsefullhttps://www.spreaker.com/episode/goldman-sachs-q4-2025-earnings-analysis--70228955
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is my co-host Jordan. Today we're unpacking Goldman Sachs' fourth quarter 2025 results, and wow, what a quarter this was.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Goldman absolutely crushed it this quarter - $14.01 earnings per share, 16% ROE. Walk us through these headline numbers.

**JORDAN**: Alex, these results are genuinely impressive. For the full year, they delivered $51.32 in earnings per share - that's a 27% increase year-over-year. Their return on equity hit 15% for the full year and 16% return on tangible equity. But here's what really caught my attention - since their 2020 investor day, they've increased firm-wide revenues by roughly 60% and grown EPS by 144%. That's execution at scale.

**ALEX**: And they're clearly feeling confident about their position. CEO David Solomon was pretty bullish on the call, talking about how they've maintained their number one M&A adviser position for 23 consecutive years. That's remarkable staying power. But Jordan, there was some significant news buried in these results - what's the story with Apple Card?

**JORDAN**: Right, so Goldman announced they're transitioning the Apple Card portfolio. This had a net positive impact of $0.46 to EPS this quarter because while they took a $2.3 billion revenue reduction, they released $2.5 billion in reserves. Solomon called this one of their "final steps to narrow strategic focus." They're clearly trying to get out of the consumer lending business and refocus on their core strengths.

**ALEX**: Speaking of strategic focus, they laid out some pretty ambitious targets for their asset and wealth management business. What stood out to you there?

**JORDAN**: This was huge, Alex. They're increasing their pretax margin target for asset and wealth management to 30%, which they say will drive high-teen returns in that segment. They now have $3.6 trillion in assets under supervision, and they're targeting 5% long-term fee-based net inflows annually in wealth management. Solomon emphasized they see this as a massive growth opportunity - their current market share in ultra-high-net-worth is only mid-single digits despite being the leader.

**ALEX**: The investment banking outlook seems particularly interesting. They mentioned their backlog is at a four-year high. What's driving that optimism?

**JORDAN**: Solomon was really bullish here. He talked about several catalysts - corporate focus on scale and innovation, massive capital flows into AI, and increased sponsor activity. Get this - sponsors are sitting on about $1 trillion of dry powder and have roughly $4 trillion of value across their portfolio companies. Goldman's betting big that 2026 will see significant M&A activity. Solomon even suggested that in a base case scenario for M&A volumes, we could approach 2021 levels.

**ALEX**: Now, one thing that came up repeatedly was this "One Goldman Sachs 3.0" initiative powered by AI. This sounds pretty transformative, but Solomon was notably cautious about providing specific metrics. What's your read on this?

**JORDAN**: Yeah, that was interesting. Solomon emphasized this isn't about transforming the whole firm - it's about driving productivity and efficiency. They've identified six specific processes to attack with AI-driven redesign. He was pretty honest that he hoped to provide more transparency on this call but wasn't ready yet. The goal is to free up capacity to invest in growth areas like wealth management. It's a smart approach - use AI to become more eff

This episode includes AI-generated content.]]>SP100-GS-Q4-2025-enMon, 23 Feb 2026 16:48:48 +0000trueBeta Finch# Beta Finch Podcast Script: Goldman Sachs Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is my co-host Jordan. Today...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and joining me as always is my co-host Jordan. Today we're unpacking Goldman Sachs' fourth quarter 2025 results, and wow, what a quarter this was.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, Goldman absolutely crushed it this quarter - $14.01 earnings per share, 16% ROE. Walk us through these headline numbers.

**JORDAN**: Alex, these results are genuinely impressive. For the full year, they delivered $51.32 in earnings per share - that's a 27% increase year-over-year. Their return on equity hit 15% for the full year and 16% return on tangible equity. But here's what really caught my attention - since their 2020 investor day, they've increased firm-wide revenues by roughly 60% and grown EPS by 144%. That's execution at scale.

**ALEX**: And they're clearly feeling confident about their position. CEO David Solomon was pretty bullish on the call, talking about how they've maintained their number one M&A adviser position for 23 consecutive years. That's remarkable staying power. But Jordan, there was some significant news buried in these results - what's the story with Apple Card?

**JORDAN**: Right, so Goldman announced they're transitioning the Apple Card portfolio. This had a net positive impact of $0.46 to EPS this quarter because while they took a $2.3 billion revenue reduction, they released $2.5 billion in reserves. Solomon called this one of their "final steps to narrow strategic focus." They're clearly trying to get out of the consumer lending business and refocus on their core strengths.

**ALEX**: Speaking of strategic focus, they laid out some pretty ambitious targets for their asset and wealth management business. What stood out to you there?

**JORDAN**: This was huge, Alex. They're increasing their pretax margin target for asset and wealth management to 30%, which they say will drive high-teen returns in that segment. They now have $3.6 trillion in assets under supervision, and they're targeting 5% long-term fee-based net inflows annually in wealth management. Solomon emphasized they see this as a massive growth opportunity - their current market share in ultra-high-net-worth is only mid-single digits despite being the leader.

**ALEX**: The investment banking outlook seems particularly interesting. They mentioned their backlog is at a four-year high. What's driving that optimism?

**JORDAN**: Solomon was really bullish here. He talked about several catalysts - corporate focus on scale and innovation, massive capital flows into AI, and increased sponsor activity. Get this - sponsors are sitting on about $1 trillion of dry powder and have roughly $4 trillion of value across their portfolio companies. Goldman's betting big that 2026 will see significant M&A activity. Solomon even suggested that in a base case scenario for M&A volumes, we could approach 2021 levels.

**ALEX**: Now, one thing that came up repeatedly was this "One Goldman Sachs 3.0" initiative powered by AI. This sounds pretty transformative, but Solomon was notably cautious about providing specific metrics. What's your read on this?

**JORDAN**: Yeah, that was interesting. Solomon emphasized this isn't about transforming the whole firm - it's about driving productivity and efficiency. They've identified six specific processes to attack with AI-driven redesign. He was pretty honest that he hoped to provide more transparency on this call but wasn't ready yet. The...]]>559falsefullhttps://www.spreaker.com/episode/applied-materials-q1-2026-earnings-analysis--70228951
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Applied Materials' Q1 2026 earnings call - that's AMAT for those keeping score at home.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. So Applied Materials - for folks who might not know - they're basically the behind-the-scenes heroes making the tools that manufacture semiconductors. Think of them as the company that makes the machines that make the chips.

**ALEX:** Exactly. And what's interesting about this quarter is we're seeing some really strong AI-driven demand flowing through to their business. CEO Gary Dickerson opened by highlighting "strong demand across AI, foundry-logic, and memory" with customers accelerating their technology roadmaps.

**JORDAN:** Right, and that's showing up in their financials. While they didn't give us specific revenue numbers in this transcript, CFO Brice Hill mentioned they delivered "strong revenue, margins, and cash flow" and that their backlog remains elevated with book-to-bill around unity.

**ALEX:** That book-to-bill metric is key for equipment companies like Applied Materials. When it's at or above 1.0, it means they're booking new orders at the same rate or faster than they're shipping products. It's a good leading indicator of future revenue.

**JORDAN:** What really caught my attention was the breadth of growth drivers they're seeing. It's not just one area - they mentioned AI, advanced packaging, HBM memory, and even improvements in both DRAM and NAND flash memory.

**ALEX:** HBM is High Bandwidth Memory, by the way - it's the super-fast memory that AI chips need to process all that data. Gary Dickerson specifically called out "strong pull for tools supporting HBM" with visibility extending through multiple quarters.

**JORDAN:** And here's something I found fascinating - they're not just riding the AI wave passively. When asked about advanced packaging, Dickerson talked about their "comprehensive toolset across wafer-level packaging, hybrid bonding, and inspection/metrology." They're positioning themselves across the entire value chain.

**ALEX:** That's Applied Materials' sweet spot - materials engineering. They keep emphasizing these complex new chip architectures like gate-all-around transistors and backside power delivery, which create "new materials and integration challenges" where their expertise becomes even more valuable.

**JORDAN:** Speaking of challenges, there was an interesting exchange about China and export controls. Dickerson said demand there "remains mixed by segment, with mature nodes steady and certain leading-edge areas impacted by restrictions." But they seem to be managing this well with their global footprint.

**ALEX:** Right, and what I appreciated was their transparency about supply chain issues. Brice Hill mentioned they're "expanding capacity in critical product lines" and that lead times are improving as they qualify additional suppliers. That's exactly what you want to hear from a company in this space.

**JORDAN:** The services business also looks solid. Hill talked about growth being "supported by our expanding installed base" and higher attachment to performance-based agreements. That's recurring revenue, which investors love because it's more predictable than equipment sales.

**ALEX:** Let's talk about what this means looking forward. One analyst asked about sustainability of AI demand, and Dickerson seemed pretty confident, saying their "pipeline and customer engagements give us conf

This episode includes AI-generated content.]]>SP100-AMAT-Q1-2026-enMon, 23 Feb 2026 16:48:43 +0000trueBeta Finch# Beta Finch Podcast Script - Applied Materials Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex. **JORDAN:** And I'm...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Applied Materials' Q1 2026 earnings call - that's AMAT for those keeping score at home.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. So Applied Materials - for folks who might not know - they're basically the behind-the-scenes heroes making the tools that manufacture semiconductors. Think of them as the company that makes the machines that make the chips.

**ALEX:** Exactly. And what's interesting about this quarter is we're seeing some really strong AI-driven demand flowing through to their business. CEO Gary Dickerson opened by highlighting "strong demand across AI, foundry-logic, and memory" with customers accelerating their technology roadmaps.

**JORDAN:** Right, and that's showing up in their financials. While they didn't give us specific revenue numbers in this transcript, CFO Brice Hill mentioned they delivered "strong revenue, margins, and cash flow" and that their backlog remains elevated with book-to-bill around unity.

**ALEX:** That book-to-bill metric is key for equipment companies like Applied Materials. When it's at or above 1.0, it means they're booking new orders at the same rate or faster than they're shipping products. It's a good leading indicator of future revenue.

**JORDAN:** What really caught my attention was the breadth of growth drivers they're seeing. It's not just one area - they mentioned AI, advanced packaging, HBM memory, and even improvements in both DRAM and NAND flash memory.

**ALEX:** HBM is High Bandwidth Memory, by the way - it's the super-fast memory that AI chips need to process all that data. Gary Dickerson specifically called out "strong pull for tools supporting HBM" with visibility extending through multiple quarters.

**JORDAN:** And here's something I found fascinating - they're not just riding the AI wave passively. When asked about advanced packaging, Dickerson talked about their "comprehensive toolset across wafer-level packaging, hybrid bonding, and inspection/metrology." They're positioning themselves across the entire value chain.

**ALEX:** That's Applied Materials' sweet spot - materials engineering. They keep emphasizing these complex new chip architectures like gate-all-around transistors and backside power delivery, which create "new materials and integration challenges" where their expertise becomes even more valuable.

**JORDAN:** Speaking of challenges, there was an interesting exchange about China and export controls. Dickerson said demand there "remains mixed by segment, with mature nodes steady and certain leading-edge areas impacted by restrictions." But they seem to be managing this well with their global footprint.

**ALEX:** Right, and what I appreciated was their transparency about supply chain issues. Brice Hill mentioned they're "expanding capacity in critical product lines" and that lead times are improving as they qualify additional suppliers. That's exactly what you want to hear from a company in this space.

**JORDAN:** The services business also looks solid. Hill talked about growth being "supported by our expanding installed base" and higher attachment to performance-based agreements. That's recurring revenue, which investors love because it's more predictable than equipment sales.

**ALEX:** Let's talk about what this means looking...]]>461falsefullhttps://www.spreaker.com/episode/thermo-fisher-q4-2025-earnings-analysis--70225192
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Thermo Fisher just delivered some really solid numbers to cap off 2025, plus they dropped a massive $9 billion acquisition announcement. There's a lot to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Q4 revenue came in at $12.21 billion, up 7% year-over-year. For the full year, they hit $44.56 billion in revenue, growing 4%. But here's what I found interesting - their adjusted EPS grew 8% in the quarter to $6.57, and 5% for the full year to $22.87.

**JORDAN:** That EPS growth is noteworthy because it shows they're managing their operations really well despite some headwinds. CEO Marc Casper mentioned they faced over 100 basis points of margin pressure from tariffs and foreign exchange impacts. Yet they still delivered solid earnings growth - that's the power of their PPI business system at work.

**ALEX:** Speaking of headwinds, let's talk about how different end markets performed. Pharma and biotech was the standout - high single-digit growth in Q4 and mid-single digits for the full year. That's their core market, so seeing strength there is crucial.

**JORDAN:** Right, and Casper gave some really interesting color on customer sentiment in pharma during the Q&A. He talked about meeting with pharma CEOs who were much more optimistic, saying the tone in January customer meetings was "quite positive." He even shared this great anecdote about a pharma CEO who was so engaged in their discussion that he literally went and found his head of development mid-conversation to dive deeper into specifics.

**ALEX:** That's the kind of customer relationship that's hard to quantify but incredibly valuable. It speaks to their "trusted partner" positioning. But not all end markets were as rosy - academic and government declined low single digits both for the quarter and full year, largely due to macro conditions in the US and China.

**JORDAN:** Yeah, and that's reflected in their 2026 guidance assumptions. They're basically planning for similar market conditions to 2025, which seems prudent. They're guiding for 3-4% organic growth and 4-6% reported revenue growth, targeting $46.3 to $47.2 billion in revenue.

**ALEX:** The earnings guidance is where things get interesting though. They're projecting 6-8% adjusted EPS growth, hitting $24.22 to $24.80 per share. That's pretty strong earnings leverage even with modest revenue growth.

**JORDAN:** Exactly, and that doesn't even include the potential impact from their big acquisition announcement - Clario. This is a $9 billion deal for a digital endpoint data provider that generated about $1.5 billion in 2025 revenue. If it closes by year-end as expected, it could add another $0.45 in adjusted EPS.

**ALEX:** Let's dig into that Clario deal because it's fascinating strategically. They're essentially buying capabilities in one of the fastest-growing areas of clinical research - digital endpoints for clinical trials. This fits perfectly with their "Accelerated Drug Development" solution that combines their pharma services and clinical research businesses.

**JORDAN:** And Casper was really enthusiastic about this during the call. He talked about how it will enable "even deeper clinical insights" and "further accelerate the digital transformation of clinical research." Plus, they mentioned it has an attractive double-digit return profile and will be accretive to both organic growth and margins.

**AL

This episode includes AI-generated content.]]>SP100-TMO-Q4-2025-enMon, 23 Feb 2026 12:38:19 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Thermo Fisher Scientific's Q4 2025 results. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter to analyze! Thermo Fisher just delivered some really solid numbers to cap off 2025, plus they dropped a massive $9 billion acquisition announcement. There's a lot to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers, Jordan. Q4 revenue came in at $12.21 billion, up 7% year-over-year. For the full year, they hit $44.56 billion in revenue, growing 4%. But here's what I found interesting - their adjusted EPS grew 8% in the quarter to $6.57, and 5% for the full year to $22.87.

**JORDAN:** That EPS growth is noteworthy because it shows they're managing their operations really well despite some headwinds. CEO Marc Casper mentioned they faced over 100 basis points of margin pressure from tariffs and foreign exchange impacts. Yet they still delivered solid earnings growth - that's the power of their PPI business system at work.

**ALEX:** Speaking of headwinds, let's talk about how different end markets performed. Pharma and biotech was the standout - high single-digit growth in Q4 and mid-single digits for the full year. That's their core market, so seeing strength there is crucial.

**JORDAN:** Right, and Casper gave some really interesting color on customer sentiment in pharma during the Q&A. He talked about meeting with pharma CEOs who were much more optimistic, saying the tone in January customer meetings was "quite positive." He even shared this great anecdote about a pharma CEO who was so engaged in their discussion that he literally went and found his head of development mid-conversation to dive deeper into specifics.

**ALEX:** That's the kind of customer relationship that's hard to quantify but incredibly valuable. It speaks to their "trusted partner" positioning. But not all end markets were as rosy - academic and government declined low single digits both for the quarter and full year, largely due to macro conditions in the US and China.

**JORDAN:** Yeah, and that's reflected in their 2026 guidance assumptions. They're basically planning for similar market conditions to 2025, which seems prudent. They're guiding for 3-4% organic growth and 4-6% reported revenue growth, targeting $46.3 to $47.2 billion in revenue.

**ALEX:** The earnings guidance is where things get interesting though. They're projecting 6-8% adjusted EPS growth, hitting $24.22 to $24.80 per share. That's pretty strong earnings leverage even with modest revenue growth.

**JORDAN:** Exactly, and that doesn't even include the potential impact from their big acquisition announcement - Clario. This is a $9 billion deal for a digital endpoint data provider that generated about $1.5 billion in 2025 revenue. If it closes by year-end as expected, it could add another $0.45 in adjusted EPS.

**ALEX:** Let's dig into that Clario deal because it's fascinating strategically. They're essentially buying capabilities in one of the fastest-growing areas of clinical research - digital endpoints for clinical trials. This fits perfectly with their "Accelerated Drug Development" solution that combines their pharma services and clinical research businesses.

**JORDAN:** And Casper was really enthusiastic about this during the call. He talked about how it will enable "even deeper clinical insights" and "further accelerate the digital transformation of clinical research."...]]>536falsefullhttps://www.spreaker.com/episode/visa-q1-2026-earnings-analysis--70224201
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Visa's Q1 2026 earnings call - and wow, what a quarter for the payments giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the headline numbers because Visa really delivered here.

**ALEX:** They certainly did! Net revenue hit $10.9 billion, up 15% year-over-year, and earnings per share also jumped 15%. What caught my attention was how broad-based this growth was - it wasn't just one segment carrying the load.

**JORDAN:** Right, and the underlying business metrics looked solid too. Payments volume grew 8% to nearly $4 trillion - that's trillion with a T - and they processed 69 billion transactions, up 9% year-over-year. That tells me consumer spending is holding up pretty well.

**ALEX:** What really stood out was their value-added services segment. Jordan, this grew 28% and represented about 50% of their overall revenue growth in the quarter. That's a massive shift from being just a card network to becoming this comprehensive payments technology platform.

**JORDAN:** And it's smart business too, Alex. These value-added services are higher margin and less commodity-like than basic transaction processing. CEO Ryan McInerney spent a lot of time talking about their "Visa as a service" stack - essentially positioning themselves as what he called a "payment hyperscaler."

**ALEX:** I loved that terminology. They're really trying to be the AWS of payments. Speaking of innovation, let's talk about some of the tech stuff because there were some fascinating updates.

**JORDAN:** The tokenization story is incredible. They now have 17.5 billion tokens globally - that's over three times the number of physical cards! And get this - they've reduced guest checkout from 44% of e-commerce transactions in 2019 to just 16% today. Among their top 25 merchants, it's under 4%.

**ALEX:** That's a user experience revolution right there. No more typing in your card number every time you shop online. But what really got my attention was their push into what they're calling "AgenTik Commerce" - basically AI agents making payments on your behalf.

**JORDAN:** Yeah, they're working with over 100 partners on this, including AWS and Ramp. Imagine an AI assistant that can automatically book your travel or make purchases while you sleep, but with all the security and trust of the Visa network behind it. It's still early days, but the potential is huge.

**ALEX:** Now let's talk about something that's been getting a lot of buzz - stablecoins. Visa is clearly making moves here, but it sounds like they're being pretty strategic about it.

**JORDAN:** Exactly. They've reached a $4.6 billion annualized run rate for stablecoin settlement, which is still small for Visa but growing fast. What I found interesting was McInerney's comments about where they see product-market fit. He's not betting big on stablecoin payments in developed markets like the US or UK.

**ALEX:** Right, because we already have plenty of ways to pay digitally. But in markets with currency volatility or limited banking infrastructure? That's where stablecoins make sense as an on-ramp and off-ramp to the traditional financial system.

**JORDAN:** And they're now issuing stablecoin cards in over 50 countries. It's a smart way to bridge the crypto world with traditional payments without taking huge risks.

**ALEX:** Let's shift to the numbers going forward. CFO Chris Suh maintained their full-year guidance despite some headwinds.

**JORDAN:** Yeah, they're dealing with lower-than-expected currency volatility, which actual

This episode includes AI-generated content.]]>SP100-V-Q1-2026-enMon, 23 Feb 2026 10:51:18 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Visa's Q1 2026 earnings call - and wow, what a quarter for the payments giant....
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Visa's Q1 2026 earnings call - and wow, what a quarter for the payments giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the headline numbers because Visa really delivered here.

**ALEX:** They certainly did! Net revenue hit $10.9 billion, up 15% year-over-year, and earnings per share also jumped 15%. What caught my attention was how broad-based this growth was - it wasn't just one segment carrying the load.

**JORDAN:** Right, and the underlying business metrics looked solid too. Payments volume grew 8% to nearly $4 trillion - that's trillion with a T - and they processed 69 billion transactions, up 9% year-over-year. That tells me consumer spending is holding up pretty well.

**ALEX:** What really stood out was their value-added services segment. Jordan, this grew 28% and represented about 50% of their overall revenue growth in the quarter. That's a massive shift from being just a card network to becoming this comprehensive payments technology platform.

**JORDAN:** And it's smart business too, Alex. These value-added services are higher margin and less commodity-like than basic transaction processing. CEO Ryan McInerney spent a lot of time talking about their "Visa as a service" stack - essentially positioning themselves as what he called a "payment hyperscaler."

**ALEX:** I loved that terminology. They're really trying to be the AWS of payments. Speaking of innovation, let's talk about some of the tech stuff because there were some fascinating updates.

**JORDAN:** The tokenization story is incredible. They now have 17.5 billion tokens globally - that's over three times the number of physical cards! And get this - they've reduced guest checkout from 44% of e-commerce transactions in 2019 to just 16% today. Among their top 25 merchants, it's under 4%.

**ALEX:** That's a user experience revolution right there. No more typing in your card number every time you shop online. But what really got my attention was their push into what they're calling "AgenTik Commerce" - basically AI agents making payments on your behalf.

**JORDAN:** Yeah, they're working with over 100 partners on this, including AWS and Ramp. Imagine an AI assistant that can automatically book your travel or make purchases while you sleep, but with all the security and trust of the Visa network behind it. It's still early days, but the potential is huge.

**ALEX:** Now let's talk about something that's been getting a lot of buzz - stablecoins. Visa is clearly making moves here, but it sounds like they're being pretty strategic about it.

**JORDAN:** Exactly. They've reached a $4.6 billion annualized run rate for stablecoin settlement, which is still small for Visa but growing fast. What I found interesting was McInerney's comments about where they see product-market fit. He's not betting big on stablecoin payments in developed markets like the US or UK.

**ALEX:** Right, because we already have plenty of ways to pay digitally. But in markets with currency volatility or limited banking infrastructure? That's where stablecoins make sense as an on-ramp and off-ramp to the traditional financial system.

**JORDAN:** And they're now issuing stablecoin cards in over 50 countries. It's a smart way to bridge the crypto world with traditional payments without taking huge risks.

**ALEX:** Let's shift to the...]]>503falsefullhttps://www.spreaker.com/episode/s-p-global-q4-2025-earnings-analysis--70224200
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into S&P Global's Q4 2025 earnings call - and wow, what a year it's been for this financial data giant.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, S&P Global really delivered some impressive numbers here. Let's start with the headline figures.

**ALEX**: They certainly did. Revenue grew 9% reported, 8% organic constant currency for Q4. For the full year, they hit the high end of their original guidance on revenue growth, margins, AND earnings per share. EPS grew 14% for the year, and get this - they returned 113% of adjusted free cash flow to shareholders.

**JORDAN**: That's a massive cash return. And speaking of returns, they just announced their 53rd consecutive year of dividend increases. Plus they repurchased over $5 billion in stock during 2025. But what really caught my attention was how CEO Martina Cheung framed their strategic vision.

**ALEX**: Right, she kept coming back to this concept of "advancing essential intelligence." Over 95% of their revenue is tied to proprietary benchmarks, differentiated data, and critical workflow tools. And Jordan, they expect that percentage to increase over time.

**JORDAN**: That's a key point because it speaks to their competitive moat, especially with all the AI disruption happening. Speaking of which, they made some fascinating comments about AI being a "net tailwind" for their business. They've launched AI products in every division and are seeing real customer adoption.

**ALEX**: The AI discussion was particularly interesting during the Q&A. With all the recent announcements from companies like Anthropic about financial services plugins, investors were clearly concerned about potential disruption to S&P's workflow products.

**JORDAN**: Martina's response was pretty compelling though. She emphasized that their workflow tools aren't just simple apps - they're enterprise-grade solutions that have been refined over years. Products like iLEVEL and Capital IQ Pro integrate deeply into regulated environments and provide mission-critical functionality that can't easily be replicated.

**ALEX**: And she mentioned something that I found particularly telling - customers are telling them they want fewer vendors, not more. They want S&P to embed the latest AI technology directly into their existing platforms rather than having to work with multiple providers.

**JORDAN**: Exactly. And they're seeing tangible results from their AI investments. For example, they deployed an automated data ingestion tool on iLEVEL, and within six months, nearly 20% of customers opted for that add-on feature. That's real revenue generation from AI enhancements.

**ALEX**: Now let's talk about their 2026 outlook because this is where things get really interesting for investors. They're guiding for 6% to 8% organic constant currency revenue growth, continued margin expansion, and 9% to 10% EPS growth.

**JORDAN**: But here's what's fascinating - they're being quite prudent about their market-driven businesses. For their Ratings division, they're expecting "Billed Issuance" - basically the debt they rate - to grow only low to mid-single digits. That's despite some pretty favorable conditions.

**ALEX**: Right, and CFO Eric Aboaf walked through their assumptions. They're expecting most 2026 debt refinancing to happen this year, but they're not counting on massive pull-forward from 2027 and 2028. They're also being conservative about M&A activity and hyperscale infrastructure spending, even though there's a lot of

This episode includes AI-generated content.]]>SP100-SPGI-Q4-2025-enMon, 23 Feb 2026 10:51:13 +0000trueBeta Finch**Beta Finch Podcast Script: S&P Global Q4 2025 Earnings** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving into S&P Global's Q4 2025 earnings call - and wow, what a...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into S&P Global's Q4 2025 earnings call - and wow, what a year it's been for this financial data giant.

**ALEX**: Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, S&P Global really delivered some impressive numbers here. Let's start with the headline figures.

**ALEX**: They certainly did. Revenue grew 9% reported, 8% organic constant currency for Q4. For the full year, they hit the high end of their original guidance on revenue growth, margins, AND earnings per share. EPS grew 14% for the year, and get this - they returned 113% of adjusted free cash flow to shareholders.

**JORDAN**: That's a massive cash return. And speaking of returns, they just announced their 53rd consecutive year of dividend increases. Plus they repurchased over $5 billion in stock during 2025. But what really caught my attention was how CEO Martina Cheung framed their strategic vision.

**ALEX**: Right, she kept coming back to this concept of "advancing essential intelligence." Over 95% of their revenue is tied to proprietary benchmarks, differentiated data, and critical workflow tools. And Jordan, they expect that percentage to increase over time.

**JORDAN**: That's a key point because it speaks to their competitive moat, especially with all the AI disruption happening. Speaking of which, they made some fascinating comments about AI being a "net tailwind" for their business. They've launched AI products in every division and are seeing real customer adoption.

**ALEX**: The AI discussion was particularly interesting during the Q&A. With all the recent announcements from companies like Anthropic about financial services plugins, investors were clearly concerned about potential disruption to S&P's workflow products.

**JORDAN**: Martina's response was pretty compelling though. She emphasized that their workflow tools aren't just simple apps - they're enterprise-grade solutions that have been refined over years. Products like iLEVEL and Capital IQ Pro integrate deeply into regulated environments and provide mission-critical functionality that can't easily be replicated.

**ALEX**: And she mentioned something that I found particularly telling - customers are telling them they want fewer vendors, not more. They want S&P to embed the latest AI technology directly into their existing platforms rather than having to work with multiple providers.

**JORDAN**: Exactly. And they're seeing tangible results from their AI investments. For example, they deployed an automated data ingestion tool on iLEVEL, and within six months, nearly 20% of customers opted for that add-on feature. That's real revenue generation from AI enhancements.

**ALEX**: Now let's talk about their 2026 outlook because this is where things get really interesting for investors. They're guiding for 6% to 8% organic constant currency revenue growth, continued margin expansion, and 9% to 10% EPS growth.

**JORDAN**: But here's what's fascinating - they're being quite prudent about their market-driven businesses. For their Ratings division, they're expecting "Billed Issuance" - basically the debt they rate - to grow only low to mid-single digits. That's despite some pretty favorable conditions.

**ALEX**: Right, and CFO Eric Aboaf walked through their assumptions. They're expecting most 2026 debt refinancing to happen this year, but they're not counting...]]>451falsefullhttps://www.spreaker.com/episode/citigroup-q4-2025-earnings-analysis--70224198
**JORDAN**: That's right, Alex. But before we get into the numbers, I need to share our disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks, Jordan. Now, let's talk about these results because Citi really delivered some impressive numbers. They reported adjusted EPS of $1.81 for the quarter and a full-year adjusted return on tangible common equity of 8.8% - that's a 180 basis point improvement year-over-year when you adjust for their Russia and Banamex impacts.

**JORDAN**: What really caught my attention was the revenue story. Adjusted revenues were up 7% for the full year to $86.6 billion - that's their strongest growth in over a decade, Alex. And here's the kicker: every single one of their five business segments hit record revenues. Services up 8%, Markets delivering record performance even beating their stellar 2020 numbers, and Banking had their best M&A revenue year in Citi's history.

**ALEX**: That M&A performance is particularly noteworthy. CEO Jane Fraser mentioned they had a role in 15 of the 25 largest investment banking transactions of the year, advising big names like Boeing, Pfizer, and Johnson & Johnson. Their investment banking wallet share increased 30 basis points year-over-year. Jordan, what's your take on the efficiency story here?

**JORDAN**: The efficiency gains are really the underlying theme of this transformation story, Alex. They delivered positive operating leverage for the second straight year - not just at the firm level but in every single business. Their efficiency ratio improved to 63% on an adjusted basis. Fraser was particularly excited about their AI adoption, with colleagues in 84 countries using their proprietary AI tools over 21 million times, with adoption now above 70%.

**ALEX**: Speaking of transformation, there was some significant regulatory news. The OCC terminated article 17 of their consent order in December, and Fraser mentioned that over 80% of their transformation programs are now at or near target state. This feels like a major milestone for Citi's multi-year remediation efforts.

**JORDAN**: Absolutely. And Fraser was pretty confident about completing the remaining work, though she was careful to note that timing ultimately lies with the regulators. The focus is now shifting from just risk and controls to using AI and automation to improve client experience while reducing expenses. They're starting with over 50 of their largest and most complex processes.

**ALEX**: Let's talk about the forward-looking guidance because this is where it gets interesting for investors. CFO Mark Mason provided some pretty specific expectations for 2026. They're guiding for net interest income excluding markets to grow 5-6%, driven by volume growth in cards and wealth, plus deposit growth in services and wealth.

**JORDAN**: Right, and they're targeting an efficiency ratio of around 60% for 2026 - that's moving from their previous target of "below 60%" to "around 60%," giving them flexibility to invest in growth. Mason was clear that 2026 is focused on delivering that 10-11% return on tangible common equity they've been targeting, but he emphasized that's just a waypoint, not the destination.

**ALEX**: One area that stood out in the Q&A was the discussion around capital returns. They repurchased over $13 billion in shares during 2025, including $4.5 billion in Q4. With a CET1 ratio of 13.2% - about 160 basis points above their regulatory requirement - they're targeting a 100 basis point

This episode includes AI-generated content.]]>SP100-C-Q4-2025-enMon, 23 Feb 2026 10:51:09 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Citigroup's Q4 2025 earnings call. Jordan, this was quite the quarter for Citi - and notably, CFO Mark Mason's final...
**JORDAN**: That's right, Alex. But before we get into the numbers, I need to share our disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks, Jordan. Now, let's talk about these results because Citi really delivered some impressive numbers. They reported adjusted EPS of $1.81 for the quarter and a full-year adjusted return on tangible common equity of 8.8% - that's a 180 basis point improvement year-over-year when you adjust for their Russia and Banamex impacts.

**JORDAN**: What really caught my attention was the revenue story. Adjusted revenues were up 7% for the full year to $86.6 billion - that's their strongest growth in over a decade, Alex. And here's the kicker: every single one of their five business segments hit record revenues. Services up 8%, Markets delivering record performance even beating their stellar 2020 numbers, and Banking had their best M&A revenue year in Citi's history.

**ALEX**: That M&A performance is particularly noteworthy. CEO Jane Fraser mentioned they had a role in 15 of the 25 largest investment banking transactions of the year, advising big names like Boeing, Pfizer, and Johnson & Johnson. Their investment banking wallet share increased 30 basis points year-over-year. Jordan, what's your take on the efficiency story here?

**JORDAN**: The efficiency gains are really the underlying theme of this transformation story, Alex. They delivered positive operating leverage for the second straight year - not just at the firm level but in every single business. Their efficiency ratio improved to 63% on an adjusted basis. Fraser was particularly excited about their AI adoption, with colleagues in 84 countries using their proprietary AI tools over 21 million times, with adoption now above 70%.

**ALEX**: Speaking of transformation, there was some significant regulatory news. The OCC terminated article 17 of their consent order in December, and Fraser mentioned that over 80% of their transformation programs are now at or near target state. This feels like a major milestone for Citi's multi-year remediation efforts.

**JORDAN**: Absolutely. And Fraser was pretty confident about completing the remaining work, though she was careful to note that timing ultimately lies with the regulators. The focus is now shifting from just risk and controls to using AI and automation to improve client experience while reducing expenses. They're starting with over 50 of their largest and most complex processes.

**ALEX**: Let's talk about the forward-looking guidance because this is where it gets interesting for investors. CFO Mark Mason provided some pretty specific expectations for 2026. They're guiding for net interest income excluding markets to grow 5-6%, driven by volume growth in cards and wealth, plus deposit growth in services and wealth.

**JORDAN**: Right, and they're targeting an efficiency ratio of around 60% for 2026 - that's moving from their previous target of "below 60%" to "around 60%," giving them flexibility to invest in growth. Mason was clear that 2026 is focused on delivering that 10-11% return on tangible common equity they've been targeting, but he emphasized that's just a waypoint, not the destination.

**ALEX**: One area that stood out in the Q&A was the discussion around capital returns. They repurchased over $13 billion in shares during 2025, including $4.5 billion in Q4. With a CET1 ratio of...]]>456falsefullhttps://www.spreaker.com/episode/boeing-q4-2025-earnings-analysis--70222811
JORDAN: There really is, Alex. But before we get into the nitty-gritty, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Absolutely. Now Jordan, let's start with the headline numbers because they're actually pretty impressive on the surface.

JORDAN: They really are! Boeing reported $23.9 billion in quarterly revenue – and get this – that's their highest quarterly total since 2018. Revenue was up a massive 57% year-over-year. For the full year, they hit $89.5 billion, up 34%.

ALEX: That's a significant turnaround. What's driving those numbers?

JORDAN: It's really a combination of higher commercial deliveries and better operational performance across the board. They delivered 600 commercial aircraft for the year – again, the most since 2018. The 737 MAX program delivered 447 planes, while the 787 contributed 88 deliveries.

ALEX: Now, the earnings picture gets a bit more complex, right? Because there's this big one-time gain in there.

JORDAN: Exactly. Core earnings per share came in at $9.92, but here's the thing – $11.83 of that was from selling their Digital Aviation Solutions business for about $10.6 billion. Strip that out, and you're looking at underlying operations that are still losing money, but improving significantly from the prior year.

ALEX: Let's talk about what CEO Kelly Ortberg had to say about their turnaround plan. He seems cautiously optimistic but realistic about the challenges ahead.

JORDAN: I thought his tone was really measured. He said "we haven't fully turned the corner, but we're making real progress." That feels honest – they're not overselling the recovery. He highlighted their four-point plan: stabilize the business, execute on development programs, change the culture, and build for the future.

ALEX: Speaking of those development programs, there's some movement on the certification front for their delayed aircraft, right?

JORDAN: Yes, but it's a mixed bag. The 737-10 got approval for its final phase of certification flight testing, which is progress. They still expect both the 737-7 and 737-10 to get certified in 2026. For the 777X, they're sticking with first delivery in 2027, though they did mention a potential engine durability issue they're working through with GE.

ALEX: Now let's get to what investors are probably most interested in – the cash flow situation. This has been Boeing's Achilles' heel for years.

JORDAN: This is where it gets really interesting. They generated positive free cash flow of $375 million in Q4 and used $1.9 billion for the full year – but that was actually better than expected. More importantly, CFO Jay Mollave guided to positive free cash flow of $1 billion to $3 billion for 2026.

ALEX: But there are a lot of moving parts affecting that cash flow, aren't there?

JORDAN: Oh absolutely. Mollave walked through what he called "legacy issues" that are weighing on cash flow. The biggest one is the 777X program, which won't start delivering until 2027, so they're spending cash to build planes but not getting the full payment from customers yet. He said that program alone will be a higher cash use in 2026 than 2025.

ALEX: And then there are these "customer considerations" – essentially compensation for past delivery delays.

JORDAN: Right, and "excess advances" where they've already taken customer cash for planes they haven't delivered yet. These are both legacies of the production problems and MAX grounding from years past. Mollave said when you adjust for all these temporary issues, the underlying b

This episode includes AI-generated content.]]>SP100-BA-Q4-2025-enMon, 23 Feb 2026 09:13:16 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Boeing's Q4 2025 earnings, which just dropped, and wow – there's a lot to unpack here. JORDAN: There really is,...
JORDAN: There really is, Alex. But before we get into the nitty-gritty, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Absolutely. Now Jordan, let's start with the headline numbers because they're actually pretty impressive on the surface.

JORDAN: They really are! Boeing reported $23.9 billion in quarterly revenue – and get this – that's their highest quarterly total since 2018. Revenue was up a massive 57% year-over-year. For the full year, they hit $89.5 billion, up 34%.

ALEX: That's a significant turnaround. What's driving those numbers?

JORDAN: It's really a combination of higher commercial deliveries and better operational performance across the board. They delivered 600 commercial aircraft for the year – again, the most since 2018. The 737 MAX program delivered 447 planes, while the 787 contributed 88 deliveries.

ALEX: Now, the earnings picture gets a bit more complex, right? Because there's this big one-time gain in there.

JORDAN: Exactly. Core earnings per share came in at $9.92, but here's the thing – $11.83 of that was from selling their Digital Aviation Solutions business for about $10.6 billion. Strip that out, and you're looking at underlying operations that are still losing money, but improving significantly from the prior year.

ALEX: Let's talk about what CEO Kelly Ortberg had to say about their turnaround plan. He seems cautiously optimistic but realistic about the challenges ahead.

JORDAN: I thought his tone was really measured. He said "we haven't fully turned the corner, but we're making real progress." That feels honest – they're not overselling the recovery. He highlighted their four-point plan: stabilize the business, execute on development programs, change the culture, and build for the future.

ALEX: Speaking of those development programs, there's some movement on the certification front for their delayed aircraft, right?

JORDAN: Yes, but it's a mixed bag. The 737-10 got approval for its final phase of certification flight testing, which is progress. They still expect both the 737-7 and 737-10 to get certified in 2026. For the 777X, they're sticking with first delivery in 2027, though they did mention a potential engine durability issue they're working through with GE.

ALEX: Now let's get to what investors are probably most interested in – the cash flow situation. This has been Boeing's Achilles' heel for years.

JORDAN: This is where it gets really interesting. They generated positive free cash flow of $375 million in Q4 and used $1.9 billion for the full year – but that was actually better than expected. More importantly, CFO Jay Mollave guided to positive free cash flow of $1 billion to $3 billion for 2026.

ALEX: But there are a lot of moving parts affecting that cash flow, aren't there?

JORDAN: Oh absolutely. Mollave walked through what he called "legacy issues" that are weighing on cash flow. The biggest one is the 777X program, which won't start delivering until 2027, so they're spending cash to build planes but not getting the full payment from customers yet. He said that program alone will be a higher cash use in 2026 than 2025.

ALEX: And then there are these "customer considerations" – essentially compensation for past delivery delays.

JORDAN: Right, and "excess advances" where they've already taken customer cash for planes they haven't...]]>513falsefullhttps://www.spreaker.com/episode/abbott-q4-2025-earnings-analysis--70222809
---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Abbott's fourth quarter 2025 results, and folks, there's quite a story here.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Abbott just reported their Q4 numbers, and CEO Robert Ford had some interesting things to say about the year ahead. What caught your attention first?

**JORDAN:** Alex, the headline numbers tell a tale of two companies, honestly. On one hand, you've got Abbott delivering on their original double-digit EPS growth target with adjusted earnings per share hitting $1.50 – that's 12% growth year-over-year. But then there's this nutrition business headwind that's creating some near-term challenges.

**ALEX:** Right, and let's talk about that guidance because it's pretty telling. For 2026, Abbott is projecting organic sales growth of 6.5% to 7.5% – so 7% at the midpoint – and they're calling for 10% growth in adjusted EPS. That EPS growth is solid, but that revenue guidance seems a bit more cautious than what some were expecting.

**JORDAN:** Exactly, and Ford was pretty transparent about why. The nutrition business is essentially going through what he called a "transition back to a more sustainable volume-driven business." Here's what's fascinating – Abbott has been raising prices to offset post-pandemic commodity cost increases, but now those higher prices are actually suppressing demand as consumers become more price-sensitive.

**ALEX:** It's like a classic consumer goods dilemma, right? You raise prices to maintain margins, but eventually you price yourself out of volume growth. Ford mentioned they started implementing "price and promotion initiatives" in Q4 to try to reignite volume growth. How big of an impact is this having on the overall company?

**JORDAN:** Well, nutrition is a meaningful piece of Abbott's portfolio, but what I found encouraging is how Ford framed the rest of the business. He said a "significant majority of the company" is either maintaining high single-digit growth or actually accelerating. The medical devices segment, for example, grew 10.5% in the quarter.

**ALEX:** And that medical devices growth is really impressive when you dig into the details. Continuous glucose monitors grew 17% for the full year, exceeding $7.5 billion in sales. That's the third consecutive year their CGM business has grown by more than a billion dollars. Jordan, when an analyst asked about CGM growth expectations, Ford had a pretty confident response.

**JORDAN:** He did! Ford pushed back on the narrative that the CGM market is slowing down, saying "I don't consider growing a billion dollars every single year and doing it four years in a row to be slowing down." He sees continued penetration opportunities across all patient groups – intensive insulin users, basal insulin users, and non-insulin users. Plus, there's potential for expanded reimbursement coverage for non-insulin Type 2 diabetes patients.

**ALEX:** Speaking of new products, Abbott got FDA approval for their BOLT PFA catheter in December and CE Mark approval for their Tactiflex Duo ablation catheter. Ford seemed pretty excited about their electrophysiology portfolio positioning.

**JORDAN:** Absolutely. He made this great point about how three years ago, there were concerns that Abbott's EP franchise would struggle without PFA technology, but they've maintained double-digit growth even without those products. Now with Volt launching in the US and Tactiflex Duo internationally, Ford said "I do

This episode includes AI-generated content.]]>SP100-ABT-Q4-2025-enMon, 23 Feb 2026 09:13:05 +0000trueBeta Finch**Beta Finch Podcast Script: Abbott Laboratories Q4 2025 Earnings** --- **ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host...
---

**ALEX:** Welcome back to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Abbott's fourth quarter 2025 results, and folks, there's quite a story here.

Before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Abbott just reported their Q4 numbers, and CEO Robert Ford had some interesting things to say about the year ahead. What caught your attention first?

**JORDAN:** Alex, the headline numbers tell a tale of two companies, honestly. On one hand, you've got Abbott delivering on their original double-digit EPS growth target with adjusted earnings per share hitting $1.50 – that's 12% growth year-over-year. But then there's this nutrition business headwind that's creating some near-term challenges.

**ALEX:** Right, and let's talk about that guidance because it's pretty telling. For 2026, Abbott is projecting organic sales growth of 6.5% to 7.5% – so 7% at the midpoint – and they're calling for 10% growth in adjusted EPS. That EPS growth is solid, but that revenue guidance seems a bit more cautious than what some were expecting.

**JORDAN:** Exactly, and Ford was pretty transparent about why. The nutrition business is essentially going through what he called a "transition back to a more sustainable volume-driven business." Here's what's fascinating – Abbott has been raising prices to offset post-pandemic commodity cost increases, but now those higher prices are actually suppressing demand as consumers become more price-sensitive.

**ALEX:** It's like a classic consumer goods dilemma, right? You raise prices to maintain margins, but eventually you price yourself out of volume growth. Ford mentioned they started implementing "price and promotion initiatives" in Q4 to try to reignite volume growth. How big of an impact is this having on the overall company?

**JORDAN:** Well, nutrition is a meaningful piece of Abbott's portfolio, but what I found encouraging is how Ford framed the rest of the business. He said a "significant majority of the company" is either maintaining high single-digit growth or actually accelerating. The medical devices segment, for example, grew 10.5% in the quarter.

**ALEX:** And that medical devices growth is really impressive when you dig into the details. Continuous glucose monitors grew 17% for the full year, exceeding $7.5 billion in sales. That's the third consecutive year their CGM business has grown by more than a billion dollars. Jordan, when an analyst asked about CGM growth expectations, Ford had a pretty confident response.

**JORDAN:** He did! Ford pushed back on the narrative that the CGM market is slowing down, saying "I don't consider growing a billion dollars every single year and doing it four years in a row to be slowing down." He sees continued penetration opportunities across all patient groups – intensive insulin users, basal insulin users, and non-insulin users. Plus, there's potential for expanded reimbursement coverage for non-insulin Type 2 diabetes patients.

**ALEX:** Speaking of new products, Abbott got FDA approval for their BOLT PFA catheter in December and CE Mark approval for their Tactiflex Duo ablation catheter. Ford seemed pretty excited about their electrophysiology portfolio positioning.

**JORDAN:** Absolutely. He made this great point about how three years ago, there were concerns that Abbott's EP franchise would struggle without PFA technology, but they've maintained...]]>506falsefullhttps://www.spreaker.com/episode/ups-q4-2025-earnings-analysis--70221670
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into UPS's Q4 2025 earnings call - and wow, there's a lot to unpack here.

But before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, this was quite the call. UPS is in the middle of what they're calling their "Amazon accelerated glide down" - essentially deliberately shrinking their network while trying to improve profitability. How'd they do in Q4?

JORDAN: Alex, the headline numbers actually look pretty solid considering they're in the middle of this massive transformation. Q4 revenue came in at $24.5 billion with operating profit of $2.9 billion - that's an 11.8% operating margin. For the full year 2025, they hit $88.7 billion in revenue with $8.7 billion in operating profit.

But here's what's really interesting - they exceeded their own internal expectations despite deliberately reducing Amazon volume by about 1 million pieces per day. That tells you something about the quality improvements they're seeing.

ALEX: Right, and that's the key theme here - this isn't just about getting smaller, it's about getting more profitable per package. What stood out to you in terms of revenue quality improvements?

JORDAN: The numbers are actually quite impressive. U.S. revenue per piece grew 7.1% year-over-year, and in Q4 specifically it jumped 8.3% - that's their strongest fourth quarter revenue per piece growth in four years. They're also seeing their customer mix improve dramatically. Small and medium business penetration hit 31.8% of total volume, and B2B grew to 42.3% - both record highs.

CEO Carol Tomé made a point of saying this isn't a "shrink-the-company strategy" but rather growing in the best parts of the market. They're essentially trading low-margin Amazon volume for higher-margin enterprise and SMB business.

ALEX: Let's talk about the costs though, because this transformation isn't free. They took some pretty significant charges this quarter, right?

JORDAN: Absolutely. They took a $137 million after-tax write-off for their MD-11 aircraft fleet - they're accelerating the retirement of these older, less efficient planes and replacing them with newer Boeing 767s. CFO Brian Dykes mentioned they had about $50 million in incremental lease costs in Q4 just to replace that capacity, and that'll roughly double in 2026.

They also delivered $3.5 billion in savings from network reconfiguration - they closed 93 buildings in the U.S., removed 26.9 million labor hours, and cut 48,000 positions. It's a massive operational overhaul.

ALEX: Now, one of the most interesting developments was around their economy product called "Groundsaver." They're basically handing some of that delivery back to the U.S. Postal Service. What's the story there?

JORDAN: This is actually a reversal of something they did previously. UPS had been doing more of this economy delivery in-house, which was costing them big - we're talking about $400-500 million in headwinds in 2025. Now they're going back to having USPS handle the final mile for some of these packages, which should improve their economics significantly.

Brian Dykes said they expect to see benefits start materializing in the second half of 2026, though the full benefit might not come until 2027. They're using what they call "density matching technology" to decide which packages UPS delivers versus which ones go to USPS.

ALEX: Let's talk guidance because 2026 sounds like it's going to be a tale of two halves. What are they expecting?

JORDAN: Exactly right, Alex. For full year 2026, they're guiding to about $89.7 billi

This episode includes AI-generated content.]]>SP100-UPS-Q4-2025-enMon, 23 Feb 2026 07:35:27 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into UPS's Q4 2025 earnings call - and...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the numbers that move markets. I'm Alex, and joining me as always is Jordan. Today we're diving into UPS's Q4 2025 earnings call - and wow, there's a lot to unpack here.

But before we get started, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, this was quite the call. UPS is in the middle of what they're calling their "Amazon accelerated glide down" - essentially deliberately shrinking their network while trying to improve profitability. How'd they do in Q4?

JORDAN: Alex, the headline numbers actually look pretty solid considering they're in the middle of this massive transformation. Q4 revenue came in at $24.5 billion with operating profit of $2.9 billion - that's an 11.8% operating margin. For the full year 2025, they hit $88.7 billion in revenue with $8.7 billion in operating profit.

But here's what's really interesting - they exceeded their own internal expectations despite deliberately reducing Amazon volume by about 1 million pieces per day. That tells you something about the quality improvements they're seeing.

ALEX: Right, and that's the key theme here - this isn't just about getting smaller, it's about getting more profitable per package. What stood out to you in terms of revenue quality improvements?

JORDAN: The numbers are actually quite impressive. U.S. revenue per piece grew 7.1% year-over-year, and in Q4 specifically it jumped 8.3% - that's their strongest fourth quarter revenue per piece growth in four years. They're also seeing their customer mix improve dramatically. Small and medium business penetration hit 31.8% of total volume, and B2B grew to 42.3% - both record highs.

CEO Carol Tomé made a point of saying this isn't a "shrink-the-company strategy" but rather growing in the best parts of the market. They're essentially trading low-margin Amazon volume for higher-margin enterprise and SMB business.

ALEX: Let's talk about the costs though, because this transformation isn't free. They took some pretty significant charges this quarter, right?

JORDAN: Absolutely. They took a $137 million after-tax write-off for their MD-11 aircraft fleet - they're accelerating the retirement of these older, less efficient planes and replacing them with newer Boeing 767s. CFO Brian Dykes mentioned they had about $50 million in incremental lease costs in Q4 just to replace that capacity, and that'll roughly double in 2026.

They also delivered $3.5 billion in savings from network reconfiguration - they closed 93 buildings in the U.S., removed 26.9 million labor hours, and cut 48,000 positions. It's a massive operational overhaul.

ALEX: Now, one of the most interesting developments was around their economy product called "Groundsaver." They're basically handing some of that delivery back to the U.S. Postal Service. What's the story there?

JORDAN: This is actually a reversal of something they did previously. UPS had been doing more of this economy delivery in-house, which was costing them big - we're talking about $400-500 million in headwinds in 2025. Now they're going back to having USPS handle the final mile for some of these packages, which should improve their economics significantly.

Brian Dykes said they expect to see benefits start materializing in the second half of 2026, though the full benefit might not come until 2027. They're using what they call "density matching technology" to decide which packages UPS delivers versus which ones go to USPS.

ALEX: Let's talk guidance because...]]>526falsefullhttps://www.spreaker.com/episode/bofa-q4-2025-earnings-analysis--70221668
JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q4 2025 results, which came out this morning with some pretty solid numbers.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now, let's talk about these results. Bank of America delivered $7.6 billion in net income for Q4, which is up 12% year-over-year. Earnings per share came in at 98 cents, up a whopping 18% from last year.

ALEX: That's a strong finish to 2025. What really caught my attention was the revenue growth - 7% year-over-year, led by net interest income jumping 10% to $15.9 billion. And get this - they delivered 330 basis points of operating leverage in the quarter.

JORDAN: Operating leverage is really the name of the game for banks right now, and Bank of America seems to be executing well on that front. CEO Brian Moynihan highlighted that they kept headcount flat across the entire year despite growing client activity and volumes. That's impressive discipline.

ALEX: Let's break down some of the key drivers. Loan growth was robust at 8% year-over-year, and deposits grew 3%. Both of those outpaced industry averages. What's interesting is they're seeing growth across all their business segments.

JORDAN: Right, and looking at the deposit story - this has been a challenge across the industry post-pandemic. But Bank of America actually added 680,000 new consumer checking accounts during the year while maintaining an average balance of over $9,000. That's 28 consecutive quarters of net growth, or seven straight years.

ALEX: That's remarkable consistency. Now, let's talk about their outlook because this is where it gets really interesting. CFO Alastair Borthwick reiterated their guidance for 5% to 7% net interest income growth in 2026.

JORDAN: And here's why that's significant - they have about $12 to $15 billion in mortgage-backed securities and mortgage loans rolling off each quarter in 2026. These will be replaced with new assets yielding 150 to 200 basis points higher. That's essentially free money dropping to the bottom line.

ALEX: The asset repricing story is huge for Bank of America. They've been positioned for rising rates, but even in a declining rate environment, they're benefiting from this roll-off dynamic. Speaking of rates, how are they thinking about sensitivity?

JORDAN: Good question. They said that if rates dropped another 100 basis points instantly, NII would decline by about $2 billion over 12 months. But if rates went up 100 basis points, they'd benefit by around $700 million. So they're still somewhat asset-sensitive, but much less than before.

ALEX: Let's talk about their business segments. Consumer Banking continues to be a profit machine with a 28% return on allocated capital and what looks like around a 50% profit margin.

JORDAN: And Wealth Management is really hitting its stride. Net income grew from $1 billion in Q2 to $1.4 billion in Q4, with the return on allocated capital jumping from 20% to 28%. They added $500 billion in client balances across the year to reach $4.8 trillion total.

ALEX: Global Markets had another strong quarter too - their 15th consecutive quarter of improvement in sales and trading, generating nearly $21 billion in revenue for the full year. That's a record.

JORDAN: What I found fascinating in the Q&A was the discussion around technology and AI investments. Moynihan mentioned they have 18,000 people coding at the company, and AI has already taken 30% out of the coding process, saving them about 2,000 people equivalent in productivity.

ALEX: That's the kind of operational efficiency that drives long-term competitive advantages. They're spending s

This episode includes AI-generated content.]]>SP100-BAC-Q4-2025-enMon, 23 Feb 2026 07:35:22 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q4 2025 results, which came out this morning with some pretty solid numbers. ALEX: Before we get started, I...
JORDAN: And I'm Jordan. Today we're diving into Bank of America's Q4 2025 results, which came out this morning with some pretty solid numbers.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now, let's talk about these results. Bank of America delivered $7.6 billion in net income for Q4, which is up 12% year-over-year. Earnings per share came in at 98 cents, up a whopping 18% from last year.

ALEX: That's a strong finish to 2025. What really caught my attention was the revenue growth - 7% year-over-year, led by net interest income jumping 10% to $15.9 billion. And get this - they delivered 330 basis points of operating leverage in the quarter.

JORDAN: Operating leverage is really the name of the game for banks right now, and Bank of America seems to be executing well on that front. CEO Brian Moynihan highlighted that they kept headcount flat across the entire year despite growing client activity and volumes. That's impressive discipline.

ALEX: Let's break down some of the key drivers. Loan growth was robust at 8% year-over-year, and deposits grew 3%. Both of those outpaced industry averages. What's interesting is they're seeing growth across all their business segments.

JORDAN: Right, and looking at the deposit story - this has been a challenge across the industry post-pandemic. But Bank of America actually added 680,000 new consumer checking accounts during the year while maintaining an average balance of over $9,000. That's 28 consecutive quarters of net growth, or seven straight years.

ALEX: That's remarkable consistency. Now, let's talk about their outlook because this is where it gets really interesting. CFO Alastair Borthwick reiterated their guidance for 5% to 7% net interest income growth in 2026.

JORDAN: And here's why that's significant - they have about $12 to $15 billion in mortgage-backed securities and mortgage loans rolling off each quarter in 2026. These will be replaced with new assets yielding 150 to 200 basis points higher. That's essentially free money dropping to the bottom line.

ALEX: The asset repricing story is huge for Bank of America. They've been positioned for rising rates, but even in a declining rate environment, they're benefiting from this roll-off dynamic. Speaking of rates, how are they thinking about sensitivity?

JORDAN: Good question. They said that if rates dropped another 100 basis points instantly, NII would decline by about $2 billion over 12 months. But if rates went up 100 basis points, they'd benefit by around $700 million. So they're still somewhat asset-sensitive, but much less than before.

ALEX: Let's talk about their business segments. Consumer Banking continues to be a profit machine with a 28% return on allocated capital and what looks like around a 50% profit margin.

JORDAN: And Wealth Management is really hitting its stride. Net income grew from $1 billion in Q2 to $1.4 billion in Q4, with the return on allocated capital jumping from 20% to 28%. They added $500 billion in client balances across the year to reach $4.8 trillion total.

ALEX: Global Markets had another strong quarter too - their 15th consecutive quarter of improvement in sales and trading, generating nearly $21 billion in revenue for the full year. That's a record.

JORDAN: What I found fascinating in the Q&A was the discussion around technology and AI investments. Moynihan mentioned they have 18,000 people coding at the company, and AI has already taken 30% out of the coding process, saving them about...]]>474falsefullhttps://www.spreaker.com/episode/mondelez-q4-2025-earnings-analysis--70220801
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense quarterly reports into digestible insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Mondelez International's Q4 2025 earnings call - that's the snacking giant behind brands like Oreo, Cadbury, and Trident gum.

**ALEX:** Before we dig in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, this earnings call was fascinating because it was all about one commodity - cocoa. The chocolate world has been turned upside down.

**ALEX:** Right, and what a wild ride it's been! So Jordan, let's start with the big picture. What happened with cocoa prices?

**JORDAN:** Well, it's actually a tale of two stories. Throughout most of 2025, cocoa prices were sky-high due to supply issues in West Africa. Mondelez had to take significant price increases on their chocolate products. But then, in just the last couple weeks before this earnings call, cocoa spot prices absolutely cratered - we're talking about an unprecedented drop.

**ALEX:** And here's the kicker - Mondelez can't really benefit from these lower prices in 2026 because they're already hedged at the higher prices, right?

**JORDAN:** Exactly! CEO Dirk Van de Put was very clear about this. He said their cocoa coverage for 2026 is locked in at much higher costs than current market prices. In fact, CFO Luca Zaramella mentioned they're facing a massive one billion dollar inventory accounting expense in Q1 alone as they adjust their books to reflect these hedged costs.

**ALEX:** A billion dollars! That's going to be a significant hit to their first quarter profits. But let's talk about how this played out in different markets during 2025.

**JORDAN:** The performance was really mixed. Van de Put said that markets like India, Brazil, Australia, and South Africa held up well despite the price increases. About half of European markets performed as expected. But the northern European markets - Germany, UK, the Nordics - showed much higher price elasticity than they anticipated.

**ALEX:** Meaning consumers really pulled back when prices went up in those markets?

**JORDAN:** Exactly. And here's an interesting insight from the call - Van de Put said penetration didn't really decline, but frequency and quantity of purchases did. So people are still buying chocolate, just less often and in smaller amounts.

**ALEX:** That's a crucial distinction for investors to understand. Now, what's their strategy for 2026?

**JORDAN:** They're taking a multi-pronged approach. First, they're keeping chocolate pricing flat for 2026 - no more increases despite their higher hedged costs. Second, they're significantly ramping up advertising and brand investment, focusing specifically on getting consumers back to normal consumption patterns.

**ALEX:** And they mentioned some interesting innovation partnerships, didn't they?

**JORDAN:** Yes! The Biscoff collaboration was apparently very successful in 2025, and they're planning to take it "to the next level" in 2026. Van de Put seemed really excited about their innovation pipeline, particularly in Europe.

**ALEX:** Let's talk numbers. What's their guidance for 2026?

**JORDAN:** They're projecting organic sales growth of 0% to 2% for 2026. That's pretty conservative, and they admitted they built in flexibility because of uncertainty around how competitors might react to the cocoa price volatility.

**ALEX:** The emerging markets story seems more positive though.

**JORDAN:** Absolutely. Emerging markets finished 2025 with high single-digit growth, and they expect that momentum to continue. The challenge is really in devel

This episode includes AI-generated content.]]>SP100-MDLZ-Q4-2025-enMon, 23 Feb 2026 06:02:51 +0000trueBeta Finch**Beta Finch Podcast Script: Mondelez International Q4 2025 Earnings** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense quarterly reports into digestible insights. I'm Alex. **JORDAN:** And I'm Jordan....
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense quarterly reports into digestible insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Mondelez International's Q4 2025 earnings call - that's the snacking giant behind brands like Oreo, Cadbury, and Trident gum.

**ALEX:** Before we dig in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, this earnings call was fascinating because it was all about one commodity - cocoa. The chocolate world has been turned upside down.

**ALEX:** Right, and what a wild ride it's been! So Jordan, let's start with the big picture. What happened with cocoa prices?

**JORDAN:** Well, it's actually a tale of two stories. Throughout most of 2025, cocoa prices were sky-high due to supply issues in West Africa. Mondelez had to take significant price increases on their chocolate products. But then, in just the last couple weeks before this earnings call, cocoa spot prices absolutely cratered - we're talking about an unprecedented drop.

**ALEX:** And here's the kicker - Mondelez can't really benefit from these lower prices in 2026 because they're already hedged at the higher prices, right?

**JORDAN:** Exactly! CEO Dirk Van de Put was very clear about this. He said their cocoa coverage for 2026 is locked in at much higher costs than current market prices. In fact, CFO Luca Zaramella mentioned they're facing a massive one billion dollar inventory accounting expense in Q1 alone as they adjust their books to reflect these hedged costs.

**ALEX:** A billion dollars! That's going to be a significant hit to their first quarter profits. But let's talk about how this played out in different markets during 2025.

**JORDAN:** The performance was really mixed. Van de Put said that markets like India, Brazil, Australia, and South Africa held up well despite the price increases. About half of European markets performed as expected. But the northern European markets - Germany, UK, the Nordics - showed much higher price elasticity than they anticipated.

**ALEX:** Meaning consumers really pulled back when prices went up in those markets?

**JORDAN:** Exactly. And here's an interesting insight from the call - Van de Put said penetration didn't really decline, but frequency and quantity of purchases did. So people are still buying chocolate, just less often and in smaller amounts.

**ALEX:** That's a crucial distinction for investors to understand. Now, what's their strategy for 2026?

**JORDAN:** They're taking a multi-pronged approach. First, they're keeping chocolate pricing flat for 2026 - no more increases despite their higher hedged costs. Second, they're significantly ramping up advertising and brand investment, focusing specifically on getting consumers back to normal consumption patterns.

**ALEX:** And they mentioned some interesting innovation partnerships, didn't they?

**JORDAN:** Yes! The Biscoff collaboration was apparently very successful in 2025, and they're planning to take it "to the next level" in 2026. Van de Put seemed really excited about their innovation pipeline, particularly in Europe.

**ALEX:** Let's talk numbers. What's their guidance for 2026?

**JORDAN:** They're projecting organic sales growth of 0% to 2% for 2026. That's pretty conservative, and they admitted they built in flexibility because of uncertainty around how competitors might react to the cocoa price volatility.

**ALEX:** The emerging...]]>503falsefullhttps://www.spreaker.com/episode/starbucks-q1-2026-earnings-analysis--70220344
JORDAN: Absolutely, Alex. But before we get into the details, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk about what CEO Brian Niccol is calling the "Back to Starbucks" plan. The headline here is that they're finally seeing transaction-led growth again. Revenue hit $9.9 billion, up 5%, with global comparable store sales growing 4%.

JORDAN: What really caught my attention was the U.S. performance. They had 4% comp growth with 3% transaction growth - and this is the first time in eight quarters that their Starbucks Rewards transactions grew year-over-year. That's huge because it means people are actually coming back to the stores more frequently.

ALEX: Right, and it wasn't just rewards members. Non-rewards customers grew transactions even faster than rewards members. Niccol made a point about this - he said when he first arrived, non-rewards customers had been declining consistently, which is never healthy for a business.

JORDAN: The interesting thing is how they're driving this growth. It's not through discounting - they specifically mentioned that value perception scores held strong paired with average ticket growth. They're creating value through what they call the "Green Apron service model" and menu innovation, not price cuts.

ALEX: Let's talk about that Green Apron model because it seems to be the foundation of everything. Essentially, they've invested heavily in labor - bigger rosters, better training, new customer service standards. CFO Catherine Smith mentioned they're anniversarying these investments by Q4, which should help margins going forward.

JORDAN: The proof is in the pudding too. Those 650 pilot stores that got the full Green Apron treatment are still outperforming the rest of the fleet by about 200 basis points in comp growth. And get this - they're hitting their four-minute service targets even with meaningful transaction growth. That's operational excellence.

ALEX: Now, the earnings picture is more complicated. EPS came in at $0.56, down 19% year-over-year. Operating margins contracted 180 basis points to 10.1%. But management is basically saying "top line first, then earnings will follow."

JORDAN: Exactly. And they're not just hoping margins improve - they have a concrete plan. Niccol announced a $2 billion cost efficiency program over the next two years covering procurement, technology, and general administrative functions. Plus, they expect coffee prices and tariff pressures to peak in Q2 and find relief in the back half of the year.

ALEX: The guidance for fiscal 2026 reflects this cautious optimism. They're projecting 3% or better global comp sales growth, but EPS guidance of $2.15 to $2.40 is pretty wide. When an analyst asked about scenarios for the high and low end, Niccol basically said it comes down to maintaining comp performance.

JORDAN: Speaking of guidance, there's a big strategic shift happening in China. They're forming a joint venture with Boyu Capital where Boyu gets up to 60% of retail operations and Starbucks keeps 40% plus the brand and IP licensing. This could be about 40 basis points accretive to consolidated margins annually.

ALEX: That China move is fascinating because it shows they're willing to give up control for better local execution. China had 7% comp growth in Q1 - their third consecutive quarter of growth. Sometimes the best strategy is partnering with someone who knows the market better.

JORDAN: One thing I loved from the Q&A was when they talked about the afternoon opp

This episode includes AI-generated content.]]>SP100-SBUX-Q1-2026-enMon, 23 Feb 2026 04:55:35 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Starbucks' first quarter 2026 results. Jordan, this feels like a real turnaround story unfolding. JORDAN: Absolutely, Alex....
JORDAN: Absolutely, Alex. But before we get into the details, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that, Jordan. Now, let's talk about what CEO Brian Niccol is calling the "Back to Starbucks" plan. The headline here is that they're finally seeing transaction-led growth again. Revenue hit $9.9 billion, up 5%, with global comparable store sales growing 4%.

JORDAN: What really caught my attention was the U.S. performance. They had 4% comp growth with 3% transaction growth - and this is the first time in eight quarters that their Starbucks Rewards transactions grew year-over-year. That's huge because it means people are actually coming back to the stores more frequently.

ALEX: Right, and it wasn't just rewards members. Non-rewards customers grew transactions even faster than rewards members. Niccol made a point about this - he said when he first arrived, non-rewards customers had been declining consistently, which is never healthy for a business.

JORDAN: The interesting thing is how they're driving this growth. It's not through discounting - they specifically mentioned that value perception scores held strong paired with average ticket growth. They're creating value through what they call the "Green Apron service model" and menu innovation, not price cuts.

ALEX: Let's talk about that Green Apron model because it seems to be the foundation of everything. Essentially, they've invested heavily in labor - bigger rosters, better training, new customer service standards. CFO Catherine Smith mentioned they're anniversarying these investments by Q4, which should help margins going forward.

JORDAN: The proof is in the pudding too. Those 650 pilot stores that got the full Green Apron treatment are still outperforming the rest of the fleet by about 200 basis points in comp growth. And get this - they're hitting their four-minute service targets even with meaningful transaction growth. That's operational excellence.

ALEX: Now, the earnings picture is more complicated. EPS came in at $0.56, down 19% year-over-year. Operating margins contracted 180 basis points to 10.1%. But management is basically saying "top line first, then earnings will follow."

JORDAN: Exactly. And they're not just hoping margins improve - they have a concrete plan. Niccol announced a $2 billion cost efficiency program over the next two years covering procurement, technology, and general administrative functions. Plus, they expect coffee prices and tariff pressures to peak in Q2 and find relief in the back half of the year.

ALEX: The guidance for fiscal 2026 reflects this cautious optimism. They're projecting 3% or better global comp sales growth, but EPS guidance of $2.15 to $2.40 is pretty wide. When an analyst asked about scenarios for the high and low end, Niccol basically said it comes down to maintaining comp performance.

JORDAN: Speaking of guidance, there's a big strategic shift happening in China. They're forming a joint venture with Boyu Capital where Boyu gets up to 60% of retail operations and Starbucks keeps 40% plus the brand and IP licensing. This could be about 40 basis points accretive to consolidated margins annually.

ALEX: That China move is fascinating because it shows they're willing to give up control for better local execution. China had 7% comp growth in Q1 - their third consecutive quarter of growth. Sometimes the best strategy is partnering...]]>452falsefullhttps://www.spreaker.com/episode/qualcomm-q1-2026-earnings-analysis--70220343
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Qualcomm's first quarter 2026 results, and wow, this one's a bit of a tale of two cities.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. So Alex, let's start with the headline numbers because they're pretty impressive on the surface.

**ALEX**: They really are. Qualcomm delivered record-breaking results - $12.3 billion in revenue and $3.50 in non-GAAP earnings per share. Both numbers hit records, with EPS coming in at the high end of their guidance range.

**JORDAN**: The breakdown is interesting too. Their chip business, QCT, hit a record $10.6 billion, while their licensing division QTL brought in $1.6 billion. But here's where it gets complicated - they're guiding down significantly for next quarter.

**ALEX**: Right, and that's the big story here. For Q2, they're forecasting total revenue of $10.2 to $11 billion, which at the midpoint represents a pretty substantial sequential decline. The handset business specifically is expected to drop from $7.8 billion to about $6 billion.

**JORDAN**: And the reason? It's all about memory shortages. CEO Cristiano Amon was very clear about this - the AI data center boom is sucking up all the high-bandwidth memory, leaving smartphone makers scrambling for DRAM.

**ALEX**: Let me read you what Amon said because it really captures the situation: "As memory suppliers redirect manufacturing capacity to HBM to meet AI data center demand, the resulting industry-wide memory shortage and price increases are likely to define the overall scale of the handset industry through the fiscal year."

**JORDAN**: It's fascinating how the AI boom is creating these ripple effects. Chinese smartphone makers in particular are being cautious, reducing their chipset inventory because they can't get enough memory to build phones.

**ALEX**: But here's what's interesting - Qualcomm is emphasizing this isn't a demand problem. Consumer appetite for premium smartphones remains strong. It's purely a supply constraint. CFO Akash Palkhiwala mentioned they saw handset units exceeding expectations in December, especially in the premium tier.

**JORDAN**: That's a crucial distinction for investors. If this were a demand issue, you'd be worried about long-term market trends. But supply constraints, while painful in the near term, typically resolve themselves.

**ALEX**: Speaking of the premium tier, Qualcomm dropped some interesting details about their market position. They're expecting about 75% share of Samsung's upcoming premium devices, which is consistent with prior expectations. And they highlighted this interesting "dual flagship" strategy where OEMs are launching multiple premium tiers.

**JORDAN**: The automotive story continues to be a bright spot. They hit another record with $1.1 billion in automotive revenue, up 15% year-over-year, and they're guiding for even stronger growth - greater than 35% year-over-year growth in Q2.

**ALEX**: The Volkswagen Group partnership announcement is huge. This isn't just about infotainment systems - Qualcomm would serve as the primary technology provider for VW's software-defined vehicle architecture, including their joint venture with Rivian. That's Audi, Porsche, the whole VW ecosystem.

**JORDAN**: And they're expanding into new territories. The robotics announcement caught my attention - they're launching a full suite of robotics technologies with the Dragon Wing IQ 10 series. They're already working with companies like

This episode includes AI-generated content.]]>SP100-QCOM-Q1-2026-enMon, 23 Feb 2026 04:55:29 +0000trueBeta Finch**Beta Finch Podcast Script: Qualcomm Q1 2026 Earnings** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex. **JORDAN**: And I'm...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into conversations you can actually follow. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Qualcomm's first quarter 2026 results, and wow, this one's a bit of a tale of two cities.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. So Alex, let's start with the headline numbers because they're pretty impressive on the surface.

**ALEX**: They really are. Qualcomm delivered record-breaking results - $12.3 billion in revenue and $3.50 in non-GAAP earnings per share. Both numbers hit records, with EPS coming in at the high end of their guidance range.

**JORDAN**: The breakdown is interesting too. Their chip business, QCT, hit a record $10.6 billion, while their licensing division QTL brought in $1.6 billion. But here's where it gets complicated - they're guiding down significantly for next quarter.

**ALEX**: Right, and that's the big story here. For Q2, they're forecasting total revenue of $10.2 to $11 billion, which at the midpoint represents a pretty substantial sequential decline. The handset business specifically is expected to drop from $7.8 billion to about $6 billion.

**JORDAN**: And the reason? It's all about memory shortages. CEO Cristiano Amon was very clear about this - the AI data center boom is sucking up all the high-bandwidth memory, leaving smartphone makers scrambling for DRAM.

**ALEX**: Let me read you what Amon said because it really captures the situation: "As memory suppliers redirect manufacturing capacity to HBM to meet AI data center demand, the resulting industry-wide memory shortage and price increases are likely to define the overall scale of the handset industry through the fiscal year."

**JORDAN**: It's fascinating how the AI boom is creating these ripple effects. Chinese smartphone makers in particular are being cautious, reducing their chipset inventory because they can't get enough memory to build phones.

**ALEX**: But here's what's interesting - Qualcomm is emphasizing this isn't a demand problem. Consumer appetite for premium smartphones remains strong. It's purely a supply constraint. CFO Akash Palkhiwala mentioned they saw handset units exceeding expectations in December, especially in the premium tier.

**JORDAN**: That's a crucial distinction for investors. If this were a demand issue, you'd be worried about long-term market trends. But supply constraints, while painful in the near term, typically resolve themselves.

**ALEX**: Speaking of the premium tier, Qualcomm dropped some interesting details about their market position. They're expecting about 75% share of Samsung's upcoming premium devices, which is consistent with prior expectations. And they highlighted this interesting "dual flagship" strategy where OEMs are launching multiple premium tiers.

**JORDAN**: The automotive story continues to be a bright spot. They hit another record with $1.1 billion in automotive revenue, up 15% year-over-year, and they're guiding for even stronger growth - greater than 35% year-over-year growth in Q2.

**ALEX**: The Volkswagen Group partnership announcement is huge. This isn't just about infotainment systems - Qualcomm would serve as the primary technology provider for VW's software-defined vehicle architecture, including their joint venture with Rivian. That's Audi, Porsche, the whole VW ecosystem.

**JORDAN**: And they're expanding into new territories. The...]]>512falsefullhttps://www.spreaker.com/episode/boston-scientific-q4-2025-earnings-analysis--70219555
JORDAN: And I'm Jordan. Today we're diving into Boston Scientific's fourth quarter and full year 2025 results - and wow, what a year it's been for this medical device giant.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, Boston Scientific just wrapped up what CEO Mike Mahoney called an "outstanding" year. Let's start with the headline numbers - they're pretty impressive.

ALEX: They really are. For the full year, Boston Scientific hit over $20 billion in sales - that's 19% operational growth and nearly 16% organic growth. They actually exceeded their guidance of around 15.5%. And on the bottom line? Adjusted earnings per share of $3.06, up 22% year-over-year.

JORDAN: That's their third consecutive year of 20%+ EPS growth, which is remarkable consistency in this industry. But what I found interesting was the fourth quarter specifically - 13% organic growth, which hit the high end of their guidance range. The question is, what's driving all this growth?

ALEX: Two words: EP and WATCHMAN. Their electrophysiology business grew 35% in Q4 and a staggering 73% for the full year. That's largely driven by their FARAPULSE technology - basically a next-generation treatment for atrial fibrillation that uses pulsed field ablation instead of traditional methods.

JORDAN: And WATCHMAN, their left atrial appendage closure device, grew 29% in the quarter. Mike Mahoney mentioned they've now treated more than 25,000 patients with what they call "concomitant procedures" - essentially doing WATCHMAN and EP procedures together, which is more efficient for hospitals.

ALEX: But here's where it gets really interesting - and where some investors got a bit nervous during the earnings call. There were questions about whether growth is slowing, especially in the U.S. EP market. Some analysts were expecting even higher numbers.

JORDAN: Right, and Mahoney pushed back on this pretty hard. He said competitors are claiming the EP market grew 25% in Q4, but Boston Scientific thinks it was more like 18-20%. And even at that growth rate, they're significantly outpacing competitors - some major players only grew 6.5% and 12.5% respectively.

ALEX: That's a crucial point for investors. Market share dynamics are shifting as competitors launch their own PFA products, but Boston Scientific believes they'll maintain clear market leadership. Mahoney said by year-end 2026, their PFA share might equal all other competitors combined, but they'll still be the leader.

JORDAN: And looking ahead, they're guiding for some pretty solid numbers in 2026. Organic revenue growth of 10-11% for the full year, though Q1 will be softer at 8.5-10% due to some one-time headwinds and tough comparisons.

ALEX: Those headwinds include discontinuing a product called ACURATE and a temporary withdrawal of certain sizes of their AXIOS device due to manufacturing issues. But they expect both situations to resolve by mid-year.

JORDAN: Let's talk about what could be a game-changer - the CHAMPION trial results. This is a major clinical study comparing their WATCHMAN device to blood thinners for stroke prevention. Dr. Ken Stein, their Chief Medical Officer, said results will be presented at the American College of Cardiology conference.

ALEX: If positive, this could be huge. Currently, WATCHMAN is indicated for about 5 million patients globally who can't tolerate blood thinners. But if CHAMPION shows WATCHMAN is as effective as blood thinners with better bleeding outcomes, that addressable market could jump to 20 million patients.

JORDAN: That would essentially position WATCHMAN as a first-line therapy instead of just for patients who ca

This episode includes AI-generated content.]]>SP100-BSX-Q4-2025-enMon, 23 Feb 2026 03:15:02 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Boston Scientific's fourth quarter and full year 2025 results - and wow, what a year it's been for this medical device giant....
JORDAN: And I'm Jordan. Today we're diving into Boston Scientific's fourth quarter and full year 2025 results - and wow, what a year it's been for this medical device giant.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, Boston Scientific just wrapped up what CEO Mike Mahoney called an "outstanding" year. Let's start with the headline numbers - they're pretty impressive.

ALEX: They really are. For the full year, Boston Scientific hit over $20 billion in sales - that's 19% operational growth and nearly 16% organic growth. They actually exceeded their guidance of around 15.5%. And on the bottom line? Adjusted earnings per share of $3.06, up 22% year-over-year.

JORDAN: That's their third consecutive year of 20%+ EPS growth, which is remarkable consistency in this industry. But what I found interesting was the fourth quarter specifically - 13% organic growth, which hit the high end of their guidance range. The question is, what's driving all this growth?

ALEX: Two words: EP and WATCHMAN. Their electrophysiology business grew 35% in Q4 and a staggering 73% for the full year. That's largely driven by their FARAPULSE technology - basically a next-generation treatment for atrial fibrillation that uses pulsed field ablation instead of traditional methods.

JORDAN: And WATCHMAN, their left atrial appendage closure device, grew 29% in the quarter. Mike Mahoney mentioned they've now treated more than 25,000 patients with what they call "concomitant procedures" - essentially doing WATCHMAN and EP procedures together, which is more efficient for hospitals.

ALEX: But here's where it gets really interesting - and where some investors got a bit nervous during the earnings call. There were questions about whether growth is slowing, especially in the U.S. EP market. Some analysts were expecting even higher numbers.

JORDAN: Right, and Mahoney pushed back on this pretty hard. He said competitors are claiming the EP market grew 25% in Q4, but Boston Scientific thinks it was more like 18-20%. And even at that growth rate, they're significantly outpacing competitors - some major players only grew 6.5% and 12.5% respectively.

ALEX: That's a crucial point for investors. Market share dynamics are shifting as competitors launch their own PFA products, but Boston Scientific believes they'll maintain clear market leadership. Mahoney said by year-end 2026, their PFA share might equal all other competitors combined, but they'll still be the leader.

JORDAN: And looking ahead, they're guiding for some pretty solid numbers in 2026. Organic revenue growth of 10-11% for the full year, though Q1 will be softer at 8.5-10% due to some one-time headwinds and tough comparisons.

ALEX: Those headwinds include discontinuing a product called ACURATE and a temporary withdrawal of certain sizes of their AXIOS device due to manufacturing issues. But they expect both situations to resolve by mid-year.

JORDAN: Let's talk about what could be a game-changer - the CHAMPION trial results. This is a major clinical study comparing their WATCHMAN device to blood thinners for stroke prevention. Dr. Ken Stein, their Chief Medical Officer, said results will be presented at the American College of Cardiology conference.

ALEX: If positive, this could be huge. Currently, WATCHMAN is indicated for about 5 million patients globally who can't tolerate blood thinners. But if CHAMPION shows WATCHMAN is as effective as blood thinners with better bleeding outcomes, that addressable market...]]>522falsefullhttps://www.spreaker.com/episode/booking-holdings-q4-2025-earnings-analysis--70219553
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Booking Holdings' fourth quarter earnings call - and wow, what a quarter they had.

Before we get started though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of wow - Glenn Fogel just celebrated his 26th year at the company! That might make him the longest-tenured executive in tech. But beyond that milestone, Booking absolutely crushed their fourth quarter numbers.

**ALEX**: Let's break down those numbers, Jordan. Room nights hit 285 million - that's a 9% year-over-year increase that actually exceeded the high end of their expectations. And both gross bookings and revenue jumped 16%. What's driving this growth?

**JORDAN**: The strength is really coming from Asia and the U.S., both delivering low double-digit growth. What I found interesting is that the U.S. acceleration has been building all year - they went from low single-digit growth in the first half to low double-digit growth in Q4. That's a pretty impressive turnaround.

**ALEX**: And the profitability story is even better. Adjusted EBITDA reached $2.2 billion, up 19% year-over-year, with margins expanding 80 basis points to nearly 37%. A big driver here is their transformation program that launched in late 2024.

**JORDAN**: Right, and this transformation program is fascinating. They've already achieved $550 million in annual run-rate savings - hitting the high end of their guidance. CFO Ewout Steenbergen said they expect $500 to $550 million in additional in-year savings for 2026. That's serious operational efficiency.

**ALEX**: But here's what I love about their strategy - they're not just pocketing those savings. They're reinvesting about $700 million above baseline into strategic priorities like AI, their connected trip vision, and geographic expansion. It's classic reinvestment for growth.

**JORDAN**: Speaking of AI, Glenn Fogel had some really compelling commentary on this. He talked about how they've been using AI for over a decade, but now with generative AI, they're rolling out what he calls "agentic capabilities" across their platforms. And unlike a lot of companies that talk about AI but don't show results, Booking is actually seeing it in their P&L.

**ALEX**: That's a great point. Steenbergen specifically called out how their customer service costs are actually down year-over-year despite 10% booking growth. That's a roughly 10% decline in customer service cost per booking - real, measurable AI impact.

**JORDAN**: Now let's talk about their competitive moat, because there was a really interesting exchange about large language models potentially disrupting travel booking. An analyst asked about companies like ChatGPT potentially becoming travel agents.

**ALEX**: And Fogel's response was brilliant. He basically said - good luck with that! He pointed out that Booking works with over 4 million properties, processes 100+ payment methods across 50+ currencies, deals with regulations across 200+ countries, and has thousands of partner service people. That's not something you just replicate overnight.

**JORDAN**: Exactly. He compared it to their relationship with Google - Google captures demand at the top of the funnel through search, Booking handles the complex backend of actually completing transactions. Both companies have thrived in that relationship, and he sees a similar dynamic potentially playing out with AI companies.

**ALEX**: Let's touch on their loyalty program, Genius, because the numbers there are impressive. Level 2 and 3 Genius members now represent over 30% of their active base but account for a high

This episode includes AI-generated content.]]>SP100-BKNG-Q4-2025-enMon, 23 Feb 2026 03:14:57 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Booking Holdings' fourth quarter earnings call - and wow, what a quarter...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Booking Holdings' fourth quarter earnings call - and wow, what a quarter they had.

Before we get started though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of wow - Glenn Fogel just celebrated his 26th year at the company! That might make him the longest-tenured executive in tech. But beyond that milestone, Booking absolutely crushed their fourth quarter numbers.

**ALEX**: Let's break down those numbers, Jordan. Room nights hit 285 million - that's a 9% year-over-year increase that actually exceeded the high end of their expectations. And both gross bookings and revenue jumped 16%. What's driving this growth?

**JORDAN**: The strength is really coming from Asia and the U.S., both delivering low double-digit growth. What I found interesting is that the U.S. acceleration has been building all year - they went from low single-digit growth in the first half to low double-digit growth in Q4. That's a pretty impressive turnaround.

**ALEX**: And the profitability story is even better. Adjusted EBITDA reached $2.2 billion, up 19% year-over-year, with margins expanding 80 basis points to nearly 37%. A big driver here is their transformation program that launched in late 2024.

**JORDAN**: Right, and this transformation program is fascinating. They've already achieved $550 million in annual run-rate savings - hitting the high end of their guidance. CFO Ewout Steenbergen said they expect $500 to $550 million in additional in-year savings for 2026. That's serious operational efficiency.

**ALEX**: But here's what I love about their strategy - they're not just pocketing those savings. They're reinvesting about $700 million above baseline into strategic priorities like AI, their connected trip vision, and geographic expansion. It's classic reinvestment for growth.

**JORDAN**: Speaking of AI, Glenn Fogel had some really compelling commentary on this. He talked about how they've been using AI for over a decade, but now with generative AI, they're rolling out what he calls "agentic capabilities" across their platforms. And unlike a lot of companies that talk about AI but don't show results, Booking is actually seeing it in their P&L.

**ALEX**: That's a great point. Steenbergen specifically called out how their customer service costs are actually down year-over-year despite 10% booking growth. That's a roughly 10% decline in customer service cost per booking - real, measurable AI impact.

**JORDAN**: Now let's talk about their competitive moat, because there was a really interesting exchange about large language models potentially disrupting travel booking. An analyst asked about companies like ChatGPT potentially becoming travel agents.

**ALEX**: And Fogel's response was brilliant. He basically said - good luck with that! He pointed out that Booking works with over 4 million properties, processes 100+ payment methods across 50+ currencies, deals with regulations across 200+ countries, and has thousands of partner service people. That's not something you just replicate overnight.

**JORDAN**: Exactly. He compared it to their relationship with Google - Google captures demand at the top of the funnel through search, Booking handles the complex backend of actually completing transactions. Both companies have thrived in that relationship, and he sees a similar dynamic potentially playing out with AI companies.

**ALEX**: Let's touch on their loyalty...]]>508falsefullhttps://www.spreaker.com/episode/pfizer-q4-2025-earnings-analysis--70217743
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex.

**JORDAN**: And I'm Jordan. Before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. Today we're breaking down Pfizer's Q4 2025 earnings, and wow - this was a packed call. We've got solid financial performance, major obesity drug developments, and some really interesting strategic moves. Let's start with the numbers, Jordan.

**JORDAN**: The headline numbers tell a story of resilience, Alex. Pfizer posted $62.6 billion in full-year revenue versus $63.6 billion last year - that's a 2% operational decline. But here's the key detail: when you strip out their COVID products, they actually grew operational revenue by 6%.

**ALEX**: That's huge because it shows the underlying business is healthy. What about profitability?

**JORDAN**: Even better news there. Adjusted earnings per share came in at $3.22 versus $3.11 last year, beating expectations. They expanded gross margins to 76%, and their recently launched and acquired products - which is really their growth engine - delivered over $10 billion in revenue with 14% operational growth.

**ALEX**: Now, the elephant in the room with Pfizer has always been their COVID business decline. How bad was that impact in Q4?

**JORDAN**: Pretty significant. COVID products dropped about 40% operationally year-over-year in Q4. But Alex, this is actually old news at this point. What's more interesting is how well they're managing through it. Their non-COVID business grew 9% in the quarter, driven by products like Abrysvo, Eliquis, Prevnar, and the Vyndaqel family.

**ALEX**: Speaking of managing through challenges, they reaffirmed their 2026 guidance today. Walk us through what they're expecting.

**JORDAN**: They're guiding for $59.5 to $62.5 billion in revenue and $2.80 to $3.00 in adjusted EPS for 2026. What's notable is they're expecting COVID revenues to drop to about $5 billion, and they're anticipating $1.5 billion in revenue compression from generic competition. But even with those headwinds, they expect their core business excluding COVID and loss-of-exclusivity products to grow about 4% operationally.

**ALEX**: Now let's talk about the real headline from today's call - their obesity drug data. This feels like a potential game-changer, Jordan.

**JORDAN**: Absolutely, Alex. They announced results from their VESPER-3 study for PF-3944, which is their investigational obesity treatment. And the key differentiator here is that it's designed for monthly dosing instead of weekly like current GLP-1 drugs.

**ALEX**: Monthly dosing - that's a big deal for patient convenience. What kind of weight loss are we talking about?

**JORDAN**: The data showed 10-12% placebo-adjusted weight loss at 28 weeks for their planned phase 3 doses. But here's what's really interesting - their modeling suggests the higher dose they're planning could deliver nearly 16% weight loss. And importantly, they didn't see a weight loss plateau at 28 weeks, suggesting patients could lose even more weight over time.

**ALEX**: How does that stack up against what's already on the market?

**JORDAN**: It's competitive with existing weekly GLP-1s like Ozempic and Wegovy, but the monthly dosing is the real differentiator. During the Q&A, their commercial team emphasized that reducing from four injections per month to just one could be a major advantage for patient compliance and switching existing patients to their therapy.

**ALEX**: What about side effects? That's always a concern with these obesity drugs.

**JORDAN**: The safety prof

This episode includes AI-generated content.]]>SP100-PFE-Q4-2025-enSun, 22 Feb 2026 22:33:14 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex. **JORDAN**: And I'm Jordan. Before we...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex.

**JORDAN**: And I'm Jordan. Before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. Today we're breaking down Pfizer's Q4 2025 earnings, and wow - this was a packed call. We've got solid financial performance, major obesity drug developments, and some really interesting strategic moves. Let's start with the numbers, Jordan.

**JORDAN**: The headline numbers tell a story of resilience, Alex. Pfizer posted $62.6 billion in full-year revenue versus $63.6 billion last year - that's a 2% operational decline. But here's the key detail: when you strip out their COVID products, they actually grew operational revenue by 6%.

**ALEX**: That's huge because it shows the underlying business is healthy. What about profitability?

**JORDAN**: Even better news there. Adjusted earnings per share came in at $3.22 versus $3.11 last year, beating expectations. They expanded gross margins to 76%, and their recently launched and acquired products - which is really their growth engine - delivered over $10 billion in revenue with 14% operational growth.

**ALEX**: Now, the elephant in the room with Pfizer has always been their COVID business decline. How bad was that impact in Q4?

**JORDAN**: Pretty significant. COVID products dropped about 40% operationally year-over-year in Q4. But Alex, this is actually old news at this point. What's more interesting is how well they're managing through it. Their non-COVID business grew 9% in the quarter, driven by products like Abrysvo, Eliquis, Prevnar, and the Vyndaqel family.

**ALEX**: Speaking of managing through challenges, they reaffirmed their 2026 guidance today. Walk us through what they're expecting.

**JORDAN**: They're guiding for $59.5 to $62.5 billion in revenue and $2.80 to $3.00 in adjusted EPS for 2026. What's notable is they're expecting COVID revenues to drop to about $5 billion, and they're anticipating $1.5 billion in revenue compression from generic competition. But even with those headwinds, they expect their core business excluding COVID and loss-of-exclusivity products to grow about 4% operationally.

**ALEX**: Now let's talk about the real headline from today's call - their obesity drug data. This feels like a potential game-changer, Jordan.

**JORDAN**: Absolutely, Alex. They announced results from their VESPER-3 study for PF-3944, which is their investigational obesity treatment. And the key differentiator here is that it's designed for monthly dosing instead of weekly like current GLP-1 drugs.

**ALEX**: Monthly dosing - that's a big deal for patient convenience. What kind of weight loss are we talking about?

**JORDAN**: The data showed 10-12% placebo-adjusted weight loss at 28 weeks for their planned phase 3 doses. But here's what's really interesting - their modeling suggests the higher dose they're planning could deliver nearly 16% weight loss. And importantly, they didn't see a weight loss plateau at 28 weeks, suggesting patients could lose even more weight over time.

**ALEX**: How does that stack up against what's already on the market?

**JORDAN**: It's competitive with existing weekly GLP-1s like Ozempic and Wegovy, but the monthly dosing is the real differentiator. During the Q&A, their commercial team emphasized that reducing from four injections per month to just one could be a major advantage for patient...]]>84falsefullhttps://www.spreaker.com/episode/pfizer-q4-2024-earnings-analysis--70217742
JORDAN: Thanks Alex. And wow, what a call this was. Pfizer really came out swinging with some solid numbers and a pretty clear roadmap for 2025.

ALEX: Absolutely. Let's start with the headline numbers because they're actually pretty impressive. Pfizer delivered $63.6 billion in full-year revenue for 2024, which beat expectations. But here's what really caught my attention - if you strip out their COVID products, they saw 12% operational growth. That's above their own guidance of 9% to 11%.

JORDAN: That's a key point, Alex. The market has been so focused on Pfizer's post-COVID transition, and this shows they're actually executing well on the non-COVID business. Their adjusted earnings per share hit $3.11 for the full year, which was significantly ahead of expectations. And they're guiding for 2025 revenue between $61 billion to $64 billion.

ALEX: Right, and CEO Albert Bourla was pretty confident on the call. He said, and I'm paraphrasing here, "Pfizer knows how to execute well when we set our focus on something." He pointed to their COVID vaccine development, then Paxlovid, and now he's saying they're applying that same focused execution to R&D productivity.

JORDAN: Speaking of R&D, that was probably the biggest strategic story from this call. They've completely reorganized their research and development under Chris Boshoff into four focused units - oncology, vaccines, internal medicine, and inflammation & immunology. Boshoff said they want each unit to "operate with the focus and agility of a biotech company."

ALEX: That's fascinating because it suggests they're trying to move faster and be more decisive. And they're putting their money where their mouth is - they expect at least four regulatory decisions this year, up to nine Phase 3 readouts, and 13 potential pivotal program starts. Those are some pretty aggressive targets.

JORDAN: The oncology story is particularly compelling. Their Padcev drug, which they got from the Seagen acquisition, is already the number one prescribed first-line treatment for certain bladder cancers. And they've got potential data coming this year that could nearly triple the addressable patient population if it's successful.

ALEX: Let's talk about some of the individual products because there were some real standouts. Vyndaqel, their heart disease drug, grew 90% year-over-year in the U.S. That's just massive growth for a specialty drug.

JORDAN: And Nurtec, their migraine treatment, grew 36% with about 49% market share in its category. But I thought one of the most interesting exchanges was about their COVID business. An analyst asked about sustainability, and management was pretty confident that it's now a "predictable and durable" revenue stream.

ALEX: That's important because the street has been treating COVID revenues as this wild card. But Aamir Malik, who runs U.S. commercial, explained how Paxlovid usage directly tracks disease burden, and they've got multi-year international contracts. So it sounds like they've built a more stable foundation there.

JORDAN: The financial discipline story was also compelling. They returned $9.5 billion to shareholders through dividends, invested nearly $11 billion in R&D, and paid down $7.8 billion in debt. CFO Dave Denton said they now have capacity for $10 billion to $15 billion in business development deals in 2025 if they choose to pursue them.

ALEX: That's a lot of firepower. And when an analyst asked about their BD strategy, Andrew Baum, who oversees portfolio planning, said t

This episode includes AI-generated content.]]>SP100-PFE-Q4-2024-enSun, 22 Feb 2026 22:33:11 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Pfizer's Q4 2024 results that just dropped. Before we get started though, I need to mention that this podcast is AI-generated...
JORDAN: Thanks Alex. And wow, what a call this was. Pfizer really came out swinging with some solid numbers and a pretty clear roadmap for 2025.

ALEX: Absolutely. Let's start with the headline numbers because they're actually pretty impressive. Pfizer delivered $63.6 billion in full-year revenue for 2024, which beat expectations. But here's what really caught my attention - if you strip out their COVID products, they saw 12% operational growth. That's above their own guidance of 9% to 11%.

JORDAN: That's a key point, Alex. The market has been so focused on Pfizer's post-COVID transition, and this shows they're actually executing well on the non-COVID business. Their adjusted earnings per share hit $3.11 for the full year, which was significantly ahead of expectations. And they're guiding for 2025 revenue between $61 billion to $64 billion.

ALEX: Right, and CEO Albert Bourla was pretty confident on the call. He said, and I'm paraphrasing here, "Pfizer knows how to execute well when we set our focus on something." He pointed to their COVID vaccine development, then Paxlovid, and now he's saying they're applying that same focused execution to R&D productivity.

JORDAN: Speaking of R&D, that was probably the biggest strategic story from this call. They've completely reorganized their research and development under Chris Boshoff into four focused units - oncology, vaccines, internal medicine, and inflammation & immunology. Boshoff said they want each unit to "operate with the focus and agility of a biotech company."

ALEX: That's fascinating because it suggests they're trying to move faster and be more decisive. And they're putting their money where their mouth is - they expect at least four regulatory decisions this year, up to nine Phase 3 readouts, and 13 potential pivotal program starts. Those are some pretty aggressive targets.

JORDAN: The oncology story is particularly compelling. Their Padcev drug, which they got from the Seagen acquisition, is already the number one prescribed first-line treatment for certain bladder cancers. And they've got potential data coming this year that could nearly triple the addressable patient population if it's successful.

ALEX: Let's talk about some of the individual products because there were some real standouts. Vyndaqel, their heart disease drug, grew 90% year-over-year in the U.S. That's just massive growth for a specialty drug.

JORDAN: And Nurtec, their migraine treatment, grew 36% with about 49% market share in its category. But I thought one of the most interesting exchanges was about their COVID business. An analyst asked about sustainability, and management was pretty confident that it's now a "predictable and durable" revenue stream.

ALEX: That's important because the street has been treating COVID revenues as this wild card. But Aamir Malik, who runs U.S. commercial, explained how Paxlovid usage directly tracks disease burden, and they've got multi-year international contracts. So it sounds like they've built a more stable foundation there.

JORDAN: The financial discipline story was also compelling. They returned $9.5 billion to shareholders through dividends, invested nearly $11 billion in R&D, and paid down $7.8 billion in debt. CFO Dave Denton said they now have capacity for $10 billion to $15 billion in business development deals in 2025 if they choose to pursue them.

ALEX: That's...]]>44falsefullhttps://www.spreaker.com/episode/pfizer-q3-2024-earnings-analysis--70217741
**JORDAN**: Hey everyone! Today we're diving into Pfizer's Q3 2024 earnings, and wow - this was a solid quarter that really shows the pharma giant is hitting its stride post-pandemic.

**ALEX**: Before we jump in, I need to share our mandatory disclaimer - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Pfizer really delivered here.

**ALEX**: They did! Total revenue came in at $17.7 billion, which represents an impressive 32% operational growth year-over-year. But here's what I found interesting - it wasn't just COVID products driving this growth.

**JORDAN**: Right, and that's crucial context. PAXLOVID contributed $2.7 billion and COMIRNATY added $1.4 billion, but their non-COVID business also showed robust performance with $13.6 billion in revenue - that's 14% operational growth on its own.

**ALEX**: That non-COVID growth is really the story here. It shows their underlying business is healthy and growing, which addresses one of the biggest concerns investors have had about Pfizer - what happens when COVID revenue normalizes?

**JORDAN**: Exactly. And speaking of normalization, CEO Albert Bourla made some fascinating comments about COVID becoming "normal business" now. He pointed out that PAXLOVID usage patterns in 2024 are almost identical to 2023 - 4.9 million patients treated through Q3 this year versus 5.2 million last year.

**ALEX**: That predictability is huge for investors. Bourla even said they'll stop separating COVID from non-COVID business because "it's Pfizer business." But let's talk about their star performers outside of COVID.

**JORDAN**: Oncology was the standout with 31% year-over-year growth. XTANDI grew 28%, TALZENNA surged 77%, and they're seeing great momentum with newer launches like PADCEV, which has become the most prescribed first-line treatment for advanced bladder cancer.

**ALEX**: The TALZENNA data was particularly exciting. They announced that TALZENNA combined with XTANDI showed statistically significant overall survival benefit in prostate cancer patients - becoming the first and only such combination to do so. That's huge for a cancer that's the second most common in men.

**JORDAN**: And don't sleep on their pipeline. They've got multiple Phase III trials starting, including their CDK4 inhibitor for breast cancer and several next-generation ADCs for lung cancer. The Seagen acquisition is really paying dividends here.

**ALEX**: Speaking of Seagen, that integration seems to be going smoothly. They retained the vast majority of Seagen employees and the legacy Seagen products contributed $854 million in Q3 alone, with PADCEV generating over $400 million.

**JORDAN**: Now, we can't ignore the elephant in the room - the activist investor situation with Starboard Value.

**ALEX**: Bourla addressed this head-on, which I appreciated. He acknowledged they met with Starboard two weeks ago and said while they agree with some points, they have "vastly different views on many others." Particularly around capital deployment and business development.

**JORDAN**: His response was pretty measured. He defended deals like Seagen and BioNTech as transformational, and pointed out they've been executing a five-point strategic plan since January that's showing results. Three consecutive quarters of revenue growth, successful cost reduction programs, strong pipeline advancement.

**ALEX**: The cost management story is compelling too. They're on track to deliver $4 billion in net cost savings from their realignment program and expect $1.5 billion in manufacturing savings by 2027.

This episode includes AI-generated content.]]>SP100-PFE-Q3-2024-enSun, 22 Feb 2026 22:33:07 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex, and with me as always is Jordan. **JORDAN**: Hey everyone! Today we're diving into Pfizer's Q3 2024 earnings, and...
**JORDAN**: Hey everyone! Today we're diving into Pfizer's Q3 2024 earnings, and wow - this was a solid quarter that really shows the pharma giant is hitting its stride post-pandemic.

**ALEX**: Before we jump in, I need to share our mandatory disclaimer - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Pfizer really delivered here.

**ALEX**: They did! Total revenue came in at $17.7 billion, which represents an impressive 32% operational growth year-over-year. But here's what I found interesting - it wasn't just COVID products driving this growth.

**JORDAN**: Right, and that's crucial context. PAXLOVID contributed $2.7 billion and COMIRNATY added $1.4 billion, but their non-COVID business also showed robust performance with $13.6 billion in revenue - that's 14% operational growth on its own.

**ALEX**: That non-COVID growth is really the story here. It shows their underlying business is healthy and growing, which addresses one of the biggest concerns investors have had about Pfizer - what happens when COVID revenue normalizes?

**JORDAN**: Exactly. And speaking of normalization, CEO Albert Bourla made some fascinating comments about COVID becoming "normal business" now. He pointed out that PAXLOVID usage patterns in 2024 are almost identical to 2023 - 4.9 million patients treated through Q3 this year versus 5.2 million last year.

**ALEX**: That predictability is huge for investors. Bourla even said they'll stop separating COVID from non-COVID business because "it's Pfizer business." But let's talk about their star performers outside of COVID.

**JORDAN**: Oncology was the standout with 31% year-over-year growth. XTANDI grew 28%, TALZENNA surged 77%, and they're seeing great momentum with newer launches like PADCEV, which has become the most prescribed first-line treatment for advanced bladder cancer.

**ALEX**: The TALZENNA data was particularly exciting. They announced that TALZENNA combined with XTANDI showed statistically significant overall survival benefit in prostate cancer patients - becoming the first and only such combination to do so. That's huge for a cancer that's the second most common in men.

**JORDAN**: And don't sleep on their pipeline. They've got multiple Phase III trials starting, including their CDK4 inhibitor for breast cancer and several next-generation ADCs for lung cancer. The Seagen acquisition is really paying dividends here.

**ALEX**: Speaking of Seagen, that integration seems to be going smoothly. They retained the vast majority of Seagen employees and the legacy Seagen products contributed $854 million in Q3 alone, with PADCEV generating over $400 million.

**JORDAN**: Now, we can't ignore the elephant in the room - the activist investor situation with Starboard Value.

**ALEX**: Bourla addressed this head-on, which I appreciated. He acknowledged they met with Starboard two weeks ago and said while they agree with some points, they have "vastly different views on many others." Particularly around capital deployment and business development.

**JORDAN**: His response was pretty measured. He defended deals like Seagen and BioNTech as transformational, and pointed out they've been executing a five-point strategic plan since January that's showing results. Three consecutive quarters of revenue growth, successful cost reduction programs, strong pipeline advancement.

**ALEX**: The cost management story is...]]>77falsefullhttps://www.spreaker.com/episode/merck-q4-2025-earnings-analysis--70217740
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Merck's Q4 2025 earnings - and folks, this one's got some really interesting moving parts.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's start with the headline numbers because Merck delivered some solid, if not spectacular, results.

**ALEX:** Right, so Q4 revenue came in at $16.4 billion - that's 5% growth year-over-year, or 4% if you strip out foreign exchange impacts. But what's really interesting here is the story behind these numbers.

**JORDAN:** Exactly. Keytruda, their blockbuster cancer drug, continues to be the workhorse with $8.4 billion in sales, up 5%. But here's what caught my attention - CEO Rob Davis mentioned they now see a path to over $70 billion in potential commercial opportunity by the mid-2030s. That's $20 billion more than just a year ago!

**ALEX:** That's a massive increase in their pipeline projections. And Jordan, this gets to the heart of what investors are really worried about with Merck - what happens when Keytruda loses patent protection?

**JORDAN:** Bingo. The so-called "patent cliff." But here's where it gets interesting - Davis dropped some news about potentially extending Keytruda's protection. They have additional patents that could push the loss of exclusivity from December 2028 out to May or even November 2029.

**ALEX:** That's huge if it holds up. An extra year of Keytruda exclusivity could be worth billions. But let's talk about some of the challenges they're facing. Gardasil, their HPV vaccine, saw sales drop 35% to $1 billion, largely due to lower demand in China and Japan.

**JORDAN:** Yeah, that's a significant headwind. And looking at their 2026 guidance, they're projecting pretty modest growth - just 1% to 3% revenue growth to between $65.5 and $67 billion. That includes dealing with about $2.5 billion in headwinds from generic competition and pricing pressures.

**ALEX:** Speaking of 2026, there's this massive one-time charge of about $9 billion related to their acquisition of Sidera Therapeutics. This deal is all about MK1406, a potentially first-in-class flu prevention drug.

**JORDAN:** This acquisition really stood out to me. Management thinks MK1406 has greater than $5 billion in revenue potential. It's designed as a long-acting antiviral that could prevent influenza in high-risk individuals - basically a once-per-season shot instead of the traditional annual flu vaccine approach.

**ALEX:** The timing is interesting too, given we're in the middle of what seems to be a pretty severe flu season. Dr. Dean Li, their R&D chief, mentioned they've completed enrollment in the Northern Hemisphere for their Phase 3 trial and are now enrolling patients in the Southern Hemisphere.

**JORDAN:** Let's pivot to some of their other growth drivers. Winrevair, their pulmonary arterial hypertension drug, continues to impress with $467 million in global sales. They had over 1,500 new patients start treatment in the U.S. alone this quarter.

**ALEX:** And they just launched Ohtuvayre for COPD after acquiring Verona Pharma. That brought in $178 million in just part of the quarter. These respiratory drugs are clearly becoming a key growth pillar for Merck post-Keytruda.

**JORDAN:** What I found fascinating in the Q&A was the discussion around their HIV programs. They have this two-drug combination that showed non-inferior results to the standard three-drug regimen. Dr. Li was particularly excited abou

This episode includes AI-generated content.]]>SP100-MRK-Q4-2025-enSun, 22 Feb 2026 22:33:03 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT - MERCK Q4 2025 EARNINGS** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex....
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Merck's Q4 2025 earnings - and folks, this one's got some really interesting moving parts.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's start with the headline numbers because Merck delivered some solid, if not spectacular, results.

**ALEX:** Right, so Q4 revenue came in at $16.4 billion - that's 5% growth year-over-year, or 4% if you strip out foreign exchange impacts. But what's really interesting here is the story behind these numbers.

**JORDAN:** Exactly. Keytruda, their blockbuster cancer drug, continues to be the workhorse with $8.4 billion in sales, up 5%. But here's what caught my attention - CEO Rob Davis mentioned they now see a path to over $70 billion in potential commercial opportunity by the mid-2030s. That's $20 billion more than just a year ago!

**ALEX:** That's a massive increase in their pipeline projections. And Jordan, this gets to the heart of what investors are really worried about with Merck - what happens when Keytruda loses patent protection?

**JORDAN:** Bingo. The so-called "patent cliff." But here's where it gets interesting - Davis dropped some news about potentially extending Keytruda's protection. They have additional patents that could push the loss of exclusivity from December 2028 out to May or even November 2029.

**ALEX:** That's huge if it holds up. An extra year of Keytruda exclusivity could be worth billions. But let's talk about some of the challenges they're facing. Gardasil, their HPV vaccine, saw sales drop 35% to $1 billion, largely due to lower demand in China and Japan.

**JORDAN:** Yeah, that's a significant headwind. And looking at their 2026 guidance, they're projecting pretty modest growth - just 1% to 3% revenue growth to between $65.5 and $67 billion. That includes dealing with about $2.5 billion in headwinds from generic competition and pricing pressures.

**ALEX:** Speaking of 2026, there's this massive one-time charge of about $9 billion related to their acquisition of Sidera Therapeutics. This deal is all about MK1406, a potentially first-in-class flu prevention drug.

**JORDAN:** This acquisition really stood out to me. Management thinks MK1406 has greater than $5 billion in revenue potential. It's designed as a long-acting antiviral that could prevent influenza in high-risk individuals - basically a once-per-season shot instead of the traditional annual flu vaccine approach.

**ALEX:** The timing is interesting too, given we're in the middle of what seems to be a pretty severe flu season. Dr. Dean Li, their R&D chief, mentioned they've completed enrollment in the Northern Hemisphere for their Phase 3 trial and are now enrolling patients in the Southern Hemisphere.

**JORDAN:** Let's pivot to some of their other growth drivers. Winrevair, their pulmonary arterial hypertension drug, continues to impress with $467 million in global sales. They had over 1,500 new patients start treatment in the U.S. alone this quarter.

**ALEX:** And they just launched Ohtuvayre for COPD after acquiring Verona Pharma. That brought in $178 million in just part of the quarter. These respiratory drugs are clearly becoming a key growth pillar for Merck post-Keytruda.

**JORDAN:** What I found fascinating in the Q&A was the...]]>47falsefullhttps://www.spreaker.com/episode/altria-q4-2025-earnings-analysis--70217739
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into tobacco giant Altria's fourth quarter 2025 results. Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Thanks Alex. And wow, what a quarter for Altria. The company delivered some solid financials but also took a massive $1.3 billion impairment charge on their e-vapor business. That's not exactly chump change.

ALEX: Absolutely not. Let's start with the big picture numbers. Altria grew adjusted earnings per share by 4.4% for the full year and returned a whopping $8 billion to shareholders through dividends and share buybacks. That's serious cash returning to investors.

JORDAN: Right, and they're guiding for 2026 EPS between $5.56 and $5.72, which represents 2.5% to 5.5% growth. But here's the interesting part - CEO Billy Gifford said that growth will be "weighted to the second half of the year." That suggests a slower start to 2026.

ALEX: That timing issue ties into one of their big strategic moves. Altria is investing heavily in what they call "import-export capabilities" - basically a duty drawback program where they can manufacture cigarettes for international markets and then reimport them to get tax benefits. It's a complex play, but CFO Sal Mancuso said it has a payback period of less than a year.

JORDAN: That's actually pretty clever from a financial engineering standpoint. But let's talk about the elephant in the room - that $1.3 billion e-vapor impairment. They acquired NJOY to get into the vaping space, but the market is absolutely dominated by illegal flavored disposables from China.

ALEX: Exactly. Gifford said illegal products represent about 70% of the e-vapor category. Think about that - seven out of ten vaping products sold in the US are essentially operating outside FDA regulations. That makes it nearly impossible for legitimate companies like Altria to compete profitably.

JORDAN: But there might be a silver lining here. The company is seeing early signs that federal enforcement is starting to bite. Disposable e-vapor volume growth slowed from over 50% in 2024 to about 30% in 2025. Plus, Congress allocated at least $200 million in tobacco user fees specifically for enforcement activities.

ALEX: That enforcement angle is crucial for understanding Altria's strategy. They're basically saying "we'll wait on the sidelines until the government cleans up the illegal competition." Meanwhile, they're focusing on their nicotine pouch business, which is actually performing pretty well.

JORDAN: Speaking of nicotine pouches, their ON! brand is interesting. They got FDA authorization for ON! PLUS in December - that's their premium product with what they call "innovative pouch material and smooth flavor." They're positioning it as a premium option that can command higher prices than their classic ON! pouches.

ALEX: The numbers back that up. Helix, which makes the ON! products, shipped over 177 million cans for the full year, up about 11%. And while competitors were cutting prices - down 12% year-over-year according to Altria - they actually raised ON! prices by 3%.

JORDAN: But let's be real about the core business. Cigarette volumes declined 10% for the full year. That's a serious headwind. Even more concerning, Marlboro's retail share dropped below 40% for the first time ever.

ALEX: That Marlboro number caught my attention too. But Gifford pushed back on concerns during the Q&A, saying they're focused on "maximizing profitability over the long term" rather than chasing market share. They're also aggressively promoting their Basic discount brand in about 30,000 stores t

This episode includes AI-generated content.]]>SP100-MO-Q4-2025-enSun, 22 Feb 2026 22:33:00 +0000trueBeta Finch**Beta Finch Podcast Script: Altria (MO) Q4 2025 Earnings** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into tobacco giant Altria's fourth quarter 2025 results....
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into tobacco giant Altria's fourth quarter 2025 results. Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Thanks Alex. And wow, what a quarter for Altria. The company delivered some solid financials but also took a massive $1.3 billion impairment charge on their e-vapor business. That's not exactly chump change.

ALEX: Absolutely not. Let's start with the big picture numbers. Altria grew adjusted earnings per share by 4.4% for the full year and returned a whopping $8 billion to shareholders through dividends and share buybacks. That's serious cash returning to investors.

JORDAN: Right, and they're guiding for 2026 EPS between $5.56 and $5.72, which represents 2.5% to 5.5% growth. But here's the interesting part - CEO Billy Gifford said that growth will be "weighted to the second half of the year." That suggests a slower start to 2026.

ALEX: That timing issue ties into one of their big strategic moves. Altria is investing heavily in what they call "import-export capabilities" - basically a duty drawback program where they can manufacture cigarettes for international markets and then reimport them to get tax benefits. It's a complex play, but CFO Sal Mancuso said it has a payback period of less than a year.

JORDAN: That's actually pretty clever from a financial engineering standpoint. But let's talk about the elephant in the room - that $1.3 billion e-vapor impairment. They acquired NJOY to get into the vaping space, but the market is absolutely dominated by illegal flavored disposables from China.

ALEX: Exactly. Gifford said illegal products represent about 70% of the e-vapor category. Think about that - seven out of ten vaping products sold in the US are essentially operating outside FDA regulations. That makes it nearly impossible for legitimate companies like Altria to compete profitably.

JORDAN: But there might be a silver lining here. The company is seeing early signs that federal enforcement is starting to bite. Disposable e-vapor volume growth slowed from over 50% in 2024 to about 30% in 2025. Plus, Congress allocated at least $200 million in tobacco user fees specifically for enforcement activities.

ALEX: That enforcement angle is crucial for understanding Altria's strategy. They're basically saying "we'll wait on the sidelines until the government cleans up the illegal competition." Meanwhile, they're focusing on their nicotine pouch business, which is actually performing pretty well.

JORDAN: Speaking of nicotine pouches, their ON! brand is interesting. They got FDA authorization for ON! PLUS in December - that's their premium product with what they call "innovative pouch material and smooth flavor." They're positioning it as a premium option that can command higher prices than their classic ON! pouches.

ALEX: The numbers back that up. Helix, which makes the ON! products, shipped over 177 million cans for the full year, up about 11%. And while competitors were cutting prices - down 12% year-over-year according to Altria - they actually raised ON! prices by 3%.

JORDAN: But let's be real about the core business. Cigarette volumes declined 10% for the full year. That's a serious headwind. Even more concerning, Marlboro's retail share dropped below 40% for the first time ever.

ALEX: That Marlboro number caught my attention too. But Gifford pushed back on concerns during the Q&A, saying they're focused on "maximizing profitability over...]]>54falsefullhttps://www.spreaker.com/episode/medtronic-q3-2026-earnings-analysis--70217738
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex quarterly reports into clear insights. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Medtronic's Q3 2026 results, and wow - this was quite the quarter for the medical device giant.

**ALEX**: Before we jump in, I need to share our mandatory disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Right, thanks Alex. So Medtronic - ticker MDT - just reported some pretty impressive numbers. Let's start with the headline figures. Revenue hit $9 billion, growing 8.7% reported and 6% organically. That's actually a 50 basis point acceleration from the prior quarter.

**ALEX**: And they beat their own guidance by 50 basis points too. The real star here was their cardiovascular portfolio, which grew 11% year-over-year - that's the strongest growth they've seen in cardiovascular in the last ten years, excluding COVID comps.

**JORDAN**: The standout within cardio was their Cardiac Ablation Solutions, or CAS business, which includes their pulse field ablation technology. This grew 80% year-over-year, with PFA accounting for 80% of that revenue. CEO Geoffrey Martha seems really excited about this - they're calling it one of their "generational growth drivers."

**ALEX**: Speaking of growth drivers, Medtronic is really pushing four major ones: their PFA technology, the Simplicity Spyral system for hypertension, Altaviva for urinary incontinence, and their Hugo surgical robot. Jordan, what caught your attention in the management commentary?

**JORDAN**: What's fascinating is how they're building entirely new markets. Take their Simplicity system for hypertension - they launched a direct-to-consumer campaign called "Go Beyond" and saw website visits jump from 50,000 in Q2 to 2.5 million in Q3. That's a 50x increase! They opened over 200 new accounts this quarter and now have about 100 million covered lives, which is roughly one-third of the US population.

**ALEX**: That consumer demand story is really compelling. And it sounds like they're seeing great patient outcomes, which is driving physician excitement. But let's talk numbers - what about profitability?

**JORDAN**: Adjusted EPS came in at $1.36, beating the midpoint of guidance by 3 cents. However, gross margins are taking a hit from business mix - specifically from CAS and their Diabetes business. CFO Thierry Pieton explained that CAS currently has an unfavorable mix of lower-margin capital equipment to higher-margin catheters, since they're still in early launch phase.

**ALEX**: But that should improve over time as the installed base grows and catheter sales increase relative to the initial capital equipment, right?

**JORDAN**: Exactly. Pieton said they expect to see that mix inflection in the second half of next year, with CAS actually driving gross margin improvement as early as fiscal 2027. There's also the Diabetes business separation they're planning - since Diabetes has lower margins than the rest of the business, spinning it off should provide a natural margin lift.

**ALEX**: Let's talk about that guidance for fiscal 2027. They're maintaining their expectation for high-single-digit EPS growth, but there are some moving pieces.

**JORDAN**: Right, there are several puts and takes. They'll have a full year of tariff impact - about $300 million versus $185 million in 2026. There's an extra selling week that will help growth. And the Diabetes separation will create some temporary dilution of 1-2 cents per month between the IPO and the full split, since they lose 20% of Diabetes profits but don't get the share buyback benefit until the full separation.

**ALEX**: The Q&A session had some interest

This episode includes AI-generated content.]]>SP100-MDT-Q3-2026-enSun, 22 Feb 2026 22:32:56 +0000trueBeta Finch# Beta Finch Podcast Script - Medtronic Q3 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex quarterly reports into clear insights. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving into...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex quarterly reports into clear insights. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Medtronic's Q3 2026 results, and wow - this was quite the quarter for the medical device giant.

**ALEX**: Before we jump in, I need to share our mandatory disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Right, thanks Alex. So Medtronic - ticker MDT - just reported some pretty impressive numbers. Let's start with the headline figures. Revenue hit $9 billion, growing 8.7% reported and 6% organically. That's actually a 50 basis point acceleration from the prior quarter.

**ALEX**: And they beat their own guidance by 50 basis points too. The real star here was their cardiovascular portfolio, which grew 11% year-over-year - that's the strongest growth they've seen in cardiovascular in the last ten years, excluding COVID comps.

**JORDAN**: The standout within cardio was their Cardiac Ablation Solutions, or CAS business, which includes their pulse field ablation technology. This grew 80% year-over-year, with PFA accounting for 80% of that revenue. CEO Geoffrey Martha seems really excited about this - they're calling it one of their "generational growth drivers."

**ALEX**: Speaking of growth drivers, Medtronic is really pushing four major ones: their PFA technology, the Simplicity Spyral system for hypertension, Altaviva for urinary incontinence, and their Hugo surgical robot. Jordan, what caught your attention in the management commentary?

**JORDAN**: What's fascinating is how they're building entirely new markets. Take their Simplicity system for hypertension - they launched a direct-to-consumer campaign called "Go Beyond" and saw website visits jump from 50,000 in Q2 to 2.5 million in Q3. That's a 50x increase! They opened over 200 new accounts this quarter and now have about 100 million covered lives, which is roughly one-third of the US population.

**ALEX**: That consumer demand story is really compelling. And it sounds like they're seeing great patient outcomes, which is driving physician excitement. But let's talk numbers - what about profitability?

**JORDAN**: Adjusted EPS came in at $1.36, beating the midpoint of guidance by 3 cents. However, gross margins are taking a hit from business mix - specifically from CAS and their Diabetes business. CFO Thierry Pieton explained that CAS currently has an unfavorable mix of lower-margin capital equipment to higher-margin catheters, since they're still in early launch phase.

**ALEX**: But that should improve over time as the installed base grows and catheter sales increase relative to the initial capital equipment, right?

**JORDAN**: Exactly. Pieton said they expect to see that mix inflection in the second half of next year, with CAS actually driving gross margin improvement as early as fiscal 2027. There's also the Diabetes business separation they're planning - since Diabetes has lower margins than the rest of the business, spinning it off should provide a natural margin lift.

**ALEX**: Let's talk about that guidance for fiscal 2027. They're maintaining their expectation for high-single-digit EPS growth, but there are some moving pieces.

**JORDAN**: Right, there are several puts and takes. They'll have a full year of tariff impact - about $300 million versus $185 million in 2026. There's an extra selling week that will help growth. And the Diabetes separation will create some temporary dilution of 1-2 cents per month between the IPO and the full split, since...]]>122falsefullhttps://www.spreaker.com/episode/mcdonald-s-q4-2025-earnings-analysis--70217737
**[INTRO MUSIC]**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into McDonald's Q4 2025 results. Jordan, this was quite the quarter for the Golden Arches.

JORDAN: Absolutely, Alex! And before we dig in, I need to mention - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that reminder, Jordan. Now, let's talk numbers. McDonald's delivered some impressive results - system-wide sales hit nearly $140 billion, up 5.5% in constant currency for the full year. But what really caught my eye was that Q4 comp sales growth of 5.7% globally. That's pretty strong in what they're calling a "challenging industry backdrop."

JORDAN: Right, and breaking that down by segment - the U.S. was particularly strong at 6.8% comp growth, well above expectations. What's interesting is they had positive guest counts, which is always a key indicator of sustainable growth. CEO Chris Kempczinski mentioned they achieved their highest quarterly comparable guest count gap to competitors "in recent history."

ALEX: That's a fancy way of saying they're stealing customers from the competition! And speaking of the U.S., their value strategy seems to be working. They launched McValue early in the year, then relaunched Extra Value Meals in September. The results? They gained share with low-income consumers in December and saw meaningful improvement in value and affordability scores.

JORDAN: The marketing machine was firing on all cylinders too. The MONOPOLY promotion became one of their largest digital customer acquisition events ever - they now have 46 million 90-day active users in their U.S. loyalty app alone. But get this - the Grinch Meal campaign set new sales records, including the highest single sales day in McDonald's history!

ALEX: 50 million pairs of Grinch-themed socks sold globally! They literally became the largest seller of socks in the world for nearly a week. Only McDonald's could pull that off.

JORDAN: The international segments held up well too. International Operated Markets grew comp sales 5.2% - that's three consecutive quarters above 4% growth. The U.K., Germany, and Australia all delivered mid-to-high single-digit comp growth, with each market gaining market share.

ALEX: Now, let's talk about what's coming next because this is where it gets really interesting. They're accelerating restaurant openings - targeting 2,600 gross openings in 2026, up from 2,275 in 2025. That puts them on track for 50,000 restaurants by end of 2027.

JORDAN: The capital expenditure guidance reflects this growth - they're expecting $3.7 to $3.9 billion in CapEx for 2026, up from $3.4 billion in 2025. CFO Ian Borden was clear this increase was planned and keeps them on track with their December 2023 investor day targets.

ALEX: But here's what I found most intriguing - the menu innovation pipeline. New Chief Restaurant Experience Officer Jill McDonald outlined some ambitious plans. They're rolling out "Best Burger" to nearly all markets by end of 2026, and the Big Arch burger is gaining permanent spots on menus after successful pilots.

JORDAN: And beverages - this could be huge, Alex. They're targeting a $100 billion global beverage opportunity with new offerings under the McCafe brand. Energy drinks, indulgent iced coffees, fruity refreshers, crafted sodas. They even mentioned continuing their Red Bull collaboration. Their beverage test in 500+ U.S. restaurants exceeded expectations and drove incremental occasions across different dayparts.

ALEX: The chicken category focus is smart too - it's twice the size of beef and faster growing. They grew chicken category share across their top 10 markets in 2025 and are targeting at least 1 percen

This episode includes AI-generated content.]]>SP100-MCD-Q4-2025-enSun, 22 Feb 2026 22:32:53 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** **[INTRO MUSIC]** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into McDonald's Q4 2025 results. Jordan, this was quite the quarter for the Golden...
**[INTRO MUSIC]**

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into McDonald's Q4 2025 results. Jordan, this was quite the quarter for the Golden Arches.

JORDAN: Absolutely, Alex! And before we dig in, I need to mention - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks for that reminder, Jordan. Now, let's talk numbers. McDonald's delivered some impressive results - system-wide sales hit nearly $140 billion, up 5.5% in constant currency for the full year. But what really caught my eye was that Q4 comp sales growth of 5.7% globally. That's pretty strong in what they're calling a "challenging industry backdrop."

JORDAN: Right, and breaking that down by segment - the U.S. was particularly strong at 6.8% comp growth, well above expectations. What's interesting is they had positive guest counts, which is always a key indicator of sustainable growth. CEO Chris Kempczinski mentioned they achieved their highest quarterly comparable guest count gap to competitors "in recent history."

ALEX: That's a fancy way of saying they're stealing customers from the competition! And speaking of the U.S., their value strategy seems to be working. They launched McValue early in the year, then relaunched Extra Value Meals in September. The results? They gained share with low-income consumers in December and saw meaningful improvement in value and affordability scores.

JORDAN: The marketing machine was firing on all cylinders too. The MONOPOLY promotion became one of their largest digital customer acquisition events ever - they now have 46 million 90-day active users in their U.S. loyalty app alone. But get this - the Grinch Meal campaign set new sales records, including the highest single sales day in McDonald's history!

ALEX: 50 million pairs of Grinch-themed socks sold globally! They literally became the largest seller of socks in the world for nearly a week. Only McDonald's could pull that off.

JORDAN: The international segments held up well too. International Operated Markets grew comp sales 5.2% - that's three consecutive quarters above 4% growth. The U.K., Germany, and Australia all delivered mid-to-high single-digit comp growth, with each market gaining market share.

ALEX: Now, let's talk about what's coming next because this is where it gets really interesting. They're accelerating restaurant openings - targeting 2,600 gross openings in 2026, up from 2,275 in 2025. That puts them on track for 50,000 restaurants by end of 2027.

JORDAN: The capital expenditure guidance reflects this growth - they're expecting $3.7 to $3.9 billion in CapEx for 2026, up from $3.4 billion in 2025. CFO Ian Borden was clear this increase was planned and keeps them on track with their December 2023 investor day targets.

ALEX: But here's what I found most intriguing - the menu innovation pipeline. New Chief Restaurant Experience Officer Jill McDonald outlined some ambitious plans. They're rolling out "Best Burger" to nearly all markets by end of 2026, and the Big Arch burger is gaining permanent spots on menus after successful pilots.

JORDAN: And beverages - this could be huge, Alex. They're targeting a $100 billion global beverage opportunity with new offerings under the McCafe brand. Energy drinks, indulgent iced coffees, fruity refreshers, crafted sodas. They even mentioned continuing their Red Bull collaboration. Their beverage test in 500+ U.S. restaurants exceeded expectations and drove incremental occasions across different dayparts.

ALEX: The chicken category focus is smart too - it's...]]>57falsefullhttps://www.spreaker.com/episode/mastercard-q4-2025-earnings-analysis--70217736
**JORDAN**: And I'm Jordan. Before we dive in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. Today we're breaking down Mastercard's Q4 2025 earnings call, and wow - this was a masterclass in how to deliver consistent growth in an uncertain world. The headline numbers here are impressive: 15% revenue growth on a currency-neutral basis, with their value-added services segment absolutely crushing it at 22% growth.

**JORDAN**: Yeah Alex, those VAS numbers really caught my attention. But let's start with the big picture - Mastercard hit $4.76 in earnings per share, up 20% year-over-year. What's interesting is how broad-based this growth was. They're not just relying on one region or one business line.

**ALEX**: Exactly. And CEO Michael Miebach was pretty confident in his opening remarks. He emphasized three key factors driving their success: focus, innovation, and diversification. But Jordan, what really stood out to me was this idea of a "virtuous cycle" between their payment network and services offerings. Can you break that down?

**JORDAN**: It's actually quite elegant when you think about it. More transactions flowing through their network means more data. More data enables better services and analytics they can sell to banks and merchants. Those better services help their partners grow, which drives more transactions back through the network. Rinse and repeat. They mentioned that 60% of their value-added services revenue is "network-linked," meaning it directly benefits from transaction growth.

**ALEX**: That's a powerful moat. Now, let's talk about some of the big strategic wins they announced. The Capital One renewal was huge news - they're extending their credit partnership and Capital One will use more Mastercard services across their entire business.

**JORDAN**: Right, and this came up multiple times in the Q&A. What's significant is that Capital One chose to deepen their relationship with Mastercard even as they're integrating the Discover network they acquired. That's a strong vote of confidence in Mastercard's value proposition. Miebach emphasized that banks choose Mastercard for their global acceptance, security, and digital capabilities - not just price.

**ALEX**: Speaking of big wins, they had some impressive international expansion stories. A nearly 10 million card migration in Turkey with Yapi Credi, new partnerships across Latin America with Scotiabank, and some exclusive deals in South Africa that could increase their market share by multiple percentage points.

**JORDAN**: The international story is really compelling. Remember, about 70% of their business comes from outside the US, so these wins matter. But Alex, I want to pivot to something that came up in the Q&A that I think investors should pay attention to - the regulatory environment.

**ALEX**: Oh yes, the Credit Card Competition Act discussion. Miebach was pretty direct about this - he called it a "race to the bottom for the cheapest network option, but not the safest." His argument is that there's been little progress on the bill since 2023, and there's united opposition because it takes payment choice away from consumers and could create cybersecurity risks.

**JORDAN**: And there was also discussion about the potential 10% interest rate cap on credit cards. While Mastercard doesn't set interest rates, Miebach acknowledged they're actively engaged in industry discussions about affordability. He emphasized the unintended consequences - like potentially cutting off credit access for vulnerable consumers who need it most.

**ALEX**: T

This episode includes AI-generated content.]]>SP100-MA-Q4-2025-enSun, 22 Feb 2026 22:32:49 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results to help you understand what's really happening in the markets. I'm Alex. **JORDAN**: And I'm Jordan. Before we dive in, this podcast is...
**JORDAN**: And I'm Jordan. Before we dive in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Thanks Jordan. Today we're breaking down Mastercard's Q4 2025 earnings call, and wow - this was a masterclass in how to deliver consistent growth in an uncertain world. The headline numbers here are impressive: 15% revenue growth on a currency-neutral basis, with their value-added services segment absolutely crushing it at 22% growth.

**JORDAN**: Yeah Alex, those VAS numbers really caught my attention. But let's start with the big picture - Mastercard hit $4.76 in earnings per share, up 20% year-over-year. What's interesting is how broad-based this growth was. They're not just relying on one region or one business line.

**ALEX**: Exactly. And CEO Michael Miebach was pretty confident in his opening remarks. He emphasized three key factors driving their success: focus, innovation, and diversification. But Jordan, what really stood out to me was this idea of a "virtuous cycle" between their payment network and services offerings. Can you break that down?

**JORDAN**: It's actually quite elegant when you think about it. More transactions flowing through their network means more data. More data enables better services and analytics they can sell to banks and merchants. Those better services help their partners grow, which drives more transactions back through the network. Rinse and repeat. They mentioned that 60% of their value-added services revenue is "network-linked," meaning it directly benefits from transaction growth.

**ALEX**: That's a powerful moat. Now, let's talk about some of the big strategic wins they announced. The Capital One renewal was huge news - they're extending their credit partnership and Capital One will use more Mastercard services across their entire business.

**JORDAN**: Right, and this came up multiple times in the Q&A. What's significant is that Capital One chose to deepen their relationship with Mastercard even as they're integrating the Discover network they acquired. That's a strong vote of confidence in Mastercard's value proposition. Miebach emphasized that banks choose Mastercard for their global acceptance, security, and digital capabilities - not just price.

**ALEX**: Speaking of big wins, they had some impressive international expansion stories. A nearly 10 million card migration in Turkey with Yapi Credi, new partnerships across Latin America with Scotiabank, and some exclusive deals in South Africa that could increase their market share by multiple percentage points.

**JORDAN**: The international story is really compelling. Remember, about 70% of their business comes from outside the US, so these wins matter. But Alex, I want to pivot to something that came up in the Q&A that I think investors should pay attention to - the regulatory environment.

**ALEX**: Oh yes, the Credit Card Competition Act discussion. Miebach was pretty direct about this - he called it a "race to the bottom for the cheapest network option, but not the safest." His argument is that there's been little progress on the bill since 2023, and there's united opposition because it takes payment choice away from consumers and could create cybersecurity risks.

**JORDAN**: And there was also discussion about the potential 10% interest rate cap on credit cards. While Mastercard doesn't set interest rates, Miebach acknowledged they're actively engaged in industry discussions about affordability. He emphasized the unintended...]]>65falsefullhttps://www.spreaker.com/episode/lam-research-q2-2026-earnings-analysis--70217735
JORDAN: Thanks Alex. And wow, what a quarter for Lam Research! The semiconductor equipment maker absolutely crushed it with record revenues of $5.34 billion - that's their tenth consecutive quarter of growth. They beat the midpoint of guidance and exceeded expectations across the board.

ALEX: The numbers really tell the story here. For the full year 2025, they hit record revenues of $20.6 billion, up 27% year-over-year. But what's even more impressive is the profitability - gross margins of 49.9%, operating margins of 34.1%, and earnings per share of $4.89, up 49% from the prior year.

JORDAN: And looking ahead, CEO Tim Archer and CFO Doug Bettinger painted a picture of an industry that's absolutely on fire. They're projecting wafer fabrication equipment spending - that's WFE - to jump from about $110 billion in 2025 to $135 billion in 2026. That's roughly 23% growth!

ALEX: But here's the fascinating part - and this came up multiple times in the Q&A - the industry is actually constrained by clean room space shortages. Tim Archer mentioned that chipmakers are essentially sold out, which is creating this pent-up demand situation.

JORDAN: Right, it's almost like a luxury problem to have. The demand is there, the orders are there, but customers literally don't have the physical space to install all the equipment they want. Doug Bettinger mentioned they expect 2026 to be "second-half weighted" because of these constraints, with growth ramping as more clean room space comes online.

ALEX: The AI boom is really driving everything here. Lam is particularly well-positioned because AI chips require more complex manufacturing processes - specifically more deposition and etching, which is exactly what Lam specializes in. Archer talked about how they're seeing accelerated adoption of advanced technologies like gate-all-around transistors and 3D advanced packaging.

JORDAN: One product that really stood out was their Aqara conductor etch system. They've doubled its installed base over the past year and are winning production contracts for the most advanced chip manufacturing. Tim Archer explained that as critical dimensions keep shrinking - we're talking 10 to 20% smaller with each new technology node - Lam's tools become even more essential.

ALEX: The memory business is particularly interesting. DRAM was a standout, making up 23% of systems revenue, up from 16% in the previous quarter. This is largely driven by high-bandwidth memory or HBM demand for AI applications. But what caught my attention was their advanced packaging business - they expect it to grow more than 40% in 2026.

JORDAN: And then there's NAND flash memory, which has been a bit of a sleeper story. While it was down sequentially in Q2, management is seeing new use cases emerging, particularly for AI inference applications. They mentioned that for every 2-3 million AI accelerators sold, they estimate a one-point increase in NAND bit demand growth.

ALEX: Let's talk about the geographic mix because it's quite telling. China represented 35% of revenue, down from 43% in the prior quarter. Management expects China to be roughly flat year-over-year in 2026, while everywhere else grows substantially. This shift is partly due to regulatory changes but also reflects where the cutting-edge demand is coming from.

JORDAN: The guidance for Q3 2026 shows continued momentum - they're expecting revenue of $5.7 billion, plus or minus $300 million, with gross margins around 49%. What's remarkable is that they're alread

This episode includes AI-generated content.]]>SP100-LRCX-Q2-2026-enSun, 22 Feb 2026 22:32:46 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Lam Research's Q2 2026 earnings call. Before we get started, I want to remind our listeners that this podcast is AI-generated...
JORDAN: Thanks Alex. And wow, what a quarter for Lam Research! The semiconductor equipment maker absolutely crushed it with record revenues of $5.34 billion - that's their tenth consecutive quarter of growth. They beat the midpoint of guidance and exceeded expectations across the board.

ALEX: The numbers really tell the story here. For the full year 2025, they hit record revenues of $20.6 billion, up 27% year-over-year. But what's even more impressive is the profitability - gross margins of 49.9%, operating margins of 34.1%, and earnings per share of $4.89, up 49% from the prior year.

JORDAN: And looking ahead, CEO Tim Archer and CFO Doug Bettinger painted a picture of an industry that's absolutely on fire. They're projecting wafer fabrication equipment spending - that's WFE - to jump from about $110 billion in 2025 to $135 billion in 2026. That's roughly 23% growth!

ALEX: But here's the fascinating part - and this came up multiple times in the Q&A - the industry is actually constrained by clean room space shortages. Tim Archer mentioned that chipmakers are essentially sold out, which is creating this pent-up demand situation.

JORDAN: Right, it's almost like a luxury problem to have. The demand is there, the orders are there, but customers literally don't have the physical space to install all the equipment they want. Doug Bettinger mentioned they expect 2026 to be "second-half weighted" because of these constraints, with growth ramping as more clean room space comes online.

ALEX: The AI boom is really driving everything here. Lam is particularly well-positioned because AI chips require more complex manufacturing processes - specifically more deposition and etching, which is exactly what Lam specializes in. Archer talked about how they're seeing accelerated adoption of advanced technologies like gate-all-around transistors and 3D advanced packaging.

JORDAN: One product that really stood out was their Aqara conductor etch system. They've doubled its installed base over the past year and are winning production contracts for the most advanced chip manufacturing. Tim Archer explained that as critical dimensions keep shrinking - we're talking 10 to 20% smaller with each new technology node - Lam's tools become even more essential.

ALEX: The memory business is particularly interesting. DRAM was a standout, making up 23% of systems revenue, up from 16% in the previous quarter. This is largely driven by high-bandwidth memory or HBM demand for AI applications. But what caught my attention was their advanced packaging business - they expect it to grow more than 40% in 2026.

JORDAN: And then there's NAND flash memory, which has been a bit of a sleeper story. While it was down sequentially in Q2, management is seeing new use cases emerging, particularly for AI inference applications. They mentioned that for every 2-3 million AI accelerators sold, they estimate a one-point increase in NAND bit demand growth.

ALEX: Let's talk about the geographic mix because it's quite telling. China represented 35% of revenue, down from 43% in the prior quarter. Management expects China to be roughly flat year-over-year in 2026, while everywhere else grows substantially. This shift is partly due to regulatory changes but also reflects where the cutting-edge demand is coming from.

JORDAN: The guidance for Q3 2026 shows continued momentum - they're expecting revenue of...]]>53falsefullhttps://www.spreaker.com/episode/eli-lilly-q4-2025-earnings-analysis--70217734
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Eli Lilly's blockbuster Q4 2025 results - and folks, when I say blockbuster, I mean it. This pharmaceutical giant just delivered some truly staggering numbers.

But before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, where do we even start with these numbers? Lilly just reported 45% full-year revenue growth - that's not a typo, folks - forty-five percent. We're talking about $65.2 billion in revenue for 2025, with earnings per share jumping 86% to $24.21.

**ALEX**: It's almost surreal when you see numbers like that from a major pharma company. Jordan, what's driving this incredible performance?

**JORDAN**: It all comes down to one word: incretins. These are the diabetes and obesity drugs that have become absolute juggernauts. Their key products - we're talking Mounjaro, Zepbound, and their international rollouts - generated over $13 billion in Q4 revenue alone and grew 91% compared to the same quarter last year.

**ALEX**: Let's break that down for our listeners. Mounjaro is their diabetes drug, Zepbound is the obesity treatment, but they're essentially the same molecule - tirzepatide - just branded differently for different conditions. And the demand has been absolutely explosive.

**JORDAN**: Exactly. What's fascinating is how they've captured market leadership. In the US, Mounjaro now has over 55% of new prescriptions in the diabetes incretin market, while Zepbound commands nearly 70% share in the branded obesity market. But here's what really caught my attention - they're not just winning in the US anymore.

**ALEX**: Right, their international business has been crushing it. CEO David Ricks mentioned they're now the incretin market share leader outside the US as well. That's a huge development because historically, US pharma companies have struggled to replicate their domestic success internationally, especially in obesity treatments.

**JORDAN**: And they're not slowing down. Looking ahead to 2026, management guided to revenue between $80-83 billion. That's another 25% growth at the midpoint. But here's where it gets interesting - they're expecting significant pricing headwinds.

**ALEX**: This is crucial for investors to understand. Lilly is projecting price declines in the low-to-mid teens for 2026. That's a massive headwind, but they believe volume growth will more than offset it.

**JORDAN**: The pricing pressure comes from several factors. First, they struck a deal with the US government to provide obesity medicines to Medicare patients for just $50 per month out-of-pocket starting no later than July 1st. That's huge for patient access but means lower prices for Lilly.

**ALEX**: They're also facing competition from oral versions of these drugs. During the call, they discussed launching their own oral obesity treatment, orforglipron, which they expect to get FDA approval for in Q2 2026.

**JORDAN**: The oral competition point is really interesting. When Novo Nordisk launched oral Wegovy recently, instead of cannibalizing existing injectable sales, it actually expanded the overall market. Lilly's management seems confident this trend will continue - that oral options bring new patients into treatment rather than just switching existing ones.

**ALEX**: Let's talk about their direct-to-consumer business because this is revolutionary for pharma. They've reached 1 million patients on their US direct-to-patient platform. Think about that - patients are buying prescription obesity drugs directly from the manufacturer, often payin

This episode includes AI-generated content.]]>SP100-LLY-Q4-2025-enSun, 22 Feb 2026 22:32:42 +0000trueBeta Finch**Beta Finch Podcast Script: Eli Lilly Q4 2025 Earnings** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Eli Lilly's blockbuster Q4 2025 results - and...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into Eli Lilly's blockbuster Q4 2025 results - and folks, when I say blockbuster, I mean it. This pharmaceutical giant just delivered some truly staggering numbers.

But before we jump in, I need to share our standard disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, where do we even start with these numbers? Lilly just reported 45% full-year revenue growth - that's not a typo, folks - forty-five percent. We're talking about $65.2 billion in revenue for 2025, with earnings per share jumping 86% to $24.21.

**ALEX**: It's almost surreal when you see numbers like that from a major pharma company. Jordan, what's driving this incredible performance?

**JORDAN**: It all comes down to one word: incretins. These are the diabetes and obesity drugs that have become absolute juggernauts. Their key products - we're talking Mounjaro, Zepbound, and their international rollouts - generated over $13 billion in Q4 revenue alone and grew 91% compared to the same quarter last year.

**ALEX**: Let's break that down for our listeners. Mounjaro is their diabetes drug, Zepbound is the obesity treatment, but they're essentially the same molecule - tirzepatide - just branded differently for different conditions. And the demand has been absolutely explosive.

**JORDAN**: Exactly. What's fascinating is how they've captured market leadership. In the US, Mounjaro now has over 55% of new prescriptions in the diabetes incretin market, while Zepbound commands nearly 70% share in the branded obesity market. But here's what really caught my attention - they're not just winning in the US anymore.

**ALEX**: Right, their international business has been crushing it. CEO David Ricks mentioned they're now the incretin market share leader outside the US as well. That's a huge development because historically, US pharma companies have struggled to replicate their domestic success internationally, especially in obesity treatments.

**JORDAN**: And they're not slowing down. Looking ahead to 2026, management guided to revenue between $80-83 billion. That's another 25% growth at the midpoint. But here's where it gets interesting - they're expecting significant pricing headwinds.

**ALEX**: This is crucial for investors to understand. Lilly is projecting price declines in the low-to-mid teens for 2026. That's a massive headwind, but they believe volume growth will more than offset it.

**JORDAN**: The pricing pressure comes from several factors. First, they struck a deal with the US government to provide obesity medicines to Medicare patients for just $50 per month out-of-pocket starting no later than July 1st. That's huge for patient access but means lower prices for Lilly.

**ALEX**: They're also facing competition from oral versions of these drugs. During the call, they discussed launching their own oral obesity treatment, orforglipron, which they expect to get FDA approval for in Q2 2026.

**JORDAN**: The oral competition point is really interesting. When Novo Nordisk launched oral Wegovy recently, instead of cannibalizing existing injectable sales, it actually expanded the overall market. Lilly's management seems confident this trend will continue - that oral options bring new patients into treatment rather than just switching existing ones.

**ALEX**: Let's talk about their direct-to-consumer business because this is revolutionary for pharma. They've reached 1 million...]]>53falsefullhttps://www.spreaker.com/episode/eli-lilly-q4-2024-earnings-analysis--70217733
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Eli Lilly's Q4 2024 earnings - and wow, what a quarter for the pharmaceutical giant.

**ALEX:** Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely crucial reminder there. Now Alex, let's talk numbers because Lilly absolutely crushed it this quarter.

**ALEX:** They really did, Jordan. Revenue grew 45% in Q4 alone, and for the full year, they posted 32% growth. But here's the kicker - they exceeded their initial guidance by $4 billion. That's not a small miss on the upside, that's a massive beat.

**JORDAN:** And when you dig into what's driving this growth, it's really the incretin story - Mounjaro and Zepbound. Global Mounjaro sales hit $3.5 billion in Q4, while US Zepbound brought in $1.9 billion. These are the diabetes and obesity drugs that everyone's talking about.

**ALEX:** What I found fascinating in the call was CEO Dave Ricks addressing what he called the "turbulence" around demand predictions. There's been this narrative that maybe the obesity market isn't as big as everyone thought, with prescription growth slowing and supply catching up faster than expected.

**JORDAN:** Right, and one analyst - Steve Scala - basically asked the uncomfortable question everyone's thinking: "Are we all over our skis on this market?" But Ricks pushed back hard, saying they still believe this is a market with hundreds of millions of people globally and they're still gating promotion and launches because they can't make enough.

**ALEX:** That confidence is backed up by some interesting data points. Zepbound actually became the market leader in anti-obesity prescriptions in Q4, and they're seeing strong adherence rates - better than competitors in some cases.

**JORDAN:** Speaking of competition, let's talk about what's coming next because this is where it gets really interesting. They have Orforglipron, which is their oral GLP-1 drug, potentially launching in 2026. This could be a game-changer because it doesn't require refrigeration and addresses the 20-25% of patients who have needle phobia.

**ALEX:** The development timeline for Orforglipron is aggressive too. They're expecting multiple readouts in 2025 - up to five studies in diabetes and two in obesity. Dan Skovronsky, their Chief Scientific Officer, said they're aiming for efficacy similar to injectable single-acting GLP-1s, which would put it in the Ozempic range rather than the tirzepatide range.

**JORDAN:** But here's what I found most intriguing - they're not just staying in their lane. They're exploring incretins for brain health, substance use disorders, pain, and inflammation. They're essentially asking: "What else can these molecules do?"

**ALEX:** The pipeline is incredibly robust. Eight new Phase III programs started in 2024, and they're planning more for 2025. They're also expecting data from the tirzepatide cardiovascular outcomes study in Q3, which could be huge for reimbursement.

**JORDAN:** Let's talk margins because this is where Lilly is really showing operational leverage. Gross margins hit 83.2% in Q4, and they're guiding for 340 basis points of operating margin expansion in 2025. That's massive.

**ALEX:** CFO Lucas Montarce made an interesting comment about long-term margins though. They're not chasing the 50% operating margins that some analysts are projecting for the end of the decade. They believe reinvesting in R&D is more important for sustainable growth, keeping them in the low 40s range.

**JORDAN:** Smart approach, especially when you look at

This episode includes AI-generated content.]]>SP100-LLY-Q4-2024-enSun, 22 Feb 2026 22:32:38 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Eli Lilly's Q4 2024...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex corporate calls into clear insights. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Eli Lilly's Q4 2024 earnings - and wow, what a quarter for the pharmaceutical giant.

**ALEX:** Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely crucial reminder there. Now Alex, let's talk numbers because Lilly absolutely crushed it this quarter.

**ALEX:** They really did, Jordan. Revenue grew 45% in Q4 alone, and for the full year, they posted 32% growth. But here's the kicker - they exceeded their initial guidance by $4 billion. That's not a small miss on the upside, that's a massive beat.

**JORDAN:** And when you dig into what's driving this growth, it's really the incretin story - Mounjaro and Zepbound. Global Mounjaro sales hit $3.5 billion in Q4, while US Zepbound brought in $1.9 billion. These are the diabetes and obesity drugs that everyone's talking about.

**ALEX:** What I found fascinating in the call was CEO Dave Ricks addressing what he called the "turbulence" around demand predictions. There's been this narrative that maybe the obesity market isn't as big as everyone thought, with prescription growth slowing and supply catching up faster than expected.

**JORDAN:** Right, and one analyst - Steve Scala - basically asked the uncomfortable question everyone's thinking: "Are we all over our skis on this market?" But Ricks pushed back hard, saying they still believe this is a market with hundreds of millions of people globally and they're still gating promotion and launches because they can't make enough.

**ALEX:** That confidence is backed up by some interesting data points. Zepbound actually became the market leader in anti-obesity prescriptions in Q4, and they're seeing strong adherence rates - better than competitors in some cases.

**JORDAN:** Speaking of competition, let's talk about what's coming next because this is where it gets really interesting. They have Orforglipron, which is their oral GLP-1 drug, potentially launching in 2026. This could be a game-changer because it doesn't require refrigeration and addresses the 20-25% of patients who have needle phobia.

**ALEX:** The development timeline for Orforglipron is aggressive too. They're expecting multiple readouts in 2025 - up to five studies in diabetes and two in obesity. Dan Skovronsky, their Chief Scientific Officer, said they're aiming for efficacy similar to injectable single-acting GLP-1s, which would put it in the Ozempic range rather than the tirzepatide range.

**JORDAN:** But here's what I found most intriguing - they're not just staying in their lane. They're exploring incretins for brain health, substance use disorders, pain, and inflammation. They're essentially asking: "What else can these molecules do?"

**ALEX:** The pipeline is incredibly robust. Eight new Phase III programs started in 2024, and they're planning more for 2025. They're also expecting data from the tirzepatide cardiovascular outcomes study in Q3, which could be huge for reimbursement.

**JORDAN:** Let's talk margins because this is where Lilly is really showing operational leverage. Gross margins hit 83.2% in Q4, and they're guiding for 340 basis points of operating margin expansion in 2025. That's massive.

**ALEX:** CFO Lucas Montarce made an interesting comment about long-term margins though. They're not chasing the 50% operating margins that some analysts are projecting for the end of the decade....]]>74falsefullhttps://www.spreaker.com/episode/eli-lilly-q3-2024-earnings-analysis--70217731
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Eli Lilly's third quarter 2024 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and what a quarter this was for Lilly! The pharmaceutical giant absolutely crushed it with 42% revenue growth, though there's definitely some nuance to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers. Lilly reported revenue growth of 42% after excluding their divested olanzapine portfolio, which is just massive for a company this size. The real stars of the show were their incretin drugs - Mounjaro and Zepbound - which drove over $3 billion in new product revenue growth.

**JORDAN:** Right, and when we look at Mounjaro specifically, it hit $3.1 billion in global sales with almost $2.4 billion coming from the U.S. alone. But here's where it gets interesting - despite strong underlying demand with 25% sequential quarter-over-quarter prescription volume growth, there were some channel inventory dynamics that created headwinds.

**ALEX:** Can you explain what that means for our listeners who might not be familiar with pharmaceutical distribution?

**JORDAN:** Sure! So basically, wholesalers and retailers were destocking - meaning they were drawing down their inventory levels of these drugs. Lilly estimated this impacted Q3 sales by mid-single digits. It's not a demand problem, it's more about the complexity of managing cold-chain storage for a dozen different dose combinations across the supply chain.

**ALEX:** That's a crucial distinction. The underlying demand is actually accelerating, but the financial results got a bit choppy because of these logistical challenges. What's Lilly doing about it?

**JORDAN:** Well, they're being much more strategic now. CEO Dave Ricks mentioned they've basically changed their approach to demand generation. Previously, they were being prudent about marketing spend because they didn't want to create demand they couldn't fulfill. Now, with supply constraints easing, they're ramping up direct-to-consumer advertising for the first time and increasing their healthcare provider promotional efforts.

**ALEX:** Speaking of supply, Lilly continues to throw absolutely massive amounts of capital at manufacturing. They announced nearly $2 billion in additional manufacturing investments in Ireland, bringing their total commitments since 2020 to over $20 billion. Plus, they're building this fascinating $4.5 billion "Lilly Medicine Foundry" facility.

**JORDAN:** The scale of that investment really shows their confidence in the long-term opportunity. And it's paying off - they're on track to exceed their target of producing at least 1.5 times the saleable doses of incretin medicines in the second half of this year compared to last year.

**ALEX:** Let's talk about the guidance update. Lilly raised their revenue guidance to $45.4-46 billion, with the midpoint representing about 50% growth in Q4 compared to last year. That's actually an acceleration from the 42% they just posted.

**JORDAN:** Exactly, and Lucas Montarce, their new CFO, was careful to explain that when you strip out the channel dynamics, this acceleration is actually quite consistent with their trajectory. The growth is coming from several factors: ramped up demand generation in the U.S., international Mounjaro launches in new countries, and continued strong performance across their non-incretin portfolio.

**ALEX:** Speaking of their broader portfolio, I was impressed that their non-incretin business still grew 17% excluding the olanzapine divestiture. Verzenio in oncology continues to perform well, and they got some importa

This episode includes AI-generated content.]]>SP100-LLY-Q3-2024-enSun, 22 Feb 2026 22:32:34 +0000trueBeta Finch# Beta Finch Podcast Script: Eli Lilly Q3 2024 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Eli Lilly's third quarter 2024 results. This podcast is...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into Eli Lilly's third quarter 2024 results. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex, and what a quarter this was for Lilly! The pharmaceutical giant absolutely crushed it with 42% revenue growth, though there's definitely some nuance to unpack here.

**ALEX:** Absolutely. Let's start with the headline numbers. Lilly reported revenue growth of 42% after excluding their divested olanzapine portfolio, which is just massive for a company this size. The real stars of the show were their incretin drugs - Mounjaro and Zepbound - which drove over $3 billion in new product revenue growth.

**JORDAN:** Right, and when we look at Mounjaro specifically, it hit $3.1 billion in global sales with almost $2.4 billion coming from the U.S. alone. But here's where it gets interesting - despite strong underlying demand with 25% sequential quarter-over-quarter prescription volume growth, there were some channel inventory dynamics that created headwinds.

**ALEX:** Can you explain what that means for our listeners who might not be familiar with pharmaceutical distribution?

**JORDAN:** Sure! So basically, wholesalers and retailers were destocking - meaning they were drawing down their inventory levels of these drugs. Lilly estimated this impacted Q3 sales by mid-single digits. It's not a demand problem, it's more about the complexity of managing cold-chain storage for a dozen different dose combinations across the supply chain.

**ALEX:** That's a crucial distinction. The underlying demand is actually accelerating, but the financial results got a bit choppy because of these logistical challenges. What's Lilly doing about it?

**JORDAN:** Well, they're being much more strategic now. CEO Dave Ricks mentioned they've basically changed their approach to demand generation. Previously, they were being prudent about marketing spend because they didn't want to create demand they couldn't fulfill. Now, with supply constraints easing, they're ramping up direct-to-consumer advertising for the first time and increasing their healthcare provider promotional efforts.

**ALEX:** Speaking of supply, Lilly continues to throw absolutely massive amounts of capital at manufacturing. They announced nearly $2 billion in additional manufacturing investments in Ireland, bringing their total commitments since 2020 to over $20 billion. Plus, they're building this fascinating $4.5 billion "Lilly Medicine Foundry" facility.

**JORDAN:** The scale of that investment really shows their confidence in the long-term opportunity. And it's paying off - they're on track to exceed their target of producing at least 1.5 times the saleable doses of incretin medicines in the second half of this year compared to last year.

**ALEX:** Let's talk about the guidance update. Lilly raised their revenue guidance to $45.4-46 billion, with the midpoint representing about 50% growth in Q4 compared to last year. That's actually an acceleration from the 42% they just posted.

**JORDAN:** Exactly, and Lucas Montarce, their new CFO, was careful to explain that when you strip out the channel dynamics, this acceleration is actually quite consistent with their trajectory. The growth is coming from several factors: ramped up demand generation in the U.S., international Mounjaro launches in new countries, and continued strong performance across their non-incretin portfolio.

**ALEX:** Speaking of their broader portfolio, I was impressed that their non-incretin...]]>64falsefullhttps://www.spreaker.com/episode/linde-q4-2025-earnings-analysis--70217330
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Linde's Q4 2025 results, and folks, this industrial gas giant just delivered some impressive numbers despite a pretty challenging macro environment.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter it was for Linde! They posted record quarterly and annual performance across operating profit, margins, and EPS. Fourth quarter sales hit $8.8 billion, up 6% year-over-year, with EPS of $4.20 - also up 6%. But here's what's really impressive - they maintained a 29.5% operating margin despite all the industrial headwinds.

**ALEX**: That margin performance is remarkable, especially when you consider what CEO Sanjiv Lamba called "a study in contrast" in the economic environment. On one hand, you had this massive AI and digital infrastructure boom driving unprecedented activity. But on the other hand, traditional industrial markets like manufacturing, metals, and chemicals were still struggling.

**JORDAN**: Exactly. And Lamba really painted this picture of geographic unevenness. The US remained resilient - no surprise there - with growth across almost every end market. Electronics and commercial space really stood out. But Europe? Still broadly weak across manufacturing sectors, though there were some bright spots in Scandinavian countries and maybe - and I stress maybe - some early optimism in Germany.

**ALEX**: What caught my attention was their commentary on China. After several tough quarters, Lamba mentioned they're finally seeing some bottoming out. Their China merchant business actually grew faster than the published industrial production number for the first time in a while. That's significant.

**JORDAN**: Absolutely. And let's talk about what's really driving growth here - their project backlog. They're sitting on a record $10 billion backlog, and that doesn't even include over half a billion in space-related investments. This space opportunity is fascinating, Alex. They're supporting about 65-75% of all launches, and with 189 launches last year, that's serious business.

**ALEX**: The space angle is really compelling. They just started up a plant in Brownsville in January, and Lamba mentioned they're building out networks in Texas and Florida - the two major launch hubs. He's expecting this to become a billion-dollar business for them in the coming years. Double-digit growth in a secular trend - that's exactly what investors want to see.

**JORDAN**: And speaking of growth investments, their CapEx jumped 17% in Q4, largely driven by that record project backlog. Now, this did pressure their return on capital down to the low-to-mid 20% range, but management says that's expected and temporary as these projects come online.

**ALEX**: Let's talk guidance because this is where it gets interesting. They're projecting 2026 EPS growth of 6-9%, which puts them in the $17.40 to $17.90 range. Now, some analysts were hoping for that 10%+ growth we've seen historically, so this might seem a bit conservative.

**JORDAN**: It definitely feels conservative, and management admitted as much. CFO Matt White used words like "guarded" and "prudent." But here's the thing - they're assuming zero base volume growth and are essentially letting investors plug in their own macro assumptions. That's smart positioning in an uncertain environment.

**ALEX**: What I found most intriguing in the Q&A was the discussion around restructuring. They took $230 million in restructuring charges in Q4, mostly in EMEA, and expect the bulk of benefits to hit in the second half of 2026

This episode includes AI-generated content.]]>SP100-LIN-Q4-2025-enSun, 22 Feb 2026 21:35:48 +0000trueBeta Finch# Beta Finch Podcast Script: Linde Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Linde's Q4 2025 results, and folks, this industrial gas...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is Jordan. Today we're diving into Linde's Q4 2025 results, and folks, this industrial gas giant just delivered some impressive numbers despite a pretty challenging macro environment.

Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And what a quarter it was for Linde! They posted record quarterly and annual performance across operating profit, margins, and EPS. Fourth quarter sales hit $8.8 billion, up 6% year-over-year, with EPS of $4.20 - also up 6%. But here's what's really impressive - they maintained a 29.5% operating margin despite all the industrial headwinds.

**ALEX**: That margin performance is remarkable, especially when you consider what CEO Sanjiv Lamba called "a study in contrast" in the economic environment. On one hand, you had this massive AI and digital infrastructure boom driving unprecedented activity. But on the other hand, traditional industrial markets like manufacturing, metals, and chemicals were still struggling.

**JORDAN**: Exactly. And Lamba really painted this picture of geographic unevenness. The US remained resilient - no surprise there - with growth across almost every end market. Electronics and commercial space really stood out. But Europe? Still broadly weak across manufacturing sectors, though there were some bright spots in Scandinavian countries and maybe - and I stress maybe - some early optimism in Germany.

**ALEX**: What caught my attention was their commentary on China. After several tough quarters, Lamba mentioned they're finally seeing some bottoming out. Their China merchant business actually grew faster than the published industrial production number for the first time in a while. That's significant.

**JORDAN**: Absolutely. And let's talk about what's really driving growth here - their project backlog. They're sitting on a record $10 billion backlog, and that doesn't even include over half a billion in space-related investments. This space opportunity is fascinating, Alex. They're supporting about 65-75% of all launches, and with 189 launches last year, that's serious business.

**ALEX**: The space angle is really compelling. They just started up a plant in Brownsville in January, and Lamba mentioned they're building out networks in Texas and Florida - the two major launch hubs. He's expecting this to become a billion-dollar business for them in the coming years. Double-digit growth in a secular trend - that's exactly what investors want to see.

**JORDAN**: And speaking of growth investments, their CapEx jumped 17% in Q4, largely driven by that record project backlog. Now, this did pressure their return on capital down to the low-to-mid 20% range, but management says that's expected and temporary as these projects come online.

**ALEX**: Let's talk guidance because this is where it gets interesting. They're projecting 2026 EPS growth of 6-9%, which puts them in the $17.40 to $17.90 range. Now, some analysts were hoping for that 10%+ growth we've seen historically, so this might seem a bit conservative.

**JORDAN**: It definitely feels conservative, and management admitted as much. CFO Matt White used words like "guarded" and "prudent." But here's the thing - they're assuming zero base volume growth and are essentially letting investors plug in their own macro assumptions. That's smart positioning in an uncertain environment.

**ALEX**: What I found most intriguing in the Q&A was the discussion around restructuring. They took...]]>311falsefullhttps://www.spreaker.com/episode/coca-cola-q4-2025-earnings-analysis--70217329
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to bring you what really matters. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Coca-Cola's Q4 2025 earnings call - and wow, what a historic moment this was.

**ALEX:** Absolutely. Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** So Alex, let's start with the elephant in the room - this was CEO James Quincey's final earnings call after a decade at the helm.

**ALEX:** Right, and what a send-off! Quincey handed the reins to Henrique Braun, who's been with the company for over 30 years. But let's talk numbers first - Coca-Cola delivered on both their top and bottom line guidance for 2025, which is no small feat given the challenging macro environment.

**JORDAN:** The headline numbers are solid. They achieved 4% comparable earnings per share growth despite facing 5 points of currency headwinds and a 2-point increase in their tax rate. That's actually pretty impressive when you break it down.

**ALEX:** And they maintained their streak of gaining value share for 19 consecutive quarters. That's nearly five years of consistently winning market share, Jordan.

**JORDAN:** Let's dig into the Q4 specifics because there's an interesting story in the price-mix numbers. They reported only 1% price-mix growth, but CFO John Murphy clarified that underlying pricing was actually 4%, with a 3% negative mix impact from geography and timing issues.

**ALEX:** That's a perfect example of why Quincey urged analysts to take a "4-quarter view" rather than getting caught up in quarterly noise. When you smooth out the mix effects, you see consistent 5% revenue growth, which aligns with their long-term algorithm.

**JORDAN:** Speaking of long-term, let's talk about their 2026 guidance. They're projecting 4% to 5% organic revenue growth and 7% to 8% comparable EPS growth. But here's the kicker - they're expecting a more balanced mix between volume and pricing going forward.

**ALEX:** That's a key shift, Jordan. For the past few years, they've been heavily price-driven due to inflation. Now they're signaling a return to more balanced growth, which suggests they believe they can start winning back volume while maintaining pricing power.

**JORDAN:** But it's not all smooth sailing. They're facing some headwinds in key markets. Mexico is implementing an excise tax that will pressure volumes, China continues to see softer consumer spending, and India needs to rebuild momentum after a challenging 2025.

**ALEX:** New CEO Henrique Braun was pretty candid about this. He mentioned that their "all-weather strategy" helps them leverage strong markets to offset weaker ones. It's essentially a global portfolio approach - when one region struggles, others can pick up the slack.

**JORDAN:** Let's talk about innovation because Braun made some interesting comments here. He said their innovation "is not where it needs to be" and they need to get closer to consumers and improve speed to market.

**ALEX:** That was refreshingly honest. He talked about wanting to better anticipate the next growth opportunities in beverages and be more proactive rather than reactive. They announced two new billion-dollar brands - innocent and Santa Clara from Mexico - bringing their total to 32 billion-dollar brands.

**JORDAN:** The Mexico example is fascinating because Santa Clara started as a local value-added dairy brand and grew into a billion-dollar business. That's exactly the playbook Braun wants to replicate - start local, learn what works, then scale globally.

**ALEX:** Now let's talk about North America, which has been a real bright spo

This episode includes AI-generated content.]]>SP100-KO-Q4-2025-enSun, 22 Feb 2026 21:35:45 +0000trueBeta Finch**Beta Finch - Episode 127: Coca-Cola Q4 2025** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to bring you what really matters. I'm Alex. **JORDAN:** And I'm Jordan. Today we're...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to bring you what really matters. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Coca-Cola's Q4 2025 earnings call - and wow, what a historic moment this was.

**ALEX:** Absolutely. Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** So Alex, let's start with the elephant in the room - this was CEO James Quincey's final earnings call after a decade at the helm.

**ALEX:** Right, and what a send-off! Quincey handed the reins to Henrique Braun, who's been with the company for over 30 years. But let's talk numbers first - Coca-Cola delivered on both their top and bottom line guidance for 2025, which is no small feat given the challenging macro environment.

**JORDAN:** The headline numbers are solid. They achieved 4% comparable earnings per share growth despite facing 5 points of currency headwinds and a 2-point increase in their tax rate. That's actually pretty impressive when you break it down.

**ALEX:** And they maintained their streak of gaining value share for 19 consecutive quarters. That's nearly five years of consistently winning market share, Jordan.

**JORDAN:** Let's dig into the Q4 specifics because there's an interesting story in the price-mix numbers. They reported only 1% price-mix growth, but CFO John Murphy clarified that underlying pricing was actually 4%, with a 3% negative mix impact from geography and timing issues.

**ALEX:** That's a perfect example of why Quincey urged analysts to take a "4-quarter view" rather than getting caught up in quarterly noise. When you smooth out the mix effects, you see consistent 5% revenue growth, which aligns with their long-term algorithm.

**JORDAN:** Speaking of long-term, let's talk about their 2026 guidance. They're projecting 4% to 5% organic revenue growth and 7% to 8% comparable EPS growth. But here's the kicker - they're expecting a more balanced mix between volume and pricing going forward.

**ALEX:** That's a key shift, Jordan. For the past few years, they've been heavily price-driven due to inflation. Now they're signaling a return to more balanced growth, which suggests they believe they can start winning back volume while maintaining pricing power.

**JORDAN:** But it's not all smooth sailing. They're facing some headwinds in key markets. Mexico is implementing an excise tax that will pressure volumes, China continues to see softer consumer spending, and India needs to rebuild momentum after a challenging 2025.

**ALEX:** New CEO Henrique Braun was pretty candid about this. He mentioned that their "all-weather strategy" helps them leverage strong markets to offset weaker ones. It's essentially a global portfolio approach - when one region struggles, others can pick up the slack.

**JORDAN:** Let's talk about innovation because Braun made some interesting comments here. He said their innovation "is not where it needs to be" and they need to get closer to consumers and improve speed to market.

**ALEX:** That was refreshingly honest. He talked about wanting to better anticipate the next growth opportunities in beverages and be more proactive rather than reactive. They announced two new billion-dollar brands - innocent and Santa Clara from Mexico - bringing their total to 32 billion-dollar brands.

**JORDAN:** The Mexico example is fascinating because Santa Clara started as a local value-added dairy brand and grew into a billion-dollar business. That's...]]>125falsefullhttps://www.spreaker.com/episode/kla-q2-2026-earnings-analysis--70217328
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex quarterly reports into digestible insights. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into KLA Corporation's Q2 2026 earnings - that's ticker KLAC for those following along.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, KLA just posted some pretty impressive numbers. Walk us through the headline figures.

**JORDAN:** Alex, these results are really something. KLA delivered $3.3 billion in revenue for Q2, which represents 17% year-over-year growth. But here's what really caught my attention - their earnings per share jumped 29% to $8.85 on a non-GAAP basis. That's some serious operating leverage right there.

**ALEX:** That leverage is exactly what you want to see in a capital equipment company. And they're not just growing - they're throwing off serious cash. What did free cash flow look like?

**JORDAN:** Record-breaking, Alex. They hit $1.26 billion in quarterly free cash flow, and for the full year they generated $4.4 billion - that's 30% growth year-over-year. They returned $3 billion to shareholders through dividends and buybacks. For a company with their market cap, that's substantial capital allocation.

**ALEX:** Now, KLA is a semiconductor equipment company, specifically focused on process control - think inspection and measurement tools that ensure chips are made correctly. What's driving this growth?

**JORDAN:** It's really the AI story, Alex. CEO Rick Wallace was crystal clear that AI infrastructure demand is a core driver. Their tools are essential for manufacturing the advanced chips needed for AI applications - everything from leading-edge foundry logic to high-bandwidth memory, or HBM.

What's fascinating is they're seeing process control intensity increase dramatically, especially in memory. Wallace mentioned that DRAM manufacturing now looks "much more similar to what logic did not that long ago" in terms of requiring sophisticated inspection tools.

**ALEX:** That's a key point about intensity. Can you break that down for our listeners?

**JORDAN:** Absolutely. Process control intensity basically means how much inspection and measurement equipment you need per dollar of total semiconductor equipment spending. As chips get more complex - smaller features, more layers, tighter specifications - you need proportionally more of KLA's tools.

In DRAM memory, they're seeing about 100 basis points of intensity increase with EUV lithography adoption, and another 100 basis points with HBM. That's essentially doubling their addressable market per chip produced.

**ALEX:** Speaking of markets, let's talk guidance. What's KLA expecting for 2026?

**JORDAN:** Here's where it gets interesting. For the full year, they're guiding for mid-single digit revenue growth, but CFO Bren Higgins emphasized that growth will accelerate in the second half. They're expecting the core wafer fab equipment market to grow high single to low double digits to about $120 billion, plus an additional $12 billion advanced packaging market.

But there's a constraint story here, Alex.

**ALEX:** Right, supply constraints. This came up multiple times in the Q&A. What's the issue?

**JORDAN:** Two main problems. First, KLA themselves are constrained by long lead-time components, especially optics. Higgins said decisions they made last summer are affecting what they can ship in the first half of 2026. Their lead times are extending because demand is so strong.

But second, and this is crucial - their customers are also constrained. Multiple executives mentioned that chipmakers are "frustrated with the shells that they ha

This episode includes AI-generated content.]]>SP100-KLAC-Q2-2026-enSun, 22 Feb 2026 21:35:41 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex quarterly reports into digestible insights. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex quarterly reports into digestible insights. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into KLA Corporation's Q2 2026 earnings - that's ticker KLAC for those following along.

Before we jump in, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, KLA just posted some pretty impressive numbers. Walk us through the headline figures.

**JORDAN:** Alex, these results are really something. KLA delivered $3.3 billion in revenue for Q2, which represents 17% year-over-year growth. But here's what really caught my attention - their earnings per share jumped 29% to $8.85 on a non-GAAP basis. That's some serious operating leverage right there.

**ALEX:** That leverage is exactly what you want to see in a capital equipment company. And they're not just growing - they're throwing off serious cash. What did free cash flow look like?

**JORDAN:** Record-breaking, Alex. They hit $1.26 billion in quarterly free cash flow, and for the full year they generated $4.4 billion - that's 30% growth year-over-year. They returned $3 billion to shareholders through dividends and buybacks. For a company with their market cap, that's substantial capital allocation.

**ALEX:** Now, KLA is a semiconductor equipment company, specifically focused on process control - think inspection and measurement tools that ensure chips are made correctly. What's driving this growth?

**JORDAN:** It's really the AI story, Alex. CEO Rick Wallace was crystal clear that AI infrastructure demand is a core driver. Their tools are essential for manufacturing the advanced chips needed for AI applications - everything from leading-edge foundry logic to high-bandwidth memory, or HBM.

What's fascinating is they're seeing process control intensity increase dramatically, especially in memory. Wallace mentioned that DRAM manufacturing now looks "much more similar to what logic did not that long ago" in terms of requiring sophisticated inspection tools.

**ALEX:** That's a key point about intensity. Can you break that down for our listeners?

**JORDAN:** Absolutely. Process control intensity basically means how much inspection and measurement equipment you need per dollar of total semiconductor equipment spending. As chips get more complex - smaller features, more layers, tighter specifications - you need proportionally more of KLA's tools.

In DRAM memory, they're seeing about 100 basis points of intensity increase with EUV lithography adoption, and another 100 basis points with HBM. That's essentially doubling their addressable market per chip produced.

**ALEX:** Speaking of markets, let's talk guidance. What's KLA expecting for 2026?

**JORDAN:** Here's where it gets interesting. For the full year, they're guiding for mid-single digit revenue growth, but CFO Bren Higgins emphasized that growth will accelerate in the second half. They're expecting the core wafer fab equipment market to grow high single to low double digits to about $120 billion, plus an additional $12 billion advanced packaging market.

But there's a constraint story here, Alex.

**ALEX:** Right, supply constraints. This came up multiple times in the Q&A. What's the issue?

**JORDAN:** Two main problems. First, KLA themselves are constrained by long lead-time components, especially optics. Higgins said decisions they made last summer are affecting what they can ship in the first half of 2026. Their lead times are extending because...]]>165falsefullhttps://www.spreaker.com/episode/ibm-q4-2025-earnings-analysis--70217326
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into IBM's Q4 2025 earnings, and wow - this might be the strongest quarter we've seen from Big Blue in over a decade.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, let's talk numbers because IBM just delivered some pretty impressive results. What caught your eye first?

ALEX: The headline number is huge - 9% revenue growth in Q4, which is their highest in over three years. But what's really striking is the full-year performance. They hit 6% revenue growth for 2025, which might not sound earth-shattering, but for IBM, this represents their best year in ages.

JORDAN: And the cash generation story is even better. They generated $14.7 billion in free cash flow - that's their highest level in over a decade and represents their best free cash flow margin in their 114-year history. That's not a typo, folks - 114 years.

ALEX: Let's break down what's driving this transformation. CEO Arvind Krishna has been repositioning IBM as a software-led company, and it's really paying off. Software now represents 45% of their business, up from just 25% back in 2018.

JORDAN: The software segment is where the magic is happening. It grew 11% in Q4 and 9% for the full year - which Krishna called their highest annual software growth rate in history. Three of their four software sub-segments hit double-digit growth.

ALEX: What's particularly interesting is their AI strategy. Their cumulative Gen AI book of business now stands at over $12.5 billion. That's split between more than $2 billion in software and over $10.5 billion in consulting.

JORDAN: But here's the kicker - this is the last quarter they're going to report that Gen AI metric separately. CFO Jim Kavanaugh said AI is now so embedded across their entire business that a standalone metric doesn't capture the full value anymore.

ALEX: That's actually a smart move. It shows they're not treating AI as a separate product line but as a foundational technology that enhances everything they do. Speaking of which, their mainframe business had an absolute monster year.

JORDAN: The Z17 mainframe launch has been phenomenal. Infrastructure revenue grew 17% in Q4, with IBM Z up 61% year-over-year. Krishna mentioned this represents the highest annual revenue for their mainframe business in about twenty years.

ALEX: What's fascinating about the mainframe story is how they're positioning it for the AI era. The Z17 can process 50% more AI inferencing operations per day than the previous generation, and it brings real-time AI capabilities directly into the mainframe environment.

JORDAN: That's a key differentiator. Instead of having to send data off-platform for AI processing - which takes seconds - they can do it inline in milliseconds. For financial institutions and other mission-critical applications, that speed difference is game-changing.

ALEX: Let's talk acquisitions because that's been a big part of their strategy. They're in the process of acquiring Confluent, which should close by mid-2026. Kavanaugh expects about $600 million in dilution from that deal initially.

JORDAN: But they're confident it'll be accretive to adjusted EBITDA within the first full year. This follows their successful HashiCorp acquisition, which delivered record bookings and is already ahead of accretion expectations.

ALEX: The productivity story is remarkable too. They originally set a goal to achieve $2 billion in productivity savings by the end of 2024. They're now at $4.5 billion in annual run-rate savings and expect to hit $5.5 billion by the end of 2026.

JORDAN: That productiv

This episode includes AI-generated content.]]>SP100-IBM-Q4-2025-enSun, 22 Feb 2026 21:35:37 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into IBM's Q4 2025 earnings, and wow - this might be the strongest quarter we've seen from Big...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into IBM's Q4 2025 earnings, and wow - this might be the strongest quarter we've seen from Big Blue in over a decade.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, let's talk numbers because IBM just delivered some pretty impressive results. What caught your eye first?

ALEX: The headline number is huge - 9% revenue growth in Q4, which is their highest in over three years. But what's really striking is the full-year performance. They hit 6% revenue growth for 2025, which might not sound earth-shattering, but for IBM, this represents their best year in ages.

JORDAN: And the cash generation story is even better. They generated $14.7 billion in free cash flow - that's their highest level in over a decade and represents their best free cash flow margin in their 114-year history. That's not a typo, folks - 114 years.

ALEX: Let's break down what's driving this transformation. CEO Arvind Krishna has been repositioning IBM as a software-led company, and it's really paying off. Software now represents 45% of their business, up from just 25% back in 2018.

JORDAN: The software segment is where the magic is happening. It grew 11% in Q4 and 9% for the full year - which Krishna called their highest annual software growth rate in history. Three of their four software sub-segments hit double-digit growth.

ALEX: What's particularly interesting is their AI strategy. Their cumulative Gen AI book of business now stands at over $12.5 billion. That's split between more than $2 billion in software and over $10.5 billion in consulting.

JORDAN: But here's the kicker - this is the last quarter they're going to report that Gen AI metric separately. CFO Jim Kavanaugh said AI is now so embedded across their entire business that a standalone metric doesn't capture the full value anymore.

ALEX: That's actually a smart move. It shows they're not treating AI as a separate product line but as a foundational technology that enhances everything they do. Speaking of which, their mainframe business had an absolute monster year.

JORDAN: The Z17 mainframe launch has been phenomenal. Infrastructure revenue grew 17% in Q4, with IBM Z up 61% year-over-year. Krishna mentioned this represents the highest annual revenue for their mainframe business in about twenty years.

ALEX: What's fascinating about the mainframe story is how they're positioning it for the AI era. The Z17 can process 50% more AI inferencing operations per day than the previous generation, and it brings real-time AI capabilities directly into the mainframe environment.

JORDAN: That's a key differentiator. Instead of having to send data off-platform for AI processing - which takes seconds - they can do it inline in milliseconds. For financial institutions and other mission-critical applications, that speed difference is game-changing.

ALEX: Let's talk acquisitions because that's been a big part of their strategy. They're in the process of acquiring Confluent, which should close by mid-2026. Kavanaugh expects about $600 million in dilution from that deal initially.

JORDAN: But they're confident it'll be accretive to adjusted EBITDA within the first full year. This follows their successful HashiCorp acquisition, which delivered record bookings and is already ahead of accretion expectations.

ALEX: The productivity story is remarkable too. They originally set a goal to achieve...]]>171falsefullhttps://www.spreaker.com/episode/honeywell-q4-2025-earnings-analysis--70217325
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex.

JORDAN: And I'm Jordan. Before we dive in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Today we're breaking down Honeywell's Q4 2025 earnings call, and wow - there's a lot happening at this industrial giant. Jordan, where do we even start with this one?

JORDAN: Alex, this is probably one of the busiest transformation stories we've covered. Honeywell is essentially splitting itself into three separate companies while posting some pretty impressive numbers. Let's start with the financial highlights because they're actually quite strong.

ALEX: Right, so Q4 revenue grew 11% organically, or 6% if you exclude this Bombardier agreement impact they keep mentioning. What really caught my attention was their orders growth - up 23% in the quarter. That's huge for an industrial company.

JORDAN: Exactly, and that massive order growth pushed their backlog to over $37 billion, which is a new record. CEO Vimal Kapur seemed pretty excited about this, calling it validation of their market positions. But here's what I find interesting - they're guiding for 2026 organic sales growth of just 3% to 6%. That seems conservative given the order strength, doesn't it?

ALEX: It does feel conservative, but I think management is being cautious about the macro environment. They're seeing some weakness in Europe and China, particularly in their industrial automation business. CFO Mike Stepniak mentioned that different regions are performing very differently - the US and Middle East are strong, but Europe is just "okay."

JORDAN: And speaking of regional differences, let's talk about their pricing power. Honeywell has been capturing about 4% price increases, which is well above their historical 1-2% range. Kapur explained this isn't just tariff pass-throughs - they're seeing persistent inflation in labor costs, electronics, and commodities that's forcing a more mature pricing strategy.

ALEX: That's a key point because sustainable pricing power often separates great industrial companies from average ones. Now, Jordan, let's dive into this massive portfolio transformation they're executing. Can you walk our listeners through what's happening?

JORDAN: Sure. So Honeywell is essentially breaking itself apart. They already spun off their Advanced Materials business in October - that's now trading as Solstice. Next up, they're spinning off Aerospace in Q3 2026, which is actually ahead of their original timeline. They've already named the leadership team for that spin-off.

ALEX: And they're not stopping there. They announced they're selling their Productivity Solutions and Services business plus their Warehouse and Workflow Solutions. Kapur said they expect to sign deals in Q2. What's the strategic logic here?

JORDAN: It's all about focus and growth rates, Alex. By shedding these businesses, Honeywell is essentially choosing to exit the transportation, logistics, and warehouse markets to concentrate on three core areas: process automation, buildings, and industrial sensing. The remaining industrial automation business becomes much simpler - basically a sensing and measurement company.

ALEX: That makes sense. Sometimes less really is more in the corporate world. Now, there was some interesting discussion about their quantum computing venture, Quantinuum. This isn't your typical industrial business unit.

JORDAN: Not at all! Quantinuum just raised $840 million at a $10 billion valuation and launched something called Helios, which they claim is the world's most accurate commercial quantum computer. Honeywell is investing about $100 million more in 2026 than they

This episode includes AI-generated content.]]>SP100-HON-Q4-2025-enSun, 22 Feb 2026 21:35:33 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex. JORDAN: And I'm Jordan. Before we dive in, this podcast is...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex.

JORDAN: And I'm Jordan. Before we dive in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Today we're breaking down Honeywell's Q4 2025 earnings call, and wow - there's a lot happening at this industrial giant. Jordan, where do we even start with this one?

JORDAN: Alex, this is probably one of the busiest transformation stories we've covered. Honeywell is essentially splitting itself into three separate companies while posting some pretty impressive numbers. Let's start with the financial highlights because they're actually quite strong.

ALEX: Right, so Q4 revenue grew 11% organically, or 6% if you exclude this Bombardier agreement impact they keep mentioning. What really caught my attention was their orders growth - up 23% in the quarter. That's huge for an industrial company.

JORDAN: Exactly, and that massive order growth pushed their backlog to over $37 billion, which is a new record. CEO Vimal Kapur seemed pretty excited about this, calling it validation of their market positions. But here's what I find interesting - they're guiding for 2026 organic sales growth of just 3% to 6%. That seems conservative given the order strength, doesn't it?

ALEX: It does feel conservative, but I think management is being cautious about the macro environment. They're seeing some weakness in Europe and China, particularly in their industrial automation business. CFO Mike Stepniak mentioned that different regions are performing very differently - the US and Middle East are strong, but Europe is just "okay."

JORDAN: And speaking of regional differences, let's talk about their pricing power. Honeywell has been capturing about 4% price increases, which is well above their historical 1-2% range. Kapur explained this isn't just tariff pass-throughs - they're seeing persistent inflation in labor costs, electronics, and commodities that's forcing a more mature pricing strategy.

ALEX: That's a key point because sustainable pricing power often separates great industrial companies from average ones. Now, Jordan, let's dive into this massive portfolio transformation they're executing. Can you walk our listeners through what's happening?

JORDAN: Sure. So Honeywell is essentially breaking itself apart. They already spun off their Advanced Materials business in October - that's now trading as Solstice. Next up, they're spinning off Aerospace in Q3 2026, which is actually ahead of their original timeline. They've already named the leadership team for that spin-off.

ALEX: And they're not stopping there. They announced they're selling their Productivity Solutions and Services business plus their Warehouse and Workflow Solutions. Kapur said they expect to sign deals in Q2. What's the strategic logic here?

JORDAN: It's all about focus and growth rates, Alex. By shedding these businesses, Honeywell is essentially choosing to exit the transportation, logistics, and warehouse markets to concentrate on three core areas: process automation, buildings, and industrial sensing. The remaining industrial automation business becomes much simpler - basically a sensing and measurement company.

ALEX: That makes sense. Sometimes less really is more in the corporate world. Now, there was some interesting discussion about their quantum computing venture, Quantinuum. This isn't your typical industrial business unit.

JORDAN: Not at all! Quantinuum just raised $840 million at a $10 billion valuation and launched something...]]>195falsefullhttps://www.spreaker.com/episode/gilead-q4-2025-earnings-analysis--70217324
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Gilead Sciences' Q4 2025 results - and folks, there's a lot to dig into here.

Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Gilead! The biotech giant just wrapped up what CEO Dan O'Day called "a remarkable year" - and the numbers certainly back that up. They hit $28.9 billion in total product sales for 2025, beating their guidance range and showing some serious momentum heading into 2026.

**ALEX:** Absolutely, Jordan. Let's break down those headline numbers first. Total product sales came in at $7.9 billion for Q4, up 5% year-over-year. But here's what caught my attention - when you strip out their COVID drug Veclury, which has been declining as expected, their base business actually grew 7% in the quarter and 4% for the full year.

**JORDAN:** That's a key distinction, Alex. And speaking of key numbers, their HIV business - which is still their cash cow - delivered $20.8 billion in sales for the year, up 6%. But here's where it gets interesting: they faced an estimated $900 million headwind from Medicare Part D redesign changes. Without that policy impact, their HIV business would have grown 10%.

**ALEX:** That Medicare Part D impact is huge context, Jordan. For listeners who might not be familiar, this was a policy change that affected how drug pricing works for seniors on Medicare. So when Gilead says their underlying HIV business grew 10%, that's actually pretty impressive growth for what's considered a mature market.

**JORDAN:** Exactly. And let's talk about the star of the show - YES2GO. This is their twice-yearly injectable HIV prevention drug that launched in 2025, and it's already showing blockbuster potential. They did $150 million in sales for the year, and here's the kicker - they're guiding for $800 million in 2026.

**ALEX:** That's more than a 5x increase, Jordan. During the Q&A, analysts were really pressing on how realistic that number is. Management seems confident though, citing 90% payer coverage already - including all major insurers - with about 90% of covered patients getting it with zero co-pay.

**JORDAN:** The coverage piece is critical, Alex. Commercial launch is one thing, but getting insurance companies to pay for a premium-priced injectable is another. The fact that they hit their 90% coverage target well ahead of their one-year timeline suggests the value proposition is resonating with payers.

**ALEX:** Let's shift to their pipeline, because this is where things get really interesting for long-term investors. They have four potential product launches coming in 2026, plus five Phase III data readouts across HIV, cancer, and liver disease.

**JORDAN:** Right, and this diversification strategy is really starting to pay off. Their cancer drug Trodelvy grew 6% to $1.4 billion, and they just got positive Phase III data that could expand it from second-line to first-line treatment in triple-negative breast cancer. That's potentially doubling the addressable market.

**ALEX:** And Trodelvy isn't their only oncology play. They're preparing to launch something called Anidocel - a CAR-T therapy for multiple myeloma. The clinical data looks strong with a 96% overall response rate and what they're calling a "best-in-disease" safety profile.

**JORDAN:** The safety piece is huge in CAR-T, Alex. These are powerful but potentially toxic treatments. If they can deliver the efficacy without the severe side effects, that's a real competitive advant

This episode includes AI-generated content.]]>SP100-GILD-Q4-2025-enSun, 22 Feb 2026 21:35:30 +0000trueBeta Finch# Beta Finch Podcast Script: Gilead Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into the numbers that move markets. I'm Alex, and as always, I'm joined by my co-host Jordan. Today we're unpacking Gilead Sciences' Q4 2025 results - and folks, there's a lot to dig into here.

Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And what a quarter this was for Gilead! The biotech giant just wrapped up what CEO Dan O'Day called "a remarkable year" - and the numbers certainly back that up. They hit $28.9 billion in total product sales for 2025, beating their guidance range and showing some serious momentum heading into 2026.

**ALEX:** Absolutely, Jordan. Let's break down those headline numbers first. Total product sales came in at $7.9 billion for Q4, up 5% year-over-year. But here's what caught my attention - when you strip out their COVID drug Veclury, which has been declining as expected, their base business actually grew 7% in the quarter and 4% for the full year.

**JORDAN:** That's a key distinction, Alex. And speaking of key numbers, their HIV business - which is still their cash cow - delivered $20.8 billion in sales for the year, up 6%. But here's where it gets interesting: they faced an estimated $900 million headwind from Medicare Part D redesign changes. Without that policy impact, their HIV business would have grown 10%.

**ALEX:** That Medicare Part D impact is huge context, Jordan. For listeners who might not be familiar, this was a policy change that affected how drug pricing works for seniors on Medicare. So when Gilead says their underlying HIV business grew 10%, that's actually pretty impressive growth for what's considered a mature market.

**JORDAN:** Exactly. And let's talk about the star of the show - YES2GO. This is their twice-yearly injectable HIV prevention drug that launched in 2025, and it's already showing blockbuster potential. They did $150 million in sales for the year, and here's the kicker - they're guiding for $800 million in 2026.

**ALEX:** That's more than a 5x increase, Jordan. During the Q&A, analysts were really pressing on how realistic that number is. Management seems confident though, citing 90% payer coverage already - including all major insurers - with about 90% of covered patients getting it with zero co-pay.

**JORDAN:** The coverage piece is critical, Alex. Commercial launch is one thing, but getting insurance companies to pay for a premium-priced injectable is another. The fact that they hit their 90% coverage target well ahead of their one-year timeline suggests the value proposition is resonating with payers.

**ALEX:** Let's shift to their pipeline, because this is where things get really interesting for long-term investors. They have four potential product launches coming in 2026, plus five Phase III data readouts across HIV, cancer, and liver disease.

**JORDAN:** Right, and this diversification strategy is really starting to pay off. Their cancer drug Trodelvy grew 6% to $1.4 billion, and they just got positive Phase III data that could expand it from second-line to first-line treatment in triple-negative breast cancer. That's potentially doubling the addressable market.

**ALEX:** And Trodelvy isn't their only oncology play. They're preparing to launch something called Anidocel - a CAR-T therapy for multiple myeloma. The clinical data looks strong with a 96% overall response rate and what they're calling a "best-in-disease" safety profile.

**JORDAN:** The safety piece is huge in CAR-T, Alex. These are...]]>72falsefullhttps://www.spreaker.com/episode/ge-vernova-q4-2025-earnings-analysis--70217323
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're diving into GE Vernova's fourth quarter 2025 earnings - and wow, what a quarter this was.

**JORDAN:** Absolutely, Alex. But before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks Jordan. So GE Vernova - this is the power generation and electrical equipment spinoff from GE that's been really making waves since going public. Jordan, what jumped out at you first from these numbers?

**JORDAN:** The scale is just incredible, Alex. We're talking about a $150 billion backlog - that's up 25% or $31 billion year-over-year. And they booked $59 billion in orders for the full year, up 34%. For context, their revenue was $38 billion, so they're booking orders at about 1.5 times their current revenue run rate.

**ALEX:** That's a massive order book. And CEO Scott Strazik seemed particularly excited about their gas power business. Can you break down what's happening there?

**JORDAN:** Gas power is absolutely on fire - no pun intended. They went from having 46 gigawatts under contract at the start of 2025 to 83 gigawatts by year-end. That's almost doubling their contracted capacity in a single year. And here's the kicker - they expect to hit 100 gigawatts by the end of 2026.

**ALEX:** What's driving this demand surge?

**JORDAN:** It's really the perfect storm of factors. You've got data centers consuming massive amounts of power, aging grid infrastructure, and the need for reliable baseload power as renewable intermittency creates challenges. Strazik mentioned they signed 6 gigawatts of new gas contracts just in the last three weeks of December alone.

**ALEX:** And they're not just winning on volume - they're getting better pricing too, right?

**JORDAN:** Exactly. This was one of the most interesting parts of the call. They added $8 billion in equipment backlog margin dollars in 2025 - that's more than the previous two years combined. In their Power segment specifically, they saw 11 percentage points of margin improvement in their equipment backlog. Strazik mentioned their current slot reservation agreements are pricing 10 to 20 points higher than their existing backlog.

**ALEX:** That pricing power is impressive. Now, it wasn't all good news though. Their Wind segment continues to struggle, particularly with offshore projects.

**JORDAN:** Yeah, the Wind segment is definitely the problem child. They had $600 million in losses for the year, which was worse than their $400 million expectation. The big issue was a U.S. government stop-work order on December 22nd that halted all offshore wind construction, including their Vineyard Wind project that was nearly complete.

**ALEX:** That's got to be frustrating - being so close to finishing a project and then getting shut down by regulatory action.

**JORDAN:** Absolutely. CFO Ken Parks said they only had 10 turbines left needing blades and 1 turbine left to install when the order came down. The good news is they got an injunction yesterday, so they might be able to resume work. But if they can't complete those remaining 11 turbines, it could impact 2026 revenue by about $250 million.

**ALEX:** Let's talk about their Electrification business - that seems to be a real growth driver.

**JORDAN:** This is probably the most exciting part of the story long-term. Electrification revenue grew 26% in 2025, and they're expecting it to hit $13.5 to $14 billion in 2026. To put that in perspective, this business was doing about $5 billion in revenue back in 2022. So we're talking about nearly tripli

This episode includes AI-generated content.]]>SP100-GEV-Q4-2025-enSun, 22 Feb 2026 21:35:27 +0000trueBeta Finch# Beta Finch Podcast Script - GE Vernova Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we decode the latest corporate results so you don't have to. I'm Alex, and joining me as always is Jordan. Today we're diving into GE Vernova's fourth quarter 2025 earnings - and wow, what a quarter this was.

**JORDAN:** Absolutely, Alex. But before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks Jordan. So GE Vernova - this is the power generation and electrical equipment spinoff from GE that's been really making waves since going public. Jordan, what jumped out at you first from these numbers?

**JORDAN:** The scale is just incredible, Alex. We're talking about a $150 billion backlog - that's up 25% or $31 billion year-over-year. And they booked $59 billion in orders for the full year, up 34%. For context, their revenue was $38 billion, so they're booking orders at about 1.5 times their current revenue run rate.

**ALEX:** That's a massive order book. And CEO Scott Strazik seemed particularly excited about their gas power business. Can you break down what's happening there?

**JORDAN:** Gas power is absolutely on fire - no pun intended. They went from having 46 gigawatts under contract at the start of 2025 to 83 gigawatts by year-end. That's almost doubling their contracted capacity in a single year. And here's the kicker - they expect to hit 100 gigawatts by the end of 2026.

**ALEX:** What's driving this demand surge?

**JORDAN:** It's really the perfect storm of factors. You've got data centers consuming massive amounts of power, aging grid infrastructure, and the need for reliable baseload power as renewable intermittency creates challenges. Strazik mentioned they signed 6 gigawatts of new gas contracts just in the last three weeks of December alone.

**ALEX:** And they're not just winning on volume - they're getting better pricing too, right?

**JORDAN:** Exactly. This was one of the most interesting parts of the call. They added $8 billion in equipment backlog margin dollars in 2025 - that's more than the previous two years combined. In their Power segment specifically, they saw 11 percentage points of margin improvement in their equipment backlog. Strazik mentioned their current slot reservation agreements are pricing 10 to 20 points higher than their existing backlog.

**ALEX:** That pricing power is impressive. Now, it wasn't all good news though. Their Wind segment continues to struggle, particularly with offshore projects.

**JORDAN:** Yeah, the Wind segment is definitely the problem child. They had $600 million in losses for the year, which was worse than their $400 million expectation. The big issue was a U.S. government stop-work order on December 22nd that halted all offshore wind construction, including their Vineyard Wind project that was nearly complete.

**ALEX:** That's got to be frustrating - being so close to finishing a project and then getting shut down by regulatory action.

**JORDAN:** Absolutely. CFO Ken Parks said they only had 10 turbines left needing blades and 1 turbine left to install when the order came down. The good news is they got an injunction yesterday, so they might be able to resume work. But if they can't complete those remaining 11 turbines, it could impact 2026 revenue by about $250 million.

**ALEX:** Let's talk about their Electrification business - that seems to be a real growth driver.

**JORDAN:** This is probably the most exciting part of the story long-term. Electrification revenue grew 26% in 2025, and they're expecting it to...]]>55falsefullhttps://www.spreaker.com/episode/duke-energy-q4-2025-earnings-analysis--70217322
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results so you don't have to. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Duke Energy's fourth quarter 2025 earnings call, and folks, this utility is making some serious power moves.

Now, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, Duke Energy really delivered some impressive numbers. Let's start with the headline figures - they posted earnings per share of $6.31 for 2025, which represents 7% growth year-over-year and came in above the midpoint of their guidance range. But here's what really caught my attention - they're projecting 2026 EPS guidance of $6.55 to $6.80 and extending their long-term growth target of 5% to 7% through 2030.

**ALEX**: That's solid execution, Jordan. But what really stood out to me was the sheer scale of their capital investment plans. CEO Harry Sideris announced they're raising their five-year capital plan to $103 billion - that's a $6 billion increase from their previous plan. He called it "the largest fully regulated capital plan in the industry." That's not just growth, that's transformation.

**JORDAN**: Absolutely, and when you dig into what's driving that massive capital spend, it's fascinating. They're adding approximately 14 gigawatts of incremental capacity over the next five years. That includes breaking ground on five gigawatts of new natural gas generation across the Carolinas and Indiana. But here's the kicker - they've already locked in contracts for the supply chain and workforce needed to support this build.

**ALEX**: Smart planning there. And speaking of smart planning, let's talk about the data center story because this is where Duke is really differentiating itself. Since their third quarter call, they've signed electric service agreements for another 1.5 gigawatts of new data centers, bringing their total to 4.5 gigawatts under contract.

**JORDAN**: The data center angle is crucial, Alex. CFO Brian Savoy mentioned they have another 9 gigawatts in their active pipeline. But what I really appreciated was how they're protecting existing customers. These contracts include minimum billing requirements, termination charges, and refundable capital advances. Basically, the data centers pay their fair share and then some.

**ALEX**: That customer protection angle came up repeatedly in the Q&A. One analyst asked about affordability concerns, and Sideris was pretty direct about it. He acknowledged that families and businesses feel every rate increase, especially with housing costs, insurance, and food prices all going up. But he emphasized that Duke's rate increases have averaged below inflation over the past decade, and they're using tax credits - over $500 million annually from their nuclear operations - to help offset customer costs.

**JORDAN**: Which brings us to an interesting regulatory story. They just completed settlements in South Carolina that were fully approved in December, and they're progressing with multiyear rate plans in North Carolina that would take effect in 2027. The North Carolina case is particularly important because it includes their proposal to combine the Carolinas utilities, which could save customers over $1 billion through 2038.

**ALEX**: Now Jordan, one thing that jumped out during the Q&A was when an analyst asked about the gap between their 9.6% earnings base growth and their 5% to 7% EPS growth target. Savoy explained that the difference comes from normal utility math - holding company costs, equity dilution from funding the investments. But he was very confident about hitting t

This episode includes AI-generated content.]]>SP100-DUK-Q4-2025-enSun, 22 Feb 2026 21:35:23 +0000trueBeta Finch# Beta Finch Podcast Script: Duke Energy Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results so you don't have to. I'm Alex, and I'm here with my co-host Jordan. Today we're...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we dive deep into quarterly results so you don't have to. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Duke Energy's fourth quarter 2025 earnings call, and folks, this utility is making some serious power moves.

Now, before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And wow, Duke Energy really delivered some impressive numbers. Let's start with the headline figures - they posted earnings per share of $6.31 for 2025, which represents 7% growth year-over-year and came in above the midpoint of their guidance range. But here's what really caught my attention - they're projecting 2026 EPS guidance of $6.55 to $6.80 and extending their long-term growth target of 5% to 7% through 2030.

**ALEX**: That's solid execution, Jordan. But what really stood out to me was the sheer scale of their capital investment plans. CEO Harry Sideris announced they're raising their five-year capital plan to $103 billion - that's a $6 billion increase from their previous plan. He called it "the largest fully regulated capital plan in the industry." That's not just growth, that's transformation.

**JORDAN**: Absolutely, and when you dig into what's driving that massive capital spend, it's fascinating. They're adding approximately 14 gigawatts of incremental capacity over the next five years. That includes breaking ground on five gigawatts of new natural gas generation across the Carolinas and Indiana. But here's the kicker - they've already locked in contracts for the supply chain and workforce needed to support this build.

**ALEX**: Smart planning there. And speaking of smart planning, let's talk about the data center story because this is where Duke is really differentiating itself. Since their third quarter call, they've signed electric service agreements for another 1.5 gigawatts of new data centers, bringing their total to 4.5 gigawatts under contract.

**JORDAN**: The data center angle is crucial, Alex. CFO Brian Savoy mentioned they have another 9 gigawatts in their active pipeline. But what I really appreciated was how they're protecting existing customers. These contracts include minimum billing requirements, termination charges, and refundable capital advances. Basically, the data centers pay their fair share and then some.

**ALEX**: That customer protection angle came up repeatedly in the Q&A. One analyst asked about affordability concerns, and Sideris was pretty direct about it. He acknowledged that families and businesses feel every rate increase, especially with housing costs, insurance, and food prices all going up. But he emphasized that Duke's rate increases have averaged below inflation over the past decade, and they're using tax credits - over $500 million annually from their nuclear operations - to help offset customer costs.

**JORDAN**: Which brings us to an interesting regulatory story. They just completed settlements in South Carolina that were fully approved in December, and they're progressing with multiyear rate plans in North Carolina that would take effect in 2027. The North Carolina case is particularly important because it includes their proposal to combine the Carolinas utilities, which could save customers over $1 billion through 2038.

**ALEX**: Now Jordan, one thing that jumped out during the Q&A was when an analyst asked about the gap between their 9.6% earnings base growth and their 5% to 7% EPS growth target. Savoy explained that the difference comes from normal utility math -...]]>83falsefullhttps://www.spreaker.com/episode/disney-q1-2026-earnings-analysis--70217320
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Disney's Q1 2026 earnings - and wow, what a quarter this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now, Alex, Disney just reported some pretty impressive numbers. The experiences segment hit over $10 billion in quarterly revenue for the first time ever. That's massive.

**ALEX:** It really is, Jordan. But let's start with the big picture here. Disney seems to be firing on all cylinders - their film studio generated over $6.5 billion in global box office revenue in calendar 2025, making it their third biggest year ever. We're talking about three billion-dollar movies: Avatar: Fire and Ash, Zootopia 2, and Lilo and Stitch.

**JORDAN:** And Zootopia 2 became Hollywood's highest-grossing animated film of all time at $1.7 billion. But here's what I find fascinating - CEO Bob Iger specifically mentioned how these theatrical successes are creating this flywheel effect. When Zootopia 2 and Avatar hit Disney Plus, they're seeing millions of first streams and hundreds of millions of new viewing hours.

**ALEX:** That interconnected strategy is really paying off. Speaking of streaming, they saw a 13% increase in subscription revenue, and the segment is now profitable with margins hitting around that 10% target they set.

**JORDAN:** Right, and CFO Hugh Johnston mentioned they're actually exceeding that target - they hit 12% revenue growth with about 50% earnings growth in streaming. That's serious operating leverage. But what caught my attention was this OpenAI partnership with Sora.

**ALEX:** Oh, the AI content play. So Disney struck a three-year licensing deal where users can prompt Sora to create 30-second videos featuring about 250 Disney characters. Iger was careful to note these don't include human voices or faces - probably for obvious legal and creative reasons.

**JORDAN:** And they're planning to curate this Sora-generated content on Disney Plus as a way to add short-form video features. Iger mentioned they've noticed the huge growth in short-form content on platforms like YouTube, so this is their way of jumping into that space while maintaining that Disney brand control.

**ALEX:** What I found interesting was when an analyst asked about the impact on traditional programming needs, and Iger basically said this won't cannibalize anything. He sees AI as serving three purposes: enhancing creativity, improving productivity, and creating better connectivity with consumers.

**JORDAN:** Smart positioning. Now, let's talk ESPN because that NFL Network acquisition they just closed is a big deal. ESPN delivered its second-highest Monday Night Football viewership in twenty years, and they're gearing up for their first Super Bowl broadcast.

**ALEX:** And Jordan, the timing couldn't be better with ESPN launching their direct-to-consumer streaming service. The subscriber decline in traditional ESPN slowed to just 4% - a major improvement from the 7-8% drops they were seeing before.

**JORDAN:** The bundling strategy is clearly working. Subscribers who get the Disney Plus, Hulu, and ESPN bundle are churning less, which is huge for lifetime value. Iger mentioned they're working toward a fully integrated app experience by the end of the calendar year.

**ALEX:** Let's shift to experiences because $10 billion in quarterly revenue is just staggering. They've got expansion projects at every single theme park, the new Frozen land opening at Disneyland Paris next month, and they just launched the Disney Destiny cru

This episode includes AI-generated content.]]>SP100-DIS-Q1-2026-enSun, 22 Feb 2026 21:35:20 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn quarterly reports into conversations that actually make sense. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Disney's Q1 2026 earnings - and wow, what a quarter this was.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now, Alex, Disney just reported some pretty impressive numbers. The experiences segment hit over $10 billion in quarterly revenue for the first time ever. That's massive.

**ALEX:** It really is, Jordan. But let's start with the big picture here. Disney seems to be firing on all cylinders - their film studio generated over $6.5 billion in global box office revenue in calendar 2025, making it their third biggest year ever. We're talking about three billion-dollar movies: Avatar: Fire and Ash, Zootopia 2, and Lilo and Stitch.

**JORDAN:** And Zootopia 2 became Hollywood's highest-grossing animated film of all time at $1.7 billion. But here's what I find fascinating - CEO Bob Iger specifically mentioned how these theatrical successes are creating this flywheel effect. When Zootopia 2 and Avatar hit Disney Plus, they're seeing millions of first streams and hundreds of millions of new viewing hours.

**ALEX:** That interconnected strategy is really paying off. Speaking of streaming, they saw a 13% increase in subscription revenue, and the segment is now profitable with margins hitting around that 10% target they set.

**JORDAN:** Right, and CFO Hugh Johnston mentioned they're actually exceeding that target - they hit 12% revenue growth with about 50% earnings growth in streaming. That's serious operating leverage. But what caught my attention was this OpenAI partnership with Sora.

**ALEX:** Oh, the AI content play. So Disney struck a three-year licensing deal where users can prompt Sora to create 30-second videos featuring about 250 Disney characters. Iger was careful to note these don't include human voices or faces - probably for obvious legal and creative reasons.

**JORDAN:** And they're planning to curate this Sora-generated content on Disney Plus as a way to add short-form video features. Iger mentioned they've noticed the huge growth in short-form content on platforms like YouTube, so this is their way of jumping into that space while maintaining that Disney brand control.

**ALEX:** What I found interesting was when an analyst asked about the impact on traditional programming needs, and Iger basically said this won't cannibalize anything. He sees AI as serving three purposes: enhancing creativity, improving productivity, and creating better connectivity with consumers.

**JORDAN:** Smart positioning. Now, let's talk ESPN because that NFL Network acquisition they just closed is a big deal. ESPN delivered its second-highest Monday Night Football viewership in twenty years, and they're gearing up for their first Super Bowl broadcast.

**ALEX:** And Jordan, the timing couldn't be better with ESPN launching their direct-to-consumer streaming service. The subscriber decline in traditional ESPN slowed to just 4% - a major improvement from the 7-8% drops they were seeing before.

**JORDAN:** The bundling strategy is clearly working. Subscribers who get the Disney Plus, Hulu, and ESPN bundle are churning less, which is huge for lifetime value. Iger mentioned they're working toward a fully integrated app experience by the end of the calendar year.

**ALEX:** Let's shift to experiences because $10 billion in quarterly revenue is just staggering....]]>143falsefullhttps://www.spreaker.com/episode/deere-q1-2026-earnings-analysis--70217319
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by Jordan. Today we're digging into Deere & Company's first quarter 2026 results - and folks, this is a company that's showing some real signs of life after what's been a pretty challenging agricultural cycle.

JORDAN: That's right, Alex. And before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks, Jordan. Now, let's talk numbers because Deere really impressed here. They posted $9.6 billion in net sales and revenues, up 13% year-over-year, with equipment operations specifically growing 18% to $8 billion. Net income came in at $656 million, or $2.42 per share.

JORDAN: What I found particularly encouraging is that they beat their own expectations across the board. Management said all business segments performed ahead of plan, driven primarily by better-than-expected shipment volumes. And here's the kicker - they're calling 2026 the bottom of the current agricultural cycle.

ALEX: That's huge, Jordan. Let's break down the segments because there are some really interesting dynamics here. Small Ag & Turf was the star performer with 24% growth to $2.2 billion in sales and a 9% operating margin. Meanwhile, Construction & Forestry jumped 34% to $2.7 billion.

JORDAN: The Construction & Forestry story is particularly compelling. Their order bank has risen by over 50% in just the past quarter - that's the highest level since May 2024. Management is seeing strength across infrastructure projects, data center construction, and rental re-fleeting. It's giving them clear visibility into the second half of the fiscal year.

ALEX: And that's translating into some serious guidance raises. They bumped their Construction & Forestry net sales forecast to up around 15% for the full year, with operating margins now expected between 9-11%. But what really caught my attention was the Large Ag discussion.

JORDAN: Right, so Large Ag has been the problem child for Deere, but there are green shoots emerging. While the North American Large Ag industry is still expected to decline 15-20% this year, management noted that large tractor order velocity has picked up, and their rolling order books now provide visibility into the fourth quarter.

ALEX: The used inventory story is fascinating too. They've made significant progress reducing used equipment inventory - model year 2022 and 2023 8R tractors are down over 40% from their peak, and just in this quarter alone, they dropped 20% sequentially. That's clearing the trade ladder and enabling more replacement demand.

JORDAN: Let's talk about some of the strategic moves they're making. The big announcement is their new Deere-designed 20-ton class excavators launching at CONEXPO. This is their first fully Deere-designed and North Carolina-built excavator line, targeting about 40% of the North American construction equipment market.

ALEX: And they completed the acquisition of Tenna, which is all about digitizing construction workflows and fleet management. This fits into their three-layer strategy: machines, tasks, and job sites. They want to help contractors optimize not just individual machines, but entire operations.

JORDAN: The technology adoption numbers are impressive too. They now have over 500 million engaged acres - that's up 10% from a year ago, with nearly a third being "highly engaged." On the combine side, 99% of combines ordered through their early order program had some level of harvest automation, with nearly 80% taking the ultimate package.

ALEX: Now, it wasn't all sunshine and rainbows. They're dealing with $1.2 billion in tariff costs this year, and there are some reg

This episode includes AI-generated content.]]>SP100-DE-Q1-2026-enSun, 22 Feb 2026 21:35:15 +0000trueBeta Finch**Beta Finch Podcast Script: Deere Q1 2026 Earnings** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by Jordan. Today we're digging into Deere & Company's first quarter 2026 results - and folks,...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined as always by Jordan. Today we're digging into Deere & Company's first quarter 2026 results - and folks, this is a company that's showing some real signs of life after what's been a pretty challenging agricultural cycle.

JORDAN: That's right, Alex. And before we dive in, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks, Jordan. Now, let's talk numbers because Deere really impressed here. They posted $9.6 billion in net sales and revenues, up 13% year-over-year, with equipment operations specifically growing 18% to $8 billion. Net income came in at $656 million, or $2.42 per share.

JORDAN: What I found particularly encouraging is that they beat their own expectations across the board. Management said all business segments performed ahead of plan, driven primarily by better-than-expected shipment volumes. And here's the kicker - they're calling 2026 the bottom of the current agricultural cycle.

ALEX: That's huge, Jordan. Let's break down the segments because there are some really interesting dynamics here. Small Ag & Turf was the star performer with 24% growth to $2.2 billion in sales and a 9% operating margin. Meanwhile, Construction & Forestry jumped 34% to $2.7 billion.

JORDAN: The Construction & Forestry story is particularly compelling. Their order bank has risen by over 50% in just the past quarter - that's the highest level since May 2024. Management is seeing strength across infrastructure projects, data center construction, and rental re-fleeting. It's giving them clear visibility into the second half of the fiscal year.

ALEX: And that's translating into some serious guidance raises. They bumped their Construction & Forestry net sales forecast to up around 15% for the full year, with operating margins now expected between 9-11%. But what really caught my attention was the Large Ag discussion.

JORDAN: Right, so Large Ag has been the problem child for Deere, but there are green shoots emerging. While the North American Large Ag industry is still expected to decline 15-20% this year, management noted that large tractor order velocity has picked up, and their rolling order books now provide visibility into the fourth quarter.

ALEX: The used inventory story is fascinating too. They've made significant progress reducing used equipment inventory - model year 2022 and 2023 8R tractors are down over 40% from their peak, and just in this quarter alone, they dropped 20% sequentially. That's clearing the trade ladder and enabling more replacement demand.

JORDAN: Let's talk about some of the strategic moves they're making. The big announcement is their new Deere-designed 20-ton class excavators launching at CONEXPO. This is their first fully Deere-designed and North Carolina-built excavator line, targeting about 40% of the North American construction equipment market.

ALEX: And they completed the acquisition of Tenna, which is all about digitizing construction workflows and fleet management. This fits into their three-layer strategy: machines, tasks, and job sites. They want to help contractors optimize not just individual machines, but entire operations.

JORDAN: The technology adoption numbers are impressive too. They now have over 500 million engaged acres - that's up 10% from a year ago, with nearly a third being "highly engaged." On the combine side, 99% of combines ordered through their early order program had some level of harvest automation, with nearly 80% taking the ultimate package.
459falsefullhttps://www.spreaker.com/episode/chevron-q4-2025-earnings-analysis--70217318
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Chevron's fourth quarter 2025 results, and wow - there's a lot to unpack here.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the headline numbers. How did Chevron perform in Q4?

**ALEX:** Pretty solid quarter, Jordan. Chevron reported earnings of $2.8 billion, or $1.39 per share. But the adjusted earnings were even better at $3 billion, or $1.52 per share. What really caught my eye though was that cash flow from operations hit $10.8 billion for the quarter.

**JORDAN:** That's impressive, especially when you consider oil prices were down nearly 15% year-over-year. But here's what's really striking - their adjusted free cash flow was up over 35% for the full year, excluding asset sales. That tells me their operational efficiency improvements are really paying off.

**ALEX:** Exactly! And speaking of efficiency, CEO Mike Wirth made some pretty bold statements about their cost reduction program. They've already captured $1.5 billion in savings in 2025, with a run rate of over $2 billion. But get this - they're targeting $3 to $4 billion in total savings by 2026.

**JORDAN:** That's huge. And it's not just about cutting costs - they're fundamentally restructuring how they operate. CFO Eimear Bonner mentioned they've consolidated all their shale operations into one business unit. That means the Permian, the DJ Basin, the Bakken, and even Argentina are all under one roof now.

**ALEX:** Which brings us to production numbers. Chevron hit some major milestones - they reached record production levels globally and hit that symbolic 1 million barrels per day in the Permian. Plus, they're guiding for 7% to 10% production growth in 2026.

**JORDAN:** But here's what I found most interesting from the call - Venezuela. Wirth spent considerable time discussing their operations there, which have been somewhat under the radar. They've grown production by over 200,000 barrels per day since 2022, and they see potential for another 50% growth over the next 18-24 months.

**ALEX:** That Venezuela discussion was fascinating. Wirth emphasized they've been there for over a century and are operating under a self-funding model where the ventures pay for their own expansion through cash flow. No new capital required from Chevron's balance sheet.

**JORDAN:** And then there was that awkward moment when they had to address the recent power outage at their massive Tengiz operation in Kazakhstan. Wirth was careful not to speculate on the cause, but he did say it wasn't sabotage or cyber-related - just a mechanical issue.

**ALEX:** Right, and he seemed confident they'd be back to full production within February. The fact that their 2026 guidance of $6 billion in free cash flow from TCO remains unchanged tells me they're not too worried about long-term impacts.

**JORDAN:** Let's talk about their international expansion strategy. There were several interesting tidbits in the Q&A about potential new opportunities in Libya and Iraq - countries where Chevron has been notably absent.

**ALEX:** Wirth made a really interesting comment about how fiscal terms in the Middle East have become more competitive recently. He specifically mentioned seeing "a notable uptick in inbound inquiries" after political developments. It sounds like they're being courted more aggressively than in the past.

**JORDAN:** But they're staying disciplined. Wirth repeatedly emphasized that any new investments have to compete with their existing portfolio on returns. They're not just going to chase

This episode includes AI-generated content.]]>SP100-CVX-Q4-2025-enSun, 22 Feb 2026 21:35:10 +0000trueBeta Finch# Beta Finch Podcast Script: Chevron Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Chevron's fourth quarter 2025 results, and wow - there's a lot...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Chevron's fourth quarter 2025 results, and wow - there's a lot to unpack here.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. So Alex, let's start with the headline numbers. How did Chevron perform in Q4?

**ALEX:** Pretty solid quarter, Jordan. Chevron reported earnings of $2.8 billion, or $1.39 per share. But the adjusted earnings were even better at $3 billion, or $1.52 per share. What really caught my eye though was that cash flow from operations hit $10.8 billion for the quarter.

**JORDAN:** That's impressive, especially when you consider oil prices were down nearly 15% year-over-year. But here's what's really striking - their adjusted free cash flow was up over 35% for the full year, excluding asset sales. That tells me their operational efficiency improvements are really paying off.

**ALEX:** Exactly! And speaking of efficiency, CEO Mike Wirth made some pretty bold statements about their cost reduction program. They've already captured $1.5 billion in savings in 2025, with a run rate of over $2 billion. But get this - they're targeting $3 to $4 billion in total savings by 2026.

**JORDAN:** That's huge. And it's not just about cutting costs - they're fundamentally restructuring how they operate. CFO Eimear Bonner mentioned they've consolidated all their shale operations into one business unit. That means the Permian, the DJ Basin, the Bakken, and even Argentina are all under one roof now.

**ALEX:** Which brings us to production numbers. Chevron hit some major milestones - they reached record production levels globally and hit that symbolic 1 million barrels per day in the Permian. Plus, they're guiding for 7% to 10% production growth in 2026.

**JORDAN:** But here's what I found most interesting from the call - Venezuela. Wirth spent considerable time discussing their operations there, which have been somewhat under the radar. They've grown production by over 200,000 barrels per day since 2022, and they see potential for another 50% growth over the next 18-24 months.

**ALEX:** That Venezuela discussion was fascinating. Wirth emphasized they've been there for over a century and are operating under a self-funding model where the ventures pay for their own expansion through cash flow. No new capital required from Chevron's balance sheet.

**JORDAN:** And then there was that awkward moment when they had to address the recent power outage at their massive Tengiz operation in Kazakhstan. Wirth was careful not to speculate on the cause, but he did say it wasn't sabotage or cyber-related - just a mechanical issue.

**ALEX:** Right, and he seemed confident they'd be back to full production within February. The fact that their 2026 guidance of $6 billion in free cash flow from TCO remains unchanged tells me they're not too worried about long-term impacts.

**JORDAN:** Let's talk about their international expansion strategy. There were several interesting tidbits in the Q&A about potential new opportunities in Libya and Iraq - countries where Chevron has been notably absent.

**ALEX:** Wirth made a really interesting comment about how fiscal terms in the Middle East have become more competitive recently. He specifically mentioned seeing "a notable uptick in inbound inquiries" after political developments. It sounds like they're being courted more aggressively than in the past.

**JORDAN:** But they're...]]>435falsefullhttps://www.spreaker.com/episode/cisco-q2-2026-earnings-analysis--70217317
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense corporate transcripts into digestible investment insights. I'm Alex, and I'm here with my co-host Jordan to break down Cisco's Q2 2026 earnings call.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

So Jordan, Cisco just delivered what CEO Chuck Robbins called their "strongest quarter yet" - what jumped out at you from these numbers?

**JORDAN**: Alex, this was genuinely impressive across the board. Cisco hit $15.3 billion in revenue - that's 10% growth year-over-year and above their guidance range. But what really caught my attention was the acceleration in product revenue, up 14%, while maintaining operating leverage with earnings per share growing 11% - faster than revenue growth.

**ALEX**: That operating leverage is key for a mature tech company like Cisco. Now, we have to talk about the elephant in the room - or should I say, the AI in the room. Their AI infrastructure business is absolutely exploding.

**JORDAN**: Absolutely. They took $2.1 billion in AI infrastructure orders from hyperscalers in Q2 alone - that's compared to $1.3 billion last quarter. Chuck Robbins said this equals the total orders they took in all of fiscal 2025. They've now raised their full-year AI order target to over $5 billion, with expectations to recognize over $3 billion in AI revenue from hyperscalers this year.

**ALEX**: What's fascinating is how they're positioning this. Cisco announced they shipped their one millionth Silicon One chip in Q2, and they just unveiled their new G300 chip delivering 102.4 terabits per second. That puts them in an exclusive club of silicon providers hitting over 100 terabits per second.

**JORDAN**: The Silicon One story is really compelling from a competitive moat perspective. Robbins emphasized the programmability aspect - this isn't just about raw performance, it's about adaptability across different use cases. And their optics division, Acacia, had its strongest quarter ever with triple-digit growth in bookings.

**ALEX**: But it's not just hyperscalers. They're building a separate pipeline of $2.5 billion across neocloud, sovereign, and enterprise AI customers. They even announced a joint venture with AMD to deliver up to one gigawatt of AI infrastructure by 2030.

**JORDAN**: That diversification is smart. Speaking of which, let's talk about their traditional business - because this wasn't just an AI story. Their campus networking refresh cycle is accelerating. They're seeing what Chuck called "faster ramps than prior product launches" across switching, routing, and wireless products.

**ALEX**: Right, and there's this massive installed base opportunity. Robbins mentioned "tens of billions of dollars" across early Catalyst generations nearing end of support. This creates a multi-year, multi-billion-dollar refresh tailwind.

**JORDAN**: But we need to address the challenges too. Gross margins declined 120 basis points year-over-year to 67.5%, primarily due to memory price inflation hitting the entire industry. CFO Mark Patterson was pretty direct about this - they've already announced price increases and are revising contractual terms with partners.

**ALEX**: During the Q&A, they seemed confident about managing this better than competitors. They've increased their advanced purchase commitments by $1.8 billion in just 90 days to secure supply. Patterson emphasized their "world-class supply chain" and financial strength as competitive advantages.

**JORDAN**: What impressed me was their customer response. Robbins mentioned having lunch with one of their biggest customers who completely understood the pricing dynamics and

This episode includes AI-generated content.]]>SP100-CSCO-Q2-2026-enSun, 22 Feb 2026 21:35:05 +0000trueBeta Finch# Beta Finch Podcast Script - Cisco Q2 2026 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense corporate transcripts into digestible investment insights. I'm Alex, and I'm here with my co-host Jordan to...
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we turn dense corporate transcripts into digestible investment insights. I'm Alex, and I'm here with my co-host Jordan to break down Cisco's Q2 2026 earnings call.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

So Jordan, Cisco just delivered what CEO Chuck Robbins called their "strongest quarter yet" - what jumped out at you from these numbers?

**JORDAN**: Alex, this was genuinely impressive across the board. Cisco hit $15.3 billion in revenue - that's 10% growth year-over-year and above their guidance range. But what really caught my attention was the acceleration in product revenue, up 14%, while maintaining operating leverage with earnings per share growing 11% - faster than revenue growth.

**ALEX**: That operating leverage is key for a mature tech company like Cisco. Now, we have to talk about the elephant in the room - or should I say, the AI in the room. Their AI infrastructure business is absolutely exploding.

**JORDAN**: Absolutely. They took $2.1 billion in AI infrastructure orders from hyperscalers in Q2 alone - that's compared to $1.3 billion last quarter. Chuck Robbins said this equals the total orders they took in all of fiscal 2025. They've now raised their full-year AI order target to over $5 billion, with expectations to recognize over $3 billion in AI revenue from hyperscalers this year.

**ALEX**: What's fascinating is how they're positioning this. Cisco announced they shipped their one millionth Silicon One chip in Q2, and they just unveiled their new G300 chip delivering 102.4 terabits per second. That puts them in an exclusive club of silicon providers hitting over 100 terabits per second.

**JORDAN**: The Silicon One story is really compelling from a competitive moat perspective. Robbins emphasized the programmability aspect - this isn't just about raw performance, it's about adaptability across different use cases. And their optics division, Acacia, had its strongest quarter ever with triple-digit growth in bookings.

**ALEX**: But it's not just hyperscalers. They're building a separate pipeline of $2.5 billion across neocloud, sovereign, and enterprise AI customers. They even announced a joint venture with AMD to deliver up to one gigawatt of AI infrastructure by 2030.

**JORDAN**: That diversification is smart. Speaking of which, let's talk about their traditional business - because this wasn't just an AI story. Their campus networking refresh cycle is accelerating. They're seeing what Chuck called "faster ramps than prior product launches" across switching, routing, and wireless products.

**ALEX**: Right, and there's this massive installed base opportunity. Robbins mentioned "tens of billions of dollars" across early Catalyst generations nearing end of support. This creates a multi-year, multi-billion-dollar refresh tailwind.

**JORDAN**: But we need to address the challenges too. Gross margins declined 120 basis points year-over-year to 67.5%, primarily due to memory price inflation hitting the entire industry. CFO Mark Patterson was pretty direct about this - they've already announced price increases and are revising contractual terms with partners.

**ALEX**: During the Q&A, they seemed confident about managing this better than competitors. They've increased their advanced purchase commitments by $1.8 billion in just 90 days to secure supply. Patterson emphasized their "world-class supply chain" and financial strength as competitive advantages.

**JORDAN**: What impressed me was...]]>536falsefullhttps://www.spreaker.com/episode/cme-group-q4-2025-earnings-analysis--70217316
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into CME Group's Q4 2025 results – and wow, what a quarter to cap off what they're calling their most successful year ever.

Now, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, CME just posted some pretty impressive numbers here. Walk us through the highlights.

**JORDAN**: Absolutely, Alex. This was a record-breaking quarter on multiple fronts. CME hit $1.65 billion in Q4 revenue, up 8% year-over-year, and for the full year they reached $6.5 billion – their fourth consecutive year of record revenues. But here's what really caught my eye: adjusted earnings per share grew 10% in the quarter to $2.77, and 9% for the full year.

**ALEX**: And those volume numbers were pretty staggering too, right?

**JORDAN**: Exactly. They averaged 28.1 million contracts daily for the year – up 6% and marking their fifth consecutive year of record volume. What's particularly interesting is this growth was broad-based across all their major asset classes. Interest rates, energy, metals, agricultural products, and crypto all hit all-time records.

**ALEX**: Speaking of crypto, that seems to be a major growth driver for them. What's happening there?

**JORDAN**: Crypto was absolutely on fire for CME. Q4 average daily volume hit 379,000 contracts – that's up 92% year-over-year, representing over $13 billion in notional value traded per day. And CEO Terry Duffy announced they're launching Cardano, Chainlink, and Stellar futures next week, plus they're rolling out 24/7 crypto trading next quarter.

**ALEX**: That's a big strategic shift. They're essentially saying crypto doesn't sleep, so neither should their platform.

**JORDAN**: Exactly, and Duffy made an interesting comment during the call about potentially expanding 24/7 trading to other asset classes if it makes sense. They're clearly being responsive to how markets are evolving, especially since the underlying crypto cash markets trade through weekends.

**ALEX**: Now, one area that's getting a lot of attention is their push into retail markets. They launched these "event contracts" – basically prediction markets. How's that going?

**JORDAN**: This is fascinating, Alex. They launched in December and have already seen over 68 million event contracts traded in just six weeks, including 7 million on market-related events. They're partnering with FanDuel for distribution, and their micro products – aimed at retail traders – were up 59% in Q4 to 4.4 million contracts daily.

**ALEX**: But there was some interesting commentary about the regulatory landscape here, wasn't there?

**JORDAN**: Yes, and Duffy was pretty direct about this during the Q&A. He emphasized that as long as the CFTC regulates these as swaps – which they currently do – CME will participate. But he was clear they don't want to get bogged down in legal battles with states over whether this constitutes gambling. His position is basically: "We follow federal regulation, and if states have issues, they should take it up with the federal government, not us."

**ALEX**: That's a pretty pragmatic stance. Now, looking at their financials, margins were strong again, right?

**JORDAN**: Very strong. Operating margin for the year was 69.4%, up 110 basis points from 2024. For Q4 specifically, they hit a 67% operating margin. They're also sitting on about $4.6 billion in cash, including $1.3 billion from their Austria sale proceeds, which the board has approved for share buybacks.

**ALEX**: And they're continuing to invest in growth initiatives. What's the 2026 guidance looking like?

**JORDAN**: They're guiding for about

This episode includes AI-generated content.]]>SP100-CME-Q4-2025-enSun, 22 Feb 2026 21:35:00 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into CME Group's Q4 2025 results – and wow, what a quarter to cap off what...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and joining me as always is Jordan. Today we're diving into CME Group's Q4 2025 results – and wow, what a quarter to cap off what they're calling their most successful year ever.

Now, before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Jordan, CME just posted some pretty impressive numbers here. Walk us through the highlights.

**JORDAN**: Absolutely, Alex. This was a record-breaking quarter on multiple fronts. CME hit $1.65 billion in Q4 revenue, up 8% year-over-year, and for the full year they reached $6.5 billion – their fourth consecutive year of record revenues. But here's what really caught my eye: adjusted earnings per share grew 10% in the quarter to $2.77, and 9% for the full year.

**ALEX**: And those volume numbers were pretty staggering too, right?

**JORDAN**: Exactly. They averaged 28.1 million contracts daily for the year – up 6% and marking their fifth consecutive year of record volume. What's particularly interesting is this growth was broad-based across all their major asset classes. Interest rates, energy, metals, agricultural products, and crypto all hit all-time records.

**ALEX**: Speaking of crypto, that seems to be a major growth driver for them. What's happening there?

**JORDAN**: Crypto was absolutely on fire for CME. Q4 average daily volume hit 379,000 contracts – that's up 92% year-over-year, representing over $13 billion in notional value traded per day. And CEO Terry Duffy announced they're launching Cardano, Chainlink, and Stellar futures next week, plus they're rolling out 24/7 crypto trading next quarter.

**ALEX**: That's a big strategic shift. They're essentially saying crypto doesn't sleep, so neither should their platform.

**JORDAN**: Exactly, and Duffy made an interesting comment during the call about potentially expanding 24/7 trading to other asset classes if it makes sense. They're clearly being responsive to how markets are evolving, especially since the underlying crypto cash markets trade through weekends.

**ALEX**: Now, one area that's getting a lot of attention is their push into retail markets. They launched these "event contracts" – basically prediction markets. How's that going?

**JORDAN**: This is fascinating, Alex. They launched in December and have already seen over 68 million event contracts traded in just six weeks, including 7 million on market-related events. They're partnering with FanDuel for distribution, and their micro products – aimed at retail traders – were up 59% in Q4 to 4.4 million contracts daily.

**ALEX**: But there was some interesting commentary about the regulatory landscape here, wasn't there?

**JORDAN**: Yes, and Duffy was pretty direct about this during the Q&A. He emphasized that as long as the CFTC regulates these as swaps – which they currently do – CME will participate. But he was clear they don't want to get bogged down in legal battles with states over whether this constitutes gambling. His position is basically: "We follow federal regulation, and if states have issues, they should take it up with the federal government, not us."

**ALEX**: That's a pretty pragmatic stance. Now, looking at their financials, margins were strong again, right?

**JORDAN**: Very strong. Operating margin for the year was 69.4%, up 110 basis points from 2024. For Q4 specifically, they hit a 67% operating margin. They're also sitting on about $4.6 billion in cash, including $1.3 billion from their Austria sale proceeds, which the board has...]]>508falsefullhttps://www.spreaker.com/episode/colgate-palmolive-q4-2025-earnings-analysis--70217315
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Colgate-Palmolive's Q4 2025 results. Now, before we get into the toothpaste and pet food numbers, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of brushing up on the details, Colgate just wrapped up what CEO Noel Wallace called a "stronger-than-expected Q4" despite some pretty challenging headwinds. The big story here isn't just the quarter though - it's their new 2030 strategy they're launching.

**ALEX**: Right, so let's start with the numbers. What stood out to you from the quarter?

**JORDAN**: Well, the momentum story is compelling. They saw sequential improvement in organic sales growth across most regions - hitting over 3% organic growth when you exclude their planned exit from private label business. That's a nice acceleration from Q3. And importantly, they delivered modest volume growth in Q4, which is no small feat in this environment.

**ALEX**: And the cash flow performance was pretty impressive too, right?

**JORDAN**: Absolutely stellar - record operating cash flow of $4.2 billion. That's giving them serious flexibility for reinvestment and potential acquisitions. Wallace kept emphasizing this "flexibility" theme throughout the call.

**ALEX**: Now, the guidance for 2026 was interesting - they gave a pretty wide range of 1% to 4% for organic sales growth. That's unusually broad for Colgate.

**JORDAN**: Yeah, and Wallace was refreshingly transparent about why. He basically said: if categories get worse, they'll be at the low end. If categories stay where they are, they'll be in the middle. If categories strengthen, they hope to hit the higher end. It's a simple framework, but it shows just how uncertain they feel about the consumer environment right now.

**ALEX**: Speaking of uncertainty, the U.S. market seems to be their biggest challenge. What's happening there?

**JORDAN**: It's pretty stark. Wallace mentioned that nine of their categories were down in volume in October, ten in November. The North American business is clearly struggling with what he called "consumer uncertainty." People are holding back on filling their pantries, buying more on promotion, and there's this general sluggishness in category growth.

**ALEX**: But there were some bright spots internationally, weren't there?

**JORDAN**: Definitely. Latin America had a really strong quarter - both Mexico and Brazil growing high single digits. And their emerging markets overall grew about 4.5% organically with good balance between price and volume. It's that classic story of developed markets struggling while emerging markets show more resilience.

**ALEX**: The Hill's pet food business also seemed to perform well despite a tough category backdrop.

**JORDAN**: Hill's was a standout - over 5% growth excluding private label, with positive volume growth. Their prescription diet business is really driving growth, and that higher-margin therapeutic segment is exactly where you want to see momentum. Wallace mentioned they're gaining share across all channels.

**ALEX**: Now, let's talk about this 2030 strategy they unveiled. It sounds like a pretty significant shift.

**JORDAN**: It's fascinating - they're basically reorganizing around what they call "omnichannel demand generation." Instead of having separate e-commerce and brick-and-mortar teams, they're creating one integrated commercial organization. Wallace said they've been sending leaders to China to learn from their team there, which has figured out how to excel in both traditional retail and online.

**ALEX**: And they're backing this up with their St

This episode includes AI-generated content.]]>SP100-CL-Q4-2025-enSun, 22 Feb 2026 21:34:55 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Colgate-Palmolive's Q4 2025 results. Now, before we get into the toothpaste and pet...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Colgate-Palmolive's Q4 2025 results. Now, before we get into the toothpaste and pet food numbers, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of brushing up on the details, Colgate just wrapped up what CEO Noel Wallace called a "stronger-than-expected Q4" despite some pretty challenging headwinds. The big story here isn't just the quarter though - it's their new 2030 strategy they're launching.

**ALEX**: Right, so let's start with the numbers. What stood out to you from the quarter?

**JORDAN**: Well, the momentum story is compelling. They saw sequential improvement in organic sales growth across most regions - hitting over 3% organic growth when you exclude their planned exit from private label business. That's a nice acceleration from Q3. And importantly, they delivered modest volume growth in Q4, which is no small feat in this environment.

**ALEX**: And the cash flow performance was pretty impressive too, right?

**JORDAN**: Absolutely stellar - record operating cash flow of $4.2 billion. That's giving them serious flexibility for reinvestment and potential acquisitions. Wallace kept emphasizing this "flexibility" theme throughout the call.

**ALEX**: Now, the guidance for 2026 was interesting - they gave a pretty wide range of 1% to 4% for organic sales growth. That's unusually broad for Colgate.

**JORDAN**: Yeah, and Wallace was refreshingly transparent about why. He basically said: if categories get worse, they'll be at the low end. If categories stay where they are, they'll be in the middle. If categories strengthen, they hope to hit the higher end. It's a simple framework, but it shows just how uncertain they feel about the consumer environment right now.

**ALEX**: Speaking of uncertainty, the U.S. market seems to be their biggest challenge. What's happening there?

**JORDAN**: It's pretty stark. Wallace mentioned that nine of their categories were down in volume in October, ten in November. The North American business is clearly struggling with what he called "consumer uncertainty." People are holding back on filling their pantries, buying more on promotion, and there's this general sluggishness in category growth.

**ALEX**: But there were some bright spots internationally, weren't there?

**JORDAN**: Definitely. Latin America had a really strong quarter - both Mexico and Brazil growing high single digits. And their emerging markets overall grew about 4.5% organically with good balance between price and volume. It's that classic story of developed markets struggling while emerging markets show more resilience.

**ALEX**: The Hill's pet food business also seemed to perform well despite a tough category backdrop.

**JORDAN**: Hill's was a standout - over 5% growth excluding private label, with positive volume growth. Their prescription diet business is really driving growth, and that higher-margin therapeutic segment is exactly where you want to see momentum. Wallace mentioned they're gaining share across all channels.

**ALEX**: Now, let's talk about this 2030 strategy they unveiled. It sounds like a pretty significant shift.

**JORDAN**: It's fascinating - they're basically reorganizing around what they call "omnichannel demand generation." Instead of having separate e-commerce and brick-and-mortar teams, they're creating one integrated commercial organization. Wallace said they've been sending...]]>468falsefullhttps://www.spreaker.com/episode/cigna-q4-2025-earnings-analysis--70217314
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest corporate results to help you understand what's moving the markets. I'm Alex, and I'm joined by my co-host Jordan. Today we're breaking down Cigna Group's fourth quarter 2025 earnings call - and folks, there's a lot to unpack here.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely, Alex. And wow, what a call this was! Cigna just delivered some impressive numbers while simultaneously announcing a massive $7 billion settlement with the FTC. It's like they cleared two major hurdles in one earnings cycle.

**ALEX:** Right? So let's start with the headline numbers. Cigna reported full-year adjusted revenue of $275 billion - that's 11% growth year-over-year. Adjusted earnings per share came in at $29.84, up 9%. For 2026, they're guiding to at least $30.25 per share. Jordan, those are some solid numbers in what CEO David Cordani called a "pivotal year."

**JORDAN:** They really are, Alex. And what caught my attention is how they're managing this transformation while maintaining growth. The company is essentially reinventing their pharmacy benefits model - moving to what they call a "rebate-free" system - while still hitting their financial targets. That takes some serious execution capability.

**ALEX:** Let's talk about that FTC settlement because it's huge. $7 billion in out-of-pocket cost relief over ten years for 100 million customers. Cordani was pretty emphatic that this positions them well for their new pharmacy model they announced back in 2025. It sounds like they saw this regulatory wave coming and built their strategy around it.

**JORDAN:** Exactly. And here's what's fascinating - they're saying this settlement actually aligns perfectly with their new business model. Instead of fighting the regulatory tide, they're riding it. The new model eliminates rebates, increases transparency, and supposedly keeps similar margin profiles. During the Q&A, analyst Lisa Gill pressed them on this, and Cordani was confident that the margin profile will remain similar even with this massive shift.

**ALEX:** That's a bold claim. They're basically saying they can completely transform how they do business while maintaining profitability. The specialty pharmacy business seems to be a big driver here - 14% revenue growth and they mentioned 13% growth in specialty scripts.

**JORDAN:** The specialty business is really their growth engine. It's gone from about 25% of the company three years ago to 35% now. Brian Evanko, the COO, highlighted that this is a $400 billion addressable market growing at high single digits. They're particularly bullish on biosimilars - expecting over $100 billion in savings from biosimilar adoption by 2030.

**ALEX:** Speaking of Evanko, he also mentioned some interesting tech innovations. They're rolling out AI-powered digital tools, including a provider matching tool and real-time cost tracking. Plus they launched something called "Clarity" - a new healthcare offering with transparent pricing that they claim can save clients up to 10% in medical costs.

**JORDAN:** The Clarity product is intriguing because it represents this broader shift toward transparency that seems to be driving everything Cigna is doing right now. No referrals needed, simple co-pay structure, single digital platform. It feels like they're trying to simplify healthcare, which honestly, is desperately needed.

**ALEX:** Now, let's talk about some challenges. The medical care ratio guidance for 2026 is 83.7% to 84.7%, which analyst Kevin Fischbeck questioned. CFO Ann Dennison explained they're being prudent about elevated cost trends, even with repricing

This episode includes AI-generated content.]]>SP100-CI-Q4-2025-enSun, 22 Feb 2026 21:34:50 +0000trueBeta Finch**Beta Finch Podcast Script** **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest corporate results to help you understand what's moving the markets. I'm Alex, and I'm joined by my co-host Jordan. Today...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the latest corporate results to help you understand what's moving the markets. I'm Alex, and I'm joined by my co-host Jordan. Today we're breaking down Cigna Group's fourth quarter 2025 earnings call - and folks, there's a lot to unpack here.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely, Alex. And wow, what a call this was! Cigna just delivered some impressive numbers while simultaneously announcing a massive $7 billion settlement with the FTC. It's like they cleared two major hurdles in one earnings cycle.

**ALEX:** Right? So let's start with the headline numbers. Cigna reported full-year adjusted revenue of $275 billion - that's 11% growth year-over-year. Adjusted earnings per share came in at $29.84, up 9%. For 2026, they're guiding to at least $30.25 per share. Jordan, those are some solid numbers in what CEO David Cordani called a "pivotal year."

**JORDAN:** They really are, Alex. And what caught my attention is how they're managing this transformation while maintaining growth. The company is essentially reinventing their pharmacy benefits model - moving to what they call a "rebate-free" system - while still hitting their financial targets. That takes some serious execution capability.

**ALEX:** Let's talk about that FTC settlement because it's huge. $7 billion in out-of-pocket cost relief over ten years for 100 million customers. Cordani was pretty emphatic that this positions them well for their new pharmacy model they announced back in 2025. It sounds like they saw this regulatory wave coming and built their strategy around it.

**JORDAN:** Exactly. And here's what's fascinating - they're saying this settlement actually aligns perfectly with their new business model. Instead of fighting the regulatory tide, they're riding it. The new model eliminates rebates, increases transparency, and supposedly keeps similar margin profiles. During the Q&A, analyst Lisa Gill pressed them on this, and Cordani was confident that the margin profile will remain similar even with this massive shift.

**ALEX:** That's a bold claim. They're basically saying they can completely transform how they do business while maintaining profitability. The specialty pharmacy business seems to be a big driver here - 14% revenue growth and they mentioned 13% growth in specialty scripts.

**JORDAN:** The specialty business is really their growth engine. It's gone from about 25% of the company three years ago to 35% now. Brian Evanko, the COO, highlighted that this is a $400 billion addressable market growing at high single digits. They're particularly bullish on biosimilars - expecting over $100 billion in savings from biosimilar adoption by 2030.

**ALEX:** Speaking of Evanko, he also mentioned some interesting tech innovations. They're rolling out AI-powered digital tools, including a provider matching tool and real-time cost tracking. Plus they launched something called "Clarity" - a new healthcare offering with transparent pricing that they claim can save clients up to 10% in medical costs.

**JORDAN:** The Clarity product is intriguing because it represents this broader shift toward transparency that seems to be driving everything Cigna is doing right now. No referrals needed, simple co-pay structure, single digital platform. It feels like they're trying to simplify healthcare, which honestly, is desperately needed.

**ALEX:** Now, let's talk about some challenges. The medical care ratio guidance for 2026 is 83.7% to 84.7%, which analyst...]]>503falsefullhttps://www.spreaker.com/episode/caterpillar-q4-2025-earnings-analysis--70217313
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dig into the numbers that matter. I'm Alex.

JORDAN: And I'm Jordan. Today we're talking about Caterpillar's Q4 2025 results, and wow - this was a record-breaking quarter in more ways than one.

ALEX: Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, when you say record-breaking, you're not kidding. Let's start with the headline numbers - what jumped out at you?

ALEX: The sheer scale of these results is impressive. Caterpillar posted record quarterly sales of $19.1 billion - that's up 18% year-over-year. But here's what's really eye-catching: their backlog hit a record $51 billion. That's up 71% from last year, Jordan. We're talking about $21 billion in new backlog growth.

JORDAN: That backlog number is staggering. And it's not just one segment driving this - they saw strength across Construction Industries, Resource Industries, and especially Power and Energy. The Power and Energy segment alone grew 23% in the quarter to $9.4 billion in sales.

ALEX: Right, and CEO Joe Creed was pretty excited about this. He mentioned they had "unprecedented order strength across all business segments." What's interesting is that only about 62% of that $51 billion backlog is expected to deliver in the next twelve months. That's lower than their historical average, which tells us they're booking orders well into 2027 and beyond.

JORDAN: That's a double-edged sword, isn't it? On one hand, it provides incredible revenue visibility. On the other hand, it locks them into deliveries at prices set today, while their costs - especially tariff costs - keep climbing. Speaking of tariffs, that was a major theme throughout this call.

ALEX: Oh absolutely. Tariffs were the elephant in the room. They faced $1.7 billion in net incremental tariff costs in 2025, and they're projecting that to jump to $2.6 billion in 2026. CFO Andrew Bonfield was pretty direct about this - he said margins will remain "near the bottom of the target range" because of these tariff headwinds.

JORDAN: And yet, they still managed to deliver a 17.2% adjusted operating profit margin for the full year, which was within their target range. That's solid execution under pressure. But let's talk about what's really driving this growth - the data center boom. This is where things get fascinating.

ALEX: Yes! The AI and cloud computing infrastructure build-out is creating massive demand for Caterpillar's power generation equipment. They announced a huge order yesterday - 2 gigawatts of power generation equipment for something called the Monarch Compute Campus. Joe Creed said this is one of their largest single orders ever for complete power solutions.

JORDAN: And get this - they've now booked four separate orders of at least one gigawatt each for data center prime power applications. Creed mentioned they're seeing customers shift from backup power to prime power, where Caterpillar equipment runs continuously to power these data centers. That's huge for their services business down the road.

ALEX: Exactly. Because when you're running equipment 24/7, you need a lot more maintenance and service. Their services revenue hit $24 billion in 2025, and they're targeting $30 billion by 2030. The data center boom could be a major driver of that growth.

JORDAN: Now, let's talk about the segments. Power and Energy was clearly the star, but Construction Industries also had a strong quarter with 15% sales growth. What's interesting is that Creed attributed some of this to returning to "normal seasonal patterns" - apparently 2025 started unusually slow.

ALEX: Right, and he's optimistic about 2026 for Construction Indust

This episode includes AI-generated content.]]>SP100-CAT-Q4-2025-enSun, 22 Feb 2026 21:34:45 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dig into the numbers that matter. I'm Alex. JORDAN: And I'm Jordan. Today we're talking about Caterpillar's Q4 2025 results, and wow - this...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we dig into the numbers that matter. I'm Alex.

JORDAN: And I'm Jordan. Today we're talking about Caterpillar's Q4 2025 results, and wow - this was a record-breaking quarter in more ways than one.

ALEX: Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, when you say record-breaking, you're not kidding. Let's start with the headline numbers - what jumped out at you?

ALEX: The sheer scale of these results is impressive. Caterpillar posted record quarterly sales of $19.1 billion - that's up 18% year-over-year. But here's what's really eye-catching: their backlog hit a record $51 billion. That's up 71% from last year, Jordan. We're talking about $21 billion in new backlog growth.

JORDAN: That backlog number is staggering. And it's not just one segment driving this - they saw strength across Construction Industries, Resource Industries, and especially Power and Energy. The Power and Energy segment alone grew 23% in the quarter to $9.4 billion in sales.

ALEX: Right, and CEO Joe Creed was pretty excited about this. He mentioned they had "unprecedented order strength across all business segments." What's interesting is that only about 62% of that $51 billion backlog is expected to deliver in the next twelve months. That's lower than their historical average, which tells us they're booking orders well into 2027 and beyond.

JORDAN: That's a double-edged sword, isn't it? On one hand, it provides incredible revenue visibility. On the other hand, it locks them into deliveries at prices set today, while their costs - especially tariff costs - keep climbing. Speaking of tariffs, that was a major theme throughout this call.

ALEX: Oh absolutely. Tariffs were the elephant in the room. They faced $1.7 billion in net incremental tariff costs in 2025, and they're projecting that to jump to $2.6 billion in 2026. CFO Andrew Bonfield was pretty direct about this - he said margins will remain "near the bottom of the target range" because of these tariff headwinds.

JORDAN: And yet, they still managed to deliver a 17.2% adjusted operating profit margin for the full year, which was within their target range. That's solid execution under pressure. But let's talk about what's really driving this growth - the data center boom. This is where things get fascinating.

ALEX: Yes! The AI and cloud computing infrastructure build-out is creating massive demand for Caterpillar's power generation equipment. They announced a huge order yesterday - 2 gigawatts of power generation equipment for something called the Monarch Compute Campus. Joe Creed said this is one of their largest single orders ever for complete power solutions.

JORDAN: And get this - they've now booked four separate orders of at least one gigawatt each for data center prime power applications. Creed mentioned they're seeing customers shift from backup power to prime power, where Caterpillar equipment runs continuously to power these data centers. That's huge for their services business down the road.

ALEX: Exactly. Because when you're running equipment 24/7, you need a lot more maintenance and service. Their services revenue hit $24 billion in 2025, and they're targeting $30 billion by 2030. The data center boom could be a major driver of that growth.

JORDAN: Now, let's talk about the segments. Power and Energy was clearly the star, but Construction Industries also had a strong quarter with 15% sales growth. What's interesting is that Creed attributed some of this...]]>520falsefullhttps://www.spreaker.com/episode/blackstone-q4-2025-earnings-analysis--70217312
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear conversations. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Blackstone's Q4 2025 earnings – and wow, what a quarter this was for the private equity giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because Blackstone just delivered what they're calling their best results in their 40-year history.

**ALEX:** The headline number that caught my eye – distributable earnings of $1.75 per share for the quarter, capping off a record year where DE increased 20% to $5.57 per share. That's $7.1 billion in distributable earnings for the full year. But Jordan, what really stood out to you?

**JORDAN:** The sheer scale of capital flows. They pulled in $71 billion in inflows just in Q4 – that's the highest level in three and a half years. For the full year, we're talking about $240 billion in fundraising. To put that in perspective, their assets under management hit nearly $1.3 trillion, up 13% year over year.

**ALEX:** That's an almost incomprehensible amount of money. And CEO Jonathan Gray made an interesting point about their market position – according to analyst research, Blackstone has an estimated 50% share of all private wealth revenue across major alternative firms.

**JORDAN:** Which brings us to one of their biggest success stories – the private wealth channel. Their fundraising there jumped 53% year over year to $43 billion. But what's driving this?

**ALEX:** Performance, performance, performance. Their BCRED product – that's their private credit offering for individual investors – delivered 10% net returns annually since inception five years ago. Their private equity flagship BXP has generated 17% annualized returns since launching just two years ago.

**JORDAN:** Let's talk about the elephant in the room though – real estate. This has been a challenging sector, but there are some interesting developments. While real estate values only appreciated about 1.5% for the full year, they're seeing positive signs.

**ALEX:** Right, construction starts have fallen to their lowest level in over 12 years in both logistics and multifamily – their two largest real estate sectors. Less supply typically means better pricing power down the road.

**JORDAN:** And they're not just sitting on the sidelines. They've deployed over $50 billion in real estate since what they call the "cycle trough" two years ago, including a Q4 commitment to privatize Alexander and Baldwin.

**ALEX:** Now let's talk about what might be the most exciting part of this call – the deal environment is finally opening up. Jonathan Gray compared it to 2013-2014, saying it feels like markets are coming out of hibernation.

**JORDAN:** The Medline IPO was a perfect example. This was a $7.2 billion IPO – the largest since 2021 and the largest sponsor-backed IPO in history. Shares popped over 40% on the first day. Gray mentioned they have "one of the largest IPO pipelines in our history."

**ALEX:** What did you make of their commentary on artificial intelligence? They seem to be positioning this as a generational investment opportunity.

**JORDAN:** It's fascinating how they're approaching it on multiple levels. They're investing in the infrastructure – data centers, power generation, the electric grid. But they're also implementing AI across their 270+ portfolio companies. CFO Michael Chae mentioned seeing real productivity gains in software engineering and cyber monitoring already.

**ALEX:** Speaking of their portfolio, the performance numbers across segments were pretty impre

This episode includes AI-generated content.]]>SP100-BX-Q4-2025-enSun, 22 Feb 2026 21:34:40 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear conversations. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Blackstone's Q4...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we turn complex financial reports into clear conversations. I'm Alex.

**JORDAN:** And I'm Jordan. Today we're diving into Blackstone's Q4 2025 earnings – and wow, what a quarter this was for the private equity giant.

**ALEX:** Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Absolutely. Now Alex, let's talk about these numbers because Blackstone just delivered what they're calling their best results in their 40-year history.

**ALEX:** The headline number that caught my eye – distributable earnings of $1.75 per share for the quarter, capping off a record year where DE increased 20% to $5.57 per share. That's $7.1 billion in distributable earnings for the full year. But Jordan, what really stood out to you?

**JORDAN:** The sheer scale of capital flows. They pulled in $71 billion in inflows just in Q4 – that's the highest level in three and a half years. For the full year, we're talking about $240 billion in fundraising. To put that in perspective, their assets under management hit nearly $1.3 trillion, up 13% year over year.

**ALEX:** That's an almost incomprehensible amount of money. And CEO Jonathan Gray made an interesting point about their market position – according to analyst research, Blackstone has an estimated 50% share of all private wealth revenue across major alternative firms.

**JORDAN:** Which brings us to one of their biggest success stories – the private wealth channel. Their fundraising there jumped 53% year over year to $43 billion. But what's driving this?

**ALEX:** Performance, performance, performance. Their BCRED product – that's their private credit offering for individual investors – delivered 10% net returns annually since inception five years ago. Their private equity flagship BXP has generated 17% annualized returns since launching just two years ago.

**JORDAN:** Let's talk about the elephant in the room though – real estate. This has been a challenging sector, but there are some interesting developments. While real estate values only appreciated about 1.5% for the full year, they're seeing positive signs.

**ALEX:** Right, construction starts have fallen to their lowest level in over 12 years in both logistics and multifamily – their two largest real estate sectors. Less supply typically means better pricing power down the road.

**JORDAN:** And they're not just sitting on the sidelines. They've deployed over $50 billion in real estate since what they call the "cycle trough" two years ago, including a Q4 commitment to privatize Alexander and Baldwin.

**ALEX:** Now let's talk about what might be the most exciting part of this call – the deal environment is finally opening up. Jonathan Gray compared it to 2013-2014, saying it feels like markets are coming out of hibernation.

**JORDAN:** The Medline IPO was a perfect example. This was a $7.2 billion IPO – the largest since 2021 and the largest sponsor-backed IPO in history. Shares popped over 40% on the first day. Gray mentioned they have "one of the largest IPO pipelines in our history."

**ALEX:** What did you make of their commentary on artificial intelligence? They seem to be positioning this as a generational investment opportunity.

**JORDAN:** It's fascinating how they're approaching it on multiple levels. They're investing in the infrastructure – data centers, power generation, the electric grid. But they're also implementing AI across their 270+ portfolio companies. CFO Michael Chae mentioned seeing...]]>487falsefullhttps://www.spreaker.com/episode/boston-scientific-earnings-analysis--70217310
JORDAN: And I'm Jordan. Today we're diving into Boston Scientific's fourth quarter and full year 2025 results - and wow, what a year it's been for this medical device giant.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, Boston Scientific just wrapped up what CEO Mike Mahoney called an "outstanding" year. Let's start with the headline numbers - they're pretty impressive.

ALEX: They really are. For the full year, Boston Scientific hit over $20 billion in sales - that's 19% operational growth and nearly 16% organic growth. They actually exceeded their guidance of around 15.5%. And on the bottom line? Adjusted earnings per share of $3.06, up 22% year-over-year.

JORDAN: That's their third consecutive year of 20%+ EPS growth, which is remarkable consistency in this industry. But what I found interesting was the fourth quarter specifically - 13% organic growth, which hit the high end of their guidance range. The question is, what's driving all this growth?

ALEX: Two words: EP and WATCHMAN. Their electrophysiology business grew 35% in Q4 and a staggering 73% for the full year. That's largely driven by their FARAPULSE technology - basically a next-generation treatment for atrial fibrillation that uses pulsed field ablation instead of traditional methods.

JORDAN: And WATCHMAN, their left atrial appendage closure device, grew 29% in the quarter. Mike Mahoney mentioned they've now treated more than 25,000 patients with what they call "concomitant procedures" - essentially doing WATCHMAN and EP procedures together, which is more efficient for hospitals.

ALEX: But here's where it gets really interesting - and where some investors got a bit nervous during the earnings call. There were questions about whether growth is slowing, especially in the U.S. EP market. Some analysts were expecting even higher numbers.

JORDAN: Right, and Mahoney pushed back on this pretty hard. He said competitors are claiming the EP market grew 25% in Q4, but Boston Scientific thinks it was more like 18-20%. And even at that growth rate, they're significantly outpacing competitors - some major players only grew 6.5% and 12.5% respectively.

ALEX: That's a crucial point for investors. Market share dynamics are shifting as competitors launch their own PFA products, but Boston Scientific believes they'll maintain clear market leadership. Mahoney said by year-end 2026, their PFA share might equal all other competitors combined, but they'll still be the leader.

JORDAN: And looking ahead, they're guiding for some pretty solid numbers in 2026. Organic revenue growth of 10-11% for the full year, though Q1 will be softer at 8.5-10% due to some one-time headwinds and tough comparisons.

ALEX: Those headwinds include discontinuing a product called ACURATE and a temporary withdrawal of certain sizes of their AXIOS device due to manufacturing issues. But they expect both situations to resolve by mid-year.

JORDAN: Let's talk about what could be a game-changer - the CHAMPION trial results. This is a major clinical study comparing their WATCHMAN device to blood thinners for stroke prevention. Dr. Ken Stein, their Chief Medical Officer, said results will be presented at the American College of Cardiology conference.

ALEX: If positive, this could be huge. Currently, WATCHMAN is indicated for about 5 million patients globally who can't tolerate blood thinners. But if CHAMPION shows WATCHMAN is as effective as blood thinners with better bleeding outcomes, that addressable market could jump to 20 million patients.

JORDAN: That would essentially position WATCHMAN as a first-line therapy instead of just for patients who ca

This episode includes AI-generated content.]]>SP100-BSX-enSun, 22 Feb 2026 21:34:34 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Boston Scientific's fourth quarter and full year 2025 results - and wow, what a year it's been for this medical device giant....
JORDAN: And I'm Jordan. Today we're diving into Boston Scientific's fourth quarter and full year 2025 results - and wow, what a year it's been for this medical device giant.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. So Alex, Boston Scientific just wrapped up what CEO Mike Mahoney called an "outstanding" year. Let's start with the headline numbers - they're pretty impressive.

ALEX: They really are. For the full year, Boston Scientific hit over $20 billion in sales - that's 19% operational growth and nearly 16% organic growth. They actually exceeded their guidance of around 15.5%. And on the bottom line? Adjusted earnings per share of $3.06, up 22% year-over-year.

JORDAN: That's their third consecutive year of 20%+ EPS growth, which is remarkable consistency in this industry. But what I found interesting was the fourth quarter specifically - 13% organic growth, which hit the high end of their guidance range. The question is, what's driving all this growth?

ALEX: Two words: EP and WATCHMAN. Their electrophysiology business grew 35% in Q4 and a staggering 73% for the full year. That's largely driven by their FARAPULSE technology - basically a next-generation treatment for atrial fibrillation that uses pulsed field ablation instead of traditional methods.

JORDAN: And WATCHMAN, their left atrial appendage closure device, grew 29% in the quarter. Mike Mahoney mentioned they've now treated more than 25,000 patients with what they call "concomitant procedures" - essentially doing WATCHMAN and EP procedures together, which is more efficient for hospitals.

ALEX: But here's where it gets really interesting - and where some investors got a bit nervous during the earnings call. There were questions about whether growth is slowing, especially in the U.S. EP market. Some analysts were expecting even higher numbers.

JORDAN: Right, and Mahoney pushed back on this pretty hard. He said competitors are claiming the EP market grew 25% in Q4, but Boston Scientific thinks it was more like 18-20%. And even at that growth rate, they're significantly outpacing competitors - some major players only grew 6.5% and 12.5% respectively.

ALEX: That's a crucial point for investors. Market share dynamics are shifting as competitors launch their own PFA products, but Boston Scientific believes they'll maintain clear market leadership. Mahoney said by year-end 2026, their PFA share might equal all other competitors combined, but they'll still be the leader.

JORDAN: And looking ahead, they're guiding for some pretty solid numbers in 2026. Organic revenue growth of 10-11% for the full year, though Q1 will be softer at 8.5-10% due to some one-time headwinds and tough comparisons.

ALEX: Those headwinds include discontinuing a product called ACURATE and a temporary withdrawal of certain sizes of their AXIOS device due to manufacturing issues. But they expect both situations to resolve by mid-year.

JORDAN: Let's talk about what could be a game-changer - the CHAMPION trial results. This is a major clinical study comparing their WATCHMAN device to blood thinners for stroke prevention. Dr. Ken Stein, their Chief Medical Officer, said results will be presented at the American College of Cardiology conference.

ALEX: If positive, this could be huge. Currently, WATCHMAN is indicated for about 5 million patients globally who can't tolerate blood thinners. But if CHAMPION shows WATCHMAN is as effective as blood thinners with better bleeding outcomes, that addressable market...]]>522falsefullhttps://www.spreaker.com/episode/bristol-myers-q4-2025-earnings-analysis--70208982
But first, Jordan, I need to get our mandatory disclaimer out of the way. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of packed earnings calls, Bristol Myers definitely delivered on that front. Let's start with the headline numbers because they tell quite a story about this company's transformation.

**ALEX**: Absolutely. So Q4 revenue came in flat year-over-year at about $12.5 billion, but here's the key detail that investors need to understand - their growth portfolio, which includes all their newer drugs, grew 15% in the quarter and represented nearly 60% of total revenue. That's a massive shift from where this company was just a few years ago.

**JORDAN**: Right, and for the full year, that growth portfolio grew 17%. What's really impressive is that despite losing roughly $4 billion in revenue from legacy products - we're talking about patent cliffs and generic competition - the growth portfolio almost completely offset those declines. That's the kind of pipeline execution that pharma investors dream about.

**ALEX**: Let's talk about some of those growth drivers. Reblozyl, their blood disorder treatment, crossed $2 billion in annual sales. Breyanzi, their CAR-T cell therapy, grew 47% in Q4. And then you have Camzyos for heart disease growing 57%. These aren't just incremental gains - these are blockbuster-level products hitting their stride.

**JORDAN**: And here's what caught my attention from CEO Christopher Boerner's comments - he emphasized they're entering 2026 with "good momentum." But the real story is what's coming in the pipeline. They're expecting six registrational data readouts in the second half of 2026. That's potentially six new revenue streams or major label expansions.

**ALEX**: Jordan, let's break down that pipeline because it spans multiple therapeutic areas. You've got Milvexian for atrial fibrillation and stroke prevention - that's a massive market where they're trying to compete with their own Eliquis. Then there's admilparent for lung fibrosis, and several multiple myeloma treatments. This isn't just one bet - it's a diversified portfolio of shots on goal.

**JORDAN**: Speaking of Eliquis, that was probably the most complex part of the call. The drug is actually expected to grow 10-15% in 2026, which surprised me given it's facing patent cliffs. But management explained they took a strategic pricing reduction that eliminates certain penalty rebates while expanding patient access.

**ALEX**: That's a fascinating strategy. CFO David Elkins explained that the roughly 40% price reduction actually helps them competitively because it removes inflationary penalties that had been building up over years. It's counterintuitive - lower prices leading to higher growth - but it makes sense when you understand the complex rebate structures in pharma.

**JORDAN**: However, they're also guiding for a $1.5 to $2 billion step-down in Eliquis revenue from 2026 to 2027, primarily due to European patent expiries. So investors are looking at one good year before facing those headwinds.

**ALEX**: Let's talk about their cost management because this is where Bristol Myers is really showing discipline. They delivered $1 billion in cost savings in 2025 and expect another billion over 2026-2027. But here's the smart part - they're reinvesting some of those savings into growth initiatives like their partnership with BioNTech on pemiglatinib.

**JORDAN**: That partnership caught

This episode includes AI-generated content.]]>SP100-BMY-Q4-2025-enSun, 22 Feb 2026 04:03:37 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we decode quarterly reports so you don't have to. I'm Alex, and I'm joined as always by my co-host Jordan. Today we're diving into Bristol Myers Squibb's Q4 2025 earnings call -...
But first, Jordan, I need to get our mandatory disclaimer out of the way. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of packed earnings calls, Bristol Myers definitely delivered on that front. Let's start with the headline numbers because they tell quite a story about this company's transformation.

**ALEX**: Absolutely. So Q4 revenue came in flat year-over-year at about $12.5 billion, but here's the key detail that investors need to understand - their growth portfolio, which includes all their newer drugs, grew 15% in the quarter and represented nearly 60% of total revenue. That's a massive shift from where this company was just a few years ago.

**JORDAN**: Right, and for the full year, that growth portfolio grew 17%. What's really impressive is that despite losing roughly $4 billion in revenue from legacy products - we're talking about patent cliffs and generic competition - the growth portfolio almost completely offset those declines. That's the kind of pipeline execution that pharma investors dream about.

**ALEX**: Let's talk about some of those growth drivers. Reblozyl, their blood disorder treatment, crossed $2 billion in annual sales. Breyanzi, their CAR-T cell therapy, grew 47% in Q4. And then you have Camzyos for heart disease growing 57%. These aren't just incremental gains - these are blockbuster-level products hitting their stride.

**JORDAN**: And here's what caught my attention from CEO Christopher Boerner's comments - he emphasized they're entering 2026 with "good momentum." But the real story is what's coming in the pipeline. They're expecting six registrational data readouts in the second half of 2026. That's potentially six new revenue streams or major label expansions.

**ALEX**: Jordan, let's break down that pipeline because it spans multiple therapeutic areas. You've got Milvexian for atrial fibrillation and stroke prevention - that's a massive market where they're trying to compete with their own Eliquis. Then there's admilparent for lung fibrosis, and several multiple myeloma treatments. This isn't just one bet - it's a diversified portfolio of shots on goal.

**JORDAN**: Speaking of Eliquis, that was probably the most complex part of the call. The drug is actually expected to grow 10-15% in 2026, which surprised me given it's facing patent cliffs. But management explained they took a strategic pricing reduction that eliminates certain penalty rebates while expanding patient access.

**ALEX**: That's a fascinating strategy. CFO David Elkins explained that the roughly 40% price reduction actually helps them competitively because it removes inflationary penalties that had been building up over years. It's counterintuitive - lower prices leading to higher growth - but it makes sense when you understand the complex rebate structures in pharma.

**JORDAN**: However, they're also guiding for a $1.5 to $2 billion step-down in Eliquis revenue from 2026 to 2027, primarily due to European patent expiries. So investors are looking at one good year before facing those headwinds.

**ALEX**: Let's talk about their cost management because this is where Bristol Myers is really showing discipline. They delivered $1 billion in cost savings in 2025 and expect another billion over 2026-2027. But here's the smart part - they're reinvesting some of those savings...]]>508falsefullhttps://www.spreaker.com/episode/booking-holdings-earnings-analysis--70208981
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Booking Holdings' fourth quarter earnings call - and wow, what a quarter they had.

Before we get started though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of wow - Glenn Fogel just celebrated his 26th year at the company! That might make him the longest-tenured executive in tech. But beyond that milestone, Booking absolutely crushed their fourth quarter numbers.

**ALEX**: Let's break down those numbers, Jordan. Room nights hit 285 million - that's a 9% year-over-year increase that actually exceeded the high end of their expectations. And both gross bookings and revenue jumped 16%. What's driving this growth?

**JORDAN**: The strength is really coming from Asia and the U.S., both delivering low double-digit growth. What I found interesting is that the U.S. acceleration has been building all year - they went from low single-digit growth in the first half to low double-digit growth in Q4. That's a pretty impressive turnaround.

**ALEX**: And the profitability story is even better. Adjusted EBITDA reached $2.2 billion, up 19% year-over-year, with margins expanding 80 basis points to nearly 37%. A big driver here is their transformation program that launched in late 2024.

**JORDAN**: Right, and this transformation program is fascinating. They've already achieved $550 million in annual run-rate savings - hitting the high end of their guidance. CFO Ewout Steenbergen said they expect $500 to $550 million in additional in-year savings for 2026. That's serious operational efficiency.

**ALEX**: But here's what I love about their strategy - they're not just pocketing those savings. They're reinvesting about $700 million above baseline into strategic priorities like AI, their connected trip vision, and geographic expansion. It's classic reinvestment for growth.

**JORDAN**: Speaking of AI, Glenn Fogel had some really compelling commentary on this. He talked about how they've been using AI for over a decade, but now with generative AI, they're rolling out what he calls "agentic capabilities" across their platforms. And unlike a lot of companies that talk about AI but don't show results, Booking is actually seeing it in their P&L.

**ALEX**: That's a great point. Steenbergen specifically called out how their customer service costs are actually down year-over-year despite 10% booking growth. That's a roughly 10% decline in customer service cost per booking - real, measurable AI impact.

**JORDAN**: Now let's talk about their competitive moat, because there was a really interesting exchange about large language models potentially disrupting travel booking. An analyst asked about companies like ChatGPT potentially becoming travel agents.

**ALEX**: And Fogel's response was brilliant. He basically said - good luck with that! He pointed out that Booking works with over 4 million properties, processes 100+ payment methods across 50+ currencies, deals with regulations across 200+ countries, and has thousands of partner service people. That's not something you just replicate overnight.

**JORDAN**: Exactly. He compared it to their relationship with Google - Google captures demand at the top of the funnel through search, Booking handles the complex backend of actually completing transactions. Both companies have thrived in that relationship, and he sees a similar dynamic potentially playing out with AI companies.

**ALEX**: Let's touch on their loyalty program, Genius, because the numbers there are impressive. Level 2 and 3 Genius members now represent over 30% of their active base but account for a high

This episode includes AI-generated content.]]>SP100-BKNG-enSun, 22 Feb 2026 04:03:32 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Booking Holdings' fourth quarter earnings call - and wow, what a quarter...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm joined by my co-host Jordan. Today we're diving into Booking Holdings' fourth quarter earnings call - and wow, what a quarter they had.

Before we get started though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Thanks Alex. And speaking of wow - Glenn Fogel just celebrated his 26th year at the company! That might make him the longest-tenured executive in tech. But beyond that milestone, Booking absolutely crushed their fourth quarter numbers.

**ALEX**: Let's break down those numbers, Jordan. Room nights hit 285 million - that's a 9% year-over-year increase that actually exceeded the high end of their expectations. And both gross bookings and revenue jumped 16%. What's driving this growth?

**JORDAN**: The strength is really coming from Asia and the U.S., both delivering low double-digit growth. What I found interesting is that the U.S. acceleration has been building all year - they went from low single-digit growth in the first half to low double-digit growth in Q4. That's a pretty impressive turnaround.

**ALEX**: And the profitability story is even better. Adjusted EBITDA reached $2.2 billion, up 19% year-over-year, with margins expanding 80 basis points to nearly 37%. A big driver here is their transformation program that launched in late 2024.

**JORDAN**: Right, and this transformation program is fascinating. They've already achieved $550 million in annual run-rate savings - hitting the high end of their guidance. CFO Ewout Steenbergen said they expect $500 to $550 million in additional in-year savings for 2026. That's serious operational efficiency.

**ALEX**: But here's what I love about their strategy - they're not just pocketing those savings. They're reinvesting about $700 million above baseline into strategic priorities like AI, their connected trip vision, and geographic expansion. It's classic reinvestment for growth.

**JORDAN**: Speaking of AI, Glenn Fogel had some really compelling commentary on this. He talked about how they've been using AI for over a decade, but now with generative AI, they're rolling out what he calls "agentic capabilities" across their platforms. And unlike a lot of companies that talk about AI but don't show results, Booking is actually seeing it in their P&L.

**ALEX**: That's a great point. Steenbergen specifically called out how their customer service costs are actually down year-over-year despite 10% booking growth. That's a roughly 10% decline in customer service cost per booking - real, measurable AI impact.

**JORDAN**: Now let's talk about their competitive moat, because there was a really interesting exchange about large language models potentially disrupting travel booking. An analyst asked about companies like ChatGPT potentially becoming travel agents.

**ALEX**: And Fogel's response was brilliant. He basically said - good luck with that! He pointed out that Booking works with over 4 million properties, processes 100+ payment methods across 50+ currencies, deals with regulations across 200+ countries, and has thousands of partner service people. That's not something you just replicate overnight.

**JORDAN**: Exactly. He compared it to their relationship with Google - Google captures demand at the top of the funnel through search, Booking handles the complex backend of actually completing transactions. Both companies have thrived in that relationship, and he sees a similar dynamic potentially playing out with AI companies.

**ALEX**: Let's touch on their loyalty...]]>508falsefullhttps://www.spreaker.com/episode/american-express-q4-2025-earnings-analysis--70208980
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into American Express's fourth quarter 2025 results, which dropped some pretty impressive numbers this morning.

**ALEX**: Before we jump in, just a quick reminder - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: So Alex, let's start with the headline numbers because American Express really delivered here.

**ALEX**: Absolutely. They posted record full-year revenues of $72 billion - that's up 10% year-over-year. Earnings per share came in at $15.38, which represents 15% growth excluding some gains. And here's what I found particularly striking - they're guiding for 2026 revenue growth of 9% to 10% with EPS between $17.30 and $17.90.

**JORDAN**: That guidance is solid, but what really caught my attention was their card fee growth. Jordan, they hit a record $10 billion in net card fees for the year, growing at 18%. That's thirty consecutive quarters of double-digit card fee growth. That's the kind of consistency that makes CFOs everywhere jealous.

**ALEX**: And it's not just about the numbers - it's about what's driving them. CEO Stephen Squeri talked extensively about their "investment philosophy," and I think this is key to understanding American Express's strategy. They spent $6.3 billion on marketing in 2025 - that's up 75% since 2019.

**JORDAN**: Right, but here's what's smart about their approach - they're not just throwing money at marketing. They're being incredibly strategic about it. During the quarter, they actually reallocated marketing dollars away from lower-cost cash back products toward their premium Platinum cards. The percentage of fee-paying products in their US consumer portfolio jumped 8 percentage points year-over-year.

**ALEX**: That Platinum card refresh is really the star of the show here. Launched in September, it's already performing better than expectations. Squeri mentioned they're seeing high customer demand, excellent engagement, great credit quality, and no change in retention rates even as the new fees kick in.

**JORDAN**: The engagement numbers are pretty remarkable. They launched a new Platinum travel app, and travel bookings were up 30% in the fourth quarter. Restaurant spending through their Resy platform was up 20%. When you can get customers to spend more while maintaining pristine credit quality, that's the holy grail of credit card business.

**ALEX**: Speaking of credit quality, let's talk about that because it's been a competitive advantage for American Express. Their delinquency and write-off rates remained flat throughout the year and are still below 2019 levels. CFO Christophe Le Caillec noted they expect credit metrics to remain "generally stable" in 2026.

**JORDAN**: That's in stark contrast to many competitors who are guiding for increases in credit losses. It really speaks to the quality of American Express's customer base. They're targeting that premium segment - millennials and Gen Z customers are now the largest share of US consumer spending, with average ages of 33 on Platinum and 29 on Gold cards.

**ALEX**: Now, one number that had investors asking questions was net card acquisitions, which were down a bit. But I think Squeri's response was telling - he said they don't focus on acquiring cards, they focus on acquiring revenue. And they're hitting their revenue targets.

**JORDAN**: Exactly. It's about quality over quantity. They're deliberately shifting toward fee-paying customers, and that's showing up in the economics. The variable customer engagement costs - basically rewards and benefits - stepped up to 45% of revenue in Q4 as they invested in those Pla

This episode includes AI-generated content.]]>SP100-AXP-Q4-2025-enSun, 22 Feb 2026 04:03:27 +0000trueBeta Finch**Beta Finch Podcast Script: American Express Q4 2025 Earnings** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN**: And I'm Jordan. Today we're diving into American Express's fourth quarter 2025 results,...
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into American Express's fourth quarter 2025 results, which dropped some pretty impressive numbers this morning.

**ALEX**: Before we jump in, just a quick reminder - this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: So Alex, let's start with the headline numbers because American Express really delivered here.

**ALEX**: Absolutely. They posted record full-year revenues of $72 billion - that's up 10% year-over-year. Earnings per share came in at $15.38, which represents 15% growth excluding some gains. And here's what I found particularly striking - they're guiding for 2026 revenue growth of 9% to 10% with EPS between $17.30 and $17.90.

**JORDAN**: That guidance is solid, but what really caught my attention was their card fee growth. Jordan, they hit a record $10 billion in net card fees for the year, growing at 18%. That's thirty consecutive quarters of double-digit card fee growth. That's the kind of consistency that makes CFOs everywhere jealous.

**ALEX**: And it's not just about the numbers - it's about what's driving them. CEO Stephen Squeri talked extensively about their "investment philosophy," and I think this is key to understanding American Express's strategy. They spent $6.3 billion on marketing in 2025 - that's up 75% since 2019.

**JORDAN**: Right, but here's what's smart about their approach - they're not just throwing money at marketing. They're being incredibly strategic about it. During the quarter, they actually reallocated marketing dollars away from lower-cost cash back products toward their premium Platinum cards. The percentage of fee-paying products in their US consumer portfolio jumped 8 percentage points year-over-year.

**ALEX**: That Platinum card refresh is really the star of the show here. Launched in September, it's already performing better than expectations. Squeri mentioned they're seeing high customer demand, excellent engagement, great credit quality, and no change in retention rates even as the new fees kick in.

**JORDAN**: The engagement numbers are pretty remarkable. They launched a new Platinum travel app, and travel bookings were up 30% in the fourth quarter. Restaurant spending through their Resy platform was up 20%. When you can get customers to spend more while maintaining pristine credit quality, that's the holy grail of credit card business.

**ALEX**: Speaking of credit quality, let's talk about that because it's been a competitive advantage for American Express. Their delinquency and write-off rates remained flat throughout the year and are still below 2019 levels. CFO Christophe Le Caillec noted they expect credit metrics to remain "generally stable" in 2026.

**JORDAN**: That's in stark contrast to many competitors who are guiding for increases in credit losses. It really speaks to the quality of American Express's customer base. They're targeting that premium segment - millennials and Gen Z customers are now the largest share of US consumer spending, with average ages of 33 on Platinum and 29 on Gold cards.

**ALEX**: Now, one number that had investors asking questions was net card acquisitions, which were down a bit. But I think Squeri's response was telling - he said they don't focus on acquiring cards, they focus on acquiring revenue. And they're hitting their revenue targets.

**JORDAN**: Exactly. It's about quality over quantity. They're deliberately shifting toward fee-paying customers, and that's showing up in...]]>509falsefullhttps://www.spreaker.com/episode/applovin-q4-2025-earnings-analysis--70208979
**JORDAN**: Thanks Alex. And wow, where do we even start with these numbers? AppLovin just delivered what CEO Adam Foroughi called "the most exceptional year we have ever delivered." We're talking about Q4 revenue of $1.66 billion, up 66% year-over-year, with adjusted EBITDA of $1.4 billion at an 84% margin. That's not a typo, folks - 84% margins.

**ALEX**: Those margins are just insane, Jordan. To put this in perspective, AppLovin is basically printing money at this scale. For the full year, they hit $5.48 billion in revenue, up 70% year-over-year, with $4.51 billion in adjusted EBITDA. That's nearly $4 billion in free cash flow for the year. And here's the kicker - they guided Q1 to sequential growth of 5% to 7%, which is unusual since Q1 is typically softer than Q4.

**JORDAN**: Right, and that sequential growth guidance is particularly impressive because it's happening despite typical seasonality headwinds AND the fact that their e-commerce business, which is still ramping, actually has worse Q1 seasonality than gaming. So the underlying strength in their core gaming business and the momentum in e-commerce must be really significant.

**ALEX**: Let's talk about the elephant in the room though - all this AI and competition fear that's been weighing on the stock. Adam Foroughi came out swinging on this topic right from the opening remarks. He basically said there's a "real disconnect between market sentiment and the reality of our business."

**JORDAN**: Yeah, his argument was fascinating. He essentially said that competition actually helps them because of how their MAX auction works. When competitors win impressions, it's usually the lower-value ones that AppLovin's model wasn't that confident about anyway. Meanwhile, AppLovin gets to collect a 5% take rate from the winning bidder. So more competition can actually expand the pie rather than just redistributing it.

**ALEX**: And on the AI disruption front, Foroughi made a counterintuitive argument. He said that if AI makes games easier to create, that actually benefits AppLovin because it creates more content, and when content becomes abundant, discovery becomes scarce. That's exactly what AppLovin's platform is designed for - efficiently matching the right user to the right content.

**JORDAN**: The e-commerce expansion is really the big growth story here though. They launched self-service onboarding in Q4 on a referral-only basis, and they're seeing some incredible early metrics. Adam mentioned they're seeing roughly 30-day LTV to customer acquisition cost breakeven when they test marketing the platform, which is exceptional for a lead generation model.

**ALEX**: That's a remarkable metric, especially when you consider they're converting 57% of qualified leads to live advertisers. Adam said they want to get that conversion rate closer to 100% before going to general availability, which they still expect in the first half of 2025. And they shared this amazing case study of an Israeli cookware company that grew from $4 million to $16 million in revenue last year, with 65% of their user acquisition spend on AppLovin's platform.

**JORDAN**: The creative automation piece is really interesting too. AppLovin is piloting generative AI tools with over 100 customers to help create ad components automatically. Right now, top gaming companies run tens of thousands of ads simultaneously, while top e-commerce companies are only running hundreds. If they can bridge that gap with AI-generated creative tools,

This episode includes AI-generated content.]]>SP100-APP-Q4-2025-enSun, 22 Feb 2026 04:03:22 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AppLovin's absolutely explosive Q4 2024 results. Before we get started though, I need to mention that this podcast is...
**JORDAN**: Thanks Alex. And wow, where do we even start with these numbers? AppLovin just delivered what CEO Adam Foroughi called "the most exceptional year we have ever delivered." We're talking about Q4 revenue of $1.66 billion, up 66% year-over-year, with adjusted EBITDA of $1.4 billion at an 84% margin. That's not a typo, folks - 84% margins.

**ALEX**: Those margins are just insane, Jordan. To put this in perspective, AppLovin is basically printing money at this scale. For the full year, they hit $5.48 billion in revenue, up 70% year-over-year, with $4.51 billion in adjusted EBITDA. That's nearly $4 billion in free cash flow for the year. And here's the kicker - they guided Q1 to sequential growth of 5% to 7%, which is unusual since Q1 is typically softer than Q4.

**JORDAN**: Right, and that sequential growth guidance is particularly impressive because it's happening despite typical seasonality headwinds AND the fact that their e-commerce business, which is still ramping, actually has worse Q1 seasonality than gaming. So the underlying strength in their core gaming business and the momentum in e-commerce must be really significant.

**ALEX**: Let's talk about the elephant in the room though - all this AI and competition fear that's been weighing on the stock. Adam Foroughi came out swinging on this topic right from the opening remarks. He basically said there's a "real disconnect between market sentiment and the reality of our business."

**JORDAN**: Yeah, his argument was fascinating. He essentially said that competition actually helps them because of how their MAX auction works. When competitors win impressions, it's usually the lower-value ones that AppLovin's model wasn't that confident about anyway. Meanwhile, AppLovin gets to collect a 5% take rate from the winning bidder. So more competition can actually expand the pie rather than just redistributing it.

**ALEX**: And on the AI disruption front, Foroughi made a counterintuitive argument. He said that if AI makes games easier to create, that actually benefits AppLovin because it creates more content, and when content becomes abundant, discovery becomes scarce. That's exactly what AppLovin's platform is designed for - efficiently matching the right user to the right content.

**JORDAN**: The e-commerce expansion is really the big growth story here though. They launched self-service onboarding in Q4 on a referral-only basis, and they're seeing some incredible early metrics. Adam mentioned they're seeing roughly 30-day LTV to customer acquisition cost breakeven when they test marketing the platform, which is exceptional for a lead generation model.

**ALEX**: That's a remarkable metric, especially when you consider they're converting 57% of qualified leads to live advertisers. Adam said they want to get that conversion rate closer to 100% before going to general availability, which they still expect in the first half of 2025. And they shared this amazing case study of an Israeli cookware company that grew from $4 million to $16 million in revenue last year, with 65% of their user acquisition spend on AppLovin's platform.

**JORDAN**: The creative automation piece is really interesting too. AppLovin is piloting generative AI tools with over 100 customers to help create ad components automatically. Right now, top gaming companies run tens of thousands of ads simultaneously, while top e-commerce...]]>460falsefullhttps://www.spreaker.com/episode/amphenol-q4-2025-earnings-analysis--70208977
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into some fascinating quarterly results. Jordan, we've got Amphenol's Q4 2025 earnings to discuss today - and wow, what a quarter this was.

JORDAN: Absolutely, Alex. But before we get into these impressive numbers, I need to share our standard disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks Jordan. Now, let's talk Amphenol - because these results are genuinely remarkable. We're looking at a company that just posted record sales of $6.4 billion for the quarter, up 49% in US dollars and 37% organically. For the full year, they hit $23.1 billion in sales. Jordan, they've literally more than doubled their revenue in just four years.

JORDAN: That's incredible scale, Alex. And what really caught my attention was their book-to-bill ratio - 1.31 to one in Q4, driven by a record $8.4 billion in orders. That's 68% growth in orders compared to last year. CEO Adam Norwitt was pretty clear about what's driving this: AI infrastructure investments are creating unprecedented demand for their interconnect products.

ALEX: Right, and this isn't just a revenue story. Their adjusted operating margin hit 27.5% in the quarter - that's a 510 basis point improvement year-over-year. For a company growing this fast, those margin numbers are exceptional. Jordan, what did you make of their strategy around acquisitions?

JORDAN: This is where it gets really interesting, Alex. They just closed their largest-ever acquisition - the CommScope CCS business - for what became over $4 billion in annualized sales after strong momentum. Norwitt was fascinating when he talked about this deal. He said they don't use the words "integration" or "synergy" at Amphenol. Instead, they let acquired companies evolve into the Amphenol family while maintaining their entrepreneurial culture.

ALEX: That's such a unique approach. And strategically, this CommScope acquisition is huge for them. It dramatically expands their fiber optic capabilities, which complements their traditional strength in high-speed copper interconnects. As Norwitt put it in the call, they can now offer customers solutions across "the entirety of the interconnect spectrum."

JORDAN: Exactly. And the timing couldn't be better with AI driving demand for both copper and fiber solutions. Speaking of AI, let's break down their IT datacom segment - it represented 38% of sales in Q4 and grew 110% organically. That's not a typo, folks - one hundred and ten percent growth.

ALEX: The breadth of their AI business really stood out to me, Jordan. Norwitt emphasized they don't have any 10% customers, meaning they're diversified across the entire AI stack - from hyperscalers to equipment manufacturers to chip designers. That's a much safer position than being dependent on one or two major customers.

JORDAN: And those record orders we mentioned? They're giving customers extended order windows to help share investment risk for these complex, high-tech products. Customers are essentially making solid commitments that give Amphenol confidence to make the capital investments needed for these next-generation systems.

ALEX: Let's talk about what this means geographically. One surprise was their strength in Europe, where they saw robust organic growth in both automotive and industrial markets. CFO Craig Lampo noted their strongest automotive growth in Q4 was actually in Europe - quite different from the doom and gloom we usually hear about that region.

JORDAN: That's a great point. And looking ahead, their Q1 2026 guidance is impressive: $6.9 to $7 billion in sales and $0.91 to $0.93 in adjusted EPS. That represents 43-45% sales growth and 44-48%

This episode includes AI-generated content.]]>SP100-APH-Q4-2025-enSun, 22 Feb 2026 04:03:17 +0000trueBeta Finch**Beta Finch Podcast Script** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into some fascinating quarterly results. Jordan, we've got Amphenol's Q4 2025 earnings to discuss...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into some fascinating quarterly results. Jordan, we've got Amphenol's Q4 2025 earnings to discuss today - and wow, what a quarter this was.

JORDAN: Absolutely, Alex. But before we get into these impressive numbers, I need to share our standard disclaimer. This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

ALEX: Thanks Jordan. Now, let's talk Amphenol - because these results are genuinely remarkable. We're looking at a company that just posted record sales of $6.4 billion for the quarter, up 49% in US dollars and 37% organically. For the full year, they hit $23.1 billion in sales. Jordan, they've literally more than doubled their revenue in just four years.

JORDAN: That's incredible scale, Alex. And what really caught my attention was their book-to-bill ratio - 1.31 to one in Q4, driven by a record $8.4 billion in orders. That's 68% growth in orders compared to last year. CEO Adam Norwitt was pretty clear about what's driving this: AI infrastructure investments are creating unprecedented demand for their interconnect products.

ALEX: Right, and this isn't just a revenue story. Their adjusted operating margin hit 27.5% in the quarter - that's a 510 basis point improvement year-over-year. For a company growing this fast, those margin numbers are exceptional. Jordan, what did you make of their strategy around acquisitions?

JORDAN: This is where it gets really interesting, Alex. They just closed their largest-ever acquisition - the CommScope CCS business - for what became over $4 billion in annualized sales after strong momentum. Norwitt was fascinating when he talked about this deal. He said they don't use the words "integration" or "synergy" at Amphenol. Instead, they let acquired companies evolve into the Amphenol family while maintaining their entrepreneurial culture.

ALEX: That's such a unique approach. And strategically, this CommScope acquisition is huge for them. It dramatically expands their fiber optic capabilities, which complements their traditional strength in high-speed copper interconnects. As Norwitt put it in the call, they can now offer customers solutions across "the entirety of the interconnect spectrum."

JORDAN: Exactly. And the timing couldn't be better with AI driving demand for both copper and fiber solutions. Speaking of AI, let's break down their IT datacom segment - it represented 38% of sales in Q4 and grew 110% organically. That's not a typo, folks - one hundred and ten percent growth.

ALEX: The breadth of their AI business really stood out to me, Jordan. Norwitt emphasized they don't have any 10% customers, meaning they're diversified across the entire AI stack - from hyperscalers to equipment manufacturers to chip designers. That's a much safer position than being dependent on one or two major customers.

JORDAN: And those record orders we mentioned? They're giving customers extended order windows to help share investment risk for these complex, high-tech products. Customers are essentially making solid commitments that give Amphenol confidence to make the capital investments needed for these next-generation systems.

ALEX: Let's talk about what this means geographically. One surprise was their strength in Europe, where they saw robust organic growth in both automotive and industrial markets. CFO Craig Lampo noted their strongest automotive growth in Q4 was actually in Europe - quite different from the doom and gloom we usually hear about that region.

JORDAN: That's a great point. And looking ahead, their Q1 2026 guidance is...]]>522falsefullhttps://www.spreaker.com/episode/amd-q2-2025-earnings-analysis--70208976
JORDAN: Thanks Alex. And wow, what a quarter for AMD! They absolutely crushed it with record revenue of $7.7 billion - that's up 32% year-over-year and beat the midpoint of their guidance. But there's definitely a story of two halves here.

ALEX: Exactly right, Jordan. On one hand, you've got this incredible momentum in traditional semiconductors - record sales for both their EPYC server chips and Ryzen consumer processors. But then there's this big cloud hanging over their AI GPU business with those U.S. export controls to China. Let's break down the numbers first.

JORDAN: So the headline numbers look strong, but dig a little deeper and you see some complexity. They reported earnings per share of 48 cents, down from 69 cents last year. But here's the kicker - they took an $800 million inventory write-down related to those export restrictions on AI chips to China. Without that charge, gross margins would have been 54% instead of the reported 43%.

ALEX: That write-down is massive, Jordan. It's essentially AMD saying "we built all these high-end AI chips for China, but now we can't sell them." CEO Lisa Su mentioned that most of this wasn't finished goods sitting on shelves - it was work-in-process inventory that will take a couple quarters to work through if and when licenses get approved.

JORDAN: Right, and that's actually somewhat encouraging because it means they're not stuck with warehouses full of obsolete products. Speaking of AI chips, let's talk about what's working. Their new MI350 series started shipping in June - ahead of schedule - and Su sounded genuinely excited about customer adoption.

ALEX: The MI350 story is fascinating. Su mentioned they're seeing faster adoption than expected, with customers wanting to deploy at scale rather than the smaller pilot deployments they saw with the MI300 series. They're positioning the MI355 as competitive with NVIDIA's B200 and GB200 chips, claiming 40% more tokens per dollar for inference workloads.

JORDAN: And here's where it gets really interesting - they announced this massive collaboration with Saudi Arabia through something called HUMAIN, described as a "multibillion-dollar" AI infrastructure deal. Plus they mentioned over 40 active sovereign AI engagements globally. This could be a game-changer for AMD's positioning against NVIDIA.

ALEX: Absolutely. But let's not forget their bread and butter businesses, because those are absolutely on fire right now. Client and Gaming revenue jumped 69% year-over-year to $3.6 billion. That's driven by what Su called "record desktop CPU sales" with their Ryzen processors consistently topping bestseller lists.

JORDAN: The client story is particularly impressive because it's not just about volume - they're moving up-market. Revenue growth of 67% year-over-year in client CPUs is largely coming from higher average selling prices as they capture more premium segments. And they're finally making real inroads in enterprise PCs, which has been a tough nut to crack against Intel.

ALEX: Data center CPUs are another bright spot. Despite all the focus on AI GPUs, AMD set records for both cloud and enterprise CPU sales. Su mentioned they've now had 33 consecutive quarters of server market share gains. Think about that - that's over eight years of steady progress against Intel.

JORDAN: The guidance for Q3 is pretty telling too. They're calling for revenue of about $8.7 billion, which implies 28% year-over-year growth. The key driver is supposed to be that MI350 ramp we talked about, even withou

This episode includes AI-generated content.]]>SP100-AMD-Q2-2025-enSun, 22 Feb 2026 04:03:12 +0000trueBeta FinchALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's Q2 2025 earnings call. Now, before we get started, I need to mention that this podcast is AI-generated content for...
JORDAN: Thanks Alex. And wow, what a quarter for AMD! They absolutely crushed it with record revenue of $7.7 billion - that's up 32% year-over-year and beat the midpoint of their guidance. But there's definitely a story of two halves here.

ALEX: Exactly right, Jordan. On one hand, you've got this incredible momentum in traditional semiconductors - record sales for both their EPYC server chips and Ryzen consumer processors. But then there's this big cloud hanging over their AI GPU business with those U.S. export controls to China. Let's break down the numbers first.

JORDAN: So the headline numbers look strong, but dig a little deeper and you see some complexity. They reported earnings per share of 48 cents, down from 69 cents last year. But here's the kicker - they took an $800 million inventory write-down related to those export restrictions on AI chips to China. Without that charge, gross margins would have been 54% instead of the reported 43%.

ALEX: That write-down is massive, Jordan. It's essentially AMD saying "we built all these high-end AI chips for China, but now we can't sell them." CEO Lisa Su mentioned that most of this wasn't finished goods sitting on shelves - it was work-in-process inventory that will take a couple quarters to work through if and when licenses get approved.

JORDAN: Right, and that's actually somewhat encouraging because it means they're not stuck with warehouses full of obsolete products. Speaking of AI chips, let's talk about what's working. Their new MI350 series started shipping in June - ahead of schedule - and Su sounded genuinely excited about customer adoption.

ALEX: The MI350 story is fascinating. Su mentioned they're seeing faster adoption than expected, with customers wanting to deploy at scale rather than the smaller pilot deployments they saw with the MI300 series. They're positioning the MI355 as competitive with NVIDIA's B200 and GB200 chips, claiming 40% more tokens per dollar for inference workloads.

JORDAN: And here's where it gets really interesting - they announced this massive collaboration with Saudi Arabia through something called HUMAIN, described as a "multibillion-dollar" AI infrastructure deal. Plus they mentioned over 40 active sovereign AI engagements globally. This could be a game-changer for AMD's positioning against NVIDIA.

ALEX: Absolutely. But let's not forget their bread and butter businesses, because those are absolutely on fire right now. Client and Gaming revenue jumped 69% year-over-year to $3.6 billion. That's driven by what Su called "record desktop CPU sales" with their Ryzen processors consistently topping bestseller lists.

JORDAN: The client story is particularly impressive because it's not just about volume - they're moving up-market. Revenue growth of 67% year-over-year in client CPUs is largely coming from higher average selling prices as they capture more premium segments. And they're finally making real inroads in enterprise PCs, which has been a tough nut to crack against Intel.

ALEX: Data center CPUs are another bright spot. Despite all the focus on AI GPUs, AMD set records for both cloud and enterprise CPU sales. Su mentioned they've now had 33 consecutive quarters of server market share gains. Think about that - that's over eight years of steady progress against Intel.

JORDAN: The guidance for Q3 is pretty telling too. They're calling for revenue of about $8.7 billion,...]]>495falsefullhttps://www.spreaker.com/episode/analog-devices-q1-2026-earnings-analysis--70208974
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the most important takeaways from quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dive into today's earnings, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks Jordan. Today we're breaking down Analog Devices' first quarter 2026 results, and wow - what a quarter this was. ADI absolutely crushed it across the board, with revenue hitting $3.16 billion, up 30% year-over-year and coming in at the high end of guidance.

**JORDAN:** That's right, Alex. And it wasn't just a revenue beat - earnings per share came in at $2.46, up 51% year-over-year, while operating margins expanded to 45.5%. But what really caught my attention was their guidance for Q2. They're projecting $3.5 billion in revenue, which would be about 11% sequential growth - way above their typical 4-5% seasonality.

**ALEX:** Absolutely massive guide. Now Jordan, let's talk about what's driving this performance because CEO Vincent Roche spent a lot of time on the call talking about their AI exposure. They mentioned that their automated test equipment and data center businesses now make up close to 20% of total revenue - that's over $2 billion on a run-rate basis.

**JORDAN:** That's a huge number, and here's the breakdown: about 40% of that AI-related revenue is from automated test equipment, or ATE, which grew about 40% last year and accelerated further in Q1. The remaining 60% is data center, split roughly equally between power management and optical connectivity solutions. Both segments are seeing what Roche called "substantial returns" from their AI investments.

**ALEX:** What I found fascinating was Roche's deep dive into their data center power story. He broke it down into two categories - power delivery, which he called "the vascular system," and power control, which he described as "the brain of the data center energy system." ADI's positioning themselves as essential to managing the massive power requirements of AI infrastructure.

**JORDAN:** Right, and this isn't just theoretical. CFO Richard Puccio mentioned that their data center business grew approximately 50% in fiscal 2025 and saw accelerated growth in the most recent quarter. When you combine that with the ATE growth, you're looking at some serious momentum in their highest-margin businesses.

**ALEX:** Now let's talk about the segment performance because it was pretty broad-based. Industrial, their largest segment at 47% of revenue, was up 38% year-over-year with all subsegments growing at least 25%. That includes record quarters for both ATE and aerospace & defense.

**JORDAN:** Communications was another standout, up 63% year-over-year, driven by that AI data center demand we mentioned plus a cyclical recovery in wireless. Even automotive, which has been a bit soft, still managed 8% year-over-year growth despite some tariff-related headwinds.

**ALEX:** Speaking of automotive, that was one of the more interesting parts of the Q&A. Management acknowledged they're seeing some sequential weakness there, calling it "flat to down" for Q2, largely due to what they called a "tariff and macro pull-in unwind." But they're confident about the second half of the year.

**JORDAN:** Yeah, and CFO Puccio was pretty clear that nothing's changed with their strong market position in automotive. They've been gaining significant content and share, particularly in Level 2+ ADAS systems, and they expect automotive to grow for the full fiscal year despite the first-half headwinds.

**ALEX:** Now Jordan, let's talk margins because this is where ADI really shines. Gross m

This episode includes AI-generated content.]]>SP100-ADI-Q1-2026-enSun, 22 Feb 2026 04:03:02 +0000trueBeta Finch# Beta Finch Podcast Script - Analog Devices Q1 2026 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the most important takeaways from quarterly reports. I'm Alex. **JORDAN:**...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you the most important takeaways from quarterly reports. I'm Alex.

**JORDAN:** And I'm Jordan. Before we dive into today's earnings, I need to share an important disclaimer: This podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks Jordan. Today we're breaking down Analog Devices' first quarter 2026 results, and wow - what a quarter this was. ADI absolutely crushed it across the board, with revenue hitting $3.16 billion, up 30% year-over-year and coming in at the high end of guidance.

**JORDAN:** That's right, Alex. And it wasn't just a revenue beat - earnings per share came in at $2.46, up 51% year-over-year, while operating margins expanded to 45.5%. But what really caught my attention was their guidance for Q2. They're projecting $3.5 billion in revenue, which would be about 11% sequential growth - way above their typical 4-5% seasonality.

**ALEX:** Absolutely massive guide. Now Jordan, let's talk about what's driving this performance because CEO Vincent Roche spent a lot of time on the call talking about their AI exposure. They mentioned that their automated test equipment and data center businesses now make up close to 20% of total revenue - that's over $2 billion on a run-rate basis.

**JORDAN:** That's a huge number, and here's the breakdown: about 40% of that AI-related revenue is from automated test equipment, or ATE, which grew about 40% last year and accelerated further in Q1. The remaining 60% is data center, split roughly equally between power management and optical connectivity solutions. Both segments are seeing what Roche called "substantial returns" from their AI investments.

**ALEX:** What I found fascinating was Roche's deep dive into their data center power story. He broke it down into two categories - power delivery, which he called "the vascular system," and power control, which he described as "the brain of the data center energy system." ADI's positioning themselves as essential to managing the massive power requirements of AI infrastructure.

**JORDAN:** Right, and this isn't just theoretical. CFO Richard Puccio mentioned that their data center business grew approximately 50% in fiscal 2025 and saw accelerated growth in the most recent quarter. When you combine that with the ATE growth, you're looking at some serious momentum in their highest-margin businesses.

**ALEX:** Now let's talk about the segment performance because it was pretty broad-based. Industrial, their largest segment at 47% of revenue, was up 38% year-over-year with all subsegments growing at least 25%. That includes record quarters for both ATE and aerospace & defense.

**JORDAN:** Communications was another standout, up 63% year-over-year, driven by that AI data center demand we mentioned plus a cyclical recovery in wireless. Even automotive, which has been a bit soft, still managed 8% year-over-year growth despite some tariff-related headwinds.

**ALEX:** Speaking of automotive, that was one of the more interesting parts of the Q&A. Management acknowledged they're seeing some sequential weakness there, calling it "flat to down" for Q2, largely due to what they called a "tariff and macro pull-in unwind." But they're confident about the second half of the year.

**JORDAN:** Yeah, and CFO Puccio was pretty clear that nothing's changed with their strong market position in automotive. They've been gaining significant content and share, particularly in Level 2+ ADAS systems, and they expect automotive to grow for the full fiscal year...]]>500falsefullhttps://www.spreaker.com/episode/abbvie-q4-2025-earnings-analysis--70208973
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we digest the latest corporate earnings so you don't have to. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into AbbVie's fourth quarter 2025 results, and wow, what a story this pharmaceutical giant has to tell.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, AbbVie just delivered what CEO Robert Michael called "another excellent year," and the numbers certainly back that up. Let's start with the headline figures.

ALEX: The numbers are pretty impressive, Jordan. AbbVie hit $61.2 billion in adjusted net revenues for the full year - that's a record high and beat their initial guidance by over $2 billion. They're looking at 8.6% sales growth despite facing nearly $16 billion in HUMIRA erosion since it lost exclusivity.

JORDAN: That HUMIRA erosion is the elephant in the room, isn't it? But what's fascinating is how they've more than offset those losses. Their adjusted earnings per share came in at $10 - that's 54 cents above their initial guidance midpoint. It really shows the power of their newer drugs.

ALEX: Exactly, and speaking of those newer drugs, let's talk about the real stars of the show - SKYRIZI and RINVOQ. These two immunology powerhouses are absolutely crushing it.

JORDAN: The numbers are staggering. Combined, SKYRIZI and RINVOQ delivered about $25.9 billion in revenue - that's an $8 billion increase year-over-year. SKYRIZI alone hit $5 billion in the quarter with 31.9% operational growth, while RINVOQ came in at nearly $2.4 billion with 28.6% growth.

ALEX: And here's what caught my attention - they're already exceeding their 2027 long-term guidance by half a billion dollars. For 2026, they're projecting combined sales of over $31 billion for these two drugs. That's remarkable momentum.

JORDAN: What's really interesting is how they're dominating in specific markets. In psoriasis, SKYRIZI has over 45% prescription share in the U.S. biologic market, and their capture rates for new patients are exceeding 55% - that's four times higher than their next closest competitor.

ALEX: The competitive dynamics in IBD are particularly noteworthy. Despite new competition, SKYRIZI maintains a 75% capture rate in frontline IBD treatment, and it's even higher - 80% - specifically in Crohn's disease.

JORDAN: Now let's talk about what's really exciting for the future - their neuroscience portfolio. This segment delivered over $10.7 billion in revenue with nearly $1.8 billion in growth. But the real story here is Vialev, their Parkinson's treatment.

ALEX: Vialev hit $183 million in the quarter - up 33% sequentially - and management is now projecting it'll reach blockbuster status in 2026. That's a billion-dollar drug in its early launch phase. Pretty remarkable.

JORDAN: And they're not stopping there. They see their entire Parkinson's franchise, including Vialev, Duopa, and the upcoming Tavapadon, potentially reaching $5 billion in peak sales. Add their migraine franchise, which they also expect to exceed $5 billion, and you're talking about some serious long-term growth drivers.

ALEX: Let's shift to their pipeline because that's where AbbVie is really investing for the future. They spent nearly $1 billion more on R&D in 2025, fully funding 90 clinical programs. They also invested over $5 billion in business development.

JORDAN: Some of those acquisitions are fascinating - they picked up an in-vivo CAR-T platform, next-generation psychedelics for depression, a long-acting amylin analog for obesity, and even a novel siRNA platform. They're clearly positioning for the next decade of growth.

ALEX: Speaking of p

This episode includes AI-generated content.]]>SP100-ABBV-Q4-2025-enSun, 22 Feb 2026 04:02:57 +0000trueBeta Finch**Beta Finch Podcast Script: AbbVie Q4 2025 Earnings** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we digest the latest corporate earnings so you don't have to. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown where we digest the latest corporate earnings so you don't have to. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into AbbVie's fourth quarter 2025 results, and wow, what a story this pharmaceutical giant has to tell.

ALEX: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, AbbVie just delivered what CEO Robert Michael called "another excellent year," and the numbers certainly back that up. Let's start with the headline figures.

ALEX: The numbers are pretty impressive, Jordan. AbbVie hit $61.2 billion in adjusted net revenues for the full year - that's a record high and beat their initial guidance by over $2 billion. They're looking at 8.6% sales growth despite facing nearly $16 billion in HUMIRA erosion since it lost exclusivity.

JORDAN: That HUMIRA erosion is the elephant in the room, isn't it? But what's fascinating is how they've more than offset those losses. Their adjusted earnings per share came in at $10 - that's 54 cents above their initial guidance midpoint. It really shows the power of their newer drugs.

ALEX: Exactly, and speaking of those newer drugs, let's talk about the real stars of the show - SKYRIZI and RINVOQ. These two immunology powerhouses are absolutely crushing it.

JORDAN: The numbers are staggering. Combined, SKYRIZI and RINVOQ delivered about $25.9 billion in revenue - that's an $8 billion increase year-over-year. SKYRIZI alone hit $5 billion in the quarter with 31.9% operational growth, while RINVOQ came in at nearly $2.4 billion with 28.6% growth.

ALEX: And here's what caught my attention - they're already exceeding their 2027 long-term guidance by half a billion dollars. For 2026, they're projecting combined sales of over $31 billion for these two drugs. That's remarkable momentum.

JORDAN: What's really interesting is how they're dominating in specific markets. In psoriasis, SKYRIZI has over 45% prescription share in the U.S. biologic market, and their capture rates for new patients are exceeding 55% - that's four times higher than their next closest competitor.

ALEX: The competitive dynamics in IBD are particularly noteworthy. Despite new competition, SKYRIZI maintains a 75% capture rate in frontline IBD treatment, and it's even higher - 80% - specifically in Crohn's disease.

JORDAN: Now let's talk about what's really exciting for the future - their neuroscience portfolio. This segment delivered over $10.7 billion in revenue with nearly $1.8 billion in growth. But the real story here is Vialev, their Parkinson's treatment.

ALEX: Vialev hit $183 million in the quarter - up 33% sequentially - and management is now projecting it'll reach blockbuster status in 2026. That's a billion-dollar drug in its early launch phase. Pretty remarkable.

JORDAN: And they're not stopping there. They see their entire Parkinson's franchise, including Vialev, Duopa, and the upcoming Tavapadon, potentially reaching $5 billion in peak sales. Add their migraine franchise, which they also expect to exceed $5 billion, and you're talking about some serious long-term growth drivers.

ALEX: Let's shift to their pipeline because that's where AbbVie is really investing for the future. They spent nearly $1 billion more on R&D in 2025, fully funding 90 clinical programs. They also invested over $5 billion in business development.

JORDAN: Some of those acquisitions are fascinating - they picked up an in-vivo CAR-T platform, next-generation...]]>508falsefullhttps://www.spreaker.com/episode/apple-q1-2026-earnings-analysis--70208972
**JORDAN:** And I'm Jordan. Today we're diving into Apple's absolutely massive Q1 2026 results that just dropped. Alex, before we get started, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks Jordan. Now, let's talk about these Apple numbers because honestly, they're pretty jaw-dropping. Apple just reported $143.8 billion in revenue - that's up 16% year-over-year and their best quarter ever. Tim Cook called it "a quarter for the record books," and I think that might be underselling it.

**JORDAN:** Right? And when you look at the iPhone specifically, we're talking about $85.3 billion in revenue - up 23% year-over-year. That's just staggering demand for the iPhone 17 lineup. But what really caught my attention was Tim Cook saying they "exited December with very lean channel inventory" because demand was so strong they basically couldn't keep up.

**ALEX:** That's a good problem to have, but it's also creating some challenges. They're actually supply-constrained going into Q2, specifically on the advanced 3-nanometer chip nodes. Tim mentioned they're in "supply chase mode" right now. Jordan, what do you make of their Q2 guidance of 13-16% revenue growth despite these constraints?

**JORDAN:** It shows the underlying demand is incredibly robust. Even with supply constraints baked into that guidance, they're still projecting double-digit growth. But here's what's interesting - they're also dealing with rising memory costs. Tim said memory had minimal impact in Q1 but expects more pressure in Q2, which is why gross margins are guided at 48-49% versus the 48.2% they just reported.

**ALEX:** Let's talk about China because that was a real standout - 38% growth year-over-year. That's near all-time high revenue levels for Apple in that market. Tim attributed it to customer enthusiasm for the iPhone 17, but also mentioned they saw strong double-digit growth in store traffic and set records for both upgraders and switchers.

**JORDAN:** The China story is fascinating because it shows Apple can still drive growth in mature markets when they have the right product. And speaking of the right product, we need to talk about the elephant in the room - AI. Apple announced a partnership with Google to develop next-generation Apple foundation models that will power a more personalized Siri coming this year.

**ALEX:** That was probably the biggest strategic announcement from the call. Tim said they chose Google's AI technology because it would "provide the most capable foundation for Apple Foundation Models." They're maintaining their privacy-first approach with on-device processing and private cloud compute, but this Google partnership could be a game-changer for Siri's capabilities.

**JORDAN:** What I found interesting was how coy they were about the financial details of that Google partnership. When analysts asked about potential revenue sharing similar to their search deal, Tim just said they're "not releasing the details of that." Given Apple's history with Google on search revenue, that could be meaningful for services revenue down the line.

**ALEX:** Speaking of services, that hit $30 billion - another all-time record and up 14% year-over-year. They had records in advertising, cloud services, music, and payment services. Kevin Parekh, the CFO, emphasized they now have over 2.5 billion active devices as a foundation for services growth.

**JORDAN:** That installed base number is crucial because it's the engine for their services growth. And when you think about it, they're adding AI capabilities that could drive more services engagement. Tim mentioned that the majority of users on AI-enabled iPhon

This episode includes AI-generated content.]]>SP100-AAPL-Q1-2026-enSun, 22 Feb 2026 04:02:52 +0000trueBeta Finch**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. **JORDAN:** And I'm Jordan. Today we're diving into Apple's absolutely massive Q1 2026 results that just dropped. Alex, before we get started, I want to make sure our...
**JORDAN:** And I'm Jordan. Today we're diving into Apple's absolutely massive Q1 2026 results that just dropped. Alex, before we get started, I want to make sure our listeners know that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX:** Thanks Jordan. Now, let's talk about these Apple numbers because honestly, they're pretty jaw-dropping. Apple just reported $143.8 billion in revenue - that's up 16% year-over-year and their best quarter ever. Tim Cook called it "a quarter for the record books," and I think that might be underselling it.

**JORDAN:** Right? And when you look at the iPhone specifically, we're talking about $85.3 billion in revenue - up 23% year-over-year. That's just staggering demand for the iPhone 17 lineup. But what really caught my attention was Tim Cook saying they "exited December with very lean channel inventory" because demand was so strong they basically couldn't keep up.

**ALEX:** That's a good problem to have, but it's also creating some challenges. They're actually supply-constrained going into Q2, specifically on the advanced 3-nanometer chip nodes. Tim mentioned they're in "supply chase mode" right now. Jordan, what do you make of their Q2 guidance of 13-16% revenue growth despite these constraints?

**JORDAN:** It shows the underlying demand is incredibly robust. Even with supply constraints baked into that guidance, they're still projecting double-digit growth. But here's what's interesting - they're also dealing with rising memory costs. Tim said memory had minimal impact in Q1 but expects more pressure in Q2, which is why gross margins are guided at 48-49% versus the 48.2% they just reported.

**ALEX:** Let's talk about China because that was a real standout - 38% growth year-over-year. That's near all-time high revenue levels for Apple in that market. Tim attributed it to customer enthusiasm for the iPhone 17, but also mentioned they saw strong double-digit growth in store traffic and set records for both upgraders and switchers.

**JORDAN:** The China story is fascinating because it shows Apple can still drive growth in mature markets when they have the right product. And speaking of the right product, we need to talk about the elephant in the room - AI. Apple announced a partnership with Google to develop next-generation Apple foundation models that will power a more personalized Siri coming this year.

**ALEX:** That was probably the biggest strategic announcement from the call. Tim said they chose Google's AI technology because it would "provide the most capable foundation for Apple Foundation Models." They're maintaining their privacy-first approach with on-device processing and private cloud compute, but this Google partnership could be a game-changer for Siri's capabilities.

**JORDAN:** What I found interesting was how coy they were about the financial details of that Google partnership. When analysts asked about potential revenue sharing similar to their search deal, Tim just said they're "not releasing the details of that." Given Apple's history with Google on search revenue, that could be meaningful for services revenue down the line.

**ALEX:** Speaking of services, that hit $30 billion - another all-time record and up 14% year-over-year. They had records in advertising, cloud services, music, and payment services. Kevin Parekh, the CFO, emphasized they now have over 2.5 billion active devices as a foundation for services growth.

**JORDAN:** That installed base number is crucial because it's the engine for their services growth. And when you think about it, they're adding AI...]]>486falsefullhttps://www.spreaker.com/episode/alphabet-q4-2025-earnings-analysis--70186113
Jordan, where do I even start with these numbers? Alphabet just posted their first $400 billion revenue year!

**JORDAN**: Alex, this was genuinely jaw-dropping. We're talking about $113.8 billion in Q4 revenue alone - that's up 17% year-over-year. But what really caught my eye was the acceleration story here. Search revenue jumped 17%, which is a significant pickup from recent quarters, and Google Cloud absolutely exploded with 48% growth hitting $17.7 billion.

**ALEX**: And let's talk about that Cloud number for a second because this is where the AI story really comes alive. They're now at a $70 billion annual run rate, and get this - their backlog grew 55% quarter-over-quarter to $240 billion. That's not a typo, folks. $240 billion in committed future revenue.

**JORDAN**: The backlog number is insane, but what's driving it is even more interesting. Sundar Pichai mentioned they've sold over 8 million paid seats of Gemini Enterprise in just four months since launch. And here's a stat that blew me away - customers using their AI products use 1.8 times as many Google Cloud products compared to those who don't. That's the power of the AI ecosystem lock-in effect.

**ALEX**: Speaking of Gemini, the usage numbers are staggering. The Gemini app now has 750 million monthly active users, and they added 100 million users just in Q4. But Jordan, what really stood out to me was how Sundar kept emphasizing this "expansionary moment" - they're not seeing cannibalization between traditional search and AI search, they're seeing people do more queries overall.

**JORDAN**: Exactly, and that's showing up in the monetization too. Philip Schindler mentioned that Gemini-based improvements in search ads are helping them better match queries and deliver ads on longer, more complex searches that were previously difficult to monetize. They're literally expanding the addressable market for search advertising.

**ALEX**: Now let's talk about the elephant in the room - that massive CapEx guidance. They're projecting $175 to $185 billion for 2026. That's nearly double what they spent in 2025. This is a company betting big on the AI infrastructure race.

**JORDAN**: And they have to, right? Sundar was very candid about being supply constrained even with their current massive investments. He said they expect to "go through the year in a supply constrained way." What's fascinating is how they're approaching efficiency - Anat Ashkenazi mentioned that about 50% of their code is now written by AI coding agents, which is then reviewed by human engineers. They're using AI to fund more AI investment.

**ALEX**: That's such a smart flywheel effect. And speaking of flywheels, let's talk about some of the strategic announcements. The Apple partnership really surprised me - Google becoming Apple's preferred cloud provider and helping develop Apple's foundation models based on Gemini technology.

**JORDAN**: That Apple deal is huge strategically. But I was equally intrigued by the Universal Commerce Protocol they announced. This could be a game-changer for how people shop online. Imagine being able to complete purchases directly in AI search results or the Gemini app. They're essentially trying to own the entire commerce funnel.

**ALEX**: And YouTube continues to be this steady growth engine. $60 billion in annual revenue across ads and subscriptions, and they're still the number one streamer in the US for nearly three years running. The creator economy numbers were impressive too - over 1 million channels used their AI cre

This episode includes AI-generated content.]]>SP100-GOOGL-Q4-2025-enSat, 21 Feb 2026 05:46:20 +0000trueBeta Finch**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and I'm here with my co-host Jordan to dive into Alphabet's absolutely monster Q4 2025 results that just dropped. This podcast is AI-generated content for educational and...
Jordan, where do I even start with these numbers? Alphabet just posted their first $400 billion revenue year!

**JORDAN**: Alex, this was genuinely jaw-dropping. We're talking about $113.8 billion in Q4 revenue alone - that's up 17% year-over-year. But what really caught my eye was the acceleration story here. Search revenue jumped 17%, which is a significant pickup from recent quarters, and Google Cloud absolutely exploded with 48% growth hitting $17.7 billion.

**ALEX**: And let's talk about that Cloud number for a second because this is where the AI story really comes alive. They're now at a $70 billion annual run rate, and get this - their backlog grew 55% quarter-over-quarter to $240 billion. That's not a typo, folks. $240 billion in committed future revenue.

**JORDAN**: The backlog number is insane, but what's driving it is even more interesting. Sundar Pichai mentioned they've sold over 8 million paid seats of Gemini Enterprise in just four months since launch. And here's a stat that blew me away - customers using their AI products use 1.8 times as many Google Cloud products compared to those who don't. That's the power of the AI ecosystem lock-in effect.

**ALEX**: Speaking of Gemini, the usage numbers are staggering. The Gemini app now has 750 million monthly active users, and they added 100 million users just in Q4. But Jordan, what really stood out to me was how Sundar kept emphasizing this "expansionary moment" - they're not seeing cannibalization between traditional search and AI search, they're seeing people do more queries overall.

**JORDAN**: Exactly, and that's showing up in the monetization too. Philip Schindler mentioned that Gemini-based improvements in search ads are helping them better match queries and deliver ads on longer, more complex searches that were previously difficult to monetize. They're literally expanding the addressable market for search advertising.

**ALEX**: Now let's talk about the elephant in the room - that massive CapEx guidance. They're projecting $175 to $185 billion for 2026. That's nearly double what they spent in 2025. This is a company betting big on the AI infrastructure race.

**JORDAN**: And they have to, right? Sundar was very candid about being supply constrained even with their current massive investments. He said they expect to "go through the year in a supply constrained way." What's fascinating is how they're approaching efficiency - Anat Ashkenazi mentioned that about 50% of their code is now written by AI coding agents, which is then reviewed by human engineers. They're using AI to fund more AI investment.

**ALEX**: That's such a smart flywheel effect. And speaking of flywheels, let's talk about some of the strategic announcements. The Apple partnership really surprised me - Google becoming Apple's preferred cloud provider and helping develop Apple's foundation models based on Gemini technology.

**JORDAN**: That Apple deal is huge strategically. But I was equally intrigued by the Universal Commerce Protocol they announced. This could be a game-changer for how people shop online. Imagine being able to complete purchases directly in AI search results or the Gemini app. They're essentially trying to own the entire commerce funnel.

**ALEX**: And YouTube continues to be this steady growth engine. $60 billion in annual revenue across ads and subscriptions, and they're still the number one streamer in the US for...]]>493falsefullhttps://www.spreaker.com/episode/netflix-q4-2025-earnings-analysis--70092320
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to give you the real story behind the numbers. I'm Alex.

**JORDAN**: And I'm Jordan. Before we dive in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Today we're breaking down Netflix's Q4 2025 earnings, and wow - there's a lot to unpack here. Jordan, let me start with the headline numbers because they're pretty impressive.

**JORDAN**: Absolutely, Alex. Netflix crushed it across the board. They delivered 16% revenue growth and - get this - 30% operating profit growth. They're guiding for 2026 revenue of $51 billion, which is 14% year-over-year growth. And their operating margins are expected to hit 31.5%, up two full percentage points.

**ALEX**: What really caught my eye was the advertising business. They said ad sales grew two and a half times in 2025, and they're expecting it to roughly double again in 2026 to about $3 billion. Jordan, that's starting to become real money for Netflix.

**JORDAN**: It really is. And here's what's interesting - they're still under 10% of TV time in all major markets and only about 7% of the addressable market for consumer and ad spend. So there's massive room for growth. But the elephant in the room here is obviously the Warner Bros. Studios and HBO acquisition they're working to close.

**ALEX**: Right, and I have to say, listening to the call, the executives sounded genuinely excited about this deal. Gregory Peters mentioned they weren't even looking to be buyers initially, but when they got "under the hood" during due diligence, several things got them excited. The film studio brings a mature theatrical business, the TV studio expands their production capability, and HBO - well, it's HBO.

**JORDAN**: What's smart about their positioning is they're framing this as an accelerant to their core strategy, not a pivot. Spencer Neumann noted that roughly 85% of the combined company's revenues post-close would still be from Netflix's core streaming business. They're not abandoning their model - they're enhancing it.

**ALEX**: And Theodore Sarandos made a really compelling point about why they think this deal will get regulatory approval. He said it's "pro-consumer, pro-innovation, pro-worker, pro-creator, and pro-growth." His argument was that the TV landscape has never been more competitive - YouTube has full-length films and NFL games, Amazon owns MGM, Apple's competing for Oscars. The lines are blurring everywhere.

**JORDAN**: That's a good point. But let's talk about something that might concern some investors - engagement growth was only up 2% year-over-year to about 1.5 billion additional hours. That's actually an acceleration from 1% growth they saw earlier, but it's still pretty modest for a growth company.

**ALEX**: True, but Gregory Peters had an interesting take on this. He said viewing of their original branded content was actually up 9% in the second half versus 7% in the first half. The slower overall growth was because they had fewer licensed titles compared to when they bulked up during the strikes in 2023 and 2024.

**JORDAN**: And they're getting more sophisticated about measuring engagement quality, not just quantity. Peters mentioned they achieved an all-time high on their primary quality metric in 2025, and customer satisfaction is also at an all-time high. Sometimes the numbers don't tell the whole story.

**ALEX**: Speaking of content, Theodore Sarandos was in full showman mode describing their upcoming slate. We're talking about the return of huge franchises - Bridgerton season four, One Piece season two, the third season of The Night Agent, second season of Beef. Plus new projects from the

This episode includes AI-generated content.]]>SP100-NFLX-Q4-2025-enTue, 17 Feb 2026 04:54:00 +0000trueBeta Finch# Beta Finch Podcast Script - Netflix Q4 2025 Earnings **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to give you the real story behind the numbers. I'm Alex. **JORDAN**: And I'm Jordan....
**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the corporate speak to give you the real story behind the numbers. I'm Alex.

**JORDAN**: And I'm Jordan. Before we dive in, this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**ALEX**: Today we're breaking down Netflix's Q4 2025 earnings, and wow - there's a lot to unpack here. Jordan, let me start with the headline numbers because they're pretty impressive.

**JORDAN**: Absolutely, Alex. Netflix crushed it across the board. They delivered 16% revenue growth and - get this - 30% operating profit growth. They're guiding for 2026 revenue of $51 billion, which is 14% year-over-year growth. And their operating margins are expected to hit 31.5%, up two full percentage points.

**ALEX**: What really caught my eye was the advertising business. They said ad sales grew two and a half times in 2025, and they're expecting it to roughly double again in 2026 to about $3 billion. Jordan, that's starting to become real money for Netflix.

**JORDAN**: It really is. And here's what's interesting - they're still under 10% of TV time in all major markets and only about 7% of the addressable market for consumer and ad spend. So there's massive room for growth. But the elephant in the room here is obviously the Warner Bros. Studios and HBO acquisition they're working to close.

**ALEX**: Right, and I have to say, listening to the call, the executives sounded genuinely excited about this deal. Gregory Peters mentioned they weren't even looking to be buyers initially, but when they got "under the hood" during due diligence, several things got them excited. The film studio brings a mature theatrical business, the TV studio expands their production capability, and HBO - well, it's HBO.

**JORDAN**: What's smart about their positioning is they're framing this as an accelerant to their core strategy, not a pivot. Spencer Neumann noted that roughly 85% of the combined company's revenues post-close would still be from Netflix's core streaming business. They're not abandoning their model - they're enhancing it.

**ALEX**: And Theodore Sarandos made a really compelling point about why they think this deal will get regulatory approval. He said it's "pro-consumer, pro-innovation, pro-worker, pro-creator, and pro-growth." His argument was that the TV landscape has never been more competitive - YouTube has full-length films and NFL games, Amazon owns MGM, Apple's competing for Oscars. The lines are blurring everywhere.

**JORDAN**: That's a good point. But let's talk about something that might concern some investors - engagement growth was only up 2% year-over-year to about 1.5 billion additional hours. That's actually an acceleration from 1% growth they saw earlier, but it's still pretty modest for a growth company.

**ALEX**: True, but Gregory Peters had an interesting take on this. He said viewing of their original branded content was actually up 9% in the second half versus 7% in the first half. The slower overall growth was because they had fewer licensed titles compared to when they bulked up during the strikes in 2023 and 2024.

**JORDAN**: And they're getting more sophisticated about measuring engagement quality, not just quantity. Peters mentioned they achieved an all-time high on their primary quality metric in 2025, and customer satisfaction is also at an all-time high. Sometimes the numbers don't tell the whole story.

**ALEX**: Speaking of content, Theodore Sarandos was in full showman mode describing their upcoming slate. We're talking about the return of huge franchises...]]>498falsefullhttps://www.spreaker.com/episode/amd-q4-2025-earnings-analysis--70092318
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's blockbuster Q4 2025 earnings call. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for AMD! Let me start with the headline numbers because they're pretty impressive. Q4 revenue hit $10.3 billion, up 34% year-over-year, and for the full year they reached a record $34.6 billion in revenue. Net income jumped 42% to $2.5 billion in the quarter.

**ALEX:** Those are strong numbers across the board. But what really caught my attention was their data center segment performance. Jordan, can you break down what's happening there?

**JORDAN:** Absolutely. The data center segment was the star of the show with $5.4 billion in revenue, up 39% year-over-year. What's fascinating is they're seeing growth on two fronts - their traditional EPYC server CPUs are crushing it, and their AI GPU business with the Instinct chips is really starting to ramp up.

**ALEX:** And Lisa Su, AMD's CEO, seemed particularly bullish about their AI prospects. She mentioned they're targeting tens of billions in AI revenue by 2027. That's a pretty bold claim.

**JORDAN:** It is bold, but they've got some big partnerships backing it up. The most notable is their multi-generation deal with OpenAI to deploy six gigawatts of Instinct GPUs. That's massive scale we're talking about. And they're expecting their next-gen MI450 chips and Helios platform to start shipping in the second half of 2026.

**ALEX:** Let's talk about that China situation though, because that added some complexity to the numbers. They had $390 million in revenue from MI308 sales to China in Q4, which wasn't in their original guidance.

**JORDAN:** Right, and that's important context. Those were from licenses approved earlier in 2025, and they're only forecasting another $100 million from China in Q1. Beyond that, they're not providing any guidance on China revenue because of the regulatory uncertainty. So investors should view those China numbers as essentially one-time benefits rather than recurring revenue.

**ALEX:** The other segment that really impressed me was their client and gaming business. $3.9 billion in revenue, up 37% year-over-year. Their Ryzen processors seem to be gaining serious market share.

**JORDAN:** That's a great point, Alex. What I found interesting is they're not just competing on the consumer side - they're making real inroads in commercial PCs. Their Ryzen CPU sell-through for commercial notebooks and desktops grew over 40% year-over-year. That's typically a stickier, higher-margin market.

**ALEX:** Speaking of margins, let's talk about profitability. Their gross margin hit 57% in Q4, though that included a one-time inventory reserve release. Even adjusting for that, they were at about 55%, which is still solid.

**JORDAN:** And Jean Hu, their CFO, seemed confident about margin progression going forward. She mentioned they're benefiting from favorable product mix across all their businesses - newer generation products in data center, moving up-market in client, and recovery in their embedded business.

**ALEX:** The Q&A session had some interesting moments too. One analyst asked about supply constraints for their server CPUs, and Lisa Su acknowledged they've been increasing supply capacity because demand has been so strong.

**JORDAN:** That's a good problem to have, but it does raise questions about whether they can meet all the demand they're seeing. Su mentioned they're working with supply chain partners on multi-year agreements, which suggests they're taking this seriously.

**ALEX:** There was a

This episode includes AI-generated content.]]>SP100-AMD-Q4-2025-enTue, 17 Feb 2026 04:53:56 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's blockbuster Q4 2025 earnings call. Before we get started, I want to remind...
---

**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex, and I'm here with my co-host Jordan to dive into AMD's blockbuster Q4 2025 earnings call. Before we get started, I want to remind everyone that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, what a quarter for AMD! Let me start with the headline numbers because they're pretty impressive. Q4 revenue hit $10.3 billion, up 34% year-over-year, and for the full year they reached a record $34.6 billion in revenue. Net income jumped 42% to $2.5 billion in the quarter.

**ALEX:** Those are strong numbers across the board. But what really caught my attention was their data center segment performance. Jordan, can you break down what's happening there?

**JORDAN:** Absolutely. The data center segment was the star of the show with $5.4 billion in revenue, up 39% year-over-year. What's fascinating is they're seeing growth on two fronts - their traditional EPYC server CPUs are crushing it, and their AI GPU business with the Instinct chips is really starting to ramp up.

**ALEX:** And Lisa Su, AMD's CEO, seemed particularly bullish about their AI prospects. She mentioned they're targeting tens of billions in AI revenue by 2027. That's a pretty bold claim.

**JORDAN:** It is bold, but they've got some big partnerships backing it up. The most notable is their multi-generation deal with OpenAI to deploy six gigawatts of Instinct GPUs. That's massive scale we're talking about. And they're expecting their next-gen MI450 chips and Helios platform to start shipping in the second half of 2026.

**ALEX:** Let's talk about that China situation though, because that added some complexity to the numbers. They had $390 million in revenue from MI308 sales to China in Q4, which wasn't in their original guidance.

**JORDAN:** Right, and that's important context. Those were from licenses approved earlier in 2025, and they're only forecasting another $100 million from China in Q1. Beyond that, they're not providing any guidance on China revenue because of the regulatory uncertainty. So investors should view those China numbers as essentially one-time benefits rather than recurring revenue.

**ALEX:** The other segment that really impressed me was their client and gaming business. $3.9 billion in revenue, up 37% year-over-year. Their Ryzen processors seem to be gaining serious market share.

**JORDAN:** That's a great point, Alex. What I found interesting is they're not just competing on the consumer side - they're making real inroads in commercial PCs. Their Ryzen CPU sell-through for commercial notebooks and desktops grew over 40% year-over-year. That's typically a stickier, higher-margin market.

**ALEX:** Speaking of margins, let's talk about profitability. Their gross margin hit 57% in Q4, though that included a one-time inventory reserve release. Even adjusting for that, they were at about 55%, which is still solid.

**JORDAN:** And Jean Hu, their CFO, seemed confident about margin progression going forward. She mentioned they're benefiting from favorable product mix across all their businesses - newer generation products in data center, moving up-market in client, and recovery in their embedded business.

**ALEX:** The Q&A session had some interesting moments too. One analyst asked about supply constraints for their server CPUs, and Lisa Su acknowledged they've been increasing supply capacity because demand has been so strong.

**JORDAN:** That's a good problem to have, but it does raise questions about whether they can meet all the demand they're...]]>524falsefullhttps://www.spreaker.com/episode/palantir-q4-2025-earnings-analysis--70092316
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's latest results. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into what might be one of the most jaw-dropping earnings reports we've covered - Palantir's Q4 2025 results that just dropped yesterday.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. And Alex, when you say "jaw-dropping," you're not kidding. I mean, where do we even start with these numbers?

**ALEX**: Let's start with the headline figure - 70% revenue growth year-over-year. For a company that's been public for several years now, that's just... unprecedented.

**JORDAN**: Right, and what really caught my attention is that this wasn't just top-line growth. Their "Rule of 40" score - which measures combined revenue growth and profit margins - hit 127. For context, anything above 40 is considered excellent for a SaaS company.

**ALEX**: And the US business is absolutely on fire. US revenue grew 93% year-over-year, now representing 77% of their total revenue. Their US commercial segment specifically grew 137% year-over-year. These aren't typos, folks.

**JORDAN**: What's fascinating is how they're achieving this. It's not just about adding more customers - though they did grow to 954 customers, up 34% year-over-year. It's about existing customers dramatically expanding their usage. Their top 20 customers now generate $94 million each in trailing twelve-month revenue, up 45% year-over-year.

**ALEX**: The deal sizes they're talking about are staggering. They mentioned a healthcare company that went from demos to a $96 million deal by year-end. An engineering services company signed an $80 million contract after just seeing some fall demos.

**JORDAN**: And here's what's really interesting about their guidance for 2026 - they're projecting $7.19 billion in revenue, which represents 61% growth. Remember, at the beginning of 2025, they were guiding for around 30% growth and ended up with 56%.

**ALEX**: Let's talk about what's driving this. Their AIP platform - that's their AI Platform - seems to be the secret sauce here. CEO Alex Karp made some pretty bold claims about how they're different from other AI companies.

**JORDAN**: Yeah, Karp was... characteristically colorful in his commentary. He basically argued that while everyone else is competing on commoditized AI models, Palantir is focused on what he called "scaling the leverage" of AI in real-world production environments.

**ALEX**: The defense business is equally impressive. US government revenue grew 66% year-over-year. They landed a $448 million contract with the Navy for modernizing shipbuilding supply chains, and their "Warp Speed" initiative seems to be expanding beyond just submarines.

**JORDAN**: Speaking of Warp Speed and their "Ship OS" - they shared some incredible efficiency gains. One shipbuilder reduced planning time from 160 hours to 10 minutes. A shipyard cut material review from weeks to less than an hour.

**ALEX**: But here's something that really stood out to me from the Q&A - when asked about international expansion, Karp was pretty blunt. He basically said they don't have the bandwidth to focus on difficult international markets because US demand is so overwhelming.

**JORDAN**: That was a fascinating strategic admission. He specifically called out Europe and Canada as markets where there's "lack of adoption," while praising adoption in places like Israel and Arab countries. It sounds like they're deliberately choosing to focus where they see the most receptive customers.

**ALEX**: The cash generation is also

This episode includes AI-generated content.]]>SP100-PLTR-Q4-2025-enTue, 17 Feb 2026 04:53:53 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- **ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's latest results. I'm Alex. **JORDAN**: And I'm Jordan....
---

**ALEX**: Welcome to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from corporate America's latest results. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into what might be one of the most jaw-dropping earnings reports we've covered - Palantir's Q4 2025 results that just dropped yesterday.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. And Alex, when you say "jaw-dropping," you're not kidding. I mean, where do we even start with these numbers?

**ALEX**: Let's start with the headline figure - 70% revenue growth year-over-year. For a company that's been public for several years now, that's just... unprecedented.

**JORDAN**: Right, and what really caught my attention is that this wasn't just top-line growth. Their "Rule of 40" score - which measures combined revenue growth and profit margins - hit 127. For context, anything above 40 is considered excellent for a SaaS company.

**ALEX**: And the US business is absolutely on fire. US revenue grew 93% year-over-year, now representing 77% of their total revenue. Their US commercial segment specifically grew 137% year-over-year. These aren't typos, folks.

**JORDAN**: What's fascinating is how they're achieving this. It's not just about adding more customers - though they did grow to 954 customers, up 34% year-over-year. It's about existing customers dramatically expanding their usage. Their top 20 customers now generate $94 million each in trailing twelve-month revenue, up 45% year-over-year.

**ALEX**: The deal sizes they're talking about are staggering. They mentioned a healthcare company that went from demos to a $96 million deal by year-end. An engineering services company signed an $80 million contract after just seeing some fall demos.

**JORDAN**: And here's what's really interesting about their guidance for 2026 - they're projecting $7.19 billion in revenue, which represents 61% growth. Remember, at the beginning of 2025, they were guiding for around 30% growth and ended up with 56%.

**ALEX**: Let's talk about what's driving this. Their AIP platform - that's their AI Platform - seems to be the secret sauce here. CEO Alex Karp made some pretty bold claims about how they're different from other AI companies.

**JORDAN**: Yeah, Karp was... characteristically colorful in his commentary. He basically argued that while everyone else is competing on commoditized AI models, Palantir is focused on what he called "scaling the leverage" of AI in real-world production environments.

**ALEX**: The defense business is equally impressive. US government revenue grew 66% year-over-year. They landed a $448 million contract with the Navy for modernizing shipbuilding supply chains, and their "Warp Speed" initiative seems to be expanding beyond just submarines.

**JORDAN**: Speaking of Warp Speed and their "Ship OS" - they shared some incredible efficiency gains. One shipbuilder reduced planning time from 160 hours to 10 minutes. A shipyard cut material review from weeks to less than an hour.

**ALEX**: But here's something that really stood out to me from the Q&A - when asked about international expansion, Karp was pretty blunt. He basically said they don't have the bandwidth to focus on difficult international markets because US demand is so overwhelming.

**JORDAN**: That was a fascinating strategic admission. He specifically called out Europe and Canada as markets where there's "lack of adoption," while praising adoption in...]]>520falsefullhttps://www.spreaker.com/episode/tesla-q4-2025-earnings-analysis--70092313
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Tesla's Q4 2025 earnings call, and folks, this was quite a ride.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, where do we even begin with this call? Elon Musk literally opened by changing Tesla's mission statement to "amazing abundance" and talked about universal high income for everyone.

ALEX: Right? And then immediately pivoted to announcing they're killing off the Model S and X next quarter. Jordan, let's start with the numbers because there's a lot to unpack here.

JORDAN: The financial picture was actually pretty solid despite some challenges. Tesla hit record gross margins at 20.1% - something they haven't achieved in over two years. Automotive margins excluding credits improved sequentially from 15.4% to 17.9%, which is impressive given they had 16% lower deliveries in the quarter.

ALEX: That margin improvement despite lower volumes tells us a lot about their operational efficiency, doesn't it?

JORDAN: Exactly. CFO Vaibhav Taneja explained this was largely due to regional mix - they had proportionally more deliveries in Asia-Pacific and EMEA markets. But here's the kicker - they ended 2025 with a bigger backlog than in recent years, and none of those countries even have the latest FSD version yet.

ALEX: Speaking of FSD, the Full Self-Driving adoption numbers were interesting. They hit nearly 1.1 million paid customers globally, with 70% being upfront purchases. But they're transitioning to a subscription-only model going forward.

JORDAN: That subscription pivot is huge, Alex. It's going to impact automotive margins in the short term, but it sets them up for recurring revenue. Think Netflix for cars, but instead of entertainment, you're getting autonomous driving.

ALEX: And on the autonomy front, they're already running fully unsupervised robotaxis in Austin - no safety monitor, no chase car, just empty cars picking up paying customers.

JORDAN: The robotaxi deployment is scaling fast too. Musk said they're "well over 500" vehicles carrying paid customers between Bay Area and Austin, and he expects that to "double every month." Those are some aggressive scaling projections.

ALEX: Now let's talk about the elephant in the room - that massive CapEx guidance. They're projecting over $20 billion in capital expenditures for 2026, more than double their previous guidance of $9 billion.

JORDAN: This is where it gets wild, Alex. They're building six new factories simultaneously - refinery, LFP factories, CyberCab, Semi, a new mega factory, and that Optimus factory. Plus massive investments in AI compute infrastructure.

ALEX: The Optimus story is fascinating. They're literally converting the Model S and X production space in Fremont into a million-unit-per-year robot factory. Musk said Optimus 3 is so human-like that people could easily mistake it for a person.

JORDAN: And he's not just talking small numbers here. Long-term, he expects to make "far more CyberCabs than all other vehicles combined" because 90% of miles driven are with one or two passengers. They're essentially redesigning transportation around autonomous two-seaters.

ALEX: The CyberCab production starts in April, by the way. No steering wheel, no pedals - it's fully autonomous or it doesn't work. That's a bold statement about their confidence in the technology.

JORDAN: But here's what really caught my attention - Musk spending his Saturdays designing the AI5 chip. When the CEO is personally involved in chip architecture on weekends, you know it's critical.

ALEX: And he thinks chip supply will be their bigges

This episode includes AI-generated content.]]>SP100-TSLA-Q4-2025-enTue, 17 Feb 2026 04:53:48 +0000trueBeta Finch**BETA FINCH PODCAST SCRIPT** --- ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex. JORDAN: And I'm Jordan. Today we're diving into Tesla's Q4 2025 earnings call, and folks, this was quite a ride. ALEX: Before we get...
---

ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown. I'm Alex.

JORDAN: And I'm Jordan. Today we're diving into Tesla's Q4 2025 earnings call, and folks, this was quite a ride.

ALEX: Before we get started, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

JORDAN: Absolutely. Now Alex, where do we even begin with this call? Elon Musk literally opened by changing Tesla's mission statement to "amazing abundance" and talked about universal high income for everyone.

ALEX: Right? And then immediately pivoted to announcing they're killing off the Model S and X next quarter. Jordan, let's start with the numbers because there's a lot to unpack here.

JORDAN: The financial picture was actually pretty solid despite some challenges. Tesla hit record gross margins at 20.1% - something they haven't achieved in over two years. Automotive margins excluding credits improved sequentially from 15.4% to 17.9%, which is impressive given they had 16% lower deliveries in the quarter.

ALEX: That margin improvement despite lower volumes tells us a lot about their operational efficiency, doesn't it?

JORDAN: Exactly. CFO Vaibhav Taneja explained this was largely due to regional mix - they had proportionally more deliveries in Asia-Pacific and EMEA markets. But here's the kicker - they ended 2025 with a bigger backlog than in recent years, and none of those countries even have the latest FSD version yet.

ALEX: Speaking of FSD, the Full Self-Driving adoption numbers were interesting. They hit nearly 1.1 million paid customers globally, with 70% being upfront purchases. But they're transitioning to a subscription-only model going forward.

JORDAN: That subscription pivot is huge, Alex. It's going to impact automotive margins in the short term, but it sets them up for recurring revenue. Think Netflix for cars, but instead of entertainment, you're getting autonomous driving.

ALEX: And on the autonomy front, they're already running fully unsupervised robotaxis in Austin - no safety monitor, no chase car, just empty cars picking up paying customers.

JORDAN: The robotaxi deployment is scaling fast too. Musk said they're "well over 500" vehicles carrying paid customers between Bay Area and Austin, and he expects that to "double every month." Those are some aggressive scaling projections.

ALEX: Now let's talk about the elephant in the room - that massive CapEx guidance. They're projecting over $20 billion in capital expenditures for 2026, more than double their previous guidance of $9 billion.

JORDAN: This is where it gets wild, Alex. They're building six new factories simultaneously - refinery, LFP factories, CyberCab, Semi, a new mega factory, and that Optimus factory. Plus massive investments in AI compute infrastructure.

ALEX: The Optimus story is fascinating. They're literally converting the Model S and X production space in Fremont into a million-unit-per-year robot factory. Musk said Optimus 3 is so human-like that people could easily mistake it for a person.

JORDAN: And he's not just talking small numbers here. Long-term, he expects to make "far more CyberCabs than all other vehicles combined" because 90% of miles driven are with one or two passengers. They're essentially redesigning transportation around autonomous two-seaters.

ALEX: The CyberCab production starts in April, by the way. No steering wheel, no pedals - it's fully autonomous or it doesn't work. That's a bold statement about their confidence in the technology.

JORDAN: But here's what really caught my attention - Musk...]]>513falsefullhttps://www.spreaker.com/episode/meta-q4-2025-earnings-analysis--70092311
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Meta's Q4 2025 earnings, and folks, this one's a doozy.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with Meta? These numbers are absolutely crushing it. We're talking about $58.9 billion in Q4 revenue - that's up 25% year-over-year. The advertising business alone hit $58.1 billion, up 24%. These are some of the strongest growth numbers we've seen from Meta in years.

**ALEX:** Right, and what's really striking is the guidance for Q1 2026. They're projecting $53.5 to $56.5 billion in revenue - that would be the fastest growth rate in almost five years. Jordan, what's driving this acceleration?

**JORDAN:** It's really a perfect storm of improvements, Alex. Susan Li, their CFO, highlighted three main drivers. First, they're seeing massive gains from their AI-powered recommendation systems. On Facebook alone, they drove a 7% lift in views of organic feed and video posts in Q4 - and get this - that was the largest quarterly revenue impact from Facebook product launches in the past two years.

**ALEX:** That's incredible. And they're not stopping there, right?

**JORDAN:** Not at all. They're completely rebuilding their AI infrastructure. Mark Zuckerberg announced they're investing between $115 to $135 billion in capital expenditures for 2026. That's a massive step-up, primarily for their new Meta Superintelligence Labs. Zuckerberg said they're six months into rebuilding their AI efforts and he's "very pleased with the quality of the team."

**ALEX:** Speaking of Zuckerberg, his vision for 2026 was pretty ambitious. He's talking about "personal superintelligence" and AI agents that really understand users' personal context. What does that actually mean for the business?

**JORDAN:** It's fascinating, Alex. He outlined three key areas. First, they're merging large language models with their existing recommendation systems. So instead of just showing you content based on past behavior, the AI will understand your personal goals and tailor feeds to help you improve your life in specific ways.

Second, they're revolutionizing commerce. Their ads help businesses find the right customers, but soon they want AI shopping tools that help users find exactly the right products from their business catalog.

**ALEX:** And the third area?

**JORDAN:** New content formats. Zuckerberg believes we're moving beyond video to more immersive, interactive experiences. He mentioned their AI glasses sales more than tripled last year, and he compared this moment to when flip phones became smartphones - inevitable transformation.

**ALEX:** Let's talk about the financials though. With all this massive investment, are they still profitable?

**JORDAN:** Here's what's interesting - despite spending up to $169 billion in total expenses for 2026, Susan Li said they expect operating income to be above 2025 levels in absolute dollars. Not growth rate, mind you, but actual dollar amounts. That's pretty impressive given the scale of investment.

**ALEX:** What about their other businesses? Reality Labs has been a drag on profitability for years.

**JORDAN:** Good news there. Zuckerberg said Reality Labs losses will be similar to 2025 levels, and this will "likely be the peak" as they start to gradually reduce losses going forward. They're shifting focus mainly to glasses and wearables rather than VR headsets.

**ALEX:** Now, during the Q&A, there were some interesting questions about their AI strategy. One analyst asked

This episode includes AI-generated content.]]>SP100-META-Q4-2025-enTue, 17 Feb 2026 04:53:44 +0000trueBeta Finch# Beta Finch Podcast Script: Meta Q4 2025 Earnings **ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Meta's...
**ALEX:** Welcome to Beta Finch, your AI-powered earnings breakdown where we dive into the numbers that move markets. I'm Alex, and I'm here with my co-host Jordan. Today we're breaking down Meta's Q4 2025 earnings, and folks, this one's a doozy.

Before we dive in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN:** Thanks Alex. And wow, where do we even start with Meta? These numbers are absolutely crushing it. We're talking about $58.9 billion in Q4 revenue - that's up 25% year-over-year. The advertising business alone hit $58.1 billion, up 24%. These are some of the strongest growth numbers we've seen from Meta in years.

**ALEX:** Right, and what's really striking is the guidance for Q1 2026. They're projecting $53.5 to $56.5 billion in revenue - that would be the fastest growth rate in almost five years. Jordan, what's driving this acceleration?

**JORDAN:** It's really a perfect storm of improvements, Alex. Susan Li, their CFO, highlighted three main drivers. First, they're seeing massive gains from their AI-powered recommendation systems. On Facebook alone, they drove a 7% lift in views of organic feed and video posts in Q4 - and get this - that was the largest quarterly revenue impact from Facebook product launches in the past two years.

**ALEX:** That's incredible. And they're not stopping there, right?

**JORDAN:** Not at all. They're completely rebuilding their AI infrastructure. Mark Zuckerberg announced they're investing between $115 to $135 billion in capital expenditures for 2026. That's a massive step-up, primarily for their new Meta Superintelligence Labs. Zuckerberg said they're six months into rebuilding their AI efforts and he's "very pleased with the quality of the team."

**ALEX:** Speaking of Zuckerberg, his vision for 2026 was pretty ambitious. He's talking about "personal superintelligence" and AI agents that really understand users' personal context. What does that actually mean for the business?

**JORDAN:** It's fascinating, Alex. He outlined three key areas. First, they're merging large language models with their existing recommendation systems. So instead of just showing you content based on past behavior, the AI will understand your personal goals and tailor feeds to help you improve your life in specific ways.

Second, they're revolutionizing commerce. Their ads help businesses find the right customers, but soon they want AI shopping tools that help users find exactly the right products from their business catalog.

**ALEX:** And the third area?

**JORDAN:** New content formats. Zuckerberg believes we're moving beyond video to more immersive, interactive experiences. He mentioned their AI glasses sales more than tripled last year, and he compared this moment to when flip phones became smartphones - inevitable transformation.

**ALEX:** Let's talk about the financials though. With all this massive investment, are they still profitable?

**JORDAN:** Here's what's interesting - despite spending up to $169 billion in total expenses for 2026, Susan Li said they expect operating income to be above 2025 levels in absolute dollars. Not growth rate, mind you, but actual dollar amounts. That's pretty impressive given the scale of investment.

**ALEX:** What about their other businesses? Reality Labs has been a drag on profitability for years.

**JORDAN:** Good news there. Zuckerberg said Reality Labs losses will be similar to 2025 levels, and this will "likely be the peak" as they start to gradually reduce losses going forward. They're shifting focus mainly...]]>487falsefullhttps://www.spreaker.com/episode/amazon-q4-2025-earnings-analysis--70092309
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Amazon's fourth quarter 2025 results, and wow - what a quarter this was.

Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Amazon just posted some impressive numbers - $213.4 billion in revenue, up 12% year over year. But the real star of the show seems to be AWS, doesn't it?

JORDAN: Absolutely, Alex. AWS is firing on all cylinders right now. They hit $35.6 billion in quarterly revenue with 24% growth - that's the fastest growth they've seen in thirteen quarters. More importantly, AWS is now running at a $142 billion annualized rate. To put that in perspective, they added $2.6 billion quarter-over-quarter and nearly $7 billion year-over-year.

ALEX: Those are massive numbers. And Andy Jassy was pretty bullish about their AI business specifically. What caught your attention there?

JORDAN: The AI story is fascinating. Their chips business - that's Graviton and Trainium combined - is now over $10 billion in annual revenue and growing triple digits. But here's the kicker: Trainium alone is a multi-billion dollar business, and they say nearly all of their Trainium 3 supply will be committed by mid-2026. That suggests incredible demand.

ALEX: Speaking of demand, they announced plans to invest about $200 billion in capital expenditures. That's a staggering number that probably has some investors nervous about returns.

JORDAN: Yeah, that $200 billion figure dominated the Q&A session. Mark Mahaney from Evercore really pressed them on return on invested capital, and Jassy's response was telling. He said they're monetizing capacity as fast as they install it, and emphasized that AWS has a 35% operating margin despite all this investment. His confidence comes from their track record - they've proven they can forecast demand and avoid wasted capacity.

ALEX: What's interesting is how Jassy framed this AI opportunity. He called it "extraordinarily unusual" and said every customer experience we know today will be reinvented with AI. That's a pretty bold statement.

JORDAN: It really is, and the numbers back up some of that optimism. Their Bedrock service is now a multi-billion dollar annualized business with customer spend growing 60% quarter-over-quarter. Amazon Nova Forge, their new pre-training customization tool, sounds like a potential game-changer for enterprises wanting to train models on their own data.

ALEX: Let's pivot to the retail side for a moment. The stores business showed solid growth, but there were some interesting trends in customer behavior.

JORDAN: Right, everyday essentials are becoming huge for them - growing nearly twice as fast as other categories and representing one out of every three units sold. Their same-day delivery reached nearly 70% more items than last year, and here's a stat that jumped out: customers using their perishables delivery service shop more than twice as often as those who don't.

ALEX: That perishables business seems to be a real growth driver. They're calling themselves a large grocer now with over $150 billion in gross sales.

JORDAN: And the speed improvements are remarkable. On Christmas Eve, customers in 4,000 US cities could order items until midday and get same-day delivery. Their "add to delivery" feature, launched just six months ago, already makes up 10% of all Prime volume. These aren't just incremental improvements - they're fundamentally changing how people shop.

ALEX: One thing that came up in the Q&A was about AI agents and shopping. There's concern that AI could compress the advertising funnel. How did Jassy respond

This episode includes AI-generated content.]]>SP100-AMZN-Q4-2025-enTue, 17 Feb 2026 04:53:41 +0000trueBeta Finch**Beta Finch: Amazon Q4 2025 Earnings Breakdown** ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Amazon's fourth quarter 2025 results, and wow - what a...
ALEX: Welcome to Beta Finch, your AI-powered earnings breakdown! I'm Alex, and joining me as always is my co-host Jordan. Today we're diving into Amazon's fourth quarter 2025 results, and wow - what a quarter this was.

Before we jump in though, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

Now Jordan, Amazon just posted some impressive numbers - $213.4 billion in revenue, up 12% year over year. But the real star of the show seems to be AWS, doesn't it?

JORDAN: Absolutely, Alex. AWS is firing on all cylinders right now. They hit $35.6 billion in quarterly revenue with 24% growth - that's the fastest growth they've seen in thirteen quarters. More importantly, AWS is now running at a $142 billion annualized rate. To put that in perspective, they added $2.6 billion quarter-over-quarter and nearly $7 billion year-over-year.

ALEX: Those are massive numbers. And Andy Jassy was pretty bullish about their AI business specifically. What caught your attention there?

JORDAN: The AI story is fascinating. Their chips business - that's Graviton and Trainium combined - is now over $10 billion in annual revenue and growing triple digits. But here's the kicker: Trainium alone is a multi-billion dollar business, and they say nearly all of their Trainium 3 supply will be committed by mid-2026. That suggests incredible demand.

ALEX: Speaking of demand, they announced plans to invest about $200 billion in capital expenditures. That's a staggering number that probably has some investors nervous about returns.

JORDAN: Yeah, that $200 billion figure dominated the Q&A session. Mark Mahaney from Evercore really pressed them on return on invested capital, and Jassy's response was telling. He said they're monetizing capacity as fast as they install it, and emphasized that AWS has a 35% operating margin despite all this investment. His confidence comes from their track record - they've proven they can forecast demand and avoid wasted capacity.

ALEX: What's interesting is how Jassy framed this AI opportunity. He called it "extraordinarily unusual" and said every customer experience we know today will be reinvented with AI. That's a pretty bold statement.

JORDAN: It really is, and the numbers back up some of that optimism. Their Bedrock service is now a multi-billion dollar annualized business with customer spend growing 60% quarter-over-quarter. Amazon Nova Forge, their new pre-training customization tool, sounds like a potential game-changer for enterprises wanting to train models on their own data.

ALEX: Let's pivot to the retail side for a moment. The stores business showed solid growth, but there were some interesting trends in customer behavior.

JORDAN: Right, everyday essentials are becoming huge for them - growing nearly twice as fast as other categories and representing one out of every three units sold. Their same-day delivery reached nearly 70% more items than last year, and here's a stat that jumped out: customers using their perishables delivery service shop more than twice as often as those who don't.

ALEX: That perishables business seems to be a real growth driver. They're calling themselves a large grocer now with over $150 billion in gross sales.

JORDAN: And the speed improvements are remarkable. On Christmas Eve, customers in 4,000 US cities could order items until midday and get same-day delivery. Their "add to delivery" feature, launched just six months ago, already makes up 10% of all Prime volume. These aren't just incremental improvements - they're fundamentally changing how people shop.

ALEX:...]]>508falsefullhttps://www.spreaker.com/episode/microsoft-q2-2026-earnings-analysis--70092307
---

**ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Microsoft's Q2 2026 results, and wow - what a quarter this was.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Microsoft just delivered some seriously impressive results.

**ALEX**: They really did, Jordan. Revenue hit $81.3 billion, up 17% year-over-year. But here's the kicker - earnings per share came in at $4.14, which is a 24% jump when you adjust for their OpenAI investment impact. Those are the kind of numbers that make investors sit up and pay attention.

**JORDAN**: What caught my eye was Microsoft Cloud crossing that $50 billion milestone for the first time - $51.5 billion to be exact, growing 26%. That's just massive scale we're talking about here. But Alex, there's an interesting paradox happening in the market reaction.

**ALEX**: Right, the stock actually dropped in after-hours trading despite these strong results. Why do you think that happened?

**JORDAN**: It comes down to two main concerns investors have. First, CapEx hit $37.5 billion this quarter - that's enormous spending on infrastructure, mostly GPUs and CPUs. Second, while Azure grew 39%, some investors were expecting even more aggressive growth given all that capital investment.

**ALEX**: That's a great point. Let me break down what Microsoft is doing with all that CapEx spending, because CEO Satya Nadella and CFO Amy Hood had some fascinating explanations during the Q&A.

**JORDAN**: Yeah, Amy Hood was really transparent about this. She said if they had allocated all their new GPUs just to Azure customers, Azure growth would have been over 40%. But they're deliberately spreading that capacity across their entire AI ecosystem.

**ALEX**: Exactly. They're using those GPUs to power Microsoft 365 Copilot, GitHub Copilot, Security Copilot, and their R&D efforts. It's not just about maximizing Azure - they're building what Nadella called the "best lifetime value portfolio."

**JORDAN**: And speaking of Copilot, the adoption numbers are incredible. Microsoft 365 Copilot now has 15 million paid seats - that's up 160% year-over-year. Daily active users increased 10x, and the average conversations per user doubled.

**ALEX**: Those usage metrics tell a compelling story about AI actually becoming sticky with enterprise customers. It's one thing to sell seats, but when you see usage intensity growing like that, it suggests real business value.

**JORDAN**: Absolutely. And let's talk about their custom silicon efforts because this was a standout moment. They launched their Maya 200 accelerator chip, which Nadella claims delivers 30% better total cost of ownership compared to their current hardware fleet.

**ALEX**: That's Microsoft's play to reduce their dependence on NVIDIA while optimizing for their specific AI workloads. They're running everything from OpenAI inferencing to their own Copilot services on these chips.

**JORDAN**: The strategic implications are huge. If Microsoft can develop superior custom chips for AI inferencing, that's a massive competitive moat. They're essentially vertically integrating their AI infrastructure stack.

**ALEX**: Now, one thing that raised some eyebrows was Microsoft's commercial remaining performance obligation - essentially their backlog of contracted revenue. It hit $625 billion, but here's the twist: 45% of that is from OpenAI.

**JORDAN**: Yeah, that OpenAI concentration became a hot topic during the Q&A. When

This episode includes AI-generated content.]]>SP100-MSFT-Q2-2026-enTue, 17 Feb 2026 04:53:37 +0000trueBeta Finch**Beta Finch Podcast Script: Microsoft Q2 2026 Earnings** --- **ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex....
---

**ALEX**: Welcome back to Beta Finch, your AI-powered earnings breakdown where we cut through the noise to bring you what really matters from the latest quarterly reports. I'm Alex.

**JORDAN**: And I'm Jordan. Today we're diving into Microsoft's Q2 2026 results, and wow - what a quarter this was.

**ALEX**: Before we jump in, I need to mention that this podcast is AI-generated content for educational and entertainment purposes only. Nothing we discuss should be considered investment advice. Always do your own research and consult a qualified financial advisor before making any investment decisions.

**JORDAN**: Absolutely. Now Alex, let's talk numbers because Microsoft just delivered some seriously impressive results.

**ALEX**: They really did, Jordan. Revenue hit $81.3 billion, up 17% year-over-year. But here's the kicker - earnings per share came in at $4.14, which is a 24% jump when you adjust for their OpenAI investment impact. Those are the kind of numbers that make investors sit up and pay attention.

**JORDAN**: What caught my eye was Microsoft Cloud crossing that $50 billion milestone for the first time - $51.5 billion to be exact, growing 26%. That's just massive scale we're talking about here. But Alex, there's an interesting paradox happening in the market reaction.

**ALEX**: Right, the stock actually dropped in after-hours trading despite these strong results. Why do you think that happened?

**JORDAN**: It comes down to two main concerns investors have. First, CapEx hit $37.5 billion this quarter - that's enormous spending on infrastructure, mostly GPUs and CPUs. Second, while Azure grew 39%, some investors were expecting even more aggressive growth given all that capital investment.

**ALEX**: That's a great point. Let me break down what Microsoft is doing with all that CapEx spending, because CEO Satya Nadella and CFO Amy Hood had some fascinating explanations during the Q&A.

**JORDAN**: Yeah, Amy Hood was really transparent about this. She said if they had allocated all their new GPUs just to Azure customers, Azure growth would have been over 40%. But they're deliberately spreading that capacity across their entire AI ecosystem.

**ALEX**: Exactly. They're using those GPUs to power Microsoft 365 Copilot, GitHub Copilot, Security Copilot, and their R&D efforts. It's not just about maximizing Azure - they're building what Nadella called the "best lifetime value portfolio."

**JORDAN**: And speaking of Copilot, the adoption numbers are incredible. Microsoft 365 Copilot now has 15 million paid seats - that's up 160% year-over-year. Daily active users increased 10x, and the average conversations per user doubled.

**ALEX**: Those usage metrics tell a compelling story about AI actually becoming sticky with enterprise customers. It's one thing to sell seats, but when you see usage intensity growing like that, it suggests real business value.

**JORDAN**: Absolutely. And let's talk about their custom silicon efforts because this was a standout moment. They launched their Maya 200 accelerator chip, which Nadella claims delivers 30% better total cost of ownership compared to their current hardware fleet.

**ALEX**: That's Microsoft's play to reduce their dependence on NVIDIA while optimizing for their specific AI workloads. They're running everything from OpenAI inferencing to their own Copilot services on these chips.

**JORDAN**: The strategic implications are huge. If Microsoft can develop superior custom chips for AI inferencing, that's a massive competitive moat. They're essentially vertically integrating their AI infrastructure stack.

**ALEX**: Now, one thing that raised some eyebrows was Microsoft's commercial remaining performance obligation - essentially their...]]>534falsefull